
<html lang="en"     class="pb-page"  data-request-id="70d068b7-f89e-45e4-af12-9768795458e5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-22;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm100762r;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore" /></meta><meta name="dc.Creator" content="Fraser F.  Fleming" /></meta><meta name="dc.Creator" content="Lihua  Yao" /></meta><meta name="dc.Creator" content="P. C.  Ravikumar" /></meta><meta name="dc.Creator" content="Lee  Funk" /></meta><meta name="dc.Creator" content="Brian C.  Shook" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 30, 2010" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100762r" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100762r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100762r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100762r" /></link>
        
    
    

<title>Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100762r" /></meta><meta property="og:title" content="Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100762r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100762r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100762r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100762r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100762r&amp;href=/doi/10.1021/jm100762r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7902-7917</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1003914" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm100286k" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fraser+F.++Fleming">Fraser F. Fleming</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lihua++Yao">Lihua Yao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=P.+C.++Ravikumar">P. C. Ravikumar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lee++Funk">Lee Funk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+C.++Shook">Brian C. Shook</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282-1530</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Mylan Pharmaceuticals Inc., 781 Chestnut Ridge Road, Morgantown, West Virginia 26505</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: (412) 396 6031. Fax: (412) 396 5683. E-mail: <a href="/cdn-cgi/l/email-protection#f3959f969e9a9d9495b3978682dd969786"><span class="__cf_email__" data-cfemail="e98f858c8480878e8fa98d9c98c78c8d9c">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100762r&amp;href=/doi/10.1021%2Fjm100762r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7902â7917</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 30, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 June 2010</li><li><span class="item_label"><b>Published</b> online</span>30 August 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100762r" title="DOI URL">https://doi.org/10.1021/jm100762r</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7902%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFraser%2BF.%2BFleming%252C%2BLihua%2BYao%252C%2BP.%2BC.%2BRavikumar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D22%26contentID%3Djm100762r%26title%3DNitrile-Containing%2BPharmaceuticals%253A%2BEfficacious%2BRoles%2Bof%2Bthe%2BNitrile%2BPharmacophore%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7917%26publicationDate%3DNovember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100762r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">17106</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">865</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100762r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fraser&quot;,&quot;last_name&quot;:&quot;F. Fleming&quot;},{&quot;first_name&quot;:&quot;Lihua&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;P.&quot;,&quot;last_name&quot;:&quot;C. Ravikumar&quot;},{&quot;first_name&quot;:&quot;Lee&quot;,&quot;last_name&quot;:&quot;Funk&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;C. Shook&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7902-7917&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100762r&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100762r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100762r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100762r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100762r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100762r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100762r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100762r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100762r&amp;href=/doi/10.1021/jm100762r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100762r" /></input><a href="/doi/pdf/10.1021/jm100762r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26pmid%3D20804202%26genre%3Darticle%26aulast%3DFleming%26date%3D2010%26atitle%3DNitrile-Containing%2BPharmaceuticals%253A%2BEfficacious%2BRoles%2Bof%2Bthe%2BNitrile%2BPharmacophore%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D22%26spage%3D7902%26epage%3D7917%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291983" title="Nitrogen compounds">Nitrogen compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jmcmar.2010.53.issue-22/production/jmcmar.2010.53.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over 30 nitrile-containing pharmaceuticals are prescribed for a diverse variety of medicinal indications with more than 20 additional nitrile-containing leads in clinical development. Trends identifying the roles of the nitrile in medical agents have emerged as the number of nitrile-containing pharmaceuticals has increased. Coupled with the increasing number of nitrile-containing agents have been structural advances that provide insight into the binding of small molecule inhibitors. X-ray crystallography in particular is providing key insight into small moleculeâprotein interactions through an increasing number of structures with inhibitors bound in the active site. Augmenting the available interactions with current nitrile-containing pharmaceuticals are details from clinical candidates no longer under development. The present review surveys this range of medicinally active nitriles by focusing on the roles of the CN unit.</div><div class="NLM_p">The prevalence of nitrile-containing pharmaceuticals and the continued stream of potential agents in the clinic attest to the biocompatibility of the nitrile functionality.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The nitrile group is not particularly electrophilic toward free nucleophiles, even glutathione,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> unless activated by adjacent structural elements such as electron withdrawing groups.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A caveat is the highly orchestrated activationâelectrophilic additions such as those being exploited in several aminonitriles for diabetes and osteoporosis treatments that feature a reversible electrophilic attack (vide infra).</div><div class="NLM_p">The nitrile group is quite robust and, in most cases, is not readily metabolized.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Metabolically, the nitrile group in most nitrile-containing drugs is passed through the body unchanged.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In cases of drug metabolism prior to elimination, the formation of glucuronides,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> conjugation with glutathione,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> N-dealkylation,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> N-acetylation,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> hydrolysis,<a onclick="showRef(event, 'cit6a cit6b cit6c cit6d'); return false;" href="javascript:void(0);" class="ref cit6a cit6b cit6c cit6d">(6a-6d)</a> and oxidation<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> typically occurs at sites remote from the nitrile and without modification of the nitrile group.</div><div class="NLM_p">Release of cyanide from aromatic or fully substituted carbons is not observed,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> whereas alkylnitriles bearing an adjacent proton can be oxidized in the liver to cyanohydrins with subsequent cyanide release.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Mandelonitrile, a cyanohydrin produced by ingesting almonds or some fruit pits, releases cyanide as the main degradation pathway and is responsible for the toxicity of cyanogenic glycosides.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The potential oxidation and cyanide ejection likely explains why only four of the bioactive nitriles in the review contain an adjacent CâH bond. Epoxidation of alkenenitriles and ring opening can potentially liberate cyanide, but the epoxidation is synthetically difficult<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and metabolism at other sites appears more likely given the success of several alkenenitrile-containing pharmaceuticals.</div><div class="NLM_p">Vildagliptin (<b>1</b>) is a recently released aminonitrile-containing antidiabetic drug in which the nitrile bearing carbon is not fully substituted (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Perhaps because of a concern for cyanide release, the metabolism has been closely examined in humans. The main metabolite comes from hydrolysis of the nitrile which likely stems from the covalent intermediate formed from this carboxyl transition structure analogue. Nitrile hydrolysis is rather rare and, when observed, is a very minor metabolic pathway.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Aminonitrile vildagliptin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nitriles are unusual functionalities by virtue of the short, polarized triple bond.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The linear, rodlike geometry has a cylindrical diameter of 3.6 Ã for the Ï-system<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> resulting in a minuscule steric demand along the axis. For comparison, the Câ¡N unit is essentially 8 times smaller than a methyl group!<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Several crystal structures show the nitrile projecting into narrow clefts to make polar interactions or hydrogen bonds in sterically congested environments.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">Nitriles often play a key role as hydrogen bond acceptors.<a onclick="showRef(event, 'ref17 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref21">(17, 21)</a> Several crystal structures show hydrogen bonding between the nitrile nitrogen and amino acids or to water which in turn is bound to the protein backbone. Many hydrogen bonds are between the nitrile and serine or arginine as expected for these hydrogen bond donors. In other clinical candidates, the strong dipole facilitates polar interactions in which the nitrile acts as a hydroxyl or carboxyl isostere.</div><div class="NLM_p last">The review is structured according to the nature of the nitrile-bearing substituent. As the number of nitrile-containing drug leads is vast, the review has focused on launched nitrile-containing pharmaceuticals and currently active clinical candidates. Most nitrile-containing pharmaceuticals are aromatics with aliphatic-, alkene-, and nitrogen-bearing nitriles being progressively less frequent. Within each class, the bioactive nitriles are collated according to common structural elements and mode of action. The hope is that this survey will allow greater deployment of this versatile functionality within drug leads.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Arylnitrile-Containing Pharmaceuticals</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By far the largest class of nitrile-containing drugs is comprised of an aromatic core with a nitrile substituent. In many cases the nitrile functions as a ketone bioisostere with the nitrile engaging in nonspecific, polar interactions. In other instances the nitrile is relatively remote from the recognition site and may polarize the aromatic Ï-system to optimize ÏâÏ interactions. Para-substituted arylnitriles are common, possibly because the excellent inductive properties of the nitrile group more strongly polarize the aromatic ring, making aromatics less susceptible to oxidative metabolism.</div><div class="NLM_p">Several substituted benzonitriles have been developed as selective inhibitors of the aromatase enzyme for the treatment of estrogen-dependent diseases. Placement of the nitrile in the para position is essential for inhibition. There is general agreement that the nitrile mimics the carbonyl group of androst-4-ene-3,17-diones by functioning as a hydrogen bond acceptor (cf. <b>2</b> and <b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><b>4</b> (fadrozole monohydrochloride), marketed by Novartis as Afema, was one of the first nonsteroidal aromatase inhibitors<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> for treatment of breast cancer.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Structureâactivity relationships identified the efficacy of electron withdrawing groups at C-4 with bromine and nitrile groups being best.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Subsequent development by Novartis identified <b>5</b> (letrozole) as a more potent oral aromatase inhibitor for the adjuvant treatment of hormonally responsive breast cancer.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Recently the crystallographic structure of enzyme-bound androstenedione was determined which may aid in designing future members of this class of inhibitors.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Nitrile-containing aromatase and aldolase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Structurally related to <b>4</b> and <b>5</b> is <b>6</b> (finrozole) which functions as both an aromatase<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and aldosterone inhibitor.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Interest in <b>6</b> was stimulated by the implication of aldosteroneâs role in several pathogenic diseases and in regulating sodium and potassium balance, extracellular fluid volume, and blood pressure. The nitrile group of <b>6</b> mimics the steroidal carbonyl by acting as a hydrogen bond acceptor. Separation of the most active finrazole enantiomer was achieved using monoclonal antibodies with a recent crystal structure showing the nitrile interacting with main chain phenylalanine and histidine residues.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Among the numerous nonsteroidal androgen receptor antagonists<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> is <b>7</b> (bicalutamide, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Launched by AstraZeneca for the treatment of advanced prostate cancer,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><b>7</b> has good oral bioavailability with minimal activity toward other steroid receptors. The crystal structure of the stronger-binding<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><i>R</i>-enantiomer shows the nitrile participating in a hydrogen bond to arginine and to a water molecule bound in the active site.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The hydrogen bonding and positioning of <b>7</b> show the nitrile mimicking the 3-keto functionality of dihydrotestosterone.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Nonsteroidal receptor antagonists in which nitriles function as carbonyl bioisosteres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several androgen receptor antagonists are in various stages of clinical trials for a variety of indications. Effort to use structurally related antagonists for the topical treatment of acne and hair loss led to the development of <b>8</b> (RU-58841),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> which was later superseded by <b>9</b> (PF-0998425).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Like <b>7</b>, the nitrile of <b>9</b> interacts with an arginine residue and has polar interactions with glutamine and leucine at the binding site.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">An excellent example of the equivalency of complex arylnitriles and steroids is apparent in the comparative cocrystal structures of the human progesterone ligand binding domain with <b>10</b> (progesterone, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a) and <b>11</b> (tanaproget, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). <b>11</b> is one of a potentially new class<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> of nonsteroidal contraceptives in clinical trials.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The key interaction with Gln 725 and Arg 766 is a hydrogen bond to the enone carbonyl of <b>10</b> which is exceptionally well mimicked by a similar interaction with the nitrile group of <b>11</b>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Hydrogen bonding to the nitrile explains the superior efficacy of this functionality over other electron withdrawing groups within this small binding pocket.</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystallizations in the human progesterone ligand binding domain.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibition of farnesyltransferase has become an important target for preventing oncogenesis by disrupting cell signaling. <b>12</b> (BMS-214662) is a farnesyltransferase inhibitor<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> that entered early clinical trials<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> for chronic myeloid leukemia (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Crystallization of <b>12</b> complexed with mammalian farnesyltransferase shows aromatic Ï-interactions within a deep hydrophobic cleft that are critical for binding.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> No specific interactions of the nitrile were identified, but for <b>12</b> the nitrile group improves pharmacokinetic properties. Solubility studies revealed that the nitrile substituent in <b>12</b> was nearly 10-fold more soluble than the corresponding bromo analogue.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Nitrile-containing farnesyltransferase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>13</b> (L-778,123) is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase which entered phase I trials for the treatment of pancreatic cancer, non-small-cell lung cancer, and head and neck cancer.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Two crystal structures of bound <b>13</b> show polar interactions of the nitrile nitrogen with glutamine and arginine in the two enzymes.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p"><b>14</b> (neratinib) is an irreversible epidermal growth factor receptor (EGFR<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: EGFR, epidermal growth factor receptor; VEGFR-2, vascular epidermal growth factor receptor 2; GABA, Î³-aminobutyric acid; 5-HT<sub>1B</sub>, 5-hydroxytryptamine receptor 1B; NNRTI, non-nucleoside reverse transcriptase inhibitor; DPP IV, dipeptidyl peptidase IV; MDR, multidrug resistance; ADME, absorption, distribution, metabolism, and excretion.</p></div> inhibitor currently in phase II trials for patients with breast cancer<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and non-small-cell lung cancer (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The related antineoplastic agent <b>15</b> (pelitinib, EKB-569) entered phase I clinical trials for treating solid tumors<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and cancers resistant to treatment with gefitinib or erlotinib.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Crystallization of <b>14</b> in a mutant kinase confirms the irreversible inhibition through Michael addition of cysteine to the enamide.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The structure reveals a polar interaction between the nitrile and a key methionine residue postulated as being critical for the remarkable selectivity exhibited over vascular epidermal growth factor receptor-2 (VEGFR-2). <b>15</b> also acts as an irreversible Michael acceptor.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a><b>16</b> (bosutinib, SKI-606) is a kinase inhibitor in phase III clinical trials for treating chronic myelogenous leukemia in patients resistant to other tyrosine kinase inhibitors.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Docking studies identified a key hydrogen bond between threonine and the nitrile nitrogen of <b>16</b> which is a common motif in these kinase inhibitors.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Nitrile-containing kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Early structureâactivity relationships for the neratinib family of kinase inhibitors was guided by recognition that the quinazoline-based inhibitors functioned through a water-bound hydrogen bond bridged to a proximal threonine residue (<b>17</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Modeling indicated that substitution of the azomethineâwater aggregate for a sp<sup>2</sup>-CN unit, <b>18</b>, would displace water and allow direct hydrogen bonding between the nitrile and the amino acid.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> This strategy was successfully applied to quinazoline analogues<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> leading to identification of <b>14</b><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and <b>15</b>.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Crystallographically guided lead optimization led to a similar substitution in quinazoline and benztriazine inhibitors of scytalone dehydratase.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Nitrile-substituted cyanoquinoline as an azomethineâwater bioisostere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>19</b> (milrinone), marketed as Primacor, is a phosphodiesterase inhibitor used for treating heart failure,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> particularly when conventional treatment with vasodilators and diuretics is ineffective (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a><b>19</b> shares some structural homology with thyroxine and stimulates the myocardial membrane in a similar manner to the hormone. <b>20</b> (Olprinone) is a structurally related phosphodiesterase inhibitor used for heart failure which both enhances myocardial contraction and acts as a vasodilator.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> X-ray crystallography of human transthyretin with <b>20</b> shows the cyanopyridone ring bound in the hormone pocket.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The nitrile binds deeper in the position occupied by iodine while binding closer and tighter to the amino acids lining the channel. Replacing the nitrile with an amino group maintains activity but with fewer contacts to residues in the binding pocket. A bromine substituent fits better in the same pocket, suggesting that the nitrile has a similar polarizing influence but with greater hydrophilicity.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The interchange of nitrile and iodine or bromine as nonclassical isosteres<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> in imidazoles,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> has been observed during lead optimization of other inodilators.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nitrile-containing cardiovascular agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>21</b> (cromakalim) is a potassium-dependent ATP channel opener used to treat hypertension.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> This âfirst generationâ treatment lacks specificity which led to the search for selective agents with decoupled anti-ischemic and vasorelaxant activity.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Of the numerous analogues pursued, <b>22</b> (BMS-191095) is particularly promising with over 4000-fold improved selectivity for the ischemic myocardium than <b>21</b>.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The receptor is assumed to have a Ï-interaction to the aromatic core and hydrogen bonding with the nitrile.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Replacement of the aromatic nitrile by iodine affords an equipotent analogue, again indicating some similarity between nitrile and halogen groups.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The hydrogen bonding, however, is not as critical as in previous examples because replacing the nitrile with iodine maintains the potency. Structureâactivity series within cromakalim-type potassium ion channel openers have shown that the cyanophenyl ring can be replaced with an N-6 pyridyl ring indicative of hydrogen bonding analogous to that observed in cyanoquinolines (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'cit67a ref71'); return false;" href="javascript:void(0);" class="ref cit67a ref71">(67a, 71)</a></div><div class="NLM_p">Several phenyl-substituted nitriles have been developed for treatment of mood disorders (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Although the receptors are usually known, in most instances the precise binding, in terms of interactions, is not well understood. (Â±)-<b>23</b> (citalopram) is a selective serotonin reuptake inhibitor prescribed for depression which has recently been superseded by the more efficacious single enantiomer <b>23</b> (escitalopram).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Molecular modeling suggests that the two enantiomers bind in the human serotonin transporter with opposite orientations of the aromatic groups and with an interaction between the nitrile and a phenylalanine residue.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a><b>24</b> (RS-8359) is a selective and reversible monoamine oxygenase inhibitor under examination for treatment of depression.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Clinical studies<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> demonstrate different efficacies for the two enantiomers of <b>24</b> and an in vivo epimerization through oxidation and reduction of the benzylic alcohol.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Nitrile-containing CNS drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>25</b> (vilazodone) is a dual-acting serotonergic antidepressant that has completed phase III clinical trials.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> During screening of a series of analogues the most efficacious leads contained electron withdrawing groups, with the nitrile or fluorine substituents being the most potent. Computed molecular electrostatic potentials and dipole moments showed a strong homology suggesting that the nitrile can function as a fluorine bioisostere.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Electrostatic mapping performed during the development of the muscarinic agonist, sabcomeline, generated similar electrostatic potential maps for the respective imidoyl nitrile, fluoride, and chloride, again suggesting the nitrile as a halogen bioisostere.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p"><b>26</b> (pericyazine) is a phenothiazine antipsychotic thought to act on several receptors in the brain but for which no specific binding is available.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a><b>27</b> (cyamemazine) is an antipsychotic widely used in France to minimize withdrawal symptoms after drug addiction.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The mechanism of cyamemazineâs anxiolytic action, and therefore the role of the functional groups, is unknown.</div><div class="NLM_p"><b>28</b> (zaleplon) is a non-benzodiazepine hypnotic drug used for treating insomnia.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Binding assays show that <b>28</b> selectively binds to GABA<sub>A</sub> receptors containing the Î±<sub>1</sub> subunit, though the exact interactions are currently unknown.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a><b>29</b> (donitriptan) is a 5-HT<sub>1B</sub> agonist<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> that entered phase II trials for the treatment of migraines.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">A series of nitrile-containing aromatics, some containing two nitriles, are ushering in a potentially revolutionary approach for treating AIDS.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a><b>30</b> (etravirine) is the first of this new type of non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV to be launched (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a><b>31</b> (dapivirine)<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> and <b>32</b> (rilpivirine) are among the many etravirine analogues under development, with <b>32</b> being touted as among âthe most potent anti-HIV agent(s) ever discovered.â<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The nitrile groups of <b>32</b> project deep into the binding pocket with the flexible pyrimidine allowing conformational mobility and potency, even with several mutation-induced changes of the binding pocket.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Crystallographic analyses of HIV-1 inhibitor complexes indicate that one nitrile binds to a water molecule that bridges to amino acids on the main chain.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Nitrile-containing anti-HIV agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>33</b> (lersivirine, UK-453,061) is a novel NNRTI currently in phase II clinical trials.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Structural optimization identified the nitrile and the corresponding chloride as being equipotent, with the nitrile being much less lipophilic and more metabolically stable.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a><b>34</b> (MIV-150) was developed as an NNRTI but is not suitable as an antiviral therapy because of poor systemic absorption after oral administration.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Exploiting the poor absorption, <b>34</b> is now being evaluated as a vaginal microbicide.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Early pharmacokinetics and oral bioavailability of <sup>14</sup>C-labeled <b>35</b> (IDX899) in humans are promising with further clinical studies in progress.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><div class="NLM_p"><b>36</b> (febuxostat) is a non-purine xanthine oxidase inhibitor used to treat gouty arthritis (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> X-ray crystallography suggests hydrogen bonding between the nitrile, a bound water, and amino acids, which positions <b>36</b> in the channel leading to the molybdenum active site.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> In the more potent inhibitor <b>37</b> (FYX-051) with better binding affinity,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> the nitrile has a direct hydrogen bond with an arginine residue.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><figure id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Nitrile-containing xanthine oxidase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>39</b> (alogliptin) is a noncovalent inhibitor of dipeptidyl peptidase IV (DPP IV) in phase III clinical trials for the treatment of diabetes (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>, bottom right).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a><b>39</b> exhibits a 10â000 times greater preference for DPP IV over the related peptidase DPP VIII and has therapeutic advantages over existing DPP IV inhibitors.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The inhibitor design was based on docking the cyanoaryl ring of a substituted quinazolinone (<b>38</b>) into a hydrophobic pocket augmented with hydrogen bonding between the nitrile and an arginine residue.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> X-ray crystallography of a cocrystal structure of <b>38</b> in the active site of DPP IV is consistent with the design motif, clearly showing a hydrogen bond from arginine to the nitrile (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>, top). Optimizations to minimize hERG activity and maximize the metabolic half-life led to <b>39</b> which presumably has analogous enzyme interactions.</div><figure id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Nitrile-containing DPP IV inhibitors.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Unfortunately no information is available for the role of the nitrile in medications <b>40</b>â<b>47</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). <b>40</b> (lodoxamide) and <b>41</b> (lodoxamide ethyl) are histamine inhibitors used as ocular anti-inflammatory agents.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Structurally related <b>42</b> (TYB-2285) entered phase II clinical trials in Japan for asthma and atopic dermatitis.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a><b>43</b> (strontium ranelate) is prescribed to promote bone formation<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> through a dual-action mechanism of preventing bone resorption while stimulating bone formation.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a><b>44</b> (ravuconazole) is a recently released broad spectrum antifungal agent<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> for which molecular modeling suggests that the cyanophenyl ring participates in Ï-stacking in the target lanosterol 14-demethylase.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a><b>45</b> (isavuconazole) is a structural isomer in advanced clinical trials as a broad-spectrum azole antifungal agent.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a><b>46</b> (NO-1886, ibrolipim) is a lipoprotein lipase activator that entered phase II trials in Japan for the potential treatment of hyperlipidemia.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a><b>47</b> (epanolol) is a Î² blocker used for angina pectoris.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Although the exact role of the nitrile is unknown in these agents, a reasonable speculation is that the nitrile was installed to balance the electronics of the aromatic rings and/or to reduce potential for oxidative metabolism.</div><figure id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Miscellaneous arylnitrile-containing inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Î±-Arylacetonitriles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Î±-Arylacetonitrile drugs contain the nitrile on a quaternary carbon adjacent to an aromatic ring. Positioning the nitrile on a fully substituted carbon prevents oxidation at the nitrile-bearing carbon and thereby prevents cyanide release.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a><b>48</b> (anastrazole), <b>49</b> (verapamil), and <b>50</b> (gallopamil) are widely prescribed and are among the best-studied nitrile-containing pharmaceuticals (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>). The blockbuster drug <b>48</b>, marketed by Astra-Zeneca under the trade name Arimidex, is considered the drug of choice for treating estrogen-dependent breast cancer.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Docking of <b>48</b> into the human aromatase homology model reveals a potential hydrogen bonding interaction of the two nitriles with an adjacent serine residue.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p"><b>49</b> is a calcium channel antagonist used as an antiarrhythmic agent to treat angina.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a><b>49</b> relaxes blood vessels so the heart does not have to pump as hard and simultaneously increases the supply of blood and oxygen to the heart which reduces chest pain. <b>50</b> is a methoxy derivative of <b>48</b> having a 10-fold increase in potency.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Molecular modeling suggests that the polar nitrile group of these inhibitors, which is required for activity,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> engages in a strong dipole interaction with the enzyme-bound calcium through the nitrile nitrogen.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><div class="NLM_p"><b>49</b> blocks the drug efflux pump P-glycoprotein and is often employed as a standard to gauge reversal of multidrug resistance (MDR). Strategies to modify verapamil into more potent and selective MDR agents highlight the necessity of the nitrile group.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><figure id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Most widely prescribed nitrile-containing pharmaceuticals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>51</b> (cilomilast, Ariflo) was developed as a phosphodiesterase inhibitor (DPP4) for use as an anti-inflammatory and antiasthmatic agent (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a><b>51</b><a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> completed phase III trials with less than ideal results, leaving the drugâs fate in question. Numerous analogues, particularly with more rigid scaffolds,<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> have been developed to optimize activity and minimize nausea, diarrhea, and headache symptoms associated with this class of inhibitors.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> A cocrystal structure with <b>51</b> bound in the phosphodiesterase reveals an interaction of the nitrile with methionine and leucine residues.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> As with many of these polar interactions, slight movement of the protein may allow intimate hydrogen bonding. <b>52</b> (levocabastine) is a selective second-generation H<sub>1</sub>-receptor antagonist used for allergic conjunctivitis.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> The precise interaction of <b>52</b> with the receptor is not known.</div><figure id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Bioactive quatarnary arylacetonitriles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><b>53</b> (piritramide, Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>) is a synthetic opioid, almost equipotent with morphine, which is prescribed for treating postoperative pain.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Structurally related <b>54</b> (diphenoxylate, lomotil) is used to treat diarrhea.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a><b>54</b> is rapidly hydrolyzed to the corresponding acid, difenoxin, which slows intestinal contractions and peristalsis, allowing the body to remove water and return the intestine to normal function.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Alkenenitrile-Containing Pharmaceuticals</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Drugs containing the unsaturated nitrile functionality are conjugated either with additional electron withdrawing groups or with heteroatoms (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>). Often the nitrile is positioned adjacent to a hydrogen bond donor or acceptor, implying an electronic role for the nitrile group. Conjugation of the nitrile with an additional electron withdrawing group facilitates Michael additions<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> as in <b>55</b> (entacapone).</div><div class="NLM_p"><b>55</b><a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> is a potent inhibitor of catechol-<i>O</i>-methyltransferase and used for treating Parkinsonâs disease by facilitating passage of dopaminergic agents across the bloodâbrain barrier.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Molecular docking reveals a series of hydrogen bonds with the nitrocatechol ring but no specific interactions for the nitrile.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a><b>56</b> (trilostane) is an inhibitor of 3Î²-hydroxysteroid dehydrogenase that was used to treat Cushingâs syndrome in humans but is now licensed only for treating dogs.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a><b>56</b> has been successfully used in treating postmenopausal women for breast cancer<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> by inhibiting 3Î²-hydroxysteroid dehydrogenase.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Molecular modeling and mutant studies demonstrate the necessity of the nitrile group and identifies an interaction with a serine residue as being critical.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><figure id="fig16" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Alkenenitrile-containing pharmaceuticals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>57</b> (lanoconazole)<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> and <b>58</b> (luliconazole)<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> are topical antifungal drugs developed and marketed in Japan. Both <b>57</b> and <b>58</b> inhibit sterol 14Î±-methylase in fungi,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> and although they are marketed as racemates, the activity resides in the <i>S</i>-enantiomer. A Ï-interaction is proposed between the enzyme and the dichlorobenzene ring<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> with the dithioalkenenitrile acting as a Michael acceptor.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a><b>59</b> (nilvadipine) is a calcium channel blocker used to treat hypertension and cerebral artery occlusion<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> and recently entered trials to treat Alzheimerâs disease.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> The role of the nitrile is unknown.</div><div class="NLM_p last">Celgene Corp.âs antitumor agent <b>60</b> (CC-5079) prevents tubulin polymerization but remains active against multidrug resistant cells.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Subsequent assays identified the <i>Z</i>-diastereomer as being more active, with molecular modeling suggesting a key hydrogen bond between the nitrile nitrogen and a tyrosine hydroxyl group in tubulin.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a><b>61</b> (levosimendan, Simdax) is a novel inodilator used to manage acute or chronic heart failure.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> As with many Ca<sup>2+</sup> sensitization and K<sup>+</sup> channel-mediators, the enzymeâinhibitor interactions are not fully resolved. Development of a related dinitrile inhibitor, <b>62</b> (KW-5092), suggests that the dinitrile creates a rigid, polar moiety comparable to a nitro group.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5"><i>N</i>-Cyanoguanidine Containing Drugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several drugs and drug leads contain the <i>N</i>-cyanoguanidine functionality.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Guanidinium cations interact strongly with carboxylates through lateral (<b>63</b>) or terminal (<b>64</b>) ionic interactions (Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>).<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> In the series of <i>N</i>-cyanoguanidine, amidine, and formamidine functionalities the nitrile significantly changes the nitrogen basicity,<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> attenuating the ionization and H-bond acceptor properties.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> The cyanoguanidine moiety can act as a bioisostere for cyanoamidine,<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> sulfonylguanidine,<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> thiourea,<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> amide, or thioamide<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> functionalities.</div><figure id="fig17" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Cyanoguanidine binding motifs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>65</b> (cimetidine) is a well-studied histamine H<sub>2</sub>-receptor antagonist that inhibits the production of acid in the stomach (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Originally used to treat heartburn and peptic ulcers, <b>65</b> is being examined for several dermatological diseases<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> and as an antitumor agent.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a><b>66</b> (pinacidil) modulates ATP-dependent potassium channels and is used to treat hypertension.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a><b>67</b> (terbogrel), a thromboxane A<sub>2</sub> synthase inhibitor, has a similar cyanoguanidine substitution and is a potential long-term antithrombotic therapy.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><figure id="fig18" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. <i>N</i>-Cyanoguanidine-containing drugs and drug leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><b>68</b> (CHS-828) is an antineoplastic agent<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> under active development by Gemin X Pharmaceuticals as GMX-1778 (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>).<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> The mechanism by which <b>68</b> triggers apoptosis remains to be clarified. <b>69</b> (KR-31378) is a potassium ATP channel opener in preclinical trials to protect retinal ganglion cells in glaucoma.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Î±-Aminonitrile Drugs and Drug Leads</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several aminonitriles have been developed as reversible inhibitors of dipeptidyl peptidase (DPP IV) for treating diabetes.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Proline peptidases cleave peptide bonds after a proline residue which, for the hydrolysis of the glucagon-like peptide 1, switches off insulin production to provide a therapeutic approach for type 2 diabetes. <b>70</b> (saxagliptin)<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> was recently launched under the name Onglyza, and the structurally related <b>1</b><a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> is licensed in Europe. The dinitrile <b>71</b> (NVP-DPP728)<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> is in phase II clinical development.</div><figure id="fig19" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Aminonitrile DPP IV inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These inhibitors function through attack of a serine residue on the nitrile, resulting in a strong, reversible inhibition with a slow off rate (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>, <b>72</b> â <b>73</b>).<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> A similar covalent binding occurs in nitrile-based cysteine protease inhibitors<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> for which high selectivity between proteases is possible.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Cocrystallization of <b>70</b> in DPP IV shows hydrogen bonding between the nitrile nitrogen and asparagines, suggesting a delicate choreography of inhibition in which the aminonitrile binds, becomes activated, and is attacked to form the covalent bond.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div><div class="NLM_p">Several cathepsins, which are cysteine proteases, have been identified as viable drug targets. The search for cathepsin K inhibitors for the treatment of osteoporosis uncovered a series of aminoacetonitrile inhibitors in which the nitrile participates in a reversible, covalent interaction with the active site cysteine residue (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Subsequent refinement identified <b>74</b> (odanacatib)<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> which is currently in phase III clinical trials.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Significant effort is focused on inhibiting cathepsin S using aminonitrile inhibitors.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Aminonitrile <b>75</b> is a potent, reversible inhibitor (IC<sub>50</sub> = 9 nM) whose cocrystallization with cathepsin S shows formation of a reversible thioimidate formed by attack of cysteine, rather than serine, on the nitrile âwarheadâ (cf. <b>73</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>).<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></div><figure id="fig20" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Cathepsin Inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05174" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05174" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Structurally diverse nitrile-containing drugs are in use for a variety of medical treatments. These range from blockbuster drugs such as <b>48</b> to numerous candidates currently being pursued in clinical trials. Surveying the interactions of the nitrile within these pharmaceuticals and drug candidates reveals that the biological function of the nitrile group varies considerably. In some instances the nitrile merely polarizes the adjacent electron density, whereas in other cases the nitrile is a key component for molecular recognition.</div><div class="NLM_p">Recent advances in molecular recognition, through crystallography, NMR, and modeling, are providing an increased understanding of the interactions between small molecule inhibitors and their targets. The survey of nitrile-containing pharmaceuticals and clinical candidates identifies several roles of the nitrile group.</div><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p>One role is as a carbonyl bioisostere. In several nonsteroidal inhibitors arylnitriles function as a carbonyl equivalent. These inhibitors have the advantage of minimizing interference with other steroid receptors and improving bioavailability. The homology is evident in the overlay of progesterone and the nitrile-inhibitor <b>76</b> in the progesterone receptor site (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>).<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> The nitrile nitrogen occupies virtually the same position as the carbonyl oxygen of progesterone and engages in the same polar interactions.</p><p class="last"><figure id="fig21" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Nitrile inhibitor <b>76</b> and progesterone (<b>10</b>) overlay. Reprinted with permission from <i>Bioorganic and Medicinal Chemistry Letters</i>.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Copyright 2009 Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p>Another role is as a hydroxyl and carboxyl surrogate. The small, polar nitrile is a strong hydrogen bond acceptor with a significant solvation shell. The combination allows the nitrile to function as hydroxyl and carboxyl surrogates. Hydrogen bonding is particularly common to the protein backbone, amino acid side chains, or water molecules enclosed within the binding domain. The relationship is exemplified by functional group replacements performed using the anticancer drug <b>79</b> (etoposide, Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>) as a lead structure.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Replacing the glycoside with a nitrile <b>77</b> was significantly more efficacious than the acid <b>78</b>.</p><p class="last"><figure id="fig22" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0022.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Comparative nitrile and acid etoposide analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The powerful electron-withdrawing nature of the CN unit allows nonspecific dipole interactions with amino acids and metal ions. In cyanoguanidines and related structures, nitrile substitution allows tuning of the guanidine basicity and hydrogen bonding properties.</p></td></tr><tr class="li1"><td valign="top">4.</td><td colspan="5" valign="top" class="paragraph"><p>Cyanoquinolines and cyanopyridines (<b>81</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>) can act as more potent azomethineâwater (<b>80</b>) bioisosteres. Interchanging a water-bound quinazoline with a 3-cyano quinoline or pyridine effectively exchanges the mobile hydrogen-bonded pyrimidineâwater complex for a direct hydrogen bond between the nitrile and the protein. Expulsion of water from the binding domain adds an additional entropic component to the binding affinity.</p><p class="last"><figure id="fig23" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0023.jpeg" id="_i8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Cyanoquinolines and cyanopyridines as azomethineâwater bioisosteres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></p></td></tr><tr class="li1"><td valign="top">5.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Carboxyl transition state analogue is another role. Several aminonitriles function as proline peptidases by reversibly forming covalently bound imino esters at the active site. Conversion of the nitrile to the imino ester appears choreographed through activation of the nitrile and addition of serine or cysteine.</p></td></tr><tr class="li1"><td valign="top">6.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Halogen bioisostere is another role. The nitrile mimics the polarization of the halides and is often an excellent halogen bioisostere.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> Being smaller than bromine or iodine, the nitrile is capable of achieving better contact with amino acids lining an active site.</p></td></tr><tr class="li1"><td valign="top">7.</td><td colspan="5" valign="top" class="paragraph"><p>The nitrile group improves ADME<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a>âtoxicology profiles. Computational properties and empirical rules such as Lipinskiâs rules<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> are routinely employed to guide structure-based drug design. While a potent molecule is essential for drug discovery, ultimately ADMEâTox properties decide which molecule is advanced into clinical trials. During optimization, leads tend to increase in size and lipophilicity<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> which can be offset by introducing the sterically insignificant nitrile group. Replacing a hydrogen with a nitrile can roughly lower cLogP<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> by half an order of magnitude and nearly an order of magnitude reduction for logâ<i>D</i>.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> A more dramatic decrease in lipophilicity by over a full order of magnitude for cLogP/logâ<i>D</i> often occurs when replacing a halogen or methyl group by a nitrile.</p><p class="last">The development of <b>33</b> from <b>82</b> (capravirine) provides an excellent case study in modulating ADME properties through nitrile substitution.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Refining <b>82</b> led to the truncated analogue <b>83</b> that was evaluated and found to be less potent and more lipophilic. Consistent with the nitrile being a halogen bioisostere, interchanging the chlorine with a nitrile (<b>83 â 84</b>) reduced the lipophilicity by an order of magnitude and increased the lipophilic ligand efficiency (LLE).<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Introduction of a second nitrile led to <b>33</b> with similar activity to <b>82</b>, 141 mass units smaller, a decreased lipophilicity, and a much improved half-life in human liver microsomes (HLM); 7.5 min for <b>82</b> compared to 73 min for <b>33</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>).</p></td></tr></table><figure id="fig24" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0024.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. ADME-directed evolution of capravirine (<b>82</b>) into lersivirine (<b>33</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">This review provides a comprehensive survey of the interactions between the nitrile group and a diverse range of bioactive receptors. Collating the nitrile-containing drugs and clinical candidates by their structural similarities reveals at least seven different modes by which nitrile substituents accentuate binding to receptor targets. A greater understanding of these specific functions is likely to facilitate lead optimizations with nitrile-containing candidates and will, optimistically, increase the number of nitrile-containing pharmaceuticals.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm100762r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fraser F. Fleming</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282-1530</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#32545e575f5b5c5554725647431c575647"><span class="__cf_email__" data-cfemail="87e1ebe2eaeee9e0e1c7e3f2f6a9e2e3f2">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lihua Yao</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282-1530</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">P. C. Ravikumar</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282-1530</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lee Funk</span> - <span class="hlFld-Affiliation affiliation">Mylan Pharmaceuticals Inc., 781 Chestnut Ridge Road, Morgantown, West Virginia 26505</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian C. Shook</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Fraser F. Fleming</b> earned his B.Sc. (Hons.) at Massey University, New Zealand, in 1986 and then pursued a Ph.D. under the direction of Edward Piers at the University of British Columbia, Canada. After graduating in 1990, he moved to Oregon State University for postdoctoral research with James D. White and in 1992 joined the faculty at Duquesne University where he is a Full Professor. His research interests lie broadly in stereochemistry and the reactions of organometallics, particularly for the development of new reactions with nitriles.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lihua Yao</b> obtained her B.Eng. in Chemical Engineering (2000) at Shanghai University of Engineeering Science, China. From 2000 until 2003, she was a Research Assistant in Shanghai Institute of Organic Chemistry, Chinese Academy Sciences, working on the development of organofluorine methodology. In 2007, she joined Duquesne University, PA, where she is currently working with Fraser Fleming on a transmissive olefination of alkenenitriles.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>P. C. Ravikumar</b> obtained his B.Sc. (2000) and M.Sc in Organic Chemistry (2002) from the University of Madras, India. He was awarded a research fellowship from the Council for Scientific and Industrial Research (CSIR), India, for his doctoral research, which he completed in 2006 at the Indian Institute of Science, Bangalore, India, under the guidance of Professor A. Srikrishna. He completed postdoctoral research with Fraser Fleming at Duquesne University, PA (2007â2008), and with Professor Seth B. Herzon at Yale University, CT (2009). He recently accepted an Assistant Professor position at the Indian Institute of Technology, Mandi, India, where he will begin his independent academic career.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lee Funk</b> received his B.A. in Chemistry from Washington and Jefferson College, PA, followed by a M.S. in Organic Chemistry from Duquesne University, PA. From 2001 through 2008 he worked as a medicinal chemist for Pharmacia (Kalamazoo, MI), Pfizer (La Jolla, CA), and GlaxoSmithKline (Collegeville, PA). As a medicinal chemist, he worked in various therapeutic targets including HCV, oncology, and osteoporosis. In 2008, he transitioned to Mylanâs legal Intellectual Property Department. He is currently working as a Senior Scientist performing prior art searches, mapping out patent landscapes, developing invalidity positions, supporting ongoing litigation, and working with R&D scientists to develop noninfringing API/formulations.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Brian C. Shook</b> received a B.S. from the University of Pittsburgh, Johnstown, PA (1996), and a Ph.D. in Synthetic Organic Chemistry from Duquesne University, PA, in 2001 under the guidance of Fraser Fleming. His thesis work included organometallic additions to unsaturated nitriles and the stereoselective cyclizations of nitrile anions to <i>cis</i>- and <i>trans</i>-decalins. He then pursued a postdoctoral appointment with Robert K. Boeckman, Jr. at the University of Rochester, NY, where he completed the asymmetric total synthesis of bengamide B. In 2002, he joined the Department of Medicinal Chemistry at Johnson & Johnson where he has worked on programs for Parkinsonâs disease, pain, migraine, and diabetes.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support for nitrile-based research from the National Science Foundation (Grant 0808996 CHE) and the National Institutes of Health (Grant 2R15AI051352-03) is gratefully acknowledged. The Center for Advanced Studies, Ludwig Maximilians University (Munich, Germany), and the University of GÃ¶teborg, Sweden, are thanked for facilitating the writing of the review by hosting a sabbatical visit (F.F.F.). Critical suggestions from Morten GrÃ¸tli and Robert Dancer are gratefully acknowledged.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This manuscript was released ASAP on August 30, 2010 with errors in Figures 10 and 24. The corrected version was posted on September 13, 2010 and again on October 25, 2010.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 183 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joannides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limberakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotti, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottolini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauckhorst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivault, F.</span><span> </span><span class="NLM_article-title">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2150</span><span class="NLM_x">â</span> <span class="NLM_lpage">2155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2007.01.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17303420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2150-2155&author=S.+T.+Murphyauthor=H.+L.+Caseauthor=E.+Ellsworthauthor=S.+Hagenauthor=M.+Hubandauthor=T.+Joannidesauthor=C.+Limberakisauthor=K.+R.+Marottiauthor=A.+M.+Ottoliniauthor=M.+Rauckhorstauthor=J.+Starrauthor=M.+Stierauthor=C.+Taylorauthor=T.+Zhuauthor=A.+Blaserauthor=W.+A.+Dennyauthor=G.+L.+Luauthor=J.+B.+Smaillauthor=F.+Rivault&title=The+synthesis+and+biological+evaluation+of+novel+series+of+nitrile-containing+fluoroquinolones+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span></div><div class="casAuthors">Murphy, Sean T.; Case, Heather L.; Ellsworth, Edmund; Hagen, Susan; Huband, Michael; Joannides, Themis; Limberakis, Chris; Marotti, Keith R.; Ottolini, Amy M.; Rauckhorst, Mark; Starr, Jeremy; Stier, Michael; Taylor, Clarke; Zhu, Tong; Blaser, Adrian; Denny, William A.; Lu, Guo-Liang; Smaill, Jeff B.; Rivault, Freddy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2150-2155</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several novel series of nitrile-contg. fluoroquinolones, e.g., I and II, with weakly basic amines are reported which have reduced potential for hERG (human ether-a-go-go gene) channel inhibition as measured by the dofetilide assay.  The new fluoroquinolones are potent against both Gram-pos. and fastidious Gram-neg. strains, including Methicillin resistant Staphylococcus aureus and fluoroquinolone-resistant Streptococcus pneumoniae.  Several analogs also showed low potential for human genotoxicity as measured by the clonogenicity test.  I and II (designated PF-00951966 and PF-02298732, resp.), which had good in vitro activity and in vitro safety profiles, also showed good pharmacokinetic properties in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhTahx73DqHrVg90H21EOLACvtfcHk0lifXNADMvkj4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D&md5=708231abc3eafe5e302e9391d5ae58cc</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.090%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DCase%26aufirst%3DH.%2BL.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DHagen%26aufirst%3DS.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DJoannides%26aufirst%3DT.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DMarotti%26aufirst%3DK.%2BR.%26aulast%3DOttolini%26aufirst%3DA.%2BM.%26aulast%3DRauckhorst%26aufirst%3DM.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DLu%26aufirst%3DG.%2BL.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DRivault%26aufirst%3DF.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520series%2520of%2520nitrile-containing%2520fluoroquinolones%2520as%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2150%26epage%3D2155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Markus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, C.-H.</span><span> </span><span class="NLM_article-title">In vitro metabolism of aromatic nitriles</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">â</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1994&pages=1729-1734&author=B.+Markusauthor=C.-H.+Kwon&title=In+vitro+metabolism+of+aromatic+nitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkus%26aufirst%3DB.%26aulast%3DKwon%26aufirst%3DC.-H.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520aromatic%2520nitriles%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1994%26volume%3D83%26spage%3D1729%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J. J.</span><span> </span><span class="NLM_article-title">A simple in vitro assay for assessing the reactivity of nitrile containing compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1136</span><span class="NLM_x">â</span> <span class="NLM_lpage">1138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2008.12.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19168354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1WrtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1136-1138&author=P.+A.+MacFaulauthor=A.+D.+Morleyauthor=J.+J.+Crawford&title=A+simple+in+vitro+assay+for+assessing+the+reactivity+of+nitrile+containing+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A simple in vitro assay for assessing the reactivity of nitrile containing compounds</span></div><div class="casAuthors">MacFaul, Philip A.; Morley, Andrew D.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1136-1138</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A quant. assay involving the reaction of nitriles with glutathione and cysteine has been used as a simple in vitro screen to assess potential toxicity risk of candidate compds. in drug discovery.  Studies have indicated that, when benchmarked with selected compds., the reaction of the nitriles with glutathione can provide a useful tool for deciding whether or not to progress compds. in the absence of radiolabelling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro23j0VCklM7Vg90H21EOLACvtfcHk0ljdi-Qzq5KOnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1WrtLs%253D&md5=d949b5d0e76c6d268f3f57cc4584f0b9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.105%26sid%3Dliteratum%253Aachs%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMorley%26aufirst%3DA.%2BD.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520simple%2520in%2520vitro%2520assay%2520for%2520assessing%2520the%2520reactivity%2520of%2520nitrile%2520containing%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1136%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelette, C.</span><span> </span><span class="NLM_article-title">A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2006.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17157022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12qtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=998-1002&author=R.+M.+Oballaauthor=J.-F.+Truchonauthor=C.+I.+Baylyauthor=N.+Chauretauthor=S.+Dayauthor=S.+Craneauthor=C.+Berthelette&title=A+generally+applicable+method+for+assessing+the+electrophilicity+and+reactivity+of+diverse+nitrile-containing+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds</span></div><div class="casAuthors">Oballa, Renata M.; Truchon, Jean-Francois; Bayly, Christopher I.; Chauret, Nathalie; Day, Stephen; Crane, Sheldon; Berthelette, Carl</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">998-1002</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nitrile-based inhibitors of cathepsin K have been known for some time and mechanism-of-action studies have demonstrated that cysteinyl proteases interact with nitriles in a reversible fashion.  Three main classes of nitrile-contg. inhibitors have been published in the cathepsin K field: (i) cyanamides, (ii) arom. nitriles, and (iii) aminoacetonitriles.  A computational approach was used to calc. the theor. reactivities of diverse nitriles and this was found to correlate with their extent of reactivity with free cysteine.  Moreover, there is a tentative link between high reactivity with cysteine and the potential to lead to irreversible covalent binding to proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSFCCd4sSYvbVg90H21EOLACvtfcHk0ljdi-Qzq5KOnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12qtr4%253D&md5=b8fff00bdd6a746753f8f244d25b0cc8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DTruchon%26aufirst%3DJ.-F.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DDay%26aufirst%3DS.%26aulast%3DCrane%26aufirst%3DS.%26aulast%3DBerthelette%26aufirst%3DC.%26atitle%3DA%2520generally%2520applicable%2520method%2520for%2520assessing%2520the%2520electrophilicity%2520and%2520reactivity%2520of%2520diverse%2520nitrile-containing%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D998%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="note"><p class="first last">For an example encountered during the development of cathepsins K<sup>a</sup> and S<sup>b</sup> analogues see the following: </p></div><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Boyd, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span> </span><span class="NLM_article-title">Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">â</span> <span class="NLM_lpage">679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=675-679&author=M.+J.+Boydauthor=S.+N.+Craneauthor=J.+Robichaudauthor=J.+Scheigetzauthor=W.+C.+Blackauthor=N.+Chauretauthor=Q.+Wangauthor=F.+Masseauthor=R.+M.+Oballa&title=Investigation+of+ketone+warheads+as+alternatives+to+the+nitrile+for+preparation+of+potent+and+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BJ.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DInvestigation%2520of%2520ketone%2520warheads%2520as%2520alternatives%2520to%2520the%2520nitrile%2520for%2520preparation%2520of%2520potent%2520and%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patterson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, W. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornsby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spraggon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Identification of selective, nonpeptidic nitrile inhibitors of cathepsin S using the substrate activity screening method</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6298</span><span class="NLM_x">â</span> <span class="NLM_lpage">6307</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060701s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6298-6307&author=A.+W.+Pattersonauthor=W.+J.+L.+Woodauthor=M.+Hornsbyauthor=S.+Lesleyauthor=G.+Spraggonauthor=J.+A.+Ellman&title=Identification+of+selective%2C+nonpeptidic+nitrile+inhibitors+of+cathepsin+S+using+the+substrate+activity+screening+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective, Nonpeptidic Nitrile Inhibitors of Cathepsin S Using the Substrate Activity Screening Method</span></div><div class="casAuthors">Patterson, Andrew W.; Wood, Warren J. L.; Hornsby, Michael; Lesley, Scott; Spraggon, Glen; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6298-6307</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The substrate activity screening method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain low nanomolar 1,4-disubstituted-1,2,3-triazole-based aldehyde inhibitors (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527).  Replacement of the metabolically labile aldehyde pharmacophore with the nitrile pharmacophore provided inhibitors with moderate potency for cathepsin S.  The inhibitors showed good selectivity over cathepsins B and L but no selectivity over cathepsin K.  X-ray structures of two crystal forms (1.5 and 1.9 Ã) of a complex between cathepsin S and a triazole inhibitor incorporating a chloromethyl ketone pharmacophore guided the design of triazole substrates with increased cleavage efficiency and selectivity for cathepsin S over cathepsins B, L, and K.  Conversion of select substrates to nitrile inhibitors yielded a low mol. wt. (414 Da) and potent (15 nM) cathepsin S inhibitor that showed >1000-fold selectivity over cathepsins B, L, and K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64WREyCNFsbVg90H21EOLACvtfcHk0ljL52wm444gog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D&md5=30ea16a66d37dac8fe5666c76e2307aa</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fjm060701s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060701s%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DHornsby%26aufirst%3DM.%26aulast%3DLesley%26aufirst%3DS.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520selective%252C%2520nonpeptidic%2520nitrile%2520inhibitors%2520of%2520cathepsin%2520S%2520using%2520the%2520substrate%2520activity%2520screening%2520method%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6298%26epage%3D6307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="note"><p class="first last">For olprinone see the following: </p></div><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kaneko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuzuriha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigematsu, A.</span><span> </span><span class="NLM_article-title">Metabolic fate of loprinone hydrochloride. 1: Blood level, distribution, metabolism, and excretion after a single intravenous administration to rats</span> <span class="citation_source-journal">Yakubutsu Dotai</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">â</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVylsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=149-162&author=K.+Kanekoauthor=K.+Tadanoauthor=K.+Nakajimaauthor=Y.+Sanoauthor=T.+Yuzurihaauthor=N.+Motojiauthor=N.+Kawaiauthor=S.+Hasegawaauthor=A.+Shigematsu&title=Metabolic+fate+of+loprinone+hydrochloride.+1%3A+Blood+level%2C+distribution%2C+metabolism%2C+and+excretion+after+a+single+intravenous+administration+to+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic fate of loprinone hydrochloride. 1: Blood level, distribution, metabolism, and excretion after a single intravenous administration to rats</span></div><div class="casAuthors">Kaneko, Kazuhiro; Tadano, Kyoichi; Nakajima, Kiyomi; Sano, Yoshihisa; Yuzuriha, Teruaki; Motoji, Naomi; Kawai, Naoshi; Hasegawa, Shinichi; Shigematsu, Akiyo</div><div class="citationInfo"><span class="NLM_cas:title">Yakubutsu Dotai</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-62</span>CODEN:
                <span class="NLM_cas:coden">YADOEL</span>;
        ISSN:<span class="NLM_cas:issn">0916-1139</span>.
    </div><div class="casAbstract">The pharmacokinetics of loprinone-HCl, a cardiotonic agent, were investigated after a single i.v. administration of the 14C-labeled compd. to male rats.  After a single i.v. administration, the plasma level of radioactivity rapidly decreased biexponentially, with corresponding half-lives of 9.7 min and 3.6 h.  Radioactivity was distributed rapidly in all tissues studied.  The highest radioactivity was obsd. in the liver and kidneys, followed by the duodenum.  The tissue levels of radioactivity decreased with half-lives similar to those in blood.  Similar distribution profiles were obsd. with whole-body autoradiog.; 96 h after administration, the level of radioactivity in all tissues was very low, reaching the detection limit.  Loprinone-HCl was metabolized to only a small extent.  In the urine and feces, the unchanged form was mainly found; however, small amts. of metabolites (the ring-opened amine form and the enol-O-glucuronide of the parent drug) were also detected.  Biliary excretion of radioactivity was 46.3% of the dose within 24 h.  Within 24 h after administration, the excretion of radioactivity was 43.0 and 47.2% of the dose in the urine and feces, resp., and the total excretion of radioactivity was 97.2% of the dose within 96 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor6pTUYVdbd7Vg90H21EOLACvtfcHk0ljL52wm444gog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVylsw%253D%253D&md5=a1bc14d4974efbbb85006b34ad2b93ae</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DTadano%26aufirst%3DK.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DYuzuriha%26aufirst%3DT.%26aulast%3DMotoji%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DHasegawa%26aufirst%3DS.%26aulast%3DShigematsu%26aufirst%3DA.%26atitle%3DMetabolic%2520fate%2520of%2520loprinone%2520hydrochloride.%25201%253A%2520Blood%2520level%252C%2520distribution%252C%2520metabolism%252C%2520and%2520excretion%2520after%2520a%2520single%2520intravenous%2520administration%2520to%2520rats%26jtitle%3DYakubutsu%2520Dotai%26date%3D1994%26volume%3D9%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For lodoxamide see the following: </p></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leong, B. K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span> </span><span class="NLM_article-title">A dosimetric endotracheal nebulization technique for pulmonary metabolic disposition studies in laboratory animals</span> <span class="citation_source-journal">Inhalation Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL1MXhsVOjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=37-51&author=B.+K.+J.+Leongauthor=J.+K.+Coombsauthor=E.+N.+Petzoldauthor=A.+J.+Hanchar&title=A+dosimetric+endotracheal+nebulization+technique+for+pulmonary+metabolic+disposition+studies+in+laboratory+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">A dosimetric endotracheal nebulization technique for pulmonary metabolic disposition studies in laboratory animals</span></div><div class="casAuthors">Leong, B. K. J.; Coombs, J. K.; Petzold, E. N.; Hanchar, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Inhalation Toxicology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">Premier Issue</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">INHTE5</span>;
        ISSN:<span class="NLM_cas:issn">0895-8378</span>.
    </div><div class="casAbstract">A technique has been developed for nebulizing microliter quantities of a radioactive soln. within the trachea at the proximity of the primary bronchi of a lightly anesthetized animal.  To demonstrate the utility of the technique, aerosols of two antiasthmatic drug solns., [3H]piriprost potassium (3H-PP), and [14C]lodoxamide tromethamine (14C-LT) were administered to beagle dogs and rhesus monkeys, resp.  Approx. 80% of the delivered radioactivity was deposited in the pulmonary system and 69-100% was subsequently recovered from the urine and feces.  The urinary metabolites excreted by two monkeys after endotracheal inhalation of 14C-LT were similar to those after i.v. injection, but were distinctly different from those after ingestion.  This technique enables the delivery of microliters of a radioactive or a highly hazardous aerosol into the lower respiratory tract (LRT) without a special animal exposure chamber or hazard containment, and permits quant. detn. of the uptake and disposition of a radioactive material by the respiratory system per se.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn1ssaSKssGrVg90H21EOLACvtfcHk0ljL52wm444gog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsVOjurs%253D&md5=a94226bddc0067ec942b61c7d3d2dc07</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeong%26aufirst%3DB.%2BK.%2BJ.%26aulast%3DCoombs%26aufirst%3DJ.%2BK.%26aulast%3DPetzold%26aufirst%3DE.%2BN.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26atitle%3DA%2520dosimetric%2520endotracheal%2520nebulization%2520technique%2520for%2520pulmonary%2520metabolic%2520disposition%2520studies%2520in%2520laboratory%2520animals%26jtitle%3DInhalation%2520Toxicol.%26date%3D1988%26spage%3D37%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For cimetidine see the following: </p></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Strong, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spino, M.</span> <span class="citation_source-journal">J. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">422</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">â</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0378-4347%2887%2980467-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3437018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL1cXoslCltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Strong%2C+H.+A.%3B+Spino%2C+M.J.+Chromatogr.+1987%2C+422%2C+301%E2%80%93308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly sensitive determination of cimetidine and its metabolites in serum and urine by high-performance liquid chromatography</span></div><div class="casAuthors">Strong, H. Andrew; Spino, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography, Biomedical Applications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">422</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-8</span>CODEN:
                <span class="NLM_cas:coden">JCBADL</span>;
        ISSN:<span class="NLM_cas:issn">0378-4347</span>.
    </div><div class="casAbstract">An HPLC method using a solid-phase extn. procedure for the quantitation of cimetidine and its metabolites (cimetidine sulfoxide and hydroxymethylcimetidine) in serum and urine is described.  Cimetidine and metabolites were eluted from an extn. column and, after sepn. by HPLC on a Resolve C8 column and acetic acid-acetonitrile (84:16) mobile phase, were detected by a multiwavelength-programmable detector set at 229 nm.  The method is highly sensitive and selective for the simultaneous detn. of cimetidine and its major metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV-9boB8J-LbVg90H21EOLACvtfcHk0lgP5n9o18m1OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXoslCltA%253D%253D&md5=e4a81fc9f65b5cb6402ed665434f66c3</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2F0378-4347%2887%2980467-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4347%252887%252980467-X%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DH.%2BA.%26aulast%3DSpino%26aufirst%3DM.%26jtitle%3DJ.%2520Chromatogr.%26date%3D1987%26volume%3D422%26spage%3D301%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ziemniak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarowitz, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schentag, J. J.</span><span> </span><span class="NLM_article-title">The pharmacokinetics and metabolism of cimetidine in neonates</span> <span class="citation_source-journal">Dev. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">â</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=6697868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2cXhtlajs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1984&pages=30-38&author=J.+A.+Ziemniakauthor=R.+J.+Wynnauthor=J.+V.+Arandaauthor=B.+J.+Zarowitzauthor=J.+J.+Schentag&title=The+pharmacokinetics+and+metabolism+of+cimetidine+in+neonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and metabolism of cimetidine in neonates</span></div><div class="casAuthors">Ziemniak, John A.; Wynn, Ralph J.; Aranda, Jacob V.; Zarowitz, Barbara J.; Schentag, Jerome J.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-8</span>CODEN:
                <span class="NLM_cas:coden">DPTHDL</span>;
        ISSN:<span class="NLM_cas:issn">0379-8305</span>.
    </div><div class="casAbstract">Cimetidine  [51481-61-9] pharmacokinetics and metab. were studied in neonates (2 full-term and 1 premature).  All infants demonstrated the capacity to eliminate cimetidine via both metabolic and renal routes.  The half-life of cimetidine ranged from 3.4-2.1 h, and decreased as total body clearance increased.  These alterations in pharmacokinetics were felt to represent developmental and maturational differences, primarily in renal function.  In contrast to the 60% routinely seen in adults, approx. 90% of the administered dose was recovered in the urine of the full-term infants as cimetidine and its known metabolites.  Cimetidine sulfoxide  [54237-72-8] and hydroxymethyl cimetidine  [59359-50-1] were detected in the serum and urine of 2 patients, and the elimination half-life of these metabolites was 2-3-fold longer than values seen for cimetidine.  During multiple dosing of cimetidine, significant accumulation of cimetidine metabolites may be expected.  The reported dose of 15-20 mg/kg/day is adequate in full-term neonates; however, it appears that premature infants and those with renal dysfunction may require lower dosing rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCU98RD8nlxbVg90H21EOLACvtfcHk0lgP5n9o18m1OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtlajs7Y%253D&md5=602a738fb64c0655d754a72d4ca1afbb</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZiemniak%26aufirst%3DJ.%2BA.%26aulast%3DWynn%26aufirst%3DR.%2BJ.%26aulast%3DAranda%26aufirst%3DJ.%2BV.%26aulast%3DZarowitz%26aufirst%3DB.%2BJ.%26aulast%3DSchentag%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520pharmacokinetics%2520and%2520metabolism%2520of%2520cimetidine%2520in%2520neonates%26jtitle%3DDev.%2520Pharmacol.%2520Ther.%26date%3D1984%26volume%3D7%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="note"><p class="first last">For entacapone see the following: </p></div><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span> </span><span class="NLM_article-title">Metabolite profiles of two [<sup>14</sup>C]-labeled catechol <i>O</i>-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2FBF03188833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=8001593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVCqurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=125-135&author=T.+Wikbergauthor=A.+Vuorela&title=Metabolite+profiles+of+two+%5B14C%5D-labeled+catechol+O-methyltransferase+inhibitors%2C+nitecapone+and+entacapone%2C+in+rat+and+mouse+urine+and+rat+bile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolite profiles of two [14C]-labeled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile</span></div><div class="casAuthors">Wikberg, T.; Vuorela, A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    </div><div class="casAbstract">The metabolites of two inhibitors of catechol O-methyltransferase, nitecapone [3-(3,4-dihydroxy-5-nitrobenzylidene)-2,4-pentanedione] and entacapone [(E)-2-cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide], excreted in urine and bile by rats and in urine by mice, were compared and quantified by using HPLC with radiochem. detection after administration of [14C]-labeled compds.  With the exception of 3-O-methylated nitecapone, no major metabolites were found in rat bile that were not found in rat urine.  For both compds. the major biotransformations were the same in the mouse and the rat.  However, a bisulfite adduct of nitecapone was found in rat urine only, and redn. of the C:C and C:O groups of the nitecapone side chain was more extensive in the mouse.  After entacapone administration, the products of amide N-dealkylation were more abundant in rat urine than in mouse urine.  Most of the dose was excreted in urine and bile as O-conjugates.  Most abundant were the O-glucuronides, while smaller amts. of O-sulfates and O-methylated metabolites were found in both species.  One non-glucuronide glycoside of entacapone was found in urine of both rats and mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkRzHV4ACYfbVg90H21EOLACvtfcHk0lgP5n9o18m1OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVCqurg%253D&md5=333689318f3eebd3c8b01fccc3b7de17</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1007%2FBF03188833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03188833%26sid%3Dliteratum%253Aachs%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DVuorela%26aufirst%3DA.%26atitle%3DMetabolite%2520profiles%2520of%2520two%2520%255B14C%255D-labeled%2520catechol%2520O-methyltransferase%2520inhibitors%252C%2520nitecapone%2520and%2520entacapone%252C%2520in%2520rat%2520and%2520mouse%2520urine%2520and%2520rat%2520bile%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1994%26volume%3D19%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottoila, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span> </span><span class="NLM_article-title">Identification of major metabolites of the catechol-<i>O</i>-methyltransferase inhibitor entacapone in rats and humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=81-92&author=T.+Wikbergauthor=A.+Vuorelaauthor=P.+Ottoilaauthor=J.+Taskinen&title=Identification+of+major+metabolites+of+the+catechol-O-methyltransferase+inhibitor+entacapone+in+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DVuorela%26aufirst%3DA.%26aulast%3DOttoila%26aufirst%3DP.%26aulast%3DTaskinen%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520major%2520metabolites%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520entacapone%2520in%2520rats%2520and%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1993%26volume%3D21%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For cromakalim see the following: </p></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kudoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Direct determination of the antihypertensive agent cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span> <span class="citation_source-journal">J. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">515</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2FS0021-9673%2801%2989359-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=2283381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVCgsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=1990&pages=597-602&author=S.+Kudohauthor=H.+Nakamura&title=Direct+determination+of+the+antihypertensive+agent+cromakalim+and+its+major+metabolites+in+human+urine+by+high-performance+liquid+chromatography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Direct determination of the antihypertensive agent Cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span></div><div class="casAuthors">Kudoh, Shinobu; Nakamura, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">JOCRAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    </div><div class="casAbstract">An HPLC method was developed for the simultaneous detn. of cromakalim and its urinary metabolites including diastereomeric glucuronides.  The method employed a strong cation-exchange precolumn (Senshu Pak SCX-2051-N) to allow direct injections of urine samples.  The unchanged drug and its 3 major metabolites were simultaneously sepd. on a reversed-phase column (Develosil ODS-5) and fluorometrically detected (excitation 254 nm, emission 306 nm) by their native fluorescence.  Gradient elution was achieved with a mobile phase contg. Na acetate buffer (pH 3.2) and acetonitrile.  The calibration curves for cromakalim and a metabolite were linear in the range from 10 to 200 ng/mL, while those for the 2 diastereomeric glucuronides were linear in the range from 20 to 400 ng/mL.  The detection limits were â¤0.3 ng/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUTJ6RRvVZkbVg90H21EOLACvtfcHk0lgwe5uUnT-Lrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVCgsb4%253D&md5=cac1d23e1ff87cf218416ca2c9c55bfd</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2FS0021-9673%2801%2989359-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9673%252801%252989359-6%26sid%3Dliteratum%253Aachs%26aulast%3DKudoh%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DDirect%2520determination%2520of%2520the%2520antihypertensive%2520agent%2520cromakalim%2520and%2520its%2520major%2520metabolites%2520in%2520human%2520urine%2520by%2520high-performance%2520liquid%2520chromatography%26jtitle%3DJ.%2520Chromatogr.%26date%3D1990%26volume%3D515%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kudoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Simultaneous determination of antihypertensive agent cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span> <span class="citation_source-journal">Anal. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">â</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2116%2Fanalsci.6.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFWhtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1990&pages=53-56&author=S.+Kudohauthor=H.+Okadaauthor=K.+Nakahiraauthor=H.+Nakamura&title=Simultaneous+determination+of+antihypertensive+agent+cromakalim+and+its+major+metabolites+in+human+urine+by+high-performance+liquid+chromatography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of antihypertensive agent Cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span></div><div class="casAuthors">Kudoh, Shinobu; Okada, Hideki; Nakahira, Kazuo; Nakamura, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-6</span>CODEN:
                <span class="NLM_cas:coden">ANSCEN</span>;
        ISSN:<span class="NLM_cas:issn">0910-6340</span>.
    </div><div class="casAbstract">An HPLC method was developed for the simultaneous detn. of cromakalim, a novel antihypertensive agent, and its major metabolites in human urine.  The urine sample was first applied onto a disposable cartridge column of octadecyl silica gel (ODS) for solid phase extn.  The charged sample was then washed with an alk. soln. prior to its elution with aq. methanol.  The eluate was introduced into an HPLC system equipped with an ODS column and was analyzed by a gradient elution technique.  In combination with fluorescence detection, this anal. method realized a sensitive detn. of cromakalim and its 3 major metabolites, simultaneously, in human urine.  Urine samples from preclin. trials (Phase I study) conducted on healthy Japanese volunteers were successfully assayed using this new method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmbEzxQh5_g7Vg90H21EOLACvtfcHk0lgwe5uUnT-Lrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFWhtb4%253D&md5=2a8ced3cf61cb65b06d5300a89111711</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.2116%2Fanalsci.6.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2116%252Fanalsci.6.53%26sid%3Dliteratum%253Aachs%26aulast%3DKudoh%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DH.%26aulast%3DNakahira%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DSimultaneous%2520determination%2520of%2520antihypertensive%2520agent%2520cromakalim%2520and%2520its%2520major%2520metabolites%2520in%2520human%2520urine%2520by%2520high-performance%2520liquid%2520chromatography%26jtitle%3DAnal.%2520Sci.%26date%3D1990%26volume%3D6%26spage%3D53%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For lersivirine see the following: </p></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Vourvahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleave, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedderman, A. N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBadie, R.</span><span> </span><span class="NLM_article-title">Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-<sup>14</sup>C2)-1<i>H</i>-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [<sup>14</sup>C]lersivirine to healthy volunteers</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">â</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=789-800&author=M.+Vourvahiauthor=M.+Gleaveauthor=A.+N.+R.+Neddermanauthor=R.+Hylandauthor=I.+Gardnerauthor=M.+Howardauthor=S.+Kempshallauthor=C.+Collinsauthor=R.+LaBadie&title=Excretion+and+metabolism+of+lersivirine+%285-%7B%5B3%2C5-diethyl-1-%282-hydroxyethyl%29%283%2C5-14C2%29-1H-pyrazol-4-yl%5Doxy%7Dbenzene-1%2C3-dicarbonitrile%29%2C+a+next-generation+non-nucleoside+reverse+transcriptase+inhibitor%2C+after+administration+of+%5B14C%5Dlersivirine+to+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVourvahi%26aufirst%3DM.%26aulast%3DGleave%26aufirst%3DM.%26aulast%3DNedderman%26aufirst%3DA.%2BN.%2BR.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DLaBadie%26aufirst%3DR.%26atitle%3DExcretion%2520and%2520metabolism%2520of%2520lersivirine%2520%25285-%257B%255B3%252C5-diethyl-1-%25282-hydroxyethyl%2529%25283%252C5-14C2%2529-1H-pyrazol-4-yl%255Doxy%257Dbenzene-1%252C3-dicarbonitrile%2529%252C%2520a%2520next-generation%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitor%252C%2520after%2520administration%2520of%2520%255B14C%255Dlersivirine%2520to%2520healthy%2520volunteers%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D789%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">For levosimendan see the following: </p></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Koskinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pykalainen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotta, T.</span><span> </span><span class="NLM_article-title">Metabolism of OR-1896, a metabolite of levosimendan, in rats and humans</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">â</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=156-170&author=M.+Koskinenauthor=J.+Puttonenauthor=M.+Pykalainenauthor=A.+Vuorelaauthor=T.+Lotta&title=Metabolism+of+OR-1896%2C+a+metabolite+of+levosimendan%2C+in+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoskinen%26aufirst%3DM.%26aulast%3DPuttonen%26aufirst%3DJ.%26aulast%3DPykalainen%26aufirst%3DM.%26aulast%3DVuorela%26aufirst%3DA.%26aulast%3DLotta%26aufirst%3DT.%26atitle%3DMetabolism%2520of%2520OR-1896%252C%2520a%2520metabolite%2520of%2520levosimendan%252C%2520in%2520rats%2520and%2520humans%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D156%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sundberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virtanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, L.</span><span> </span><span class="NLM_article-title">Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals</span> <span class="citation_source-journal">Int. J. Clin. Pharmarcol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">â</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=9876999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVags78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1998&pages=629-635&author=S.+Sundbergauthor=S.+Antilaauthor=H.+Scheininauthor=M.+Hayhaauthor=M.+Virtanenauthor=L.+Lehtonen&title=Integrated+pharmacokinetics+and+pharmacodynamics+of+the+novel+calcium+sensitizer+levosimendan+as+assessed+by+systolic+time+intervals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals</span></div><div class="casAuthors">Sundberg, S.; Antila, S.; Scheinin, H.; Hayha, M.; Virtanen, M.; Lehtonen, L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">629-635</span>CODEN:
                <span class="NLM_cas:coden">ICTHEK</span>;
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    
            (<span class="NLM_cas:orgname">Dustri-Verlag Dr. Karl Feistle</span>)
        </div><div class="casAbstract">Levosimendan is a new Ca sensitizer, acting Ca-dependently on cardiac troponin C.  In the present study pharmacokinetic-pharmacodynamic interrelations of levosimendan were assessed.  Ten healthy subjects (22-27 yr) were given single doses of 2 mg of levosimendan in 4 different formulations: i.v., conventional tablet (CT), conventional capsule (CC), and slow-release tablet (SR) on different days.  Systolic time intervals and impedance cardiog. were recorded â¤4 h post drug.  Blood plasma concns. of levosimendan and its metabolite OR-1855 were analyzed using HPLC.  Hysteresis loops were constructed by connecting the effect-concn. points in time order.  In addn., pharmacokinetic-pharmacodynamic modeling was performed with the i.v. data.  The i.v. administration, giving a maximal levosimendan concn. of 180 ng mL-1, increased heart rate by 8 beats min-1, and cardiac output by 18%.  It shortened heart rate cor. electromech. systole QS2i by 23 ms, indicating a fairly strong pos. inotropic effect.  The conventional oral formulations (giving maximal drug concns. of about 70-80 ng mL-1) increased heart rate by 4-5 beats min-1, and cardiac output by 5-8%, while QS2i shortened by 9-13 ms.  The SR formulation resulted in low drug concns. and generally weaker effects than the other formulations.  The bioavailability of CT and CC was 83 and 87%, while that of SR was only 31%.  QS2i showed counter-clockwise hysteresis after all formulations.  The mean equilibration half-time (ln(2)/ke0) after i.v. administration was 9.6 min.  Only after SR, OR-1855 was detected in appreciable amts. in plasma, the highest value being 2.2 ng Ã mL which occurred 24 h after drug intake.  In conclusion, the pharmacokinetic-dynamic behavior of the inotropism index QS2i indicates an equilibration delay of levosimendan, which most probably reflects the time the drug requires to distribute from plasma to its cardiac site of action.  The deviant kinetic-dynamic profile of the oral slow-release formulation suggests a different absorption pattern of levosimendan from this formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYhIqH9jH-1rVg90H21EOLACvtfcHk0lgwe5uUnT-Lrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVags78%253D&md5=74276e7b40260462dc37fec80c5d2bce</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSundberg%26aufirst%3DS.%26aulast%3DAntila%26aufirst%3DS.%26aulast%3DScheinin%26aufirst%3DH.%26aulast%3DHayha%26aufirst%3DM.%26aulast%3DVirtanen%26aufirst%3DM.%26aulast%3DLehtonen%26aufirst%3DL.%26atitle%3DIntegrated%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520novel%2520calcium%2520sensitizer%2520levosimendan%2520as%2520assessed%2520by%2520systolic%2520time%2520intervals%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmarcol.%2520Ther.%26date%3D1998%26volume%3D36%26spage%3D629%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">For <i>N</i>-dealkylation of verapamil see the following: </p></div><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borlak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thum, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levsen, K.</span><span> </span><span class="NLM_article-title">Verapamil: identification of novel metabolites in cultures of primary human hepatocytes and human urine by LCâMSn and LCâNMR</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">â</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=655-676&author=J.+Borlakauthor=M.+Wallesauthor=M.+Elendauthor=T.+Thumauthor=A.+Preissauthor=K.+Levsen&title=Verapamil%3A+identification+of+novel+metabolites+in+cultures+of+primary+human+hepatocytes+and+human+urine+by+LC%E2%88%92MSn+and+LC%E2%88%92NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorlak%26aufirst%3DJ.%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DElend%26aufirst%3DM.%26aulast%3DThum%26aufirst%3DT.%26aulast%3DPreiss%26aufirst%3DA.%26aulast%3DLevsen%26aufirst%3DK.%26atitle%3DVerapamil%253A%2520identification%2520of%2520novel%2520metabolites%2520in%2520cultures%2520of%2520primary%2520human%2520hepatocytes%2520and%2520human%2520urine%2520by%2520LC%25E2%2588%2592MSn%2520and%2520LC%25E2%2588%2592NMR%26jtitle%3DXenobiotica%26date%3D2003%26volume%3D33%26spage%3D655%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McIlhenny, H. M.</span><span> </span><span class="NLM_article-title">Metabolism of [<sup>14</sup>C]-verapamil</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">â</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00294a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1971&pages=1178-1184&author=H.+M.+McIlhenny&title=Metabolism+of+%5B14C%5D-verapamil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm00294a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00294a010%26sid%3Dliteratum%253Aachs%26aulast%3DMcIlhenny%26aufirst%3DH.%2BM.%26atitle%3DMetabolism%2520of%2520%255B14C%255D-verapamil%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1971%26volume%3D14%26spage%3D1178%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For N-dealkylation of zaleplon see the following: </p></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">HorstkÃ¶tter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaschke, G.</span><span> </span><span class="NLM_article-title">Separation and identification of zaleplon metabolites in human urine using capillary electrophoresis with laser-induced fluorescence detection and liquid chromatographyâmass spectrometry</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1014</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1014&publication_year=2003&pages=71-81&author=C.+Horstk%C3%B6tterauthor=D.+Schepmannauthor=G.+Blaschke&title=Separation+and+identification+of+zaleplon+metabolites+in+human+urine+using+capillary+electrophoresis+with+laser-induced+fluorescence+detection+and+liquid+chromatography%E2%88%92mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorstk%25C3%25B6tter%26aufirst%3DC.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DBlaschke%26aufirst%3DG.%26atitle%3DSeparation%2520and%2520identification%2520of%2520zaleplon%2520metabolites%2520in%2520human%2520urine%2520using%2520capillary%2520electrophoresis%2520with%2520laser-induced%2520fluorescence%2520detection%2520and%2520liquid%2520chromatography%25E2%2588%2592mass%2520spectrometry%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2003%26volume%3D1014%26spage%3D71%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Renwick, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, B. G.</span><span> </span><span class="NLM_article-title">Metabolism of zaleplon by human hepatic microsomal cytochrome P450 isoforms</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">â</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=337-348&author=A.+B.+Renwickauthor=H.+Mistryauthor=S.+E.+Ballauthor=D.+G.+Waltersauthor=J.+Kaoauthor=B.+G.+Lake&title=Metabolism+of+zaleplon+by+human+hepatic+microsomal+cytochrome+P450+isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRenwick%26aufirst%3DA.%2BB.%26aulast%3DMistry%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DS.%2BE.%26aulast%3DWalters%26aufirst%3DD.%2BG.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DLake%26aufirst%3DB.%2BG.%26atitle%3DMetabolism%2520of%2520zaleplon%2520by%2520human%2520hepatic%2520microsomal%2520cytochrome%2520P450%2520isoforms%26jtitle%3DXenobiotica%26date%3D1998%26volume%3D28%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For N-dealkylation of citalopram see the following: </p></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sindrup, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broesen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaes-Joergensen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overoe, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, L. F.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms</span> <span class="citation_source-journal">Ther. Drug Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">â</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1097%2F00007691-199302000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=8451774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVaksLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1993&pages=11-17&author=S.+H.+Sindrupauthor=K.+Broesenauthor=M.+G.+J.+Hansenauthor=T.+Aaes-Joergensenauthor=K.+F.+Overoeauthor=L.+F.+Gram&title=Pharmacokinetics+of+citalopram+in+relation+to+the+sparteine+and+the+mephenytoin+oxidation+polymorphisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms</span></div><div class="casAuthors">Sindrup, S. H.; Broesen, K.; Hansen, M. G. J.; Aaes-Joergensen, T.; Overoe, K. F.; Gram, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Drug Monitoring</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">TDMODV</span>;
        ISSN:<span class="NLM_cas:issn">0163-4356</span>.
    </div><div class="casAbstract">The relationship between the metab. of the selective serotonin reuptake inhibitor citalopram and the sparteine and mephenytoin oxidn. polymorphisms was studied in 24 healthy men constituting panels of extensive metabolizers of sparteine and mephenytoin, poor metabolizers of sparteine, and poor metabolizers of mephenytoin.  Each subject was given 40 mg citalopram/day for 10 days, and citalopram and its desmethyl and didesmethyl metabolites were assayed in blood serum and urine.  A nonenantioselective HPLC method showed that the citalopram elimination partially depended on the mephenytoin oxygenase, since steady-state serum concn., half-life, and area under the serum concn./time curve for citalopram were higher in poor metabolizers than in extensive metabolizers of mephenytoin.  Both citalopram total clearance and demethylation clearance (formation of desmethylcitalopram) were lower in poor metabolizers of mephenytoin compared to extensive metabolizers.  The demethylation of desmethylcitalopram to didesmethylcitalopram depended on the sparteine oxygenase CYP2D6.  Didesmethylcitalopram could virtually not be detected in any poor metabolizers of sparteine, contrasting measurable serum levels in all sparteine/mephenytoin extensive metabolizers.  The demethylation clearance of desmethylcitalopram was lower in sparteine poor metabolizers compared to extensive metabolizers.  During administration of citalopram, there was a modest increase in sparteine metabolic ratio from median 0.31 to 0.80 in extensive metabolizers of sparteine, whereas the mephenytoin S/R ratio was unaltered during the citalopram treatment.  The sparteine and mephenytoin oxidn. polymorphism may contribute to the total pharmacokinetic variability of citalopram.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKX0vV6c--1LVg90H21EOLACvtfcHk0litZdC9QUKCHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVaksLc%253D&md5=176bc44781e0d3eeaac22126b6934da9</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1097%2F00007691-199302000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007691-199302000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DSindrup%26aufirst%3DS.%2BH.%26aulast%3DBroesen%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DAaes-Joergensen%26aufirst%3DT.%26aulast%3DOveroe%26aufirst%3DK.%2BF.%26aulast%3DGram%26aufirst%3DL.%2BF.%26atitle%3DPharmacokinetics%2520of%2520citalopram%2520in%2520relation%2520to%2520the%2520sparteine%2520and%2520the%2520mephenytoin%2520oxidation%2520polymorphisms%26jtitle%3DTher.%2520Drug%2520Monit.%26date%3D1993%26volume%3D15%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For N-dealkylation of gallopamil see the followng: </p></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Weymann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hege, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller-Peltzer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollmann, M.</span><span> </span><span class="NLM_article-title">Metabolism of the calcium antagonist gallopamil in man</span> <span class="citation_source-journal">Arzneim.-Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">â</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=2757679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL1MXksV2rsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1989&pages=605-607&author=J.+Weymannauthor=V.+Buehlerauthor=H.+C.+Hegeauthor=H.+Mueller-Peltzerauthor=G.+Schenkauthor=B.+Stierenauthor=M.+Hollmann&title=Metabolism+of+the+calcium+antagonist+gallopamil+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of the calcium antagonist gallopamil in man</span></div><div class="casAuthors">Weymann, J.; Buehler, V.; Hege, H. C.; Mueller-Peltzer, H.; Schenk, G.; Stieren, B.; Hollmann, M.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-7</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">The metab. of gallopamil (I) was studied in humans after oral administration of 50 mg or i.v. administration of 2 mg.  The clearance of the drug was largely metabolic with little excretion of unchanged drug.  After oral administration of labeled I, most of the radioactivity in plasma was due to metabolites.  The drug was excreted in urine and feces to the extent of â¼50 and 40%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNNEBXzQysubVg90H21EOLACvtfcHk0lgy3mmipwKr6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXksV2rsbY%253D&md5=30d41f76ea51d02cb4ad67fa97d09411</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeymann%26aufirst%3DJ.%26aulast%3DBuehler%26aufirst%3DV.%26aulast%3DHege%26aufirst%3DH.%2BC.%26aulast%3DMueller-Peltzer%26aufirst%3DH.%26aulast%3DSchenk%26aufirst%3DG.%26aulast%3DStieren%26aufirst%3DB.%26aulast%3DHollmann%26aufirst%3DM.%26atitle%3DMetabolism%2520of%2520the%2520calcium%2520antagonist%2520gallopamil%2520in%2520man%26jtitle%3DArzneim.-Forsch.%26date%3D1989%26volume%3D39%26spage%3D605%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><div class="note"><p class="first last">For N-acetylation of alogliptin see the following: </p></div><span class="NLM_contrib-group">Christopher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekki, Q. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wann, E. R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, A.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.clinthera.2008.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18405789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=513-527&author=R.+Christopherauthor=P.+Covingtonauthor=M.+Davenportauthor=P.+Fleckauthor=Q.+A+Mekkiauthor=E.+R+Wannauthor=A.+Karim&title=Pharmacokinetics%2C+pharmacodynamics%2C+and+tolerability+of+single+increasing+doses+of+the+dipeptidyl+peptidase-4+inhibitor+alogliptin+in+healthy+male+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects</span></div><div class="casAuthors">Christopher, Ronald; Covington, Paul; Davenport, Michael; Fleck, Penny; Mekki, Qais A.; Wann, Elisabeth R.; Karim, Aziz</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">513-527</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">Alogliptin is a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor that is under development for the treatment of type 2 diabetes.  This study was conducted to characterize the pharmacokinetics, pharmacodynamics, and tolerability of single oral doses of alogliptin in healthy male subjects.  This was a randomized, double-blind, placebo-controlled study in which healthy, nonobese male subjects between the ages of 18 and 55 years were assigned to 1 of 6 cohorts: alogliptin 25, 50, 100, 200, 400, or 800 mg.  One subject in each cohort received placebo.  An ascending-dose strategy was used, in which each cohort received its assigned dose only after review of the safety data from the previous cohort.  Blood and urine were collected over 72 h after dosing for pharmacokinetic anal. and detn. of plasma DPP-4 inhibition and active glucagon-like peptide-1 (GLP-1) concns.  Thirty-six subjects (6 per cohort) were enrolled and completed the study (29/36 [81%] white; mean age, 26.6 years; mean wt., 76.0 kg).  Alogliptin was rapidly absorbed (median Tmax, 1-2 h) and eliminated slowly (mean t1/2, 12.4-21.4 h), primarily via urinary excretion (mean fraction of drug excreted in urine from 0 to 72 h after dosing, 60-71%).  Cmax and AUC0-â increased dose proportionally over the range from 25 to 100 mg.  The metabolites M-I (N-demethylated) and M-II (N-acetylated) accounted for <2% and <6%, resp., of alogliptin concns. in plasma and urine.  Across alogliptin doses, mean peak DPP-4 inhibition ranged from 93% to 99%, and mean inhibition at 24 h after dosing ranged from 74% to 97%.  Exposure to active GLP-1 was 2- to 4-fold greater for all alogliptin doses compared with placebo; no dose response was apparent.  Hypoglycemia (asymptomatic) was reported in 5 subjects (1 receiving alogliptin 50 mg, 2 receiving alogliptin 200 mg, 1 receiving alogliptin 400 mg, 1 receiving placebo).  Other adverse events were reported in 1 subject each: dizziness (alogliptin 100 mg), syncope (alogliptin 200 mg), constipation (alogliptin 200 mg), viral infection (alogliptin 400 mg), hot flush (placebo), and nausea (placebo).  In these healthy male subjects, alogliptin at single doses up to 800 mg inhibited plasma DPP-4 activity, increased active GLP-1, and was generally well tolerated, with no dose-limiting toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQKWGGvZPSibVg90H21EOLACvtfcHk0lgy3mmipwKr6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLfI&md5=c1fd088985499025d3207a285a6e8577</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2008.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2008.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DChristopher%26aufirst%3DR.%26aulast%3DCovington%26aufirst%3DP.%26aulast%3DDavenport%26aufirst%3DM.%26aulast%3DFleck%26aufirst%3DP.%26aulast%3DMekki%26aufirst%3DQ.%2BA%26aulast%3DWann%26aufirst%3DE.%2BR%26aulast%3DKarim%26aufirst%3DA.%26atitle%3DPharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520tolerability%2520of%2520single%2520increasing%2520doses%2520of%2520the%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520alogliptin%2520in%2520healthy%2520male%2520subjects%26jtitle%3DClin.%2520Ther.%26date%3D2008%26volume%3D30%26spage%3D513%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="note"><p class="first last">For oxidation of trilostane: </p></div><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatematsu, A.</span><span> </span><span class="NLM_article-title">Study on metabolites of trilostane, an inhibitor of adrenal steroidogenesis</span> <span class="citation_source-journal">J. Pharmacobio-Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">S10</span><span class="NLM_x">â</span> <span class="NLM_lpage">S-22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1980&pages=S10-S-22&author=M.+Suzukiauthor=Y.+Moriauthor=M.+Tsuboiauthor=A.+Tatematsu&title=Study+on+metabolites+of+trilostane%2C+an+inhibitor+of+adrenal+steroidogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DTsuboi%26aufirst%3DM.%26aulast%3DTatematsu%26aufirst%3DA.%26atitle%3DStudy%2520on%2520metabolites%2520of%2520trilostane%252C%2520an%2520inhibitor%2520of%2520adrenal%2520steroidogenesis%26jtitle%3DJ.%2520Pharmacobio-Dyn.%26date%3D1980%26volume%3D3%26spage%3DS10%26epage%3DS-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation and methylation of cimetidine:</p></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Waring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. L.</span><span> </span><span class="NLM_article-title">Novel aspects of the metabolism of cimetidine in the guinea pig</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">â</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1042%2Fbst0140098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL28Xhsl2ltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1986&pages=98-99&author=R.+H.+Waringauthor=S.+C.+Mitchellauthor=R.+Blundellauthor=R.+L.+Smith&title=Novel+aspects+of+the+metabolism+of+cimetidine+in+the+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel aspects of the metabolism of cimetidine in the guinea pig</span></div><div class="casAuthors">Waring, R. H.; Mitchell, S. C.; Blundell, R.; Smith, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-9</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    </div><div class="casAbstract">In guinea pigs given 14C-labeled cimetidine  [51481-61-9] orally, excellent recovery of the drug was obtained, with the fecal and urinary routes of elimination being of equal importance.  Cimetidine sulfoxide  [54237-72-8] was the major metabolite in urine, feces, and bile; other radioactive compds. identified in urine, feces, and bile were the N'-glucuronide  [101912-02-1] and a small amt. of cimetidine guanylurea  [77076-18-7] in the urine.  In addn., a previously unreported metabolite was found in the urine and was identified as N-methylcimetidine  [52378-54-8]; N-methylcimetidine sulfoxide  [101912-01-0] was also detected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE27OoGqvJQrVg90H21EOLACvtfcHk0lgy3mmipwKr6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xhsl2ltL0%253D&md5=e9a56da3e620d6959d5c52d8ab986e50</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1042%2Fbst0140098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0140098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DR.%2BH.%26aulast%3DMitchell%26aufirst%3DS.%2BC.%26aulast%3DBlundell%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BL.%26atitle%3DNovel%2520aspects%2520of%2520the%2520metabolism%2520of%2520cimetidine%2520in%2520the%2520guinea%2520pig%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1986%26volume%3D14%26spage%3D98%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Taylor, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresswell, P. R.</span><span> </span><span class="NLM_article-title">The metabolism of cimetidine in the rat, dog and man</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">â</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1042%2Fbst0030884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaE28XktFemu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1975&pages=884-885&author=D.+C.+Taylorauthor=P.+R.+Cresswell&title=The+metabolism+of+cimetidine+in+the+rat%2C+dog+and+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of cimetidine in the rat, dog and man</span></div><div class="casAuthors">Taylor, Donald C.; Cresswell, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">884-5</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    </div><div class="casAbstract">The patterns of labeled metabolites of 2-3H- or 2-14C-labeled cimetidine (I) [51481-61-9] (i.v. or oral) in urine were similar in rats, dogs, and man: the major metabolite was the sulfoxide of I with smaller amts. of the hydroxymethyl deriv. II [59359-50-1] and the guanylurea III [59359-51-2].  In 24 hr after oral administration of I to female rats, male rats, dogs, and man, the percentages of label excreted in urine were 64, 58, 72, and 69 resp.; after i.v. doses these values were 73, 71, 98, and 97% resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprBeRhrRbDybVg90H21EOLACvtfcHk0lgkJCgEavkzhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XktFemu7c%253D&md5=bab9b2702d3cbeaf19e028dd4745ccee</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1042%2Fbst0030884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0030884%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DD.%2BC.%26aulast%3DCresswell%26aufirst%3DP.%2BR.%26atitle%3DThe%2520metabolism%2520of%2520cimetidine%2520in%2520the%2520rat%252C%2520dog%2520and%2520man%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1975%26volume%3D3%26spage%3D884%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation of pinicidil:</p></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">DeLong, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldham, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSante, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, D. P.</span><span> </span><span class="NLM_article-title">Disposition of [<sup>14</sup>C]pinacidil in humans</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1988&pages=153-156&author=A.+F.+DeLongauthor=S.+W.+Oldhamauthor=K.+A.+DeSanteauthor=G.+Nellauthor=D.+P.+Henry&title=Disposition+of+%5B14C%5Dpinacidil+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeLong%26aufirst%3DA.%2BF.%26aulast%3DOldham%26aufirst%3DS.%2BW.%26aulast%3DDeSante%26aufirst%3DK.%2BA.%26aulast%3DNell%26aufirst%3DG.%26aulast%3DHenry%26aufirst%3DD.%2BP.%26atitle%3DDisposition%2520of%2520%255B14C%255Dpinacidil%2520in%2520humans%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1988%26volume%3D77%26spage%3D153%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">McBurney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. W.</span><span> </span><span class="NLM_article-title">Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-<i>N</i>-oxide following i.v. and oral administration in healthy volunteers</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">â</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1365-2125.1985.tb02618.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3978025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2MXhslamsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1985&pages=91-94&author=A.+McBurneyauthor=P.+R.+Farrowauthor=S.+Ainsworthauthor=J.+W.+Ward&title=Serum+concentrations+and+urinary+excretion+of+pinacidil+and+its+major+metabolite%2C+pinacidil+pyridine-N-oxide+following+i.v.+and+oral+administration+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers</span></div><div class="casAuthors">McBurney, A.; Farrow, P. R.; Ainsworth, S.; Ward, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-4</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Serum concns. of pinacidil  [60560-33-0] and its major metabolite pinacidil pyridine-N-oxide  [83285-82-9] were detd. following administration of both an i.v. soln. and a sustained release oral prepn. to healthy volunteers.  Mean bioavailability of pinacidil was 57.1%.  Following i.v. administration, the mean area under the concn.-time curve (AUC0-8 h) metabolite/AUC0-8 h pinacidil ratio was 0.559 and after oral administration, 0.825.  Only 1 subject had serum metabolite concns. in excess of pinacidil during the i.v. study whereas three subjects achieved metabolite concns. in excess of pinacidil during the oral study.  The mean serum elimination half-life of metabolite was longer than parent drug following i.v. administration but not after oral administration.  No significant difference was found in the max. measured metabolite concn. (Cmax.m) between the studies.  The time to Cmax.m was delayed following oral dosage.  Urinary excretion (24 L) of metabolite was increased following oral administration whilst that of pinacidil was decreased.  These results suggest that pinacidil pyridine-N-oxide may be a first-pass metabolite of pinacidil.  In most patients pinacidil pyridine-N-oxide is unlikely to contribute significantly to the hypotensive effect of pinacidil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIthVj6HqfC7Vg90H21EOLACvtfcHk0lgkJCgEavkzhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhslamsb8%253D&md5=7442165c083e40f448a8926a1c43bdec</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1985.tb02618.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1985.tb02618.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcBurney%26aufirst%3DA.%26aulast%3DFarrow%26aufirst%3DP.%2BR.%26aulast%3DAinsworth%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DJ.%2BW.%26atitle%3DSerum%2520concentrations%2520and%2520urinary%2520excretion%2520of%2520pinacidil%2520and%2520its%2520major%2520metabolite%252C%2520pinacidil%2520pyridine-N-oxide%2520following%2520i.v.%2520and%2520oral%2520administration%2520in%2520healthy%2520volunteers%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D19%26spage%3D91%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation of letrozole see the following:</p></div><div class="NLM_citation" id="cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Rodriguez-Flores, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salcedo, A. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, L. M.</span><span> </span><span class="NLM_article-title">Rapid quantitative analysis of letrozole, fluoxetine and their metabolites in biological and environmental samples by MEKC</span> <span class="citation_source-journal">Electrophoresis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">â</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=624-632&author=J.+Rodriguez-Floresauthor=A.+M.+C.+Salcedoauthor=L.+M.+Fernandez&title=Rapid+quantitative+analysis+of+letrozole%2C+fluoxetine+and+their+metabolites+in+biological+and+environmental+samples+by+MEKC"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Flores%26aufirst%3DJ.%26aulast%3DSalcedo%26aufirst%3DA.%2BM.%2BC.%26aulast%3DFernandez%26aufirst%3DL.%2BM.%26atitle%3DRapid%2520quantitative%2520analysis%2520of%2520letrozole%252C%2520fluoxetine%2520and%2520their%2520metabolites%2520in%2520biological%2520and%2520environmental%2520samples%2520by%2520MEKC%26jtitle%3DElectrophoresis%26date%3D2009%26volume%3D30%26spage%3D624%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Rodriguez, F., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salcedo, A. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villasenor Llerena, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz Fernandez, L.</span><span> </span><span class="NLM_article-title">Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1185</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">â</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1185&publication_year=2008&pages=281-290&author=F.%2C+J.+Rodriguezauthor=A.+M.+C.+Salcedoauthor=M.+J.+Villasenor+Llerenaauthor=L.+Munoz+Fernandez&title=Micellar+electrokinetic+chromatographic+method+for+the+determination+of+letrozole%2C+citalopram+and+their+metabolites+in+human+urine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DF.%252C%2BJ.%26aulast%3DSalcedo%26aufirst%3DA.%2BM.%2BC.%26aulast%3DVillasenor%2BLlerena%26aufirst%3DM.%2BJ.%26aulast%3DMunoz%2BFernandez%26aufirst%3DL.%26atitle%3DMicellar%2520electrokinetic%2520chromatographic%2520method%2520for%2520the%2520determination%2520of%2520letrozole%252C%2520citalopram%2520and%2520their%2520metabolites%2520in%2520human%2520urine%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2008%26volume%3D1185%26spage%3D281%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation of nilvadipine see:</p></div><div class="NLM_citation" id="cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Terashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiokawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, H.</span><span> </span><span class="NLM_article-title">Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">â</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=1415-1425&author=S.+Terashitaauthor=Y.+Tokumaauthor=T.+Fujiwaraauthor=Y.+Shiokawaauthor=K.+Okumuraauthor=H.+Noguchi&title=Metabolism+of+nilvadipine%2C+a+new+dihydropyridine+calcium+antagonist%2C+in+rats+and+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTokuma%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DShiokawa%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DH.%26atitle%3DMetabolism%2520of%2520nilvadipine%252C%2520a%2520new%2520dihydropyridine%2520calcium%2520antagonist%252C%2520in%2520rats%2520and%2520dogs%26jtitle%3DXenobiotica%26date%3D1987%26volume%3D17%26spage%3D1415%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wit, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Genderen, H.</span><span> </span><span class="NLM_article-title">Metabolism of the herbicide 2,6-dichlorobenzonitrile in rabbits and rats</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">â</span> <span class="NLM_lpage">706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1966&pages=698-706&author=J.+G.+Witauthor=H.+van+Genderen&title=Metabolism+of+the+herbicide+2%2C6-dichlorobenzonitrile+in+rabbits+and+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWit%26aufirst%3DJ.%2BG.%26aulast%3Dvan%2BGenderen%26aufirst%3DH.%26atitle%3DMetabolism%2520of%2520the%2520herbicide%25202%252C6-dichlorobenzonitrile%2520in%2520rabbits%2520and%2520rats%26jtitle%3DBiochem.%2520J.%26date%3D1966%26volume%3D101%26spage%3D698%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hutson, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoadley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donninger, C.</span><span> </span><span class="NLM_article-title">Mercapturic acid formation in the metabolism of 2-chloro-4-ethylamino-6-(1-methyl-1-cyanoethylamino)-<i>s</i>-triazine in the rat</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">â</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf60169a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1970&pages=507-512&author=D.+H.+Hutsonauthor=E.+C.+Hoadleyauthor=M.+H.+Griffithsauthor=C.+Donninger&title=Mercapturic+acid+formation+in+the+metabolism+of+2-chloro-4-ethylamino-6-%281-methyl-1-cyanoethylamino%29-s-triazine+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjf60169a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf60169a035%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DD.%2BH.%26aulast%3DHoadley%26aufirst%3DE.%2BC.%26aulast%3DGriffiths%26aufirst%3DM.%2BH.%26aulast%3DDonninger%26aufirst%3DC.%26atitle%3DMercapturic%2520acid%2520formation%2520in%2520the%2520metabolism%2520of%25202-chloro-4-ethylamino-6-%25281-methyl-1-cyanoethylamino%2529-s-triazine%2520in%2520the%2520rat%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D1970%26volume%3D18%26spage%3D507%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tanii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">Influence of ethanol on the in vivo and in vitro metabolism of nitriles in mice</span> <span class="citation_source-journal">Arch. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2FBF00340977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3964080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL28Xht1Ckurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1986&pages=171-176&author=H.+Taniiauthor=K.+Hashimoto&title=Influence+of+ethanol+on+the+in+vivo+and+in+vitro+metabolism+of+nitriles+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of ethanol on the in vivo and in vitro metabolism of nitriles in mice</span></div><div class="casAuthors">Tanii, Hideji; Hashimoto, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-6</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    </div><div class="casAbstract">The effect of EtOH  [64-17-5] on metab. of 20 nitriles was studied in vivo and in vitro in mice.  The hepatic microsomal metabolizing activity for nitriles was at a max. 13 h after EtOH dosing (4.0 g/kg).  Using microsomes from mice pretreated with EtOH under the above conditions, enhancement of the in vitro metab. of nitriles was 1.00-1.83 compared with the glucose-treated control.  When mice were orally given nitriles 13 h after dosing with either EtOH (4.0 g/kg) or glucose (7.0 g/kg), the hepatic metabolizing activity of nitriles for the EtOH-treated group was always higher than that for the glucose group, although no change in the content of hepatic microsomal cytochrome P 450  [9035-51-2] was obsd. between the 2 groups.  However, EtOH added to the incubation mixt. inhibited the in vitro metab. of most nitriles.  Evidently EtOH can enhance the acute toxicity of nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXhcc0k5uTZ7Vg90H21EOLACvtfcHk0lgY00EJEr2Heg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1Ckurc%253D&md5=dbd8ed200e84144d02f3fd68f099b63a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2FBF00340977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00340977%26sid%3Dliteratum%253Aachs%26aulast%3DTanii%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DInfluence%2520of%2520ethanol%2520on%2520the%2520in%2520vivo%2520and%2520in%2520vitro%2520metabolism%2520of%2520nitriles%2520in%2520mice%26jtitle%3DArch.%2520Toxicol.%26date%3D1986%26volume%3D58%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Singh, P. D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, S. P.</span><span> </span><span class="NLM_article-title">Metabolism of mandelonitrile in the rat</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2207</span><span class="NLM_x">â</span> <span class="NLM_lpage">2209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=2207-2209&author=P.+D.+A.+Singhauthor=J.+R.+Jacksonauthor=S.+P.+James&title=Metabolism+of+mandelonitrile+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%2BD.%2BA.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DJames%26aufirst%3DS.%2BP.%26atitle%3DMetabolism%2520of%2520mandelonitrile%2520in%2520the%2520rat%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D2207%26epage%3D2209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, A. I.</span><span> </span><span class="NLM_article-title">Synthesis of 2-tetralones via a novel 1,2-carbonyl transposition of 1-tetralones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3243</span><span class="NLM_x">â</span> <span class="NLM_lpage">3246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=3243-3246&author=D.+C.+Prydeauthor=S.+S.+Henryauthor=A.+I.+Meyers&title=Synthesis+of+2-tetralones+via+a+novel+1%2C2-carbonyl+transposition+of+1-tetralones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DHenry%26aufirst%3DS.%2BS.%26aulast%3DMeyers%26aufirst%3DA.%2BI.%26atitle%3DSynthesis%2520of%25202-tetralones%2520via%2520a%2520novel%25201%252C2-carbonyl%2520transposition%2520of%25201-tetralones%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D3243%26epage%3D3246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aiai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudy-Flocâh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grel, P.</span><span> </span><span class="NLM_article-title">First Sharpless epoxidation of electrophilic 2-cyano allylic alcohols</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2249</span><span class="NLM_x">â</span> <span class="NLM_lpage">2252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=2249-2252&author=M.+Aiaiauthor=A.+Robertauthor=M.+Baudy-Floc%E2%80%99hauthor=P.+Le+Grel&title=First+Sharpless+epoxidation+of+electrophilic+2-cyano+allylic+alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAiai%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DA.%26aulast%3DBaudy-Floc%25E2%2580%2599h%26aufirst%3DM.%26aulast%3DLe%2BGrel%26aufirst%3DP.%26atitle%3DFirst%2520Sharpless%2520epoxidation%2520of%2520electrophilic%25202-cyano%2520allylic%2520alcohols%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1995%26volume%3D6%26spage%3D2249%26epage%3D2252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Miyashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikoshi, A.</span><span> </span><span class="NLM_article-title">Fluoride-promoted epoxidation of Î±,Î²-unsaturated compounds</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=285-288&author=M.+Miyashitaauthor=T.+Suzukiauthor=A.+Yoshikoshi&title=Fluoride-promoted+epoxidation+of+%CE%B1%2C%CE%B2-unsaturated+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyashita%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYoshikoshi%26aufirst%3DA.%26atitle%3DFluoride-promoted%2520epoxidation%2520of%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520compounds%26jtitle%3DChem.%2520Lett.%26date%3D1987%26spage%3D285%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einolf, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D.</span><span> </span><span class="NLM_article-title">Absorption, metabolism, and excretion of [<sup>14</sup>C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">â</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=536-544&author=H.+Heauthor=P.+Tranauthor=H.+Yinauthor=H.+Smithauthor=Y.+Batardauthor=L.+Wangauthor=H.+Einolfauthor=H.+Guauthor=J.+B.+Mangoldauthor=V.+Fischerauthor=D.+Howard&title=Absorption%2C+metabolism%2C+and+excretion+of+%5B14C%5Dvildagliptin%2C+a+novel+dipeptidyl+peptidase+4+inhibitor%2C+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DTran%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DH.%26aulast%3DBatard%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DEinolf%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DMangold%26aufirst%3DJ.%2BB.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHoward%26aufirst%3DD.%26atitle%3DAbsorption%252C%2520metabolism%252C%2520and%2520excretion%2520of%2520%255B14C%255Dvildagliptin%252C%2520a%2520novel%2520dipeptidyl%2520peptidase%25204%2520inhibitor%252C%2520in%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D536%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Urinary metabolites of pinacidil. II. Species difference in the metabolism of pinacidil</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">â</span> <span class="NLM_lpage">656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1993&pages=649-656&author=K.+Sakamotoauthor=Y.+Nakamura&title=Urinary+metabolites+of+pinacidil.+II.+Species+difference+in+the+metabolism+of+pinacidil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DUrinary%2520metabolites%2520of%2520pinacidil.%2520II.%2520Species%2520difference%2520in%2520the%2520metabolism%2520of%2520pinacidil%26jtitle%3DXenobiotica%26date%3D1993%26volume%3D23%26spage%3D649%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Urinary metabolites of pinacidil: I. Isolation and identification of the metabolites in rat urine</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">â</span> <span class="NLM_lpage">400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1993&pages=391-400&author=K.+Sakamotoauthor=Y.+Nakamura&title=Urinary+metabolites+of+pinacidil%3A+I.+Isolation+and+identification+of+the+metabolites+in+rat+urine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DUrinary%2520metabolites%2520of%2520pinacidil%253A%2520I.%2520Isolation%2520and%2520identification%2520of%2520the%2520metabolites%2520in%2520rat%2520urine%26jtitle%3DXenobiotica%26date%3D1993%26volume%3D23%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For an example where nitrile hydrolysis may be present or an artifact of the analysis technique see ref <a onclick="showRef(event, 'cit10h'); return false;" href="javascript:void(0);" class="ref cit10h">10h</a>. An extensive metabolic profiling of lersivirine identified less than two percent of metabolites arising from nitrile hydrolysis.<a onclick="showRef(event, 'cit6e'); return false;" href="javascript:void(0);" class="ref cit6e">(6e)</a></p></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Le Questel, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, C.</span><span> </span><span class="NLM_article-title">Hydrogen-bond acceptor properties of nitriles: a combined crystallographic and ab initio theoretical investigation</span> <span class="citation_source-journal">J. Phys. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2F1099-1395%28200006%2913%3A6%3C347%3A%3AAID-POC251%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Kmsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=347-358&author=J.-Y.+Le+Questelauthor=M.+Berthelotauthor=C.+Laurence&title=Hydrogen-bond+acceptor+properties+of+nitriles%3A+a+combined+crystallographic+and+ab+initio+theoretical+investigation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen-bond acceptor properties of nitriles: a combined crystallographic and ab initio theoretical investigation</span></div><div class="casAuthors">Le Questel, Jean-Yves; Berthelot, Michel; Laurence, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-358</span>CODEN:
                <span class="NLM_cas:coden">JPOCEE</span>;
        ISSN:<span class="NLM_cas:issn">0894-3230</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The H-bond ability of N in X-Câ¡NÂ·Â·Â·HO-R systems was studied using crystallog. data retrieved from the Cambridge Structural Database and via ab initio calcns.  The classification of H-bond geometries by the nature of the donor shows that the strength of the interaction increases in the order H2O â alcs. < phenols.  If the H-bond geometries are classified according to the nature of the acceptor inside each sample of donor, the strongest H bonds are always obsd. for "push-pull" nitriles, as obsd. in soln. on the pKHB scale for such mols.  Ab initio MO calcns. are then used to compute descriptors of H-bond basicity (enthalpy ÎHÂ°, H-bond length and min. electrostatic potential of the base) for H-bond formation between H2O and 18 nitriles embracing a wide range of structure and basicity.  Correlations between the H-bond basicity scale pKHB and these quantum-mech. descriptors allow the calcn. of pKHB values for exptl. inaccessible bases and the treatment of polyfunctional nitriles.  They also confirm the super-basicity of the nitrile group of cimetidine (I), a well known antiulcer drug.  This property might be relevant in the mol. recognition of I by the H2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bBQPgdH--7Vg90H21EOLACvtfcHk0lgBODvktzdxAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Kmsbs%253D&md5=bf5ce14ba874919ad07b71c58bc2645a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F1099-1395%28200006%2913%3A6%3C347%3A%3AAID-POC251%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-1395%2528200006%252913%253A6%253C347%253A%253AAID-POC251%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BQuestel%26aufirst%3DJ.-Y.%26aulast%3DBerthelot%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DC.%26atitle%3DHydrogen-bond%2520acceptor%2520properties%2520of%2520nitriles%253A%2520a%2520combined%2520crystallographic%2520and%2520ab%2520initio%2520theoretical%2520investigation%26jtitle%3DJ.%2520Phys.%2520Org.%2520Chem.%26date%3D2000%26volume%3D13%26spage%3D347%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> The mean bond length of 1.14 Ã was obtained by averaging 5059 nitriles located in the Cambridge Structural Database.</p></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sheppard, W. A.</span> In  <span class="citation_source-book">The Chemistry of the Cyano Group</span>; <span class="NLM_contrib-group">Rappoport, Z.</span>, Ed.; <span class="NLM_publisher-name">Interscience</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1970</span><span class="NLM_x">; </span>Chapter 5.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&author=W.+A.+Sheppardauthor=Z.+Rappoport&title=The+Chemistry+of+the+Cyano+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DW.%2BA.%26btitle%3DThe%2520Chemistry%2520of%2520the%2520Cyano%2520Group%26aulast%3DRappoport%26aufirst%3DZ.%26pub%3DInterscience%26date%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">Based on a comparison of <i>A</i> values for nitrile and methyl groups:</p></div><span class="NLM_contrib-group">Eliel, E. L.; Wilen, S. H.; Mander, L. N.</span> <span class="citation_source-book">Stereochemistry of Organic Compounds</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1994</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">696</span>â <span class="NLM_lpage">697</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=696-697&author=E.+L.+Eliel&author=S.+H.+Wilen&author=L.+N.+Mander&title=Stereochemistry+of+Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEliel%26aufirst%3DE.%2BL.%26btitle%3DStereochemistry%2520of%2520Organic%2520Compounds%26pub%3DWiley%26date%3D1994%26spage%3D696%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">See, for example, the cocrystal structures of cathepsin K with bound inhibitor: </p></div><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomuraa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohdaa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasakia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemuraa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadaa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometania, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasakia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacobb, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missbachb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattmannb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betscharta, C.</span><span> </span><span class="NLM_article-title">Novel scaffold for cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6096</span><span class="NLM_x">â</span> <span class="NLM_lpage">6100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2007.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17911019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6096-6100&author=N.+Tenoauthor=T.+Miyakeauthor=T.+Eharaauthor=O.+Irieauthor=J.+Sakakiauthor=O.+Ohmoriauthor=H.+Gunjiauthor=N.+Matsuuraauthor=K.+Masuyaauthor=Y.+Hitomiauthor=K.+Nonomuraaauthor=M.+Horiuchiaauthor=K.+Gohdaaauthor=A.+Iwasakiaauthor=I.+Umemuraaauthor=S.+Tadaaauthor=M.+Kometaniaauthor=G.+Iwasakiaauthor=S.+W.+Cowan-Jacobbauthor=M.+Missbachbauthor=R.+Lattmannbauthor=C.+Betscharta&title=Novel+scaffold+for+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel scaffold for cathepsin K inhibitors</span></div><div class="casAuthors">Teno, Naoki; Miyake, Takahiro; Ehara, Takeru; Irie, Osamu; Sakaki, Junichi; Ohmori, Osamu; Gunji, Hiroki; Matsuura, Naoko; Masuya, Keiichi; Hitomi, Yuko; Nonomura, Kazuhiko; Horiuchi, Miyuki; Gohda, Keigo; Iwasaki, Atsuko; Umemura, Ichiro; Tada, Sachiyo; Kometani, Motohiko; Iwasaki, Genji; Cowan-Jacob, Sandra W.; Missbach, Martin; Lattmann, Rene; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6096-6100</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pyrrolopyrimidine, a novel scaffold, allows to adjust interactions within the S3 subsite of cathepsin K.  The core intermediate 10 (I) facilitated the P3 optimization and identified highly potent and selective cathepsin K inhibitors 11-20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovAekeL5ajUrVg90H21EOLACvtfcHk0lixq7tswJrksA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N&md5=9320305ef6bd02c637ffb0dd1afd367d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DEhara%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DSakaki%26aufirst%3DJ.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DGunji%26aufirst%3DH.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DHitomi%26aufirst%3DY.%26aulast%3DNonomuraa%26aufirst%3DK.%26aulast%3DHoriuchia%26aufirst%3DM.%26aulast%3DGohdaa%26aufirst%3DK.%26aulast%3DIwasakia%26aufirst%3DA.%26aulast%3DUmemuraa%26aufirst%3DI.%26aulast%3DTadaa%26aufirst%3DS.%26aulast%3DKometania%26aufirst%3DM.%26aulast%3DIwasakia%26aufirst%3DG.%26aulast%3DCowan-Jacobb%26aufirst%3DS.%2BW.%26aulast%3DMissbachb%26aufirst%3DM.%26aulast%3DLattmannb%26aufirst%3DR.%26aulast%3DBetscharta%26aufirst%3DC.%26atitle%3DNovel%2520scaffold%2520for%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6096%26epage%3D6100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">The hydrogen bond acceptor properties of nitriles are variously described as âmedium to weakâ<a onclick="showRef(event, 'cit21a'); return false;" href="javascript:void(0);" class="ref cit21a">(21a)</a> and excellent.<a onclick="showRef(event, 'cit21b'); return false;" href="javascript:void(0);" class="ref cit21b">(21b)</a></p></div><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pKBHX Database: toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4073</span><span class="NLM_x">â</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.-Y.+Le+Questelauthor=E.+Renault&title=The+pKBHX+Database%3A+toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0lixq7tswJrksA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.-Y.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pKBHX%2520Database%253A%2520toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4073%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Allerhand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleyer, P.</span><span> </span><span class="NLM_article-title">von Rague nitriles and isonitriles as proton acceptors in hydrogen bonding: correlation of ÎÎ½OH with acceptor structure</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">â</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00890a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=866-870&author=A.+Allerhandauthor=P.+Schleyer&title=von+Rague+nitriles+and+isonitriles+as+proton+acceptors+in+hydrogen+bonding%3A+correlation+of+%CE%94%CE%BDOH+with+acceptor+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fja00890a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00890a006%26sid%3Dliteratum%253Aachs%26aulast%3DAllerhand%26aufirst%3DA.%26aulast%3DSchleyer%26aufirst%3DP.%26atitle%3Dvon%2520Rague%2520nitriles%2520and%2520isonitriles%2520as%2520proton%2520acceptors%2520in%2520hydrogen%2520bonding%253A%2520correlation%2520of%2520%25CE%2594%25CE%25BDOH%2520with%2520acceptor%2520structure%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26spage%3D866%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A,</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palusczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17Î±-hydroxylase/C17,20-lyase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">â</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000955s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=672-680&author=M.+Recanatiniauthor=A.+Bisiauthor=A.+Cavalliauthor=F.+Bellutiauthor=S.+Gobbiauthor=A%2C+Rampaauthor=P.+Valentiauthor=M.+Palzerauthor=A.+Palusczakauthor=R.+W.+Hartmann&title=A+new+class+of+nonsteroidal+aromatase+inhibitors%3A+design+and+synthesis+of+chromone+and+xanthone+derivatives+and+inhibition+of+the+P450+enzymes+aromatase+and+17%CE%B1-hydroxylase%2FC17%2C20-lyase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm000955s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000955s%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRampa%26aufirst%3DA%252C%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DPalzer%26aufirst%3DM.%26aulast%3DPalusczak%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DA%2520new%2520class%2520of%2520nonsteroidal%2520aromatase%2520inhibitors%253A%2520design%2520and%2520synthesis%2520of%2520chromone%2520and%2520xanthone%2520derivatives%2520and%2520inhibition%2520of%2520the%2520P450%2520enzymes%2520aromatase%2520and%252017%25CE%25B1-hydroxylase%252FC17%252C20-lyase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D672%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batzl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rihs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span> </span><span class="NLM_article-title">Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">â</span> <span class="NLM_lpage">1400</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00062a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1393-1400&author=P.+Furetauthor=C.+Batzlauthor=A.+Bhatnagarauthor=E.+Francotteauthor=G.+Rihsauthor=M.+Lang&title=Aromatase+inhibitors%3A+synthesis%2C+biological+activity%2C+and+binding+mode+of+azole-type+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm00062a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00062a012%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DBatzl%26aufirst%3DC.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DFrancotte%26aufirst%3DE.%26aulast%3DRihs%26aufirst%3DG.%26aulast%3DLang%26aufirst%3DM.%26atitle%3DAromatase%2520inhibitors%253A%2520synthesis%252C%2520biological%2520activity%252C%2520and%2520binding%2520mode%2520of%2520azole-type%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D1393%26epage%3D1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">Modeling indicates that the nitrile mimics the carbonyl by interacting with amino acids at the active site, possibly through hydrogen bonds.<a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kelloff, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubet, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawk, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigman, C. C.</span><span> </span><span class="NLM_article-title">Aromatase inhibitors as potential cancer chemopreventives</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=65-78&author=G.+J.+Kelloffauthor=R.+A.+Lubetauthor=R.+Liebermanauthor=K.+Eisenhauerauthor=V.+E.+Steeleauthor=J.+A.+Crowellauthor=E.+T.+Hawkauthor=C.+W.+Booneauthor=C.+C.+Sigman&title=Aromatase+inhibitors+as+potential+cancer+chemopreventives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelloff%26aufirst%3DG.%2BJ.%26aulast%3DLubet%26aufirst%3DR.%2BA.%26aulast%3DLieberman%26aufirst%3DR.%26aulast%3DEisenhauer%26aufirst%3DK.%26aulast%3DSteele%26aufirst%3DV.%2BE.%26aulast%3DCrowell%26aufirst%3DJ.%2BA.%26aulast%3DHawk%26aufirst%3DE.%2BT.%26aulast%3DBoone%26aufirst%3DC.%2BW.%26aulast%3DSigman%26aufirst%3DC.%2BC.%26atitle%3DAromatase%2520inhibitors%2520as%2520potential%2520cancer%2520chemopreventives%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D1998%26volume%3D7%26spage%3D65%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Browne, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnager, A.</span><span> </span><span class="NLM_article-title">Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">â</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=725-736&author=L.+J.+Browneauthor=C.+Gudeauthor=H.+Rodriguezauthor=R.+E.+Steeleauthor=A.+Bhatnager&title=Fadrozole+hydrochloride%3A+a+potent%2C+selective%2C+nonsteroidal+inhibitor+of+aromatase+for+the+treatment+of+estrogen-dependent+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a038%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DL.%2BJ.%26aulast%3DGude%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DH.%26aulast%3DSteele%26aufirst%3DR.%2BE.%26aulast%3DBhatnager%26aufirst%3DA.%26atitle%3DFadrozole%2520hydrochloride%253A%2520a%2520potent%252C%2520selective%252C%2520nonsteroidal%2520inhibitor%2520of%2520aromatase%2520for%2520the%2520treatment%2520of%2520estrogen-dependent%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D725%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bhatnagar, A. S.</span><span> </span><span class="NLM_article-title">The discovery and mechanism of action of letrozole</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2Fs10549-007-9696-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17912633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=7-17&author=A.+S.+Bhatnagar&title=The+discovery+and+mechanism+of+action+of+letrozole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and mechanism of action of letrozole</span></div><div class="casAuthors">Bhatnagar, Ajay S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Because estrogen contributes to the promotion and progression of breast cancer, a greater understanding of the role of estrogen in breast cancer has led to therapeutic strategies targeting estrogen synthesis, the estrogen receptor, and intracellular signaling pathways.  The enzyme aromatase catalyzes the final step in estrogen biosynthesis and was identified as an attractive target for selective inhibition.  Modern third-generation aromatase inhibitors (AIs) effectively block the prodn. of estrogen without exerting effects on other steroidogenic pathways.  The discovery of letrozole (Femara) achieved the goal of discovering a highly potent and totally selective AI.  Letrozole has greater potency than other AIs, including anastrozole, exemestane, formestane, and aminoglutethimide.  Moreover, letrozole produces near complete inhibition of aromatase in peripheral tissues and is assocd. with greater suppression of estrogen than is achieved with other AIs.  The potent anti-tumor effects of letrozole were demonstrated in several animal models.  Studies with MCF-7Ca xenografts successfully predicted that letrozole would be clin. superior to the previous gold std. tamoxifen and also indicated that it may be more effective than other AIs.  An extensive program of randomized clin. trials has demonstrated the clin. benefits of letrozole across the spectrum of hormone-responsive breast cancer in postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAJhzeEx05lrVg90H21EOLACvtfcHk0ljkTjJKXjx5aw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL&md5=4215659d9116c2cb13d100d04b4acb66</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9696-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9696-3%26sid%3Dliteratum%253Aachs%26aulast%3DBhatnagar%26aufirst%3DA.%2BS.%26atitle%3DThe%2520discovery%2520and%2520mechanism%2520of%2520action%2520of%2520letrozole%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D105%26spage%3D7%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">â</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1210%2Fme.2006-0281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17095574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWisLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=401-414&author=Y.+Hongauthor=B.+Yuauthor=M.+Shermanauthor=Y.-C.+Yuanauthor=D.+Zhouauthor=S.+Chen&title=Molecular+basis+for+the+aromatization+reaction+and+exemestane-mediated+irreversible+inhibition+of+human+aromatase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase</span></div><div class="casAuthors">Hong, Yanyan; Yu, Bin; Sherman, Mark; Yuan, Yate-Ching; Zhou, Dujin; Chen, Shiuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">401-414</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Aromatase converts androgens to arom. estrogens.  Aromatase inhibitors have been used as first-line drugs in the treatment of hormone-dependent breast cancer.  Structural basis of the aromatization reaction and drug recognition by aromatase has remained elusive because of its unknown three-dimensional structure.  In this study, recombinant human aromatase was expressed and purified from Escherichia coli.  Using this purified and active prepn., the three-dimensional folding of aromatase was revealed by proteomic anal.  Combined with site-directed mutagenesis, several crit. residues involved in enzyme catalysis and suicide inhibition by exemestane were evaluated.  Based on our results, a new clamping mechanism of substrate/exemestane binding to the active site is proposed.  These structure-function studies of aromatase would provide useful information to design more effective aromatase inhibitors for the prevention and the treatment of hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri-iuXzRqjmLVg90H21EOLACvtfcHk0ljkTjJKXjx5aw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWisLc%253D&md5=2071364cd5e744da728d25fdb8e3a118</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1210%2Fme.2006-0281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2006-0281%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DSherman%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DY.-C.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DMolecular%2520basis%2520for%2520the%2520aromatization%2520reaction%2520and%2520exemestane-mediated%2520irreversible%2520inhibition%2520of%2520human%2520aromatase%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D401%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ahokoshi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irjala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taalikka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manninen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halonen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kangas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huupponen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">â</span> <span class="NLM_lpage">704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1046%2Fj.0306-5251.2001.01488.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=11736883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVenug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2001&pages=702-704&author=O.+Ahokoshiauthor=K.+Irjalaauthor=M.+Taalikkaauthor=P.+Manninenauthor=K.+Halonenauthor=L.+Kangasauthor=E.+Salminenauthor=R.+Huupponenauthor=H.+Scheinin&title=Pharmacokinetics+of+finrozole+%28MPV-2213ad%29%2C+a+novel+selective+aromatase+inhibitor%2C+in+healthy+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men</span></div><div class="casAuthors">Ahokoshi, Outi; Irjala, Kerttu; Taalikka, Mikko; Manninen, Pekka; Halonen, Kaija; Kangas, Lauri; Salminen, Eeva; Huupponen, Risto; Scheinin, Harry</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">702-704</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The objective was to investigate the pharmacokinetics of finrozole (MPV-2213ad), a novel competitive aromatase enzyme inhibitor, in healthy male volunteers.  The study was an open, partly randomized cross-over study including 23 volunteers receiving single doses of 3, 9 mg or 30 mg of finrozole as tablets or soln. with 14 days between the administrations.  The highest dose was given as tablets only.  Serum concns. of finrozole were detd. using high performance liq. chromatog. combined with mass spectrometry.  The mean time to peak serum concn. ranged from 2.5 to 3.1, and 0.6-0.7 h after tablets and soln., resp.  The Cmax values increased as the dose increased.  The calcd. apparent mean elimination half-life (t1/2,z) was approx. 3 h after the soln., and approx. 8 h after the tablet.  The AUC(0,â) after finrozole tablets increased proportionally from 3 mg to 9 mg and from 3 to 30 mg.  The calcd. relative mean bioavailabilities (AUC(0,â) - ratio) for the 3 mg and 9 mg doses of finrozole as tablets were 89% and 78%, resp.  The absorption of finrozole from the tablet formulation was relatively rapid, and the apparent elimination half-life was longer after the tablet than after the soln., probably reflecting overlap of the absorption with the elimination phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWxsxsdh-wK7Vg90H21EOLACvtfcHk0ljkTjJKXjx5aw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVenug%253D%253D&md5=86128f354fdb5cb611fead2d33cf7ad5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1046%2Fj.0306-5251.2001.01488.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0306-5251.2001.01488.x%26sid%3Dliteratum%253Aachs%26aulast%3DAhokoshi%26aufirst%3DO.%26aulast%3DIrjala%26aufirst%3DK.%26aulast%3DTaalikka%26aufirst%3DM.%26aulast%3DManninen%26aufirst%3DP.%26aulast%3DHalonen%26aufirst%3DK.%26aulast%3DKangas%26aufirst%3DL.%26aulast%3DSalminen%26aufirst%3DE.%26aulast%3DHuupponen%26aufirst%3DR.%26aulast%3DScheinin%26aufirst%3DH.%26atitle%3DPharmacokinetics%2520of%2520finrozole%2520%2528MPV-2213ad%2529%252C%2520a%2520novel%2520selective%2520aromatase%2520inhibitor%252C%2520in%2520healthy%2520men%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2001%26volume%3D52%26spage%3D702%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Roumen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeters, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmen, J. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beugels, I. P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custers, E. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Gooyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieterse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilbers, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, J. F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vekemans, J. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottenheijm, H. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermans, J. J. R.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1<i>H</i>-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1712</span><span class="NLM_x">â</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901356d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1712-1725&author=L.+Roumenauthor=J.+W.+Peetersauthor=J.+M.+A.+Emmenauthor=I.+P.+E.+Beugelsauthor=E.+M.+G.+Custersauthor=M.+de+Gooyerauthor=R.+Plateauthor=K.+Pieterseauthor=P.+A.+J.+Hilbersauthor=J.+F.+M.+Smitsauthor=J.+A.+J.+Vekemansauthor=D.+Leysenauthor=H.+C.+J.+Ottenheijmauthor=H.+M.+Janssenauthor=J.+J.+R.+Hermans&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+of+1-benzyl-1H-imidazoles+as+selective+inhibitors+of+aldosterone+synthase+%28CYP11B2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901356d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901356d%26sid%3Dliteratum%253Aachs%26aulast%3DRoumen%26aufirst%3DL.%26aulast%3DPeeters%26aufirst%3DJ.%2BW.%26aulast%3DEmmen%26aufirst%3DJ.%2BM.%2BA.%26aulast%3DBeugels%26aufirst%3DI.%2BP.%2BE.%26aulast%3DCusters%26aufirst%3DE.%2BM.%2BG.%26aulast%3Dde%2BGooyer%26aufirst%3DM.%26aulast%3DPlate%26aufirst%3DR.%26aulast%3DPieterse%26aufirst%3DK.%26aulast%3DHilbers%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DSmits%26aufirst%3DJ.%2BF.%2BM.%26aulast%3DVekemans%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DLeysen%26aufirst%3DD.%26aulast%3DOttenheijm%26aufirst%3DH.%2BC.%2BJ.%26aulast%3DJanssen%26aufirst%3DH.%2BM.%26aulast%3DHermans%26aufirst%3DJ.%2BJ.%2BR.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520of%25201-benzyl-1H-imidazoles%2520as%2520selective%2520inhibitors%2520of%2520aldosterone%2520synthase%2520%2528CYP11B2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1712%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Parkkinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanen, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivula, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouvinen, J.</span><span> </span><span class="NLM_article-title">Crystal structures of an enantioselective Fab-fragment in free and complex forms</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2006&pages=471-480&author=T.+Parkkinenauthor=T.+K.+Nevanenauthor=A.+Koivulaauthor=J.+Rouvinen&title=Crystal+structures+of+an+enantioselective+Fab-fragment+in+free+and+complex+forms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParkkinen%26aufirst%3DT.%26aulast%3DNevanen%26aufirst%3DT.%2BK.%26aulast%3DKoivula%26aufirst%3DA.%26aulast%3DRouvinen%26aufirst%3DJ.%26atitle%3DCrystal%2520structures%2520of%2520an%2520enantioselective%2520Fab-fragment%2520in%2520free%2520and%2520complex%2520forms%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D357%26spage%3D471%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Chemistry and structural biology of androgen receptor</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3352</span><span class="NLM_x">â</span> <span class="NLM_lpage">3370</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr020456u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Witr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=3352-3370&author=W.+Gaoauthor=C.+E.+Bohlauthor=J.+T.+Dalton&title=Chemistry+and+structural+biology+of+androgen+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31aR"><div class="casContent"><span class="casTitleNuber">31a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and structural biology of androgen receptor</span></div><div class="casAuthors">Gao, Wenqing; Bohl, Casey E.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3352-3370</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Androgen receptor (AR) is a sol. protein that functions as an intracellular transcriptional factor.  AR function is regulated by the binding of androgens, which initiates sequential conformational changes of the receptor that affect receptor-protein interactions and receptor-DNA interactions.  AR-regulated gene expression is responsible for male sexual differentiation and male pubertal changes.  AR ligands are widely used in a variety of clin. applications (i.e., agonists are employed for hypogonadism, while antagonists are used for prostate cancer therapy).  The current review focuses on well-characterized AR ligands that bind to the AR with high affinity and integrates discussion regarding the biol., metab., and structure-activity relationships for therapeutic and emerging classes of AR ligands.  The known AR ligands can be classified as steroidal or nonsteroidal based on their structure or as agonist or antagonist based on their ability to activate or inhibit transcription of AR target genes.  Synthetic AR ligands were first developed by modifying the steroidal structure of endogenous androgens.  The structure-activity relationship of these steroidal AR ligands is well documented and is only be briefly summarized in this review.  However, low oral bioavailability, poor pharmacokinetic properties, and side effects have limited the use of many steroidal AR ligands.  Until recently, it was considered impossible to sep. the androgenic and anabolic effects of AR ligands due to their reliance on a single AR.  However, newly discovered nonsteroidal AR ligands may provide a new strategy to achieve tissue selectivity, as is possible with estrogen receptor ligands.  Novel nonsteroidal pharmacophores are summarized in this review with discussion of the emerging structure-activity relationships and examples of their tissue selectivity included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGociW1GV0jzxrVg90H21EOLACvtfcHk0lhOYMHJaY428Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Witr0%253D&md5=2f81782984773c7395f51171c2613667</span></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1021%2Fcr020456u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020456u%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DW.%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DChemistry%2520and%2520structural%2520biology%2520of%2520androgen%2520receptor%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D3352%26epage%3D3370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Singh, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrie, F.</span><span> </span><span class="NLM_article-title">Androgen receptor antagonists (antiandrogens): structureâactivity relationships</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">â</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F0929867003375371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=10637363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12rsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=211-247&author=S.+M.+Singhauthor=S.+Gauthierauthor=F.+Labrie&title=Androgen+receptor+antagonists+%28antiandrogens%29%3A+structure%E2%88%92activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31b</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen receptor antagonists (antiandrogens): structure-activity relationships</span></div><div class="casAuthors">Singh, Shankar M.; Gauthier, Sylvain; Labrie, Fernand</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-247</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 161 refs.  Prostate cancer, acne, seborrhea, hirsutism, and androgenic alopecia are well recognized to depend upon an excess or increased sensitivity to androgens or to be at least sensitive to androgens.  It thus seems logical to use antiandrogens as therapeutic agents to prevent androgens from binding to the androgen receptor.  The two predominant naturally occurring androgens are testosterone (T) and dihydrotestosterone (DHT).  DHT is the more potent androgen in vivo and in vitro.  All androgen-responsive genes are activated by androgen receptor (AR) bound to either T or DHT and it is believed that AR is more transcriptionally active when bound to DHT than T.  The two classes of antiandrogens, presently available, are the steroidal derivs., all of which possess mixed agonistic and antagonistic activities, and the pure non-steroidal antiandrogens of the class of flutamide and its derivs.  The intrinsic androgenic, estrogenic and glucocorticoid activities of steroidal derivs. have limited their use in the treatment of prostate cancer.  The non-steroidal flutamide and its derivs. display pure antiandrogenic activity, without exerting agonistic or any other hormonal activity.  Flutamide (89) and its derivs., Casodex (108) and Anandron (114), are highly effective in the treatment of prostate cancer.  The combination of flutamide and Anandron with castration has shown prolongation of life in prostate cancer.  Furthermore, combined androgen blockade in assocn. with radical prostatectomy or radiotherapy are very effective in the treatment of localized prostate cancer.  Such an approach certainly raises the hope of a further improvement in prostate cancer therapy.  However, all antiandrogens, developed so-far display moderate affinity for the androgen receptor, and thus moderate efficacy in vitro and in vivo.  There is thus a need for next-generation antiandrogens, which could display an equal or even higher affinity for AR compared to the natural androgens, and at the same time maintain its pure antiandrogenic activity, and thus providing improved androgen blockade using possibly antiandrogens alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrufSBc6mxWqLVg90H21EOLACvtfcHk0lhOYMHJaY428Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12rsbg%253D&md5=e38003b98538072c00d57e2da1d2b139</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.2174%2F0929867003375371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867003375371%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BM.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DLabrie%26aufirst%3DF.%26atitle%3DAndrogen%2520receptor%2520antagonists%2520%2528antiandrogens%2529%253A%2520structure%25E2%2588%2592activity%2520relationships%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D211%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wellington, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keam, S. J.</span><span> </span><span class="NLM_article-title">Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">â</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2165%2F00002512-200724020-00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17313204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=169-171&author=K.+Wellingtonauthor=S.+J.+Keam&title=Spotlight+on+bicalutamide+150mg+in+the+treatment+of+locally+advanced+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer</span></div><div class="casAuthors">Wellington, Keri; Keam, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-171</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Bicalutamide (Casodex) is a competitive androgen receptor antagonist that inactivates androgen-regulated prostate cell growth and function, leading to cell apoptosis and inhibition of prostate cancer growth.  It is administered orally as a once-daily dose.  In the EU and a no. of other countries, bicalutamide 150 mg/day is approved in men with locally advanced nonmetastatic prostate cancer as immediate therapy either as an adjuvant to active treatment or as monotherapy as an alternative to surgical or medical castration.  Combined anal. of the three trials that comprise the bicalutamide Early Prostate Cancer program showed that bicalutamide administered in conjunction with std. care in men with locally advanced prostate cancer offers disease-free survival benefits over std. care alone and is generally well tolerated.  Overall survival was improved to a greater extent in the subgroup of patients who received bicalutamide plus radiation therapy compared with radiation therapy alone.  Men with localized prostate cancer do not benefit from the addn. of bicalutamide to std. care.  Combined anal. of two other studies in men with locally advanced prostate cancer show that bicalutamide monotherapy offers better tolerability and higher health-related quality-of-life scores for sexual interest and phys. capacity compared with surgical or medical castration, while achieving disease-free and overall survival durations that were not significantly different.  Thus, when treatment options are being evaluated, bicalutamide as adjuvant therapy or monotherapy should be considered as an alternative to other available hormonal therapies in men with locally advanced prostate cancer, esp. in those who wish to maintain an active lifestyle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGr0AhMTRO6rVg90H21EOLACvtfcHk0li4Isfiog251Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsbw%253D&md5=ccd4458e34985d032edf2ba1c5baaba6</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.2165%2F00002512-200724020-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200724020-00008%26sid%3Dliteratum%253Aachs%26aulast%3DWellington%26aufirst%3DK.%26aulast%3DKeam%26aufirst%3DS.%2BJ.%26atitle%3DSpotlight%2520on%2520bicalutamide%2520150mg%2520in%2520the%2520treatment%2520of%2520locally%2520advanced%2520prostate%2520cancer%26jtitle%3DDrugs%2520Aging%26date%3D2007%26volume%3D24%26spage%3D169%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fradet, Y.</span><span> </span><span class="NLM_article-title">Bicalutamide (Casodex) in the treatment of prostate cancer</span> <span class="citation_source-journal">Exp. Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">â</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1586%2F14737140.4.1.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=14748655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVGmsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=37-48&author=Y.+Fradet&title=Bicalutamide+%28Casodex%29+in+the+treatment+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Bicalutamide (Casodex) in the treatment of prostate cancer</span></div><div class="casAuthors">Fradet, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-48</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Prostate cancer is an important health care issue in men worldwide.  With the advent of prostate-specific antigen screening and improved diagnostic techniques, prostate cancer is now being diagnosed in younger men and at earlier disease stages.  As a result, patients often live with their disease for many years after diagnosis.  This shift in the patient profile has focused attention to the impact of treatment on quality of life.  Medical/surgical castration has traditionally been the mainstay of hormonal therapy but is assocd. with side effects including loss of libido and impotence.  Nonsteroidal antiandrogens such as bicalutamide (Casodex) offer an effective alternative to castration with potential quality-of-life benefits.  This paper reviews the evidence concerning the use of bicalutamide at all stages of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5VWR9COicwrVg90H21EOLACvtfcHk0li4Isfiog251Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVGmsLw%253D&md5=d6ba5c8a85a70bf8d04fce3adc29c613</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1586%2F14737140.4.1.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.4.1.37%26sid%3Dliteratum%253Aachs%26aulast%3DFradet%26aufirst%3DY.%26atitle%3DBicalutamide%2520%2528Casodex%2529%2520in%2520the%2520treatment%2520of%2520prostate%2520cancer%26jtitle%3DExp.%2520Rev.%2520Anticancer%2520Ther.%26date%3D2004%26volume%3D4%26spage%3D37%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kirkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">â</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990027x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=581-590&author=L.+Kirkovskyauthor=A.+Mukherjeeauthor=D.+Yinauthor=J.+T.+Daltonauthor=D.+D.+Miller&title=Chiral+nonsteroidal+affinity+ligands+for+the+androgen+receptor.+1.+Bicalutamide+analogues+bearing+electrophilic+groups+in+the+B+aromatic+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm990027x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990027x%26sid%3Dliteratum%253Aachs%26aulast%3DKirkovsky%26aufirst%3DL.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DYin%26aufirst%3DD.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DChiral%2520nonsteroidal%2520affinity%2520ligands%2520for%2520the%2520androgen%2520receptor.%25201.%2520Bicalutamide%2520analogues%2520bearing%2520electrophilic%2520groups%2520in%2520the%2520B%2520aromatic%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D581%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">6201</span><span class="NLM_x">â</span> <span class="NLM_lpage">6206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1073%2Fpnas.0500381102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15833816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=6201-6206&author=C.+E.+Bohlauthor=W.+Gaoauthor=D.+D.+Millerauthor=C.+E.+Bellauthor=J.+T.+Dalton&title=Structural+basis+for+antagonism+and+resistance+of+bicalutamide+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span></div><div class="casAuthors">Bohl, Casey E.; Gao, Wenqing; Miller, Duane D.; Bell, Charles E.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6201-6206</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Carcinoma of the prostate is the most commonly diagnosed cancer in men.  The current pharmacol. treatment of choice for progressive androgen-dependent prostate cancer is the nonsteroidal antiandrogen, bicalutamide, either as monotherapy or with adjuvant castration or LH-releasing hormone superagonists to block the synthesis of endogenous testosterone.  To date, no nonsteroidal or antagonist-bound androgen receptor (AR) structure is available.  The authors solved the x-ray crystal structure of the mutant W741L AR ligand-binding domain bound to R-bicalutamide at 1.8-Ã resoln.  This mutation confers agonist activity to bicalutamide and is likely involved in bicalutamide withdrawal syndrome.  The three-dimensional structure demonstrates that the B ring of R-bicalutamide in the W741L mutant is accommodated at the location of the indole ring of Trp-741 in the WT AR bound to dihydrotestosterone.  Knowledge of the binding mechanism for R-bicalutamide will provide mol. rationale for the development of new antiandrogens and selective AR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQ1V6LCoc07Vg90H21EOLACvtfcHk0li4Isfiog251Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D&md5=0ca230450eba66abd4136bfb95928ce0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0500381102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0500381102%26sid%3Dliteratum%253Aachs%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DBell%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DStructural%2520basis%2520for%2520antagonism%2520and%2520resistance%2520of%2520bicalutamide%2520in%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D6201%26epage%3D6206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Van Dort, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.-W.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">â</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1045-1047&author=M.+E.+Van+Dortauthor=Y.-W.+Jung&title=Synthesis+and+structure%E2%88%92activity+studies+of+side-chain+derivatized+arylhydantoins+for+investigation+as+androgen+receptor+radioligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDort%26aufirst%3DM.%2BE.%26aulast%3DJung%26aufirst%3DY.-W.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520studies%2520of%2520side-chain%2520derivatized%2520arylhydantoins%2520for%2520investigation%2520as%2520androgen%2520receptor%2520radioligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1045%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Li, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iula, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dettling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanmugasundaram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Camp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen-Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boys, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoge, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovdahl, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asbill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciotti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7010</span><span class="NLM_x">â</span> <span class="NLM_lpage">7014</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8009316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7010-7014&author=J.+J.+Liauthor=D.+M.+Iulaauthor=M.+N.+Nguyenauthor=L.-Y.+Huauthor=D.+Dettlingauthor=T.+R.+Johnsonauthor=D.+Y.+Duauthor=V.+Shanmugasundaramauthor=J.+A.+Van+Campauthor=Z.+Wangauthor=G.+H.+Williamauthor=Y.+Wen-Songauthor=M.+L.+Boysauthor=K.+J.+Wadeauthor=E.+M.+Drummondauthor=B.+M.+Samasauthor=B.+A.+Lefkerauthor=G.+S.+Hogeauthor=M.+J.+Lovdahlauthor=J.+Asbillauthor=M.+Carrollauthor=M.+A.+Meadeauthor=S.+M.+Ciottiauthor=T.+Krieger-Burke&title=Rational+design+and+synthesis+of+4-%28%281R%2C2R%29-2-hydroxycyclohexyl%29-2%28trifluoromethyl%29benzonitrile+%28PF-998425%29%2C+a+novel%2C+nonsteroidal+androgen+receptor+antagonist+devoid+of+phototoxicity+for+dermatological+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm8009316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8009316%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DIula%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DM.%2BN.%26aulast%3DHu%26aufirst%3DL.-Y.%26aulast%3DDettling%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DT.%2BR.%26aulast%3DDu%26aufirst%3DD.%2BY.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DVan%2BCamp%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWilliam%26aufirst%3DG.%2BH.%26aulast%3DWen-Song%26aufirst%3DY.%26aulast%3DBoys%26aufirst%3DM.%2BL.%26aulast%3DWade%26aufirst%3DK.%2BJ.%26aulast%3DDrummond%26aufirst%3DE.%2BM.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DHoge%26aufirst%3DG.%2BS.%26aulast%3DLovdahl%26aufirst%3DM.%2BJ.%26aulast%3DAsbill%26aufirst%3DJ.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DMeade%26aufirst%3DM.%2BA.%26aulast%3DCiotti%26aufirst%3DS.%2BM.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%25204-%2528%25281R%252C2R%2529-2-hydroxycyclohexyl%2529-2%2528trifluoromethyl%2529benzonitrile%2520%2528PF-998425%2529%252C%2520a%2520novel%252C%2520nonsteroidal%2520androgen%2520receptor%2520antagonist%2520devoid%2520of%2520phototoxicity%2520for%2520dermatological%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7010%26epage%3D7014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kern, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terefenko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrodin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yudt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span> </span><span class="NLM_article-title">5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6666</span><span class="NLM_x">â</span> <span class="NLM_lpage">6669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6666-6669&author=J.+C.+Kernauthor=E.+Terefenkoauthor=E.+Trybulskiauthor=T.+J.+Berrodinauthor=J.+Cohenauthor=R.+C.+Winnekerauthor=M.+R.+Yudtauthor=Z.+Zhangauthor=Y.+Zhuauthor=P.+Zhang&title=5-Aryl+indanones+and+derivatives+as+non-steroidal+progesterone+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKern%26aufirst%3DJ.%2BC.%26aulast%3DTerefenko%26aufirst%3DE.%26aulast%3DTrybulski%26aufirst%3DE.%26aulast%3DBerrodin%26aufirst%3DT.%2BJ.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DYudt%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26atitle%3D5-Aryl%2520indanones%2520and%2520derivatives%2520as%2520non-steroidal%2520progesterone%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6666%26epage%3D6669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, L.</span><span> </span><span class="NLM_article-title">Andrew Fensome receives Robertson Award</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span></span><div class="citationLinks">[<a href="/doi/10.1021/cen-v085n037.p040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Gqs7zP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=40&author=L.+Wang&title=Andrew+Fensome+receives+Robertson+Award"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Arnold takes Genencor Prize in Enzyme Engineering</span></div><div class="casAuthors">Wang, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Engineering News</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">40</span>CODEN:
                <span class="NLM_cas:coden">CENEAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-2347</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Frances H. Arnold, Dick & Barbara Dickinson Professor of Chem. Engineering & Biochem. at California Institute of Technol., is the recipient of the 2007 Award in Enzyme Engineering, sponsored by Genencor.  Arnold pioneered directed evolution, an approach to protein engineering that is used in thousands of labs. worldwide and enables many industrial and medical biotechnol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofKHTQzl6zxLVg90H21EOLACvtfcHk0ljrZB5e5GnaRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Gqs7zP&md5=43138e0323b613325f11fdf62fa22a99</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1021%2Fcen-v085n037.p040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v085n037.p040%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DAndrew%2520Fensome%2520receives%2520Robertson%2520Award%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2007%26volume%3D85%26spage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fensome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malakian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terefenko, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, J.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationship of novel 6-aryl-1,4-dihydrobenzo[<i>d</i>][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5092</span><span class="NLM_x">â</span> <span class="NLM_lpage">5095</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050358b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5092-5095&author=A.+Fensomeauthor=R.+Benderauthor=R.+Chopraauthor=J.+Cohenauthor=M.+A.+Collinsauthor=V.+Hudakauthor=K.+Malakianauthor=S.+Lockheadauthor=A.+Ollandauthor=K.+Svensonauthor=E.+A.+Terefenkoauthor=R.+J.+Unwallaauthor=J.+M.+Wilhelmauthor=S.+Wolfromauthor=Y.+Zhuauthor=R.+C.+Winnekerauthor=J.+Wrobel&title=Synthesis+and+structure%E2%88%92activity+relationship+of+novel+6-aryl-1%2C4-dihydrobenzo%5Bd%5D%5B1%2C3%5Doxazine-2-thiones+as+progesterone+receptor+modulators+leading+to+the+potent+and+selective+nonsteroidal+progesterone+receptor+agonist+tanaproget"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1021%2Fjm050358b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050358b%26sid%3Dliteratum%253Aachs%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DBender%26aufirst%3DR.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%2BA.%26aulast%3DHudak%26aufirst%3DV.%26aulast%3DMalakian%26aufirst%3DK.%26aulast%3DLockhead%26aufirst%3DS.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DTerefenko%26aufirst%3DE.%2BA.%26aulast%3DUnwalla%26aufirst%3DR.%2BJ.%26aulast%3DWilhelm%26aufirst%3DJ.%2BM.%26aulast%3DWolfrom%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DWrobel%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520novel%25206-aryl-1%252C4-dihydrobenzo%255Bd%255D%255B1%252C3%255Doxazine-2-thiones%2520as%2520progesterone%2520receptor%2520modulators%2520leading%2520to%2520the%2520potent%2520and%2520selective%2520nonsteroidal%2520progesterone%2520receptor%2520agonist%2520tanaproget%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5092%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zhou, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayne, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span> </span><span class="NLM_article-title">Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3349</span><span class="NLM_x">â</span> <span class="NLM_lpage">3360</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100052k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3349-3360&author=H.-B.+Zhouauthor=J.+H.+Leeauthor=C.+G.+Mayneauthor=K.+E.+Carlsonauthor=J.+A.+Katzenellenbogen&title=Imaging+progesterone+receptor+in+breast+tumors%3A+synthesis+and+receptor+binding+affinity+of+fluoroalkyl-substituted+analogues+of+tanaproget"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm100052k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100052k%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-B.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMayne%26aufirst%3DC.%2BG.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DImaging%2520progesterone%2520receptor%2520in%2520breast%2520tumors%253A%2520synthesis%2520and%2520receptor%2520binding%2520affinity%2520of%2520fluoroalkyl-substituted%2520analogues%2520of%2520tanaproget%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3349%26epage%3D3360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Shivakumar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancet, J. E.</span><span> </span><span class="NLM_article-title">The role of farnesyl transferase inhibitors in the treatment of patients with leukemia and myelodysplastic syndrome</span> <span class="citation_source-journal">Clin. Leuk.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.3816%2FCLK.2006.n.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFKqtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=80-83&author=L.+Shivakumarauthor=J.+E.+Lancet&title=The+role+of+farnesyl+transferase+inhibitors+in+the+treatment+of+patients+with+leukemia+and+myelodysplastic+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of farnesyl transferase inhibitors in the treatment of patients with leukemia and myelodysplastic syndrome</span></div><div class="casAuthors">Shivakumar, Latha; Lancet, Jeffrey E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Leukemia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">80-83</span>CODEN:
                <span class="NLM_cas:coden">CLLEAW</span>;
        ISSN:<span class="NLM_cas:issn">1931-6925</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group</span>)
        </div><div class="casAbstract">A review.  Farnesyl transferase inhibitors (FTIs) inhibit farnesylation of various proteins playing a key role in cell growth and proliferation, including Ras, Rho, lamins, and centromere proteins.  Several FTIs have demonstrated antitumor activity in preclin. models of several tumors, including hematol. malignancies.  Nonpeptidomimetic FTIs, tipifarnib, lonafarnib, and BMS-214662 have demonstrated promising clin. activity along with acceptable toxicity profiles in the setting of leukemias and myelodysplastic syndrome (MDS).  Tipifarnib and lonafarnib are in the most advanced stages of clin. development for the treatment of hematol. malignancies, including acute myeloid leukemia, chronic myeloid leukemia and MDS.  Treatment with tipifarnib has been effective in the treatment of patients with acute myeloid leukemia and MDS, in the first-line and postremission (maintenance therapy) settings.  Continuous administration of lonafarnib resulted in hematol. responses in patients with chronic myeloid leukemia and MDS with tolerable toxicities.  Based on the results from various preliminary studies, FTIs are being pursued as important therapeutic options for the management of a variety of hematopoietic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomT1Lg9kO-prVg90H21EOLACvtfcHk0ljkwRDFHvIEWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFKqtbs%253D&md5=dd2df1d2c566049ccbe045923c72d7c5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3816%2FCLK.2006.n.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLK.2006.n.011%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DL.%26aulast%3DLancet%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520role%2520of%2520farnesyl%2520transferase%2520inhibitors%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520leukemia%2520and%2520myelodysplastic%2520syndrome%26jtitle%3DClin.%2520Leuk.%26date%3D2006%26volume%3D1%26spage%3D80%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bailey, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulkerin, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span> </span><span class="NLM_article-title">Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3623</span><span class="NLM_x">â</span> <span class="NLM_lpage">3629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1158%2F1078-0432.CCR-07-0158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17510207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCquro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3623-3629&author=H.+H.+Baileyauthor=D.+B.+Albertiauthor=J.+P.+Thomasauthor=D.+L.+Mulkerinauthor=K.+A.+Bingerauthor=M.+M.+Gottardisauthor=R.+E.+Martellauthor=G.+Wilding&title=Phase+I+trial+of+weekly+paclitaxel+and+BMS-214662+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of Weekly Paclitaxel and BMS-214662 in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Bailey, Howard H.; Alberti, Dona B.; Thomas, James P.; Mulkerin, Daniel L.; Binger, Kimberly A.; Gottardis, Marco M.; Martell, Robert E.; Wilding, George</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3623-3629</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To assess the max. tolerated dose (MTD), dose-limiting toxicity (DLT), pharmacodynamics, and antitumor activity of continuous weekly-administered paclitaxel and BMS-214662, a novel farnesyl transferase inhibitor.  Exptl. DESIGN: Patients were treated every week as tolerated with i.v. paclitaxel (fixed dose, 80 mg/m2/wk) administered over 1 h followed by i.v.  BMS-214662 (escalating doses, 80-245 mg/m2/wk) over 1 h starting 30 min after completion of paclitaxel.  RESULTS: Twenty-six patients received 94 courses (one course, 21 days) of study treatment.  Two patients received five courses of BMS-214662 as a weekly 24-h infusion (209 mg/m2/wk).  The most common toxicities were grade 1 to 2 nausea/vomiting and/or diarrhea.  DLTs obsd. at or near the MTD (200 mg/m2/wk) were grade 4 febrile neutropenia with sepsis occurring on day 2 of course 1 (245 mg/m2/wk), reversible grade 3 to 4 serum transaminase increases on day 2, and grade 3 diarrhea (200 and 245 mg/m2/wk).  Objective partial responses were obsd. in patients with pretreated head and neck, ovarian, and hormone-refractory prostate carcinomas, and leiomyosarcoma.  The obsd. pharmacokinetics of paclitaxel and BMS-214662 imply no interaction between the two.  Significant inhibition (>80%) of farnesyl transferase activity in peripheral mononuclear cells was obsd. at the end of BMS-214662 infusion.  CONCLUSIONS: Pretreated patients with advanced malignancies can tolerate weekly paclitaxel and BMS-214662 at doses that achieve objective clin. benefit.  Due to multiple DLTs occurring at the expanded MTD, the recommended phase 2 dose and schedule is paclitaxel (80 mg/m2 over 1 h) and BMS-214662 (160 mg/m2 over 1 h) administered weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprmFlxN5xPIbVg90H21EOLACvtfcHk0ljkwRDFHvIEWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCquro%253D&md5=75209f76ca1a9779d481c2f26f503214</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0158%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DH.%2BH.%26aulast%3DAlberti%26aufirst%3DD.%2BB.%26aulast%3DThomas%26aufirst%3DJ.%2BP.%26aulast%3DMulkerin%26aufirst%3DD.%2BL.%26aulast%3DBinger%26aufirst%3DK.%2BA.%26aulast%3DGottardis%26aufirst%3DM.%2BM.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DWilding%26aufirst%3DG.%26atitle%3DPhase%2520I%2520trial%2520of%2520weekly%2520paclitaxel%2520and%2520BMS-214662%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3623%26epage%3D3629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Caponigro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, J.</span><span> </span><span class="NLM_article-title">Farnesyl transferase inhibitors in clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">â</span> <span class="NLM_lpage">954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=943-954&author=F.+Caponigroauthor=M.+Casaleauthor=J.+Bryce&title=Farnesyl+transferase+inhibitors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaponigro%26aufirst%3DF.%26aulast%3DCasale%26aufirst%3DM.%26aulast%3DBryce%26aufirst%3DJ.%26atitle%3DFarnesyl%2520transferase%2520inhibitors%2520in%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D943%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Jorgensen, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holyoake, T. L.</span><span> </span><span class="NLM_article-title">Characterization of cancer stem cells in chronic myeloid leukaemia</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">â</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1042%2FBST0351347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17956348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eqsr7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1347-1351&author=H.+G.+Jorgensenauthor=T.+L.+Holyoake&title=Characterization+of+cancer+stem+cells+in+chronic+myeloid+leukaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of cancer stem cells in chronic myeloid leukaemia</span></div><div class="casAuthors">Jorgensen, H. G.; Holyoake, T. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1347-1351</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  CML (chronic myeloid leukemia) is a myeloproliferative disease that originates in an HSC (hemopoietic stem cell) as a result of the t(9;22) translocation, giving rise to the Ph (Philadelphia chromosome) and bcr-abl oncoprotein.  The disease starts in CP (chronic phase), but as a result of genomic instability, it progresses over time to accelerated phase and then to BC (blast crisis), becoming increasingly resistant to therapy.  Bcr-abl is a constitutively active tyrosine kinase that was targeted by TKIs (tyrosine kinase inhibitors), including IM (imatinib mesylate), nilotinib and dasatinib.  The authors have developed various flow cytometry techniques suitable for isolation of candidate CML stem cells from CP patients at diagnosis that efflux Hoechst dye, express CD34, lack CD38 and are cytokine-non-responsive in culture over periods of up to 12 days in growth factors.  These stem cells were shown to regenerate bcr-abl-pos. hemopoiesis in immunocompromised mice upon transplantation.  The authors previously demonstrated that IM was antiproliferative for CML stem cells but did not induce apoptosis.  Clin. experience now confirms that IM may not target CML stem cells in vivo with few patients achieving complete mol. remission and relapse occurring rapidly upon drug withdrawal.  The authors' recent efforts have focused on understanding why CML stem cells are resistant to IM and on trying to find novel ways to induce apoptosis of this population.  The authors have shown that CML stem cells express very high levels of functional wild-type bcr-abl; no kinase domain mutations were detected in the stem cell population.  Dasatinib, a more potent multitargeted TKI than IM, inhibits bcr-abl activity more efficiently than IM but still does not induce apoptosis of the stem cell population.  Most recently, the authors have tested a no. of novel drug combinations and found that FTIs (farnesyl transferase inhibitors) have activity against CML.  BMS-214662 is the most effective of these and induces apoptosis of phenotypically and functionally defined CML stem cells in vitro, as a single agent and in combination with IM or dasatinib.  The effect against CML stem cells is selective with little effect on normal stem cells.  The drug is also effective against BC CML stem cells and equally effective against wild-type and mutant bcr-abl, including the most resistant mutant T315I.  In assocn. with apoptosis, there is activation of caspase 8 and caspase 3, inhibition of the MAPK pathway, IAP-1 (inhibitor of apoptosis protein-1), NF-ÎºB (nuclear factor ÎºB) and iNOS (inducible nitric oxide synthase).  Furthermore, BMS-214662 synergizes with MEK1/2 [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) kinase 1/2] inhibitors, suggesting a second mechanism other that RAS inhibition for induction of apoptosis.  The authors' intentions are now to explore the activity of BMS-214662 in other cancer stem cell disorders and to move this preclin. work to a clin. trial combining dasatinib with BMS-214662 in CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxx1OoamSXibVg90H21EOLACvtfcHk0liicr9VR9HqYQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eqsr7O&md5=a799ec24869d0a1fff5dbc2a69780054</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1042%2FBST0351347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0351347%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DH.%2BG.%26aulast%3DHolyoake%26aufirst%3DT.%2BL.%26atitle%3DCharacterization%2520of%2520cancer%2520stem%2520cells%2520in%2520chronic%2520myeloid%2520leukaemia%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D1347%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Reid, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span> </span><span class="NLM_article-title">Crystal structures of the anticancer clinical candidates R115777 (tipifarnib) and BMS-214662 complexed with protein farnesyltransferase suggest a mechanism of FTI selectivity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6877</span><span class="NLM_x">â</span> <span class="NLM_lpage">6884</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049723b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=6877-6884&author=T.+S.+Reidauthor=L.+S.+Beese&title=Crystal+structures+of+the+anticancer+clinical+candidates+R115777+%28tipifarnib%29+and+BMS-214662+complexed+with+protein+farnesyltransferase+suggest+a+mechanism+of+FTI+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi049723b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049723b%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DT.%2BS.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26atitle%3DCrystal%2520structures%2520of%2520the%2520anticancer%2520clinical%2520candidates%2520R115777%2520%2528tipifarnib%2529%2520and%2520BMS-214662%2520complexed%2520with%2520protein%2520farnesyltransferase%2520suggest%2520a%2520mechanism%2520of%2520FTI%2520selectivity%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D6877%26epage%3D6884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penhallow, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-7-cyano-2,3,4,5-tetrahydro-1-(1<i>H</i>-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1<i>H</i>-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">â</span> <span class="NLM_lpage">3595</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000248z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3587-3595&author=J.+T.+Huntauthor=C.+Z.+Dingauthor=R.+Batorskyauthor=M.+Bednarzauthor=R.+Bhideauthor=Y.+Choauthor=S.+Chongauthor=S.+Chaoauthor=J.+Gullo-Brownauthor=P.+Guoauthor=S.+K.+Kimauthor=F.+Y.+F.+Leeauthor=K.+Leftherisauthor=A.+Millerauthor=T.+Mittauthor=M.+Patelauthor=B.+A.+Penhallowauthor=C.+Riccaauthor=W.+C.+Roseauthor=R.+C.+Schmidtauthor=W.+A.+Slusarchykauthor=G.+Viteauthor=V.+Manne&title=Discovery+of+%28R%29-7-cyano-2%2C3%2C4%2C5-tetrahydro-1-%281H-imidazol-4-ylmethyl%29-3-%28phenylmethyl%29-4-%282-thienylsulfonyl%29-1H-1%2C4-benzodiazepine+%28BMS-214662%29%2C+a+farnesyltransferase+inhibitor+with+potent+preclinical+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm000248z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000248z%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DBatorsky%26aufirst%3DR.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DBhide%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DChong%26aufirst%3DS.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DMitt%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPenhallow%26aufirst%3DB.%2BA.%26aulast%3DRicca%26aufirst%3DC.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DSchmidt%26aufirst%3DR.%2BC.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BA.%26aulast%3DVite%26aufirst%3DG.%26aulast%3DManne%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520%2528R%2529-7-cyano-2%252C3%252C4%252C5-tetrahydro-1-%25281H-imidazol-4-ylmethyl%2529-3-%2528phenylmethyl%2529-4-%25282-thienylsulfonyl%2529-1H-1%252C4-benzodiazepine%2520%2528BMS-214662%2529%252C%2520a%2520farnesyltransferase%2520inhibitor%2520with%2520potent%2520preclinical%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3587%26epage%3D3595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Martin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiel, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaney, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regine, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohiuddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosato, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, S. M.</span><span> </span><span class="NLM_article-title">A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5447</span><span class="NLM_x">â</span> <span class="NLM_lpage">5454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1158%2F1078-0432.CCR-04-0248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15328183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFSltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=5447-5454&author=N.+E.+Martinauthor=T.+B.+Brunnerauthor=K.+D.+Kielauthor=T.+F.+DeLaneyauthor=W.+F.+Regineauthor=M.+Mohiuddinauthor=E.+F.+Rosatoauthor=D.+G.+Hallerauthor=J.+P.+Stevensonauthor=D.+Smithauthor=B.+Pramanikauthor=J.+Tepperauthor=W.+K.+Tanakaauthor=B.+Morrisonauthor=P.+Deutschauthor=A.+K.+Guptaauthor=R.+J.+Muschelauthor=W.+G.+McKennaauthor=E.+J.+Bernhardauthor=S.+M.+Hahn&title=A+phase+I+trial+of+the+dual+farnesyltransferase+and+geranylgeranyltransferase+inhibitor+L-778%2C123+and+radiotherapy+for+locally+advanced+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer</span></div><div class="casAuthors">Martin, Neil E.; Brunner, Thomas B.; Kiel, Krystina D.; DeLaney, Thomas F.; Regine, William F.; Mohiuddin, Mohammed; Rosato, Ernest F.; Haller, Daniel G.; Stevenson, James P.; Smith, Debbie; Pramanik, Barnali; Tepper, Joel; Tanaka, Wesley K.; Morrison, Briggs; Deutsch, Paul; Gupta, Anjali K.; Muschel, Ruth J.; McKenna, W. Gillies; Bernhard, Eric J.; Hahn, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5447-5454</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Preclin. and clin. studies have demonstrated that inhibition of prenylation can radiosensitize cell lines with activation of Ras and produce clin. response in patients with cancer.  The aim of this study was to det. the maximally tolerated dose of the dual farnesyltransferase and geranylgeranyltransferase I inhibitor L-778,123 in combination with radiotherapy for patients with locally advanced pancreatic cancer.  L-778,123 was given by continuous i.v. infusion with concomitant radiotherapy to 59.4 Gy in std. fractions.  Two L-778,123 dose levels were tested: 280 mg/m2/day over weeks 1, 2, 4, and 5 for dose level 1; and 560 mg/m2/day over weeks 1, 2, 4, 5, and 7 for dose level 2.  There were no dose-limiting toxicities obsd. in the eight patients treated on dose level 1.  Two of the four patients on dose level 2 experienced dose-limiting toxicities consisting of grade 3 diarrhea in one case and grade 3 gastrointestinal hemorrhage assocd. with grade 3 thrombocytopenia and neutropenia in the other case.  Other common toxicities were mild neutropenia, dehydration, hyperglycemia, and nausea/vomiting.  One patient on dose level 1 showed a partial response of 6 mo in duration.  Both reversible inhibition of HDJ2 farnesylation and radiosensitization of a study patient-derived cell line were demonstrated in the presence of L-778,123.  K-RAS mutations were found in three of the four patients evaluated.  The combination of L-778,123 and radiotherapy at dose level 1 showed acceptable toxicity in patients with locally advanced pancreatic cancer.  Radiosensitization of a patient-derived pancreatic cancer cell line was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-CjOMRzk8JLVg90H21EOLACvtfcHk0liicr9VR9HqYQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFSltLg%253D&md5=cb80a9340dbafafced681366cceaf51c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-0248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-0248%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DN.%2BE.%26aulast%3DBrunner%26aufirst%3DT.%2BB.%26aulast%3DKiel%26aufirst%3DK.%2BD.%26aulast%3DDeLaney%26aufirst%3DT.%2BF.%26aulast%3DRegine%26aufirst%3DW.%2BF.%26aulast%3DMohiuddin%26aufirst%3DM.%26aulast%3DRosato%26aufirst%3DE.%2BF.%26aulast%3DHaller%26aufirst%3DD.%2BG.%26aulast%3DStevenson%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DTepper%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DW.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DDeutsch%26aufirst%3DP.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DMuschel%26aufirst%3DR.%2BJ.%26aulast%3DMcKenna%26aufirst%3DW.%2BG.%26aulast%3DBernhard%26aufirst%3DE.%2BJ.%26aulast%3DHahn%26aufirst%3DS.%2BM.%26atitle%3DA%2520phase%2520I%2520trial%2520of%2520the%2520dual%2520farnesyltransferase%2520and%2520geranylgeranyltransferase%2520inhibitor%2520L-778%252C123%2520and%2520radiotherapy%2520for%2520locally%2520advanced%2520pancreatic%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D5447%26epage%3D5454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Reid, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span> </span><span class="NLM_article-title">Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-i by different binding modes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">9000</span><span class="NLM_x">â</span> <span class="NLM_lpage">9008</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049280b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=9000-9008&author=T.+S.+Reidauthor=S.+B.+Longauthor=L.+S.+Beese&title=Crystallographic+analysis+reveals+that+anticancer+clinical+candidate+L-778%2C123+inhibits+protein+farnesyltransferase+and+geranylgeranyltransferase-i+by+different+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi049280b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049280b%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DT.%2BS.%26aulast%3DLong%26aufirst%3DS.%2BB.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26atitle%3DCrystallographic%2520analysis%2520reveals%2520that%2520anticancer%2520clinical%2520candidate%2520L-778%252C123%2520inhibits%2520protein%2520farnesyltransferase%2520and%2520geranylgeranyltransferase-i%2520by%2520different%2520binding%2520modes%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D9000%26epage%3D9008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Burstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badwe, R.</span><span> </span><span class="NLM_article-title">Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">â</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1200%2FJCO.2009.25.8707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=20142587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1301-1307&author=H.+J.+Bursteinauthor=Y.+Sunauthor=L.+Y.+Dirixauthor=Z.+Jiangauthor=R.+Paridaensauthor=A.+R.+Tanauthor=A.+Awadaauthor=A.+Ranadeauthor=S.+Jiaoauthor=G.+Schwartzauthor=R+Abbasauthor=C.+Powellauthor=K.+Turnbullauthor=J.+Vermetteauthor=C.+Zacharchukauthor=R.+Badwe&title=Neratinib%2C+an+irreversible+ErbB+receptor+tyrosine+kinase+inhibitor%2C+in+patients+with+advanced+ErbB2-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span></div><div class="casAuthors">Burstein, Harold J.; Sun, Yan; Dirix, Luc Y.; Jiang, Zefei; Paridaens, Robert; Tan, Antoinette R.; Awada, Ahmad; Ranade, Anantbhushan; Jiao, Shunchang; Schwartz, Gary; Abbas, Richat; Powell, Christine; Turnbull, Kathleen; Vermette, Jennifer; Zacharchuk, Charles; Badwe, Rajendra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1301-1307</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Neratinib is an oral, irreversible pan-ErbB receptor tyrosine kinase inhibitor.  The efficacy and safety of neratinib were evaluated in two cohorts of patients with advanced ErbB2-pos. breast cancer-those with and those without prior trastuzumab treatment-in an open-label, multicenter, phase II trial.  Patients in the two cohorts (prior trastuzumab, n = 66; no prior trastuzumab, n = 70) received oral neratinib 240 mg once daily.  The primary end point was the 16-wk progression-free survival (PFS) rate for the evaluable population (prior trastuzumab, n = 63; no prior trastuzumab, n = 64), as assessed by independent review.  The 16-wk PFS rates were 59% for patients with prior trastuzumab treatment and 78% for patients with no prior trastuzumab treatment.  Median PFS was 22.3 and 39.6 wk, resp.  Objective response rates were 24% among patients with prior trastuzumab treatment and 56% in the trastuzumab-naive cohort.  The most common adverse events were diarrhea, nausea, vomiting, and fatigue.  Diarrhea was the most frequent grades 3 to 4 adverse event, occurring in 30% of patients with prior trastuzumab treatment and in 13% of patients with no prior trastuzumab treatment, which prompted dose redns. in 29% and 4% of patients, resp., but treatment discontinuation in only one patient.  No neratinib-related, grades 3 or 4 cardiotoxicity was reported.  Oral neratinib showed substantial clin. activity and was reasonably well tolerated among both heavily pretreated and trastuzumab-naive patients who had advanced, ErbB2-pos. breast cancer.  Diarrhea was the most common adverse effect but was manageable with antidiarrheal agents and dose modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbEv1WYAZUbVg90H21EOLACvtfcHk0lgd_dLNvvLUmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D&md5=11b07ce171753c7499b50d52786859e8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.8707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.8707%26sid%3Dliteratum%253Aachs%26aulast%3DBurstein%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DA.%2BR.%26aulast%3DAwada%26aufirst%3DA.%26aulast%3DRanade%26aufirst%3DA.%26aulast%3DJiao%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%26aulast%3DAbbas%26aufirst%3DR%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DTurnbull%26aufirst%3DK.%26aulast%3DVermette%26aufirst%3DJ.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DBadwe%26aufirst%3DR.%26atitle%3DNeratinib%252C%2520an%2520irreversible%2520ErbB%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520ErbB2-positive%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1301%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozer, H.</span><span> </span><span class="NLM_article-title">Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">â</span> <span class="NLM_lpage">1751</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1735-1751&author=P.+Boseauthor=H.+Ozer&title=Neratinib%3A+an+oral%2C+irreversible+dual+EGFR%2FHER2+inhibitor+for+breast+and+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DOzer%26aufirst%3DH.%26atitle%3DNeratinib%253A%2520an%2520oral%252C%2520irreversible%2520dual%2520EGFR%252FHER2%2520inhibitor%2520for%2520breast%2520and%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D1735%26epage%3D1751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Erlichman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, J. P.</span><span> </span><span class="NLM_article-title">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2252</span><span class="NLM_x">â</span> <span class="NLM_lpage">2260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1200%2FJCO.2005.01.8960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16710023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2252-2260&author=C.+Erlichmanauthor=M.+Hidalgoauthor=J.+P.+Boni&title=Phase+I+study+of+EKB-569%2C+an+irreversible+inhibitor+of+the+epidermal+growth+factor+receptor%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span></div><div class="casAuthors">Erlichman, Charles; Hidalgo, Manuel; Boni, Joseph P.; Martins, Patricia; Quinn, Susan E.; Zacharchuk, Charles; Amorusi, Peter; Adjei, Alex A.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2252-2260</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The max. tolerated dose (MTD) and the dose-limiting toxicities of EKB-569, a selective, irreversible inhibitor of the epidermal growth factor receptor (EGFR), when administered orally once daily on an intermittent-dose schedule (14 days of a 28-day cycle) or on a continuous-dose schedule (each day of a 28-day cycle), were detd. in patients with advanced solid tumors.  Planned dose escalation was 25, 50, 75, 125, 175, and 225 mg.  Pharmacokinetic sampling was performed on days 1 and 14 for the intermittent-dose cohort and on days 1 and 15 for the continuous-dose cohort.  Thirty patients received a median of two cycles (range, one to 10 cycles) in the intermittent-dose cohort; 29 patients received a median of three cycles (range, one to eight cycles) in the continuous-dose cohort.  Dose-limiting toxicity was grade 3 diarrhea, and the MTD was 75 mg EKB-569 per day for both cohorts.  Other common toxicities included rash, nausea, and asthenia.  Exposure to EKB-569 was dose proportional.  At the MTD, the mean Â± std. deviation terminal half-life was 21.7 Â± 4.2 h and peak concn. increased 1.2-fold from day 1 to day 14/15.  No major antitumor responses were obsd.  However, one patient with non-small-cell lung cancer and one with cutaneous squamous cell carcinoma had stable disease for 33 and 24 wk, resp.  The MTD of once-daily oral EKB-569 is 75 mg.  The tolerable toxicity profile and long half-life of this irreversible EGFR inhibitor warrant its further evaluation as a single agent and in combination with other drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWU_wd20ORbVg90H21EOLACvtfcHk0lgd_dLNvvLUmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D&md5=3a7766538e63808314fe4ea73b5f766d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.8960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.8960%26sid%3Dliteratum%253Aachs%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DJ.%2BP.%26atitle%3DPhase%2520I%2520study%2520of%2520EKB-569%252C%2520an%2520irreversible%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2252%26epage%3D2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godin-Heymann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brannigan, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isselbacher, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">7665</span><span class="NLM_x">â</span> <span class="NLM_lpage">7670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=7665-7670&author=E.+L.+Kwakauthor=R.+Sordellaauthor=D.+W.+Bellauthor=N.+Godin-Heymannauthor=R.+A.+Okimotoauthor=B.+W.+Branniganauthor=P.+L.+Harrisauthor=D.+R.+Driscollauthor=P.+Fidiasauthor=T.+J.+Lynchauthor=S.+K.+Rabindranauthor=J.+P.+McGinnisauthor=A.+Wissnerauthor=S.+V.+Sharmaauthor=K.+J.+Isselbacherauthor=J.+Settlemanauthor=D.+A.+Haber&title=Irreversible+inhibitors+of+the+EGF+receptor+may+circumvent+acquired+resistance+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DGodin-Heymann%26aufirst%3DN.%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBrannigan%26aufirst%3DB.%2BW.%26aulast%3DHarris%26aufirst%3DP.%2BL.%26aulast%3DDriscoll%26aufirst%3DD.%2BR.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26aulast%3DIsselbacher%26aufirst%3DK.%2BJ.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DIrreversible%2520inhibitors%2520of%2520the%2520EGF%2520receptor%2520may%2520circumvent%2520acquired%2520resistance%2520to%2520gefitinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D7665%26epage%3D7670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">â</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.-H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.-K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+mutation+in+EGFR+kinase+causes+drug+resistance+by+increasing+the+affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0ljzcwdXdmhWGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520mutation%2520in%2520EGFR%2520kinase%2520causes%2520drug%2520resistance%2520by%2520increasing%2520the%2520affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingalls, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nittoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganzo, F.</span><span> </span><span class="NLM_article-title">Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3635</span><span class="NLM_x">â</span> <span class="NLM_lpage">3648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=3635-3648&author=A.+Wissnerauthor=H.+L.+Fraserauthor=C.+L.+Ingallsauthor=R.+G.+Dushinauthor=M.+B.+Floydauthor=K.+Cheungauthor=T.+Nittoliauthor=M.+R.+Raviauthor=X.+Tanauthor=F.+Loganzo&title=Dual+irreversible+kinase+inhibitors%3A+quinazoline-based+inhibitors+incorporating+two+independent+reactive+centers+with+each+targeting+different+cysteine+residues+in+the+kinase+domains+of+EGFR+and+VEGFR-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFraser%26aufirst%3DH.%2BL.%26aulast%3DIngalls%26aufirst%3DC.%2BL.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DNittoli%26aufirst%3DT.%26aulast%3DRavi%26aufirst%3DM.%2BR.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLoganzo%26aufirst%3DF.%26atitle%3DDual%2520irreversible%2520kinase%2520inhibitors%253A%2520quinazoline-based%2520inhibitors%2520incorporating%2520two%2520independent%2520reactive%2520centers%2520with%2520each%2520targeting%2520different%2520cysteine%2520residues%2520in%2520the%2520kinase%2520domains%2520of%2520EGFR%2520and%2520VEGFR-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D3635%26epage%3D3648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">â</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53aR"><div class="casContent"><span class="casTitleNuber">53a</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Nonselective Kinase Inhibition: Striking the Right Balance</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1413-1437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Marketed kinase inhibitors (MKIs) can deliver superior efficacy compared to inhibitors with high specificity for a single kinase, and the recent introduction of several MKIs to the market opens the door to a new era of safer and effective anticancer therapy.  The key to combining high efficacy with acceptable safety is to inhibit multiple targets in a selectively nonselective fashion.  Strategies for intentionally designing MKIs are emerging, but the field is still in its infancy and we are as medicinal chemists currently on the steepest part of the learning curve.  MTDD can be time-consuming and expensive, and we need to become more proficient first at identifying disease-relevant target combinations and second at discovering MKIs that combine optimal physicochem. and biol. properties.  Bold and innovative medicinal chem. strategies are required to tackle "difficult combinations" where the disease rationale is compelling but where it is a struggle to combine all the desired attributes of an oral MKI drug into a single mol.  At present it is unclear to what extent MKIs with highly tuned selectivity profiles can be rationally designed, particularly for targets that are unrelated by sequence.  In addn. to the well-known selectivity challenge, the physicochem. property profiles of AT P-competitive MKIs can be inherently challenging and limited scope for patentability can also be a serious hindrance.  On the plus side, the amt. of kinase-specific structural information is growing very rapidly, and ultimately this may reveal distinct features and design rules that enable a medicinal chemist to rationally modify and refine the profile of MKIs.  In addn., increasing SAR knowledge is emerging from large scale panel screening with the binding profiles starting to reveal to medicinal chemists how chem. structure affects cross-reactivity across large parts of the kinome.  The merit of MKIs compared with single kinase inhibitors is a subject of controversy in drug discovery that is unlikely to be resolved in the near future.  At the start of a new MTDD project, a rigorous debate needs to take place as to whether it makes more sense to seek a combination of highly selective agents or a DML.  Many factors need to be taken into account in this decision such as the no., similarity, and promiscuity of the targets in the profile and the disease area.  Conformational plasticity and the occurrence of multiple binding modes complicate the in silico prediction of kinase polypharmacol. based solely upon protein structure.  The use of ligand-based similarity to assess the feasibility of a given combination can add real value.  Currently, serendipity plays a significant role in MKI discovery and many, if not most, MKIs have been discovered by chance during the search for selective inhibitors.  Medicinal chemists need to be alert to the possibilities when a surprising combination is found by chance.  To exploit such serendipity, you need a good appreciation of when you have a sufficiently high quality starting compd. and then you need to be able to make and test sufficient analogs to explore your new disease-based hypothesis.  MKIs are costly to develop and are consequently priced at a premium level, so they will need to show clear improvements in order to get reimbursement.  There have already been problems with reimbursement for some MKIs in some markets due to concerns from funding bodies over insufficient efficacy.  The true value of MKIs relative to other anticancer drugs still has to be established, and the results from recent clin. trials have been mixed.  Despite the broad activity profile of many MKIs, the patient response can be inconsistent and unpredictable.  The identification of predictive biomarkers of response or resistance is a crit. step to ascertain which specific combination of targets produces a significant clin. benefit with respect to specific tumor types.  More clin. feedback is needed to facilitate the design of the next generation of inhibitors with more precisely defined profiles.  Although it might seem immeasurably distant at the present time, the ultimate goal should be to derive the prerequisite knowledge and tools so that MTDD becomes a rational endeavor rather than a black box approach that relies upon serendipity.  This will help banish claims that MKIs are merely dirty, nonspecific drugs with insufficient specificity for treating a wider range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-L-NWmtdikbVg90H21EOLACvtfcHk0ljzcwdXdmhWGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF&md5=3c915b5debf9d005993c8ad31c68bc2e</span></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit53b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Keller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafhause, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummendorf, T. H.</span><span> </span><span class="NLM_article-title">Bosutinib</span> <span class="citation_source-journal">Recent Res. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2F978-3-642-01222-8_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=20072835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgsLnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=119-127&author=G.+Kellerauthor=P.+Schafhauseauthor=T.+H.+Brummendorf&title=Bosutinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53bR"><div class="casContent"><span class="casTitleNuber">53b</span><div class="casTitle"><span class="NLM_cas:atitle">Bosutinib</span></div><div class="casAuthors">Keller, Gunhild; Schafhausen, Philippe; Bruemmendorf, Tim H.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Results in Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">Small Molecules in Oncology</span>),
    <span class="NLM_cas:pages">119-127</span>CODEN:
                <span class="NLM_cas:coden">RRCRBU</span>;
        ISSN:<span class="NLM_cas:issn">0080-0015</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Bosutinib (SKI-606) is a 7-alkoxy-3-quinolinecarbonitrile, which functions as a dual inhibitor of Src and Abl kinases.  In biochem. and proliferation assays, the compd. was shown to be active against src family kinases and Bcr-Abl at IC50s of 100 and 90 nM, resp.  The bcr-abl fusion gene product, a consecutively activated tyrosine kinase, which is crucial for the development of chronic myeloid leukemia (CML), is highly sensitive to bosutinib.  Interestingly, distinctly lower concns. of the dual src/abl inhibitor are required to ablate Bcr-Abl phosphorylation when compared to first-generation tyrosine kinase inhibitor imatinib (IM).  Bosutinib is a potent inhibitor of CML cell proliferation in vitro and in vivo expts. and has demonstrated promising harboring results in CML patients resistance or intolerance to IM in ongoing phase I/II clin. trials.  Remarkably, bosutinib has been found to be capable of overcoming the majority of IM-resistant bcr-abl mutations.  A randomized open label phase III clin. study to compare the efficacy of bosutinib and IM in first-line therapy of Ph+ chronic phase (CP) CML has recently been initiated.  In a phase I/II clin. study with subjects suffering from advanced stages of solid tumors, long-term responses have also been reported.  In conclusion, Bosutinib is a promising novel small mol. inhibitor for targeted therapy of CML and solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGremOsWiws7jrVg90H21EOLACvtfcHk0lgpEAfZ9Dm_Rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgsLnE&md5=9b601b52d7c0aec8b9b2ebf375bb3b16</span></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-01222-8_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-01222-8_9%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DG.%26aulast%3DSchafhause%26aufirst%3DP.%26aulast%3DBrummendorf%26aufirst%3DT.%2BH.%26atitle%3DBosutinib%26jtitle%3DRecent%2520Res.%2520Cancer%26date%3D2010%26volume%3D184%26spage%3D119%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Gunby, R. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sottocornola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mologni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartari, C. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belloni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapozza, L.</span><span> </span><span class="NLM_article-title">Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5759</span><span class="NLM_x">â</span> <span class="NLM_lpage">5768</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060380k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5759-5768&author=R.+H+Gunbyauthor=S.+Ahmedauthor=R.+Sottocornolaauthor=M.+Gasserauthor=S.+Redaelliauthor=L.+Mologniauthor=C.+J+Tartariauthor=V.+Belloniauthor=C.+Gambacorti-Passeriniauthor=L.+Scapozza&title=Structural+insights+into+the+ATP+binding+pocket+of+the+anaplastic+lymphoma+kinase+by+site-directed+mutagenesis%2C+inhibitor+binding+analysis%2C+and+homology+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm060380k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060380k%26sid%3Dliteratum%253Aachs%26aulast%3DGunby%26aufirst%3DR.%2BH%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DSottocornola%26aufirst%3DR.%26aulast%3DGasser%26aufirst%3DM.%26aulast%3DRedaelli%26aufirst%3DS.%26aulast%3DMologni%26aufirst%3DL.%26aulast%3DTartari%26aufirst%3DC.%2BJ%26aulast%3DBelloni%26aufirst%3DV.%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26aulast%3DScapozza%26aufirst%3DL.%26atitle%3DStructural%2520insights%2520into%2520the%2520ATP%2520binding%2520pocket%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520by%2520site-directed%2520mutagenesis%252C%2520inhibitor%2520binding%2520analysis%252C%2520and%2520homology%2520modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5759%26epage%3D5768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek-Klumpers, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">â</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1107-1131&author=H.-R.+Tsouauthor=E.+G.+Overbeek-Klumpersauthor=W.+A.+Hallettauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=R.+S.+Michalakauthor=R.+Nilakantanauthor=C.+Discafaniauthor=J.+Golasauthor=S.+K.+Rabindranauthor=R.+Shenauthor=X.+Shiauthor=Y.+F.+Wangauthor=J.+Upeslacisauthor=A.+Wissner&title=Optimization+of+6%2C7-disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+orally+active%2C+irreversible+inhibitors+of+human+epidermal+growth+factor+receptor-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1021%2Fjm040159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040159c%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DOverbeek-Klumpers%26aufirst%3DE.%2BG.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMichalak%26aufirst%3DR.%2BS.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DUpeslacis%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DOptimization%2520of%25206%252C7-disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520orally%2520active%252C%2520irreversible%2520inhibitors%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520kinase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1107%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span> </span><span class="NLM_article-title">4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3244</span><span class="NLM_x">â</span> <span class="NLM_lpage">3256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000206a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3244-3256&author=A.+Wissnerauthor=D.+M.+Bergerauthor=D.+H.+Boschelliauthor=M.+B.+Floydauthor=L.+M.+Greenbergerauthor=B.+C.+Gruberauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=R.+Nilakantanauthor=M.+F.+Reichauthor=R.+Shenauthor=H.-R.+Tsouauthor=E.+Upeslacisauthor=Y.+F.+Wangauthor=B.+Wuauthor=F.+Yeauthor=N.+Zhang&title=4-Anilino-6%2C7-dialkoxyquinoline-3-carbonitrile+inhibitors+of+epidermal+growth+factor+receptor+kinase+and+their+bioisosteric+relationship+to+the+4-anilino-6%2C7-dialkoxyquinazoline+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1021%2Fjm000206a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000206a%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DUpeslacis%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26atitle%3D4-Anilino-6%252C7-dialkoxyquinoline-3-carbonitrile%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520and%2520their%2520bioisosteric%2520relationship%2520to%2520the%25204-anilino-6%252C7-dialkoxyquinazoline%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3244%26epage%3D3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Boschelli, D. H.</span><span> </span><span class="NLM_article-title">4-Anilino-3-quinolinecarbonitriles: an emerging class of kinase inhibitorsâan update</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">â</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlShtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=457-463&author=D.+H.+Boschelli&title=4-Anilino-3-quinolinecarbonitriles%3A+an+emerging+class+of+kinase+inhibitors%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">4-Anilino-3-quinolinecarbonitriles: an emerging class of kinase inhibitors - an update</span></div><div class="casAuthors">Boschelli, Diane H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Reviews--Online</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-463</span>CODEN:
                <span class="NLM_cas:coden">MCREC9</span>;
        ISSN:<span class="NLM_cas:issn">1567-2034</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2000, Wyeth disclosed that 4-(3-bromoanilino)-6,7-dimethoxy-3-quinolinecarbonitrile was a potent and selective EGFR kinase inhibitor.  Subsequent reports showed that variation of the substituents on the 4-anilino group of the 3-quminolinecarbonitrile core changed the kinase specificity from EGFR to either Src or MEK.  This article is an update of a 2002 review that summarized Wyeth's efforts in the area of 4-anilino-3-qumiolinecarbonitrile kinase inhibitors.  Since then, Wyeth has reported the SAR of EKB-569, an irreversible EGFR inhibitor currently in clin. trials.  Variation of the 4-anilino group of EKB-569 provided HKI-272, a dual inhibitor of EGFR and HER-2.  In addn., the 3-quinolinecarbonitnrile analogs of known quinazoline EGFR inhibitors were prepd.  SKI-606, initially reported to be a Src inhibitor, was found to also inhibit Abl kinase and therefore could be a potential alternative treatment to Gleevec.  SKI-606 was also efficacious in a rat model of stroke.  Addnl. Src kinase inhibitors, including some tricyclic analogs, were obtained by variation of the substituent at C-7.  Finally, 3-quinolinecarbonitrile MEK inhibitors with potent cell activity were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqpIUJ4gjFrVg90H21EOLACvtfcHk0lgb7ix1OhC4sA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlShtLc%253D&md5=416e305ae8cb1a7b306daa2423ba5e25</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26atitle%3D4-Anilino-3-quinolinecarbonitriles%253A%2520an%2520emerging%2520class%2520of%2520kinase%2520inhibitors%25E2%2580%2594an%2520update%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2004%26volume%3D1%26spage%3D457%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span> </span><span class="NLM_article-title">Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles: analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">â</span> <span class="NLM_lpage">2897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2893-2897&author=A.+Wissnerauthor=M.+B.+Floydauthor=S.+K.+Rabindranauthor=R.+Nilakantanauthor=L.+M.+Greenbergerauthor=R.+Shenauthor=Y.-F.+Wangauthor=H.-R.+Tsou&title=Syntheses+and+EGFR+and+HER-2+kinase+inhibitory+activities+of+4-anilinoquinoline-3-carbonitriles%3A+analogues+of+three+important+4-anilinoquinazolines+currently+undergoing+clinical+evaluation+as+therapeutic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DSyntheses%2520and%2520EGFR%2520and%2520HER-2%2520kinase%2520inhibitory%2520activities%2520of%25204-anilinoquinoline-3-carbonitriles%253A%2520analogues%2520of%2520three%2520important%25204-anilinoquinazolines%2520currently%2520undergoing%2520clinical%2520evaluation%2520as%2520therapeutic%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2893%26epage%3D2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Torrance, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discfani, C. M.</span><span> </span><span class="NLM_article-title">Combinatorial chemoprevention of intestinal neoplasia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">â</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2F79534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=10973323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1024-1028&author=C.+J.+Torranceauthor=P.+E.+Jacksonauthor=E.+Montgomeryauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=A.+Wissnerauthor=M.+Nunesauthor=P.+Frostauthor=C.+M.+Discfani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57bR"><div class="casContent"><span class="casTitleNuber">57b</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial chemoprevention of intestinal neoplasia</span></div><div class="casAuthors">Torrance, Christopher J.; Jackson, Peta E.; Montgomery, Elizabeth; Kinzler, Kenneth W.; Vogelstein, Bert; Wissner, Allan; Nunes, Maria; Frost, Philip; Discafani, Carolyn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1024-1028</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A combination of two drugs afforded remarkable protection from intestinal neoplasia in APCMin/+ mice, a murine model of human familial adenomatous polyposis (FAP).  One of the drugs was sulindac, a prototypical non-steroidal anti-inflammatory drug with established chemopreventive activity.  The second drug was EKB569, a newly developed, irreversible inhibitor of the epidermal growth factor receptor kinase.  Although 100% of the untreated APCMin/+ mice developed -20 polyps, nearly half the mice treated with these two agents developed no polyps at all.  These results suggest a powerful strategy for the chemoprevention of human colonic neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysAYwWewtCrVg90H21EOLACvtfcHk0lgb7ix1OhC4sA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D&md5=2b1da2bdcd72fec51856ff25643efd4c</span></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=10.1038%2F79534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79534%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BE.%26aulast%3DMontgomery%26aufirst%3DE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DM.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DDiscfani%26aufirst%3DC.%2BM.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D1024%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wawrzak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, D. B.</span><span> </span><span class="NLM_article-title">Structure-based design of potent inhibitors of scytalone dehydratase: displacement of a water molecule from the active site</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">17735</span><span class="NLM_x">â</span> <span class="NLM_lpage">17744</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981848r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK1cXns1ahur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=17735-17744&author=J.+M.+Chenauthor=S.+L.+Xuauthor=Z.+Wawrzakauthor=G.+S.+Basarabauthor=D.+B.+Jordan&title=Structure-based+design+of+potent+inhibitors+of+scytalone+dehydratase%3A+displacement+of+a+water+molecule+from+the+active+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent Inhibitors of Scytalone Dehydratase: Displacement of a Water Molecule from the Active Site</span></div><div class="casAuthors">Chen, James M.; Xu, Simon L.; Wawrzak, Zdzislaw; Basarab, Gregory S.; Jordan, Douglas B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17735-17744</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Scytalone dehydratase (SD) is a mol. target of inhibitor design efforts aimed at protecting rice plants from the fungal disease caused by Magnaporthe grisea.  As detd. from x-ray diffraction data of an SD-inhibitor complex [Lundqvist et al. (1994) Structure (London) 2, 937-944], there is an extended hydrogen-bonding network between protein side chains, the inhibitor, and two bound water mols.  From models of SD complexed to quinazoline and benzotriazine inhibitors, a new class of potent SD inhibitors involving the displacement of an active-site water mol. were designed.  We were able to increase inhibitory potency by synthesizing compds. with a nitrile functionality displayed into the space occupied by one of the crystallog. water mols.  Sixteen inhibitors are compared.  The net conversion of potent quinazoline and benztriazine inhibitors to cyanoquinolines and cyanocinnolines increased binding potency 2-20-fold.  Replacement of the nitrile with a hydrogen atom lowered binding affinity 100-30 000-fold.  X-ray crystallog. data at 1.65 Ã resoln. on a SD-inhibitor complex confirmed that the nitrile functionality displaced the water mol. as intended and that a favorable orientation was created with tyrosines 30 and 50 which had been part of the hydrogen-bonding network with the water mol.  Addnl. data on inhibitors presented herein reveals the importance of two hydrogen-bonding networks toward inhibitory potency: one between Asn131 and an appropriately positioned inhibitor heteroatom and one between a bound water mol. and a second inhibitor heteroatom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmVth3Jjz37Vg90H21EOLACvtfcHk0lgb7ix1OhC4sA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1ahur8%253D&md5=e75ce5e856763fbded15acc1db5421d1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbi981848r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981848r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DS.%2BL.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DJordan%26aufirst%3DD.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520inhibitors%2520of%2520scytalone%2520dehydratase%253A%2520displacement%2520of%2520a%2520water%2520molecule%2520from%2520the%2520active%2520site%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D17735%26epage%3D17744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Bayram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheorghiade, M.</span><span> </span><span class="NLM_article-title">Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">47G</span><span class="NLM_x">â</span> <span class="NLM_lpage">58G</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=47G-58G&author=M.+Bayramauthor=L.+De+Lucaauthor=M.+B.+Massieauthor=M.+Gheorghiade&title=Reassessment+of+dobutamine%2C+dopamine%2C+and+milrinone+in+the+management+of+acute+heart+failure+syndromes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBayram%26aufirst%3DM.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DMassie%26aufirst%3DM.%2BB.%26aulast%3DGheorghiade%26aufirst%3DM.%26atitle%3DReassessment%2520of%2520dobutamine%252C%2520dopamine%252C%2520and%2520milrinone%2520in%2520the%2520management%2520of%2520acute%2520heart%2520failure%2520syndromes%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2005%26volume%3D96%26spage%3D47G%26epage%3D58G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Hannon, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housmans, P. R.</span><span> </span><span class="NLM_article-title">Inotropic therapy</span> <span class="citation_source-journal">Adv. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVant7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1-15&author=J.+D.+Hannonauthor=P.+R.+Housmans&title=Inotropic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Inotropic therapy</span></div><div class="casAuthors">Hannon, James D.; Housmans, Philippe R.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cardiovascular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">69LKDN</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review on inotropic therapy, emphasizing on epinephrine, norepinephrine, dopamine, dobutamine, milrinone and levosimendan, as well as the evolving therapies, such as SERCA expression and myosin activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSeiUijEFUV7Vg90H21EOLACvtfcHk0li8nq9m5HjlYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVant7w%253D&md5=0b4bd0fd5c44070b2f50fb15a35b33c1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHannon%26aufirst%3DJ.%2BD.%26aulast%3DHousmans%26aufirst%3DP.%2BR.%26atitle%3DInotropic%2520therapy%26jtitle%3DAdv.%2520Cardiovasc.%2520Pharmacol.%26date%3D2008%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Mizushige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yukiiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span> </span><span class="NLM_article-title">Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">â</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=163-174&author=K.+Mizushigeauthor=T.+Uedaauthor=K.+Yukiiriauthor=H.+Suzuki&title=Olprinone%3A+a+phosphodiesterase+III+inhibitor+with+positive+inotropic+and+vasodilator+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizushige%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DYukiiri%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DH.%26atitle%3DOlprinone%253A%2520a%2520phosphodiesterase%2520III%2520inhibitor%2520with%2520positive%2520inotropic%2520and%2520vasodilator%2520effects%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2002%26volume%3D20%26spage%3D163%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wojtczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, V.</span><span> </span><span class="NLM_article-title">Structural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 Ã of the human serum transthyretinâmilrinone complex</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">6202</span><span class="NLM_x">â</span> <span class="NLM_lpage">6206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=6202-6206&author=A.+Wojtczakauthor=J.+R.+Luftauthor=V.+Cody&title=Structural+aspects+of+inotropic+bipyridine+binding.+Crystal+structure+determination+to+1.9+%C3%85+of+the+human+serum+transthyretin%E2%88%92milrinone+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DLuft%26aufirst%3DJ.%2BR.%26aulast%3DCody%26aufirst%3DV.%26atitle%3DStructural%2520aspects%2520of%2520inotropic%2520bipyridine%2520binding.%2520Crystal%2520structure%2520determination%2520to%25201.9%2520%25C3%2585%2520of%2520the%2520human%2520serum%2520transthyretin%25E2%2588%2592milrinone%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D6202%26epage%3D6206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cody, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojtczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciszak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennemann, G.</span><span> </span><span class="NLM_article-title">Differences in inhibitor and substrate binding in transthyretin crystal complexes</span> <span class="citation_source-journal">Prog. Thyroid Res., Proc. Int. Thyroid Conf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">â</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3sXpsVCquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=793-796&author=V.+Codyauthor=A.+Wojtczakauthor=E.+Ciszakauthor=J.+Luftauthor=A.+Gordonauthor=J.+Grossauthor=G.+Hennemann&title=Differences+in+inhibitor+and+substrate+binding+in+transthyretin+crystal+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62bR"><div class="casContent"><span class="casTitleNuber">62b</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in inhibitor and substrate binding in transthyretin crystal complexes</span></div><div class="casAuthors">Cody, Vivian; Wojtczak, Andrzej; Ciszak, Ewa; Luft, Joseph</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">793-6</span>CODEN:
                <span class="NLM_cas:coden">58JYAY</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Balkema</span>)
        </div><div class="casAbstract">Crystal structure detns. of transthyretin-competitor cocrystd. complexes were investigated and preliminary results of 4 inhibitor complexes [3,3'-diiodothyronine, the bromoflavonoids 3-methyl-6,4'-dihydroxy-3',5'-dibromoflavone (EMD 21388) and 4,6,2',4'-tetrahydroxy-3',5'-dibromoaurone (EMD 47021), and the ionotropic cardioactive drug milrinone are presented.  Results indicated that EMD 21388 and EMD 47021, competitive inhibitors of T4 binding to transthyretin, occupy the hormone binding site in different ways from T4 as well as from models proposed from computer graphic studies.  In the case of milrinone and 3,3'-diiodothyronine, binding was similar to that of T4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAiP9_YQ1ObVg90H21EOLACvtfcHk0li8nq9m5HjlYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpsVCquw%253D%253D&md5=3be00963db946881ab306c04997d00ed</span></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCody%26aufirst%3DV.%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DCiszak%26aufirst%3DE.%26aulast%3DLuft%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DHennemann%26aufirst%3DG.%26atitle%3DDifferences%2520in%2520inhibitor%2520and%2520substrate%2520binding%2520in%2520transthyretin%2520crystal%2520complexes%26jtitle%3DProg.%2520Thyroid%2520Res.%252C%2520Proc.%2520Int.%2520Thyroid%2520Conf.%26date%3D1991%26spage%3D793%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Cody, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojtczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blas, S. D.</span><span> </span><span class="NLM_article-title">Structureâactivity relationships of milrinone analogs determined in vitro in a rabbit heart membrane Ca<sup>2+</sup>-ATPase model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1990</span><span class="NLM_x">â</span> <span class="NLM_lpage">1997</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00011a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1990-1997&author=V.+Codyauthor=A.+Wojtczakauthor=F.+B.+Davisauthor=P.+J.+Davisauthor=S.+D.+Blas&title=Structure%E2%88%92activity+relationships+of+milrinone+analogs+determined+in+vitro+in+a+rabbit+heart+membrane+Ca2%2B-ATPase+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm00011a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00011a018%26sid%3Dliteratum%253Aachs%26aulast%3DCody%26aufirst%3DV.%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DF.%2BB.%26aulast%3DDavis%26aufirst%3DP.%2BJ.%26aulast%3DBlas%26aufirst%3DS.%2BD.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520milrinone%2520analogs%2520determined%2520in%2520vitro%2520in%2520a%2520rabbit%2520heart%2520membrane%2520Ca2%252B-ATPase%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1990%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Thornber, C. W.</span><span> </span><span class="NLM_article-title">Isosterism and molecular modification in drug design</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">â</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1039%2Fcs9790800563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL3cXktlKmsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1979&pages=563-580&author=C.+W.+Thornber&title=Isosterism+and+molecular+modification+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Isosterism and molecular modification in drug design</span></div><div class="casAuthors">Thornber, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">563-80</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    </div><div class="casAbstract">A review  with 76 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Xf7UcnFrA7Vg90H21EOLACvtfcHk0liNG5Q0Qefgcw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktlKmsL0%253D&md5=25e8bd3c46affd25b72fbf87a44a3b27</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1039%2Fcs9790800563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcs9790800563%26sid%3Dliteratum%253Aachs%26aulast%3DThornber%26aufirst%3DC.%2BW.%26atitle%3DIsosterism%2520and%2520molecular%2520modification%2520in%2520drug%2520design%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D1979%26volume%3D8%26spage%3D563%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Matthews, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitten, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barney, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, T.</span><span> </span><span class="NLM_article-title">Synthesis and cardiotonic activity of novel biimidazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00163a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=317-327&author=D.+P.+Matthewsauthor=J.+R.+McCarthyauthor=J.+P.+Whittenauthor=P.+R.+Kastnerauthor=C.+L.+Barneyauthor=F.+N.+Marshallauthor=M.+A.+Ertelauthor=T.+Burkhardauthor=P.+J.+Sheaauthor=T.+Kariya&title=Synthesis+and+cardiotonic+activity+of+novel+biimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm00163a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00163a052%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BP.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DKastner%26aufirst%3DP.%2BR.%26aulast%3DBarney%26aufirst%3DC.%2BL.%26aulast%3DMarshall%26aufirst%3DF.%2BN.%26aulast%3DErtel%26aufirst%3DM.%2BA.%26aulast%3DBurkhard%26aufirst%3DT.%26aulast%3DShea%26aufirst%3DP.%2BJ.%26aulast%3DKariya%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520cardiotonic%2520activity%2520of%2520novel%2520biimidazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D317%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefaniak, M. H.</span><span> </span><span class="NLM_article-title">2(1<i>H</i>)-Quinolinones with cardiac stimulant activity. 3. Synthesis and biological properties of 6-imidazol-1-yl derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1552</span><span class="NLM_x">â</span> <span class="NLM_lpage">1558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00127a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1552-1558&author=A.+S.+Bellauthor=S.+F.+Campbellauthor=D.+S.+Morrisauthor=D.+A.+Robertsauthor=M.+H.+Stefaniak&title=2%281H%29-Quinolinones+with+cardiac+stimulant+activity.+3.+Synthesis+and+biological+properties+of+6-imidazol-1-yl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm00127a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00127a025%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DCampbell%26aufirst%3DS.%2BF.%26aulast%3DMorris%26aufirst%3DD.%2BS.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DStefaniak%26aufirst%3DM.%2BH.%26atitle%3D2%25281H%2529-Quinolinones%2520with%2520cardiac%2520stimulant%2520activity.%25203.%2520Synthesis%2520and%2520biological%2520properties%2520of%25206-imidazol-1-yl%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1552%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cecchetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabarrini, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, S.</span><span> </span><span class="NLM_article-title">From cromakalim to different structural classes of KATP channel openers</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">â</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802606777323683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16787279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2is78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1049-1068&author=V.+Cecchettiauthor=O.+Tabarriniauthor=S.+Sabatini&title=From+cromakalim+to+different+structural+classes+of+KATP+channel+openers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67aR"><div class="casContent"><span class="casTitleNuber">67a</span><div class="casTitle"><span class="NLM_cas:atitle">From cromakalim to different structural classes of KATP channel openers</span></div><div class="casAuthors">Cecchetti, Violetta; Tabarrini, Oriana; Sabatini, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1049-1068</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP-Sensitive K channel openers (KATPCOs) are a group of compds. with a broad spectrum of potential therapeutic applications, as they constitute efficient tools for dampening cell excitability.  Interest in the KATPCOs was triggered in the early 1980s by the discovery of the benzopyran-based structure cromakalim (CRK), which is a powerful smooth muscle relaxant.  CRK can be considered the archetype of KATPCOs and is by far the most mimicked structure.  In many structure-activity studies various substitutions were made at the different positions of the benzopyran ring permitting the optimal activity to be correlated with a specific set of structural characteristics and stereochem. features of the mol.  Thus, many potent benzopyran derivs. were identified.  The benzopyran nucleus itself was also modified in both the arom. ring and in the pyran moiety.  The intention of this review is to bring together all the different structural classes of KATPCOs arising from the replacement of CRK benzopyran-based structure with various ring systems; design, structure-activity relationship, and synthesis will be given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Quwwyf_G0bVg90H21EOLACvtfcHk0liNG5Q0Qefgcw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2is78%253D&md5=8ff46cc2949761da891d0a5f2fbb7e2a</span></div><a href="/servlet/linkout?suffix=cit67a&amp;dbid=16384&amp;doi=10.2174%2F156802606777323683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777323683%26sid%3Dliteratum%253Aachs%26aulast%3DCecchetti%26aufirst%3DV.%26aulast%3DTabarrini%26aufirst%3DO.%26aulast%3DSabatini%26aufirst%3DS.%26atitle%3DFrom%2520cromakalim%2520to%2520different%2520structural%2520classes%2520of%2520KATP%2520channel%2520openers%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2006%26volume%3D6%26spage%3D1049%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit67b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Salamon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannhold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, W.</span><span> </span><span class="NLM_article-title">6-Sulfonylchromenes as highly potent KATP-channel openers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">â</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010999g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1086-1089&author=E.+Salamonauthor=R.+Mannholdauthor=H.+Weberauthor=H.+Lemoineauthor=W.+Frank&title=6-Sulfonylchromenes+as+highly+potent+KATP-channel+openers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67b&amp;dbid=16384&amp;doi=10.1021%2Fjm010999g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010999g%26sid%3Dliteratum%253Aachs%26aulast%3DSalamon%26aufirst%3DE.%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DWeber%26aufirst%3DH.%26aulast%3DLemoine%26aufirst%3DH.%26aulast%3DFrank%26aufirst%3DW.%26atitle%3D6-Sulfonylchromenes%2520as%2520highly%2520potent%2520KATP-channel%2520openers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1086%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovnyak, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span> </span><span class="NLM_article-title">Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3711</span><span class="NLM_x">â</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990196h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3711-3717&author=C.+Z.+Dingauthor=G.+C.+Rovnyakauthor=R.+N.+Misraauthor=G.+J.+Groverauthor=A.+V.+Millerauthor=S.+Z.+Ahmedauthor=Y.+Kellyauthor=D.+E.+Normandinauthor=P.+G.+Slephauthor=K.+S.+Atwal&title=Cardioselective+antiischemic+ATP-sensitive+potassium+channel+%28KATP%29+openers.+6.+Effect+of+modifications+at+C6+of+benzopyranyl+cyanoguanidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1021%2Fjm990196h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990196h%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DRovnyak%26aufirst%3DG.%2BC.%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DMiller%26aufirst%3DA.%2BV.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DKelly%26aufirst%3DY.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DCardioselective%2520antiischemic%2520ATP-sensitive%2520potassium%2520channel%2520%2528KATP%2529%2520openers.%25206.%2520Effect%2520of%2520modifications%2520at%2520C6%2520of%2520benzopyranyl%2520cyanoguanidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3711%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit68b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzwonczyk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCullough, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span> </span><span class="NLM_article-title">Cardioselective anti-ischemic ATP-sensitive potassium channel openers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3971</span><span class="NLM_x">â</span> <span class="NLM_lpage">3974</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00076a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3971-3974&author=K.+S.+Atwalauthor=G.+J.+Groverauthor=S.+Z.+Ahmedauthor=F.+N.+Ferraraauthor=T.+W.+Harperauthor=K.+S.+Kimauthor=P.+G.+Slephauthor=S.+Dzwonczykauthor=A.+D.+Russellauthor=S.+Morelandauthor=J.+R.+McCulloughauthor=D.+E.+Normandin&title=Cardioselective+anti-ischemic+ATP-sensitive+potassium+channel+openers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=10.1021%2Fjm00076a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00076a027%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DFerrara%26aufirst%3DF.%2BN.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DDzwonczyk%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DA.%2BD.%26aulast%3DMoreland%26aufirst%3DS.%26aulast%3DMcCullough%26aufirst%3DJ.%2BR.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26atitle%3DCardioselective%2520anti-ischemic%2520ATP-sensitive%2520potassium%2520channel%2520openers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3971%26epage%3D3974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gaspar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snipes, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busija, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domoki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busija, D. W.</span><span> </span><span class="NLM_article-title">ROS-independent preconditioning in neurons via activation of mitoKATP channels by BMS-191095</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1090</span><span class="NLM_x">â</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fsj.jcbfm.9600611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18212794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1SgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1090-1103&author=T.+Gasparauthor=J.+A.+Snipesauthor=A.+R.+Busijaauthor=B.+Kisauthor=F.+Domokiauthor=F.+Bariauthor=D.+W.+Busija&title=ROS-independent+preconditioning+in+neurons+via+activation+of+mitoKATP+channels+by+BMS-191095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69aR"><div class="casContent"><span class="casTitleNuber">69a</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-independent preconditioning in neurons via activation of mitoKATP channels by BMS-191095</span></div><div class="casAuthors">Gaspar, Tamas; Snipes, James A.; Busija, Anna R.; Kis, Bela; Domoki, Ferenc; Bari, Ferenc; Busija, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1090-1103</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Previously, we have shown that the selective mitochondrial ATP-sensitive potassium (mitoKATP) channel opener BMS-191095 (BMS) induces neuronal preconditioning (PC); however, the exact mechanism of BMS-induced neuroprotection remains unclear.  In this study, we have identified key components of the cascade resulting in delayed neuronal PC with BMS using isolated rat brain mitochondria and primary cultures of rat cortical neurons.  BMS depolarized isolated mitochondria without an increase in reactive oxygen species (ROS) generation and induced rapid phosphorylation of Akt and glycogen synthase kinase-3Î².  Long-term (3 days) treatment of neurons with BMS resulted in sustained mitochondrial depolarization, decreased basal ROS generation, and elevated ATP levels.  This treatment also elicited almost complete protection against glutamate excitotoxicity, which could be abolished using the phosphoinositide 3-kinase (PI3K) inhibitor wortmannin, but not with the superoxide dismutase (SOD) mimetic M40401.  Long-term BMS treatment induced a PI3K-dependent increase in the expression and activity of catalase without affecting manganese SOD and copper/zinc-dependent SOD.  Finally, the catalase inhibitor 3-aminotriazole dose-dependently antagonized the neuroprotective effect of BMS-induced PC.  In summary, BMS depolarizes mitochondria without ROS generation, activates the PI3K-Akt pathway, improves ATP content, and increases catalase expression.  These mechanisms appear to play important roles in the neuroprotective effect of BMS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt0AMIgX8ybLVg90H21EOLACvtfcHk0lgeS33o4xx5hA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1SgsL0%253D&md5=f4abef03fc1e89e81ec8a295691b940e</span></div><a href="/servlet/linkout?suffix=cit69a&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600611%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DT.%26aulast%3DSnipes%26aufirst%3DJ.%2BA.%26aulast%3DBusija%26aufirst%3DA.%2BR.%26aulast%3DKis%26aufirst%3DB.%26aulast%3DDomoki%26aufirst%3DF.%26aulast%3DBari%26aufirst%3DF.%26aulast%3DBusija%26aufirst%3DD.%2BW.%26atitle%3DROS-independent%2520preconditioning%2520in%2520neurons%2520via%2520activation%2520of%2520mitoKATP%2520channels%2520by%2520BMS-191095%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2008%26volume%3D28%26spage%3D1090%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit69b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rovnyak, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzwonczyk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santafianos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traeger, S. C.</span><span> </span><span class="NLM_article-title">Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(<i>N</i>-aryl)-substituted benzopyran derivatives with high selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9605905" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=24-34&author=G.+C.+Rovnyakauthor=S.+Z.+Ahmedauthor=C.+Z.+Dingauthor=S.+Dzwonczykauthor=F.+N.+Ferraraauthor=W.+G.+Humphreysauthor=G.+J.+Groverauthor=D.+Santafianosauthor=K.+S.+Atwalauthor=A.+J.+Bairdauthor=L.+G.+McLaughlinauthor=D.+E.+Normandinauthor=P.+G.+Slephauthor=S.+C.+Traeger&title=Cardioselective+antiischemic+ATP-sensitive+potassium+channel+%28KATP%29+openers.+5.+Identification+of+4-%28N-aryl%29-substituted+benzopyran+derivatives+with+high+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69b&amp;dbid=16384&amp;doi=10.1021%2Fjm9605905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9605905%26sid%3Dliteratum%253Aachs%26aulast%3DRovnyak%26aufirst%3DG.%2BC.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DDzwonczyk%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DF.%2BN.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DSantafianos%26aufirst%3DD.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DBaird%26aufirst%3DA.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DL.%2BG.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26atitle%3DCardioselective%2520antiischemic%2520ATP-sensitive%2520potassium%2520channel%2520%2528KATP%2529%2520openers.%25205.%2520Identification%2520of%25204-%2528N-aryl%2529-substituted%2520benzopyran%2520derivatives%2520with%2520high%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D24%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Horino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagechika, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]heptenyloxy)benzopyran derivatives and their analogs</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">â</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1998&pages=602-609&author=H.+Horinoauthor=T.+Mimuraauthor=K.+Kagechikaauthor=M.+Ohtaauthor=H.+Kuboauthor=M.+Kitagawa&title=Synthesis+and+antihypertensive+activity+of+4-%28diazabicyclo%5B4.1.0%5Dheptenyloxy%29benzopyran+derivatives+and+their+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorino%26aufirst%3DH.%26aulast%3DMimura%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DH.%26aulast%3DKitagawa%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%25204-%2528diazabicyclo%255B4.1.0%255Dheptenyloxy%2529benzopyran%2520derivatives%2520and%2520their%2520analogs%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1998%26volume%3D46%26spage%3D602%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit70b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bergmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gericke, R.</span><span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2<i>H</i>-1-benzopyrans and related compounds, new potassium channel activators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">â</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00164a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=492-504&author=R.+Bergmannauthor=R.+Gericke&title=Synthesis+and+antihypertensive+activity+of+4-%281%2C2-dihydro-2-oxo-1-pyridyl%29-2H-1-benzopyrans+and+related+compounds%2C+new+potassium+channel+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70b&amp;dbid=16384&amp;doi=10.1021%2Fjm00164a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00164a005%26sid%3Dliteratum%253Aachs%26aulast%3DBergmann%26aufirst%3DR.%26aulast%3DGericke%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%25204-%25281%252C2-dihydro-2-oxo-1-pyridyl%2529-2H-1-benzopyrans%2520and%2520related%2520compounds%252C%2520new%2520potassium%2520channel%2520activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D492%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traeger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickinson, K. E. J.</span><span> </span><span class="NLM_article-title">Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970762d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=271-275&author=K.+S.+Atwalauthor=G.+J.+Groverauthor=N.+J.+Lodgeauthor=D.+E.+Normandinauthor=S.+C.+Traegerauthor=P.+G.+Slephauthor=R.+B.+Cohenauthor=C.+C.+Brysonauthor=K.+E.+J.+Dickinson&title=Binding+of+ATP-sensitive+potassium+channel+%28KATP%29+openers+to+cardiac+membranes%3A+correlation+of+binding+affinities+with+cardioprotective+and+smooth+muscle+relaxing+potencies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm970762d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970762d%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DCohen%26aufirst%3DR.%2BB.%26aulast%3DBryson%26aufirst%3DC.%2BC.%26aulast%3DDickinson%26aufirst%3DK.%2BE.%2BJ.%26atitle%3DBinding%2520of%2520ATP-sensitive%2520potassium%2520channel%2520%2528KATP%2529%2520openers%2520to%2520cardiac%2520membranes%253A%2520correlation%2520of%2520binding%2520affinities%2520with%2520cardioprotective%2520and%2520smooth%2520muscle%2520relaxing%2520potencies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D271%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1742-7843.2006.pto_295.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16918708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1egsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=91-95&author=C.+Sanchez&title=The+pharmacology+of+citalopram+enantiomers%3A+the+antagonism+by+R-citalopram+on+the+effect+of+S-citalopram"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram</span></div><div class="casAuthors">Sanchez, Connie</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-95</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent results on the in vivo and in vitro pharmacol. of escitalopram are summarized.  The exact mol. mechanism by which R-citalopram inhibits the effect of S-citalopram on the serotonin transporter remains to be elucidated.  Preliminary evidence indicates an effect of R-citalopram on the assocn. of escitalopram with the high affinity primary site, and on its dissocn. from the serotonin transporter, via an allosteric mechanism.  Escitalopram can be considered as an allosteric serotonin reuptake inhibitor.  This serotonin dual action in binding to two sites on the serotonin transporter (both the primary site and the allosteric site) is hypothesized to be responsible for a longer binding to, and therefore greater inhibition of the serotonin transporter by escitalopram.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYDiKuN86bVg90H21EOLACvtfcHk0lg6YiXxyQHRcA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1egsrk%253D&md5=7ab6c4f4549d521e3fb01a42621fc5e2</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2006.pto_295.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2006.pto_295.x%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DThe%2520pharmacology%2520of%2520citalopram%2520enantiomers%253A%2520the%2520antagonism%2520by%2520R-citalopram%2520on%2520the%2520effect%2520of%2520S-citalopram%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2006%26volume%3D99%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Koldso, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severinsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiborg, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinning, S.</span><span> </span><span class="NLM_article-title">The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">â</span> <span class="NLM_lpage">1322</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja906923j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=1311-1322&author=H.+Koldsoauthor=K.+Severinsenauthor=T.+T.+Tranauthor=L.+Celikauthor=H.+H.+Jensenauthor=O.+Wiborgauthor=B.+Schiottauthor=S.+Sinning&title=The+two+enantiomers+of+citalopram+bind+to+the+human+serotonin+transporter+in+reversed+orientations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fja906923j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja906923j%26sid%3Dliteratum%253Aachs%26aulast%3DKoldso%26aufirst%3DH.%26aulast%3DSeverinsen%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%2BT.%26aulast%3DCelik%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DH.%2BH.%26aulast%3DWiborg%26aufirst%3DO.%26aulast%3DSchiott%26aufirst%3DB.%26aulast%3DSinning%26aufirst%3DS.%26atitle%3DThe%2520two%2520enantiomers%2520of%2520citalopram%2520bind%2520to%2520the%2520human%2520serotonin%2520transporter%2520in%2520reversed%2520orientations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D1311%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Puchler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plenker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitanai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, P. U.</span><span> </span><span class="NLM_article-title">The pharmacokinetic profile of RS-8359</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">S11</span><span class="NLM_x">â</span> <span class="NLM_lpage">S16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1997&pages=S11-S16&author=K.+Puchlerauthor=K.+Sasaharaauthor=A.+Plenkerauthor=T.+Nitanaiauthor=P.+U.+Witte&title=The+pharmacokinetic+profile+of+RS-8359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuchler%26aufirst%3DK.%26aulast%3DSasahara%26aufirst%3DK.%26aulast%3DPlenker%26aufirst%3DA.%26aulast%3DNitanai%26aufirst%3DT.%26aulast%3DWitte%26aufirst%3DP.%2BU.%26atitle%3DThe%2520pharmacokinetic%2520profile%2520of%2520RS-8359%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1997%26volume%3D12%26spage%3DS11%26epage%3DS16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Takasaki, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitanai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span> </span><span class="NLM_article-title">Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug-metabolizing enzymes</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">â</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=135-141&author=W.+Takasakiauthor=M.+Yamamuraauthor=A.+Nozakiauthor=T.+Nitanaiauthor=K.+Sasaharaauthor=K.+Itohauthor=Y.+Tanaka&title=Stereoselective+pharmacokinetics+of+RS-8359%2C+a+selective+and+reversible+MAO-A+inhibitor%2C+by+species-dependent+drug-metabolizing+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakasaki%26aufirst%3DW.%26aulast%3DYamamura%26aufirst%3DM.%26aulast%3DNozaki%26aufirst%3DA.%26aulast%3DNitanai%26aufirst%3DT.%26aulast%3DSasahara%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DStereoselective%2520pharmacokinetics%2520of%2520RS-8359%252C%2520a%2520selective%2520and%2520reversible%2520MAO-A%2520inhibitor%252C%2520by%2520species-dependent%2520drug-metabolizing%2520enzymes%26jtitle%3DChirality%26date%3D2005%26volume%3D17%26spage%3D135%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span> </span><span class="NLM_article-title">Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">â</span> <span class="NLM_lpage">706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=698-706&author=K.+Itohauthor=K.+Hoshinoauthor=A.+Endoauthor=T.+Asakawaauthor=K.+Yamakamiauthor=C.+Nojiauthor=T.+Kosakaauthor=Y.+Tanaka&title=Chiral+inversion+of+RS-8359%3A+a+selective+and+reversible+MAO-A+inhibitor+via+oxido-reduction+of+keto-alcohol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DA.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DYamakami%26aufirst%3DK.%26aulast%3DNoji%26aufirst%3DC.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DChiral%2520inversion%2520of%2520RS-8359%253A%2520a%2520selective%2520and%2520reversible%2520MAO-A%2520inhibitor%2520via%2520oxido-reduction%2520of%2520keto-alcohol%26jtitle%3DChirality%26date%3D2006%26volume%3D18%26spage%3D698%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Khan, A.</span><span> </span><span class="NLM_article-title">Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">â</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1753-1764&author=A.+Khan&title=Vilazodone%2C+a+novel+dual-acting+serotonergic+antidepressant+for+managing+major+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%26atitle%3DVilazodone%252C%2520a%2520novel%2520dual-acting%2520serotonergic%2520antidepressant%2520for%2520managing%2520major%2520depression%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D1753%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Heinrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boettcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gericke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfried, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Amsterdam, C.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationship in a class of indolebutylpiperazines as dual 5-HT1A receptor agonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4684</span><span class="NLM_x">â</span> <span class="NLM_lpage">4692</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040793q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4684-4692&author=T.+Heinrichauthor=H.+Boettcherauthor=R.+Gerickeauthor=G.+D.+Bartoszykauthor=S.+Anzaliauthor=C.+A.+Seyfriedauthor=H.+E.+Greinerauthor=C.+van+Amsterdam&title=Synthesis+and+structure%E2%88%92activity+relationship+in+a+class+of+indolebutylpiperazines+as+dual+5-HT1A+receptor+agonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm040793q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040793q%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DBoettcher%26aufirst%3DH.%26aulast%3DGericke%26aufirst%3DR.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26aulast%3DAnzali%26aufirst%3DS.%26aulast%3DSeyfried%26aufirst%3DC.%2BA.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3Dvan%2BAmsterdam%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520in%2520a%2520class%2520of%2520indolebutylpiperazines%2520as%2520dual%25205-HT1A%2520receptor%2520agonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4684%26epage%3D4692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, M. S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loudon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlek, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span> </span><span class="NLM_article-title">Design of [<i>R</i>-(<i>Z</i>)]-(+)-Î±-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the <i>N</i>-methoxyimidoyl nitrile group as a novel ester bioisostere</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4265</span><span class="NLM_x">â</span> <span class="NLM_lpage">4280</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9702903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4265-4280&author=S.+M.+Bromidgeauthor=F.+Brownauthor=F.+Cassidyauthor=M.+S.+G.+Clarkauthor=S.+Dabbsauthor=M.+S.+Hadleyauthor=J.+Hawkinsauthor=J.+M.+Loudonauthor=C.+B.+Naylorauthor=B.+S.+Orlekauthor=G.+J.+Riley&title=Design+of+%5BR-%28Z%29%5D-%28%2B%29-%CE%B1-%28methoxyimino%29-1-azabicyclo%5B2.2.2%5Doctane-3-acetonitrile+%28SB+202026%29%2C+a+functionally+selective+azabicyclic+muscarinic+M1+agonist+incorporating+the+N-methoxyimidoyl+nitrile+group+as+a+novel+ester+bioisostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm9702903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9702903%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBrown%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DF.%26aulast%3DClark%26aufirst%3DM.%2BS.%2BG.%26aulast%3DDabbs%26aufirst%3DS.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DLoudon%26aufirst%3DJ.%2BM.%26aulast%3DNaylor%26aufirst%3DC.%2BB.%26aulast%3DOrlek%26aufirst%3DB.%2BS.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26atitle%3DDesign%2520of%2520%255BR-%2528Z%2529%255D-%2528%252B%2529-%25CE%25B1-%2528methoxyimino%2529-1-azabicyclo%255B2.2.2%255Doctane-3-acetonitrile%2520%2528SB%2520202026%2529%252C%2520a%2520functionally%2520selective%2520azabicyclic%2520muscarinic%2520M1%2520agonist%2520incorporating%2520the%2520N-methoxyimidoyl%2520nitrile%2520group%2520as%2520a%2520novel%2520ester%2520bioisostere%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4265%26epage%3D4280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Vialla, A.</span><span> </span><span class="NLM_article-title">Propericiazine (Neuleptil), chemistry, and pharmacology</span> <span class="citation_source-journal">Encephale</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFGktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1969&pages=3-7&author=A.+Vialla&title=Propericiazine+%28Neuleptil%29%2C+chemistry%2C+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Propericiazine (Neuleptil), chemistry, and pharmacology</span></div><div class="casAuthors">Vialla, A.</div><div class="citationInfo"><span class="NLM_cas:title">Encephale</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3-7</span>CODEN:
                <span class="NLM_cas:coden">ENCEAN</span>;
        ISSN:<span class="NLM_cas:issn">0013-7006</span>.
    </div><div class="casAbstract">A summary of available information on 8909 R.P. (propericiazine) regarding chem. structure, phys. props., metabolism, pharmacol., toxicol., and human tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NlBODZpMS7Vg90H21EOLACvtfcHk0li6fDYDZI57zg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFGktQ%253D%253D&md5=f03739bb835201fffc4a94c813dc37d0</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVialla%26aufirst%3DA.%26atitle%3DPropericiazine%2520%2528Neuleptil%2529%252C%2520chemistry%252C%2520and%2520pharmacology%26jtitle%3DEncephale%26date%3D1969%26volume%3D58%26spage%3D3%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Favre, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubin, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frija-Orvoen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejoyeux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Acosta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermadi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span> </span><span class="NLM_article-title">Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome</span> <span class="citation_source-journal">Hum. Psychopharmacol. Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">â</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fhup.718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16118830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2qsL3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=511-519&author=J.-D.+Favreauthor=H.+Allainauthor=H.-J.+Aubinauthor=E.+Frija-Orvoenauthor=C.+Gilletauthor=M.+Lejoyeuxauthor=A.+Payenauthor=M.+Weberauthor=S.+Garcia-Acostaauthor=I.+Kermadiauthor=M.+Dib&title=Double-blind+study+of+cyamemazine+and+diazepam+in+the+alcohol+withdrawal+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81aR"><div class="casContent"><span class="casTitleNuber">81a</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome</span></div><div class="casAuthors">Favre, Jean-Daniel; Allain, Herve; Aubin, Henri-Jean; Frija-Orvoen, Elizabeth; Gillet, Claudine; Lejoyeux, Michel; Payen, Alain; Weber, Michel; Garcia-Acosta, Stephanie; Kermadi, Imane; Dib, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">511-519</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objective Cyamemazine is an original phenothiazine deriv. which showed similar efficacy and tolerability to lorazepam during ethanol withdrawal in mice.  This study investigated cyamemazine for its efficacy and tolerability in alc.-dependent patients electing an alc. withdrawal procedure, in comparison with diazepam.  Method A multicenter, randomized, double-blind study in 89 alc.-dependent patients (CIWA-Ar score between 10 and 30), electing an alc. withdrawal procedure, was used to find EDs of cyamemazine and to compare it with diazepam for efficacy and tolerability.  On day 1 (D1), cyamemazine or diazepam (50 mg and 10 mg capsule, resp.) were administered at hourly intervals to reduce CIWA-Ar = 5, up to a max. of eight administrations.  Starting from D2, the compds. were given twice a day in progressively decreasing doses during a max. period of 13 days (Dend).  Results At h8 (8 h after the first treatment of D1), therapeutic success (CIWA-Ar score â¤ 5) was achieved in 32 out of 43 ITT patients treated with cyamemazine (74.4%), a value very similar to that of diazepam (32/44; 72.7%).  Most such patients (29/32) were controlled with 2-6 capsules of cyamemazine (100-300 mg).  In the PP population, cyamemazine (n = 28) was significantly non-inferior to diazepam (n = 33), with a threshold of 10% for non-inferiority bound and 2.5% for one-sided type I error rate.  Such therapeutic similarity was confirmed by the anal. of other efficacy criteria.  Safety anal. did not show substantial differences between the two treatments.  Conclusions Cyamemazine showed similar efficacy and tolerability to diazepam for the treatment of alc. withdrawal symptoms at therapeutic doses in the range 100-300 mg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo22g6qHFCNrVg90H21EOLACvtfcHk0li6fDYDZI57zg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2qsL3P&md5=5d6a1e28f677c3da42ac8a1b66a3a83d</span></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1002%2Fhup.718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhup.718%26sid%3Dliteratum%253Aachs%26aulast%3DFavre%26aufirst%3DJ.-D.%26aulast%3DAllain%26aufirst%3DH.%26aulast%3DAubin%26aufirst%3DH.-J.%26aulast%3DFrija-Orvoen%26aufirst%3DE.%26aulast%3DGillet%26aufirst%3DC.%26aulast%3DLejoyeux%26aufirst%3DM.%26aulast%3DPayen%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DGarcia-Acosta%26aufirst%3DS.%26aulast%3DKermadi%26aufirst%3DI.%26aulast%3DDib%26aufirst%3DM.%26atitle%3DDouble-blind%2520study%2520of%2520cyamemazine%2520and%2520diazepam%2520in%2520the%2520alcohol%2520withdrawal%2520syndrome%26jtitle%3DHum.%2520Psychopharmacol.%2520Clin.%2520Exp.%26date%3D2005%26volume%3D20%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lemoine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermadi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Acosta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garay, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span> </span><span class="NLM_article-title">Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.pnpbp.2005.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16243418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGls7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=131-137&author=P.+Lemoineauthor=I.+Kermadiauthor=S.+Garcia-Acostaauthor=R.+P.+Garayauthor=M.+Dib&title=Double-blind%2C+comparative+study+of+cyamemazine+vs.+bromazepam+in+the+benzodiazepine+withdrawal+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome</span></div><div class="casAuthors">Lemoine, Patrick; Kermadi, Imane; Garcia-Acosta, Stephanie; Garay, Ricardo P.; Dib, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-137</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyamemazine is an anxiolytic antipsychotic, which reduces ethanol withdrawal symptoms.  Here, we investigated if cyamemazine can be also effective as substitute drug to facilitate benzodiazepine withdrawal.  A total of 168 patients treated with benzodiazepines for at least 3 mo and with a < 18 score in the Hamilton Anxiety Rating Scale (HARS) were included in the study.  Previous benzodiazepine treatment was withdrawn, and patients were randomized to a 4-wk treatment with cyamemazine (25-50 mg q.d.) or bromazepam (3-6 mg q.d.), followed by 2 wk of placebo.  The primary efficacy variable was the maximal anxiety rebound as measured with the HARS during the 42 days of treatment.  No statistically significant differences between treatment groups were found for the extent or incidence of rebound anxiety.  Considering all dropout patients as withdrawal failures, after 6 mo of follow-up, 56/84 patients in the cyamemazine group (66.7%) and 55/84 patients in the bromazepam group (65.5%) were successfully withdrawn. 28 patients in the cyamemazine group and 18 in the bromazepam group had an adverse event, including anxiety, insomnia, dry mouth and somnolence.  No extra-pyramidal symptoms were reported.  In conclusion, cyamemazine was comparable to bromazepam in ensuring successful benzodiazepine withdrawal and in controlling the acute benzodiazepine withdrawal syndrome.  Cyamemazine may be useful to facilitate benzodiazepine withdrawal in those patients where bromazepam substitution is not appropriate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdpkcTEVaqUbVg90H21EOLACvtfcHk0li6fDYDZI57zg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGls7rL&md5=b40bd0cd8cbe1ada7ebb16d4012b825f</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2005.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2005.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DLemoine%26aufirst%3DP.%26aulast%3DKermadi%26aufirst%3DI.%26aulast%3DGarcia-Acosta%26aufirst%3DS.%26aulast%3DGaray%26aufirst%3DR.%2BP.%26aulast%3DDib%26aufirst%3DM.%26atitle%3DDouble-blind%252C%2520comparative%2520study%2520of%2520cyamemazine%2520vs.%2520bromazepam%2520in%2520the%2520benzodiazepine%2520withdrawal%2520syndrome%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2006%26volume%3D30%26spage%3D131%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Patat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paty, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindmarch, I.</span><span> </span><span class="NLM_article-title">Pharmacodynamic profile of zaleplon, a new non-benzodiazepine hypnotic agent</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">â</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fhup.310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12404558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms1Srsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=369-392&author=A.+Patatauthor=I.+Patyauthor=I.+Hindmarch&title=Pharmacodynamic+profile+of+zaleplon%2C+a+new+non-benzodiazepine+hypnotic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic profile of zaleplon, a new non-benzodiazepine hypnotic agent</span></div><div class="casAuthors">Patat, Alain; Paty, Isabelle; Hindmarch, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">369-392</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The challenge in developing hypnotic agents for the treatment of insomnia is to balance the sedative effect needed at bedtime with the residual sedation on awakening.  Zaleplon is a novel pyrazolopyrimidine hypnotic agent that acts as a selective agonist to the brain omega receptor situated on the alpha subunit of the GABA A receptor complex.  Zaleplon was proven to be an effective hypnotic drug as it consistently and significantly reduced latency to persistent sleep in insomniac patients for doses of 10 mg and above in polysomnog. studies.  The pharmacodynamic profile of zaleplon on psychomotor performance, actual driving and cognitive function, including memory, was assessed in several randomized, double-blind, placebo-controlled studies in healthy young subjects as well as insomniac patients by using various pos. controls (zolpidem, zopiclone, triazolam and flurazepam).  The recommended hypnotic dose of zaleplon in young adults (10 mg) produced minimal or no impairment of psychomotor and memory performance even when administered during the night as little as 1 h before waking.  No impairment of actual driving was obsd. when zaleplon 10 mg was administered either at bedtime or in the middle of the night as little as 4 h before waking.  Zaleplon 20 mg, twice the recommended dose, generally produced significant impairment of performance and cognitive functions when these functions were measured at the time of peak plasma concn., i.e. 1 h after dose administration, and no impairment of driving abilities was obsd. 4 h after a middle-of-the-night administration.  In contrast, consistent detrimental residual effects on various aspects of psychomotor and cognitive functions were obsd. with the therapeutic doses of the various commonly prescribed hypnotic agents used as comparators, e.g. zolpidem 10 mg up to 5 h after dose administration, zopiclone 7.5 mg up to 10 h after, flurazepam 30 mg up to 14 h after and triazolam 0.25 mg up to 6 h after.  Also, zolpidem 10 mg and zopiclone 7.5 mg were also shown to significantly impair driving ability the next morning when this was measured 4 h and up to 10 h after dose administration, resp.  The present review shows that zaleplon 10 mg has little or no residual effect when administered in the middle of the night, as late as 1 h before waking, and is devoid of impairment of driving abilities as assessed by actual driving 4 h after dose administration.  The lack of clin. significant or minimally statistically significant residual effects of zaleplon even at its peak concn. may be explained by its unique pharmacokinetic (rapid elimination half-life) and pharmacodynamic (low affinity, and specific binding profile to various subunits of the GABAA receptor) profiles.  These properties allow zaleplon to be used for treatment of symptoms only when they occur, either at bedtime or later in the night, without incurring significant risk of developing next-day impairment of psychomotor and cognitive functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEZhhQtQTkd7Vg90H21EOLACvtfcHk0lhRln-iojcD0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms1Srsrg%253D&md5=32568e09ff25802d0d14b22e39e5ba95</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fhup.310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhup.310%26sid%3Dliteratum%253Aachs%26aulast%3DPatat%26aufirst%3DA.%26aulast%3DPaty%26aufirst%3DI.%26aulast%3DHindmarch%26aufirst%3DI.%26atitle%3DPharmacodynamic%2520profile%2520of%2520zaleplon%252C%2520a%2520new%2520non-benzodiazepine%2520hypnotic%2520agent%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2001%26volume%3D16%26spage%3D369%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Sanger, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrault, G.</span><span> </span><span class="NLM_article-title">Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0014-2999%2896%2900510-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=8905326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK28XmtV2jt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=1996&pages=35-42&author=D.+J.+Sangerauthor=E.+Morelauthor=G.+Perrault&title=Comparison+of+the+pharmacological+profiles+of+the+hypnotic+drugs%2C+zaleplon+and+zolpidem"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem</span></div><div class="casAuthors">Sanger, David J.; Morel, Eliane; Perrault, Ghislaine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The BZ1 (Ï1)-selective compd., zolpidem, is a clin. effective hypnotic drug with a pharmacol. profile which differs from those of benzodiazepine anxiolytics and hypnotics.  Zaleplon (CL 284,846) has recently been described as a hypnotic agent which also has BZ1 (Ï1) receptor selectivity.  The pharmacol. effects of zolpidem and zaleplon were therefore compared in mice and rats.  Both drugs blocked tonic convulsions induced in mice by pentylenetetrazole and electroconvulsive shock and clonic convulsions induced by isoniazid.  Zaleplon was more potent than zolpidem but the maximal effect of zolpidem for increasing the latency to isoniazid-induced convulsions was greater than that of zaleplon.  Little tolerance developed to the anticonvulsant effect of zaleplon against isoniazid-induced seizures following twice daily administration of 10 or 30 mg/kg for 10 days.  Both compds. reduced locomotor activity and produced motor deficits in the rotarod and loaded grid tests in mice.  However, while zaleplon produced all three effects at similar doses, zolpidem showed the greatest potency for reducing locomotion.  Zaleplon and zolpidem also decreased locomotion and produced a rotarod deficit in rats.  Again, the difference between the doses giving rise to these two effects was greater for zolpidem than for zaleplon.  In a drug discrimination procedure using rats trained to discriminate a dose (5 mg/kg) of chlordiazepoxide, zaleplon produced partial substitution for chlordiazepoxide at doses which greatly reduced response rates.  These results show that zaleplon and zolpidem have similar pharmacol. profiles, presumably related to their BZ1 (Ï 1) receptor selectivity.  However, the difference between doses producing motor deficits (rotarod, loaded grid) and those giving rise to other effects (anticonvulsant, decreased locomotion) was greater for zolpidem than for zaleplon.  This difference may be related to a greater in vivo intrinsic activity of zolpidem as indicated by the different efficacies of the two drugs to antagonize isoniazid-induced convulsions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrStY2JEXGKIbVg90H21EOLACvtfcHk0lhRln-iojcD0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtV2jt7s%253D&md5=ab5173b02670dc20786d1341f290c739</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900510-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900510-9%26sid%3Dliteratum%253Aachs%26aulast%3DSanger%26aufirst%3DD.%2BJ.%26aulast%3DMorel%26aufirst%3DE.%26aulast%3DPerrault%26aufirst%3DG.%26atitle%3DComparison%2520of%2520the%2520pharmacological%2520profiles%2520of%2520the%2520hypnotic%2520drugs%252C%2520zaleplon%2520and%2520zolpidem%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D313%26spage%3D35%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Munoz-Islas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Mena, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano-Cuenca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lopez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centurion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehrotra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MaassenVanDenBrink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalon, C. M.</span><span> </span><span class="NLM_article-title">Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">â</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fsj.bjp.0706839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16880765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos12msro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=82-91&author=E.+Munoz-Islasauthor=S.+Guptaauthor=L.+R.+Jimenez-Menaauthor=J.+Lozano-Cuencaauthor=A.+Sanchez-Lopezauthor=D.+Centurionauthor=S.+Mehrotraauthor=A.+MaassenVanDenBrinkauthor=C.+M.+Villalon&title=Donitriptan%2C+but+not+sumatriptan%2C+inhibits+capsaicin-induced+canine+external+carotid+vasodilatation+via+5-HT1B+rather+than+5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors</span></div><div class="casAuthors">Munoz-Islas, E.; Gupta, S.; Jimenez-Mena, L. R.; Lozano-Cuenca, J.; Sanchez-Lopez, A.; Centurion, D.; Mehrotra, S.; MaassenVanDenBrink, A.; Villalon, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-91</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It has been suggested that during a migraine attack capsaicin-sensitive trigeminal sensory nerves release calcitonin gene-related peptide (CGRP), resulting in cranial vasodilatation and central nociception; hence, trigeminal inhibition may prevent this vasodilatation and abort migraine headache.  This study investigated the effects of the agonists sumatriptan (5-HT1B/1D water-sol.), donitriptan (5-HT1B/1D lipid-sol.), PNU-142633 (5-HT1D water-sol.) and PNU-109291 (5-HT1D lipid-sol.) on vasodilator responses to capsaicin, Î±-CGRP and acetylcholine in dog external carotid artery.  Exptl. approach: 59 vagosympathectomized dogs were anesthetized with sodium pentobarbitone.  Blood pressure and heart rate were recorded with a pressure transducer, connected to a cannula inserted into a femoral artery.  A precalibrated flow probe was placed around the common carotid artery, with ligation of the internal carotid and occipital branches, and connected to an ultrasonic flowmeter.  The thyroid artery was cannulated for infusion of agonists.  Intracarotid infusions of capsaicin, Î±-CGRP and acetylcholine dose-dependently increased blood flow through the carotid artery.  These responses remained unaffected after i.v. infusions of sumatriptan, PNU-142633, PNU-109291 or physiol. saline; in contrast, donitriptan significantly attenuated the vasodilator responses to capsaicin, but not those to Î±-CGRP or acetylcholine.  Only sumatriptan and donitriptan dose-dependently decreased the carotid blood flow.  Interestingly, i.v. administration of the antagonist, SB224289 (5-HT1B), but not of BRL15572 (5-HT1D), abolished the inhibition by donitriptan.  Our results suggest that the inhibition produced by donitriptan of capsaicin-induced external carotid vasodilatation is mainly mediated by 5-HT1B, rather than 5-HT1D, receptors, probably by a central mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0WlWWrUIx4rVg90H21EOLACvtfcHk0lhRln-iojcD0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos12msro%253D&md5=31bb6cdac12dc4caff3ba7ba147ebdb8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706839%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Islas%26aufirst%3DE.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DJimenez-Mena%26aufirst%3DL.%2BR.%26aulast%3DLozano-Cuenca%26aufirst%3DJ.%26aulast%3DSanchez-Lopez%26aufirst%3DA.%26aulast%3DCenturion%26aufirst%3DD.%26aulast%3DMehrotra%26aufirst%3DS.%26aulast%3DMaassenVanDenBrink%26aufirst%3DA.%26aulast%3DVillalon%26aufirst%3DC.%2BM.%26atitle%3DDonitriptan%252C%2520but%2520not%2520sumatriptan%252C%2520inhibits%2520capsaicin-induced%2520canine%2520external%2520carotid%2520vasodilatation%2520via%25205-HT1B%2520rather%2520than%25205-HT1D%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D82%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verscheure, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, G. W.</span><span> </span><span class="NLM_article-title">Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: further insights into its mechanism of action relevant to headache relief</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">â</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1124%2Fjpet.102.047225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12606602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt12lsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=749-754&author=R.+Letienneauthor=Y.+Verscheureauthor=M.+Perezauthor=B.+Le+Grandauthor=F.+C.+Colpaertauthor=G.+W.+John&title=Donitriptan+selectively+decreases+jugular+venous+oxygen+saturation+in+the+anesthetized+pig%3A+further+insights+into+its+mechanism+of+action+relevant+to+headache+relief"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: Further insights into its mechanism of action relevant to headache relief</span></div><div class="casAuthors">Letienne, Robert; Verscheure, Yvan; Perez, Michel; Le Grand, Bruno; Colpaert, Francis C.; John, Gareth W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">749-754</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of donitriptan on systemic arterial-jugular venous oxygen satn. difference were evaluated in pentobarbitone-anesthetized pigs.  Oxygen and carbon dioxide partial pressures in systemic arterial and jugular venous blood as well as Hb oxygen satn. were detd. by conventional blood gas anal.  Vehicle (40% polyethyleneglycol in saline, n = 9) or donitriptan (0.01, 0.04, 0.16, 0.63, 2.5, 10, and 40 Î¼g/kg, n = 7) were cumulatively infused over 15 min/dose.  The involvement of 5-hydroxytryptamine1B (5-HT1B) receptors was assessed in the presence of the 5-HT1B/1D receptor antagonist, GR 127935.  Donitriptan decreased markedly and dose dependently jugular venous oxygen satn. [ED50 0.5 (0.3-1.1) Î¼g/kg], in parallel with increases in carotid vascular resistance [ED50 0.9 (0.7-1.1) Î¼g/kg].  Since arterial oxygen satn. and partial pressure remained unchanged, donitriptan significantly increased arteriovenous oxygen satn. difference from 0.63 Î¼g/kg (maximal variation: 57Â±18%, P < 0.05 compared with vehicle).  Unexpectedly, donitriptan from 2.5 Î¼g/kg induced marked and significant increases in carbon dioxide partial pressure (pVCO2) in venous blood (maximal increase 18.8Â±5.7%; P < 0.05 compared with vehicle).  Pretreatment with GR 127935 (0.63 mg/kg, n = 5) abolished the fall in venous oxygen satn. and the increase in carotid vascular resistance and reduced the increases in pVCO2 induced by donitriptan.  The results demonstrate that donitriptan, via 5-HT1B receptor activation, decreases the oxygen satn. of venous blood draining the head, concomitantly with cranial vasoconstriction.  Since donitriptan also increased pVCO2, an effect upon cerebral oxygen consumption and metab. is suggested in addn. to cranial vasoconstriction, which may be relevant to its headache-relieving effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLrcnmGaVoV7Vg90H21EOLACvtfcHk0lg6yuxxVkbApg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt12lsro%253D&md5=709486177f70bd841fa3dc4b9ab2c5f2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.047225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.047225%26sid%3Dliteratum%253Aachs%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DVerscheure%26aufirst%3DY.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26aulast%3DJohn%26aufirst%3DG.%2BW.%26atitle%3DDonitriptan%2520selectively%2520decreases%2520jugular%2520venous%2520oxygen%2520saturation%2520in%2520the%2520anesthetized%2520pig%253A%2520further%2520insights%2520into%2520its%2520mechanism%2520of%2520action%2520relevant%2520to%2520headache%2520relief%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D749%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Mehellou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Twenty-six years of anti-HIV drug discovery: Where do we stand and where do we go?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">â</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900492g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=521-538&author=Y.+Mehellouauthor=E.+De+Clercq&title=Twenty-six+years+of+anti-HIV+drug+discovery%3A+Where+do+we+stand+and+where+do+we+go%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm900492g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900492g%26sid%3Dliteratum%253Aachs%26aulast%3DMehellou%26aufirst%3DY.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DTwenty-six%2520years%2520of%2520anti-HIV%2520drug%2520discovery%253A%2520Where%2520do%2520we%2520stand%2520and%2520where%2520do%2520we%2520go%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D521%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Hughes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, R. D.</span><span> </span><span class="NLM_article-title">New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2445</span><span class="NLM_x">â</span> <span class="NLM_lpage">2466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1517%2F14656560903176446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19678794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCgsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2445-2466&author=C.+A.+Hughesauthor=L.+Robinsonauthor=A.+Tsengauthor=R.+D.+MacArthur&title=New+antiretroviral+drugs%3A+a+review+of+the+efficacy%2C+safety%2C+pharmacokinetics%2C+and+resistance+profile+of+tipranavir%2C+darunavir%2C+etravirine%2C+rilpivirine%2C+maraviroc%2C+and+raltegravir"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir</span></div><div class="casAuthors">Hughes, Christine A.; Robinson, Linda; Tseng, Alice; MacArthur, Rodger D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2445-2466</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The introduction and approval of new antiretroviral agents in the US and Canada bring new opportunities and new challenges.  Arguably, for the first time ever, clinicians have the drugs necessary to achieve the goal of suppressing HIV RNA to levels less than 50 copies/mL in even the most treatment-experienced patients and in those with extensive drug-limiting resistance mutations.  However, the use of these new agents is complicated by many drug-drug interactions and - to some extent - pre-existing mutations.  To derive max. durability from the use of these newer drugs, a thorough understanding of their indications and limitations is crit.  To thoroughly review the six most recently approved or soon-to-be-approved antiretroviral drugs in the US and Canada: tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.  Discussion of the indications for, and pharmacokinetics, resistance profile, activity, toxicity, and clin. trials results of, the six new agents.  These six new agents have resulted in marked progress towards the goal of being able to provide HIV-infected individuals with the drugs necessary to achieve decades of durable suppression of HIV without substantial toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TA0zt9ijibVg90H21EOLACvtfcHk0lg6yuxxVkbApg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCgsrbI&md5=f8193ed818b0304dbb718b8668fe9170</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1517%2F14656560903176446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903176446%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DC.%2BA.%26aulast%3DRobinson%26aufirst%3DL.%26aulast%3DTseng%26aufirst%3DA.%26aulast%3DMacArthur%26aufirst%3DR.%2BD.%26atitle%3DNew%2520antiretroviral%2520drugs%253A%2520a%2520review%2520of%2520the%2520efficacy%252C%2520safety%252C%2520pharmacokinetics%252C%2520and%2520resistance%2520profile%2520of%2520tipranavir%252C%2520darunavir%252C%2520etravirine%252C%2520rilpivirine%252C%2520maraviroc%252C%2520and%2520raltegravir%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D2445%26epage%3D2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nuttall, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thake, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferkany, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchnick, M. A.</span><span> </span><span class="NLM_article-title">Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [<sup>14</sup>C]dapivirine for 7 days</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">â</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=909-914&author=J.+P.+Nuttallauthor=D.+C.+Thakeauthor=M.+G.+Lewisauthor=J.+W.+Ferkanyauthor=J.+W.+Romanoauthor=M.+A.+Mitchnick&title=Concentrations+of+dapivirine+in+the+rhesus+macaque+and+rabbit+following+once+daily+intravaginal+administration+of+a+gel+formulation+of+%5B14C%5Ddapivirine+for+7+days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNuttall%26aufirst%3DJ.%2BP.%26aulast%3DThake%26aufirst%3DD.%2BC.%26aulast%3DLewis%26aufirst%3DM.%2BG.%26aulast%3DFerkany%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BW.%26aulast%3DMitchnick%26aufirst%3DM.%2BA.%26atitle%3DConcentrations%2520of%2520dapivirine%2520in%2520the%2520rhesus%2520macaque%2520and%2520rabbit%2520following%2520once%2520daily%2520intravaginal%2520administration%2520of%2520a%2520gel%2520formulation%2520of%2520%255B14C%255Ddapivirine%2520for%25207%2520days%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit88b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Herrewege, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michiels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Roey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kestens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P.</span><span> </span><span class="NLM_article-title">In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">â</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=337-339&author=Y.+Van+Herrewegeauthor=J.+Michielsauthor=J.+Van+Roeyauthor=K.+Fransenauthor=L.+Kestensauthor=J.+Balzariniauthor=P.+Lewiauthor=G.+Vanhamauthor=P.+Janssen&title=In+vitro+evaluation+of+nonnucleoside+reverse+transcriptase+inhibitors+UC-781+and+TMC120-R147681+as+human+immunodeficiency+virus+microbicides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHerrewege%26aufirst%3DY.%26aulast%3DMichiels%26aufirst%3DJ.%26aulast%3DVan%2BRoey%26aufirst%3DJ.%26aulast%3DFransen%26aufirst%3DK.%26aulast%3DKestens%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DLewi%26aufirst%3DP.%26aulast%3DVanham%26aufirst%3DG.%26aulast%3DJanssen%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitors%2520UC-781%2520and%2520TMC120-R147681%2520as%2520human%2520immunodeficiency%2520virus%2520microbicides%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D337%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Emerging anti-HIV drugs</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">â</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1517%2F14728214.10.2.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15934866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=241-274&author=E.+De+Clercq&title=Emerging+anti-HIV+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging anti-HIV drugs</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-274</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There are now exactly 20 anti-HIV drugs licenced (approved) for clin. use, and > 30 anti-HIV compds. under (pre)clin. development.  The licenced anti-HIV drugs fall into five categories: nucleoside reverse transcriptase inhibitors (NRTIs: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir and emtricitabine); nucleotide reverse transcriptase inhibitors (NtRTIs: tenofovir disproxil fumarate); non-nucleoside reverse transcriptase inhibitors (NNRTIs: nevirapine, delavirdine and efavirenz); protease inhibitors (PIs: saquinavir, indinavir, ritonavir, nelfinavir, amprenavir, lopinavir, atazanavir and fosamprenavir); and fusion inhibitors (FIs: enfuvirtide).  The compds. that are currently under clin. (Phase I, II or III) or preclin. investigation are either targeted at the same specific viral proteins as the licenced compds. (i.e., reverse transcriptase [NRTIs: PSI-5004, (-)-dOTC, DPC-817, elvucitabine, alovudine, MIV-210, amdoxovir, DOT; NNRTIs: thiocarboxanilide, UC-781, capravirine, dapivirine, etravirine, rilpivirine], protease [PIs: tipranavir, TMC-114]) or other specific viral proteins (i.e., gp120: cyanovirin N; attachment inhibitors: Als, such as BMS-488043; integrase: L-870,812, PDPV-165; capsid proteins: PA-457, Î±-HCG); or cellular proteins (CD4 down-modulators: CADAs; CXCR4 antagonists: AMD-070, CS-3955; CCR5 antagonists: TAK-220, SCH-D, AK-602, UK-427857).  Combination therapy is likely to remain the gold std. for the treatment of AIDS so as to maximize potency, minimize toxicity and diminish the risk for resistance development.  Ideally, pill burden should be reduced to once-daily dosing so as to optimize the patient's compliance and reduce the treatment costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxT0HJuG64arVg90H21EOLACvtfcHk0lhfNUpeVUdSsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D&md5=8b3186fe7585205c72c9bb25c6493382</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.2.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.2.241%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DEmerging%2520anti-HIV%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D241%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors</span> <span class="citation_source-journal">Prog. Biophys. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.pbiomolbio.2004.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15572156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVahu7bJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=209-231&author=K.+Dasauthor=P.+J.+Lewiauthor=S.+H.+Hughesauthor=E.+Arnold&title=Crystallography+and+the+design+of+anti-AIDS+drugs%3A+conformational+flexibility+and+positional+adaptability+are+important+in+the+design+of+non-nucleoside+HIV-1+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors</span></div><div class="casAuthors">Das, Kalyan; Lewi, Paul J.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-231</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug resistance is a key cause of failure for treatment of HIV infection.  The efficacy of non-nucleoside reverse transcriptase inhibiting (NNRTI) drugs is impaired by rapid emergence of drug-resistance mutations.  A multidisciplinary effort led to the discovery of the potent NNRTIs dapivirine and etravirine, both of which are diarylpyrimidine (DAPY) derivs.  Systematic structural and mol. modeling studies of HIV-1 reverse transcriptase (RT)/NNRTI complexes revealed different modes of inhibitor binding, and some of the DAPY inhibitors can bind to RT in different conformations.  The torsional flexibility ("wiggling") of the inhibitors can generate numerous conformational variants and the compactness of the inhibitors permits significant repositioning and reorientation (translation and rotation) within the pocket ("jiggling").  Such adaptations appear to be crit. for the ability of the diarylpyrimidine NNRTIs to retain their potency against a wide range of drug-resistant HIV-1 RTs.  Exploitation of inhibitor conformational flexibility (such as torsional flexibility about strategically located chem. bonds) can be a powerful element of drug design, esp. for the design of drugs that will be effective against rapidly mutating targets (which is a collection of related targets).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHOTy1wHSn77Vg90H21EOLACvtfcHk0lhfNUpeVUdSsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVahu7bJ&md5=8a99e29ecdfd6e630e8c2ec6363b3618</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2004.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2004.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DK.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DCrystallography%2520and%2520the%2520design%2520of%2520anti-AIDS%2520drugs%253A%2520conformational%2520flexibility%2520and%2520positional%2520adaptability%2520are%2520important%2520in%2520the%2520design%2520of%2520non-nucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D88%26spage%3D209%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jonge, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koymans, L. M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daeyaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludovici, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Corte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavash, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de BÃ©thune, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2550</span><span class="NLM_x">â</span> <span class="NLM_lpage">2560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030558s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisl2it70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2550-2560&author=K.+Dasauthor=A.+D.+Clarkauthor=P.+J.+Lewiauthor=J.+Heeresauthor=M.+R.+De+Jongeauthor=L.+M.+H.+Koymansauthor=H.+M.+Vinkersauthor=F.+Daeyaertauthor=D.+W.+Ludoviciauthor=M.+J.+Kuklaauthor=B.+De+Corteauthor=R.+W.+Kavashauthor=C.+Y.+Hoauthor=H.+Yeauthor=M.+A.+Lichtensteinauthor=K.+Andriesauthor=R.+Pauwelsauthor=M.+P.+de+B%C3%A9thuneauthor=P.+L.+Boyerauthor=P.+Clarkauthor=S.+H.+Hughesauthor=P.+A.+J.+Janssenauthor=E.+Arnold&title=Roles+of+conformational+and+positional+adaptability+in+structure-based+design+of+TMC125-R165335+%28etravirine%29+and+related+non-nucleoside+reverse+transcriptase+inhibitors+that+are+highly+potent+and+effective+against+wild-type+and+drug-resistant+HIV-1+variants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (Etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants</span></div><div class="casAuthors">Das, Kalyan; Clark, Arthur D., Jr.; Lewi, Paul J.; Heeres, Jan; De Jonge, Marc R.; Koymans, Lucien M. H.; Vinkers, H. Maarten; Daeyaert, Frederik; Ludovici, Donald W.; Kukla, Michael J.; De Corte, Bart; Kavash, Robert W.; Ho, Chih Y.; Ye, Hong; Lichtenstein, Mark. A.; Andries, Koen; Pauwels, Rudi; De Bethune, Marie-Pierre; Boyer, Paul L.; Clark, Patrick; Hughes, Stephen H.; Janssen, Paul A. J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2550-2560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial drop in viral load similar to that obsd. with a five-drug combination in naive patients and retains potency in patients infected with NNRTI-resistant HIV-1 variants.  TMC125-R165335 and related anti-AIDS drug candidates can bind the enzyme RT in multiple conformations and thereby escape the effects of drug-resistance mutations.  Structural studies showed that this inhibitor and other diarylpyrimidine (DAPY) analogs can adapt to changes in the NNRTI-binding pocket in several ways: (1) DAPY analogs can bind in at least two conformationally distinct modes; (2) within a given binding mode, torsional flexibility ("wiggling") of DAPY analogs permits access to numerous conformational variants; and (3) the compact design of the DAPY analogs permits significant repositioning and reorientation (translation and rotation) within the pocket ("jiggling").  Such adaptations appear to be crit. for potency against wild-type and a wide range of drug-resistant mutant HIV-1 RTs.  Exploitation of favorable components of inhibitor conformational flexibility (such as torsional flexibility about strategically located chem. bonds) can be a powerful drug design concept, esp. for designing drugs that will be effective against rapidly mutating targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNFqXwggOSMLVg90H21EOLACvtfcHk0lhQ9_H6DQf4-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisl2it70%253D&md5=56c2fce83bead1990e138ee7486a373d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm030558s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030558s%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DDe%2BJonge%26aufirst%3DM.%2BR.%26aulast%3DKoymans%26aufirst%3DL.%2BM.%2BH.%26aulast%3DVinkers%26aufirst%3DH.%2BM.%26aulast%3DDaeyaert%26aufirst%3DF.%26aulast%3DLudovici%26aufirst%3DD.%2BW.%26aulast%3DKukla%26aufirst%3DM.%2BJ.%26aulast%3DDe%2BCorte%26aufirst%3DB.%26aulast%3DKavash%26aufirst%3DR.%2BW.%26aulast%3DHo%26aufirst%3DC.%2BY.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DLichtenstein%26aufirst%3DM.%2BA.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3Dde%2BB%25C3%25A9thune%26aufirst%3DM.%2BP.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DRoles%2520of%2520conformational%2520and%2520positional%2520adaptability%2520in%2520structure-based%2520design%2520of%2520TMC125-R165335%2520%2528etravirine%2529%2520and%2520related%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520that%2520are%2520highly%2520potent%2520and%2520effective%2520against%2520wild-type%2520and%2520drug-resistant%2520HIV-1%2520variants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2550%26epage%3D2560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Faetkenheuer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plettenburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. M.</span><span> </span><span class="NLM_article-title">Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">â</span> <span class="NLM_lpage">2122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=2115-2122&author=G.+Faetkenheuerauthor=S.+Staszewskiauthor=A.+Plettenburgauthor=F.+Hackmanauthor=G.+Laytonauthor=L.+McFadyenauthor=J.+Davisauthor=T.+M.+Jenkins&title=Activity%2C+pharmacokinetics+and+safety+of+lersivirine+%28UK-453%2C061%29%2C+a+next-generation+nonnucleoside+reverse+transcriptase+inhibitor%2C+during+7-day+monotherapy+in+HIV-1-infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaetkenheuer%26aufirst%3DG.%26aulast%3DStaszewski%26aufirst%3DS.%26aulast%3DPlettenburg%26aufirst%3DA.%26aulast%3DHackman%26aufirst%3DF.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DMcFadyen%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DJenkins%26aufirst%3DT.%2BM.%26atitle%3DActivity%252C%2520pharmacokinetics%2520and%2520safety%2520of%2520lersivirine%2520%2528UK-453%252C061%2529%252C%2520a%2520next-generation%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitor%252C%2520during%25207-day%2520monotherapy%2520in%2520HIV-1-infected%2520patients%26jtitle%3DAIDS%26date%3D2009%26volume%3D23%26spage%3D2115%26epage%3D2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit92b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abdel-Malak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mousa, S. A.</span><span> </span><span class="NLM_article-title">The rise of second-generation non-nucleoside reverse transcriptase inhibitors: etravirine, rilpivirine, UK-453061 and RDEA-806</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">â</span> <span class="NLM_lpage">699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1358%2Fdof.2008.033.08.1206423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKmsrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=691-699&author=M.+Abdel-Malakauthor=C.+Gallatiauthor=S.+A.+Mousa&title=The+rise+of+second-generation+non-nucleoside+reverse+transcriptase+inhibitors%3A+etravirine%2C+rilpivirine%2C+UK-453061+and+RDEA-806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92bR"><div class="casContent"><span class="casTitleNuber">92b</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of second-generation non-nucleoside reverse transcriptase inhibitors: etravirine, rilpivirine, UK-453061 and RDEA-806</span></div><div class="casAuthors">Abdel-Malak, Mark; Gallati, Christine; Mousa, Shaker A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">691-699</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a crucial component of current highly active antiretroviral therapy (HAART) treatments for HIV-1 infection.  One of the major limitations of the two most widely used NNRTIs, efavirenz and nevirapine, is their low genetic barrier to resistance, in addn. to their undesirable side effects.  The goal of current investigational NNRTI development is to create a safe, well-tolerated drug with a high genetic barrier to resistance that is active against known NNRTI-assocd. resistance mutations.  This review discusses three investigational NNRTIs, rilpivirine (TMC-278), UK-453061 and RDEA-806, which are at different stages of development, as well as etravirine (TMC-125), a second-generation NNRTI that was recently granted accelerated approval by the FDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoAT-pAXVU_rVg90H21EOLACvtfcHk0lhQ9_H6DQf4-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKmsrfE&md5=dd1eceaf192811f1e0127f4a1419c0b5</span></div><a href="/servlet/linkout?suffix=cit92b&amp;dbid=16384&amp;doi=10.1358%2Fdof.2008.033.08.1206423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2008.033.08.1206423%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Malak%26aufirst%3DM.%26aulast%3DGallati%26aufirst%3DC.%26aulast%3DMousa%26aufirst%3DS.%2BA.%26atitle%3DThe%2520rise%2520of%2520second-generation%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%253A%2520etravirine%252C%2520rilpivirine%252C%2520UK-453061%2520and%2520RDEA-806%26jtitle%3DDrugs%2520Future%26date%3D2008%26volume%3D33%26spage%3D691%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 3: optimisation of physicochemical properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5603</span><span class="NLM_x">â</span> <span class="NLM_lpage">5606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2009.08.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19717303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5603-5606&author=C.+E.+Mowbrayauthor=R.+Corbauauthor=M.+Hawesauthor=L.+H.+Jonesauthor=J.+E.+Millsauthor=M.+Perrosauthor=M.+D.+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+3%3A+optimisation+of+physicochemical+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93aR"><div class="casContent"><span class="casTitleNuber">93a</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole NNRTIs 3: Optimisation of physicochemical properties</span></div><div class="casAuthors">Mowbray, Charles E.; Corbau, Romuald; Hawes, Michael; Jones, Lyn H.; Mills, James E.; Perros, Manos; Selby, Matthew D.; Stupple, Paul A.; Webster, Rob; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5603-5606</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our efforts to reduce overall lipophilicity and increase ligand-lipophilicity efficiency (LLE) by modification of the 3- and 5-substituents of pyrazole I, a novel non-nucleoside HIV reverse transcriptase inhibitor (NNRTI) prototype were unsuccessful.  In contrast replacement of the substituted benzyl group with corresponding phenylthio or phenoxy groups resulted in marked improvements in potency, ligand efficiency (LE) and LLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoctiZUAaZLMrVg90H21EOLACvtfcHk0lhQ9_H6DQf4-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E&md5=f25509e8183b985daae551f052c3e3e7</span></div><a href="/servlet/linkout?suffix=cit93a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.043%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25203%253A%2520optimisation%2520of%2520physicochemical%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5603%26epage%3D5606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit93b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mowbray, C. E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinton, F. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5857</span><span class="NLM_x">â</span> <span class="NLM_lpage">5860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5857-5860&author=C.+E+Mowbrayauthor=C.+Burtauthor=R.+Corbauauthor=S.+Gaytonauthor=M.+Hawesauthor=M.+Perrosauthor=I.+Tranauthor=D.+A+Priceauthor=F.+J+Quintonauthor=M.+D+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+4%3A+selection+of+UK-453%2C061+%28lersivirine%29+as+a+development+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DGayton%26aufirst%3DS.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DPrice%26aufirst%3DD.%2BA%26aulast%3DQuinton%26aufirst%3DF.%2BJ%26aulast%3DSelby%26aufirst%3DM.%2BD%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25204%253A%2520selection%2520of%2520UK-453%252C061%2520%2528lersivirine%2529%2520as%2520a%2520development%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5857%26epage%3D5860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Hoegberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahlberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noreen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kangasmetsae, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahlberg, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LÃ¶vgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridborg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BÃ¤ckbro, K.</span><span> </span><span class="NLM_article-title">Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structureâactivity relationship studies of PETT analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">â</span> <span class="NLM_lpage">4160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4150-4160&author=M.+Hoegbergauthor=C.+Sahlbergauthor=P.+Engelhardtauthor=R.+Noreenauthor=J.+Kangasmetsaeauthor=N.+G.+Johanssonauthor=B.+Oebergauthor=L.+Vrangauthor=H.+Zhangauthor=B.-L.+Sahlbergauthor=T.+Ungeauthor=S.+L%C3%B6vgrenauthor=K.+Fridborgauthor=K.+B%C3%A4ckbro&title=Urea-PETT+compounds+as+a+new+class+of+HIV-1+reverse+transcriptase+inhibitors.+3.+Synthesis+and+further+structure%E2%88%92activity+relationship+studies+of+PETT+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoegberg%26aufirst%3DM.%26aulast%3DSahlberg%26aufirst%3DC.%26aulast%3DEngelhardt%26aufirst%3DP.%26aulast%3DNoreen%26aufirst%3DR.%26aulast%3DKangasmetsae%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DOeberg%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSahlberg%26aufirst%3DB.-L.%26aulast%3DUnge%26aufirst%3DT.%26aulast%3DL%25C3%25B6vgren%26aufirst%3DS.%26aulast%3DFridborg%26aufirst%3DK.%26aulast%3DB%25C3%25A4ckbro%26aufirst%3DK.%26atitle%3DUrea-PETT%2520compounds%2520as%2520a%2520new%2520class%2520of%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors.%25203.%2520Synthesis%2520and%2520further%2520structure%25E2%2588%2592activity%2520relationship%2520studies%2520of%2520PETT%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4150%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crostarosa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aravantinou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akpogheneta, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasny, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piatak, M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chudolij, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zydowsky, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbiani, M.</span><span> </span><span class="NLM_article-title">A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">e8060</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1-14&issue=e8060&author=F.+Crostarosaauthor=M.+Aravantinouauthor=O.+J.+Akpoghenetaauthor=E.+Jasnyauthor=A.+Shawauthor=J.+Kenneyauthor=M.+Piatakauthor=J.+D.+Lifsonauthor=A.+Teitelbaumauthor=L.+Huauthor=A.+Chudolijauthor=T.+M.+Zydowskyauthor=J.+Blanchardauthor=A.+Gettieauthor=M.+Robbiani&title=A+macaque+model+to+study+vaginal+HSV-2%2Fimmunodeficiency+virus+co-infection+and+the+impact+of+HSV-2+on+microbicide+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrostarosa%26aufirst%3DF.%26aulast%3DAravantinou%26aufirst%3DM.%26aulast%3DAkpogheneta%26aufirst%3DO.%2BJ.%26aulast%3DJasny%26aufirst%3DE.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DKenney%26aufirst%3DJ.%26aulast%3DPiatak%26aufirst%3DM.%26aulast%3DLifson%26aufirst%3DJ.%2BD.%26aulast%3DTeitelbaum%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DChudolij%26aufirst%3DA.%26aulast%3DZydowsky%26aufirst%3DT.%2BM.%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DGettie%26aufirst%3DA.%26aulast%3DRobbiani%26aufirst%3DM.%26atitle%3DA%2520macaque%2520model%2520to%2520study%2520vaginal%2520HSV-2%252Fimmunodeficiency%2520virus%2520co-infection%2520and%2520the%2520impact%2520of%2520HSV-2%2520on%2520microbicide%2520efficacy%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3De8060%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit95b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fernandez-Romero, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turville, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titchen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudol, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbiani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckheit, R. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. M.</span><span> </span><span class="NLM_article-title">Carrageenan/MIV-150 (PC-815), a combination microbicide</span> <span class="citation_source-journal">Sex. Transm. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtVGh" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=9-14&author=J.+A.+Fernandez-Romeroauthor=M.+Thornauthor=S.+G.+Turvilleauthor=K.+Titchenauthor=K.+Sudolauthor=J.+Liauthor=T.+Millerauthor=M.+Robbianiauthor=R.+A.+Maguireauthor=R.+W.+Buckheitauthor=T.+L.+Hartmanauthor=D.+M.+Phillips&title=Carrageenan%2FMIV-150+%28PC-815%29%2C+a+combination+microbicide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95bR"><div class="casContent"><span class="casTitleNuber">95b</span><div class="casTitle"><span class="NLM_cas:atitle">Carrageenan/MIV-150 (PC-815), a Combination Microbicide</span></div><div class="casAuthors">Fernandez-Romero, Jose A.; Thorn, Mitchell; Turville, Stuart G.; Titchen, Kanani; Sudol, Kristin; Li, Jifan; Miller, Todd; Robbiani, Melissa; Maguire, Robin A.; Buckheit, Robert W., Jr.; Hartman, Tracy L.; Phillips, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Sexually Transmitted Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">STRDDM</span>;
        ISSN:<span class="NLM_cas:issn">0148-5717</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: The objective of this article is to study the effect of PC-815, a novel combination microbicide contg. carrageenan and the nonnucleoside reverse transcriptase inhibitor (NNRTI) MIV-150, in blocking HIV-1 and HIV-2 infections in vitro as compared with Carraguard alone.  GOAL: The goal of this study was to develop a combination microbicide that is more efficacious than Carraguard against HIV-1 and HIV-2.  Study design: The microtiter syncytial assay was used to evaluate: (1) the antiviral and virucidal activity of MIV-150 against HIV-1MN; (2) the additive effect of MIV-150 when combined with carrageenan; and (3) a possible interference of seminal fluid in the antiviral activity of these compds.  Results: MIV-150 effectively inactivated free virus.  Combination of MIV-150 and Carraguard demonstrated an additive antiviral effect.  Seminal fluid had no effect on the antiviral activity of MIV-150 or Carraguard.  The av. concn. that blocks 50% of infection (EC50) for PC-815 was approx. 10 times stronger than Carraguard for the different clin. isolates used in the study.  Conclusion: Theor., PC-815 is likely to be a more efficacious microbicide than Carraguard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPg-FD1H2srVg90H21EOLACvtfcHk0lh--8TRpJaeBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtVGh&md5=3b1e11d70010dd34e7db05ee9ca75ae3</span></div><a href="/servlet/linkout?suffix=cit95b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Romero%26aufirst%3DJ.%2BA.%26aulast%3DThorn%26aufirst%3DM.%26aulast%3DTurville%26aufirst%3DS.%2BG.%26aulast%3DTitchen%26aufirst%3DK.%26aulast%3DSudol%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DRobbiani%26aufirst%3DM.%26aulast%3DMaguire%26aufirst%3DR.%2BA.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DHartman%26aufirst%3DT.%2BL.%26aulast%3DPhillips%26aufirst%3DD.%2BM.%26atitle%3DCarrageenan%252FMIV-150%2520%2528PC-815%2529%252C%2520a%2520combination%2520microbicide%26jtitle%3DSex.%2520Transm.%2520Dis.%26date%3D2006%26volume%3D34%26spage%3D9%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Zhou, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissling, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayers, D.</span><span> </span><span class="NLM_article-title">Microdose pharmacokinetics of IDX899 and IDX989, candidate HIV-1 non-nucleoside reverse transcriptase inhibitors, following oral and intravenous administration in healthy male subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1408</span><span class="NLM_x">â</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1177%2F0091270009343698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19776293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1408-1416&author=X.-J.+Zhouauthor=R.+C.+Garnerauthor=S.+Nicholsonauthor=C.+J.+Kisslingauthor=D.+Mayers&title=Microdose+pharmacokinetics+of+IDX899+and+IDX989%2C+candidate+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors%2C+following+oral+and+intravenous+administration+in+healthy+male+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Microdose pharmacokinetics of IDX899 and IDX989, candidate HIV-1 non-nucleoside reverse transcriptase inhibitors, following oral and intravenous administration in healthy male subjects</span></div><div class="casAuthors">Zhou, Xiao-Jian; Garner, R. Colin; Nicholson, Sheila; Kissling, C. James; Mayers, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1408-1416</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">IDX899 and IDX989 are new non-nucleoside reverse-transcriptase inhibitors (NNRTIs) that exhibit potent inhibition of HIV-1 replication, including NNRTI-resistant mutants.  This microdose study investigates the pharmacokinetics and detd. oral bioavailability.  For each compd., 4 healthy male subjects are randomized to receive via a crossover design a single 100-Î¼g oral and i.v. dose together with 100 nCi of [14C]-labeled drug.  Plasma and urine samples are obtained over a period of 168 h postdose and analyzed for total, unchanged drug and major metabolites using an accelerator mass spectrometry method.  Based on total radioactivity, oral absorption is near complete.  For the parent drug, mean abs. bioavailability is 61% and 65% for IDX899 and IDX989, resp.  Both compds. are extensively metabolized esp. after oral dosing.  Obsd. terminal phase half-lives after oral and i.v. doses range from 4 to 10 h and are comparable for the 2 compds.  Urine excretion of radioactivity for both compds. is less than 10%.  These data show for the first time that IDX899 and IDX989 possess favorable pharmacokinetic properties in humans, including high mean abs. bioavailability and long half-life.  IDX899 has been selected based on these initial pharmacokinetic assessments and other criteria as the candidate for further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARInsgz8HPbVg90H21EOLACvtfcHk0lignBZthB6HUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLvO&md5=2bb99ad00f2630d15e6066f349dbf94b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1177%2F0091270009343698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009343698%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.-J.%26aulast%3DGarner%26aufirst%3DR.%2BC.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DKissling%26aufirst%3DC.%2BJ.%26aulast%3DMayers%26aufirst%3DD.%26atitle%3DMicrodose%2520pharmacokinetics%2520of%2520IDX899%2520and%2520IDX989%252C%2520candidate%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%252C%2520following%2520oral%2520and%2520intravenous%2520administration%2520in%2520healthy%2520male%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D1408%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Pascual, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasothan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Febuxostat</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=191-192&author=E.+Pascualauthor=F.+Siveraauthor=U.+Yasothanauthor=P.+Kirkpatrick&title=Febuxostat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPascual%26aufirst%3DE.%26aulast%3DSivera%26aufirst%3DF.%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DFebuxostat%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D191%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eger, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T.</span><span> </span><span class="NLM_article-title">An extremely potent inhibitor of xanthine oxidoreductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1848</span><span class="NLM_x">â</span> <span class="NLM_lpage">1855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=1848-1855&author=K.+Okamotoauthor=B.+T.+Egerauthor=T.+Nishinoauthor=S.+Kondoauthor=E.+F.+Paiauthor=T.+Nishino&title=An+extremely+potent+inhibitor+of+xanthine+oxidoreductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DEger%26aufirst%3DB.%2BT.%26aulast%3DNishino%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DAn%2520extremely%2520potent%2520inhibitor%2520of%2520xanthine%2520oxidoreductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D1848%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Sato, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashizawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, O.</span><span> </span><span class="NLM_article-title">Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051âa xanthine oxidoreductase inhibitor for the treatment of hyperuricemia</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6225</span><span class="NLM_x">â</span> <span class="NLM_lpage">6229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6225-6229&author=T+Satoauthor=N.+Ashizawaauthor=K.+Matsumotoauthor=T.+Iwanagaauthor=H.+Nakamuraauthor=T.+Inoueauthor=O.+Nagata&title=Discovery+of+3-%283-cyano-4-pyridyl%29-5-%284-pyridyl%29-1%2C2%2C4-triazole%2C+FYX-051%E2%80%94a+xanthine+oxidoreductase+inhibitor+for+the+treatment+of+hyperuricemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT%26aulast%3DAshizawa%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DO.%26atitle%3DDiscovery%2520of%25203-%25283-cyano-4-pyridyl%2529-5-%25284-pyridyl%2529-1%252C2%252C4-triazole%252C%2520FYX-051%25E2%2580%2594a%2520xanthine%2520oxidoreductase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hyperuricemia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6225%26epage%3D6229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hille, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eger, B. T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T.</span><span> </span><span class="NLM_article-title">The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">7931</span><span class="NLM_x">â</span> <span class="NLM_lpage">7936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=7931-7936&author=K.+Okamotoauthor=K.+Matsumotoauthor=R.+Hilleauthor=B.+T+Egerauthor=E.+F.+Paiauthor=T.+Nishino&title=The+crystal+structure+of+xanthine+oxidoreductase+during+catalysis%3A+implications+for+reaction+mechanism+and+enzyme+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DHille%26aufirst%3DR.%26aulast%3DEger%26aufirst%3DB.%2BT%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DThe%2520crystal%2520structure%2520of%2520xanthine%2520oxidoreductase%2520during%2520catalysis%253A%2520implications%2520for%2520reaction%2520mechanism%2520and%2520enzyme%2520inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D7931%26epage%3D7936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Pratley, R. E.</span><span> </span><span class="NLM_article-title">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">â</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1517%2F14656560802694713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19191685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=503-512&author=R.+E.+Pratley&title=Alogliptin%3A+a+new%2C+highly+selective+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Pratley, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-512</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Alogliptin is a potent, highly selective dipeptidyl peptidase-4 inhibitor now undergoing clin. testing to support a new drug application for the treatment of type 2 diabetes.  Objective: To provide an overview of the mechanism by which alogliptin reduces hyperglycemia and to summarize the pharmacol., efficacy and safety of the drug.  Methods: A Medline search was conducted and abstrs. and presentations from recent American Diabetes Assocn. and European Assocn. for the Study of Diabetes (EASD) meetings were reviewed.  The results of phase II and phase III human studies were evaluated for clin. efficacy, safety and tolerability in patients with type 2 diabetes.  Results/conclusions: Alogliptin is effective as a treatment for type 2 diabetes, either as monotherapy or in combination with metformin, thiazolidinediones, sulfonylureas and insulin.  It is well tolerated and has an excellent safety profile.  Addnl. studies are needed to evaluate the long-term safety and efficacy of alogliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVASaAmsEezrVg90H21EOLACvtfcHk0lignBZthB6HUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D&md5=26b93655020e344a7a063a25aaed728d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1517%2F14656560802694713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560802694713%26sid%3Dliteratum%253Aachs%26aulast%3DPratley%26aufirst%3DR.%2BE.%26atitle%3DAlogliptin%253A%2520a%2520new%252C%2520highly%2520selective%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D503%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Andukuri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drincic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendell, M.</span><span> </span><span class="NLM_article-title">Alogliptin: a new addition to the class of DPP-4 inhibitors</span> <span class="citation_source-journal">Diabetes, Metab. Syndr. Obes.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">â</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWmtrrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=117-126&author=R.+Andukuriauthor=A.+Drincicauthor=M.+Rendell&title=Alogliptin%3A+a+new+addition+to+the+class+of+DPP-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102aR"><div class="casContent"><span class="casTitleNuber">102a</span><div class="casTitle"><span class="NLM_cas:atitle">Alogliptin: a new addition to the class of DPP-4 inhibitors</span></div><div class="casAuthors">Andukuri, Radha; Drincic, Andjela; Rendell, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Metabolic Syndrome and Obesity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-126</span>CODEN:
                <span class="NLM_cas:coden">DMSOAD</span>;
        ISSN:<span class="NLM_cas:issn">1178-7007</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Alogliptin is an oral antihyperglycemic agent that is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4).  Inhibition of DPP-4 elevates levels of the incretin hormones glucagon-like peptide (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) by preventing their degrdn.  To review the evolution of alogliptin and its pharmacokinetics, pharmacodynamics, clin. efficacy and adverse effects.  In addn., we compared alogliptin to other DPP-4 inhibitors.  A comprehensive literature search was performed using the term 'alogliptin'.  Original research articles and review articles as well as scientific abstrs. were included.  Alogliptin raises postprandial levels of GLP-1.  It has excellent bioavailability exhibiting a median Tmax ranging from 1 to 2 h and a mean half-life of 12.4 to 21.4 h across all doses.  When given as monotherapy, mean Hb A1c (HbA1c) redns. achieved were 0.5% to 0.6%.  Combination therapy yielded similar redns. (-0.5% with metformin, -0.6% with glyburide, -0.8% with pioglitazone and -0.6% with insulin).  Administration of alogliptin does not promote wt. loss but has not resulted in wt. gain.  The agent is relatively well tolerated with few adverse effects, the major finding being a marginally higher rate of skin events, primarily pruritus.  Alogliptin causes significant redns. in HbA1c when used alone or in combination with other oral agents in patients with type 2 diabetes similar to other DPP-4 inhibitors in current clin. use.  The side effect profile also does not differ from that of other DPP-4 inhibitors.  However, long-term studies are necessary before the place of alogliptin in the management of type 2 diabetes can be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL2BZsv0XCALVg90H21EOLACvtfcHk0lhGlQzeu5jwQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWmtrrI&md5=1c7eb061b36ea68ae65c64f206673608</span></div><a href="/servlet/linkout?suffix=cit102a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndukuri%26aufirst%3DR.%26aulast%3DDrincic%26aufirst%3DA.%26aulast%3DRendell%26aufirst%3DM.%26atitle%3DAlogliptin%253A%2520a%2520new%2520addition%2520to%2520the%2520class%2520of%2520DPP-4%2520inhibitors%26jtitle%3DDiabetes%252C%2520Metab.%2520Syndr.%2520Obes.%26date%3D2009%26volume%3D2%26spage%3D117%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit102b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">589</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">â</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.ejphar.2008.04.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18538760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVCmt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=589&publication_year=2008&pages=306-314&author=B.+Leeauthor=L.+Shiauthor=D.+B.+Kasselauthor=T.+Asakawaauthor=K.+Takeuchiauthor=R.+J.+Christopher&title=Pharmacokinetic%2C+pharmacodynamic%2C+and+efficacy+profiles+of+alogliptin%2C+a+novel+inhibitor+of+dipeptidyl+peptidase-4%2C+in+rats%2C+dogs%2C+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102bR"><div class="casContent"><span class="casTitleNuber">102b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys</span></div><div class="casAuthors">Lee, Bumsup; Shi, Lihong; Kassel, Daniel B.; Asakawa, Tomoko; Takeuchi, Koji; Christopher, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">589</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">306-314</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of the present research was to characterize the pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel quinazolinone-based dipeptidyl peptidase-4 (DPP-4) inhibitor.  Alogliptin potently inhibited human DPP-4 in vitro (mean IC50, â¼ 6.9 nM) and exhibited > 10,000-fold selectivity for DPP-4 over the closely related serine proteases DPP-2, DPP-8, DPP-9, fibroblast activation protein/seprase, prolyl endopeptidase, and tryptase (IC50 > 100,000 nM).  Abs. oral bioavailability of alogliptin in rats, dogs, and monkeys was 45%, 86%, and 72% to 88%, resp.  After a single oral dose of alogliptin, plasma DPP-4 inhibition was obsd. within 15 min and max. inhibition was > 90% in rats, dogs, and monkeys; inhibition was sustained for 12 h in rats (43%) and dogs (65%) and 24 h in monkeys (> 80%).  From Emax modeling, 50% inhibition of DPP-4 activity was obsd. at a mean alogliptin plasma concn. (EC50) of 3.4 to 5.6 ng/mL (10.0 to 16.5 nM) in rats, dogs, and monkeys.  In Zucker fa/fa rats, a single dose of alogliptin (0.3, 1, 3, and 10 mg/kg) inhibited plasma DPP-4 (91% to 100% at 2 h and 20% to 66% at 24 h), increased plasma GLP-1 (2- to 3-fold increase in AUC0-20 min) and increased early-phase insulin secretion (1.5- to 2.6-fold increase in AUC0-20 min) and reduced blood glucose excursion (31%-67% decrease in AUC0-90 min) after oral glucose challenge.  Alogliptin (30 and 100 mg/kg) had no effect on fasting plasma glucose in normoglycemic rats.  In summary, these data suggest that alogliptin is a potent and highly selective DPP-4 inhibitor with demonstrated efficacy in Zucker fa/fa rats and potential for once-daily dosing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEb5VESLzp5rVg90H21EOLACvtfcHk0lhGlQzeu5jwQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVCmt7o%253D&md5=51aee5f0d4021832896d021a25b64f54</span></div><a href="/servlet/linkout?suffix=cit102b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.04.047%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26atitle%3DPharmacokinetic%252C%2520pharmacodynamic%252C%2520and%2520efficacy%2520profiles%2520of%2520alogliptin%252C%2520a%2520novel%2520inhibitor%2520of%2520dipeptidyl%2520peptidase-4%252C%2520in%2520rats%252C%2520dogs%252C%2520and%2520monkeys%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D589%26spage%3D306%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II.</span><span> </span><span class="NLM_article-title">Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">â</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070104l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2297-2300&author=J.+Fengauthor=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+A.+Staffordauthor=S.+W.+Kaldorauthor=D.+B.+Kasselauthor=M.+Navreauthor=L.+Shiauthor=R.+J.+Skeneauthor=T.+Asakawaauthor=K.+Takeuchiauthor=R.+Xuauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Discovery+of+alogliptin%3A+a+potent%2C+selective%2C+bioavailable%2C+and+efficacious+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm070104l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070104l%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520alogliptin%253A%2520a%2520potent%252C%2520selective%252C%2520bioavailable%252C%2520and%2520efficacious%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2297%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Johnson, H. G.</span><span> </span><span class="NLM_article-title">New anti-allergy drugsâthe lodoxamides</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">â</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1980&pages=343-345&author=H.+G.+Johnson&title=New+anti-allergy+drugs%E2%80%94the+lodoxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DH.%2BG.%26atitle%3DNew%2520anti-allergy%2520drugs%25E2%2580%2594the%2520lodoxamides%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1980%26volume%3D1%26spage%3D343%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">TYB-2285 (Toyobo)</span> <span class="citation_source-journal">Curr. Opin. Anti-Inflammatory Immunomodulatory Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">â</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=113-116&author=P.+Norman&title=TYB-2285+%28Toyobo%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DTYB-2285%2520%2528Toyobo%2529%26jtitle%3DCurr.%2520Opin.%2520Anti-Inflammatory%2520Immunomodulatory%2520Invest.%2520Drugs%26date%3D2000%26volume%3D2%26spage%3D113%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit105b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsushima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, T.</span><span> </span><span class="NLM_article-title">Novel antiallergic and antiinflammatory agents. Part II: synthesis and pharmacology of TYB-2285 and its related compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">â</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=1077-1087&author=M.+Banauthor=H.+Taguchiauthor=T.+Katsushimaauthor=M.+Takahashiauthor=K.+Shinodaauthor=A.+Watanabeauthor=T.+Tominaga&title=Novel+antiallergic+and+antiinflammatory+agents.+Part+II%3A+synthesis+and+pharmacology+of+TYB-2285+and+its+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DH.%26aulast%3DKatsushima%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DShinoda%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DTominaga%26aufirst%3DT.%26atitle%3DNovel%2520antiallergic%2520and%2520antiinflammatory%2520agents.%2520Part%2520II%253A%2520synthesis%2520and%2520pharmacology%2520of%2520TYB-2285%2520and%2520its%2520related%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D1077%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Ortolani, S.</span><span> </span><span class="NLM_article-title">Strontium ranelate: a new first-line treatment for patients with postmenopausal osteoporosis</span> <span class="citation_source-journal">Postmenopausal Osteoporosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ahtb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=247-253&author=S.+Ortolani&title=Strontium+ranelate%3A+a+new+first-line+treatment+for+patients+with+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Strontium ranelate: a new first-line treatment for patients with postmenopausal osteoporosis</span></div><div class="casAuthors">Ortolani, S.</div><div class="citationInfo"><span class="NLM_cas:title">Postmenopausal Osteoporosis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">69IQIV</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Strontium ranelate is composed of an org. moiety (ranelic acid) and two atoms of stable (non-radioactive) strontium.  It is capable of stimulating bone formation while inhibiting bone resorption.  The scientific rationale for the use of this agent in osteoporosis, and the results of the first major clin. studies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1jWupUCtYt7Vg90H21EOLACvtfcHk0lgQfBBGXNtWWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ahtb7M&md5=28eb3360641b7e93cdfa4276ae925ddc</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrtolani%26aufirst%3DS.%26atitle%3DStrontium%2520ranelate%253A%2520a%2520new%2520first-line%2520treatment%2520for%2520patients%2520with%2520postmenopausal%2520osteoporosis%26jtitle%3DPostmenopausal%2520Osteoporosis%26date%3D2006%26spage%3D247%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maimoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badoud, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois-Ferriere, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammann, P.</span><span> </span><span class="NLM_article-title">Strontium ranelate improves implant osseointegration</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1436</span><span class="NLM_x">â</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=1436-1441&author=L.+Maimounauthor=T.+C.+Brennanauthor=I.+Badoudauthor=V.+Dubois-Ferriereauthor=R.+Rizzoliauthor=P.+Ammann&title=Strontium+ranelate+improves+implant+osseointegration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaimoun%26aufirst%3DL.%26aulast%3DBrennan%26aufirst%3DT.%2BC.%26aulast%3DBadoud%26aufirst%3DI.%26aulast%3DDubois-Ferriere%26aufirst%3DV.%26aulast%3DRizzoli%26aufirst%3DR.%26aulast%3DAmmann%26aufirst%3DP.%26atitle%3DStrontium%2520ranelate%2520improves%2520implant%2520osseointegration%26jtitle%3DBone%26date%3D2010%26volume%3D46%26spage%3D1436%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit107b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">There has been some question as to whether this dual action mechanism operates: </p></div><span class="NLM_contrib-group">Blake, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compston, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogelman, I.</span><span> </span><span class="NLM_article-title">Could strontium ranelate have a synertistic role in the treatment of osteoporosis?</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1354</span><span class="NLM_x">â</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1359%2Fjbmr.090601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19558313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaitrvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=1354-1357&author=G.+M.+Blakeauthor=J.+E.+Compstonauthor=I.+Fogelman&title=Could+strontium+ranelate+have+a+synertistic+role+in+the+treatment+of+osteoporosis%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107bR"><div class="casContent"><span class="casTitleNuber">107b</span><div class="casTitle"><span class="NLM_cas:atitle">Could strontium ranelate have a synertistic role in the treatment of osteoporosis?</span></div><div class="casAuthors">Blake, Glen M.; Compston, Juliet E.; Fogelman, Ignac</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1354-1357</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">A review.  The research of Recker et al. (2009) entitled 'Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochem. markers of bone turnover in postmenopausal women with osteoporosis' is reviewed with commentary and refs.  These authors present results from a randomized active comparator study in osteoporotic postmenopausal women that provide compelling evidence that treatment with strontium ranelate (SrR) has only a modest effect on bone remodeling as assessed by biochem. markers of bone turnover and bone histomorphometry.  They report that changes in biochem. markers during 6-mo treatment with SrR failed to confirm any bone-forming activity.  They conclude that the modest effect of SrR on bone remodeling and cell activity may indicate that its effects on fracture redn. are mediated by a different mechanism than that obsd. with anabolic or the more potent antiresorptive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2DZqwfRKnoLVg90H21EOLACvtfcHk0lgQfBBGXNtWWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaitrvE&md5=3721c0ea3647f0feb685fe91636a3cc0</span></div><a href="/servlet/linkout?suffix=cit107b&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.090601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.090601%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DG.%2BM.%26aulast%3DCompston%26aufirst%3DJ.%2BE.%26aulast%3DFogelman%26aufirst%3DI.%26atitle%3DCould%2520strontium%2520ranelate%2520have%2520a%2520synertistic%2520role%2520in%2520the%2520treatment%2520of%2520osteoporosis%253F%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D1354%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pasqualotto, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldani, L. Z.</span><span> </span><span class="NLM_article-title">Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">â</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=165-174&author=A.+C.+Pasqualottoauthor=K.+O.+Thieleauthor=L.+Z.+Goldani&title=Novel+triazole+antifungal+drugs%3A+focus+on+isavuconazole%2C+ravuconazole+and+albaconazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasqualotto%26aufirst%3DA.%2BC.%26aulast%3DThiele%26aufirst%3DK.%2BO.%26aulast%3DGoldani%26aufirst%3DL.%2BZ.%26atitle%3DNovel%2520triazole%2520antifungal%2520drugs%253A%2520focus%2520on%2520isavuconazole%252C%2520ravuconazole%2520and%2520albaconazole%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit108b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Petrikkos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiada, A.</span><span> </span><span class="NLM_article-title">Recent advances in antifungal chemotherapy</span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">â</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.ijantimicag.2007.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17524625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFartrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=108-117&author=G.+Petrikkosauthor=A.+Skiada&title=Recent+advances+in+antifungal+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108bR"><div class="casContent"><span class="casTitleNuber">108b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in antifungal chemotherapy</span></div><div class="casAuthors">Petrikkos, George; Skiada, Anna</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  For over 50 years, amphotericin B deoxycholate (AmBD) has been the 'gold std.' in antifungal chemotherapy, despite its frequent toxicities.  However, improved treatment options for invasive fungal infections (IFIs) have been developed during the last 15 years.  Newer antifungal agents, including less toxic lipid prepns. of AmBD, triazoles and the echinocandins, have been added to our armamentarium against IFIs.  Some of these newer drugs can now replace AmBD as primary therapy (e.g. caspofungin for candidiasis, voriconazole for aspergillosis), while others offer new therapeutic options for difficult-to-treat IFIs (e.g. posaconazole for zygomycosis, fusariosis and chromoblastomycosis).  It is interesting that extended use of newer antifungals such as fluconazole, despite decreasing the mortality attributed to candidiasis, resulted in selection of species resistant to several antifungals (Candida krusei, Candida glabrata); while several publications suggest that prolonged use of voriconazole may expose severely immunocompromised patients to the risk of zygomycosis (breakthrough).  On the other hand, the differences in the mode of action of newer antifungals such as echinocandins raise the question whether combination antifungal therapy is more effective than monotherapy.  Finally, the availability of an oral formulation with excellent biosafety of several newer antifungals (e.g. posaconazole) makes them candidates for prophylactic or prolonged maintenance therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMHOCuOah7RbVg90H21EOLACvtfcHk0lgQfBBGXNtWWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFartrc%253D&md5=e07e916c897a5867e356f11201914bd8</span></div><a href="/servlet/linkout?suffix=cit108b&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2007.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2007.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DPetrikkos%26aufirst%3DG.%26aulast%3DSkiada%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520antifungal%2520chemotherapy%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2007%26volume%3D30%26spage%3D108%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit108c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yamazumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. N.</span><span> </span><span class="NLM_article-title">In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of <i>Cryptococcus neoformans</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2883</span><span class="NLM_x">â</span> <span class="NLM_lpage">2886</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2883-2886&author=T.+Yamazumiauthor=M.+A.+Pfallerauthor=S.+A.+Messerauthor=A.+Houstonauthor=R.+J.+Hollisauthor=R.+N.+Jones&title=In+vitro+activities+of+ravuconazole+%28BMS-207147%29+against+541+clinical+isolates+of+Cryptococcus+neoformans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamazumi%26aufirst%3DT.%26aulast%3DPfaller%26aufirst%3DM.%2BA.%26aulast%3DMesser%26aufirst%3DS.%2BA.%26aulast%3DHouston%26aufirst%3DA.%26aulast%3DHollis%26aufirst%3DR.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DIn%2520vitro%2520activities%2520of%2520ravuconazole%2520%2528BMS-207147%2529%2520against%2520541%2520clinical%2520isolates%2520of%2520Cryptococcus%2520neoformans%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2883%26epage%3D2886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Three-dimensional model of lanosterol 14Î±-demethylase from <i>Cryptococcus neoformans</i>: active-site characterization and insights into azole binding</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3487</span><span class="NLM_x">â</span> <span class="NLM_lpage">3495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3487-3495&author=C.+Shengauthor=Z.+Miaoauthor=H.+Jiauthor=J.+Yaoauthor=W.+Wangauthor=X.+Cheauthor=G.+Dongauthor=J.+Luauthor=W.+Guoauthor=W.+Zhang&title=Three-dimensional+model+of+lanosterol+14%CE%B1-demethylase+from+Cryptococcus+neoformans%3A+active-site+characterization+and+insights+into+azole+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DThree-dimensional%2520model%2520of%2520lanosterol%252014%25CE%25B1-demethylase%2520from%2520Cryptococcus%2520neoformans%253A%2520active-site%2520characterization%2520and%2520insights%2520into%2520azole%2520binding%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3487%26epage%3D3495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schmitt-Hoffmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spickermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeckel, K.</span><span> </span><span class="NLM_article-title">Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4885</span><span class="NLM_x">â</span> <span class="NLM_lpage">4890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4885-4890&author=A.+Schmitt-Hoffmannauthor=B.+Roosauthor=J.+Spickermannauthor=M.+Heepauthor=E.+Peterfaiauthor=D.+J.+Edwardsauthor=K.+Stoeckel&title=Effect+of+mild+and+moderate+liver+disease+on+the+pharmacokinetics+of+isavuconazole+after+intravenous+and+oral+administration+of+a+single+dose+of+the+prodrug+BAL8557"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt-Hoffmann%26aufirst%3DA.%26aulast%3DRoos%26aufirst%3DB.%26aulast%3DSpickermann%26aufirst%3DJ.%26aulast%3DHeep%26aufirst%3DM.%26aulast%3DPeterfai%26aufirst%3DE.%26aulast%3DEdwards%26aufirst%3DD.%2BJ.%26aulast%3DStoeckel%26aufirst%3DK.%26atitle%3DEffect%2520of%2520mild%2520and%2520moderate%2520liver%2520disease%2520on%2520the%2520pharmacokinetics%2520of%2520isavuconazole%2520after%2520intravenous%2520and%2520oral%2520administration%2520of%2520a%2520single%2520dose%2520of%2520the%2520prodrug%2520BAL8557%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4885%26epage%3D4890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit110b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verweij, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederhold, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lass-Florl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghannoum, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinea, J.</span><span> </span><span class="NLM_article-title">In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries</span> <span class="citation_source-journal">J. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">â</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19567347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFylt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=272-281&author=P.+E.+Verweijauthor=G.+M.+Gonzalezauthor=N.+P.+Wiederholdauthor=C.+Lass-Florlauthor=P.+Warnauthor=M.+Heepauthor=M.+A.+Ghannoumauthor=J.+Guinea&title=In+vitro+antifungal+activity+of+isavuconazole+against+345+mucorales+isolates+collected+at+study+centers+in+eight+countries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110bR"><div class="casContent"><span class="casTitleNuber">110b</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries</span></div><div class="casAuthors">Verweij, P. E.; Gonzalez, G. M.; Wiederhold, N. P.; Lass-Florl, C.; Warn, P.; Heep, M.; Ghannoum, M. A.; Guinea, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">Although mucormycoses (formerly zygomycoses) are relatively uncommon, they are assocd. with high mortality and treatment options are limited.  Isavuconazole is a novel, water sol., broad-spectrum azole in clin. development for the treatment of invasive aspergillosis and candidiasis.  The objective of this report was to collate data on the in vitro activity of isavuconazole against a collection of 345 diverse Mucorales isolates, collected and tested at eight study centers in Europe, Mexico and North America.  Each study center undertook min. inhibitory concn. (MIC) susceptibility testing of their isolates, according to EUCAST or CLSI guidelines.  Across all study centers, isavuconazole exhibited MIC50 values of 1-4 mg/L and MIC90 values of 4-16 mg/L against the five genera.  There were also marked differences in MIC distributions, which could be ascribed to differences in inoculum and/or endpoint.  EUCAST guidelines appeared to generate modal MICs 2-fold higher than CLSI.  These results confirm that isavuconazole possesses at least partial antifungal activity against Mucorales.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoShda_vi7UOLVg90H21EOLACvtfcHk0lhlKtl_YQclug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFylt78%253D&md5=989fc1da0071586ef267a83a9817f6eb</span></div><a href="/servlet/linkout?suffix=cit110b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerweij%26aufirst%3DP.%2BE.%26aulast%3DGonzalez%26aufirst%3DG.%2BM.%26aulast%3DWiederhold%26aufirst%3DN.%2BP.%26aulast%3DLass-Florl%26aufirst%3DC.%26aulast%3DWarn%26aufirst%3DP.%26aulast%3DHeep%26aufirst%3DM.%26aulast%3DGhannoum%26aufirst%3DM.%2BA.%26aulast%3DGuinea%26aufirst%3DJ.%26atitle%3DIn%2520vitro%2520antifungal%2520activity%2520of%2520isavuconazole%2520against%2520345%2520mucorales%2520isolates%2520collected%2520at%2520study%2520centers%2520in%2520eight%2520countries%26jtitle%3DJ.%2520Chemother.%26date%3D2009%26volume%3D21%26spage%3D272%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, K.</span><span> </span><span class="NLM_article-title">Lipoprotein lipase activator NO-1886</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=133-142&author=W.+Yinauthor=K.+Tsutsumi&title=Lipoprotein+lipase+activator+NO-1886"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DTsutsumi%26aufirst%3DK.%26atitle%3DLipoprotein%2520lipase%2520activator%2520NO-1886%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2003%26volume%3D21%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Blake, P.</span><span> </span><span class="NLM_article-title">An overview of clinical trial experience with epanolol</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=81-85&author=P.+Blake&title=An+overview+of+clinical+trial+experience+with+epanolol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DP.%26atitle%3DAn%2520overview%2520of%2520clinical%2520trial%2520experience%2520with%2520epanolol%26jtitle%3DDrugs%26date%3D1989%26volume%3D38%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit112b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Harry, J. D.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of epanolol. Pharmacodynamic aspects</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=18-27&author=J.+D.+Harry&title=Clinical+pharmacology+of+epanolol.+Pharmacodynamic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarry%26aufirst%3DJ.%2BD.%26atitle%3DClinical%2520pharmacology%2520of%2520epanolol.%2520Pharmacodynamic%2520aspects%26jtitle%3DDrugs%26date%3D1989%26volume%3D38%26spage%3D18%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tanii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">Structureâtoxicity relationship of aliphatic nitriles</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">â</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0378-4274%2884%2990077-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=6474517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2cXmt1Ciurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1984&pages=267-272&author=H.+Taniiauthor=K.+Hashimoto&title=Structure%E2%88%92toxicity+relationship+of+aliphatic+nitriles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113aR"><div class="casContent"><span class="casTitleNuber">113a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-toxicity relationship of aliphatic nitriles</span></div><div class="casAuthors">Tanii, Hideji; Hashimoto, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-72</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    </div><div class="casAbstract">Acute toxicity, in vitro metab., and structure-toxicity relations of aliph. mononitriles were examd. in mice pretreated with CCl4  [56-23-5].  The LD50 in mice pretreated with CCl4 (LD50-CCl4) was increased in most nitriles compared to that in untreated animals (LD50-control) with different degrees among compds.  Microsomal metab. of nitriles to cyanide was completely inhibited when microsomes were prepd. from livers of mice pretreated with CCl4.  Log (1/LD50-CCl4) was a linear function of partition coeff., log P, i.e., log (1/LD50-CCl4) = -0.371 log P-0.152, and the equation was significant, provided aceto-  [75-05-8] and 3-hydroxypropionitrile  [109-78-4] were omitted from the anal.  These 2 compds. seem to be different from the others in exerting their biol. effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRW3q6SVdzE7Vg90H21EOLACvtfcHk0lhN-kCh8I2a8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmt1Ciurs%253D&md5=035dc260fe0055b320eb388f7f67a72d</span></div><a href="/servlet/linkout?suffix=cit113a&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2884%2990077-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252884%252990077-8%26sid%3Dliteratum%253Aachs%26aulast%3DTanii%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592toxicity%2520relationship%2520of%2520aliphatic%2520nitriles%26jtitle%3DToxicol.%2520Lett.%26date%3D1984%26volume%3D22%26spage%3D267%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit113b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ahmed, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieff, N. M.</span><span> </span><span class="NLM_article-title">Aliphatic nitriles: metabolism and toxicity</span> <span class="citation_source-journal">Prog. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL3sXltFOhtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1983&pages=229-294&author=A.+E.+Ahmedauthor=N.+M.+Trieff&title=Aliphatic+nitriles%3A+metabolism+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113bR"><div class="casContent"><span class="casTitleNuber">113b</span><div class="casTitle"><span class="NLM_cas:atitle">Aliphatic nitriles: metabolism and toxicity</span></div><div class="casAuthors">Ahmed, A. E.; Trieff, N. M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Drug Metabolism</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">229-94</span>CODEN:
                <span class="NLM_cas:coden">PDMEDP</span>;
        ISSN:<span class="NLM_cas:issn">0364-8974</span>.
    </div><div class="casAbstract">A review with many refs. on the metab., toxicity, and environmental impact of aliph. nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnlhtDsizb7Vg90H21EOLACvtfcHk0lhN-kCh8I2a8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltFOhtLc%253D&md5=7bfd3e56a5b91f79cff2fdde2ff3c4a7</span></div><a href="/servlet/linkout?suffix=cit113b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%2BE.%26aulast%3DTrieff%26aufirst%3DN.%2BM.%26atitle%3DAliphatic%2520nitriles%253A%2520metabolism%2520and%2520toxicity%26jtitle%3DProg.%2520Drug%2520Metab.%26date%3D1983%26volume%3D7%26spage%3D229%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit113c"><span><div class="note"><p class="first last">For recent AMES analyses of several alkylnitriles see the following: </p></div><span class="NLM_contrib-group">Wu, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hseu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. C.</span><span> </span><span class="NLM_article-title">Comparative investigations of genotoxic activity of five nitriles in the comet assay and the Ames test</span> <span class="citation_source-journal">J. Hazard. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">â</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.jhazmat.2009.03.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19414215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlyjsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2009&pages=492-497&author=J.-C.+Wuauthor=Y.+C.+Hseuauthor=C.-H.+Chenauthor=S.-H.+Wangauthor=S.+C.+Chen&title=Comparative+investigations+of+genotoxic+activity+of+five+nitriles+in+the+comet+assay+and+the+Ames+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113cR"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative investigations of genotoxic activity of five nitriles in the comet assay and the Ames test</span></div><div class="casAuthors">Wu, Jong-C.; Hseu, You C.; Chen, Chin-H.; Wang, Shu- H.; Chen, Ssu. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hazardous Materials</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">492-497</span>CODEN:
                <span class="NLM_cas:coden">JHMAD9</span>;
        ISSN:<span class="NLM_cas:issn">0304-3894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two short-term assays, the modified Ames test and the comet assay, were carried out to evaluate the genotoxicity of 5 nitriles (acetonitrile, propionitrile, methacrylonitrile, butyronitrile, and benzonitrile).  With the comet assay, all the nitriles studied were found to induce the genotoxicity in human lymphocytes and Hep G2 cells.  Except for butyronitrile, the genotoxic potency in lymphocytes was more pronounced than that in Hep G2 cells, and the rank order of genotoxicity induced by these 5 nitriles in lymphocytes was different from that in Hep G2 cells, indicating that the pathways leading to genotoxicity in both types of cells were different.  In the modified Ames test, no tested nitriles showed mutagenic activity on Salmonella typhimurium strain TA 98 and TA 100 with and without metabolic activation.  Comparing the results obtained from both tests, the comet assay seems to be more sensitive than the modified Ames test.  Thus, the comet assay can be used to detect the genotoxicity of all nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9dHOwwV-HrVg90H21EOLACvtfcHk0lhN-kCh8I2a8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlyjsrY%253D&md5=176179197fe05f8293c609b2bb30c723</span></div><a href="/servlet/linkout?suffix=cit113c&amp;dbid=16384&amp;doi=10.1016%2Fj.jhazmat.2009.03.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhazmat.2009.03.121%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-C.%26aulast%3DHseu%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DWang%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DS.%2BC.%26atitle%3DComparative%2520investigations%2520of%2520genotoxic%2520activity%2520of%2520five%2520nitriles%2520in%2520the%2520comet%2520assay%2520and%2520the%2520Ames%2520test%26jtitle%3DJ.%2520Hazard.%2520Mater.%26date%3D2009%26volume%3D169%26spage%3D492%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, D. A.</span><span> </span><span class="NLM_article-title">Anastrozole use in early stage breast cancer of post-menopausal women</span> <span class="citation_source-journal">Clin. Med. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19794821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKjs73O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=141-156&author=M.+Milaniauthor=G.+Jhaauthor=D.+A.+Potter&title=Anastrozole+use+in+early+stage+breast+cancer+of+post-menopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114aR"><div class="casContent"><span class="casTitleNuber">114a</span><div class="casTitle"><span class="NLM_cas:atitle">Anastrozole use in early stage breast cancer of post-menopausal women</span></div><div class="casAuthors">Milani, Monica; Jha, Gautam; Potter, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Medicine: Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-156</span>CODEN:
                <span class="NLM_cas:coden">CMTLCY</span>;
        ISSN:<span class="NLM_cas:issn">1179-1713</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica</span>)
        </div><div class="casAbstract">A review.  The majority of breast cancers express the estrogen receptor and depend on estradiol (E2) for their growth.  Hormonal therapy aims at depriving estrogen signaling either by using selective estrogen receptor modulators (SERM)-that interfere with the binding of E2 to its receptor (ER)-or aromatase inhibitors (AI)-that block the aromatase-dependent synthesis of E2.  While SERMs are recommended for both pre- and post-menopausal patients, AIs are indicated only for post-menopausal patients.  For the past 20 years, the SERM tamoxifen has been considered the "gold std." for the treatment of hormone receptor pos. breast cancers.  However, tamoxifen's role is now challenged by third generation AIs, such as anastrozole, which exhibit greater efficacy in the adjuvant setting in several recently reported trials.  This review will focus on anastrozole's mechanism of action, dosing, pharmacol., pharmacokinetics, and clin. applications.  It will briefly discuss the clin. trials that detd. anastrozole's efficacy in the treatment of advanced breast cancer (ABC) and in the neo-adjuvant setting.  Finally, it will present the clin. trials that established anastrozole as a frontline agent in the treatment of post-menopausal women with hormone receptor pos. early breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohKKI6OgFNxLVg90H21EOLACvtfcHk0lhN-kCh8I2a8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKjs73O&md5=e8b154730698d2aa438aa6dddddd540c</span></div><a href="/servlet/linkout?suffix=cit114a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilani%26aufirst%3DM.%26aulast%3DJha%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DD.%2BA.%26atitle%3DAnastrozole%2520use%2520in%2520early%2520stage%2520breast%2520cancer%2520of%2520post-menopausal%2520women%26jtitle%3DClin.%2520Med.%2520Ther.%26date%3D2009%26volume%3D1%26spage%3D141%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit114b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gangadhara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelli, G.</span><span> </span><span class="NLM_article-title">Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women</span> <span class="citation_source-journal">Ther. Clin. Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19753124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yltL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=291-300&author=S.+Gangadharaauthor=G.+Bertelli&title=Long-term+efficacy+and+safety+of+anastrozole+for+adjuvant+treatment+of+early+breast+cancer+in+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114bR"><div class="casContent"><span class="casTitleNuber">114b</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women</span></div><div class="casAuthors">Gangadhara, Sharath; Bertelli, Gianfilippo</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-300</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1178-203X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  For more than 20 years, tamoxifen has been the gold std. for the adjuvant treatment of postmenopausal women with hormone-responsive early breast cancer.  However, recent randomized trials have shown efficacy and tolerability benefits with the third-generation aromatase inhibitor anastrozole, resulting in an increased use of this agent in the adjuvant setting.  Data on anastrozole's long-term efficacy and tolerability are therefore of interest in clin. practice and will be reviewed here, esp. in the light of the 100-mo anal. of the ATAC (Anastrozole, Tamoxifen Alone or in Combination) trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwHF4VpLSG0bVg90H21EOLACvtfcHk0lhjGwEH5QZ48g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yltL8%253D&md5=97242d458accd9c554107e80c252b946</span></div><a href="/servlet/linkout?suffix=cit114b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangadhara%26aufirst%3DS.%26aulast%3DBertelli%26aufirst%3DG.%26atitle%3DLong-term%2520efficacy%2520and%2520safety%2520of%2520anastrozole%2520for%2520adjuvant%2520treatment%2520of%2520early%2520breast%2520cancer%2520in%2520postmenopausal%2520women%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2009%26volume%3D5%26spage%3D291%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modeling</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">603</span><span class="NLM_x">â</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=603-618&issue=3&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Non-steroidal+aromatase+inhibitors+based+on+a+biphenyl+scaffold%3A+synthesis%2C+in+vitro+SAR%2C+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DNon-steroidal%2520aromatase%2520inhibitors%2520based%2520on%2520a%2520biphenyl%2520scaffold%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520and%2520molecular%2520modeling%26jtitle%3DChemMedChem%26date%3D2008%26issue%3D3%26spage%3D603%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit115b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2940</span><span class="NLM_x">â</span> <span class="NLM_lpage">2952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2940-2952&issue=5&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Dual+aromatase-sulfatase+inhibitors+based+on+the+anastrozole+template%3A+synthesis%2C+in+vitro+SAR%2C+molecular+modelling+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDual%2520aromatase-sulfatase%2520inhibitors%2520based%2520on%2520the%2520anastrozole%2520template%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520molecular%2520modelling%2520and%2520in%2520vivo%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26issue%3D5%26spage%3D2940%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cooper-DeHoff, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handberg, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legler, U. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepine, C. J.</span><span> </span><span class="NLM_article-title">INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study</span> <span class="citation_source-journal">Expert Rev. Cardiovasc. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">â</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1586%2Ferc.09.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19900016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2ksrjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1329-1340&author=R.+M.+Cooper-DeHoffauthor=E.+M.+Handbergauthor=G.+Manciaauthor=Q.+Zhouauthor=A.+Championauthor=U.+F.+Leglerauthor=C.+J.+Pepine&title=INVEST+revisited%3A+review+of+findings+from+the+International+Verapamil+SR-Trandolapril+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116aR"><div class="casContent"><span class="casTitleNuber">116a</span><div class="casTitle"><span class="NLM_cas:atitle">INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study</span></div><div class="casAuthors">Cooper-DeHoff, Rhonda M.; Handberg, Eileen M.; Mancia, Giuseppe; Zhou, Qian; Champion, Annette; Legler, Udo F.; Pepine, Carl J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Cardiovascular Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1340</span>CODEN:
                <span class="NLM_cas:coden">ERCTAS</span>;
        ISSN:<span class="NLM_cas:issn">1477-9072</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The International Verapamil SR-Trandolapril Study (INVEST), a randomized trial of 22,576 predominantly elderly patients with an av. 2.7-yr follow-up, compared a calcium antagonist-led strategy (verapamil SR plus trandolapril) with a Î²-blocker-led strategy (atenolol plus hydrochlorothiazide) for hypertension treatment and prevention of cardiovascular outcomes in coronary artery disease patients.  Patients received individualized dose and drug titrn. following a flexible, multi-drug, guideline-based treatment algorithm, with the objective of achieving optimal blood pressure (BP) control individualized for comorbidities (e.g., diabetes).  The primary outcome (PO) was first occurrence of death (all-cause), nonfatal myocardial infarction or nonfatal stroke.  The strategies resulted in significant and very similar BP redn., with approx. 70% of patients in both strategies achieving BP control (<140/90 mmHg).  Increasing no. of office visits with BP in control was assocd. with reduced risk of the PO.  Overall, there was no difference in the PO comparing the strategies; however, new-onset diabetes occurred more frequently in those assigned the atenolol strategy.  This report summarizes findings from INVEST and puts them in perspective with our current state of knowledge derived from other large hypertension treatment trials.  INVEST findings support that BP redn. is important for prevention of adverse cardiovascular morbidity and mortality, and selection of antihypertensive agents should be based on patient comorbidities and other risk factors (e.g., risk for diabetes) and not necessarily that any one drug be given to all.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7JaZ_1oRZ57Vg90H21EOLACvtfcHk0lhjGwEH5QZ48g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2ksrjM&md5=86cc8f0acf12ec0e77e1df0e7ab5edef</span></div><a href="/servlet/linkout?suffix=cit116a&amp;dbid=16384&amp;doi=10.1586%2Ferc.09.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Ferc.09.102%26sid%3Dliteratum%253Aachs%26aulast%3DCooper-DeHoff%26aufirst%3DR.%2BM.%26aulast%3DHandberg%26aufirst%3DE.%2BM.%26aulast%3DMancia%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DChampion%26aufirst%3DA.%26aulast%3DLegler%26aufirst%3DU.%2BF.%26aulast%3DPepine%26aufirst%3DC.%2BJ.%26atitle%3DINVEST%2520revisited%253A%2520review%2520of%2520findings%2520from%2520the%2520International%2520Verapamil%2520SR-Trandolapril%2520Study%26jtitle%3DExpert%2520Rev.%2520Cardiovasc.%2520Ther.%26date%3D2009%26volume%3D7%26spage%3D1329%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit116b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sica, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisant, L. M.</span><span> </span><span class="NLM_article-title">Pharmacologic and therapeutic considerations in hypertension therapy with calcium channel blockers: focus on verapamil</span> <span class="citation_source-journal">J. Clin. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1524-6175.2007.06504.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVKjtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1-22&author=D.+A.+Sicaauthor=L.+M.+Prisant&title=Pharmacologic+and+therapeutic+considerations+in+hypertension+therapy+with+calcium+channel+blockers%3A+focus+on+verapamil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116bR"><div class="casContent"><span class="casTitleNuber">116b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic and therapeutic considerations in hypertension therapy with calcium channel blockers: focus on verapamil</span></div><div class="casAuthors">Sica, Domenic A.; Prisant, L. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hypertension (Shelton, CT, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2, Suppl. 2</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">JCHYFN</span>;
        ISSN:<span class="NLM_cas:issn">1524-6175</span>.
    
            (<span class="NLM_cas:orgname">Le Jacq Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past 2 decades, calcium channel blockers have emerged as important and useful agents for treating hypertension.  The safety of this drug class has been vigorously debated for some time, and it has only been in the past few years that such debate has been quieted by favorable outcomes data with these compds.  Calcium channel blockers are a heterogeneous group of compds. as alike as they are dissimilar.  Calcium channel blockers can be sepd. into dihydropyridine and nondihydropyridine subclasses, with representatives of the latter being verapamil and diltiazem.  A lengthy treatment experience exists for verapamil, a compd. that has progressed from an immediate-release to a sustained-release and, more recently, a delayed/sustained-release formulation designated for administration at bedtime.  This latter formulation synchronizes drug delivery with the early morning rise in blood pressure, which is a particularly attractive feature when viewed in the context of the distinctive pharmacokinetic and pharmacodynamic features of verapamil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgY1o3sbX-fLVg90H21EOLACvtfcHk0ljhHJyo-S2OGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVKjtLs%253D&md5=26d0e822546b776080ea986a6ab7980b</span></div><a href="/servlet/linkout?suffix=cit116b&amp;dbid=16384&amp;doi=10.1111%2Fj.1524-6175.2007.06504.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1524-6175.2007.06504.x%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DD.%2BA.%26aulast%3DPrisant%26aufirst%3DL.%2BM.%26atitle%3DPharmacologic%2520and%2520therapeutic%2520considerations%2520in%2520hypertension%2520therapy%2520with%2520calcium%2520channel%2520blockers%253A%2520focus%2520on%2520verapamil%26jtitle%3DJ.%2520Clin.%2520Hypertens.%26date%3D2007%26volume%3D9%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Brogden, R. N</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P.</span><span> </span><span class="NLM_article-title">Gallopamil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart disease</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">â</span> <span class="NLM_lpage">115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1994&pages=93-115&author=R.+N+Brogdenauthor=P.+Benfield&title=Gallopamil.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+potential+in+ischaemic+heart+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrogden%26aufirst%3DR.%2BN%26aulast%3DBenfield%26aufirst%3DP.%26atitle%3DGallopamil.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520potential%2520in%2520ischaemic%2520heart%2520disease%26jtitle%3DDrugs%26date%3D1994%26volume%3D47%26spage%3D93%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Mannhold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtje, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koke, V.</span><span> </span><span class="NLM_article-title">Importance of nitrile substitution for the calcium antagonistic action of verapamil</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">â</span> <span class="NLM_lpage">998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fardp.19863191107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2sXht1eguw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1986&pages=990-998&author=R.+Mannholdauthor=H.+D.+Holtjeauthor=V.+Koke&title=Importance+of+nitrile+substitution+for+the+calcium+antagonistic+action+of+verapamil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of nitrile substitution for the calcium antagonistic action of verapamil</span></div><div class="casAuthors">Mannhold, Raimund; Hoeltje, Hans Dieter; Koke, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">990-8</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    </div><div class="casAbstract">The effects of (Â±)-verapamil (I)  [56949-77-0], its congeners, obtained by exchange of the nitrile substituent, and D 846 (II)  [103768-76-9], a structural isomer, on the contractile activity were investigated in isotonically contracting cat papillary muscle.  Results indicate that the nitrile substituent is essential for the neg. inotropic action of verapamil.  Investigations with an ortho disubstituted structural isomer of verapamil showed an unchanged mode of action, while potency is decreased.  These findings can be explained on the basis of differences in the steric and electronic properties of the mols. under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXA0EE76sNXrVg90H21EOLACvtfcHk0ljhHJyo-S2OGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXht1eguw%253D%253D&md5=85324463efafbd3a8db9d8b6251fcbf8</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fardp.19863191107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19863191107%26sid%3Dliteratum%253Aachs%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DHoltje%26aufirst%3DH.%2BD.%26aulast%3DKoke%26aufirst%3DV.%26atitle%3DImportance%2520of%2520nitrile%2520substitution%2520for%2520the%2520calcium%2520antagonistic%2520action%2520of%2520verapamil%26jtitle%3DArch.%2520Pharm.%26date%3D1986%26volume%3D319%26spage%3D990%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Cheng, R. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonov, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhorov, B. S.</span><span> </span><span class="NLM_article-title">Structural model for phenylalkylamine binding to L-type calcium channels</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">28332</span><span class="NLM_x">â</span> <span class="NLM_lpage">28342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=28332-28342&author=R.+C.+K.+Chengauthor=D.+B.+Tikhonovauthor=B.+S.+Zhorov&title=Structural+model+for+phenylalkylamine+binding+to+L-type+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DR.%2BC.%2BK.%26aulast%3DTikhonov%26aufirst%3DD.%2BB.%26aulast%3DZhorov%26aufirst%3DB.%2BS.%26atitle%3DStructural%2520model%2520for%2520phenylalkylamine%2520binding%2520to%2520L-type%2520calcium%2520channels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D28332%26epage%3D28342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citarella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span> </span><span class="NLM_article-title">Novel multidrug resistance reversal agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">â</span> <span class="NLM_lpage">2161</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9804477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2145-2161&author=D.+Bergerauthor=R.+Citarellaauthor=M.+Dutiaauthor=L.+Greenbergerauthor=W.+Hallettauthor=R.+Paulauthor=D.+Powell&title=Novel+multidrug+resistance+reversal+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120a&amp;dbid=16384&amp;doi=10.1021%2Fjm9804477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9804477%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DD.%26aulast%3DCitarella%26aufirst%3DR.%26aulast%3DDutia%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DHallett%26aufirst%3DW.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DD.%26atitle%3DNovel%2520multidrug%2520resistance%2520reversal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2145%26epage%3D2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit120b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Teodori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quidu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier-Suillerot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapecchi, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">â</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980440p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1687-1697&author=E.+Teodoriauthor=S.+Deiauthor=P.+Quiduauthor=R.+Budriesiauthor=A.+Chiariniauthor=A.+Garnier-Suillerotauthor=F.+Gualtieriauthor=D.+Manettiauthor=M.+N.+Romanelliauthor=S.+Scapecchi&title=Design%2C+synthesis%2C+and+in+vitro+activity+of+catamphiphilic+reverters+of+multidrug+resistance%3A+discovery+of+a+selective%2C+highly+efficacious+chemosensitizer+with+potency+in+the+nanomolar+range"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120b&amp;dbid=16384&amp;doi=10.1021%2Fjm980440p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980440p%26sid%3Dliteratum%253Aachs%26aulast%3DTeodori%26aufirst%3DE.%26aulast%3DDei%26aufirst%3DS.%26aulast%3DQuidu%26aufirst%3DP.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DChiarini%26aufirst%3DA.%26aulast%3DGarnier-Suillerot%26aufirst%3DA.%26aulast%3DGualtieri%26aufirst%3DF.%26aulast%3DManetti%26aufirst%3DD.%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DScapecchi%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520activity%2520of%2520catamphiphilic%2520reverters%2520of%2520multidrug%2520resistance%253A%2520discovery%2520of%2520a%2520selective%252C%2520highly%2520efficacious%2520chemosensitizer%2520with%2520potency%2520in%2520the%2520nanomolar%2520range%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1687%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Rennard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knobil, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabe, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locantore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonica, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnhart, F.</span><span> </span><span class="NLM_article-title">The efficacy and safety of cilomilast in COPD</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3-57&author=S.+Rennardauthor=K.+Knobilauthor=K.+F.+Rabeauthor=A.+Morrisauthor=N.+Schachterauthor=N.+Locantoreauthor=W.+G.+Canonicaauthor=Y.+Zhuauthor=F.+Barnhart&title=The+efficacy+and+safety+of+cilomilast+in+COPD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRennard%26aufirst%3DS.%26aulast%3DKnobil%26aufirst%3DK.%26aulast%3DRabe%26aufirst%3DK.%2BF.%26aulast%3DMorris%26aufirst%3DA.%26aulast%3DSchachter%26aufirst%3DN.%26aulast%3DLocantore%26aufirst%3DN.%26aulast%3DCanonica%26aufirst%3DW.%2BG.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DBarnhart%26aufirst%3DF.%26atitle%3DThe%2520efficacy%2520and%2520safety%2520of%2520cilomilast%2520in%2520COPD%26jtitle%3DDrugs%26date%3D2008%26volume%3D68%26spage%3D3%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Christensen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWolf, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnette, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslinski, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochnowicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grous, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillegas, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâLeary Bartus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torphy, T. J.</span><span> </span><span class="NLM_article-title">1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">â</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970090r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=821-835&author=S.+B.+Christensenauthor=A.+Guiderauthor=C.+J.+Forsterauthor=J.+G.+Gleasonauthor=P.+E.+Benderauthor=J.+M.+Karpinskiauthor=W.+E.+DeWolfauthor=M.+S.+Barnetteauthor=D.+C.+Underwoodauthor=D.+E.+Griswoldauthor=L.+B.+Cieslinskiauthor=M.+Burmanauthor=S.+Bochnowiczauthor=R.+R.+Osbornauthor=C.+D.+Manningauthor=M.+Grousauthor=L.+M.+Hillegasauthor=J.+O%E2%80%99Leary+Bartusauthor=M.+D.+Ryanauthor=D.+S.+Egglestonauthor=R.+C.+Haltiwangerauthor=T.+J.+Torphy&title=1%2C4-Cyclohexanecarboxylates%3A+potent+and+selective+inhibitors+of+phosophodiesterase+4+for+the+treatment+of+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm970090r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970090r%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DGuider%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DC.%2BJ.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBender%26aufirst%3DP.%2BE.%26aulast%3DKarpinski%26aufirst%3DJ.%2BM.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DBarnette%26aufirst%3DM.%2BS.%26aulast%3DUnderwood%26aufirst%3DD.%2BC.%26aulast%3DGriswold%26aufirst%3DD.%2BE.%26aulast%3DCieslinski%26aufirst%3DL.%2BB.%26aulast%3DBurman%26aufirst%3DM.%26aulast%3DBochnowicz%26aufirst%3DS.%26aulast%3DOsborn%26aufirst%3DR.%2BR.%26aulast%3DManning%26aufirst%3DC.%2BD.%26aulast%3DGrous%26aufirst%3DM.%26aulast%3DHillegas%26aufirst%3DL.%2BM.%26aulast%3DO%25E2%2580%2599Leary%2BBartus%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DM.%2BD.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DTorphy%26aufirst%3DT.%2BJ.%26atitle%3D1%252C4-Cyclohexanecarboxylates%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosophodiesterase%25204%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D821%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Ochiai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Orally active PDE4 inhibitors with therapeutic potential</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1323</span><span class="NLM_x">â</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1323-1327&author=H.+Ochiaiauthor=T.+Ohtaniauthor=A.+Ishidaauthor=K.+Kishikawaauthor=T.+Obataauthor=H.+Nakaiauthor=M.+Toda&title=Orally+active+PDE4+inhibitors+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOchiai%26aufirst%3DH.%26aulast%3DOhtani%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DA.%26aulast%3DKishikawa%26aufirst%3DK.%26aulast%3DObata%26aufirst%3DT.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DOrally%2520active%2520PDE4%2520inhibitors%2520with%2520therapeutic%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1323%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Kodimuthali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabaris, S. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, M.</span><span> </span><span class="NLM_article-title">Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">â</span> <span class="NLM_lpage">5489</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800582j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5471-5489&author=A.+Kodimuthaliauthor=S.+S.+L.+Jabarisauthor=M.+Pal&title=Recent+advances+on+phosphodiesterase+4+inhibitors+for+the+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm800582j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800582j%26sid%3Dliteratum%253Aachs%26aulast%3DKodimuthali%26aufirst%3DA.%26aulast%3DJabaris%26aufirst%3DS.%2BS.%2BL.%26aulast%3DPal%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520on%2520phosphodiesterase%25204%2520inhibitors%2520for%2520the%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5471%26epage%3D5489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizizad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span> </span><span class="NLM_article-title">Structural basis for the activity of drugs that inhibit phosphodiesterases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2233</span><span class="NLM_x">â</span> <span class="NLM_lpage">2247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.str.2004.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15576036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2233-2247&author=G.+L.+Cardauthor=B.+P.+Englandauthor=Y.+Suzukiauthor=D.+Fongauthor=B.+Powellauthor=B.+Leeauthor=C.+Luuauthor=M.+Tabrizizadauthor=S.+Gilletteauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.-H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+J.+Zhang&title=Structural+basis+for+the+activity+of+drugs+that+inhibit+phosphodiesterases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases</span></div><div class="casAuthors">Card, Graeme L.; England, Bruce P.; Suzuki, Yoshihisa; Fong, Daniel; Powell, Ben; Lee, Byunghun; Luu, Catherine; Tabrizizad, Maryam; Gillette, Sam; Ibrahim, Prabha N.; Artis, Dean R.; Bollag, Gideon; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2233-2247</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases.  The authors describe the high-resoln. crystal structures of the catalytic domains of PDE4B, PDE4D, and PDE5A with ten different inhibitors, including the drug candidates cilomilast and roflumilast, for respiratory diseases.  These cocrystal structures reveal a common scheme of inhibitor binding to the PDEs: (i) a hydrophobic clamp formed by highly conserved hydrophobic residues that sandwich the inhibitor in the active site; (ii) hydrogen bonding to an invariant glutamine that controls the orientation of inhibitor binding.  A scaffold can be readily identified for any given inhibitor based on the formation of these two types of conserved interactions.  These structural insights will enable the design of isoform-selective inhibitors with improved binding affinity and should facilitate the discovery of more potent and selective PDE inhibitors for the treatment of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8l4KWCohSy7Vg90H21EOLACvtfcHk0lgb1cxD61ErTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K&md5=0fa91e4b9047e3df3946c526592be396</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520activity%2520of%2520drugs%2520that%2520inhibit%2520phosphodiesterases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D2233%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Noble, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTavish, D.</span><span> </span><span class="NLM_article-title">Levocabastine: an update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">â</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1032-1049&author=S.+Nobleauthor=D.+McTavish&title=Levocabastine%3A+an+update+of+its+pharmacology%2C+clinical+efficacy+and+tolerability+in+the+topical+treatment+of+allergic+rhinitis+and+conjunctivitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DS.%26aulast%3DMcTavish%26aufirst%3DD.%26atitle%3DLevocabastine%253A%2520an%2520update%2520of%2520its%2520pharmacology%252C%2520clinical%2520efficacy%2520and%2520tolerability%2520in%2520the%2520topical%2520treatment%2520of%2520allergic%2520rhinitis%2520and%2520conjunctivitis%26jtitle%3DDrugs%26date%3D1995%26volume%3D50%26spage%3D1032%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottiger, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M.</span><span> </span><span class="NLM_article-title">New insights in postoperative pain therapy</span> <span class="citation_source-journal">Anasthesiol Intensivmed Notfallmed Schmerzther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">â</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1055%2Fs-2004-814314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15042506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A280%3ADC%252BD2c7kslyktg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=157-164&author=A.+Brackauthor=B.+W.+Bottigerauthor=M.+Schafer&title=New+insights+in+postoperative+pain+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127aR"><div class="casContent"><span class="casTitleNuber">127a</span><div class="casTitle"><span class="NLM_cas:atitle">New insights in postoperative pain therapy</span></div><div class="casAuthors">Brack A; Bottiger B W; Schafer M</div><div class="citationInfo"><span class="NLM_cas:title">Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-64</span>
        ISSN:<span class="NLM_cas:issn">0939-2661</span>.
    </div><div class="casAbstract">In this review, novel clinical studies on postoperative pain therapy are summarized.  Based on these studies, several conclusions can be drawn: i) following tonsillectomy, postoperative therapy with NSAIDs leads to a significant increase in the number of reoperations; thus NSAIDs should be used with caution; ii) COX-2 inhibitors in combination with intravenous opioids improve recovery and functional outcome after knee replacement surgery; iii) the combination therapy of different non-opioid analgesics has no proven clinical efficacy and should not be used routinely; iv) patients' age is not a determinant in postoperative opioid titration after surgery; in contrast, it does predict opioid consumption during the first postoperative day; v) morphine and piritramide have identical analgesic efficacy and induce nausea and vomiting with the incidence; opioid selection can, thus, be based on economic considerations and vi) if tramadol is ineffective in postoperative pain therapy, this might be caused by an allelic variant of one of the cytochrome P450 enzymes (CYP2D6); these patients should be treated with a different opioid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlxfC9Cq1Eu3qj_yg7twvpfW6udTcc2eaP6dJDzVIwTrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7kslyktg%253D%253D&md5=ecb88b77d074e41b99f50301e202e135</span></div><a href="/servlet/linkout?suffix=cit127a&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-814314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-814314%26sid%3Dliteratum%253Aachs%26aulast%3DBrack%26aufirst%3DA.%26aulast%3DBottiger%26aufirst%3DB.%2BW.%26aulast%3DSchafer%26aufirst%3DM.%26atitle%3DNew%2520insights%2520in%2520postoperative%2520pain%2520therapy%26jtitle%3DAnasthesiol%2520Intensivmed%2520Notfallmed%2520Schmerzther%26date%3D2004%26volume%3D39%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit127b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bouillon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kietzmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meineke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeft, A.</span><span> </span><span class="NLM_article-title">Population pharmacokinetics of piritramide in surgical patients</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1999&pages=7-15&author=T.+Bouillonauthor=D.+Kietzmannauthor=R.+Portauthor=I.+Meinekeauthor=A.+Hoeft&title=Population+pharmacokinetics+of+piritramide+in+surgical+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouillon%26aufirst%3DT.%26aulast%3DKietzmann%26aufirst%3DD.%26aulast%3DPort%26aufirst%3DR.%26aulast%3DMeineke%26aufirst%3DI.%26aulast%3DHoeft%26aufirst%3DA.%26atitle%3DPopulation%2520pharmacokinetics%2520of%2520piritramide%2520in%2520surgical%2520patients%26jtitle%3DAnesthesiology%26date%3D1999%26volume%3D90%26spage%3D7%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit127c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Freye, E.</span><span> </span><span class="NLM_article-title">Postoperative pain treatment</span> <span class="citation_source-journal">Anaesthesiol. Reanim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">â</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=1686169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A280%3ADyaK387ltlaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1991&pages=379-392&author=E.+Freye&title=Postoperative+pain+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127cR"><div class="casContent"><span class="casTitleNuber">127c</span><div class="casTitle"><span class="NLM_cas:atitle">Postoperative pain treatment</span></div><div class="casAuthors">Freye E</div><div class="citationInfo"><span class="NLM_cas:title">Anaesthesiologie und Reanimation</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">379-92</span>
        ISSN:<span class="NLM_cas:issn">0323-4983</span>.
    </div><div class="casAbstract">The postoperative care of patients usually is characterized by the fact that the individual need of pain killers is not sufficiently recognized.  An opioid given only when asked for, results in an underdosage as the patient does not receive the analgesic in time, so that he suffers pain.  As there is insufficient knowledge with regard to the pharmacology of opioids which can be used for postoperative pain therapy, physicians and nurses usually tend to give a lower dose in order to avoid any possible side-effects.  Considerations which lead to opioid underdosage include: the development of addiction and possible side-effects such as respiratory depression, heavy sedation, possible constipation and urinary retention.  The aim in postoperative pain therapy is a time-contingent dosing after careful intravenous titration of the compound in the lower dose range during continuous supervision.  Thus, the individual need in the recovery room can be estimated.  Only such a procedure helps to keep the patient pain-free over a long period of time, reduces the workload of nurses during the night, results in the reduction of complications and finally may even reduce the hospital stay.  Piritramide is a compound which has a number of potential advantages with regard to efficacy and side-effects in postoperative pain therapy.  It has the highest analgesic potency among those compounds suitable for postoperative pain therapy; when compared with pethidine, pentazocine or nalbuphine it shows remarkable cardiovascular stability.  In comparison to morphine, pethidine and pentazocine, piritramide has a lower incidence of nausea and vomiting.  With a mean duration of action of up to six hours, piritramide has an advantage over pentazocine (3 hours), pethidine (2-3 hours) and morphine (5-6 hours).  Compared to other mixed narcotic analgesics, piritramide does not induce dysphoric side-effects when given in the higher dose range and does not lead to addiction.  It is derived from the same group of agents such as fentanyl or alfentanil which are used in neuroleptanaesthesia so that there is an increase in analgesia one to the interaction with the same receptor site.  Piritramide has a fast onset of action, 2-5 minutes after intravenous injection and a peak action after 10 minutes.  In comparison to pethidine it has no cardiovascular effects, in particular no myocardial depression or increased myocardial oxygen demand (MVO2).  Last but not least, the cost-effectiveness is a financial factor of increasing importance to the institution that runs the hospital.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_OKFQZ1VQ0Nts4TFFB11gfW6udTcc2eaP6dJDzVIwTrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387ltlaiug%253D%253D&md5=5b9e4f021ec85202864ed757dc1286fd</span></div><a href="/servlet/linkout?suffix=cit127c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFreye%26aufirst%3DE.%26atitle%3DPostoperative%2520pain%2520treatment%26jtitle%3DAnaesthesiol.%2520Reanim.%26date%3D1991%26volume%3D16%26spage%3D379%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Jackson, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. E. H.</span><span> </span><span class="NLM_article-title">The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma</span> <span class="citation_source-journal">J. Pharmacol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">â</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0160-5402%2887%2990069-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3682841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2sXmt1ygtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1987&pages=189-197&author=L.+S.+Jacksonauthor=J.+E.+H.+Stafford&title=The+evaluation+and+application+of+a+radioimmunoassay+for+the+measurement+of+diphenoxylic+acid%2C+the+major+metabolite+of+diphenoxylate+hydrochloride+%28Lomotil%29%2C+in+human+plasma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma</span></div><div class="casAuthors">Jackson, L. S.; Stafford, J. E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Methods</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-97</span>CODEN:
                <span class="NLM_cas:coden">JPMED9</span>;
        ISSN:<span class="NLM_cas:issn">0160-5402</span>.
    </div><div class="casAbstract">Antibodies to diphenoxylic acid (I) the pharmacol. active metabolite of Lomotil, were used to develop a precise and specific radioimmunoassay for the measurement of I in human plasma.  Plasma I levels in human volunteers rose to a mean max. level of 87.8 ng mL-1 3.3 h after dosing with 10 mg Lomotil.  By 24 h, plasma levels had decreased to 14.26 ng mL-1.  The appearance and elimination of plasma I could be described by a biexponential  function.  The appearance half-life was 0.82 h, and the elimination half-life was 7.24 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAq-T4TUzAL7Vg90H21EOLACvtfcHk0lgBhpG5OH3a5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmt1ygtr8%253D&md5=3c14d05f03974a512b6343a12ff74cb2</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2F0160-5402%2887%2990069-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0160-5402%252887%252990069-6%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DL.%2BS.%26aulast%3DStafford%26aufirst%3DJ.%2BE.%2BH.%26atitle%3DThe%2520evaluation%2520and%2520application%2520of%2520a%2520radioimmunoassay%2520for%2520the%2520measurement%2520of%2520diphenoxylic%2520acid%252C%2520the%2520major%2520metabolite%2520of%2520diphenoxylate%2520hydrochloride%2520%2528Lomotil%2529%252C%2520in%2520human%2520plasma%26jtitle%3DJ.%2520Pharmacol.%2520Methods%26date%3D1987%26volume%3D18%26spage%3D189%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Fleming, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span> </span><span class="NLM_article-title">Unsaturated nitriles: conjugate additions of carbon nucleophiles to a recalcitrant class of acceptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2035</span><span class="NLM_x">â</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr020045d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFKhurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=2035-2078&author=F.+F.+Flemingauthor=Q.+Wang&title=Unsaturated+nitriles%3A+conjugate+additions+of+carbon+nucleophiles+to+a+recalcitrant+class+of+acceptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Unsaturated Nitriles: Conjugate Additions of Carbon Nucleophiles to a Recalcitrant Class of Acceptors</span></div><div class="casAuthors">Fleming, Fraser F.; Wang, Qunzhao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2035-2077</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The review surveys conjugate addns. of various carbon nucleophiles to Î±,Î²-unsatd. nitriles not bearing an addnl. electron-withdrawing group.  The reactions of alkenenitriles are grouped according to the nature of a nucleophile and include addns. of Grignard and copper reagents, radical addns. of various organometallics, addn. of stabilized carbanions, addns. of enamines, etc.  Conjugate addns. to alkynenitriles are also reviewed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX3P5jUE6kwbVg90H21EOLACvtfcHk0liD8Dg7vrmXEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFKhurc%253D&md5=006c51a35bc2fcbf90b4cabe0709e1a6</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fcr020045d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020045d%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DUnsaturated%2520nitriles%253A%2520conjugate%2520additions%2520of%2520carbon%2520nucleophiles%2520to%2520a%2520recalcitrant%2520class%2520of%2520acceptors%26jtitle%3DChem.%2520Rev.%26date%3D2003%26volume%3D103%26spage%3D2035%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Seeberger, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, R. A.</span><span> </span><span class="NLM_article-title">Levodopa/carbidopa/entacapone in Parkinsonâs disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">â</span> <span class="NLM_lpage">940</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1586%2Fern.09.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19589043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=929-940&author=L.+C.+Seebergerauthor=R.+A.+Hauser&title=Levodopa%2Fcarbidopa%2Fentacapone+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Levodopa/carbidopa/entacapone in Parkinson's disease</span></div><div class="casAuthors">Seeberger, Lauren C.; Hauser, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">929-940</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is assocd. with the development of motor complications.  Mounting evidence indicates the short half-life of levodopa and resultant pulsatile stimulation of striatal dopamine receptors leads to wearing off, motor fluctuations and dyskinesias.  Longer acting dopaminergic agents, such as dopamine agonists, are less likely to cause motor fluctuations and dyskinesias but are not as efficacious for control of motor symptoms.  Therefore, there is interest in exploring ways to deliver levodopa in a more continuous fashion, in an effort to maintain benefit through the day and reduce the development of motor fluctuations and dyskinesias.  A dopa decarboxylase inhibitor (DDCI), such as carbidopa or benserazide, is administered with levodopa to attenuate its peripheral conversion to dopamine, reduce nausea and increase central bioavailability.  When levodopa is administered with a DDCI, its main route of peripheral metab. is via catechol-O-Me transferase (COMT).  A COMT inhibitor can be added to the combination of levodopa and a DDCI to further extend the levodopa peripheral half-life and increase central bioavailability.  Stalevo is a combination tablet comprised of levodopa, carbidopa, and the COMT inhibitor entacapone.  It is available in fixed-dose combinations of levodopa/carbidopa/entacapone, 50/12.5/200, 75/18.75/200, 100/25/200, 125/31.25/200, 150/37.5/200 and 200/50/200 mg.  Stalevo is currently approved for use in Parkinson's disease patients with end-of-dose wearing off.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGVC48bEG7YrVg90H21EOLACvtfcHk0liD8Dg7vrmXEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtLs%253D&md5=e4fd4790ddf82f86134bde9dc17231ca</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1586%2Fern.09.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.64%26sid%3Dliteratum%253Aachs%26aulast%3DSeeberger%26aufirst%3DL.%2BC.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26atitle%3DLevodopa%252Fcarbidopa%252Fentacapone%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D929%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lees, A. J.</span><span> </span><span class="NLM_article-title">Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinsonâs disease</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1755-5949.2007.00035.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18482101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvValsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=83-93&author=A.+J.+Lees&title=Evidence-based+efficacy+comparison+of+tolcapone+and+entacapone+as+adjunctive+therapy+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131aR"><div class="casContent"><span class="casTitleNuber">131a</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinson's disease</span></div><div class="casAuthors">Lees, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The relative efficacy has not been adequately established for the two catechol-O-methyltransferase (COMT) inhibitors that are currently available for adjunctive therapy in Parkinson's disease; tolcapone and entacapone.  A recent Cochrane meta-anal. of 14 studies in 2566 patients, conducted to assess the efficacy and safety of tolcapone and entacapone, found both to be statistically superior to placebo in increasing ON time and decreasing OFF time.  The meta-anal. also showed that the weighted mean difference from baseline to endpoint in tolcapone-treated patients was twice that in entacapone-treated patients for both placebo-cor. ON time and OFF time.  Withdrawal rates were generally lower for tolcapone.  Two addnl. studies have examd. the switch between tolcapone and entacapone.  In 40 Parkinson's disease patients with fluctuations who were switched from tolcapone to entacapone, improvements in ON time and redns. in OFF time were approx. twice the magnitude for tolcapone than for entacapone.  In a second study examg. the switch from entacapone to tolcapone, the results for several exploratory variables also suggested that tolcapone has greater efficacy than entacapone.  These findings indicate that tolcapone should be considered in all patients with entacapone-refractory motor fluctuations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXBklO3rk1LrVg90H21EOLACvtfcHk0liD8Dg7vrmXEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvValsr4%253D&md5=05ad47a9c34a362e745e9b04bbe763de</span></div><a href="/servlet/linkout?suffix=cit131a&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2007.00035.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2007.00035.x%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%2BJ.%26atitle%3DEvidence-based%2520efficacy%2520comparison%2520of%2520tolcapone%2520and%2520entacapone%2520as%2520adjunctive%2520therapy%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2008%26volume%3D14%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit131b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Clinical pharmacology and therapeutic use of COMT inhibition in Parkinsonâs disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">IV/37</span><span class="NLM_x">â</span> <span class="NLM_lpage">IV/48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=IV%2F37-IV%2F48&author=A.+Gordinauthor=D.+J.+Brooks&title=Clinical+pharmacology+and+therapeutic+use+of+COMT+inhibition+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520pharmacology%2520and%2520therapeutic%2520use%2520of%2520COMT%2520inhibition%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3DIV%252F37%26epage%3DIV%252F48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tervoa, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NyrÃ¶nenb, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¶nkkÃ¶a, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posoa, A.</span><span> </span><span class="NLM_article-title">A structureâactivity relationship study of catechol-<i>O</i>-methyltransferase inhibitors combining molecular docking and 3D QSAR methods</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=797-810&author=A.+J.+Tervoaauthor=T.+H.+Nyr%C3%B6nenbauthor=T.+R%C3%B6nkk%C3%B6aauthor=A.+Posoa&title=A+structure%E2%88%92activity+relationship+study+of+catechol-O-methyltransferase+inhibitors+combining+molecular+docking+and+3D+QSAR+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTervoa%26aufirst%3DA.%2BJ.%26aulast%3DNyr%25C3%25B6nenb%26aufirst%3DT.%2BH.%26aulast%3DR%25C3%25B6nkk%25C3%25B6a%26aufirst%3DT.%26aulast%3DPosoa%26aufirst%3DA.%26atitle%3DA%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520of%2520catechol-O-methyltransferase%2520inhibitors%2520combining%2520molecular%2520docking%2520and%25203D%2520QSAR%2520methods%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2003%26volume%3D17%26spage%3D797%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For cocrystalization of COMT with a related inhibitor see the following:</p></div><div class="NLM_citation" id="cit132b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span> </span><span class="NLM_article-title">Crystallization and preliminary crystallographic characterization of catechol-<i>O</i>-methyltransferase in complex with its cosubstrate and an inhibitor</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">D57</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">â</span> <span class="NLM_lpage">908</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D57&publication_year=2001&pages=906-908&author=M.+L.+Rodriguesauthor=M.+Archerauthor=M.+J.+Bonifacioauthor=P.+Soares-da-Silvaauthor=M.+A.+Carrondo&title=Crystallization+and+preliminary+crystallographic+characterization+of+catechol-O-methyltransferase+in+complex+with+its+cosubstrate+and+an+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26atitle%3DCrystallization%2520and%2520preliminary%2520crystallographic%2520characterization%2520of%2520catechol-O-methyltransferase%2520in%2520complex%2520with%2520its%2520cosubstrate%2520and%2520an%2520inhibitor%26jtitle%3DActa%2520Crystallogr.%26date%3D2001%26volume%3DD57%26spage%3D906%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit132c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matias, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Kinetics and crystal structure of catechol-<i>O</i>-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">â</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=795-805&author=M.+J.+Bonifacioauthor=M.+Archerauthor=M.+L.+Rodriguesauthor=P.+M.+Matiasauthor=D.+A.+Learmonthauthor=M.+A.+Carrondoauthor=P.+Soares-da-Silva&title=Kinetics+and+crystal+structure+of+catechol-O-methyltransferase+complex+with+co-substrate+and+a+novel+inhibitor+with+potential+therapeutic+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DMatias%26aufirst%3DP.%2BM.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DKinetics%2520and%2520crystal%2520structure%2520of%2520catechol-O-methyltransferase%2520complex%2520with%2520co-substrate%2520and%2520a%2520novel%2520inhibitor%2520with%2520potential%2520therapeutic%2520application%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D795%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Reine, N. J.</span><span> </span><span class="NLM_article-title">Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane</span> <span class="citation_source-journal">Clin. Tech. Small Anim. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1053%2Fj.ctsap.2007.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17542193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A280%3ADC%252BD2szjtFaktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=18-25&author=N.+J.+Reine&title=Medical+management+of+pituitary-dependent+hyperadrenocorticism%3A+mitotane+versus+trilostane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane</span></div><div class="casAuthors">Reine Nyssa J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical techniques in small animal practice</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-25</span>
        ISSN:<span class="NLM_cas:issn">1096-2867</span>.
    </div><div class="casAbstract">Pituitary-dependent hyperadrenocorticism is a common endocrine disorder in dogs in the United States.  Once a diagnosis is established, a decision must be made whether or not to pursue treatment, and if so, which medication to use.  Historically, mitotane (Lysodren, o,p'-DDD, Bristol-Myers Squibb, New York) has been the most commonly used treatment for medical management.  Its use is complicated and comes with many potential side effects, making many practitioners wary of its use.  Recently, trilostane has been proven to be an effective treatment of pituitary-dependent hyperadrenocorticism and is approved for use in other countries.  Treatment with trilostane is somewhat simpler and the incidence of side effects seems to be less when compared with mitotane therapy.  Either treatment can be a safe and effective method of treatment for pituitary-dependent hyperadrenocorticism when the practitioner and client are well educated regarding their use and an appropriate monitoring protocol is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh_BgfmzyKLmLFM_lbR1VmfW6udTcc2ebcOJmwUGHmGbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szjtFaktw%253D%253D&md5=f608420380f602f42400351d8d76d3ad</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1053%2Fj.ctsap.2007.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ctsap.2007.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DReine%26aufirst%3DN.%2BJ.%26atitle%3DMedical%2520management%2520of%2520pituitary-dependent%2520hyperadrenocorticism%253A%2520mitotane%2520versus%2520trilostane%26jtitle%3DClin.%2520Tech.%2520Small%2520Anim.%2520Pract.%26date%3D2007%26volume%3D22%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Puddefoot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malouitre, S. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, G. P.</span><span> </span><span class="NLM_article-title">Non-competitive steroid inhibition of oestrogen receptor functions</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fijc.10547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12209583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2002&pages=17-22&author=J.+R.+Puddefootauthor=S.+Barkerauthor=H.+R.+Gloverauthor=S.+D.+M.+Malouitreauthor=G.+P.+Vinson&title=Non-competitive+steroid+inhibition+of+oestrogen+receptor+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Non-competitive steroid inhibition of oestrogen receptor functions</span></div><div class="casAuthors">Puddefoot, John R.; Barker, Stewart; Glover, Hilary R.; Malouitre, Sylvanie D. M.; Vinson, Gavin P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-22</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Currently available antiestrogens, such as tamoxifen, are competitive inhibitors that bind to the ligand binding sites of estrogen receptors, ERÎ± and ERÎ².  The search for alternative anti-hormone therapies is prompted by the need for drugs that are effective when tumors become tamoxifen resistant.  The existence of different receptor isoforms also raise the possibility of improving selectivity.  Earlier use of the 3Î²-hydroxysteroid dehydrogenase inhibitor, trilostane (4Î±,5-epoxy-17Î²-hydroxy-3-oxo-5Î±-androstane-2Î±-carbonitrile), suggested that it had beneficial actions in breast cancer that were only partially attributable to inhibition of steroidogenesis.  The present studies on the interactions of trilostane with estrogen receptors show that it (i) inhibits estrogen-stimulated proliferation in MCF-7 breast cancer cells, (ii) enhances the affinity of estradiol binding to ER in rat uteri and specifically increases estradiol binding to an ERÎ²-like isoform, (iii) inhibits ERÎ± and ERÎ² binding to the classical vitellogenin gene estrogen response element (ERE) and (iv) inhibits estrogen-stimulated gene transcription in ERE-linked reporter systems in MCF-7 cells.  The results demonstrate a novel, presumably allosteric, mode of antiestrogen action.  The beneficial actions of trilostane in breast cancer may be attributed to the combination of this antiestrogen effect with its well documented suppression of steroidogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXRx5v_vaMbVg90H21EOLACvtfcHk0lg_tBnxWyxTjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVejtr8%253D&md5=a61f89821270b45f2b00be9bcae6c9d9</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1002%2Fijc.10547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10547%26sid%3Dliteratum%253Aachs%26aulast%3DPuddefoot%26aufirst%3DJ.%2BR.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DGlover%26aufirst%3DH.%2BR.%26aulast%3DMalouitre%26aufirst%3DS.%2BD.%2BM.%26aulast%3DVinson%26aufirst%3DG.%2BP.%26atitle%3DNon-competitive%2520steroid%2520inhibition%2520of%2520oestrogen%2520receptor%2520functions%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2002%26volume%3D101%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Huq, F.</span><span> </span><span class="NLM_article-title">Molecular modelling analysis of the metabolism of trilostane</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">â</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=353-358&author=F.+Huq&title=Molecular+modelling+analysis+of+the+metabolism+of+trilostane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuq%26aufirst%3DF.%26atitle%3DMolecular%2520modelling%2520analysis%2520of%2520the%2520metabolism%2520of%2520trilostane%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2007%26volume%3D2%26spage%3D353%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Thomas, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshkelani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrell, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucholtz, K. M.</span><span> </span><span class="NLM_article-title">Structure/function of the inhibition of human 3Î²-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.jsbmb.2008.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVCitbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=66-73&author=J.+L.+Thomasauthor=V.+L.+Mackauthor=J.+A.+Glowauthor=D.+Moshkelaniauthor=J.+R.+Terrellauthor=K.+M.+Bucholtz&title=Structure%2Ffunction+of+the+inhibition+of+human+3%CE%B2-hydroxysteroid+dehydrogenase+type+1+and+type+2+by+trilostane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Structure/function of the inhibition of human 3Î²-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane</span></div><div class="casAuthors">Thomas, James L.; Mack, Vance L.; Glow, Jason A.; Moshkelani, Delaram; Terrell, J. Ross; Bucholtz, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">66-73</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The human type 1 (placenta, breast tumors) and type 2 (gonads, adrenals) isoforms of 3Î²-hydroxysteroid dehydrogenase/isomerase (3Î²-HSD) are key enzymes in biosynthesis of all active steroid hormones.  Human 3Î²-HSD1 is a crit. enzyme in the conversion of DHEA to estradiol in breast tumors and may be a major target enzyme for the treatment of breast cancer.  3Î²-HSD2 participates in the prodn. of cortisol and aldosterone in the human adrenal gland.  The goals of this project are to evaluate the role of the 2Î±-cyano group on trilostane (2Î±-cyano-4Î±,5Î±-epoxy-17Î²-ol-androstane-3-one) and det. which amino acids may be crit. for 3Î²-HSD1 specificity.  Trilostane without the 2Î±-cyano group, 4Î±,5Î±-epoxy-testosterone, was synthesized.  Using our structural model of 3Î²-HSD1, trilostane or 4Î±,5Î±-epoxy-testosterone was docked in the active site using Autodock 3.0, and the potentially crit. residues (Met187 and Ser124) were identified.  The M187T and S124T mutants of 3Î²-HSD1 were created, expressed and purified.  Dixon analyses of the inhibition of wild-type 3Î²-HSD1, 3Î²-HSD2, M187T and S124T by trilostane and 4Î±,5Î±-epoxy-testosterone suggest that the 2Î±-cyano group of trilostane is anchored by Ser124 in both isoenzymes.  Kinetic analyses of cofactor and substrate utilization as well as the inhibition kinetics of M187T and the wild-type enzymes suggest that the 16-fold higher-affinity inhibition of 3Î²-HSD1 by trilostane may be related to the presence of Met187 in 3Î²-HSD1 and Thr187 in 3Î²-HSD2.  This structure/function information may lead to the prodn. of more highly specific inhibitors of 3Î²-HSD1 to block the hormone-dependent growth of breast tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSbMzVATeG4LVg90H21EOLACvtfcHk0lieRsojS6tKIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVCitbw%253D&md5=bf741e014162365900e0bc0887987a5a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2008.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2008.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BL.%26aulast%3DMack%26aufirst%3DV.%2BL.%26aulast%3DGlow%26aufirst%3DJ.%2BA.%26aulast%3DMoshkelani%26aufirst%3DD.%26aulast%3DTerrell%26aufirst%3DJ.%2BR.%26aulast%3DBucholtz%26aufirst%3DK.%2BM.%26atitle%3DStructure%252Ffunction%2520of%2520the%2520inhibition%2520of%2520human%25203%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520and%2520type%25202%2520by%2520trilostane%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D2008%26volume%3D111%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Niwano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, A.</span><span> </span><span class="NLM_article-title">Lanoconazole and its related optically active compound NND-502: novel antifungal imidazoles with a ketene dithioacetal structure</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Infect. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">â</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F1568012033483097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVektLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=147-160&author=Y.+Niwanoauthor=T.+Ohmiauthor=A.+Seoauthor=H.+Kodamaauthor=H.+Kogaauthor=A.+Sakai&title=Lanoconazole+and+its+related+optically+active+compound+NND-502%3A+novel+antifungal+imidazoles+with+a+ketene+dithioacetal+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Lanoconazole and its related optically active compound NND-502: Novel antifungal imidazoles with a ketene dithioacetal structure</span></div><div class="casAuthors">Niwano, Yoshimi; Ohmi, Tetsuto; Seo, Akira; Kodama, Hiroki; Koga, Hiroyasu; Sakai, Atsusi</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Infective Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-160</span>CODEN:
                <span class="NLM_cas:coden">CMCAFL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0126</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Imidazole antifungal agents have been successfully developed in medicine mainly for the treatment of superficial skin fungal infections.  Through the screening for novel imidazole compds., it was found that remarkable augmentation of in vitro antifungal activity is brought by the introduction of imidazole moiety to a unique structure ketene dithioacetal, and among these imidazole compds. (Â±)-(E)-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolyl-acetonitrile (generic name: lanoconazole, CAS 101530-10-3) is now available as a topical drug used for the treatment of superficial skin fungal infections in Japan.  Lanoconazole exerted 30-700 times more potent activity as measured by MICs (min. inhibitory concns.) against dermatophytes than did other antifungal imidazole compds., bifonazole and clotrimazole.  In therapeutic expts. using guinea pig models of infections, lanoconazole also exhibited excellent curative effect on two tinea models (tinea pedis and tinea corporis) and a cutaneous candidiasis model as compared to other ref. agent, bifonazole, clotrimazole and/or tolnaftate, a thiocarbamate class of compd., in term of eradicating fungi from the infected loci.  Since lanoconazole is a racemic compd. and only the R-enantiomer was found to be active, extensive screening for optically active-related compd. was further conducted.  As a result, an optically active compd. NND-502 was found to have more potent antifungal activity than lanoconazole and terbinafine, an allylamine class of antifungal agent.  In an in vivo study with a guinea pig model of tinea pedis, short-term treatment regimen of topical NND-502 achieved a complete mycol. cure, while that of topical lanoconazole and terbinafine did not.  Furthermore, the potentiality of the compd. for the oral and i.v. treatment of aspergillosis, one of the major deep-seated fungal infections, has been found out as well as for the topical treatment of dermatophytosis.  The oral regimen of NND-502 in a murine model of systemic aspergillosis was apparently superior to that of itraconazole, a triazole compd., in terms of prolonging survival.  I.v. NND-502 also proved highly effective in a rat model of pulmonary aspergillosis compared with i.v. amphotericin B in terms of not only prolonging survival but also eradication of fungi from the lung.  These encouraging results suggest that the related compds. of lanoconazole could bring considerable progress in the antifungal chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozibWyXs9KOrVg90H21EOLACvtfcHk0lieRsojS6tKIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVektLY%253D&md5=ed81a414fc3f7a9904f3f252c1a7be60</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.2174%2F1568012033483097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568012033483097%26sid%3Dliteratum%253Aachs%26aulast%3DNiwano%26aufirst%3DY.%26aulast%3DOhmi%26aufirst%3DT.%26aulast%3DSeo%26aufirst%3DA.%26aulast%3DKodama%26aufirst%3DH.%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DA.%26atitle%3DLanoconazole%2520and%2520its%2520related%2520optically%2520active%2520compound%2520NND-502%253A%2520novel%2520antifungal%2520imidazoles%2520with%2520a%2520ketene%2520dithioacetal%2520structure%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Infect.%2520Agents%26date%3D2003%26volume%3D2%26spage%3D147%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, R.</span><span> </span><span class="NLM_article-title">In vitro antifungal activities of luliconazole, a new topical imidazole</span> <span class="citation_source-journal">Med. Mycol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">â</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1080%2F13693780802541518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19115136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ansr7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=640-647&author=H.+Kogaauthor=Y.+Nanjohauthor=K.+Makimuraauthor=R.+Tsuboi&title=In+vitro+antifungal+activities+of+luliconazole%2C+a+new+topical+imidazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antifungal activities of luliconazole, a new topical imidazole</span></div><div class="casAuthors">Koga, Hiroyasu; Nanjoh, Yasuko; Makimura, Koichi; Tsuboi, Ryoji</div><div class="citationInfo"><span class="NLM_cas:title">Medical Mycology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">640-647</span>CODEN:
                <span class="NLM_cas:coden">MEMYFR</span>;
        ISSN:<span class="NLM_cas:issn">1369-3786</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Luliconazole is a topical antifungal drug newly developed in Japan.  The present study compares the in vitro antifungal activity of luliconazole against clin. important dermatomycotic fungi with that of other representative antifungal drugs.  The ref. drugs chosen were five classes of nine topical agents, i.e., allylamine (terbinafine), thiocarbamate (liranaftate), benzylamine (butenafine), morpholine (amorolfine), and azole (ketoconazole, clotrimazole, neticonazole, miconazole and bifonazole).  The min. inhibitory concns. (MIC) of luliconazole and the ref. drugs against Trichophyton spp. (T. rubrum, T. mentagrophytes and T. tonsurans) and Candida albicans were measured by the standardized broth microdilution method.  Luliconazole demonstrated greater potency against Trichophyton spp. (MIC range: â¤0.00012-0.002 Î¼g/mL) than the ref. drugs, with T. rubrum being the most susceptible to it.  Luliconazole was also highly active against Candida albicans (MIC range: 0.031-0.13 Î¼g/mL), proving to be more potent than terbinafine, liranaftate, butenafine, amorolfine, and bifonazole, but less than ketoconazole, clotrimazole, neticonazole, and miconazole.  Further, the MIC of luliconazole against Malassezia restricta, an important pathogenic agent involved in seborrhoeic dermatitis, was very low (MIC range: 0.004-0.016 Î¼g/mL) suggesting action comparable to or stronger than that of ketoconazole.  These results indicate a possible clin. role for luliconazole with its broad-spectrum antimycotic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHAEAWw-uEs7Vg90H21EOLACvtfcHk0lieRsojS6tKIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ansr7O&md5=29eb4f67c521a1c7b1790e91438b274b</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1080%2F13693780802541518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13693780802541518%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DNanjoh%26aufirst%3DY.%26aulast%3DMakimura%26aufirst%3DK.%26aulast%3DTsuboi%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520antifungal%2520activities%2520of%2520luliconazole%252C%2520a%2520new%2520topical%2520imidazole%26jtitle%3DMed.%2520Mycol.%26date%3D2009%26volume%3D47%26spage%3D640%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Niwano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span> </span><span class="NLM_article-title">Inhibition of sterol 14Î±-demethylation of <i>Candida albicans</i> with NND-502, a novel optically active imidazole antimycotic agent</span> <span class="citation_source-journal">Med. Mycol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1046%2Fj.1365-280X.1999.00243.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=10520160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFaks7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1999&pages=351-355&author=Y.+Niwanoauthor=H.+Kogaauthor=H.+Kodamaauthor=K.+Kanaiauthor=T.+Miyazakiauthor=H.+Yamaguchi&title=Inhibition+of+sterol+14%CE%B1-demethylation+of+Candida+albicans+with+NND-502%2C+a+novel+optically+active+imidazole+antimycotic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of sterol 14Î±-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent</span></div><div class="casAuthors">Niwano, Y.; Koga, H.; Kodama, H.; Kanai, K.; Miyazaki, T.; Yamaguchi, H.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Mycology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">351-355</span>CODEN:
                <span class="NLM_cas:coden">MEMYFR</span>;
        ISSN:<span class="NLM_cas:issn">1369-3786</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To investigate the mode of action of the newly synthesized optically active imidazole compd., NND-502 [(-)-(E)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazoly lacetonitrile], its effect on ergosterol biosynthesis in cell-free exts. of Candida albicans was examd. and compared with that of the (S)-enantiomer of NND-502 in addn. to lanoconazole and bifonazole, both of which are clin. used for the treatment of dermatomycoses.  NND-502 was found to interfere with ergosterol biosynthesis by inhibition of sterol 14Î±-demethylase, while no interference due to the (S)-enantiomer of NND-502 was found, indicating that the stereochem. orientation of the 2,4-dichlorophenyl group plays an important role in the interaction with the enzyme.  In terms of drug concn. exerting 50% inhibition of ergosterol biosynthesis, NND-502 was 2.5 and 28 times more effective than that of lanoconazole and bifonazole, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2GWTYGpgwGbVg90H21EOLACvtfcHk0lieRsojS6tKIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFaks7o%253D&md5=65ed217203262ba026fc93c6ba3e0d3d</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-280X.1999.00243.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-280X.1999.00243.x%26sid%3Dliteratum%253Aachs%26aulast%3DNiwano%26aufirst%3DY.%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DH.%26aulast%3DKanai%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520sterol%252014%25CE%25B1-demethylation%2520of%2520Candida%2520albicans%2520with%2520NND-502%252C%2520a%2520novel%2520optically%2520active%2520imidazole%2520antimycotic%2520agent%26jtitle%3DMed.%2520Mycol.%26date%3D1999%26volume%3D37%26spage%3D351%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Huq, F.</span><span> </span><span class="NLM_article-title">A molecular modelling analysis of luliconazole, lanconazole, and bifonazole</span> <span class="citation_source-journal">J. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">â</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.3923%2Fjpt.2007.567.573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2rsb7P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=567-573&author=F.+Huq&title=A+molecular+modelling+analysis+of+luliconazole%2C+lanconazole%2C+and+bifonazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular modelling analysis of luliconazole, lanconazole, and bifonazole</span></div><div class="casAuthors">Huq, Fazlul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-573</span>CODEN:
                <span class="NLM_cas:coden">JPTOB4</span>;
        ISSN:<span class="NLM_cas:issn">1816-496X</span>.
    
            (<span class="NLM_cas:orgname">Academic Journals</span>)
        </div><div class="casAbstract">In this study, mol. modeling analyses based on mol. mechanics, semi-empirical (PM3) and DFT (at B3LYP/6-31G* level) calcns. have been carried out to obtain insight into their toxicity.  The results of the analyses show that LLZ, LCZ and BFZ have LUMO-HOMO energy differences ranging from 4.5 to 4.9 eV, indicating that the compds. would be moderately inert with BFZ being the most inert one.  The mol. surfaces of all the compds. are found to possess significant amts. of pos. charged electron-deficient regions so that they may be subject to nucleophilic attacks by glutathione and nucleobases in DNA, thus causing cellular toxicity due to glutathione depletion and DNA damage due to oxidn. of nucleobases.  However, because of kinetic inertness of the mols., the rates of such adverse reactions are expected to be low.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplTGutIeREA7Vg90H21EOLACvtfcHk0lgxBAuFSv4bFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2rsb7P&md5=87a4d87e1c2feea31b236d3a42446dd8</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.3923%2Fjpt.2007.567.573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3923%252Fjpt.2007.567.573%26sid%3Dliteratum%253Aachs%26aulast%3DHuq%26aufirst%3DF.%26atitle%3DA%2520molecular%2520modelling%2520analysis%2520of%2520luliconazole%252C%2520lanconazole%252C%2520and%2520bifonazole%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D2%26spage%3D567%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ogasawara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span> </span><span class="NLM_article-title">Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">â</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1097%2F00006231-200301000-00017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12501022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpsl2nt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=71-76&author=K.+Ogasawaraauthor=A.+Nodaauthor=S.+Yasudaauthor=M.+Kobayashiauthor=H.+Yukawaauthor=A.+Ogawa&title=Effect+of+calcium+antagonist+on+cerebral+blood+flow+and+oxygen+metabolism+in+patients+with+hypertension+and+chronic+major+cerebral+artery+occlusion%3A+a+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141aR"><div class="casContent"><span class="casTitleNuber">141a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study</span></div><div class="casAuthors">Ogasawara, K.; Noda, A.; Yasuda, S.; Kobayashi, M.; Yukawa, H.; Ogawa, A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-76</span>CODEN:
                <span class="NLM_cas:coden">NMCODC</span>;
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the effect of a calcium antagonist, nilvadipine, on cerebral blood flow and oxygen metab., we prospectively examd. five ischemic stroke patients, with both hypertension and chronic major cerebral artery occlusion, using positron emission tomog.  The blood pressure showed a significant decrease after 3 mo of nilvadipine treatment, the cerebral blood flow in the affected regions showed a significant increase and the oxygen extn. fraction showed a significant decrease.  We conclude that nilvadipine is a safe and effective antihypertensive agent for patients with both hypertension and chronic major cerebral artery occlusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonAgEH1woZb7Vg90H21EOLACvtfcHk0lgxBAuFSv4bFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpsl2nt7Y%253D&md5=c4ad86ad121f90d7afff6882749249ef</span></div><a href="/servlet/linkout?suffix=cit141a&amp;dbid=16384&amp;doi=10.1097%2F00006231-200301000-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00006231-200301000-00017%26sid%3Dliteratum%253Aachs%26aulast%3DOgasawara%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DYukawa%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DA.%26atitle%3DEffect%2520of%2520calcium%2520antagonist%2520on%2520cerebral%2520blood%2520flow%2520and%2520oxygen%2520metabolism%2520in%2520patients%2520with%2520hypertension%2520and%2520chronic%2520major%2520cerebral%2520artery%2520occlusion%253A%2520a%2520positron%2520emission%2520tomography%2520study%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2003%26volume%3D24%26spage%3D71%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit141b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rosenthal, J.</span><span> </span><span class="NLM_article-title">Nilvadipine: profile of a new calcium antagonist. An overview</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">S92</span><span class="NLM_x">â</span> <span class="NLM_lpage">S107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=S92-S107&author=J.+Rosenthal&title=Nilvadipine%3A+profile+of+a+new+calcium+antagonist.+An+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DJ.%26atitle%3DNilvadipine%253A%2520profile%2520of%2520a%2520new%2520calcium%2520antagonist.%2520An%2520overview%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1994%26volume%3D24%26spage%3DS92%26epage%3DS107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimitsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatip-Al-Khatib, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, M.</span><span> </span><span class="NLM_article-title">Nilvadipine prevents the impairment of spatial memory induced by cerebral ischemia combined with Î²-amyloid in rats</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">â</span> <span class="NLM_lpage">701</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1248%2Fbpb.30.698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17409505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1aktLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=698-701&author=K.+Iwasakiauthor=N.+Egashiraauthor=Y.+Takagakiauthor=Y.+Yoshimitsuauthor=I.+Hatip-Al-Khatibauthor=K.+Mishimaauthor=M.+Fujiwara&title=Nilvadipine+prevents+the+impairment+of+spatial+memory+induced+by+cerebral+ischemia+combined+with+%CE%B2-amyloid+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142aR"><div class="casContent"><span class="casTitleNuber">142a</span><div class="casTitle"><span class="NLM_cas:atitle">Nilvadipine prevents the impairment of spatial memory induced by cerebral ischemia combined with Î²-amyloid in rats</span></div><div class="casAuthors">Iwasaki, Katsunori; Egashira, Nobuaki; Takagaki, Yuki; Yoshimitsu, Yoshitaka; Hatip-Al-Khatib, Izzettin; Mishima, Kenichi; Fujiwara, Michihiro</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">698-701</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">In the present study, we examd. the effects of nilvadipine and amlodipine, both dihydropyridine-deriv. calcium antagonists, on the impairment of spatial memory induced by a combination of ischemia and Î²-amyloid (AÎ²).  Nilvadipine (3.2 mg/kg, i.p.) significantly prevented the impairment of spatial memory and neuronal apoptosis in this model.  By contrast, amlodipine had no effect on this impairment of spatial memory.  These findings suggest that nilvadipine may prevent impairment of spatial memory by inhibiting neuronal apoptosis; this drug might therefore be useful for the prevention of the progression to dementia in Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTi-aa9p9SabVg90H21EOLACvtfcHk0lgxBAuFSv4bFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1aktLk%253D&md5=cd01d76ba9717a2644a7065a186af10c</span></div><a href="/servlet/linkout?suffix=cit142a&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.698%26sid%3Dliteratum%253Aachs%26aulast%3DIwasaki%26aufirst%3DK.%26aulast%3DEgashira%26aufirst%3DN.%26aulast%3DTakagaki%26aufirst%3DY.%26aulast%3DYoshimitsu%26aufirst%3DY.%26aulast%3DHatip-Al-Khatib%26aufirst%3DI.%26aulast%3DMishima%26aufirst%3DK.%26aulast%3DFujiwara%26aufirst%3DM.%26atitle%3DNilvadipine%2520prevents%2520the%2520impairment%2520of%2520spatial%2520memory%2520induced%2520by%2520cerebral%2520ischemia%2520combined%2520with%2520%25CE%25B2-amyloid%2520in%2520rats%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D698%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit142b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Paris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescentini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span> </span><span class="NLM_article-title">Nilvadipine antagonizes both AÎ² vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">999</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">â</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.brainres.2003.11.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=14746921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntVymsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=999&publication_year=2004&pages=53-61&author=D.+Parisauthor=A.+Quadrosauthor=J.+Humphreyauthor=N.+Patelauthor=R.+Crescentiniauthor=F.+Crawfordauthor=M.+Mullan&title=Nilvadipine+antagonizes+both+A%CE%B2+vasoactivity+in+isolated+arteries%2C+and+the+reduced+cerebral+blood+flow+in+APPsw+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142bR"><div class="casContent"><span class="casTitleNuber">142b</span><div class="casTitle"><span class="NLM_cas:atitle">Nilvadipine antagonizes both AÎ² vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice</span></div><div class="casAuthors">Paris, Daniel; Quadros, Amita; Humphrey, James; Patel, Nikunj; Crescentini, Robert; Crawford, Fiona; Mullan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">999</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The development of Alzheimer's disease (AD) is generally thought to correlate with cerebral accumulation of AÎ².  It has previously been shown that AÎ² peptides enhance vasoconstriction in isolated arteries and oppose certain vasorelaxants.  Moreover, exogenous application of AÎ² peptides causes cerebral vasoconstriction in rodents and in transgenic mouse models of AD that overexpress AÎ² there is reduced cerebral blood flow.  In the present study, we investigated the effect of nilvadipine, a dihydropyridine-type calcium channel blocker, on AÎ² induced vasoconstriction in isolated arteries and in vivo on cerebral blood flow (CBF) of an AD transgenic mouse model overexpressing AÎ² (Tg APPsw line 2576).  Nilvadipine completely inhibited the vasoactivity elicited by AÎ² in rat aortae and in human middle cerebral arteries.  The effect of a short treatment duration (2 wk) with nilvadipine on regional CBF was investigated in 13-mo-old Tg APPsw mice and control littermates using a laser Doppler imager.  Addnl., CBF was also measured in 20-mo-old Tg APPsw mice and control littermates that were chronically treated with nilvadipine for 7 mo.  Untreated Tg APPsw mice showed a redn. of regional CBF compared to their untreated control littermates.  Nilvadipine restored cortical perfusion levels in Tg APPsw to values similar to those obsd. in control littermates without notably affecting the CBF of control mice.  All together, these data suggest that nilvadipine might be useful for the treatment of oligemia assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPAsFU2LFYELVg90H21EOLACvtfcHk0ljn7mqMTNjJ2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntVymsw%253D%253D&md5=840da6848325db1a2d622193c46480c9</span></div><a href="/servlet/linkout?suffix=cit142b&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2003.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2003.11.061%26sid%3Dliteratum%253Aachs%26aulast%3DParis%26aufirst%3DD.%26aulast%3DQuadros%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DCrescentini%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DMullan%26aufirst%3DM.%26atitle%3DNilvadipine%2520antagonizes%2520both%2520A%25CE%25B2%2520vasoactivity%2520in%2520isolated%2520arteries%252C%2520and%2520the%2520reduced%2520cerebral%2520blood%2520flow%2520in%2520APPsw%2520transgenic%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2004%26volume%3D999%26spage%3D53%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Zhang, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymon, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narla, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirling, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payvandi, F.</span><span> </span><span class="NLM_article-title">The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-Î± production with antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">â</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=951-959&author=L.-H.+Zhangauthor=L.+Wuauthor=H.+K.+Raymonauthor=R.+S.+Chenauthor=L.+Corralauthor=M.+A.+Shirleyauthor=R.+K.+Narlaauthor=J.+Gamezauthor=G.+W.+Mullerauthor=D.+I.+Stirlingauthor=J.+B.+Bartlettauthor=P.+H.+Schaferauthor=F.+Payvandi&title=The+synthetic+compound+CC-5079+is+a+potent+inhibitor+of+tubulin+polymerization+and+tumor+necrosis+factor-%CE%B1+production+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-H.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DRaymon%26aufirst%3DH.%2BK.%26aulast%3DChen%26aufirst%3DR.%2BS.%26aulast%3DCorral%26aufirst%3DL.%26aulast%3DShirley%26aufirst%3DM.%2BA.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DGamez%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DG.%2BW.%26aulast%3DStirling%26aufirst%3DD.%2BI.%26aulast%3DBartlett%26aufirst%3DJ.%2BB.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DPayvandi%26aufirst%3DF.%26atitle%3DThe%2520synthetic%2520compound%2520CC-5079%2520is%2520a%2520potent%2520inhibitor%2520of%2520tubulin%2520polymerization%2520and%2520tumor%2520necrosis%2520factor-%25CE%25B1%2520production%2520with%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D951%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogler, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanwick, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of 3,3-diarylacrylonitriles as tubulin polymerization inhibitors</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">4241</span><span class="NLM_x">â</span> <span class="NLM_lpage">4244</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo800428b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=4241-4244&author=Z.+Fangauthor=Y.+Songauthor=T.+Sarkarauthor=E.+Hamelauthor=W.+E.+Foglerauthor=G.+E.+Agostonauthor=P.+E.+Fanwickauthor=M.+Cushman&title=Stereoselective+synthesis+of+3%2C3-diarylacrylonitriles+as+tubulin+polymerization+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjo800428b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo800428b%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DSarkar%26aufirst%3DT.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFogler%26aufirst%3DW.%2BE.%26aulast%3DAgoston%26aufirst%3DG.%2BE.%26aulast%3DFanwick%26aufirst%3DP.%2BE.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DStereoselective%2520synthesis%2520of%25203%252C3-diarylacrylonitriles%2520as%2520tubulin%2520polymerization%2520inhibitors%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D4241%26epage%3D4244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nieminen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollesello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, Z.</span><span> </span><span class="NLM_article-title">Effects of levosimendan on the energy balance: preclinical and clinical evidence</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">â</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=302-310&author=M.+S.+Nieminenauthor=P.+Polleselloauthor=G.+Vajdaauthor=Z.+Papp&title=Effects+of+levosimendan+on+the+energy+balance%3A+preclinical+and+clinical+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNieminen%26aufirst%3DM.%2BS.%26aulast%3DPollesello%26aufirst%3DP.%26aulast%3DVajda%26aufirst%3DG.%26aulast%3DPapp%26aufirst%3DZ.%26atitle%3DEffects%2520of%2520levosimendan%2520on%2520the%2520energy%2520balance%253A%2520preclinical%2520and%2520clinical%2520evidence%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2009%26volume%3D53%26spage%3D302%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit145b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whig, J.</span><span> </span><span class="NLM_article-title">Levosimendan</span> <span class="citation_source-journal">J. Anaesthesiol., Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">â</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2qur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=79-82&author=S.+Guptaauthor=S.+Gargauthor=J.+Whig&title=Levosimendan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145bR"><div class="casContent"><span class="casTitleNuber">145b</span><div class="casTitle"><span class="NLM_cas:atitle">Levosimendan</span></div><div class="casAuthors">Gupta, Sushil; Garg, Shuchita; Whig, Jagdeep</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Anaesthesiology, Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-82</span>CODEN:
                <span class="NLM_cas:coden">JAPHFW</span>;
        ISSN:<span class="NLM_cas:issn">0970-9185</span>.
    
            (<span class="NLM_cas:orgname">Research Society of Anaesthesiology Clinical Pharmacology</span>)
        </div><div class="casAbstract">A review.  Levosimendan is one of the calcium sensitizers of the heart, used mainly in the management of the decompensated congestive heart failure.  It is a unique drug that improves hemodynamics without much risk of dysrrhythmias as seen with most of the inotropic agents.  The mechanism of action, pharmacol. effects and indications, and adverse effects of levosimendan are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFe-kQ5UtOf7Vg90H21EOLACvtfcHk0ljn7mqMTNjJ2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2qur4%253D&md5=a64c4886abaf58f646b03e775c4ad583</span></div><a href="/servlet/linkout?suffix=cit145b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DWhig%26aufirst%3DJ.%26atitle%3DLevosimendan%26jtitle%3DJ.%2520Anaesthesiol.%252C%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D25%26spage%3D79%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Sasho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, K.</span><span> </span><span class="NLM_article-title">Synthesis of 2-imidazolidinylidene propanedinitrile derivatives as stimulators of gastrointestinal motility. 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">â</span> <span class="NLM_lpage">579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00057a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=572-579&author=S.+Sashoauthor=H.+Obaseauthor=S.+Ichikawaauthor=T.+Kitazawaauthor=H.+Nonakaauthor=R.+Yoshizakiauthor=A.+Ishiiauthor=K.+Shuto&title=Synthesis+of+2-imidazolidinylidene+propanedinitrile+derivatives+as+stimulators+of+gastrointestinal+motility.+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm00057a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00057a007%26sid%3Dliteratum%253Aachs%26aulast%3DSasho%26aufirst%3DS.%26aulast%3DObase%26aufirst%3DH.%26aulast%3DIchikawa%26aufirst%3DS.%26aulast%3DKitazawa%26aufirst%3DT.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DYoshizaki%26aufirst%3DR.%26aulast%3DIshii%26aufirst%3DA.%26aulast%3DShuto%26aufirst%3DK.%26atitle%3DSynthesis%2520of%25202-imidazolidinylidene%2520propanedinitrile%2520derivatives%2520as%2520stimulators%2520of%2520gastrointestinal%2520motility.%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D572%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">King, B. F.</span><span> </span><span class="NLM_article-title">Novel P2X7 receptor antagonists ease the pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">â</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fsj.bjp.0707266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17471176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFemtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=565-567&author=B.+F.+King&title=Novel+P2X7+receptor+antagonists+ease+the+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147aR"><div class="casContent"><span class="casTitleNuber">147a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel P2X7 receptor antagonists ease the pain</span></div><div class="casAuthors">King, B. F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-567</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In recent months, a series of chem. diverse antagonists has been identified for the ATP-gated P2X7 receptor.  In particular, two classes of highly-selective competitive P2X7 antagonists have been developed by Michael Jarvis and his colleagues at Abbott Labs.  These di-substituted tetrazole and cyanoguanidine derivs. are outstanding for a no. of reasons (not least their stability, selectivity, potency and, of course, reversibility); most exciting is their near equal potency at human and rodent P2X7 isoforms.  Armed with drugs such as A740003 and newer A438079, Jarvis and colleagues have explored the role of P2X7 receptors in the onset and persistence of chronic pain in animal models.  Their findings, and applicability to the human condition, are reviewed in this current issue of British Journal of Pharmacol.  This accompanying Commentary describes the progress made by Jarvis and others in developing novel P2X7 antagonists for pain relief.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7XZ7FPV45OLVg90H21EOLACvtfcHk0lh0Fj_DwHwRHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFemtr4%253D&md5=545fae7c8efcbfd9afe870bdaaf7e353</span></div><a href="/servlet/linkout?suffix=cit147a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707266%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DB.%2BF.%26atitle%3DNovel%2520P2X7%2520receptor%2520antagonists%2520ease%2520the%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D565%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit147b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, B.-C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jass, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humora, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madding, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venit, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, W. J.</span><span> </span><span class="NLM_article-title">Regio- and stereoselective ring opening of epoxide with cyanoguanidine dianions, a facile synthesis of the KATP opener BMS-180448</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">â</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=1337-1340&author=B.-C+Chenauthor=S.+L.+Quinlanauthor=J.+G.+Reidauthor=P.+A.+Jassauthor=T.+P.+Robinsonauthor=W.+A.+Earlyauthor=E.+J.+Delaneyauthor=M.+J.+Humoraauthor=G.+D.+Maddingauthor=J.+J.+Venitauthor=W.+J.+Winter&title=Regio-+and+stereoselective+ring+opening+of+epoxide+with+cyanoguanidine+dianions%2C+a+facile+synthesis+of+the+KATP+opener+BMS-180448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.-C%26aulast%3DQuinlan%26aufirst%3DS.%2BL.%26aulast%3DReid%26aufirst%3DJ.%2BG.%26aulast%3DJass%26aufirst%3DP.%2BA.%26aulast%3DRobinson%26aufirst%3DT.%2BP.%26aulast%3DEarly%26aufirst%3DW.%2BA.%26aulast%3DDelaney%26aufirst%3DE.%2BJ.%26aulast%3DHumora%26aufirst%3DM.%2BJ.%26aulast%3DMadding%26aufirst%3DG.%2BD.%26aulast%3DVenit%26aufirst%3DJ.%2BJ.%26aulast%3DWinter%26aufirst%3DW.%2BJ.%26atitle%3DRegio-%2520and%2520stereoselective%2520ring%2520opening%2520of%2520epoxide%2520with%2520cyanoguanidine%2520dianions%252C%2520a%2520facile%2520synthesis%2520of%2520the%2520KATP%2520opener%2520BMS-180448%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D1337%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit147c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Toombs, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shebuski, R. J.</span><span> </span><span class="NLM_article-title">U-89232 [BMS-189365], a novel antiischemic agent derived from cromakalim</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=303-316&author=C.+F.+Toombsauthor=R.+J.+Shebuski&title=U-89232+%5BBMS-189365%5D%2C+a+novel+antiischemic+agent+derived+from+cromakalim"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToombs%26aufirst%3DC.%2BF.%26aulast%3DShebuski%26aufirst%3DR.%2BJ.%26atitle%3DU-89232%2520%255BBMS-189365%255D%252C%2520a%2520novel%2520antiischemic%2520agent%2520derived%2520from%2520cromakalim%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D1994%26volume%3D12%26spage%3D303%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Donetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cereda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellora, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallazzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Soldato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giachetti, A.</span><span> </span><span class="NLM_article-title">(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">â</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00369a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=380-386&author=A.+Donettiauthor=E.+Ceredaauthor=E.+Belloraauthor=A.+Gallazziauthor=C.+Bazzanoauthor=P.+Vanoniauthor=P.+Del+Soldatoauthor=R.+Michelettiauthor=F.+Paganiauthor=A.+Giachetti&title=%28Imidazolylphenyl%29formamidines.+A+structurally+novel+class+of+potent+histamine+H2+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm00369a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00369a025%26sid%3Dliteratum%253Aachs%26aulast%3DDonetti%26aufirst%3DA.%26aulast%3DCereda%26aufirst%3DE.%26aulast%3DBellora%26aufirst%3DE.%26aulast%3DGallazzi%26aufirst%3DA.%26aulast%3DBazzano%26aufirst%3DC.%26aulast%3DVanoni%26aufirst%3DP.%26aulast%3DDel%2BSoldato%26aufirst%3DP.%26aulast%3DMicheletti%26aufirst%3DR.%26aulast%3DPagani%26aufirst%3DF.%26aulast%3DGiachetti%26aufirst%3DA.%26atitle%3D%2528Imidazolylphenyl%2529formamidines.%2520A%2520structurally%2520novel%2520class%2520of%2520potent%2520histamine%2520H2%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D380%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Haaksma, E. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademaker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriks, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span> </span><span class="NLM_article-title">Studies on the active molecular species of the H2-receptor antagonists cimetidine and mifentidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">â</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00384a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=208-211&author=E.+E.+J.+Haaksmaauthor=B.+Rademakerauthor=K.+Kramerauthor=J.+C.+Eriksauthor=A.+Bastauthor=H.+Timmerman&title=Studies+on+the+active+molecular+species+of+the+H2-receptor+antagonists+cimetidine+and+mifentidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm00384a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00384a036%26sid%3Dliteratum%253Aachs%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3DRademaker%26aufirst%3DB.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DEriks%26aufirst%3DJ.%2BC.%26aulast%3DBast%26aufirst%3DA.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DStudies%2520on%2520the%2520active%2520molecular%2520species%2520of%2520the%2520H2-receptor%2520antagonists%2520cimetidine%2520and%2520mifentidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D208%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><div class="note"><p class="first last">For leading references see the following: </p></div><span class="NLM_contrib-group">Makowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raczynska, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmurzynski, L.</span><span> </span><span class="NLM_article-title">Ab initio study of possible and preferred basic site(s) in polyfunctional <i>N</i>1,<i>N</i>1-dimethyl-<i>N</i>2-cyanoformamidine</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">â</span> <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp002458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=869-874&author=M.+Makowskiauthor=E.+D.+Raczynskaauthor=L.+Chmurzynski&title=Ab+initio+study+of+possible+and+preferred+basic+site%28s%29+in+polyfunctional+N1%2CN1-dimethyl-N2-cyanoformamidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjp002458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp002458t%26sid%3Dliteratum%253Aachs%26aulast%3DMakowski%26aufirst%3DM.%26aulast%3DRaczynska%26aufirst%3DE.%2BD.%26aulast%3DChmurzynski%26aufirst%3DL.%26atitle%3DAb%2520initio%2520study%2520of%2520possible%2520and%2520preferred%2520basic%2520site%2528s%2529%2520in%2520polyfunctional%2520N1%252CN1-dimethyl-N2-cyanoformamidine%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2001%26volume%3D105%26spage%3D869%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Yanagisawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span> </span><span class="NLM_article-title">Histamine H2 receptor antagonists. 1. Synthesis of <i>N</i>-cyano and <i>N</i>-carbamoyl amidine derivatives and their biological activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">â</span> <span class="NLM_lpage">857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00373a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=849-857&author=I.+Yanagisawaauthor=Y.+Hirataauthor=Y.+Ishii&title=Histamine+H2+receptor+antagonists.+1.+Synthesis+of+N-cyano+and+N-carbamoyl+amidine+derivatives+and+their+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fjm00373a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00373a007%26sid%3Dliteratum%253Aachs%26aulast%3DYanagisawa%26aufirst%3DI.%26aulast%3DHirata%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DHistamine%2520H2%2520receptor%2520antagonists.%25201.%2520Synthesis%2520of%2520N-cyano%2520and%2520N-carbamoyl%2520amidine%2520derivatives%2520and%2520their%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D849%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Eda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukaya, C.</span><span> </span><span class="NLM_article-title">Novel potassium-channel openers: preparation and pharmacological evaluation of racemic and optically active <i>N</i>-(6-amino-3-pyridyl)-<i>N</i>â²-bicycloalkyl-<i>N</i>â²â²-cyanoguanidine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">â</span> <span class="NLM_lpage">1990</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00039a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1983-1990&author=M.+Edaauthor=T.+Takemotoauthor=S.+Onoauthor=T.+Okadaauthor=K.+Kosakaauthor=M.+Gohdaauthor=S.+Matznoauthor=N.+Nakamuraauthor=C.+Fukaya&title=Novel+potassium-channel+openers%3A+preparation+and+pharmacological+evaluation+of+racemic+and+optically+active+N-%286-amino-3-pyridyl%29-N%E2%80%B2-bicycloalkyl-N%E2%80%B2%E2%80%B2-cyanoguanidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm00039a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00039a011%26sid%3Dliteratum%253Aachs%26aulast%3DEda%26aufirst%3DM.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKosaka%26aufirst%3DK.%26aulast%3DGohda%26aufirst%3DM.%26aulast%3DMatzno%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DFukaya%26aufirst%3DC.%26atitle%3DNovel%2520potassium-channel%2520openers%253A%2520preparation%2520and%2520pharmacological%2520evaluation%2520of%2520racemic%2520and%2520optically%2520active%2520N-%25286-amino-3-pyridyl%2529-N%25E2%2580%25B2-bicycloalkyl-N%25E2%2580%25B2%25E2%2580%25B2-cyanoguanidine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1983%26epage%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebisu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukaya, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hihara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiraku, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanouchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span> </span><span class="NLM_article-title">Novel potassium channel openers: synthesis and pharmacological evaluation of new <i>N</i>-(substituted-3-pyridyl)-<i>N</i>â²-alkylthioureas and related compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00027a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=18-35&author=T.+Takemotoauthor=M.+Edaauthor=T.+Okadaauthor=H.+Sakashitaauthor=S.+Matznoauthor=M.+Gohdaauthor=H.+Ebisuauthor=N.+Nakamuraauthor=C.+Fukayaauthor=C.+Hiharaauthor=M.+Eirakuauthor=K.+Yamanouchiauthor=K.+Yokoyama&title=Novel+potassium+channel+openers%3A+synthesis+and+pharmacological+evaluation+of+new+N-%28substituted-3-pyridyl%29-N%E2%80%B2-alkylthioureas+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm00027a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00027a003%26sid%3Dliteratum%253Aachs%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DEda%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DMatzno%26aufirst%3DS.%26aulast%3DGohda%26aufirst%3DM.%26aulast%3DEbisu%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DFukaya%26aufirst%3DC.%26aulast%3DHihara%26aufirst%3DC.%26aulast%3DEiraku%26aufirst%3DM.%26aulast%3DYamanouchi%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26atitle%3DNovel%2520potassium%2520channel%2520openers%253A%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%2520new%2520N-%2528substituted-3-pyridyl%2529-N%25E2%2580%25B2-alkylthioureas%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D18%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwabara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, S.</span><span> </span><span class="NLM_article-title">Structureâactivity studies of <i>N</i>-cyano-3-pyridinecarboxamidines and their amide and thioamide congeners</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">â</span> <span class="NLM_lpage">2488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2485-2488&author=T.+Nakajimaauthor=T.+Kashiwabaraauthor=T.+Izawaauthor=S.+Nakajima&title=Structure%E2%88%92activity+studies+of+N-cyano-3-pyridinecarboxamidines+and+their+amide+and+thioamide+congeners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DKashiwabara%26aufirst%3DT.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DS.%26atitle%3DStructure%25E2%2588%2592activity%2520studies%2520of%2520N-cyano-3-pyridinecarboxamidines%2520and%2520their%2520amide%2520and%2520thioamide%2520congeners%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2485%26epage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Ganellin, C. R.</span><span> </span><span class="NLM_article-title">Discovery of the antiulcer drug Tagamet</span> <span class="citation_source-journal">Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">â</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2F0471780103.ch10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFelt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=295-311&author=C.+R.+Ganellin&title=Discovery+of+the+antiulcer+drug+Tagamet"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the antiulcer drug Tagamet</span></div><div class="casAuthors">Ganellin, C. Robin</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery and Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295-311</span>CODEN:
                <span class="NLM_cas:coden">69IHOA</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review on the anti-ulcer drug Tagamet (cimetidine) and the level of knowledge prevailing at the time (1964-1972) the research leading to its discovery was carried out.  The pharmacol. characterization of histamine receptors is discussed, together with the old treatment options for peptic ulcer disease and the search for new anti-ulcer drugs.  The search for an H2-receptor histamine antagonist, development of a clin. candidate drug for peptic ulcer, and discovery of cimetidine as a breakthrough in the treatment of peptic ulcer disease are addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdymfTAfY0HLVg90H21EOLACvtfcHk0lidyXhYiSCwZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFelt70%253D&md5=8c25608a8774ea8080248c15c3c12c59</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1002%2F0471780103.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471780103.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26atitle%3DDiscovery%2520of%2520the%2520antiulcer%2520drug%2520Tagamet%26jtitle%3DDrug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D1%26spage%3D295%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Scheinfeld, N.</span><span> </span><span class="NLM_article-title">Cimetidine: a review of the recent developments and reports in cutaneous medicine</span> <span class="citation_source-journal">Dermatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=4&issue=2&author=N.+Scheinfeld&title=Cimetidine%3A+a+review+of+the+recent+developments+and+reports+in+cutaneous+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScheinfeld%26aufirst%3DN.%26atitle%3DCimetidine%253A%2520a%2520review%2520of%2520the%2520recent%2520developments%2520and%2520reports%2520in%2520cutaneous%2520medicine%26jtitle%3DDermatology%26date%3D2003%26volume%3D9%26issue%3D2%26spage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeaton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">â</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16596218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Cjtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=1021-1030&author=F.+Lefrancauthor=P.+Yeatonauthor=J.+Brotchiauthor=R.+Kiss&title=Cimetidine%2C+an+unexpected+anti-tumor+agent%2C+and+its+potential+for+the+treatment+of+glioblastoma+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)</span></div><div class="casAuthors">Lefranc, Florence; Yeaton, Paul; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1030</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A review.  Cimetidine (CIM), the prototypical histamine H2 receptor antagonist (H2RA), was brought to market based on its ability to accelerate healing of gastrointestinal ulcers through the inhibition of gastric acid secretion.  Cimetidine, the most studied H2RA, has been demonstrated to possess anti-tumor activity against colon, gastric and kidney cancers, and melanomas.  This activity involves a no. of different mechanisms of action: (a) CIM antagonizes tumor cell-mediated interleukin-1-induced activation of selectins in liver sinusoids, inhibiting tumor cell binding on liver sinusoids, thereby reducing the development of liver metastasis; (b) histamine acts as a growth factor in various tumor cell types via the activation of H2 receptors; CIM therefore may antagonize this effect; (c) CIM acts as an immunomodulator by enhancing the host's immune response to tumor cells.  With respect to malignant gliomas, CIM added to temozolomide was superior in vivo when compared to temozolomide alone in extending survival of nude mice with human glioblastoma cells orthotopically xenografted into their brain.  We review the various mechanisms of action potentially assocd. with the therapeutic effects of CIM in the case of exptl. glioblastomas, observations we hope will encourage clin. investigation of CIM in the management of highly malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpinT-J1wkTTrVg90H21EOLACvtfcHk0lgmr0mtUF1GPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Cjtbs%253D&md5=210e996682a29d2306afae83b5201aba</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DYeaton%26aufirst%3DP.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DCimetidine%252C%2520an%2520unexpected%2520anti-tumor%2520agent%252C%2520and%2520its%2520potential%2520for%2520the%2520treatment%2520of%2520glioblastoma%2520%2528review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D28%26spage%3D1021%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Friedel, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogden, R. N.</span><span> </span><span class="NLM_article-title">Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">â</span> <span class="NLM_lpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=929-967&author=H.+A.+Friedelauthor=R.+N.+Brogden&title=Pinacidil.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+potential+in+the+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedel%26aufirst%3DH.%2BA.%26aulast%3DBrogden%26aufirst%3DR.%2BN.%26atitle%3DPinacidil.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520potential%2520in%2520the%2520treatment%2520of%2520hypertension%26jtitle%3DDrugs%26date%3D1990%26volume%3D39%26spage%3D929%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guth, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1365-2125.2004.02083.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15206991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlGrsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=40-51&author=B.+D.+Guthauthor=H.+Narjesauthor=H.-D.+Schubertauthor=P.+Tanswellauthor=A.+Riedelauthor=G.+Nehmiz&title=Pharmacokinetics+and+pharmacodynamics+of+terbogrel%2C+a+combined+thromboxane+A2+receptor+and+synthase+inhibitor%2C+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159aR"><div class="casContent"><span class="casTitleNuber">159a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects</span></div><div class="casAuthors">Guth, Brian D.; Narjes, Hans; Schubert, Hans-Dieter; Tanswell, Paul; Riedel, Axel; Nehmiz, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-51</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims: To characterize the pharmacokinetics of terbogrel, a new combined thromboxane A2 (TxA2) receptor and synthase inhibitor, in healthy human subjects after single or multiple oral administration.  Methods: Forty-eight healthy male subjects received a single oral dose (10, 25, 50, 100, 150 or 200 mg) of terbogrel or placebo and 32 different subjects received one of the following treatments twice daily for 7 days: 50, 100 or 150 mg terbogrel, placebo, or once-a-day 330 mg acetylsalicylic acid.  Results: Terbogrel was well tolerated without obvious adverse effects following either a single oral dose or administration over 7 days.  Plasma drug concns. were dose-linear and there was no accumulation over 7 days.  There was a dose-dependent blockade of TxA2 receptors and of inhibition of thromboxane synthase activity with values for IC50 of 12 ng ml-1 and 6.7 ng ml-1, resp.  At the highest dose tested (150 mg) there was almost complete inhibition of thromboxane synthase and thromboxane receptor occupancy.  Even at trough concns., receptor occupancy remained above 80% and thromboxane synthase was still completely inhibited.  These two activities were assocd. with a dose-dependent inhibition of platelet aggregation (>80% at the 150 mg dose of terbogrel) and enhanced prostacyclin prodn.  Conclusions: Terbogrel is a potent agent having two distinct, complimentary pharmacodynamic actions, namely inhibition of thromboxane synthase and antagonism of the TxA2 receptor.  The antithrombotic effect of terbogrel was dose-dependent and was assocd. with enhanced prostacyclin prodn.  Terbogrel is an attractive candidate for long-term therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpowTWvRF75rVg90H21EOLACvtfcHk0lgmr0mtUF1GPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlGrsbY%253D&md5=8e922fa97c25f132e8e007679efec79b</span></div><a href="/servlet/linkout?suffix=cit159a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2004.02083.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2004.02083.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuth%26aufirst%3DB.%2BD.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DSchubert%26aufirst%3DH.-D.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DRiedel%26aufirst%3DA.%26aulast%3DNehmiz%26aufirst%3DG.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520terbogrel%252C%2520a%2520combined%2520thromboxane%2520A2%2520receptor%2520and%2520synthase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D58%26spage%3D40%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit159b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Soyka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guth, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenberger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, T. H.</span><span> </span><span class="NLM_article-title">Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">â</span> <span class="NLM_lpage">1249</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9707941" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1235-1249&author=R.+Soykaauthor=B.+D.+Guthauthor=H.+M.+Weisenbergerauthor=P.+Lugerauthor=T.+H.+Mueller&title=Guanidine+derivatives+as+combined+thromboxane+A2+receptor+antagonists+and+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159b&amp;dbid=16384&amp;doi=10.1021%2Fjm9707941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707941%26sid%3Dliteratum%253Aachs%26aulast%3DSoyka%26aufirst%3DR.%26aulast%3DGuth%26aufirst%3DB.%2BD.%26aulast%3DWeisenberger%26aufirst%3DH.%2BM.%26aulast%3DLuger%26aufirst%3DP.%26aulast%3DMueller%26aufirst%3DT.%2BH.%26atitle%3DGuanidine%2520derivatives%2520as%2520combined%2520thromboxane%2520A2%2520receptor%2520antagonists%2520and%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1235%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjoerkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeaettelae, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span> </span><span class="NLM_article-title">Anticancer agent CHS-828 inhibits cellular synthesis of NAD</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">â</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2008&pages=799-804&author=U.+H.+Olesenauthor=M.+K.+Christensenauthor=F.+Bjoerklingauthor=M.+Jaeaettelaeauthor=P.+B.+Jensenauthor=M.+Sehestedauthor=S.+J.+Nielsen&title=Anticancer+agent+CHS-828+inhibits+cellular+synthesis+of+NAD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26aulast%3DBjoerkling%26aufirst%3DF.%26aulast%3DJaeaettelae%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26atitle%3DAnticancer%2520agent%2520CHS-828%2520inhibits%2520cellular%2520synthesis%2520of%2520NAD%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D367%26spage%3D799%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit160b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johanson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvidsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaerd, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlman, H.</span><span> </span><span class="NLM_article-title">Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude mice</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2005&pages=171-176&author=V.+Johansonauthor=Y.+Arvidssonauthor=L.+Koelbyauthor=P.+Bernhardtauthor=C.+Swaerdauthor=O.+Nilssonauthor=H.+Ahlman&title=Antitumoural+effects+of+the+pyridyl+cyanoguanidine+CHS+828+on+three+different+types+of+neuroendocrine+tumours+xenografted+to+nude+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohanson%26aufirst%3DV.%26aulast%3DArvidsson%26aufirst%3DY.%26aulast%3DKoelby%26aufirst%3DL.%26aulast%3DBernhardt%26aufirst%3DP.%26aulast%3DSwaerd%26aufirst%3DC.%26aulast%3DNilsson%26aufirst%3DO.%26aulast%3DAhlman%26aufirst%3DH.%26atitle%3DAntitumoural%2520effects%2520of%2520the%2520pyridyl%2520cyanoguanidine%2520CHS%2520828%2520on%2520three%2520different%2520types%2520of%2520neuroendocrine%2520tumours%2520xenografted%2520to%2520nude%2520mice%26jtitle%3DNeuroendocrinology%26date%3D2005%26volume%3D82%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauparlant, P.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">â</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.-O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Bergerauthor=M.+Mitchellauthor=G.+C.+Shoreauthor=P.+Beauparlant&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0lg-dm4ME5obAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.-O.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DShore%26aufirst%3DG.%2BC.%26aulast%3DBeauparlant%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choi, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, C. K.</span><span> </span><span class="NLM_article-title">KR-31378, a potassium-channel opener, induces the protection of retinal ganglion cells in rat retinal ischemic models</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">â</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1254%2Fjphs.FP0072067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19372634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSgurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=511-517&author=A+Choiauthor=J.-S.+Choiauthor=Y.-J.+Yoonauthor=K.-A.+Kimauthor=C.+K.+Joo&title=KR-31378%2C+a+potassium-channel+opener%2C+induces+the+protection+of+retinal+ganglion+cells+in+rat+retinal+ischemic+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162aR"><div class="casContent"><span class="casTitleNuber">162a</span><div class="casTitle"><span class="NLM_cas:atitle">KR-31378, a potassium-channel opener, induces the protection of retinal ganglion cells in rat retinal ischemic models</span></div><div class="casAuthors">Choi, Anho; Choi, Jun-Sub; Yoon, Yone-Jung; Kim, Kyung-A.; Joo, Choun-Ki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">KR-31378 is a newly developed KATP-channel opener.  To investigate the ability of KR-31378 to protect retinal ganglion cells (RGC), expts. were conducted using two retinal ischemia models.  Retinal ischemia was induced by transient high intraocular pressure (IOP) for acute ischemia and by three episcleral vein occlusion for chronic retinal ischemia.  KR-31378 was injected i.p. and administered orally in the acute and chronic ischemia models, resp.  Under the condition of chronic ischemia, RGC d. in the KR-31378-treated group was statistically higher than that in the non-treated group, and IOP was reduced.  In the acute retinal ischemia model, 90% of RGC were degenerated after one week in non-treated retina, but, RGC in KR-31378-treated retina were protected from ischemic damage in a dose-dependent manner and showed inhibited glial fibrillary acidic protein (GFAP) expression.  Furthermore, the KR-31378 protective effect was inhibited by glibenclamide treatment in acute ischemia.  These findings indicate that systemic KR-31378 treatment may protect against ischemic injury-induced ganglion cell loss in glaucoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnmAoVbiyex7Vg90H21EOLACvtfcHk0lg-dm4ME5obAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSgurg%253D&md5=c97cebbce36aa58dc26bb7bb66bd2e95</span></div><a href="/servlet/linkout?suffix=cit162a&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0072067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0072067%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DA%26aulast%3DChoi%26aufirst%3DJ.-S.%26aulast%3DYoon%26aufirst%3DY.-J.%26aulast%3DKim%26aufirst%3DK.-A.%26aulast%3DJoo%26aufirst%3DC.%2BK.%26atitle%3DKR-31378%252C%2520a%2520potassium-channel%2520opener%252C%2520induces%2520the%2520protection%2520of%2520retinal%2520ganglion%2520cells%2520in%2520rat%2520retinal%2520ischemic%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D109%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit162b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jeong, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji-Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun-Ok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eun, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suk, L. H.</span><span> </span><span class="NLM_article-title">Effects of a new neuroprotective agent KR-31378 on liver cytochrome P450s in male Sprague Dawley rats</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">â</span> <span class="NLM_lpage">804</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2FBF02980023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=14609126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVGiurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=800-804&author=T.+C.+Jeongauthor=J.+Ji-Youngauthor=J.+H.+Youngauthor=L.+D.+Haauthor=K.+Sun-Okauthor=L.+Hongauthor=Y.+S.+Eunauthor=L.+H.+Suk&title=Effects+of+a+new+neuroprotective+agent+KR-31378+on+liver+cytochrome+P450s+in+male+Sprague+Dawley+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162bR"><div class="casContent"><span class="casTitleNuber">162b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a new neuroprotective agent KR-31378 on liver cytochrome P450s in male Sprague Dawley rats</span></div><div class="casAuthors">Jeong, Tae Cheon; Kim, Ji-young; Ji, Hye Young; Lee, Dong Ha; Kim, Sun-ok; Lim, Hong; Yoo, Sung Eun; Lee, Hye Suk</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">800-804</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">The effects of KR-31378, a neuroprotective agent for ischemia-reperfusion damage, on liver microsomal cytochrome P450s (CYPs) were investigated in male Sprague Dawley rats.  When rats were treated orally with KR-31378 for 7 consecutive days, CYP3A-selective erythromycin N-demethylase (ERDM) activity was significantly induced in a dose-dependent manner.  In Western immunoblotting, CYP3A proteins were clearly induced by treatment with KR-31378.  Within 24 h after treatment with 80 mg/kg of KR-31378, ERDM activity was induced in liver microsomes in accompanied by induction of the level of CYP3A proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb-fX8UN1dVrVg90H21EOLACvtfcHk0ljf2X_4p5bY7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVGiurk%253D&md5=5fd08c4d3f6ae163cfdaf85055132489</span></div><a href="/servlet/linkout?suffix=cit162b&amp;dbid=16384&amp;doi=10.1007%2FBF02980023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02980023%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DT.%2BC.%26aulast%3DJi-Young%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DJ.%2BH.%26aulast%3DHa%26aufirst%3DL.%2BD.%26aulast%3DSun-Ok%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DEun%26aufirst%3DY.%2BS.%26aulast%3DSuk%26aufirst%3DL.%2BH.%26atitle%3DEffects%2520of%2520a%2520new%2520neuroprotective%2520agent%2520KR-31378%2520on%2520liver%2520cytochrome%2520P450s%2520in%2520male%2520Sprague%2520Dawley%2520rats%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2003%26volume%3D26%26spage%3D800%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Khun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, P.</span><span> </span><span class="NLM_article-title">Molecular recognition of ligands in dipeptidyl peptidase IV</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">â</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802607780091064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17352681" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=609-619&author=B.+Khunauthor=M.+Hennigauthor=P.+Mattei&title=Molecular+recognition+of+ligands+in+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163a&amp;dbid=16384&amp;doi=10.2174%2F156802607780091064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091064%26sid%3Dliteratum%253Aachs%26aulast%3DKhun%26aufirst%3DB.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DMattei%26aufirst%3DP.%26atitle%3DMolecular%2520recognition%2520of%2520ligands%2520in%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D609%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit163b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">11 years of cyanopyrrolidines as DPP-IV inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">â</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802607780091000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17352679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=579-595&author=J.-U.+Peters&title=11+years+of+cyanopyrrolidines+as+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163bR"><div class="casContent"><span class="casTitleNuber">163b</span><div class="casTitle"><span class="NLM_cas:atitle">11 years of cyanopyrrolidines as DPP-IV inhibitors</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyanopyrrolidines (cyanopyrrolidides, pyrrolidine-2-nitriles, prolinenitriles) as inhibitors of the serine protease dipeptidyl peptidase IV (DPP-IV, DP IV, CD26, EC 3.4.14.5) were first reported in 1995.  The interest in this compd. class grew immensely when DPP-IV was discovered as a target for the treatment of type 2 diabetes.  The research on cyanopyrrolidines cumulated in the discoveries of vildagliptin (LAF237, NVP-LAF237) and saxagliptin (BMS-477118).  These compds. entered Phase III clin. trials in 2004 and 2005, resp., and an application for market approval has been filed for vildagliptin in 2006.  Today cyanopyrrolidines are, as judged by the nos. of patent applications, the most prominent of several series of DPP-IV inhibitors, and have the potential to become valuable medicines for type 2 diabetes in the near future.  This review summarizes some historical aspects of the discovery of cyanopyrrolidine DPP-IV inhibitors, and then focuses mainly on structure-activity-relationships, the evolution of different subseries, the possibilities to improve on the chem. instability that is assocd. with this compd. class, and on the discoveries of vildagliptin and saxagliptin.  Within this context, the properties of individual compds. and results from biol. studies are discussed.  The rationale of DPP-IV inhibition, clin. data, and the relevance of selectivity over related proteases are extensively reviewed in other contributions to this issue of Curr.  Top. Med. Chem., and are therefore only very briefly touched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMheLlajHi0LVg90H21EOLACvtfcHk0ljf2X_4p5bY7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D&md5=1aed687f83d3d35a2a581956ce4b82e0</span></div><a href="/servlet/linkout?suffix=cit163b&amp;dbid=16384&amp;doi=10.2174%2F156802607780091000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091000%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3D11%2520years%2520of%2520cyanopyrrolidines%2520as%2520DPP-IV%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit163c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninan, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kervinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neeper, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayoumy, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebert, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, K. J.</span><span> </span><span class="NLM_article-title">Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">â</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=123-128&author=L.+Qiaoauthor=C.+A.+Baumannauthor=C.+S.+Cryslerauthor=N.+S.+Ninanauthor=M.+C.+Abadauthor=J.+C.+Spurlinoauthor=R.+L.+DesJarlaisauthor=J.+Kervinenauthor=M.+P.+Neeperauthor=S.+S.+Bayoumyauthor=R.+Williamsauthor=I.+C.+Deckmanauthor=M.+Dasguptaauthor=R.+L.+Reedauthor=N.+D.+Huebertauthor=B.+E.+Tomczukauthor=K.+J.+Moriarty&title=Discovery%2C+SAR%2C+and+X-ray+structure+of+novel+biaryl-based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DC.%2BA.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DNinan%26aufirst%3DN.%2BS.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DKervinen%26aufirst%3DJ.%26aulast%3DNeeper%26aufirst%3DM.%2BP.%26aulast%3DBayoumy%26aufirst%3DS.%2BS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DReed%26aufirst%3DR.%2BL.%26aulast%3DHuebert%26aufirst%3DN.%2BD.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26atitle%3DDiscovery%252C%2520SAR%252C%2520and%2520X-ray%2520structure%2520of%2520novel%2520biaryl-based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D123%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit163d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hughes, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villhauer, E. B.</span><span> </span><span class="NLM_article-title">NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">11597</span><span class="NLM_x">â</span> <span class="NLM_lpage">11603</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi990852f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=11597-11603&author=T.+E.+Hughesauthor=M.+D.+Moneauthor=M.+E.+Russellauthor=S.+C.+Weldonauthor=E.+B.+Villhauer&title=NVP-DPP728+%281-%5B%5B%5B2-%5B%285-cyanopyridin-2-yl%29amino%5Dethyl%5Damino%5Dacetyl%5D-2-cyano-%28S%29-pyrrolidine%29%2C+a+slow-binding+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163d&amp;dbid=16384&amp;doi=10.1021%2Fbi990852f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990852f%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DT.%2BE.%26aulast%3DMone%26aufirst%3DM.%2BD.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DWeldon%26aufirst%3DS.%2BC.%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26atitle%3DNVP-DPP728%2520%25281-%255B%255B%255B2-%255B%25285-cyanopyridin-2-yl%2529amino%255Dethyl%255Damino%255Dacetyl%255D-2-cyano-%2528S%2529-pyrrolidine%2529%252C%2520a%2520slow-binding%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D11597%26epage%3D11603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Saxagliptin</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">â</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2103-2114&author=S.+Dhillonauthor=J.+Weber&title=Saxagliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DSaxagliptin%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D2103%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit164b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Deacon, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span> </span><span class="NLM_article-title">Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Adv. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">â</span> <span class="NLM_lpage">499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=488-499&author=C.+F.+Deaconauthor=J.+J.+Holst&title=Saxagliptin%3A+a+new+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26atitle%3DSaxagliptin%253A%2520a%2520new%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DAdv.%2520Ther.%26date%3D2009%26volume%3D26%26spage%3D488%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johnson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braceras, R.</span><span> </span><span class="NLM_article-title">An update of recent trials with vildagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyhtbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=235-243&author=J.+T.+Johnsonauthor=K.+L.+Goldenauthor=R.+Braceras&title=An+update+of+recent+trials+with+vildagliptin%2C+a+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165aR"><div class="casContent"><span class="casTitleNuber">165a</span><div class="casTitle"><span class="NLM_cas:atitle">An update of recent trials with vildagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Johnson, John T.; Golden, Kish L.; Braceras, Rogelio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy Technology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-243</span>CODEN:
                <span class="NLM_cas:coden">JPTEEB</span>;
        ISSN:<span class="NLM_cas:issn">8755-1225</span>.
    
            (<span class="NLM_cas:orgname">Harvey Whitney Books Co.</span>)
        </div><div class="casAbstract">Objective: To review the clin. efficacy and tolerability of vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, for the treatment of type 2 diabetes, based on recent Phase 3 trials.  Data Sources: Primary literature and review articles were obtained via a MEDLINE search (2005-Nov. 2007) using the search terms diabetes, vildagliptin, and LAF-237.  Addnl. data from abstrs. presented at clin. meetings were included when appropriate.  Study Selection: Nine double-blind, randomized, multicenter, parallel-group trials and vildagliptin studies were identified and reviewed.  Data Synthesis: Vildagliptin, a selective DPP-4 inhibitor, has been shown to produce clin. significant redns. in Hb A1c (A1C) levels when used as monotherapy (0.6-1%) or in combination with other glucose-lowering agents (mean decrease 0.7%).  Phase 3 trials indicated a 24- to 52-wk sustained effect on redn. of blood glucose in patients with type 2 diabetes.  The primary endpoint for all trials was change from baseline A1C.  In the intent-to-treat population, baseline A1C was compared with end-of-study A1C.  More than 2,500 patients with type 2 diabetes enrolled in monotherapy trials; an addnl. 2,119 participated in combination therapy trials.  Males outnumbered females, and all groups included obese patients.  The most common adverse effects reported were nasopharyngitis, headache, and dizziness.  Vildagliptin was wt.-neutral and produced a rate of hypoglycemia similar to that of placebo.  Conclusions: Vildagliptin appears to be a promising agent for the management of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_h6CxIJ0UbVg90H21EOLACvtfcHk0lhiQ9ejFoYaPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyhtbbI&md5=e0812ff082b196d848ad54fab339f25f</span></div><a href="/servlet/linkout?suffix=cit165a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BT.%26aulast%3DGolden%26aufirst%3DK.%2BL.%26aulast%3DBraceras%26aufirst%3DR.%26atitle%3DAn%2520update%2520of%2520recent%2520trials%2520with%2520vildagliptin%252C%2520a%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Pharm.%2520Technol.%26date%3D2009%26volume%3D25%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit165b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mathieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrande, E.</span><span> </span><span class="NLM_article-title">Vildagliptin: a new oral treatment for type 2 diabetes mellitus</span> <span class="citation_source-journal">Vasc. Health Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">â</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19337548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlWgt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1349-1360&author=C.+Mathieuauthor=E.+Degrande&title=Vildagliptin%3A+a+new+oral+treatment+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165bR"><div class="casContent"><span class="casTitleNuber">165b</span><div class="casTitle"><span class="NLM_cas:atitle">Vildagliptin: a new oral treatment for type 2 diabetes mellitus</span></div><div class="casAuthors">Mathieu, Chantal; Degrande, Evy</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1349-1360</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1178-2048</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Vildagliptin is a new oral antidiabetic agent that enhances pancreatic islet cell responsiveness to glucose.  An extensive clin. program involving approx. 22,000 patients and 7000 patient-years of exposure to vildagliptin has shown that the agent is well tolerated and efficacious in improving glycemic control in patients with type 2 diabetes mellitus (T2DM).  Monotherapy trials have shown that significant HbA1c lowering is accompanied by body wt.-neutral and lipid-neutral effects, low risk of edema, and low risk of hypoglycemia.  These characteristics make vildagliptin a favorable partner for combination therapy.  Studies of vildagliptin as an add-on to metformin have shown significant improvements in glycemic control (comparable to that of thiazolidinedione add-on), with the combination being well tolerated and assocd. with low risks for hypoglycemia and adverse effects on wt. or lipid levels.  Good tolerability and clin. relevant improvements in glycemic control have also been obsd. with vildagliptin as an add-on treatment to sulfonylurea, thiazolidinedione, or insulin treatment or in initial combination treatment with pioglitazone.  Improved Î²-cell function and glycemic control have been shown with vildagliptin in subjects with impaired glucose tolerance and in T2DM patients with mild hyperglycemia, with some evidence in the latter suggesting the potential for modifying disease course.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQeNzdA5tYLVg90H21EOLACvtfcHk0lhiQ9ejFoYaPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlWgt70%253D&md5=6f1e386644333e07493a3058d213ca68</span></div><a href="/servlet/linkout?suffix=cit165b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DC.%26aulast%3DDegrande%26aufirst%3DE.%26atitle%3DVildagliptin%253A%2520a%2520new%2520oral%2520treatment%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DVasc.%2520Health%2520Risk%2520Manage.%26date%3D2008%26volume%3D4%26spage%3D1349%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Willand, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesquiere, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhibitor NVP-DPP728</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5741</span><span class="NLM_x">â</span> <span class="NLM_lpage">5746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5741-5746&author=N.+Willandauthor=J.+Joossensauthor=J.-C.+Gesquiereauthor=A.+L.+Tartarauthor=D.+M.+Evansauthor=M.+B.+Roe&title=Solid+and+solution+phase+syntheses+of+the+2-cyanopyrrolidide+DPP-IV+inhibitor+NVP-DPP728"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilland%26aufirst%3DN.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DGesquiere%26aufirst%3DJ.-C.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DSolid%2520and%2520solution%2520phase%2520syntheses%2520of%2520the%25202-cyanopyrrolidide%2520DPP-IV%2520inhibitor%2520NVP-DPP728%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5741%26epage%3D5746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span> </span><span class="NLM_article-title">Molecular recognition of proteinâligand complexes: applications to drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">â</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr960370z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=1359-1472&author=R.+E.+Babineauthor=S.+L.+Bender&title=Molecular+recognition+of+protein%E2%88%92ligand+complexes%3A+applications+to+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fcr960370z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr960370z%26sid%3Dliteratum%253Aachs%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DBender%26aufirst%3DS.%2BL.%26atitle%3DMolecular%2520recognition%2520of%2520protein%25E2%2588%2592ligand%2520complexes%253A%2520applications%2520to%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D1359%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Loeser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimmig, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetschow, M.</span><span> </span><span class="NLM_article-title">Interaction of papain-like cysteine proteases with dipeptide-derived nitriles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7688</span><span class="NLM_x">â</span> <span class="NLM_lpage">7707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7688-7707&author=R.+Loeserauthor=K.+Schillingauthor=E.+Dimmigauthor=M.+Guetschow&title=Interaction+of+papain-like+cysteine+proteases+with+dipeptide-derived+nitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoeser%26aufirst%3DR.%26aulast%3DSchilling%26aufirst%3DK.%26aulast%3DDimmig%26aufirst%3DE.%26aulast%3DGuetschow%26aufirst%3DM.%26atitle%3DInteraction%2520of%2520papain-like%2520cysteine%2520proteases%2520with%2520dipeptide-derived%2520nitriles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7688%26epage%3D7707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Metzler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanchunas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span> </span><span class="NLM_article-title">Involvement of DPP-IV catalytic residues in enzymeâsaxagliptin complex formation</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">â</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1110%2Fps.073253208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18227430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=240-250&author=W.+J.+Metzlerauthor=J.+Yanchunasauthor=C.+Weigeltauthor=K.+Kishauthor=H.+E.+Kleiauthor=D.+Xieauthor=Y.+Zhangauthor=M.+Corbettauthor=J.+K.+Tamuraauthor=B.+Heauthor=L.+G.+Hamannauthor=M.+S.+Kirbyauthor=J.+Marcinkeviciene&title=Involvement+of+DPP-IV+catalytic+residues+in+enzyme%E2%88%92saxagliptin+complex+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation</span></div><div class="casAuthors">Metzler, William J.; Yanchunas, Joseph; Weigelt, Carolyn; Kish, Kevin; Klei, Herbert E.; Xie, Dianlin; Zhang, Yaqun; Corbett, Martin; Tamura, James K.; He, Bin; Hamann, Lawrence G.; Kirby, Mark S.; Marcinkeviciene, Jovita</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-250</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The inhibition of DPP-IV by saxagliptin has been proposed to occur through formation of a covalent but reversible complex.  To evaluate further the mechanism of inhibition, we detd. the x-ray crystal structure of the DPP-IV:saxagliptin complex.  This structure reveals covalent attachment between S630 and the inhibitor nitrile carbon (C-O distance <1.3 Ã).  To investigate whether this serine addn. is assisted by the catalytic His-Asp dyad, we generated two mutants of DPP-IV, S630A and H740Q, and assayed them for ability to bind inhibitor.  DPP-IVH740Q bound saxagliptin with an â¼1000-fold redn. in affinity relative to DPP-IVWT, while DPP-IVS630A showed no evidence for binding inhibitor.  An analog of saxagliptin lacking the nitrile group showed unchanged binding properties to the both mutant proteins, highlighting the essential role S630 and H740 play in covalent bond formation between S630 and saxagliptin.  Further supporting mechanism-based inhibition by saxagliptin, NMR spectra of enzyme-saxagliptin complexes revealed the presence of three downfield resonances with low fractionation factors characteristic of short and strong hydrogen bonds (SSHB).  Comparison of the NMR spectra of various wild-type and mutant DPP-IV:ligand complexes enabled assignment of a resonance at â¼14 ppm to H740.  Two addnl. DPP-IV mutants, Y547F and Y547Q, generated to probe potential stabilization of the enzyme-inhibitor complex by this residue, did not show any differences in inhibitor binding either by ITC or NMR.  Together with the previously published enzymic data, the structural and binding data presented here strongly support a histidine-assisted covalent bond formation between S630 hydroxyl oxygen and the nitrile group of saxagliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JzGRDJ1J7rVg90H21EOLACvtfcHk0liAVaqZWvG1kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D&md5=d76619e8d6843e595a5bc971191a4828</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1110%2Fps.073253208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.073253208%26sid%3Dliteratum%253Aachs%26aulast%3DMetzler%26aufirst%3DW.%2BJ.%26aulast%3DYanchunas%26aufirst%3DJ.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCorbett%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DJ.%2BK.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26atitle%3DInvolvement%2520of%2520DPP-IV%2520catalytic%2520residues%2520in%2520enzyme%25E2%2588%2592saxagliptin%2520complex%2520formation%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D240%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschenes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percivala, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeaua, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ThÃ©riena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective non-basic cathepsin K inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1985</span><span class="NLM_x">â</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2005.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16413777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1985-1989&author=C.+S.+Liauthor=D.+Deschenesauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=J.+Y.+Gauthierauthor=D.+B.+Kimmelauthor=S.+Legerauthor=F.+Masseauthor=M.+E.+McGrathauthor=D.+J.+McKayauthor=M.+D.+Percivalaauthor=D.+Riendeauaauthor=S.+B.+Rodanauthor=M.+Th%C3%A9rienaauthor=V.+L.+Truongauthor=G.+Wesolowskiauthor=R.+Zamboniauthor=W.+C.+Black&title=Identification+of+a+potent+and+selective+non-basic+cathepsin+K+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent and selective non-basic cathepsin K inhibitor</span></div><div class="casAuthors">Li, Chun Sing; Deschenes, Denis; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Gauthier, Jacques Yves; Kimmel, Donald. B.; Leger, Serge; Masse, Frederic; McGrath, Mary E.; McKay, Daniel J.; Percival, M. David; Riendeau, Denis; Rodan, Sevgi B.; Therien, Michel; Truong, Vouy-Linh; Wesolowski, Gregg; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1985-1989</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous study with trifluoroethylamine as a P2-P3 amide isostere of cathepsin K inhibitor, further optimization led to identification of L-873724 (I) as a potent and selective non-basic cathepsin K inhibitor.  This compd. showed excellent pharmacokinetics and efficacy in an ovariectomized (OVX) rhesus monkey model.  The vols. of distribution close to unity were consistent with this compd. not being lysosomotropic, which is a characteristic of basic cathepsin K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVLlTt9kYhrVg90H21EOLACvtfcHk0liAVaqZWvG1kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D&md5=e63e471204893774e5a617993ed9be18</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DDeschenes%26aufirst%3DD.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPercivala%26aufirst%3DM.%2BD.%26aulast%3DRiendeaua%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DTh%25C3%25A9riena%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520non-basic%2520cathepsin%2520K%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1985%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, Le T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lia, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MassÃ©a, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmerc, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ThÃ©rien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">â</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=Le+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liaauthor=F.+Mass%C3%A9aauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmercauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Th%C3%A9rienauthor=V.+L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lg8ks6w53FqaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DLe%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLia%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9a%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmerc%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Opar, A.</span><span> </span><span class="NLM_article-title">Late-stage osteoporosis drugs illustrate challenges in the field</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">â</span> <span class="NLM_lpage">759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=757-759&author=A.+Opar&title=Late-stage+osteoporosis+drugs+illustrate+challenges+in+the+field"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOpar%26aufirst%3DA.%26atitle%3DLate-stage%2520osteoporosis%2520drugs%2520illustrate%2520challenges%2520in%2520the%2520field%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D757%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirnberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisay, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetschow, M.</span><span> </span><span class="NLM_article-title">Development of nitrile-based peptidic inhibitors of cysteine cathepsins</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">â</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802610790725452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=20166952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=294-322&author=M.+Frizlerauthor=M.+Stirnbergauthor=M.+T.+Sisayauthor=M.+Guetschow&title=Development+of+nitrile-based+peptidic+inhibitors+of+cysteine+cathepsins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Development of nitrile-based peptidic inhibitors of cysteine cathepsins</span></div><div class="casAuthors">Frizler, Maxim; Stirnberg, Marit; Sisay, Mihiret Tekeste; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-322</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now becoming clear that several papain-like cysteine cathepsins are involved in the pathophysiol. of diseases such as osteoporosis, autoimmune disorders, and cancer.  Therefore, the development of potent and selective cathepsin inhibitors is an attractive subject for medicinal chemists.  New advances have been made for nitrile-based inhibitors, leading to the identification of the cathepsin K inhibitor odanacatib and other candidates with potential for therapeutic use.  This review summarizes the development of peptidic and peptidomimetic compds. with an electrophilic nitrile 'warhead' as inhibitors of the cysteine cathepsins B, S, L, C, and K.  Peptide nitriles have been shown to reversibly react with the active site cysteine under formation of a covalent thioimidate adduct.  The structural optimization with respect to the positions P3, P2, P1, P1', and P2' resulted in the identification of potent and selective inhibitors of the corresponding cathepsins.  The underlying structure-activity relationships are discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV5N3L7sVS7Vg90H21EOLACvtfcHk0lg8ks6w53FqaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D&md5=8b0004f6aca64540b7f206ecc8527ff4</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.2174%2F156802610790725452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725452%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DStirnberg%26aufirst%3DM.%26aulast%3DSisay%26aufirst%3DM.%2BT.%26aulast%3DGuetschow%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520nitrile-based%2520peptidic%2520inhibitors%2520of%2520cysteine%2520cathepsins%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2010%26volume%3D10%26spage%3D294%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Ward, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekkali, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giradot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrapchak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeTuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spero, D. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">â</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020209i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5471-5482&author=Y.+D.+Wardauthor=D.+S.+Thomsonauthor=L.+L.+Fryeauthor=C.+L.+Cywinauthor=T.+Morwickauthor=M.+J.+Emmanuelauthor=R.+Zindellauthor=D.+McNeilauthor=Y.+Bekkaliauthor=M.+Giradotauthor=M.+Hrapchakauthor=M.+DeTuriauthor=K.+Craneauthor=D.+Whiteauthor=S.+Pavauthor=Y.+Wangauthor=M.-H.+Haoauthor=C.+A.+Grygonauthor=M.+E.+Labadiaauthor=D.+M.+Freemanauthor=W.+Davidsonauthor=J.+L.+Hopkinsauthor=M.+L.+Brownauthor=D.+M.+Spero&title=Design+and+synthesis+of+dipeptide+nitriles+as+reversible+and+potent+cathepsin+S+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fjm020209i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020209i%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DY.%2BD.%26aulast%3DThomson%26aufirst%3DD.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DEmmanuel%26aufirst%3DM.%2BJ.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DMcNeil%26aufirst%3DD.%26aulast%3DBekkali%26aufirst%3DY.%26aulast%3DGiradot%26aufirst%3DM.%26aulast%3DHrapchak%26aufirst%3DM.%26aulast%3DDeTuri%26aufirst%3DM.%26aulast%3DCrane%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DM.-H.%26aulast%3DGrygon%26aufirst%3DC.%2BA.%26aulast%3DLabadia%26aufirst%3DM.%2BE.%26aulast%3DFreeman%26aufirst%3DD.%2BM.%26aulast%3DDavidson%26aufirst%3DW.%26aulast%3DHopkins%26aufirst%3DJ.%2BL.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DSpero%26aufirst%3DD.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dipeptide%2520nitriles%2520as%2520reversible%2520and%2520potent%2520cathepsin%2520S%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5471%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duraiswami, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graybill, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygielko, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. K.</span><span> </span><span class="NLM_article-title">2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2â²,3â²:4,5]thieno[2,3-<i>b</i>]pyridine derivatives as selective progesterone receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4916</span><span class="NLM_x">â</span> <span class="NLM_lpage">4919</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4916-4919&author=Y.+Wangauthor=C.+Duraiswamiauthor=K.+P.+Madaussauthor=T.+B.+Tranauthor=S.+P.+Williamsauthor=S.-J.+Dengauthor=T.+L.+Graybillauthor=M.+Hammondauthor=D.+G.+Jonesauthor=E.+T.+Grygielkoauthor=J.+D.+Brayauthor=S.+K.+Thompson&title=2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6%2C7%2C8%2C9-tetrahydropyrido%5B2%E2%80%B2%2C3%E2%80%B2%3A4%2C5%5Dthieno%5B2%2C3-b%5Dpyridine+derivatives+as+selective+progesterone+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDuraiswami%26aufirst%3DC.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DTran%26aufirst%3DT.%2BB.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DDeng%26aufirst%3DS.-J.%26aulast%3DGraybill%26aufirst%3DT.%2BL.%26aulast%3DHammond%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DD.%2BG.%26aulast%3DGrygielko%26aufirst%3DE.%2BT.%26aulast%3DBray%26aufirst%3DJ.%2BD.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26atitle%3D2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6%252C7%252C8%252C9-tetrahydropyrido%255B2%25E2%2580%25B2%252C3%25E2%2580%25B2%253A4%252C5%255Dthieno%255B2%252C3-b%255Dpyridine%2520derivatives%2520as%2520selective%2520progesterone%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4916%26epage%3D4919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Chen, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C. N.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis and anticancer activities of new podophyllotoxin derivatives: 4-Î²-cyano-4-deoxy-4â²-demethylepipodophyllotoxin and 4-Î²-carboxyl-4-deoxy-4â²-demethylepipodophyllotoxin</span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">â</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltV2ls7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=505-508&author=Z.+X.+Chenauthor=W.+Y.+Maauthor=C.+N.+Zhang&title=Stereoselective+synthesis+and+anticancer+activities+of+new+podophyllotoxin+derivatives%3A+4-%CE%B2-cyano-4-deoxy-4%E2%80%B2-demethylepipodophyllotoxin+and+4-%CE%B2-carboxyl-4-deoxy-4%E2%80%B2-demethylepipodophyllotoxin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis and anticancer activities of new podophyllotoxin derivatives: 4-Î²-cyano-4-deoxy-4'-demethylepipodophyllotoxin and 4-Î²-carboxyl-4-deoxy-4'-demethylepipodophyllotoxin</span></div><div class="casAuthors">Chen, Zai Xin; Ma, Wei Yong; Zhang, Chun Nian</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">505-508</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Chinese Chemical Society</span>)
        </div><div class="casAbstract">4Î²-Cyano-4-deoxy-4'-demethylepipodophyllotoxin I (R = CN) was synthesized from 4'-demethylepipodophyllotoxin I (R = OH) and Me3SiCN in the presence of BF3Â·Et2O.  4Î²-Carboxyl-4-deoxy-4'-demethylepipodophyllotoxin I (R = CO2H) was obtained by hydrolyzing I (R = CN) in acetic acid and HCl.  Both of the new podophyllotoxin derivs. showed very high anticancer activities against L1210, and KB cell lines in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr92sO68ziBB7Vg90H21EOLACvtfcHk0lhyd14bAnIrfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltV2ls7s%253D&md5=095cffd33d1b11cd07913a07e3f78c27</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%2BX.%26aulast%3DMa%26aufirst%3DW.%2BY.%26aulast%3DZhang%26aufirst%3DC.%2BN.%26atitle%3DStereoselective%2520synthesis%2520and%2520anticancer%2520activities%2520of%2520new%2520podophyllotoxin%2520derivatives%253A%25204-%25CE%25B2-cyano-4-deoxy-4%25E2%2580%25B2-demethylepipodophyllotoxin%2520and%25204-%25CE%25B2-carboxyl-4-deoxy-4%25E2%2580%25B2-demethylepipodophyllotoxin%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D11%26spage%3D505%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Nogrady, T.; Weaver, D. F.</span> <span class="citation_source-book">Medicinal Chemistry: A Molecular and Biochemical Approach</span>; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">22</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=22&author=T.+Nogrady&author=D.+F.+Weaver&title=Medicinal+Chemistry%3A+A+Molecular+and+Biochemical+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNogrady%26aufirst%3DT.%26btitle%3DMedicinal%2520Chemistry%253A%2520A%2520Molecular%2520and%2520Biochemical%2520Approach%26pub%3DOxford%2520University%2520Press%26date%3D2005%26spage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="note"><p class="first last">ADME is an common acronym describing the pharamacokinetics and pharmacology of an active pharmaceutical ingredient within an organism: absorption, distribution, metabolism, and excretion.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lgduWv-4kYKhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">KeserÃ¼, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">â</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C3%BCauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit180b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D. J.</span><span> </span><span class="NLM_article-title">Is there a difference between leads and drugs? A historical perspective</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">â</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci010366a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1308-1315&author=T.+I.+Opreaauthor=A.+M.+Davisauthor=S.+J.+Teagueauthor=P.+D.+J.+Leeson&title=Is+there+a+difference+between+leads+and+drugs%3F+A+historical+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180bR"><div class="casContent"><span class="casTitleNuber">180b</span><div class="casTitle"><span class="NLM_cas:atitle">Is There a Difference between Leads and Drugs? A Historical Perspective</span></div><div class="casAuthors">Oprea, Tudor I.; Davis, Andrew M.; Teague, Simon J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To be considered for further development, lead structures should display the following properties: (1) simple chem. features, amenable for chem. optimization; (2) membership to an established SAR series; (3) favorable patent situation; and (4) good absorption, distribution, metab., and excretion (ADME) properties.  There are two distinct categories of leads: those that lack any therapeutic use (i.e., "pure" leads), and those that are marketed drugs themselves but have been altered to yield novel drugs.  We have previously analyzed the design of leadlike combinatorial libraries starting from 18 lead and drug pairs of structures (S. J. Teague et al. Angew. Chem., Int. Ed. Engl. 1999, 38, 3743-3748).  Here, we report results based on an extended dataset of 96 lead-drug pairs, of which 62 are lead structures that are not marketed as drugs, and 75 are drugs that are not presumably used as leads.  We examd. the following properties: MW (mol. wt.), CMR (the calcd. mol. refractivity), RNG (the no. of rings), RTB (the no. of rotatable bonds), the no. of hydrogen bond donors (HDO) and acceptors (HAC), the calcd. logarithm of the n-octanol/water partition (CLogP), the calcd. logarithm of the distribution coeff. at pH 7.4 (LogD74), the Daylight-fingerprint druglike score (DFPS), and the property and pharmacophore features score (PPFS).  The following differences were obsd. between the medians of drugs and leads: ÎMW = 69; ÎCMR = 1.8; ÎRNG = ÎHAC =1; ÎRTB = 2; ÎCLogP = 0.43; ÎLogD74 = 0.97; ÎHDO = 0; ÎDFPS = 0.15; ÎPPFS = 0.12.  Lead structures exhibit, on the av., less mol. complexity (less MW, less no. of rings and rotatable bonds), are less hydrophobic (lower CLogP and LogD74), and less druglike (lower druglike scores).  These findings indicate that the process of optimizing a lead into a drug results in more complex structures.  This information should be used in the design of novel combinatorial libraries that are aimed at lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4E0R8n7tLrVg90H21EOLACvtfcHk0lgduWv-4kYKhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D&md5=422b9cf937168d9c2f3d1c8429648ea0</span></div><a href="/servlet/linkout?suffix=cit180b&amp;dbid=16384&amp;doi=10.1021%2Fci010366a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010366a%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DIs%2520there%2520a%2520difference%2520between%2520leads%2520and%2520drugs%253F%2520A%2520historical%2520perspective%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D1308%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="note"><p class="first last">The term logâ<i>P</i> is the ratio of an un-ionized drug distributed between octanol and water phases at equilibrium. High logâ<i>P</i> ratios correlate with increased lipophilicity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="note"><p class="first last">The term logâ<i>D</i> is the 1-octanolâwater coefficient at different pH values.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgduWv-4kYKhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e','cit10f','cit10g','cit10h'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22a','cit22b'],'ref23':[],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38a','cit38b'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41a','cit41b'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53a','cit53b'],'ref54':['cit54'],'ref55':['cit55a','cit55b'],'ref56':['cit56'],'ref57':['cit57a','cit57b'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62a','cit62b'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67a','cit67b'],'ref68':['cit68a','cit68b'],'ref69':['cit69a','cit69b'],'ref70':['cit70a','cit70b'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81a','cit81b'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88a','cit88b'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92a','cit92b'],'ref93':['cit93a','cit93b'],'ref94':['cit94'],'ref95':['cit95a','cit95b'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102a','cit102b'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105a','cit105b'],'ref106':['cit106'],'ref107':['cit107a','cit107b'],'ref108':['cit108a','cit108b','cit108c'],'ref109':['cit109'],'ref110':['cit110a','cit110b'],'ref111':['cit111'],'ref112':['cit112a','cit112b'],'ref113':['cit113a','cit113b','cit113c'],'ref114':['cit114a','cit114b'],'ref115':['cit115a','cit115b'],'ref116':['cit116a','cit116b'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120a','cit120b'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127a','cit127b','cit127c'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131a','cit131b'],'ref132':['cit132a','cit132b','cit132c'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141a','cit141b'],'ref142':['cit142a','cit142b'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145a','cit145b'],'ref146':['cit146'],'ref147':['cit147a','cit147b','cit147c'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159a','cit159b'],'ref160':['cit160a','cit160b'],'ref161':['cit161'],'ref162':['cit162a','cit162b'],'ref163':['cit163a','cit163b','cit163c','cit163d'],'ref164':['cit164a','cit164b'],'ref165':['cit165a','cit165b'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':[],'ref179':['cit179'],'ref180':['cit180a','cit180b'],'ref181':[],'ref182':[],'ref183':['cit183']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 865 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ying Ding, Jinguo Long, Feilong Sun, <span class="NLM_string-name hlFld-ContribAuthor">Xianjie Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Isomerization/Allylic Cyanation of Alkenyl Alcohols. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c02143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c02143%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNickel-Catalyzed%252BIsomerization%25252FAllylic%252BCyanation%252Bof%252BAlkenyl%252BAlcohols%26aulast%3DDing%26aufirst%3DYing%26date%3D2021%26date%3D2021%26date%3D25062021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kunsoon Kim, Seulchan Lee, <span class="NLM_string-name hlFld-ContribAuthor">Soon Hyeok Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Direct C(sp3)âH Cyanation Enabled by a Highly Active Decatungstate Photocatalyst. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (14)
                                     , 5501-5505. <a href="https://doi.org/10.1021/acs.orglett.1c01846" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01846%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirect%252BC%252528sp3%252529%2525E2%252580%252593H%252BCyanation%252BEnabled%252Bby%252Ba%252BHighly%252BActive%252BDecatungstate%252BPhotocatalyst%26aulast%3DKim%26aufirst%3DKunsoon%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D03062021%26date%3D06072021%26volume%3D23%26issue%3D14%26spage%3D5501%26epage%3D5505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Runyou Ye, Maoshuai Zhu, Xufei Yan, Yang Long, Ying Xia, <span class="NLM_string-name hlFld-ContribAuthor">Xiangge Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Pd(II)-Catalyzed CâC Bond Cleavage by a Formal Group-Exchange Reaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (14)
                                     , 8678-8683. <a href="https://doi.org/10.1021/acscatal.1c01850" title="DOI URL">https://doi.org/10.1021/acscatal.1c01850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.1c01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.1c01850%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DPd%252528II%252529-Catalyzed%252BC%2525E2%252595%252590C%252BBond%252BCleavage%252Bby%252Ba%252BFormal%252BGroup-Exchange%252BReaction%26aulast%3DYe%26aufirst%3DRunyou%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23042021%26date%3D29062021%26date%3D01072021%26volume%3D11%26issue%3D14%26spage%3D8678%26epage%3D8683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">L. Reginald Mills, Racquel K. Edjoc, <span class="NLM_string-name hlFld-ContribAuthor">Sophie A. L. Rousseaux</span>. </span><span class="cited-content_cbyCitation_article-title">Design of an Electron-Withdrawing Benzonitrile Ligand for Ni-Catalyzed Cross-Coupling Involving Tertiary Nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (27)
                                     , 10422-10428. <a href="https://doi.org/10.1021/jacs.1c05281" title="DOI URL">https://doi.org/10.1021/jacs.1c05281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c05281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c05281%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDesign%252Bof%252Ban%252BElectron-Withdrawing%252BBenzonitrile%252BLigand%252Bfor%252BNi-Catalyzed%252BCross-Coupling%252BInvolving%252BTertiary%252BNucleophiles%26aulast%3DMills%26aufirst%3DL.%2BReginald%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23052021%26date%3D01072021%26volume%3D143%26issue%3D27%26spage%3D10422%26epage%3D10428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao-Yu Lu, Ze-Jie Xia, Ang Gao, Qi-Le Liu, Run-Chuang Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Chuang-Chuang Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Nickel/Ruthenium Strategy for Photoinduced Decarboxylative Cross-Coupling of Î±,Î²-Unsaturated Carboxylic Acids with Cycloketone Oxime Esters. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (13)
                                     , 8829-8842. <a href="https://doi.org/10.1021/acs.joc.1c00726" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00726%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDual%252BNickel%25252FRuthenium%252BStrategy%252Bfor%252BPhotoinduced%252BDecarboxylative%252BCross-Coupling%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarboxylic%252BAcids%252Bwith%252BCycloketone%252BOxime%252BEsters%26aulast%3DLu%26aufirst%3DXiao-Yu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D29032021%26date%3D10062021%26volume%3D86%26issue%3D13%26spage%3D8829%26epage%3D8842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tetsuya Ezawa, Yoshihiro Sohtome, Daisuke Hashizume, Masaya Adachi, Mai Akakabe, Hiroyuki Koshino, <span class="NLM_string-name hlFld-ContribAuthor">Mikiko Sodeoka</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamics in Catalytic Asymmetric Diastereoconvergent (3 + 2) Cycloadditions with Isomerizable Nitrones and Î±-Keto Ester Enolates. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (24)
                                     , 9094-9104. <a href="https://doi.org/10.1021/jacs.1c02833" title="DOI URL">https://doi.org/10.1021/jacs.1c02833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c02833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c02833%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDynamics%252Bin%252BCatalytic%252BAsymmetric%252BDiastereoconvergent%252B%2525283%252B%25252B%252B2%252529%252BCycloadditions%252Bwith%252BIsomerizable%252BNitrones%252Band%252B%2525CE%2525B1-Keto%252BEster%252BEnolates%26aulast%3DEzawa%26aufirst%3DTetsuya%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15032021%26date%3D10062021%26volume%3D143%26issue%3D24%26spage%3D9094%26epage%3D9104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Basujit Chatterjee, Soumyashree Jena, Vishal Chugh, Thomas WeyhermÃ¼ller, <span class="NLM_string-name hlFld-ContribAuthor">Christophe WerlÃ©</span>. </span><span class="cited-content_cbyCitation_article-title">A Molecular Iron-Based System for Divergent Bond Activation: Controlling the Reactivity of Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (12)
                                     , 7176-7185. <a href="https://doi.org/10.1021/acscatal.1c00733" title="DOI URL">https://doi.org/10.1021/acscatal.1c00733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.1c00733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.1c00733%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DA%252BMolecular%252BIron-Based%252BSystem%252Bfor%252BDivergent%252BBond%252BActivation%25253A%252BControlling%252Bthe%252BReactivity%252Bof%252BAldehydes%26aulast%3DChatterjee%26aufirst%3DBasujit%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15022021%26date%3D23042021%26date%3D04062021%26volume%3D11%26issue%3D12%26spage%3D7176%26epage%3D7185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feilong Sun, Ting Wang, Gui-Juan Cheng, <span class="NLM_string-name hlFld-ContribAuthor">Xianjie Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Nickel-Catalyzed Hydrocyanative Desymmetrization of Norbornene Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (12)
                                     , 7578-7583. <a href="https://doi.org/10.1021/acscatal.1c01971" title="DOI URL">https://doi.org/10.1021/acscatal.1c01971</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.1c01971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.1c01971%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DEnantioselective%252BNickel-Catalyzed%252BHydrocyanative%252BDesymmetrization%252Bof%252BNorbornene%252BDerivatives%26aulast%3DSun%26aufirst%3DFeilong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D03062021%26date%3D09062021%26volume%3D11%26issue%3D12%26spage%3D7578%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhuo Wang, Tao Chen, Hua Liu, Xiao-Li Zhao, Wei-Bo Hu, Hui Yang, Yahu A. Liu, <span class="NLM_string-name hlFld-ContribAuthor">Ke Wen</span>. </span><span class="cited-content_cbyCitation_article-title">Pillar[5]arene-Derived endo-Functionalized Molecular Tube for Mimicking ProteinâLigand Interactions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (9)
                                     , 6467-6477. <a href="https://doi.org/10.1021/acs.joc.1c00314" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00314%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPillar%25255B5%25255Darene-Derived%252Bendo-Functionalized%252BMolecular%252BTube%252Bfor%252BMimicking%252BProtein%2525E2%252580%252593Ligand%252BInteractions%26aulast%3DWang%26aufirst%3DZhuo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08022021%26date%3D19042021%26volume%3D86%26issue%3D9%26spage%3D6467%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin G. Reed-Berendt, Daniel E. Latham, Mubarak B. Dambatta, <span class="NLM_string-name hlFld-ContribAuthor">Louis C. Morrill</span>. </span><span class="cited-content_cbyCitation_article-title">Borrowing Hydrogen for Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2021,</strong> <em>7 </em>
                                    (4)
                                     , 570-585. <a href="https://doi.org/10.1021/acscentsci.1c00125" title="DOI URL">https://doi.org/10.1021/acscentsci.1c00125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.1c00125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.1c00125%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DBorrowing%252BHydrogen%252Bfor%252BOrganic%252BSynthesis%26aulast%3DReed-Berendt%26aufirst%3DBenjamin%2BG.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D24012021%26date%3D25032021%26volume%3D7%26issue%3D4%26spage%3D570%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Francesco Ferlin, Federica Valentini, Giulia Brufani, Daniela Lanari, <span class="NLM_string-name hlFld-ContribAuthor">Luigi Vaccaro</span>. </span><span class="cited-content_cbyCitation_article-title">Waste-Minimized Cyanosilylation of Carbonyls Using Fluoride on Polymeric Ionic Tags in Batch and under Continuous Flow Conditions. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2021,</strong> <em>9 </em>
                                    (16)
                                     , 5740-5749. <a href="https://doi.org/10.1021/acssuschemeng.1c01138" title="DOI URL">https://doi.org/10.1021/acssuschemeng.1c01138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.1c01138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.1c01138%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DWaste-Minimized%252BCyanosilylation%252Bof%252BCarbonyls%252BUsing%252BFluoride%252Bon%252BPolymeric%252BIonic%252BTags%252Bin%252BBatch%252Band%252Bunder%252BContinuous%252BFlow%252BConditions%26aulast%3DFerlin%26aufirst%3DFrancesco%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18022021%26date%3D26032021%26date%3D15042021%26volume%3D9%26issue%3D16%26spage%3D5740%26epage%3D5749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Minghao Feng, Joao De Oliveira, Antoine Sallustrau, Gianluca Destro, Pierre ThuÃ©ry, Sebastien Roy, Thibault Cantat, Charles S. Elmore, Jorg Blankenstein, FrÃ©dÃ©ric Taran, <span class="NLM_string-name hlFld-ContribAuthor">Davide Audisio</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Carbon Isotope Exchange of Pharmaceuticals via Reversible Decyanation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (15)
                                     , 5659-5665. <a href="https://doi.org/10.1021/jacs.1c01923" title="DOI URL">https://doi.org/10.1021/jacs.1c01923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c01923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c01923%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDirect%252BCarbon%252BIsotope%252BExchange%252Bof%252BPharmaceuticals%252Bvia%252BReversible%252BDecyanation%26aulast%3DFeng%26aufirst%3DMinghao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18022021%26date%3D07042021%26volume%3D143%26issue%3D15%26spage%3D5659%26epage%3D5665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junjie Ma, Hao Liu, Xin He, Zhicheng Chen, Yue Liu, Chuanfu Hou, Zhizhong Sun, <span class="NLM_string-name hlFld-ContribAuthor">Wenyi Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Ni-Catalyzed CâH Cyanation of (Hetero)arenes with 2-Cyanoisothiazolidine 1,1-Dioxide as a Cyanation Reagent. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (8)
                                     , 2868-2872. <a href="https://doi.org/10.1021/acs.orglett.1c00468" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00468%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNi-Catalyzed%252BC%2525E2%252580%252593H%252BCyanation%252Bof%252B%252528Hetero%252529arenes%252Bwith%252B2-Cyanoisothiazolidine%252B1%25252C1-Dioxide%252Bas%252Ba%252BCyanation%252BReagent%26aulast%3DMa%26aufirst%3DJunjie%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08022021%26date%3D31032021%26volume%3D23%26issue%3D8%26spage%3D2868%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shan Jiang, Christos Iliopoulos-Tsoutsouvas, Fei Tong, Christina A. Brust, Catherine M. Keenan, Jimit Girish Raghav, Tian Hua, Simiao Wu, Jo-Hao Ho, Yiran Wu, Travis W. Grim, Nikolai Zvonok, Ganesh A. Thakur, Zhi-Jie Liu, Keith A. Sharkey, Laura M. Bohn, Spyros P. Nikas, <span class="NLM_string-name hlFld-ContribAuthor">Alexandros Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3870-3884. <a href="https://doi.org/10.1021/acs.jmedchem.0c02053" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BFunctionalized%252BCannabinoid%252BReceptor%252BProbes%25253A%252BDevelopment%252Bof%252BExceptionally%252BPotent%252BAgonists%26aulast%3DJiang%26aufirst%3DShan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25112020%26date%3D24032021%26volume%3D64%26issue%3D7%26spage%3D3870%26epage%3D3884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sean W. Reilly, Yu-hong Lam, Sumei Ren, <span class="NLM_string-name hlFld-ContribAuthor">Neil A. Strotman</span>. </span><span class="cited-content_cbyCitation_article-title">Late-Stage Carbon Isotope Exchange of Aryl Nitriles through Ni-Catalyzed CâCN Bond Activation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (12)
                                     , 4817-4823. <a href="https://doi.org/10.1021/jacs.1c01454" title="DOI URL">https://doi.org/10.1021/jacs.1c01454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c01454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c01454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DLate-Stage%252BCarbon%252BIsotope%252BExchange%252Bof%252BAryl%252BNitriles%252Bthrough%252BNi-Catalyzed%252BC%2525E2%252580%252593CN%252BBond%252BActivation%26aulast%3DReilly%26aufirst%3DSean%2BW.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05022021%26date%3D16032021%26volume%3D143%26issue%3D12%26spage%3D4817%26epage%3D4823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fu-Dong Lu, Liang-Qiu Lu, Gui-Feng He, Jun-Chuan Bai, <span class="NLM_string-name hlFld-ContribAuthor">Wen-Jing Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Radical Carbocyanation of 1,3-Dienes via Photocatalytic Generation of Allylcopper Complexes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (11)
                                     , 4168-4173. <a href="https://doi.org/10.1021/jacs.1c01260" title="DOI URL">https://doi.org/10.1021/jacs.1c01260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c01260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c01260%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DEnantioselective%252BRadical%252BCarbocyanation%252Bof%252B1%25252C3-Dienes%252Bvia%252BPhotocatalytic%252BGeneration%252Bof%252BAllylcopper%252BComplexes%26aulast%3DLu%26aufirst%3DFu-Dong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D02022021%26date%3D11032021%26volume%3D143%26issue%3D11%26spage%3D4168%26epage%3D4173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amreen K. Bains, Yadav Ankit, <span class="NLM_string-name hlFld-ContribAuthor">Debashis Adhikari</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrenedione-Catalyzed Î±-Olefination of Nitriles under Visible-Light Photoredox Conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (6)
                                     , 2019-2023. <a href="https://doi.org/10.1021/acs.orglett.1c00162" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00162%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPyrenedione-Catalyzed%252B%2525CE%2525B1-Olefination%252Bof%252BNitriles%252Bunder%252BVisible-Light%252BPhotoredox%252BConditions%26aulast%3DBains%26aufirst%3DAmreen%2BK.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D10032021%26volume%3D23%26issue%3D6%26spage%3D2019%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Corie M. McHale, Lucas J. Karas, Xiqu Wang, Judy I. Wu, <span class="NLM_string-name hlFld-ContribAuthor">Ognjen Å . MiljaniÄ</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclobenzoin Esters as Hosts for Thin Guests. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (6)
                                     , 2253-2257. <a href="https://doi.org/10.1021/acs.orglett.1c00383" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00383%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCyclobenzoin%252BEsters%252Bas%252BHosts%252Bfor%252BThin%252BGuests%26aulast%3DMcHale%26aufirst%3DCorie%2BM.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01022021%26date%3D26022021%26volume%3D23%26issue%3D6%26spage%3D2253%26epage%3D2257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chufeng Zhang, Wenyan Qi, Yong Li, Minghai Tang, Tao Yang, Kongjun Liu, Yong Chen, Dexin Deng, Mingli Xiang, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(4-(2-((1H-Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1966-1988. <a href="https://doi.org/10.1021/acs.jmedchem.0c01468" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01468%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%2525284-%2525282-%252528%2525281H-Indol-5-yl%252529amino%252529-5-fluoropyrimidin-4-yl%252529-1H-pyrazol-1-yl%252529propanenitrile%252BDerivatives%252Bas%252BSelective%252BTYK2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BBowel%252BDisease%26aulast%3DZhang%26aufirst%3DChufeng%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28082020%26date%3D16022021%26volume%3D64%26issue%3D4%26spage%3D1966%26epage%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ting Cui, Yanling Zhan, Changhui Dai, Jun Lin, Ping Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peipei Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical Oxidative Regioselective CâH Cyanation of Imidazo[1,2-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c03026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c03026%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DElectrochemical%252BOxidative%252BRegioselective%252BC%2525E2%252580%252593H%252BCyanation%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyridines%26aulast%3DCui%26aufirst%3DTing%26date%3D2021%26date%3D2020%26date%3D24122020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lu Chen, Xi Chen, Tingting Zhu, Haibing Shao, Zhihua Chen, Yan Hu, Zhenjiang Liu, <span class="NLM_string-name hlFld-ContribAuthor">Chuanxiang Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanide Ion-Promoted Nucleophilic Displacement of Aromatic Nitro Groups: A Mild, One-Pot, Transition Metal-Free Synthesis of Nitrile-Containing Naphthalimide Aryl Ether Derivatives. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (3)
                                     , 3059-3064. <a href="https://doi.org/10.1021/acs.joc.0c02598" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02598%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCyanide%252BIon-Promoted%252BNucleophilic%252BDisplacement%252Bof%252BAromatic%252BNitro%252BGroups%25253A%252BA%252BMild%25252C%252BOne-Pot%25252C%252BTransition%252BMetal-Free%252BSynthesis%252Bof%252BNitrile-Containing%252BNaphthalimide%252BAryl%252BEther%252BDerivatives%26aulast%3DChen%26aufirst%3DLu%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D01112020%26date%3D12012021%26volume%3D86%26issue%3D3%26spage%3D3059%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ming Li, Cui-Tian Wang, Qiao-Fei Bao, Yi-Feng Qiu, Wan-Xu Wei, Xue-Song Li, Yu-Zhao Wang, Zhe Zhang, Jin-Lin Wang, <span class="NLM_string-name hlFld-ContribAuthor">Yong-Min Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Radical Aryl Migration Approach for the Preparation of Cyanoalkylsulfonylated Oxindoles/Cyanoalkyl Amides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 751-756. <a href="https://doi.org/10.1021/acs.orglett.0c03973" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03973%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BRadical%252BAryl%252BMigration%252BApproach%252Bfor%252Bthe%252BPreparation%252Bof%252BCyanoalkylsulfonylated%252BOxindoles%25252FCyanoalkyl%252BAmides%26aulast%3DLi%26aufirst%3DMing%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D01122020%26date%3D21012021%26volume%3D23%26issue%3D3%26spage%3D751%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rongrong Yu, Yidan Xing, <span class="NLM_string-name hlFld-ContribAuthor">Xianjie Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Regio-, Chemo-, and Enantioselective Ni-Catalyzed Hydrocyanation of 1,3-Dienes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 930-935. <a href="https://doi.org/10.1021/acs.orglett.0c04133" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04133%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRegio-%25252C%252BChemo-%25252C%252Band%252BEnantioselective%252BNi-Catalyzed%252BHydrocyanation%252Bof%252B1%25252C3-Dienes%26aulast%3DYu%26aufirst%3DRongrong%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D15122020%26date%3D22012021%26volume%3D23%26issue%3D3%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Killian Oukoloff, Goodwell Nzou, Carmine Varricchio, Bobby Lucero, Thibault Alle, Jane Kovalevich, Ludovica Monti, Anne-Sophie Cornec, Yuemang Yao, Michael J. James, John Q. Trojanowski, Virginia M.-Y. Lee, Amos B. Smith, III, Andrea Brancale, Kurt R. Brunden, <span class="NLM_string-name hlFld-ContribAuthor">Carlo Ballatore</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the StructureâActivity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-a]pyrimidines Identifies New Candidates for Neurodegenerative Tauopathies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1073-1102. <a href="https://doi.org/10.1021/acs.jmedchem.0c01605" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01605%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252Bthe%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BMicrotubule-Targeting%252B1%25252C2%25252C4-Triazolo%25255B1%25252C5-a%25255Dpyrimidines%252BIdentifies%252BNew%252BCandidates%252Bfor%252BNeurodegenerative%252BTauopathies%26aulast%3DOukoloff%26aufirst%3DKillian%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28092020%26date%3D07012021%26volume%3D64%26issue%3D2%26spage%3D1073%26epage%3D1102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jing Xiao, Fengzhe Guo, Yinfeng Li, Fangshao Li, Qiang Li, <span class="NLM_string-name hlFld-ContribAuthor">Zi-Long Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine Promoted Conversion of Esters to Nitriles and Ketones under Metal-Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (2)
                                     , 2028-2035. <a href="https://doi.org/10.1021/acs.joc.0c02794" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02794%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIodine%252BPromoted%252BConversion%252Bof%252BEsters%252Bto%252BNitriles%252Band%252BKetones%252Bunder%252BMetal-Free%252BConditions%26aulast%3DXiao%26aufirst%3DJing%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23112020%26date%3D04012021%26volume%3D86%26issue%3D2%26spage%3D2028%26epage%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Prakash Basnet, Gang Hong, Charles E. Hendrick, <span class="NLM_string-name hlFld-ContribAuthor">Marisa C. Kozlowski</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Oxidation of Aryl Malononitriles Enabling a Copper-Catalyzed Intermolecular Alkene Carbochlorination. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (2)
                                     , 433-437. <a href="https://doi.org/10.1021/acs.orglett.0c03941" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03941%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirect%252BOxidation%252Bof%252BAryl%252BMalononitriles%252BEnabling%252Ba%252BCopper-Catalyzed%252BIntermolecular%252BAlkene%252BCarbochlorination%26aulast%3DBasnet%26aufirst%3DPrakash%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28112020%26date%3D04012021%26volume%3D23%26issue%3D2%26spage%3D433%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juliana R. Alexander, Veronika I. Shchepetkina, Ksenia S. Stankevich, Rory J. Benedict, Samuel P. Bernhard, Reagan J. Dreiling, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. Cook</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed Rearrangement of N-Alloc-N-allyl Ynamides via Auto-Tandem Catalysis: Evidence for Reversible CâN Activation and Pd(0)-Accelerated Ketenimine Aza-Claisen Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (2)
                                     , 559-564. <a href="https://doi.org/10.1021/acs.orglett.0c04078" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04078%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPd-Catalyzed%252BRearrangement%252Bof%252BN-Alloc-N-allyl%252BYnamides%252Bvia%252BAuto-Tandem%252BCatalysis%25253A%252BEvidence%252Bfor%252BReversible%252BC%2525E2%252580%252593N%252BActivation%252Band%252BPd%2525280%252529-Accelerated%252BKetenimine%252BAza-Claisen%252BRearrangement%26aulast%3DAlexander%26aufirst%3DJuliana%2BR.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09122020%26date%3D07012021%26volume%3D23%26issue%3D2%26spage%3D559%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoyu Yan, Xiaoqing Li, Yitu Wang, Yuyu Dai, Xinhuan Yan, Deming Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Xiangsheng Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Iminyl-Radical-Mediated CâC Cleavage/Amination and Alkene Iminoamination Enabled by Visible-Light-Induced Cerium Catalysis. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     , 101-105. <a href="https://doi.org/10.1021/acssuschemeng.0c07850" title="DOI URL">https://doi.org/10.1021/acssuschemeng.0c07850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.0c07850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.0c07850%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DIminyl-Radical-Mediated%252BC%2525E2%252580%252593C%252BCleavage%25252FAmination%252Band%252BAlkene%252BIminoamination%252BEnabled%252Bby%252BVisible-Light-Induced%252BCerium%252BCatalysis%26aulast%3DYan%26aufirst%3DXiaoyu%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27102020%26date%3D26112020%26date%3D24122020%26volume%3D9%26issue%3D1%26spage%3D101%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu Gao, Yusheng Quan, Zhenjiang Li, Luoyu Gao, Zhihao Zhang, Xin Zou, Rui Yan, Yuanyuan Qu, <span class="NLM_string-name hlFld-ContribAuthor">Kai Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic Three-Component 1,2-Cyanoalkylacylation of Alkenes via Radical Relay. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     , 183-189. <a href="https://doi.org/10.1021/acs.orglett.0c03907" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03907%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOrganocatalytic%252BThree-Component%252B1%25252C2-Cyanoalkylacylation%252Bof%252BAlkenes%252Bvia%252BRadical%252BRelay%26aulast%3DGao%26aufirst%3DYu%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D25112020%26date%3D18122020%26volume%3D23%26issue%3D1%26spage%3D183%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Roy Weinstain, TomÃ¡Å¡ Slanina, Dnyaneshwar Kand, <span class="NLM_string-name hlFld-ContribAuthor">Petr KlÃ¡n</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2020,</strong> <em>120 </em>
                                    (24)
                                     , 13135-13272. <a href="https://doi.org/10.1021/acs.chemrev.0c00663" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00663%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DVisible-to-NIR-Light%252BActivated%252BRelease%25253A%252BFrom%252BSmall%252BMolecules%252Bto%252BNanomaterials%26aulast%3DWeinstain%26aufirst%3DRoy%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25062020%26date%3D30102020%26volume%3D120%26issue%3D24%26spage%3D13135%26epage%3D13272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Prakash Basnet, Melissa B. Sebold, Charles E. Hendrick, <span class="NLM_string-name hlFld-ContribAuthor">Marisa C. Kozlowski</span>. </span><span class="cited-content_cbyCitation_article-title">Copper Catalyzed Oxidative Arylation of Tertiary Carbon Centers. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (24)
                                     , 9524-9528. <a href="https://doi.org/10.1021/acs.orglett.0c03581" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03581%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper%252BCatalyzed%252BOxidative%252BArylation%252Bof%252BTertiary%252BCarbon%252BCenters%26aulast%3DBasnet%26aufirst%3DPrakash%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27102020%26date%3D02122020%26volume%3D22%26issue%3D24%26spage%3D9524%26epage%3D9528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jaclyn R. Patterson, Lamont R. Terrell, Carla A. Donatelli, Dennis A. Holt, Larry J. Jolivette, Ralph A. Rivero, Theresa J. Roethke, Arthur Shu, Patrick Stoy, Guosen Ye, Mark Youngman, <span class="NLM_string-name hlFld-ContribAuthor">Brian G. Lawhorn</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14867-14884. <a href="https://doi.org/10.1021/acs.jmedchem.0c01303" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01303%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BOptimization%252Bof%252Ban%252BAcyclic%252BAmine%252BSeries%252Bof%252BTRPV4%252BAntagonists%252Bby%252BElectronic%252BModulation%252Bof%252BHydrogen%252BBond%252BInteractions%26aulast%3DPatterson%26aufirst%3DJaclyn%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09082020%26date%3D17112020%26volume%3D63%26issue%3D23%26spage%3D14867%26epage%3D14884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kentaro Futatsugi, Aaron C. Smith, Meihua Tu, Brian Raymer, Kay Ahn, Steven B. Coffey, Matthew S. Dowling, Dilinie P. Fernando, Jemy A. Gutierrez, Kim Huard, Jayasankar Jasti, Amit S. Kalgutkar, John D. Knafels, Jayvardhan Pandit, Kevin D. Parris, Sylvie Perez, Jeffrey A. Pfefferkorn, David A. Price, Tim Ryder, Andre Shavnya, Ingrid A. Stock, Andy S. Tsai, Gregory J. Tesz, Benjamin A. Thuma, Yan Weng, Hanna M. Wisniewska, Gang Xing, Jun Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Thomas V. Magee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13546-13560. <a href="https://doi.org/10.1021/acs.jmedchem.0c00944" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00944%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPF-06835919%25253A%252BA%252BPotent%252BInhibitor%252Bof%252BKetohexokinase%252B%252528KHK%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BMetabolic%252BDisorders%252BDriven%252Bby%252Bthe%252BOverconsumption%252Bof%252BFructose%26aulast%3DFutatsugi%26aufirst%3DKentaro%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D27092020%26date%3D10092020%26volume%3D63%26issue%3D22%26spage%3D13546%26epage%3D13560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Padmaja D. Wakchaure, Shibaji Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Bishwajit Ganguly</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2020,</strong> <em>124 </em>
                                    (47)
                                     , 10641-10652. <a href="https://doi.org/10.1021/acs.jpcb.0c06747" title="DOI URL">https://doi.org/10.1021/acs.jpcb.0c06747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.0c06747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.0c06747%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DRevealing%252Bthe%252BInhibition%252BMechanism%252Bof%252BRNA-Dependent%252BRNA%252BPolymerase%252B%252528RdRp%252529%252Bof%252BSARS-CoV-2%252Bby%252BRemdesivir%252Band%252BNucleotide%252BAnalogues%25253A%252BA%252BMolecular%252BDynamics%252BSimulation%252BStudy%26aulast%3DWakchaure%26aufirst%3DPadmaja%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23072020%26date%3D23102020%26date%3D15112020%26volume%3D124%26issue%3D47%26spage%3D10641%26epage%3D10652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Masanori Shigeno, Kazutoshi Hayashi, Kanako Nozawa-Kumada, <span class="NLM_string-name hlFld-ContribAuthor">Yoshinori Kondo</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic C(sp2)âC(sp3) Bond Formation of Methoxyarenes by the Organic Superbase t-Bu-P4. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (22)
                                     , 9107-9113. <a href="https://doi.org/10.1021/acs.orglett.0c03507" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03507</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03507%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BC%252528sp2%252529%2525E2%252580%252593C%252528sp3%252529%252BBond%252BFormation%252Bof%252BMethoxyarenes%252Bby%252Bthe%252BOrganic%252BSuperbase%252Bt-Bu-P4%26aulast%3DShigeno%26aufirst%3DMasanori%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21102020%26date%3D11112020%26volume%3D22%26issue%3D22%26spage%3D9107%26epage%3D9113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong-Liang Su, Linh Tram, Daniel Wherritt, Hadi Arman, Wendell P. Griffith, <span class="NLM_string-name hlFld-ContribAuthor">Michael P. Doyle</span>. </span><span class="cited-content_cbyCitation_article-title">Î±-Amino Radical-Mediated Diverse Difunctionalization of Alkenes: Construction of CâC, CâN, and CâS Bonds. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (22)
                                     , 13682-13687. <a href="https://doi.org/10.1021/acscatal.0c04243" title="DOI URL">https://doi.org/10.1021/acscatal.0c04243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c04243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c04243%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3D%2525CE%2525B1-Amino%252BRadical-Mediated%252BDiverse%252BDifunctionalization%252Bof%252BAlkenes%25253A%252BConstruction%252Bof%252BC%2525E2%252580%252593C%25252C%252BC%2525E2%252580%252593N%25252C%252Band%252BC%2525E2%252580%252593S%252BBonds%26aulast%3DSu%26aufirst%3DYong-Liang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30092020%26date%3D30102020%26date%3D10112020%26volume%3D10%26issue%3D22%26spage%3D13682%26epage%3D13687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingdong Jiao, Jihui Gao, <span class="NLM_string-name hlFld-ContribAuthor">Xianjie Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of 4-Cyanotetrahydroquinolines via Ni-Catalyzed Hydrocyanation of 1,2-Dihydroquinolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (21)
                                     , 8566-8571. <a href="https://doi.org/10.1021/acs.orglett.0c03171" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03171%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEnantioselective%252BSynthesis%252Bof%252B4-Cyanotetrahydroquinolines%252Bvia%252BNi-Catalyzed%252BHydrocyanation%252Bof%252B1%25252C2-Dihydroquinolines%26aulast%3DJiao%26aufirst%3DMingdong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21092020%26date%3D21102020%26volume%3D22%26issue%3D21%26spage%3D8566%26epage%3D8571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">CÃ©line Dorval, Maxime Tricoire, Jeanne-Marie Begouin, Vincent Gandon, <span class="NLM_string-name hlFld-ContribAuthor">Corinne Gosmini</span>. </span><span class="cited-content_cbyCitation_article-title">Cobalt-Catalyzed C(sp2)âCN Bond Activation: Cross-Electrophile Coupling for Biaryl Formation and Mechanistic Insight. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (21)
                                     , 12819-12827. <a href="https://doi.org/10.1021/acscatal.0c03903" title="DOI URL">https://doi.org/10.1021/acscatal.0c03903</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03903%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCobalt-Catalyzed%252BC%252528sp2%252529%2525E2%252580%252593CN%252BBond%252BActivation%25253A%252BCross-Electrophile%252BCoupling%252Bfor%252BBiaryl%252BFormation%252Band%252BMechanistic%252BInsight%26aulast%3DDorval%26aufirst%3DC%25C3%25A9line%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07092020%26date%3D07102020%26date%3D19102020%26volume%3D10%26issue%3D21%26spage%3D12819%26epage%3D12827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aiyou Xia, Peizhuo Lv, Xin Xie, <span class="NLM_string-name hlFld-ContribAuthor">Yuanhong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Cyanation of Unactivated Alkyl Sulfonates with Zn(CN)2. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (20)
                                     , 7842-7847. <a href="https://doi.org/10.1021/acs.orglett.0c02722" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02722</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02722%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNickel-Catalyzed%252BCyanation%252Bof%252BUnactivated%252BAlkyl%252BSulfonates%252Bwith%252BZn%252528CN%2525292%26aulast%3DXia%26aufirst%3DAiyou%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D02102020%26volume%3D22%26issue%3D20%26spage%3D7842%26epage%3D7847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenghua Li, Liang Zhang, Masayoshi Nishiura, Gen Luo, Yi Luo, <span class="NLM_string-name hlFld-ContribAuthor">Zhaomin Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Cyanoborylation of Allenes by N-Heterocyclic Carbene-Copper Catalysts. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (20)
                                     , 11685-11692. <a href="https://doi.org/10.1021/acscatal.0c03018" title="DOI URL">https://doi.org/10.1021/acscatal.0c03018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03018%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DEnantioselective%252BCyanoborylation%252Bof%252BAllenes%252Bby%252BN-Heterocyclic%252BCarbene-Copper%252BCatalysts%26aulast%3DLi%26aufirst%3DZhenghua%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10072020%26date%3D31082020%26date%3D02102020%26date%3D11092020%26volume%3D10%26issue%3D20%26spage%3D11685%26epage%3D11692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kento Asai, Koji Hirano, <span class="NLM_string-name hlFld-ContribAuthor">Masahiro Miura</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent Synthesis of Isonitriles and Nitriles by Palladium-Catalyzed Benzylic Substitution with TMSCN. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (19)
                                     , 12703-12714. <a href="https://doi.org/10.1021/acs.joc.0c01861" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01861%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDivergent%252BSynthesis%252Bof%252BIsonitriles%252Band%252BNitriles%252Bby%252BPalladium-Catalyzed%252BBenzylic%252BSubstitution%252Bwith%252BTMSCN%26aulast%3DAsai%26aufirst%3DKento%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03082020%26date%3D22092020%26date%3D10092020%26volume%3D85%26issue%3D19%26spage%3D12703%26epage%3D12714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ming-Yang Xiao, Meng-Meng Zheng, Xing Peng, Xiao-Song Xue, Fa-Guang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jun-An Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Direct Construction of Cyano-tetrazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (19)
                                     , 7762-7767. <a href="https://doi.org/10.1021/acs.orglett.0c03025" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03025%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BDirect%252BConstruction%252Bof%252BCyano-tetrazoles%26aulast%3DXiao%26aufirst%3DMing-Yang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10092020%26date%3D23092020%26volume%3D22%26issue%3D19%26spage%3D7762%26epage%3D7767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Md Muktadir Talukder, John Michael O. Cue, Justin T. Miller, Prabhath L. Gamage, Amina Aslam, Gregory T. McCandless, Michael C. Biewer, <span class="NLM_string-name hlFld-ContribAuthor">Mihaela C. Stefan</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand Steric Effects of Î±-Diimine Nickel(II) and Palladium(II) Complexes in the SuzukiâMiyaura Cross-Coupling Reaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (37)
                                     , 24018-24032. <a href="https://doi.org/10.1021/acsomega.0c03415" title="DOI URL">https://doi.org/10.1021/acsomega.0c03415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c03415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c03415%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DLigand%252BSteric%252BEffects%252Bof%252B%2525CE%2525B1-Diimine%252BNickel%252528II%252529%252Band%252BPalladium%252528II%252529%252BComplexes%252Bin%252Bthe%252BSuzuki%2525E2%252580%252593Miyaura%252BCross-Coupling%252BReaction%26aulast%3DTalukder%26aufirst%3DMd%2BMuktadir%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16072020%26date%3D21082020%26date%3D10092020%26volume%3D5%26issue%3D37%26spage%3D24018%26epage%3D24032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jing Li, Linlin Shi, Shu-Ping Zhang, Xu-Yan Wang, Xinju Zhu, Xin-Qi Hao, <span class="NLM_string-name hlFld-ContribAuthor">Mao-Ping Song</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(III)-Catalyzed CâH Cyanation of 2H-Indazole with N-Cyano-N-phenyl-p-toluenesulfonamide. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (16)
                                     , 10835-10845. <a href="https://doi.org/10.1021/acs.joc.0c01386" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01386%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRh%252528III%252529-Catalyzed%252BC%2525E2%252580%252593H%252BCyanation%252Bof%252B2H-Indazole%252Bwith%252BN-Cyano-N-phenyl-p-toluenesulfonamide%26aulast%3DLi%26aufirst%3DJing%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11062020%26date%3D31072020%26date%3D21072020%26volume%3D85%26issue%3D16%26spage%3D10835%26epage%3D10845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Song Zhou, Guoyu Zhang, Liang Fu, Pinhong Chen, Yibiao Li, <span class="NLM_string-name hlFld-ContribAuthor">Guosheng Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Asymmetric Cyanation of Alkenes via Carbonyl-Assisted Coupling of Alkyl-Substituted Carbon-Centered Radicals. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (16)
                                     , 6299-6303. <a href="https://doi.org/10.1021/acs.orglett.0c02085" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02085%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BAsymmetric%252BCyanation%252Bof%252BAlkenes%252Bvia%252BCarbonyl-Assisted%252BCoupling%252Bof%252BAlkyl-Substituted%252BCarbon-Centered%252BRadicals%26aulast%3DZhou%26aufirst%3DSong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23062020%26date%3D31072020%26volume%3D22%26issue%3D16%26spage%3D6299%26epage%3D6303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter Ertl, Eva Altmann, <span class="NLM_string-name hlFld-ContribAuthor">Jeffrey M. McKenna</span>. </span><span class="cited-content_cbyCitation_article-title">The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8408-8418. <a href="https://doi.org/10.1021/acs.jmedchem.0c00754" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00754</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00754%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BMost%252BCommon%252BFunctional%252BGroups%252Bin%252BBioactive%252BMolecules%252Band%252BHow%252BTheir%252BPopularity%252BHas%252BEvolved%252Bover%252BTime%26aulast%3DErtl%26aufirst%3DPeter%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05052020%26date%3D29072020%26date%3D14072020%26volume%3D63%26issue%3D15%26spage%3D8408%26epage%3D8418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicolas Duchemin, Martin Cattoen, Oscar Gayraud, Silvia Anselmi, Bilal Siddiq, Roberto Buccafusca, Marc Daumas, Vincent Ferey, Michael Smietana, <span class="NLM_string-name hlFld-ContribAuthor">Stellios Arseniyadis</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Access to Highly Enantioenriched Î±-Branched Acrylonitriles through a One-Pot Sequential Asymmetric Michael Addition/Retro-Dieckmann/Retro-Michael Fragmentation Cascade. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (15)
                                     , 5995-6000. <a href="https://doi.org/10.1021/acs.orglett.0c02079" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02079%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirect%252BAccess%252Bto%252BHighly%252BEnantioenriched%252B%2525CE%2525B1-Branched%252BAcrylonitriles%252Bthrough%252Ba%252BOne-Pot%252BSequential%252BAsymmetric%252BMichael%252BAddition%25252FRetro-Dieckmann%25252FRetro-Michael%252BFragmentation%252BCascade%26aulast%3DDuchemin%26aufirst%3DNicolas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24062020%26date%3D28072020%26volume%3D22%26issue%3D15%26spage%3D5995%26epage%3D6000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Min Han, Min Yang, Rui Wu, Yang Li, Tao Jia, Yuanji Gao, Hai-Liang Ni, Ping Hu, Bi-Qin Wang, <span class="NLM_string-name hlFld-ContribAuthor">Peng Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Enantioselective Iridium-Catalyzed Coupling Reaction of Vinyl Azides and Racemic Allylic Carbonates. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (31)
                                     , 13398-13405. <a href="https://doi.org/10.1021/jacs.0c01766" title="DOI URL">https://doi.org/10.1021/jacs.0c01766</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c01766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c01766%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DHighly%252BEnantioselective%252BIridium-Catalyzed%252BCoupling%252BReaction%252Bof%252BVinyl%252BAzides%252Band%252BRacemic%252BAllylic%252BCarbonates%26aulast%3DHan%26aufirst%3DMin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13022020%26date%3D27072020%26date%3D14072020%26volume%3D142%26issue%3D31%26spage%3D13398%26epage%3D13405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hadis Hosseini Moghadam, Sara Sobhani, <span class="NLM_string-name hlFld-ContribAuthor">JosÃ© Miguel Sansano</span>. </span><span class="cited-content_cbyCitation_article-title">New Nanomagnetic Heterogeneous Cobalt Catalyst for the Synthesis of Aryl Nitriles and Biaryls. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (30)
                                     , 18619-18627. <a href="https://doi.org/10.1021/acsomega.0c01002" title="DOI URL">https://doi.org/10.1021/acsomega.0c01002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c01002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c01002%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DNew%252BNanomagnetic%252BHeterogeneous%252BCobalt%252BCatalyst%252Bfor%252Bthe%252BSynthesis%252Bof%252BAryl%252BNitriles%252Band%252BBiaryls%26aulast%3DMoghadam%26aufirst%3DHadis%2BHosseini%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05032020%26date%3D24062020%26date%3D22072020%26volume%3D5%26issue%3D30%26spage%3D18619%26epage%3D18627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Priyanka Chakraborty, Nidhi Garg, Eric Manoury, Rinaldo Poli, <span class="NLM_string-name hlFld-ContribAuthor">Basker Sundararaju</span>. </span><span class="cited-content_cbyCitation_article-title">C-Alkylation of Various Carbonucleophiles with Secondary Alcohols under CoIII-Catalysis. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (14)
                                     , 8023-8031. <a href="https://doi.org/10.1021/acscatal.0c01728" title="DOI URL">https://doi.org/10.1021/acscatal.0c01728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c01728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c01728%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DC-Alkylation%252Bof%252BVarious%252BCarbonucleophiles%252Bwith%252BSecondary%252BAlcohols%252Bunder%252BCoIII-Catalysis%26aulast%3DChakraborty%26aufirst%3DPriyanka%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17042020%26date%3D15062020%26date%3D08072020%26date%3D26062020%26volume%3D10%26issue%3D14%26spage%3D8023%26epage%3D8031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wen-Biao Wu, Jin-Sheng Yu, <span class="NLM_string-name hlFld-ContribAuthor">Jian Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Enantioselective Cyanation: Recent Advances and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (14)
                                     , 7668-7690. <a href="https://doi.org/10.1021/acscatal.0c01918" title="DOI URL">https://doi.org/10.1021/acscatal.0c01918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c01918%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCatalytic%252BEnantioselective%252BCyanation%25253A%252BRecent%252BAdvances%252Band%252BPerspectives%26aulast%3DWu%26aufirst%3DWen-Biao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D12062020%26date%3D28062020%26date%3D12062020%26volume%3D10%26issue%3D14%26spage%3D7668%26epage%3D7690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mai-Jan Tom, <span class="NLM_string-name hlFld-ContribAuthor">P. Andrew Evans</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective and Stereospecific Rhodium-Catalyzed Allylic Cyanomethylation with an Acetonitrile Equivalent: Construction of Acyclic Î²-Quaternary Stereogenic Nitriles. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (28)
                                     , 11957-11961. <a href="https://doi.org/10.1021/jacs.0c02316" title="DOI URL">https://doi.org/10.1021/jacs.0c02316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c02316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c02316%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DRegioselective%252Band%252BStereospecific%252BRhodium-Catalyzed%252BAllylic%252BCyanomethylation%252Bwith%252Ban%252BAcetonitrile%252BEquivalent%25253A%252BConstruction%252Bof%252BAcyclic%252B%2525CE%2525B2-Quaternary%252BStereogenic%252BNitriles%26aulast%3DTom%26aufirst%3DMai-Jan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27022020%26date%3D02072020%26date%3D02062020%26volume%3D142%26issue%3D28%26spage%3D11957%26epage%3D11961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jacob A. Smith, Spenser R. Simpson, Karl S. Westendorff, Justin Weatherford-Pratt, Jeffery T. Myers, Justin H. Wilde, Diane A. Dickie, <span class="NLM_string-name hlFld-ContribAuthor">W. Dean Harman</span>. </span><span class="cited-content_cbyCitation_article-title">Î·2 Coordination of Electron-Deficient Arenes with Group 6 Dearomatization Agents. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (13)
                                     , 2493-2510. <a href="https://doi.org/10.1021/acs.organomet.0c00277" title="DOI URL">https://doi.org/10.1021/acs.organomet.0c00277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.0c00277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.0c00277%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3D%2525CE%2525B72%252BCoordination%252Bof%252BElectron-Deficient%252BArenes%252Bwith%252BGroup%252B6%252BDearomatization%252BAgents%26aulast%3DSmith%26aufirst%3DJacob%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22042020%26date%3D25062020%26volume%3D39%26issue%3D13%26spage%3D2493%26epage%3D2510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingyue Zhao, Alejandro G. Barrado, Kristin Sprenger, Christopher Golz, Ricardo A. Mata, <span class="NLM_string-name hlFld-ContribAuthor">Manuel Alcarazo</span>. </span><span class="cited-content_cbyCitation_article-title">Electrophilic Cyanative Alkenylation of Arenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (13)
                                     , 4932-4937. <a href="https://doi.org/10.1021/acs.orglett.0c01204" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01204%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DElectrophilic%252BCyanative%252BAlkenylation%252Bof%252BArenes%26aulast%3DZhao%26aufirst%3DMingyue%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06042020%26date%3D20052020%26volume%3D22%26issue%3D13%26spage%3D4932%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hang Zhang, Yao Luo, Chenhao Zhu, Shunxi Dong, Xiaohua Liu, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoming Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Addition Reactions of Formaldehyde N,N-Dialkylhydrazone to Synthesize Chiral Nitrile Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (13)
                                     , 5217-5222. <a href="https://doi.org/10.1021/acs.orglett.0c01857" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01857%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BAsymmetric%252BAddition%252BReactions%252Bof%252BFormaldehyde%252BN%25252CN-Dialkylhydrazone%252Bto%252BSynthesize%252BChiral%252BNitrile%252BDerivatives%26aulast%3DZhang%26aufirst%3DHang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D11062020%26volume%3D22%26issue%3D13%26spage%3D5217%26epage%3D5222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manisha Bihani, Tharique N. Ansari, Lucie Finck, Pranjal P. Bora, Jacek B. Jasinski, Bhavana Pavuluri, David K. Leahy, <span class="NLM_string-name hlFld-ContribAuthor">Sachin Handa</span>. </span><span class="cited-content_cbyCitation_article-title">Scalable Î±-Arylation of Nitriles in Aqueous Micelles using Ultrasmall Pd Nanoparticles: Surprising Formation of Carbanions in Water. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (12)
                                     , 6816-6821. <a href="https://doi.org/10.1021/acscatal.0c01196" title="DOI URL">https://doi.org/10.1021/acscatal.0c01196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c01196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c01196%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DScalable%252B%2525CE%2525B1-Arylation%252Bof%252BNitriles%252Bin%252BAqueous%252BMicelles%252Busing%252BUltrasmall%252BPd%252BNanoparticles%25253A%252BSurprising%252BFormation%252Bof%252BCarbanions%252Bin%252BWater%26aulast%3DBihani%26aufirst%3DManisha%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12032020%26date%3D20042020%26date%3D05062020%26date%3D22042020%26volume%3D10%26issue%3D12%26spage%3D6816%26epage%3D6821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nils L. Frye, Anup Bhunia, <span class="NLM_string-name hlFld-ContribAuthor">Armido Studer</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Markovnikov Transfer Hydrocyanation in the Absence of Lewis Acid. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 4456-4460. <a href="https://doi.org/10.1021/acs.orglett.0c01454" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01454%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNickel-Catalyzed%252BMarkovnikov%252BTransfer%252BHydrocyanation%252Bin%252Bthe%252BAbsence%252Bof%252BLewis%252BAcid%26aulast%3DFrye%26aufirst%3DNils%2BL.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27042020%26date%3D11052020%26volume%3D22%26issue%3D11%26spage%3D4456%26epage%3D4460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao-Ye Yu, Quan-Qing Zhao, Jun Chen, Wen-Jing Xiao, <span class="NLM_string-name hlFld-ContribAuthor">Jia-Rong Chen</span>. </span><span class="cited-content_cbyCitation_article-title">When Light Meets Nitrogen-Centered Radicals: From Reagents to Catalysts. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2020,</strong> <em>53 </em>
                                    (5)
                                     , 1066-1083. <a href="https://doi.org/10.1021/acs.accounts.0c00090" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00090%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DWhen%252BLight%252BMeets%252BNitrogen-Centered%252BRadicals%25253A%252BFrom%252BReagents%252Bto%252BCatalysts%26aulast%3DYu%26aufirst%3DXiao-Ye%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26022020%26date%3D14042020%26volume%3D53%26issue%3D5%26spage%3D1066%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lulu Zhao, Yanan Dong, Qiangqiang Xia, Jianfei Bai, <span class="NLM_string-name hlFld-ContribAuthor">Yuehui Li</span>. </span><span class="cited-content_cbyCitation_article-title">Zn-Catalyzed Cyanation of Aryl Iodides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (10)
                                     , 6471-6477. <a href="https://doi.org/10.1021/acs.joc.0c00269" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00269%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DZn-Catalyzed%252BCyanation%252Bof%252BAryl%252BIodides%26aulast%3DZhao%26aufirst%3DLulu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14022020%26date%3D06052020%26date%3D23042020%26volume%3D85%26issue%3D10%26spage%3D6471%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Harald GrÃ¶ger, <span class="NLM_string-name hlFld-ContribAuthor">Yasuhisa Asano</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanide-Free Enantioselective Catalytic Strategies for the Synthesis of Chiral Nitriles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (10)
                                     , 6243-6251. <a href="https://doi.org/10.1021/acs.joc.9b02773" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02773%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCyanide-Free%252BEnantioselective%252BCatalytic%252BStrategies%252Bfor%252Bthe%252BSynthesis%252Bof%252BChiral%252BNitriles%26aulast%3DGr%25C3%25B6ger%26aufirst%3DHarald%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13102019%26date%3D01052020%26date%3D06042020%26volume%3D85%26issue%3D10%26spage%3D6243%26epage%3D6251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sang Mee Kim, On-Yu Kang, Hwan Jung Lim, <span class="NLM_string-name hlFld-ContribAuthor">Seong Jun Park</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Synthesis of N-Cyano Sulfilimines by Dearomatizing Stable Thionium Ions. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (17)
                                     , 10191-10199. <a href="https://doi.org/10.1021/acsomega.0c01086" title="DOI URL">https://doi.org/10.1021/acsomega.0c01086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c01086%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSelective%252BSynthesis%252Bof%252BN-Cyano%252BSulfilimines%252Bby%252BDearomatizing%252BStable%252BThionium%252BIons%26aulast%3DKim%26aufirst%3DSang%2BMee%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11032020%26date%3D09042020%26date%3D22042020%26volume%3D5%26issue%3D17%26spage%3D10191%26epage%3D10199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nathan D. Rudd, Mikhail Reibarkh, Rui Fang, Sachin Mittal, Paul L. Walsh, Andrew P. J. Brunskill, <span class="NLM_string-name hlFld-ContribAuthor">William P. Forrest</span>. </span><span class="cited-content_cbyCitation_article-title">Interpreting In Vitro Release Performance from Long-Acting Parenteral Nanosuspensions Using USP-4 Dissolution and Spectroscopic Techniques. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (5)
                                     , 1734-1747. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c00208" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c00208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c00208%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DInterpreting%252BIn%252BVitro%252BRelease%252BPerformance%252Bfrom%252BLong-Acting%252BParenteral%252BNanosuspensions%252BUsing%252BUSP-4%252BDissolution%252Band%252BSpectroscopic%252BTechniques%26aulast%3DRudd%26aufirst%3DNathan%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24022020%26date%3D08042020%26date%3D07042020%26date%3D17042020%26date%3D08042020%26volume%3D17%26issue%3D5%26spage%3D1734%26epage%3D1747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiwu Lu, Xu-Dong Hu, Hui Zhang, Xiao-Wen Zhang, Jinhui Cai, Muhammad Usman, Hengjiang Cong, <span class="NLM_string-name hlFld-ContribAuthor">Wen-Bo Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Assembly of Cycloenones with a Nitrile-Containing All-Carbon Quaternary Center from Malononitriles Enabled by Ni Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (16)
                                     , 7328-7333. <a href="https://doi.org/10.1021/jacs.0c02075" title="DOI URL">https://doi.org/10.1021/jacs.0c02075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c02075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c02075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DEnantioselective%252BAssembly%252Bof%252BCycloenones%252Bwith%252Ba%252BNitrile-Containing%252BAll-Carbon%252BQuaternary%252BCenter%252Bfrom%252BMalononitriles%252BEnabled%252Bby%252BNi%252BCatalysis%26aulast%3DLu%26aufirst%3DZhiwu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21022020%26date%3D13042020%26date%3D07042020%26volume%3D142%26issue%3D16%26spage%3D7328%26epage%3D7333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yajie Wang, Hua Zhang, Shangqing Xie, Hongjian Sun, Xiaoyan Li, Olaf Fuhr, <span class="NLM_string-name hlFld-ContribAuthor">Dieter Fenske</span>. </span><span class="cited-content_cbyCitation_article-title">An Air-Stable N-Heterocyclic [PSiP] Pincer Iron Hydride and an Analogous Nitrogen Iron Hydride: Synthesis and Catalytic Dehydration of Primary Amides to Nitriles. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (6)
                                     , 824-833. <a href="https://doi.org/10.1021/acs.organomet.9b00880" title="DOI URL">https://doi.org/10.1021/acs.organomet.9b00880</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.9b00880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.9b00880%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DAn%252BAir-Stable%252BN-Heterocyclic%252B%25255BPSiP%25255D%252BPincer%252BIron%252BHydride%252Band%252Ban%252BAnalogous%252BNitrogen%252BIron%252BHydride%25253A%252BSynthesis%252Band%252BCatalytic%252BDehydration%252Bof%252BPrimary%252BAmides%252Bto%252BNitriles%26aulast%3DWang%26aufirst%3DYajie%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30122019%26date%3D03032020%26volume%3D39%26issue%3D6%26spage%3D824%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jingdong Wang, Yuxin Liu, Zhonglin Wei, Jungang Cao, Dapeng Liang, Yingjie Lin, <span class="NLM_string-name hlFld-ContribAuthor">Haifeng Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-Azaindolines Using Phase-Transfer Catalysis via an Intramolecular Mannich Reaction. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (6)
                                     , 4047-4057. <a href="https://doi.org/10.1021/acs.joc.9b03025" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03025%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B4-Azaindolines%252BUsing%252BPhase-Transfer%252BCatalysis%252Bvia%252Ban%252BIntramolecular%252BMannich%252BReaction%26aulast%3DWang%26aufirst%3DJingdong%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D07112019%26date%3D11032020%26date%3D04032020%26volume%3D85%26issue%3D6%26spage%3D4047%26epage%3D4057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhong-zhong Cao, Zhiwen Nie, Tonglin Yang, Miaodong Su, Hui Li, Wei-ping Luo, Qiang Liu, <span class="NLM_string-name hlFld-ContribAuthor">Can-Cheng Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free-Catalyzed Synthesis of Allyl Nitriles via Csp2âCsp3 Coupling between Olefins and Azobis (Alkyl-carbonitrile). </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (5)
                                     , 3287-3296. <a href="https://doi.org/10.1021/acs.joc.9b03127" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03127%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free-Catalyzed%252BSynthesis%252Bof%252BAllyl%252BNitriles%252Bvia%252BCsp2%2525E2%252580%252593Csp3%252BCoupling%252Bbetween%252BOlefins%252Band%252BAzobis%252B%252528Alkyl-carbonitrile%252529%26aulast%3DCao%26aufirst%3DZhong-zhong%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19112019%26date%3D07022020%26date%3D16012020%26volume%3D85%26issue%3D5%26spage%3D3287%26epage%3D3296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yoshiyuki Takahashi, Hiroaki Tsuji, <span class="NLM_string-name hlFld-ContribAuthor">Motoi Kawatsura</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Transformation of Alkene-Tethered Oxime Ethers to Nitriles by a Traceless Directing Group Strategy. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (4)
                                     , 2654-2665. <a href="https://doi.org/10.1021/acs.joc.9b02705" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02705%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNickel-Catalyzed%252BTransformation%252Bof%252BAlkene-Tethered%252BOxime%252BEthers%252Bto%252BNitriles%252Bby%252Ba%252BTraceless%252BDirecting%252BGroup%252BStrategy%26aulast%3DTakahashi%26aufirst%3DYoshiyuki%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D07102019%26date%3D09012020%26date%3D26122019%26volume%3D85%26issue%3D4%26spage%3D2654%26epage%3D2665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gang Hong, Pradip D. Nahide, <span class="NLM_string-name hlFld-ContribAuthor">Marisa C. Kozlowski</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanomethylation of Substituted Fluorenes and Oxindoles with Alkyl Nitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (4)
                                     , 1563-1568. <a href="https://doi.org/10.1021/acs.orglett.0c00160" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00160%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCyanomethylation%252Bof%252BSubstituted%252BFluorenes%252Band%252BOxindoles%252Bwith%252BAlkyl%252BNitriles%26aulast%3DHong%26aufirst%3DGang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12012020%26date%3D11022020%26volume%3D22%26issue%3D4%26spage%3D1563%26epage%3D1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Di Wu, Jiashen Qiu, Chengqiu Li, Lexia Yuan, Hongquan Yin, <span class="NLM_string-name hlFld-ContribAuthor">Fu-Xue Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Lewis Acid-Catalyzed Asymmetric Selenocyanation of Î²-Ketoesters with N-Selenocyanatosaccharin. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (2)
                                     , 934-941. <a href="https://doi.org/10.1021/acs.joc.9b02786" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02786%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLewis%252BAcid-Catalyzed%252BAsymmetric%252BSelenocyanation%252Bof%252B%2525CE%2525B2-Ketoesters%252Bwith%252BN-Selenocyanatosaccharin%26aulast%3DWu%26aufirst%3DDi%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D23102019%26date%3D23122019%26date%3D10122019%26volume%3D85%26issue%3D2%26spage%3D934%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinguo Long, Jihui Gao, <span class="NLM_string-name hlFld-ContribAuthor">Xianjie Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Asymmetric Hydrocyanation of Allenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (2)
                                     , 376-380. <a href="https://doi.org/10.1021/acs.orglett.9b03938" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03938%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNickel-Catalyzed%252BAsymmetric%252BHydrocyanation%252Bof%252BAllenes%26aulast%3DLong%26aufirst%3DJinguo%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04112019%26date%3D08012020%26volume%3D22%26issue%3D2%26spage%3D376%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vinita Yadav, Vinod G. Landge, Murugan Subaramanian, <span class="NLM_string-name hlFld-ContribAuthor">Ekambaram Balaraman</span>. </span><span class="cited-content_cbyCitation_article-title">Manganese-Catalyzed Î±-Olefination of Nitriles with Secondary Alcohols. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 947-954. <a href="https://doi.org/10.1021/acscatal.9b02811" title="DOI URL">https://doi.org/10.1021/acscatal.9b02811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b02811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b02811%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DManganese-Catalyzed%252B%2525CE%2525B1-Olefination%252Bof%252BNitriles%252Bwith%252BSecondary%252BAlcohols%26aulast%3DYadav%26aufirst%3DVinita%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04072019%26date%3D03122019%26date%3D26122019%26date%3D06122019%26volume%3D10%26issue%3D2%26spage%3D947%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hui Chen, Shuhao Sun, Yahu A. Liu, <span class="NLM_string-name hlFld-ContribAuthor">Xuebin Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Cyanation of Aryl Halides and Hydrocyanation of Alkynes via CâCN Bond Cleavage and Cyano Transfer. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 1397-1405. <a href="https://doi.org/10.1021/acscatal.9b04586" title="DOI URL">https://doi.org/10.1021/acscatal.9b04586</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b04586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b04586%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DNickel-Catalyzed%252BCyanation%252Bof%252BAryl%252BHalides%252Band%252BHydrocyanation%252Bof%252BAlkynes%252Bvia%252BC%2525E2%252580%252593CN%252BBond%252BCleavage%252Band%252BCyano%252BTransfer%26aulast%3DChen%26aufirst%3DHui%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24102019%26date%3D19122019%26date%3D06012020%26date%3D20122019%26volume%3D10%26issue%3D2%26spage%3D1397%26epage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">L. Reginald Mills, Joshua M. Graham, Purvish Patel, <span class="NLM_string-name hlFld-ContribAuthor">Sophie A. L. Rousseaux</span>. </span><span class="cited-content_cbyCitation_article-title">Ni-Catalyzed Reductive Cyanation of Aryl Halides and Phenol Derivatives via Transnitrilation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (49)
                                     , 19257-19262. <a href="https://doi.org/10.1021/jacs.9b11208" title="DOI URL">https://doi.org/10.1021/jacs.9b11208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b11208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b11208%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DNi-Catalyzed%252BReductive%252BCyanation%252Bof%252BAryl%252BHalides%252Band%252BPhenol%252BDerivatives%252Bvia%252BTransnitrilation%26aulast%3DMills%26aufirst%3DL.%2BReginald%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17102019%26date%3D25112019%26date%3D11112019%26volume%3D141%26issue%3D49%26spage%3D19257%26epage%3D19262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tania Katsina, Sachi Prem Sharma, Roberto Buccafusca, Derek J. Quinn, Thomas S. Moody, <span class="NLM_string-name hlFld-ContribAuthor">Stellios Arseniyadis</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Palladium-Catalyzed Allylic Alkylation/retro-Dieckmann Fragmentation Strategy for the Synthesis of Î±-Substituted Acrylonitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 9348-9352. <a href="https://doi.org/10.1021/acs.orglett.9b03522" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03522%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSequential%252BPalladium-Catalyzed%252BAllylic%252BAlkylation%25252Fretro-Dieckmann%252BFragmentation%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252B%2525CE%2525B1-Substituted%252BAcrylonitriles%26aulast%3DKatsina%26aufirst%3DTania%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04102019%26date%3D11112019%26volume%3D21%26issue%3D23%26spage%3D9348%26epage%3D9352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jun Chen, Peng-Zi Wang, Bin Lu, Dong Liang, Xiao-Ye Yu, Wen-Jing Xiao, <span class="NLM_string-name hlFld-ContribAuthor">Jia-Rong Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Radical Ring-Opening Cyanation of Oxime Esters by Dual Photoredox and Copper Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 9763-9768. <a href="https://doi.org/10.1021/acs.orglett.9b03970" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03970%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEnantioselective%252BRadical%252BRing-Opening%252BCyanation%252Bof%252BOxime%252BEsters%252Bby%252BDual%252BPhotoredox%252Band%252BCopper%252BCatalysis%26aulast%3DChen%26aufirst%3DJun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06112019%26date%3D20112019%26volume%3D21%26issue%3D23%26spage%3D9763%26epage%3D9768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bernd Kuhn, Erik Gilberg, Robin Taylor, Jason Cole, <span class="NLM_string-name hlFld-ContribAuthor">Oliver Korb</span>. </span><span class="cited-content_cbyCitation_article-title">How Significant Are Unusual ProteinâLigand Interactions? Insights from Database Mining. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10441-10455. <a href="https://doi.org/10.1021/acs.jmedchem.9b01545" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01545%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BSignificant%252BAre%252BUnusual%252BProtein%2525E2%252580%252593Ligand%252BInteractions%25253F%252BInsights%252Bfrom%252BDatabase%252BMining%26aulast%3DKuhn%26aufirst%3DBernd%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17092019%26date%3D15112019%26volume%3D62%26issue%3D22%26spage%3D10441%26epage%3D10455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander W. Schuppe, Gustavo M. Borrajo-Calleja, <span class="NLM_string-name hlFld-ContribAuthor">Stephen L. Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Olefin Hydrocyanation without Cyanide. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (47)
                                     , 18668-18672. <a href="https://doi.org/10.1021/jacs.9b10875" title="DOI URL">https://doi.org/10.1021/jacs.9b10875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b10875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b10875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DEnantioselective%252BOlefin%252BHydrocyanation%252Bwithout%252BCyanide%26aulast%3DSchuppe%26aufirst%3DAlexander%2BW.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09102019%26date%3D18112019%26date%3D05112019%26volume%3D141%26issue%3D47%26spage%3D18668%26epage%3D18672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Girish
Singh Bisht, <span class="NLM_string-name hlFld-ContribAuthor">Boopathy Gnanaprakasam</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free Addition Reaction for the Synthesis of 3-(Aminobenzylidene/aminoalkylidene)indolin-2-ones and Its Synthetic Applications. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (21)
                                     , 13516-13527. <a href="https://doi.org/10.1021/acs.joc.9b01771" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01771%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTransition-Metal-Free%252BAddition%252BReaction%252Bfor%252Bthe%252BSynthesis%252Bof%252B3-%252528Aminobenzylidene%25252Faminoalkylidene%252529indolin-2-ones%252Band%252BIts%252BSynthetic%252BApplications%26aulast%3DBisht%26aufirst%3DGirish%2BSingh%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01072019%26date%3D10102019%26date%3D26092019%26volume%3D84%26issue%3D21%26spage%3D13516%26epage%3D13527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laurent Vanoye, Ahmad Hammoud, HÃ©lÃ¨ne GÃ©rard, Alexandra Barnes, RÃ©gis Philippe, Pascal Fongarland, Claude de Bellefon, <span class="NLM_string-name hlFld-ContribAuthor">Alain Favre-RÃ©guillon</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Synthesis of Nitriles from Carboxylic Acids Using Indium-Catalyzed Transnitrilation: Mechanistic and Kinetic Study. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (11)
                                     , 9705-9714. <a href="https://doi.org/10.1021/acscatal.9b02779" title="DOI URL">https://doi.org/10.1021/acscatal.9b02779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b02779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b02779%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DDirect%252BSynthesis%252Bof%252BNitriles%252Bfrom%252BCarboxylic%252BAcids%252BUsing%252BIndium-Catalyzed%252BTransnitrilation%25253A%252BMechanistic%252Band%252BKinetic%252BStudy%26aulast%3DVanoye%26aufirst%3DLaurent%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02072019%26date%3D13092019%26date%3D30092019%26date%3D18092019%26volume%3D9%26issue%3D11%26spage%3D9705%26epage%3D9714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bhaskar Paul, Milan Maji, <span class="NLM_string-name hlFld-ContribAuthor">Sabuj Kundu</span>. </span><span class="cited-content_cbyCitation_article-title">Atom-Economical and Tandem Conversion of Nitriles to N-Methylated Amides Using Methanol and Water. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (11)
                                     , 10469-10476. <a href="https://doi.org/10.1021/acscatal.9b03916" title="DOI URL">https://doi.org/10.1021/acscatal.9b03916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b03916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b03916%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DAtom-Economical%252Band%252BTandem%252BConversion%252Bof%252BNitriles%252Bto%252BN-Methylated%252BAmides%252BUsing%252BMethanol%252Band%252BWater%26aulast%3DPaul%26aufirst%3DBhaskar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12092019%26date%3D08102019%26date%3D21102019%26date%3D11102019%26volume%3D9%26issue%3D11%26spage%3D10469%26epage%3D10476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Muthukumar Kannan, <span class="NLM_string-name hlFld-ContribAuthor">Senthilkumar Muthaiah</span>. </span><span class="cited-content_cbyCitation_article-title">Extending the Chemistry of Hexamethylenetetramine in Ruthenium-Catalyzed Amine Oxidation. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2019,</strong> <em>38 </em>
                                    (19)
                                     , 3560-3567. <a href="https://doi.org/10.1021/acs.organomet.9b00399" title="DOI URL">https://doi.org/10.1021/acs.organomet.9b00399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.9b00399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.9b00399%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DExtending%252Bthe%252BChemistry%252Bof%252BHexamethylenetetramine%252Bin%252BRuthenium-Catalyzed%252BAmine%252BOxidation%26aulast%3DKannan%26aufirst%3DMuthukumar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14062019%26date%3D10092019%26volume%3D38%26issue%3D19%26spage%3D3560%26epage%3D3567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dharitri Das, Pooja Jain, Sourav Pal, <span class="NLM_string-name hlFld-ContribAuthor">Vidya Avasare</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Investigations of Aluminum Nitrite Assisted Aryl Nitrile Synthesis through C(sp3)âC(sp2) Bond Cleavage of Aryl Ketones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry C</span><span> <strong>2019,</strong> <em>123 </em>
                                    (38)
                                     , 23439-23445. <a href="https://doi.org/10.1021/acs.jpcc.9b02529" title="DOI URL">https://doi.org/10.1021/acs.jpcc.9b02529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcc.9b02529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcc.9b02529%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520C%26atitle%3DMechanistic%252BInvestigations%252Bof%252BAluminum%252BNitrite%252BAssisted%252BAryl%252BNitrile%252BSynthesis%252Bthrough%252BC%252528sp3%252529%2525E2%252580%252593C%252528sp2%252529%252BBond%252BCleavage%252Bof%252BAryl%252BKetones%26aulast%3DDas%26aufirst%3DDharitri%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17032019%26date%3D07062019%26date%3D25062019%26date%3D13062019%26volume%3D123%26issue%3D38%26spage%3D23439%26epage%3D23445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guangle Niu, Xiuli Zheng, Zheng Zhao, Haoke Zhang, Jianguo Wang, Xuewen He, Yuncong Chen, Xiujuan Shi, Chao Ma, Ryan T. K. Kwok, Jacky W. Y. Lam, Herman H. Y. Sung, Ian D. Williams, Kam Sing Wong, Pengfei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Ben Zhong Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized Acrylonitriles with Aggregation-Induced Emission: Structure Tuning by Simple Reaction-Condition Variation, Efficient Red Emission, and Two-Photon Bioimaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (38)
                                     , 15111-15120. <a href="https://doi.org/10.1021/jacs.9b06196" title="DOI URL">https://doi.org/10.1021/jacs.9b06196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b06196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b06196%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DFunctionalized%252BAcrylonitriles%252Bwith%252BAggregation-Induced%252BEmission%25253A%252BStructure%252BTuning%252Bby%252BSimple%252BReaction-Condition%252BVariation%25252C%252BEfficient%252BRed%252BEmission%25252C%252Band%252BTwo-Photon%252BBioimaging%26aulast%3DNiu%26aufirst%3DGuangle%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11062019%26date%3D04092019%26date%3D22082019%26volume%3D141%26issue%3D38%26spage%3D15111%26epage%3D15120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mikael Jumppanen, Sini M. Kinnunen, Mika J. VÃ¤limÃ¤ki, Virpi Talman, Samuli Auno, Tanja Bruun, Gustav Boije af GennÃ¤s, Henri Xhaard, Ingo B. AumÃ¼ller, Heikki Ruskoaho, <span class="NLM_string-name hlFld-ContribAuthor">Jari Yli-Kauhaluoma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Identification, and StructureâActivity Relationship Analysis of GATA4 and NKX2-5 ProteinâProtein Interaction Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 8284-8310. <a href="https://doi.org/10.1021/acs.jmedchem.9b01086" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01086%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BIdentification%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BAnalysis%252Bof%252BGATA4%252Band%252BNKX2-5%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BModulators%26aulast%3DJumppanen%26aufirst%3DMikael%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05072019%26date%3D03092019%26date%3D20082019%26volume%3D62%26issue%3D17%26spage%3D8284%26epage%3D8310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenhua Wang, Xiu Wang, Yasuyuki Ura, <span class="NLM_string-name hlFld-ContribAuthor">Yasushi Nishihara</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Decarbonylative Cyanation of Acyl Chlorides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (17)
                                     , 6779-6784. <a href="https://doi.org/10.1021/acs.orglett.9b02398" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02398%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNickel-Catalyzed%252BDecarbonylative%252BCyanation%252Bof%252BAcyl%252BChlorides%26aulast%3DWang%26aufirst%3DZhenhua%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11072019%26date%3D07082019%26volume%3D21%26issue%3D17%26spage%3D6779%26epage%3D6784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng-Zi Wang, Bin-Qing He, Ying Cheng, Jia-Rong Chen, <span class="NLM_string-name hlFld-ContribAuthor">Wen-Jing Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Radical CâC Bond Cleavage/Addition Cascade of Benzyl Cycloketone Oxime Ethers Enabled by Photogenerated Cyclic Iminyl Radicals. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (17)
                                     , 6924-6929. <a href="https://doi.org/10.1021/acs.orglett.9b02535" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02535%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRadical%252BC%2525E2%252580%252593C%252BBond%252BCleavage%25252FAddition%252BCascade%252Bof%252BBenzyl%252BCycloketone%252BOxime%252BEthers%252BEnabled%252Bby%252BPhotogenerated%252BCyclic%252BIminyl%252BRadicals%26aulast%3DWang%26aufirst%3DPeng-Zi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D22082019%26volume%3D21%26issue%3D17%26spage%3D6924%26epage%3D6929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Natalie Holmberg-Douglas, <span class="NLM_string-name hlFld-ContribAuthor">David A. Nicewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Arene Cyanation via Cation-Radical Accelerated-Nucleophilic Aromatic Substitution. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (17)
                                     , 7114-7118. <a href="https://doi.org/10.1021/acs.orglett.9b02678" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02678%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DArene%252BCyanation%252Bvia%252BCation-Radical%252BAccelerated-Nucleophilic%252BAromatic%252BSubstitution%26aulast%3DHolmberg-Douglas%26aufirst%3DNatalie%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30072019%26date%3D16082019%26volume%3D21%26issue%3D17%26spage%3D7114%26epage%3D7118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Topi Ghosh, Akbar Mohammad, <span class="NLM_string-name hlFld-ContribAuthor">Shaikh M. Mobin</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Cobalt Doped-Cerium Oxide as a Multifunctional Nanocatalyst for Various Organic Transformations. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2019,</strong> <em>7 </em>
                                    (16)
                                     , 13746-13763. <a href="https://doi.org/10.1021/acssuschemeng.9b01434" title="DOI URL">https://doi.org/10.1021/acssuschemeng.9b01434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.9b01434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.9b01434%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DHybrid%252BCobalt%252BDoped-Cerium%252BOxide%252Bas%252Ba%252BMultifunctional%252BNanocatalyst%252Bfor%252BVarious%252BOrganic%252BTransformations%26aulast%3DGhosh%26aufirst%3DTopi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D03072019%26date%3D08082019%26date%3D26072019%26volume%3D7%26issue%3D16%26spage%3D13746%26epage%3D13763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng Qian, Zhenghong Zhou, Kangfei Hu, Jiawei Wang, Zhibin Li, Zhenggen Zha, <span class="NLM_string-name hlFld-ContribAuthor">Zhiyong Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Electrocatalytic Three-Component Reaction: Synthesis of Cyanide-Functionalization Imidazo-Fused N-Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (16)
                                     , 6403-6407. <a href="https://doi.org/10.1021/acs.orglett.9b02317" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02317%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DElectrocatalytic%252BThree-Component%252BReaction%25253A%252BSynthesis%252Bof%252BCyanide-Functionalization%252BImidazo-Fused%252BN-Heterocycles%26aulast%3DQian%26aufirst%3DPeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04072019%26date%3D30072019%26volume%3D21%26issue%3D16%26spage%3D6403%26epage%3D6407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wai Chung Fu, <span class="NLM_string-name hlFld-ContribAuthor">Timothy F. Jamison</span>. </span><span class="cited-content_cbyCitation_article-title">Modular Continuous Flow Synthesis of Imatinib and Analogues. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (15)
                                     , 6112-6116. <a href="https://doi.org/10.1021/acs.orglett.9b02259" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02259%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DModular%252BContinuous%252BFlow%252BSynthesis%252Bof%252BImatinib%252Band%252BAnalogues%26aulast%3DFu%26aufirst%3DWai%2BChung%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01072019%26date%3D17072019%26volume%3D21%26issue%3D15%26spage%3D6112%26epage%3D6116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin Yang, Jia-Yu Zhang, Xin-Hua Duan, Pin Gao, Jiao Jiao, <span class="NLM_string-name hlFld-ContribAuthor">Li-Na Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Cyanoalkylation of Amines via CâC Bond Cleavage: An Approach for C(sp3)âN Bond Formations. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (13)
                                     , 8615-8629. <a href="https://doi.org/10.1021/acs.joc.9b01084" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01084%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BCyanoalkylation%252Bof%252BAmines%252Bvia%252BC%2525E2%252580%252593C%252BBond%252BCleavage%25253A%252BAn%252BApproach%252Bfor%252BC%252528sp3%252529%2525E2%252580%252593N%252BBond%252BFormations%26aulast%3DYang%26aufirst%3DLin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19042019%26date%3D20062019%26date%3D06062019%26volume%3D84%26issue%3D13%26spage%3D8615%26epage%3D8629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu-Qi Tang, Jun-Cheng Yang, Le Wang, Mingjin Fan, <span class="NLM_string-name hlFld-ContribAuthor">Li-Na Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Ni-Catalyzed Redox-Neutral Ring-Opening/Radical Addition/Ring-Closing Cascade of Cycloketone Oxime Esters and Vinyl Azides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (13)
                                     , 5178-5182. <a href="https://doi.org/10.1021/acs.orglett.9b01773" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01773%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNi-Catalyzed%252BRedox-Neutral%252BRing-Opening%25252FRadical%252BAddition%25252FRing-Closing%252BCascade%252Bof%252BCycloketone%252BOxime%252BEsters%252Band%252BVinyl%252BAzides%26aulast%3DTang%26aufirst%3DYu-Qi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21052019%26date%3D21062019%26volume%3D21%26issue%3D13%26spage%3D5178%26epage%3D5182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tamal Roy, Myungjo J. Kim, Yang Yang, Suyeon Kim, Gyumin Kang, Xinyi Ren, Anders Kadziola, Hee-Yoon Lee, Mu-Hyun Baik, <span class="NLM_string-name hlFld-ContribAuthor">Ji-Woong Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Carbon Dioxide-Catalyzed Stereoselective Cyanation Reaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (7)
                                     , 6006-6011. <a href="https://doi.org/10.1021/acscatal.9b01087" title="DOI URL">https://doi.org/10.1021/acscatal.9b01087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b01087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b01087%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCarbon%252BDioxide-Catalyzed%252BStereoselective%252BCyanation%252BReaction%26aulast%3DRoy%26aufirst%3DTamal%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15032019%26date%3D01052019%26date%3D08062019%26date%3D01052019%26volume%3D9%26issue%3D7%26spage%3D6006%26epage%3D6011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Gehringer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan A. Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5673-5724. <a href="https://doi.org/10.1021/acs.jmedchem.8b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Band%252BRe-Emerging%252BWarheads%252Bfor%252BTargeted%252BCovalent%252BInhibitors%25253A%252BApplications%252Bin%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D25012019%26date%3D19122018%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Zhang, Yu-Liang Pan, Chen Yang, Li Chen, Xin Li, <span class="NLM_string-name hlFld-ContribAuthor">Jin-Pei Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free Direct CâH Cyanoalkylation of Quinoxalin-2(1H)-Ones by Organic Photoredox Catalysis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (12)
                                     , 7786-7795. <a href="https://doi.org/10.1021/acs.joc.9b00657" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00657%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252BDirect%252BC%2525E2%252580%252593H%252BCyanoalkylation%252Bof%252BQuinoxalin-2%2525281H%252529-Ones%252Bby%252BOrganic%252BPhotoredox%252BCatalysis%26aulast%3DZhang%26aufirst%3DWei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06032019%26date%3D11062019%26date%3D29052019%26volume%3D84%26issue%3D12%26spage%3D7786%26epage%3D7795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiashen Qiu, Di Wu, Lexia Yuan, Pingliang Long, Hongquan Yin, <span class="NLM_string-name hlFld-ContribAuthor">Fu-Xue Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalyzed Asymmetric Î±-Thiocyanation of Oxindoles: Synthesis of Chiral Tertiary 3-Thiocyanatoxindoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (12)
                                     , 7917-7926. <a href="https://doi.org/10.1021/acs.joc.9b00782" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00782%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOrganocatalyzed%252BAsymmetric%252B%2525CE%2525B1-Thiocyanation%252Bof%252BOxindoles%25253A%252BSynthesis%252Bof%252BChiral%252BTertiary%252B3-Thiocyanatoxindoles%26aulast%3DQiu%26aufirst%3DJiashen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19032019%26date%3D12062019%26date%3D31052019%26volume%3D84%26issue%3D12%26spage%3D7917%26epage%3D7926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hiroyuki Okabe, Asuka Naraoka, Takahiro Isogawa, Shunsuke Oishi, <span class="NLM_string-name hlFld-ContribAuthor">Hiroshi Naka</span>. </span><span class="cited-content_cbyCitation_article-title">Acceptor-Controlled Transfer Dehydration of Amides to Nitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (12)
                                     , 4767-4770. <a href="https://doi.org/10.1021/acs.orglett.9b01657" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01657%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAcceptor-Controlled%252BTransfer%252BDehydration%252Bof%252BAmides%252Bto%252BNitriles%26aulast%3DOkabe%26aufirst%3DHiroyuki%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09052019%26date%3D03062019%26volume%3D21%26issue%3D12%26spage%3D4767%26epage%3D4770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brittney A. Klein, Ian M. Robertson, BÃ©la Reiz, Thomas Kampourakis, Liang Li, <span class="NLM_string-name hlFld-ContribAuthor">Brian D. Sykes</span>. </span><span class="cited-content_cbyCitation_article-title">Thioimidate Bond Formation between Cardiac Troponin C and Nitrile-containing Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 1007-1012. <a href="https://doi.org/10.1021/acsmedchemlett.9b00168" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00168%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThioimidate%252BBond%252BFormation%252Bbetween%252BCardiac%252BTroponin%252BC%252Band%252BNitrile-containing%252BCompounds%26aulast%3DKlein%26aufirst%3DBrittney%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12042019%26date%3D15052019%26date%3D16052019%26date%3D15052019%26volume%3D10%26issue%3D6%26spage%3D1007%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Zhang, Chen Yang, Zhi-Pei Zhang, Xin Li, <span class="NLM_string-name hlFld-ContribAuthor">Jin-Pei Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-Light-Triggered Cyanoalkylation of para-Quinone Methides and Its Application to the Synthesis of GPR40 Agonists. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (11)
                                     , 4137-4142. <a href="https://doi.org/10.1021/acs.orglett.9b01325" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01325%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVisible-Light-Triggered%252BCyanoalkylation%252Bof%252Bpara-Quinone%252BMethides%252Band%252BIts%252BApplication%252Bto%252Bthe%252BSynthesis%252Bof%252BGPR40%252BAgonists%26aulast%3DZhang%26aufirst%3DWei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16042019%26date%3D16052019%26volume%3D21%26issue%3D11%26spage%3D4137%26epage%3D4142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yihang Jiao, Mong-Feng Chiou, Yajun Li, <span class="NLM_string-name hlFld-ContribAuthor">Hongli Bao</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Radical Acyl-Cyanation of Alkenes with Mechanistic Studies on the tert-Butoxy Radical. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (6)
                                     , 5191-5197. <a href="https://doi.org/10.1021/acscatal.9b01060" title="DOI URL">https://doi.org/10.1021/acscatal.9b01060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b01060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b01060%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCopper-Catalyzed%252BRadical%252BAcyl-Cyanation%252Bof%252BAlkenes%252Bwith%252BMechanistic%252BStudies%252Bon%252Bthe%252Btert-Butoxy%252BRadical%26aulast%3DJiao%26aufirst%3DYihang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13032019%26date%3D25042019%26date%3D06052019%26date%3D01052019%26volume%3D9%26issue%3D6%26spage%3D5191%26epage%3D5197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm100762r&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-22%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm100762r%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=865&amp;pagesCount=6&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="âtrueâ" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Aminonitrile vildagliptin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Nitrile-containing aromatase and aldolase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Nonsteroidal receptor antagonists in which nitriles function as carbonyl bioisosteres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystallizations in the human progesterone ligand binding domain.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Nitrile-containing farnesyltransferase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Nitrile-containing kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Nitrile-substituted cyanoquinoline as an azomethineâwater bioisostere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nitrile-containing cardiovascular agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Nitrile-containing CNS drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Nitrile-containing anti-HIV agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Nitrile-containing xanthine oxidase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Nitrile-containing DPP IV inhibitors.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Miscellaneous arylnitrile-containing inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Most widely prescribed nitrile-containing pharmaceuticals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Bioactive quatarnary arylacetonitriles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Alkenenitrile-containing pharmaceuticals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Cyanoguanidine binding motifs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. <i>N</i>-Cyanoguanidine-containing drugs and drug leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Aminonitrile DPP IV inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Cathepsin Inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Nitrile inhibitor <b>76</b> and progesterone (<b>10</b>) overlay. Reprinted with permission from <i>Bioorganic and Medicinal Chemistry Letters</i>.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Copyright 2009 Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0022.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Comparative nitrile and acid etoposide analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0023.jpeg" id="rightTab-_i8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Cyanoquinolines and cyanopyridines as azomethineâwater bioisosteres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/medium/jm-2010-00762r_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0024.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. ADME-directed evolution of capravirine (<b>82</b>) into lersivirine (<b>33</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100762r/production/images/large/jm-2010-00762r_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100762r&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i17">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 183 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joannides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limberakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotti, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottolini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauckhorst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivault, F.</span><span> </span><span class="NLM_article-title">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2150</span><span class="NLM_x">â</span> <span class="NLM_lpage">2155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2007.01.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17303420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2150-2155&author=S.+T.+Murphyauthor=H.+L.+Caseauthor=E.+Ellsworthauthor=S.+Hagenauthor=M.+Hubandauthor=T.+Joannidesauthor=C.+Limberakisauthor=K.+R.+Marottiauthor=A.+M.+Ottoliniauthor=M.+Rauckhorstauthor=J.+Starrauthor=M.+Stierauthor=C.+Taylorauthor=T.+Zhuauthor=A.+Blaserauthor=W.+A.+Dennyauthor=G.+L.+Luauthor=J.+B.+Smaillauthor=F.+Rivault&title=The+synthesis+and+biological+evaluation+of+novel+series+of+nitrile-containing+fluoroquinolones+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span></div><div class="casAuthors">Murphy, Sean T.; Case, Heather L.; Ellsworth, Edmund; Hagen, Susan; Huband, Michael; Joannides, Themis; Limberakis, Chris; Marotti, Keith R.; Ottolini, Amy M.; Rauckhorst, Mark; Starr, Jeremy; Stier, Michael; Taylor, Clarke; Zhu, Tong; Blaser, Adrian; Denny, William A.; Lu, Guo-Liang; Smaill, Jeff B.; Rivault, Freddy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2150-2155</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several novel series of nitrile-contg. fluoroquinolones, e.g., I and II, with weakly basic amines are reported which have reduced potential for hERG (human ether-a-go-go gene) channel inhibition as measured by the dofetilide assay.  The new fluoroquinolones are potent against both Gram-pos. and fastidious Gram-neg. strains, including Methicillin resistant Staphylococcus aureus and fluoroquinolone-resistant Streptococcus pneumoniae.  Several analogs also showed low potential for human genotoxicity as measured by the clonogenicity test.  I and II (designated PF-00951966 and PF-02298732, resp.), which had good in vitro activity and in vitro safety profiles, also showed good pharmacokinetic properties in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhTahx73DqHrVg90H21EOLACvtfcHk0lh2TLKjC1yo7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D&md5=708231abc3eafe5e302e9391d5ae58cc</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.090%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DCase%26aufirst%3DH.%2BL.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DHagen%26aufirst%3DS.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DJoannides%26aufirst%3DT.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DMarotti%26aufirst%3DK.%2BR.%26aulast%3DOttolini%26aufirst%3DA.%2BM.%26aulast%3DRauckhorst%26aufirst%3DM.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DLu%26aufirst%3DG.%2BL.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DRivault%26aufirst%3DF.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520series%2520of%2520nitrile-containing%2520fluoroquinolones%2520as%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2150%26epage%3D2155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Markus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, C.-H.</span><span> </span><span class="NLM_article-title">In vitro metabolism of aromatic nitriles</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">â</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1994&pages=1729-1734&author=B.+Markusauthor=C.-H.+Kwon&title=In+vitro+metabolism+of+aromatic+nitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkus%26aufirst%3DB.%26aulast%3DKwon%26aufirst%3DC.-H.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520aromatic%2520nitriles%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1994%26volume%3D83%26spage%3D1729%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J. J.</span><span> </span><span class="NLM_article-title">A simple in vitro assay for assessing the reactivity of nitrile containing compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1136</span><span class="NLM_x">â</span> <span class="NLM_lpage">1138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2008.12.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19168354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1WrtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1136-1138&author=P.+A.+MacFaulauthor=A.+D.+Morleyauthor=J.+J.+Crawford&title=A+simple+in+vitro+assay+for+assessing+the+reactivity+of+nitrile+containing+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A simple in vitro assay for assessing the reactivity of nitrile containing compounds</span></div><div class="casAuthors">MacFaul, Philip A.; Morley, Andrew D.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1136-1138</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A quant. assay involving the reaction of nitriles with glutathione and cysteine has been used as a simple in vitro screen to assess potential toxicity risk of candidate compds. in drug discovery.  Studies have indicated that, when benchmarked with selected compds., the reaction of the nitriles with glutathione can provide a useful tool for deciding whether or not to progress compds. in the absence of radiolabelling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro23j0VCklM7Vg90H21EOLACvtfcHk0lgFkBSvVAIm7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1WrtLs%253D&md5=d949b5d0e76c6d268f3f57cc4584f0b9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.105%26sid%3Dliteratum%253Aachs%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMorley%26aufirst%3DA.%2BD.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520simple%2520in%2520vitro%2520assay%2520for%2520assessing%2520the%2520reactivity%2520of%2520nitrile%2520containing%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1136%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelette, C.</span><span> </span><span class="NLM_article-title">A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2006.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17157022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12qtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=998-1002&author=R.+M.+Oballaauthor=J.-F.+Truchonauthor=C.+I.+Baylyauthor=N.+Chauretauthor=S.+Dayauthor=S.+Craneauthor=C.+Berthelette&title=A+generally+applicable+method+for+assessing+the+electrophilicity+and+reactivity+of+diverse+nitrile-containing+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds</span></div><div class="casAuthors">Oballa, Renata M.; Truchon, Jean-Francois; Bayly, Christopher I.; Chauret, Nathalie; Day, Stephen; Crane, Sheldon; Berthelette, Carl</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">998-1002</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nitrile-based inhibitors of cathepsin K have been known for some time and mechanism-of-action studies have demonstrated that cysteinyl proteases interact with nitriles in a reversible fashion.  Three main classes of nitrile-contg. inhibitors have been published in the cathepsin K field: (i) cyanamides, (ii) arom. nitriles, and (iii) aminoacetonitriles.  A computational approach was used to calc. the theor. reactivities of diverse nitriles and this was found to correlate with their extent of reactivity with free cysteine.  Moreover, there is a tentative link between high reactivity with cysteine and the potential to lead to irreversible covalent binding to proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSFCCd4sSYvbVg90H21EOLACvtfcHk0lgFkBSvVAIm7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12qtr4%253D&md5=b8fff00bdd6a746753f8f244d25b0cc8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DTruchon%26aufirst%3DJ.-F.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DDay%26aufirst%3DS.%26aulast%3DCrane%26aufirst%3DS.%26aulast%3DBerthelette%26aufirst%3DC.%26atitle%3DA%2520generally%2520applicable%2520method%2520for%2520assessing%2520the%2520electrophilicity%2520and%2520reactivity%2520of%2520diverse%2520nitrile-containing%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D998%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="note"><p class="first last">For an example encountered during the development of cathepsins K<sup>a</sup> and S<sup>b</sup> analogues see the following: </p></div><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Boyd, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span> </span><span class="NLM_article-title">Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">â</span> <span class="NLM_lpage">679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=675-679&author=M.+J.+Boydauthor=S.+N.+Craneauthor=J.+Robichaudauthor=J.+Scheigetzauthor=W.+C.+Blackauthor=N.+Chauretauthor=Q.+Wangauthor=F.+Masseauthor=R.+M.+Oballa&title=Investigation+of+ketone+warheads+as+alternatives+to+the+nitrile+for+preparation+of+potent+and+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BJ.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DInvestigation%2520of%2520ketone%2520warheads%2520as%2520alternatives%2520to%2520the%2520nitrile%2520for%2520preparation%2520of%2520potent%2520and%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patterson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, W. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornsby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spraggon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Identification of selective, nonpeptidic nitrile inhibitors of cathepsin S using the substrate activity screening method</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6298</span><span class="NLM_x">â</span> <span class="NLM_lpage">6307</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060701s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6298-6307&author=A.+W.+Pattersonauthor=W.+J.+L.+Woodauthor=M.+Hornsbyauthor=S.+Lesleyauthor=G.+Spraggonauthor=J.+A.+Ellman&title=Identification+of+selective%2C+nonpeptidic+nitrile+inhibitors+of+cathepsin+S+using+the+substrate+activity+screening+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective, Nonpeptidic Nitrile Inhibitors of Cathepsin S Using the Substrate Activity Screening Method</span></div><div class="casAuthors">Patterson, Andrew W.; Wood, Warren J. L.; Hornsby, Michael; Lesley, Scott; Spraggon, Glen; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6298-6307</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The substrate activity screening method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain low nanomolar 1,4-disubstituted-1,2,3-triazole-based aldehyde inhibitors (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527).  Replacement of the metabolically labile aldehyde pharmacophore with the nitrile pharmacophore provided inhibitors with moderate potency for cathepsin S.  The inhibitors showed good selectivity over cathepsins B and L but no selectivity over cathepsin K.  X-ray structures of two crystal forms (1.5 and 1.9 Ã) of a complex between cathepsin S and a triazole inhibitor incorporating a chloromethyl ketone pharmacophore guided the design of triazole substrates with increased cleavage efficiency and selectivity for cathepsin S over cathepsins B, L, and K.  Conversion of select substrates to nitrile inhibitors yielded a low mol. wt. (414 Da) and potent (15 nM) cathepsin S inhibitor that showed >1000-fold selectivity over cathepsins B, L, and K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64WREyCNFsbVg90H21EOLACvtfcHk0ligCCIQ4akRnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D&md5=30ea16a66d37dac8fe5666c76e2307aa</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fjm060701s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060701s%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DHornsby%26aufirst%3DM.%26aulast%3DLesley%26aufirst%3DS.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520selective%252C%2520nonpeptidic%2520nitrile%2520inhibitors%2520of%2520cathepsin%2520S%2520using%2520the%2520substrate%2520activity%2520screening%2520method%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6298%26epage%3D6307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="note"><p class="first last">For olprinone see the following: </p></div><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kaneko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuzuriha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigematsu, A.</span><span> </span><span class="NLM_article-title">Metabolic fate of loprinone hydrochloride. 1: Blood level, distribution, metabolism, and excretion after a single intravenous administration to rats</span> <span class="citation_source-journal">Yakubutsu Dotai</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">â</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVylsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=149-162&author=K.+Kanekoauthor=K.+Tadanoauthor=K.+Nakajimaauthor=Y.+Sanoauthor=T.+Yuzurihaauthor=N.+Motojiauthor=N.+Kawaiauthor=S.+Hasegawaauthor=A.+Shigematsu&title=Metabolic+fate+of+loprinone+hydrochloride.+1%3A+Blood+level%2C+distribution%2C+metabolism%2C+and+excretion+after+a+single+intravenous+administration+to+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic fate of loprinone hydrochloride. 1: Blood level, distribution, metabolism, and excretion after a single intravenous administration to rats</span></div><div class="casAuthors">Kaneko, Kazuhiro; Tadano, Kyoichi; Nakajima, Kiyomi; Sano, Yoshihisa; Yuzuriha, Teruaki; Motoji, Naomi; Kawai, Naoshi; Hasegawa, Shinichi; Shigematsu, Akiyo</div><div class="citationInfo"><span class="NLM_cas:title">Yakubutsu Dotai</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-62</span>CODEN:
                <span class="NLM_cas:coden">YADOEL</span>;
        ISSN:<span class="NLM_cas:issn">0916-1139</span>.
    </div><div class="casAbstract">The pharmacokinetics of loprinone-HCl, a cardiotonic agent, were investigated after a single i.v. administration of the 14C-labeled compd. to male rats.  After a single i.v. administration, the plasma level of radioactivity rapidly decreased biexponentially, with corresponding half-lives of 9.7 min and 3.6 h.  Radioactivity was distributed rapidly in all tissues studied.  The highest radioactivity was obsd. in the liver and kidneys, followed by the duodenum.  The tissue levels of radioactivity decreased with half-lives similar to those in blood.  Similar distribution profiles were obsd. with whole-body autoradiog.; 96 h after administration, the level of radioactivity in all tissues was very low, reaching the detection limit.  Loprinone-HCl was metabolized to only a small extent.  In the urine and feces, the unchanged form was mainly found; however, small amts. of metabolites (the ring-opened amine form and the enol-O-glucuronide of the parent drug) were also detected.  Biliary excretion of radioactivity was 46.3% of the dose within 24 h.  Within 24 h after administration, the excretion of radioactivity was 43.0 and 47.2% of the dose in the urine and feces, resp., and the total excretion of radioactivity was 97.2% of the dose within 96 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor6pTUYVdbd7Vg90H21EOLACvtfcHk0ligCCIQ4akRnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVylsw%253D%253D&md5=a1bc14d4974efbbb85006b34ad2b93ae</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DTadano%26aufirst%3DK.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DYuzuriha%26aufirst%3DT.%26aulast%3DMotoji%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DHasegawa%26aufirst%3DS.%26aulast%3DShigematsu%26aufirst%3DA.%26atitle%3DMetabolic%2520fate%2520of%2520loprinone%2520hydrochloride.%25201%253A%2520Blood%2520level%252C%2520distribution%252C%2520metabolism%252C%2520and%2520excretion%2520after%2520a%2520single%2520intravenous%2520administration%2520to%2520rats%26jtitle%3DYakubutsu%2520Dotai%26date%3D1994%26volume%3D9%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For lodoxamide see the following: </p></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leong, B. K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span> </span><span class="NLM_article-title">A dosimetric endotracheal nebulization technique for pulmonary metabolic disposition studies in laboratory animals</span> <span class="citation_source-journal">Inhalation Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL1MXhsVOjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=37-51&author=B.+K.+J.+Leongauthor=J.+K.+Coombsauthor=E.+N.+Petzoldauthor=A.+J.+Hanchar&title=A+dosimetric+endotracheal+nebulization+technique+for+pulmonary+metabolic+disposition+studies+in+laboratory+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">A dosimetric endotracheal nebulization technique for pulmonary metabolic disposition studies in laboratory animals</span></div><div class="casAuthors">Leong, B. K. J.; Coombs, J. K.; Petzold, E. N.; Hanchar, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Inhalation Toxicology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">Premier Issue</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">INHTE5</span>;
        ISSN:<span class="NLM_cas:issn">0895-8378</span>.
    </div><div class="casAbstract">A technique has been developed for nebulizing microliter quantities of a radioactive soln. within the trachea at the proximity of the primary bronchi of a lightly anesthetized animal.  To demonstrate the utility of the technique, aerosols of two antiasthmatic drug solns., [3H]piriprost potassium (3H-PP), and [14C]lodoxamide tromethamine (14C-LT) were administered to beagle dogs and rhesus monkeys, resp.  Approx. 80% of the delivered radioactivity was deposited in the pulmonary system and 69-100% was subsequently recovered from the urine and feces.  The urinary metabolites excreted by two monkeys after endotracheal inhalation of 14C-LT were similar to those after i.v. injection, but were distinctly different from those after ingestion.  This technique enables the delivery of microliters of a radioactive or a highly hazardous aerosol into the lower respiratory tract (LRT) without a special animal exposure chamber or hazard containment, and permits quant. detn. of the uptake and disposition of a radioactive material by the respiratory system per se.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn1ssaSKssGrVg90H21EOLACvtfcHk0ligCCIQ4akRnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsVOjurs%253D&md5=a94226bddc0067ec942b61c7d3d2dc07</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeong%26aufirst%3DB.%2BK.%2BJ.%26aulast%3DCoombs%26aufirst%3DJ.%2BK.%26aulast%3DPetzold%26aufirst%3DE.%2BN.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26atitle%3DA%2520dosimetric%2520endotracheal%2520nebulization%2520technique%2520for%2520pulmonary%2520metabolic%2520disposition%2520studies%2520in%2520laboratory%2520animals%26jtitle%3DInhalation%2520Toxicol.%26date%3D1988%26spage%3D37%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For cimetidine see the following: </p></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Strong, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spino, M.</span> <span class="citation_source-journal">J. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">422</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">â</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0378-4347%2887%2980467-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3437018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL1cXoslCltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Strong%2C+H.+A.%3B+Spino%2C+M.J.+Chromatogr.+1987%2C+422%2C+301%E2%80%93308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly sensitive determination of cimetidine and its metabolites in serum and urine by high-performance liquid chromatography</span></div><div class="casAuthors">Strong, H. Andrew; Spino, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography, Biomedical Applications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">422</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-8</span>CODEN:
                <span class="NLM_cas:coden">JCBADL</span>;
        ISSN:<span class="NLM_cas:issn">0378-4347</span>.
    </div><div class="casAbstract">An HPLC method using a solid-phase extn. procedure for the quantitation of cimetidine and its metabolites (cimetidine sulfoxide and hydroxymethylcimetidine) in serum and urine is described.  Cimetidine and metabolites were eluted from an extn. column and, after sepn. by HPLC on a Resolve C8 column and acetic acid-acetonitrile (84:16) mobile phase, were detected by a multiwavelength-programmable detector set at 229 nm.  The method is highly sensitive and selective for the simultaneous detn. of cimetidine and its major metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV-9boB8J-LbVg90H21EOLACvtfcHk0lhcV-joyrlg_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXoslCltA%253D%253D&md5=e4a81fc9f65b5cb6402ed665434f66c3</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2F0378-4347%2887%2980467-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4347%252887%252980467-X%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DH.%2BA.%26aulast%3DSpino%26aufirst%3DM.%26jtitle%3DJ.%2520Chromatogr.%26date%3D1987%26volume%3D422%26spage%3D301%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ziemniak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarowitz, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schentag, J. J.</span><span> </span><span class="NLM_article-title">The pharmacokinetics and metabolism of cimetidine in neonates</span> <span class="citation_source-journal">Dev. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">â</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=6697868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2cXhtlajs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1984&pages=30-38&author=J.+A.+Ziemniakauthor=R.+J.+Wynnauthor=J.+V.+Arandaauthor=B.+J.+Zarowitzauthor=J.+J.+Schentag&title=The+pharmacokinetics+and+metabolism+of+cimetidine+in+neonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and metabolism of cimetidine in neonates</span></div><div class="casAuthors">Ziemniak, John A.; Wynn, Ralph J.; Aranda, Jacob V.; Zarowitz, Barbara J.; Schentag, Jerome J.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-8</span>CODEN:
                <span class="NLM_cas:coden">DPTHDL</span>;
        ISSN:<span class="NLM_cas:issn">0379-8305</span>.
    </div><div class="casAbstract">Cimetidine  [51481-61-9] pharmacokinetics and metab. were studied in neonates (2 full-term and 1 premature).  All infants demonstrated the capacity to eliminate cimetidine via both metabolic and renal routes.  The half-life of cimetidine ranged from 3.4-2.1 h, and decreased as total body clearance increased.  These alterations in pharmacokinetics were felt to represent developmental and maturational differences, primarily in renal function.  In contrast to the 60% routinely seen in adults, approx. 90% of the administered dose was recovered in the urine of the full-term infants as cimetidine and its known metabolites.  Cimetidine sulfoxide  [54237-72-8] and hydroxymethyl cimetidine  [59359-50-1] were detected in the serum and urine of 2 patients, and the elimination half-life of these metabolites was 2-3-fold longer than values seen for cimetidine.  During multiple dosing of cimetidine, significant accumulation of cimetidine metabolites may be expected.  The reported dose of 15-20 mg/kg/day is adequate in full-term neonates; however, it appears that premature infants and those with renal dysfunction may require lower dosing rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCU98RD8nlxbVg90H21EOLACvtfcHk0lhcV-joyrlg_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtlajs7Y%253D&md5=602a738fb64c0655d754a72d4ca1afbb</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZiemniak%26aufirst%3DJ.%2BA.%26aulast%3DWynn%26aufirst%3DR.%2BJ.%26aulast%3DAranda%26aufirst%3DJ.%2BV.%26aulast%3DZarowitz%26aufirst%3DB.%2BJ.%26aulast%3DSchentag%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520pharmacokinetics%2520and%2520metabolism%2520of%2520cimetidine%2520in%2520neonates%26jtitle%3DDev.%2520Pharmacol.%2520Ther.%26date%3D1984%26volume%3D7%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="note"><p class="first last">For entacapone see the following: </p></div><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span> </span><span class="NLM_article-title">Metabolite profiles of two [<sup>14</sup>C]-labeled catechol <i>O</i>-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2FBF03188833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=8001593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVCqurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=125-135&author=T.+Wikbergauthor=A.+Vuorela&title=Metabolite+profiles+of+two+%5B14C%5D-labeled+catechol+O-methyltransferase+inhibitors%2C+nitecapone+and+entacapone%2C+in+rat+and+mouse+urine+and+rat+bile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolite profiles of two [14C]-labeled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile</span></div><div class="casAuthors">Wikberg, T.; Vuorela, A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    </div><div class="casAbstract">The metabolites of two inhibitors of catechol O-methyltransferase, nitecapone [3-(3,4-dihydroxy-5-nitrobenzylidene)-2,4-pentanedione] and entacapone [(E)-2-cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide], excreted in urine and bile by rats and in urine by mice, were compared and quantified by using HPLC with radiochem. detection after administration of [14C]-labeled compds.  With the exception of 3-O-methylated nitecapone, no major metabolites were found in rat bile that were not found in rat urine.  For both compds. the major biotransformations were the same in the mouse and the rat.  However, a bisulfite adduct of nitecapone was found in rat urine only, and redn. of the C:C and C:O groups of the nitecapone side chain was more extensive in the mouse.  After entacapone administration, the products of amide N-dealkylation were more abundant in rat urine than in mouse urine.  Most of the dose was excreted in urine and bile as O-conjugates.  Most abundant were the O-glucuronides, while smaller amts. of O-sulfates and O-methylated metabolites were found in both species.  One non-glucuronide glycoside of entacapone was found in urine of both rats and mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkRzHV4ACYfbVg90H21EOLACvtfcHk0lhcV-joyrlg_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVCqurg%253D&md5=333689318f3eebd3c8b01fccc3b7de17</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1007%2FBF03188833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03188833%26sid%3Dliteratum%253Aachs%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DVuorela%26aufirst%3DA.%26atitle%3DMetabolite%2520profiles%2520of%2520two%2520%255B14C%255D-labeled%2520catechol%2520O-methyltransferase%2520inhibitors%252C%2520nitecapone%2520and%2520entacapone%252C%2520in%2520rat%2520and%2520mouse%2520urine%2520and%2520rat%2520bile%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1994%26volume%3D19%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottoila, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span> </span><span class="NLM_article-title">Identification of major metabolites of the catechol-<i>O</i>-methyltransferase inhibitor entacapone in rats and humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=81-92&author=T.+Wikbergauthor=A.+Vuorelaauthor=P.+Ottoilaauthor=J.+Taskinen&title=Identification+of+major+metabolites+of+the+catechol-O-methyltransferase+inhibitor+entacapone+in+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DVuorela%26aufirst%3DA.%26aulast%3DOttoila%26aufirst%3DP.%26aulast%3DTaskinen%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520major%2520metabolites%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520entacapone%2520in%2520rats%2520and%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1993%26volume%3D21%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For cromakalim see the following: </p></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kudoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Direct determination of the antihypertensive agent cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span> <span class="citation_source-journal">J. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">515</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2FS0021-9673%2801%2989359-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=2283381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVCgsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=1990&pages=597-602&author=S.+Kudohauthor=H.+Nakamura&title=Direct+determination+of+the+antihypertensive+agent+cromakalim+and+its+major+metabolites+in+human+urine+by+high-performance+liquid+chromatography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Direct determination of the antihypertensive agent Cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span></div><div class="casAuthors">Kudoh, Shinobu; Nakamura, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">JOCRAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    </div><div class="casAbstract">An HPLC method was developed for the simultaneous detn. of cromakalim and its urinary metabolites including diastereomeric glucuronides.  The method employed a strong cation-exchange precolumn (Senshu Pak SCX-2051-N) to allow direct injections of urine samples.  The unchanged drug and its 3 major metabolites were simultaneously sepd. on a reversed-phase column (Develosil ODS-5) and fluorometrically detected (excitation 254 nm, emission 306 nm) by their native fluorescence.  Gradient elution was achieved with a mobile phase contg. Na acetate buffer (pH 3.2) and acetonitrile.  The calibration curves for cromakalim and a metabolite were linear in the range from 10 to 200 ng/mL, while those for the 2 diastereomeric glucuronides were linear in the range from 20 to 400 ng/mL.  The detection limits were â¤0.3 ng/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUTJ6RRvVZkbVg90H21EOLACvtfcHk0lhOZPrqKlNUAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVCgsb4%253D&md5=cac1d23e1ff87cf218416ca2c9c55bfd</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2FS0021-9673%2801%2989359-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9673%252801%252989359-6%26sid%3Dliteratum%253Aachs%26aulast%3DKudoh%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DDirect%2520determination%2520of%2520the%2520antihypertensive%2520agent%2520cromakalim%2520and%2520its%2520major%2520metabolites%2520in%2520human%2520urine%2520by%2520high-performance%2520liquid%2520chromatography%26jtitle%3DJ.%2520Chromatogr.%26date%3D1990%26volume%3D515%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kudoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Simultaneous determination of antihypertensive agent cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span> <span class="citation_source-journal">Anal. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">â</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2116%2Fanalsci.6.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFWhtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1990&pages=53-56&author=S.+Kudohauthor=H.+Okadaauthor=K.+Nakahiraauthor=H.+Nakamura&title=Simultaneous+determination+of+antihypertensive+agent+cromakalim+and+its+major+metabolites+in+human+urine+by+high-performance+liquid+chromatography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of antihypertensive agent Cromakalim and its major metabolites in human urine by high-performance liquid chromatography</span></div><div class="casAuthors">Kudoh, Shinobu; Okada, Hideki; Nakahira, Kazuo; Nakamura, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-6</span>CODEN:
                <span class="NLM_cas:coden">ANSCEN</span>;
        ISSN:<span class="NLM_cas:issn">0910-6340</span>.
    </div><div class="casAbstract">An HPLC method was developed for the simultaneous detn. of cromakalim, a novel antihypertensive agent, and its major metabolites in human urine.  The urine sample was first applied onto a disposable cartridge column of octadecyl silica gel (ODS) for solid phase extn.  The charged sample was then washed with an alk. soln. prior to its elution with aq. methanol.  The eluate was introduced into an HPLC system equipped with an ODS column and was analyzed by a gradient elution technique.  In combination with fluorescence detection, this anal. method realized a sensitive detn. of cromakalim and its 3 major metabolites, simultaneously, in human urine.  Urine samples from preclin. trials (Phase I study) conducted on healthy Japanese volunteers were successfully assayed using this new method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmbEzxQh5_g7Vg90H21EOLACvtfcHk0lhOZPrqKlNUAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFWhtb4%253D&md5=2a8ced3cf61cb65b06d5300a89111711</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.2116%2Fanalsci.6.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2116%252Fanalsci.6.53%26sid%3Dliteratum%253Aachs%26aulast%3DKudoh%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DH.%26aulast%3DNakahira%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DSimultaneous%2520determination%2520of%2520antihypertensive%2520agent%2520cromakalim%2520and%2520its%2520major%2520metabolites%2520in%2520human%2520urine%2520by%2520high-performance%2520liquid%2520chromatography%26jtitle%3DAnal.%2520Sci.%26date%3D1990%26volume%3D6%26spage%3D53%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For lersivirine see the following: </p></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Vourvahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleave, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedderman, A. N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBadie, R.</span><span> </span><span class="NLM_article-title">Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-<sup>14</sup>C2)-1<i>H</i>-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [<sup>14</sup>C]lersivirine to healthy volunteers</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">â</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=789-800&author=M.+Vourvahiauthor=M.+Gleaveauthor=A.+N.+R.+Neddermanauthor=R.+Hylandauthor=I.+Gardnerauthor=M.+Howardauthor=S.+Kempshallauthor=C.+Collinsauthor=R.+LaBadie&title=Excretion+and+metabolism+of+lersivirine+%285-%7B%5B3%2C5-diethyl-1-%282-hydroxyethyl%29%283%2C5-14C2%29-1H-pyrazol-4-yl%5Doxy%7Dbenzene-1%2C3-dicarbonitrile%29%2C+a+next-generation+non-nucleoside+reverse+transcriptase+inhibitor%2C+after+administration+of+%5B14C%5Dlersivirine+to+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVourvahi%26aufirst%3DM.%26aulast%3DGleave%26aufirst%3DM.%26aulast%3DNedderman%26aufirst%3DA.%2BN.%2BR.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DLaBadie%26aufirst%3DR.%26atitle%3DExcretion%2520and%2520metabolism%2520of%2520lersivirine%2520%25285-%257B%255B3%252C5-diethyl-1-%25282-hydroxyethyl%2529%25283%252C5-14C2%2529-1H-pyrazol-4-yl%255Doxy%257Dbenzene-1%252C3-dicarbonitrile%2529%252C%2520a%2520next-generation%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitor%252C%2520after%2520administration%2520of%2520%255B14C%255Dlersivirine%2520to%2520healthy%2520volunteers%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D789%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">For levosimendan see the following: </p></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Koskinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pykalainen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotta, T.</span><span> </span><span class="NLM_article-title">Metabolism of OR-1896, a metabolite of levosimendan, in rats and humans</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">â</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=156-170&author=M.+Koskinenauthor=J.+Puttonenauthor=M.+Pykalainenauthor=A.+Vuorelaauthor=T.+Lotta&title=Metabolism+of+OR-1896%2C+a+metabolite+of+levosimendan%2C+in+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoskinen%26aufirst%3DM.%26aulast%3DPuttonen%26aufirst%3DJ.%26aulast%3DPykalainen%26aufirst%3DM.%26aulast%3DVuorela%26aufirst%3DA.%26aulast%3DLotta%26aufirst%3DT.%26atitle%3DMetabolism%2520of%2520OR-1896%252C%2520a%2520metabolite%2520of%2520levosimendan%252C%2520in%2520rats%2520and%2520humans%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D156%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sundberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virtanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, L.</span><span> </span><span class="NLM_article-title">Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals</span> <span class="citation_source-journal">Int. J. Clin. Pharmarcol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">â</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=9876999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVags78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1998&pages=629-635&author=S.+Sundbergauthor=S.+Antilaauthor=H.+Scheininauthor=M.+Hayhaauthor=M.+Virtanenauthor=L.+Lehtonen&title=Integrated+pharmacokinetics+and+pharmacodynamics+of+the+novel+calcium+sensitizer+levosimendan+as+assessed+by+systolic+time+intervals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals</span></div><div class="casAuthors">Sundberg, S.; Antila, S.; Scheinin, H.; Hayha, M.; Virtanen, M.; Lehtonen, L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">629-635</span>CODEN:
                <span class="NLM_cas:coden">ICTHEK</span>;
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    
            (<span class="NLM_cas:orgname">Dustri-Verlag Dr. Karl Feistle</span>)
        </div><div class="casAbstract">Levosimendan is a new Ca sensitizer, acting Ca-dependently on cardiac troponin C.  In the present study pharmacokinetic-pharmacodynamic interrelations of levosimendan were assessed.  Ten healthy subjects (22-27 yr) were given single doses of 2 mg of levosimendan in 4 different formulations: i.v., conventional tablet (CT), conventional capsule (CC), and slow-release tablet (SR) on different days.  Systolic time intervals and impedance cardiog. were recorded â¤4 h post drug.  Blood plasma concns. of levosimendan and its metabolite OR-1855 were analyzed using HPLC.  Hysteresis loops were constructed by connecting the effect-concn. points in time order.  In addn., pharmacokinetic-pharmacodynamic modeling was performed with the i.v. data.  The i.v. administration, giving a maximal levosimendan concn. of 180 ng mL-1, increased heart rate by 8 beats min-1, and cardiac output by 18%.  It shortened heart rate cor. electromech. systole QS2i by 23 ms, indicating a fairly strong pos. inotropic effect.  The conventional oral formulations (giving maximal drug concns. of about 70-80 ng mL-1) increased heart rate by 4-5 beats min-1, and cardiac output by 5-8%, while QS2i shortened by 9-13 ms.  The SR formulation resulted in low drug concns. and generally weaker effects than the other formulations.  The bioavailability of CT and CC was 83 and 87%, while that of SR was only 31%.  QS2i showed counter-clockwise hysteresis after all formulations.  The mean equilibration half-time (ln(2)/ke0) after i.v. administration was 9.6 min.  Only after SR, OR-1855 was detected in appreciable amts. in plasma, the highest value being 2.2 ng Ã mL which occurred 24 h after drug intake.  In conclusion, the pharmacokinetic-dynamic behavior of the inotropism index QS2i indicates an equilibration delay of levosimendan, which most probably reflects the time the drug requires to distribute from plasma to its cardiac site of action.  The deviant kinetic-dynamic profile of the oral slow-release formulation suggests a different absorption pattern of levosimendan from this formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYhIqH9jH-1rVg90H21EOLACvtfcHk0ljMJSpE4hSUlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVags78%253D&md5=74276e7b40260462dc37fec80c5d2bce</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSundberg%26aufirst%3DS.%26aulast%3DAntila%26aufirst%3DS.%26aulast%3DScheinin%26aufirst%3DH.%26aulast%3DHayha%26aufirst%3DM.%26aulast%3DVirtanen%26aufirst%3DM.%26aulast%3DLehtonen%26aufirst%3DL.%26atitle%3DIntegrated%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520novel%2520calcium%2520sensitizer%2520levosimendan%2520as%2520assessed%2520by%2520systolic%2520time%2520intervals%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmarcol.%2520Ther.%26date%3D1998%26volume%3D36%26spage%3D629%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">For <i>N</i>-dealkylation of verapamil see the following: </p></div><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borlak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thum, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levsen, K.</span><span> </span><span class="NLM_article-title">Verapamil: identification of novel metabolites in cultures of primary human hepatocytes and human urine by LCâMSn and LCâNMR</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">â</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=655-676&author=J.+Borlakauthor=M.+Wallesauthor=M.+Elendauthor=T.+Thumauthor=A.+Preissauthor=K.+Levsen&title=Verapamil%3A+identification+of+novel+metabolites+in+cultures+of+primary+human+hepatocytes+and+human+urine+by+LC%E2%88%92MSn+and+LC%E2%88%92NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorlak%26aufirst%3DJ.%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DElend%26aufirst%3DM.%26aulast%3DThum%26aufirst%3DT.%26aulast%3DPreiss%26aufirst%3DA.%26aulast%3DLevsen%26aufirst%3DK.%26atitle%3DVerapamil%253A%2520identification%2520of%2520novel%2520metabolites%2520in%2520cultures%2520of%2520primary%2520human%2520hepatocytes%2520and%2520human%2520urine%2520by%2520LC%25E2%2588%2592MSn%2520and%2520LC%25E2%2588%2592NMR%26jtitle%3DXenobiotica%26date%3D2003%26volume%3D33%26spage%3D655%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McIlhenny, H. M.</span><span> </span><span class="NLM_article-title">Metabolism of [<sup>14</sup>C]-verapamil</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">â</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00294a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1971&pages=1178-1184&author=H.+M.+McIlhenny&title=Metabolism+of+%5B14C%5D-verapamil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm00294a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00294a010%26sid%3Dliteratum%253Aachs%26aulast%3DMcIlhenny%26aufirst%3DH.%2BM.%26atitle%3DMetabolism%2520of%2520%255B14C%255D-verapamil%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1971%26volume%3D14%26spage%3D1178%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For N-dealkylation of zaleplon see the following: </p></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">HorstkÃ¶tter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaschke, G.</span><span> </span><span class="NLM_article-title">Separation and identification of zaleplon metabolites in human urine using capillary electrophoresis with laser-induced fluorescence detection and liquid chromatographyâmass spectrometry</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1014</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1014&publication_year=2003&pages=71-81&author=C.+Horstk%C3%B6tterauthor=D.+Schepmannauthor=G.+Blaschke&title=Separation+and+identification+of+zaleplon+metabolites+in+human+urine+using+capillary+electrophoresis+with+laser-induced+fluorescence+detection+and+liquid+chromatography%E2%88%92mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorstk%25C3%25B6tter%26aufirst%3DC.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DBlaschke%26aufirst%3DG.%26atitle%3DSeparation%2520and%2520identification%2520of%2520zaleplon%2520metabolites%2520in%2520human%2520urine%2520using%2520capillary%2520electrophoresis%2520with%2520laser-induced%2520fluorescence%2520detection%2520and%2520liquid%2520chromatography%25E2%2588%2592mass%2520spectrometry%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2003%26volume%3D1014%26spage%3D71%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Renwick, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, B. G.</span><span> </span><span class="NLM_article-title">Metabolism of zaleplon by human hepatic microsomal cytochrome P450 isoforms</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">â</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=337-348&author=A.+B.+Renwickauthor=H.+Mistryauthor=S.+E.+Ballauthor=D.+G.+Waltersauthor=J.+Kaoauthor=B.+G.+Lake&title=Metabolism+of+zaleplon+by+human+hepatic+microsomal+cytochrome+P450+isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRenwick%26aufirst%3DA.%2BB.%26aulast%3DMistry%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DS.%2BE.%26aulast%3DWalters%26aufirst%3DD.%2BG.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DLake%26aufirst%3DB.%2BG.%26atitle%3DMetabolism%2520of%2520zaleplon%2520by%2520human%2520hepatic%2520microsomal%2520cytochrome%2520P450%2520isoforms%26jtitle%3DXenobiotica%26date%3D1998%26volume%3D28%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For N-dealkylation of citalopram see the following: </p></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sindrup, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broesen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaes-Joergensen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overoe, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, L. F.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms</span> <span class="citation_source-journal">Ther. Drug Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">â</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1097%2F00007691-199302000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=8451774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVaksLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1993&pages=11-17&author=S.+H.+Sindrupauthor=K.+Broesenauthor=M.+G.+J.+Hansenauthor=T.+Aaes-Joergensenauthor=K.+F.+Overoeauthor=L.+F.+Gram&title=Pharmacokinetics+of+citalopram+in+relation+to+the+sparteine+and+the+mephenytoin+oxidation+polymorphisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms</span></div><div class="casAuthors">Sindrup, S. H.; Broesen, K.; Hansen, M. G. J.; Aaes-Joergensen, T.; Overoe, K. F.; Gram, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Drug Monitoring</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">TDMODV</span>;
        ISSN:<span class="NLM_cas:issn">0163-4356</span>.
    </div><div class="casAbstract">The relationship between the metab. of the selective serotonin reuptake inhibitor citalopram and the sparteine and mephenytoin oxidn. polymorphisms was studied in 24 healthy men constituting panels of extensive metabolizers of sparteine and mephenytoin, poor metabolizers of sparteine, and poor metabolizers of mephenytoin.  Each subject was given 40 mg citalopram/day for 10 days, and citalopram and its desmethyl and didesmethyl metabolites were assayed in blood serum and urine.  A nonenantioselective HPLC method showed that the citalopram elimination partially depended on the mephenytoin oxygenase, since steady-state serum concn., half-life, and area under the serum concn./time curve for citalopram were higher in poor metabolizers than in extensive metabolizers of mephenytoin.  Both citalopram total clearance and demethylation clearance (formation of desmethylcitalopram) were lower in poor metabolizers of mephenytoin compared to extensive metabolizers.  The demethylation of desmethylcitalopram to didesmethylcitalopram depended on the sparteine oxygenase CYP2D6.  Didesmethylcitalopram could virtually not be detected in any poor metabolizers of sparteine, contrasting measurable serum levels in all sparteine/mephenytoin extensive metabolizers.  The demethylation clearance of desmethylcitalopram was lower in sparteine poor metabolizers compared to extensive metabolizers.  During administration of citalopram, there was a modest increase in sparteine metabolic ratio from median 0.31 to 0.80 in extensive metabolizers of sparteine, whereas the mephenytoin S/R ratio was unaltered during the citalopram treatment.  The sparteine and mephenytoin oxidn. polymorphism may contribute to the total pharmacokinetic variability of citalopram.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKX0vV6c--1LVg90H21EOLACvtfcHk0ljIsV0txhpvHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVaksLc%253D&md5=176bc44781e0d3eeaac22126b6934da9</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1097%2F00007691-199302000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007691-199302000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DSindrup%26aufirst%3DS.%2BH.%26aulast%3DBroesen%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DAaes-Joergensen%26aufirst%3DT.%26aulast%3DOveroe%26aufirst%3DK.%2BF.%26aulast%3DGram%26aufirst%3DL.%2BF.%26atitle%3DPharmacokinetics%2520of%2520citalopram%2520in%2520relation%2520to%2520the%2520sparteine%2520and%2520the%2520mephenytoin%2520oxidation%2520polymorphisms%26jtitle%3DTher.%2520Drug%2520Monit.%26date%3D1993%26volume%3D15%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For N-dealkylation of gallopamil see the followng: </p></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Weymann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hege, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller-Peltzer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollmann, M.</span><span> </span><span class="NLM_article-title">Metabolism of the calcium antagonist gallopamil in man</span> <span class="citation_source-journal">Arzneim.-Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">â</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=2757679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL1MXksV2rsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1989&pages=605-607&author=J.+Weymannauthor=V.+Buehlerauthor=H.+C.+Hegeauthor=H.+Mueller-Peltzerauthor=G.+Schenkauthor=B.+Stierenauthor=M.+Hollmann&title=Metabolism+of+the+calcium+antagonist+gallopamil+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of the calcium antagonist gallopamil in man</span></div><div class="casAuthors">Weymann, J.; Buehler, V.; Hege, H. C.; Mueller-Peltzer, H.; Schenk, G.; Stieren, B.; Hollmann, M.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">605-7</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">The metab. of gallopamil (I) was studied in humans after oral administration of 50 mg or i.v. administration of 2 mg.  The clearance of the drug was largely metabolic with little excretion of unchanged drug.  After oral administration of labeled I, most of the radioactivity in plasma was due to metabolites.  The drug was excreted in urine and feces to the extent of â¼50 and 40%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNNEBXzQysubVg90H21EOLACvtfcHk0ljIsV0txhpvHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXksV2rsbY%253D&md5=30d41f76ea51d02cb4ad67fa97d09411</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeymann%26aufirst%3DJ.%26aulast%3DBuehler%26aufirst%3DV.%26aulast%3DHege%26aufirst%3DH.%2BC.%26aulast%3DMueller-Peltzer%26aufirst%3DH.%26aulast%3DSchenk%26aufirst%3DG.%26aulast%3DStieren%26aufirst%3DB.%26aulast%3DHollmann%26aufirst%3DM.%26atitle%3DMetabolism%2520of%2520the%2520calcium%2520antagonist%2520gallopamil%2520in%2520man%26jtitle%3DArzneim.-Forsch.%26date%3D1989%26volume%3D39%26spage%3D605%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><div class="note"><p class="first last">For N-acetylation of alogliptin see the following: </p></div><span class="NLM_contrib-group">Christopher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekki, Q. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wann, E. R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, A.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.clinthera.2008.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18405789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=513-527&author=R.+Christopherauthor=P.+Covingtonauthor=M.+Davenportauthor=P.+Fleckauthor=Q.+A+Mekkiauthor=E.+R+Wannauthor=A.+Karim&title=Pharmacokinetics%2C+pharmacodynamics%2C+and+tolerability+of+single+increasing+doses+of+the+dipeptidyl+peptidase-4+inhibitor+alogliptin+in+healthy+male+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects</span></div><div class="casAuthors">Christopher, Ronald; Covington, Paul; Davenport, Michael; Fleck, Penny; Mekki, Qais A.; Wann, Elisabeth R.; Karim, Aziz</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">513-527</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">Alogliptin is a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor that is under development for the treatment of type 2 diabetes.  This study was conducted to characterize the pharmacokinetics, pharmacodynamics, and tolerability of single oral doses of alogliptin in healthy male subjects.  This was a randomized, double-blind, placebo-controlled study in which healthy, nonobese male subjects between the ages of 18 and 55 years were assigned to 1 of 6 cohorts: alogliptin 25, 50, 100, 200, 400, or 800 mg.  One subject in each cohort received placebo.  An ascending-dose strategy was used, in which each cohort received its assigned dose only after review of the safety data from the previous cohort.  Blood and urine were collected over 72 h after dosing for pharmacokinetic anal. and detn. of plasma DPP-4 inhibition and active glucagon-like peptide-1 (GLP-1) concns.  Thirty-six subjects (6 per cohort) were enrolled and completed the study (29/36 [81%] white; mean age, 26.6 years; mean wt., 76.0 kg).  Alogliptin was rapidly absorbed (median Tmax, 1-2 h) and eliminated slowly (mean t1/2, 12.4-21.4 h), primarily via urinary excretion (mean fraction of drug excreted in urine from 0 to 72 h after dosing, 60-71%).  Cmax and AUC0-â increased dose proportionally over the range from 25 to 100 mg.  The metabolites M-I (N-demethylated) and M-II (N-acetylated) accounted for <2% and <6%, resp., of alogliptin concns. in plasma and urine.  Across alogliptin doses, mean peak DPP-4 inhibition ranged from 93% to 99%, and mean inhibition at 24 h after dosing ranged from 74% to 97%.  Exposure to active GLP-1 was 2- to 4-fold greater for all alogliptin doses compared with placebo; no dose response was apparent.  Hypoglycemia (asymptomatic) was reported in 5 subjects (1 receiving alogliptin 50 mg, 2 receiving alogliptin 200 mg, 1 receiving alogliptin 400 mg, 1 receiving placebo).  Other adverse events were reported in 1 subject each: dizziness (alogliptin 100 mg), syncope (alogliptin 200 mg), constipation (alogliptin 200 mg), viral infection (alogliptin 400 mg), hot flush (placebo), and nausea (placebo).  In these healthy male subjects, alogliptin at single doses up to 800 mg inhibited plasma DPP-4 activity, increased active GLP-1, and was generally well tolerated, with no dose-limiting toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQKWGGvZPSibVg90H21EOLACvtfcHk0li47DAHCQUDkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLfI&md5=c1fd088985499025d3207a285a6e8577</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2008.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2008.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DChristopher%26aufirst%3DR.%26aulast%3DCovington%26aufirst%3DP.%26aulast%3DDavenport%26aufirst%3DM.%26aulast%3DFleck%26aufirst%3DP.%26aulast%3DMekki%26aufirst%3DQ.%2BA%26aulast%3DWann%26aufirst%3DE.%2BR%26aulast%3DKarim%26aufirst%3DA.%26atitle%3DPharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520tolerability%2520of%2520single%2520increasing%2520doses%2520of%2520the%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520alogliptin%2520in%2520healthy%2520male%2520subjects%26jtitle%3DClin.%2520Ther.%26date%3D2008%26volume%3D30%26spage%3D513%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="note"><p class="first last">For oxidation of trilostane: </p></div><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatematsu, A.</span><span> </span><span class="NLM_article-title">Study on metabolites of trilostane, an inhibitor of adrenal steroidogenesis</span> <span class="citation_source-journal">J. Pharmacobio-Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">S10</span><span class="NLM_x">â</span> <span class="NLM_lpage">S-22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1980&pages=S10-S-22&author=M.+Suzukiauthor=Y.+Moriauthor=M.+Tsuboiauthor=A.+Tatematsu&title=Study+on+metabolites+of+trilostane%2C+an+inhibitor+of+adrenal+steroidogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DTsuboi%26aufirst%3DM.%26aulast%3DTatematsu%26aufirst%3DA.%26atitle%3DStudy%2520on%2520metabolites%2520of%2520trilostane%252C%2520an%2520inhibitor%2520of%2520adrenal%2520steroidogenesis%26jtitle%3DJ.%2520Pharmacobio-Dyn.%26date%3D1980%26volume%3D3%26spage%3DS10%26epage%3DS-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation and methylation of cimetidine:</p></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Waring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. L.</span><span> </span><span class="NLM_article-title">Novel aspects of the metabolism of cimetidine in the guinea pig</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">â</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1042%2Fbst0140098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL28Xhsl2ltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1986&pages=98-99&author=R.+H.+Waringauthor=S.+C.+Mitchellauthor=R.+Blundellauthor=R.+L.+Smith&title=Novel+aspects+of+the+metabolism+of+cimetidine+in+the+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel aspects of the metabolism of cimetidine in the guinea pig</span></div><div class="casAuthors">Waring, R. H.; Mitchell, S. C.; Blundell, R.; Smith, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-9</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    </div><div class="casAbstract">In guinea pigs given 14C-labeled cimetidine  [51481-61-9] orally, excellent recovery of the drug was obtained, with the fecal and urinary routes of elimination being of equal importance.  Cimetidine sulfoxide  [54237-72-8] was the major metabolite in urine, feces, and bile; other radioactive compds. identified in urine, feces, and bile were the N'-glucuronide  [101912-02-1] and a small amt. of cimetidine guanylurea  [77076-18-7] in the urine.  In addn., a previously unreported metabolite was found in the urine and was identified as N-methylcimetidine  [52378-54-8]; N-methylcimetidine sulfoxide  [101912-01-0] was also detected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE27OoGqvJQrVg90H21EOLACvtfcHk0li47DAHCQUDkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xhsl2ltL0%253D&md5=e9a56da3e620d6959d5c52d8ab986e50</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1042%2Fbst0140098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0140098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DR.%2BH.%26aulast%3DMitchell%26aufirst%3DS.%2BC.%26aulast%3DBlundell%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BL.%26atitle%3DNovel%2520aspects%2520of%2520the%2520metabolism%2520of%2520cimetidine%2520in%2520the%2520guinea%2520pig%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1986%26volume%3D14%26spage%3D98%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Taylor, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresswell, P. R.</span><span> </span><span class="NLM_article-title">The metabolism of cimetidine in the rat, dog and man</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">â</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1042%2Fbst0030884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaE28XktFemu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1975&pages=884-885&author=D.+C.+Taylorauthor=P.+R.+Cresswell&title=The+metabolism+of+cimetidine+in+the+rat%2C+dog+and+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of cimetidine in the rat, dog and man</span></div><div class="casAuthors">Taylor, Donald C.; Cresswell, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">884-5</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    </div><div class="casAbstract">The patterns of labeled metabolites of 2-3H- or 2-14C-labeled cimetidine (I) [51481-61-9] (i.v. or oral) in urine were similar in rats, dogs, and man: the major metabolite was the sulfoxide of I with smaller amts. of the hydroxymethyl deriv. II [59359-50-1] and the guanylurea III [59359-51-2].  In 24 hr after oral administration of I to female rats, male rats, dogs, and man, the percentages of label excreted in urine were 64, 58, 72, and 69 resp.; after i.v. doses these values were 73, 71, 98, and 97% resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprBeRhrRbDybVg90H21EOLACvtfcHk0li47DAHCQUDkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XktFemu7c%253D&md5=bab9b2702d3cbeaf19e028dd4745ccee</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1042%2Fbst0030884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0030884%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DD.%2BC.%26aulast%3DCresswell%26aufirst%3DP.%2BR.%26atitle%3DThe%2520metabolism%2520of%2520cimetidine%2520in%2520the%2520rat%252C%2520dog%2520and%2520man%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1975%26volume%3D3%26spage%3D884%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation of pinicidil:</p></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">DeLong, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldham, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSante, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, D. P.</span><span> </span><span class="NLM_article-title">Disposition of [<sup>14</sup>C]pinacidil in humans</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1988&pages=153-156&author=A.+F.+DeLongauthor=S.+W.+Oldhamauthor=K.+A.+DeSanteauthor=G.+Nellauthor=D.+P.+Henry&title=Disposition+of+%5B14C%5Dpinacidil+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeLong%26aufirst%3DA.%2BF.%26aulast%3DOldham%26aufirst%3DS.%2BW.%26aulast%3DDeSante%26aufirst%3DK.%2BA.%26aulast%3DNell%26aufirst%3DG.%26aulast%3DHenry%26aufirst%3DD.%2BP.%26atitle%3DDisposition%2520of%2520%255B14C%255Dpinacidil%2520in%2520humans%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1988%26volume%3D77%26spage%3D153%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">McBurney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. W.</span><span> </span><span class="NLM_article-title">Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-<i>N</i>-oxide following i.v. and oral administration in healthy volunteers</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">â</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1365-2125.1985.tb02618.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3978025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2MXhslamsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1985&pages=91-94&author=A.+McBurneyauthor=P.+R.+Farrowauthor=S.+Ainsworthauthor=J.+W.+Ward&title=Serum+concentrations+and+urinary+excretion+of+pinacidil+and+its+major+metabolite%2C+pinacidil+pyridine-N-oxide+following+i.v.+and+oral+administration+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers</span></div><div class="casAuthors">McBurney, A.; Farrow, P. R.; Ainsworth, S.; Ward, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-4</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Serum concns. of pinacidil  [60560-33-0] and its major metabolite pinacidil pyridine-N-oxide  [83285-82-9] were detd. following administration of both an i.v. soln. and a sustained release oral prepn. to healthy volunteers.  Mean bioavailability of pinacidil was 57.1%.  Following i.v. administration, the mean area under the concn.-time curve (AUC0-8 h) metabolite/AUC0-8 h pinacidil ratio was 0.559 and after oral administration, 0.825.  Only 1 subject had serum metabolite concns. in excess of pinacidil during the i.v. study whereas three subjects achieved metabolite concns. in excess of pinacidil during the oral study.  The mean serum elimination half-life of metabolite was longer than parent drug following i.v. administration but not after oral administration.  No significant difference was found in the max. measured metabolite concn. (Cmax.m) between the studies.  The time to Cmax.m was delayed following oral dosage.  Urinary excretion (24 L) of metabolite was increased following oral administration whilst that of pinacidil was decreased.  These results suggest that pinacidil pyridine-N-oxide may be a first-pass metabolite of pinacidil.  In most patients pinacidil pyridine-N-oxide is unlikely to contribute significantly to the hypotensive effect of pinacidil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIthVj6HqfC7Vg90H21EOLACvtfcHk0ljQtGTU60r44w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhslamsb8%253D&md5=7442165c083e40f448a8926a1c43bdec</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1985.tb02618.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1985.tb02618.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcBurney%26aufirst%3DA.%26aulast%3DFarrow%26aufirst%3DP.%2BR.%26aulast%3DAinsworth%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DJ.%2BW.%26atitle%3DSerum%2520concentrations%2520and%2520urinary%2520excretion%2520of%2520pinacidil%2520and%2520its%2520major%2520metabolite%252C%2520pinacidil%2520pyridine-N-oxide%2520following%2520i.v.%2520and%2520oral%2520administration%2520in%2520healthy%2520volunteers%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D19%26spage%3D91%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation of letrozole see the following:</p></div><div class="NLM_citation" id="rightTab-cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Rodriguez-Flores, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salcedo, A. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, L. M.</span><span> </span><span class="NLM_article-title">Rapid quantitative analysis of letrozole, fluoxetine and their metabolites in biological and environmental samples by MEKC</span> <span class="citation_source-journal">Electrophoresis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">â</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=624-632&author=J.+Rodriguez-Floresauthor=A.+M.+C.+Salcedoauthor=L.+M.+Fernandez&title=Rapid+quantitative+analysis+of+letrozole%2C+fluoxetine+and+their+metabolites+in+biological+and+environmental+samples+by+MEKC"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Flores%26aufirst%3DJ.%26aulast%3DSalcedo%26aufirst%3DA.%2BM.%2BC.%26aulast%3DFernandez%26aufirst%3DL.%2BM.%26atitle%3DRapid%2520quantitative%2520analysis%2520of%2520letrozole%252C%2520fluoxetine%2520and%2520their%2520metabolites%2520in%2520biological%2520and%2520environmental%2520samples%2520by%2520MEKC%26jtitle%3DElectrophoresis%26date%3D2009%26volume%3D30%26spage%3D624%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Rodriguez, F., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salcedo, A. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villasenor Llerena, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz Fernandez, L.</span><span> </span><span class="NLM_article-title">Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1185</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">â</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1185&publication_year=2008&pages=281-290&author=F.%2C+J.+Rodriguezauthor=A.+M.+C.+Salcedoauthor=M.+J.+Villasenor+Llerenaauthor=L.+Munoz+Fernandez&title=Micellar+electrokinetic+chromatographic+method+for+the+determination+of+letrozole%2C+citalopram+and+their+metabolites+in+human+urine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DF.%252C%2BJ.%26aulast%3DSalcedo%26aufirst%3DA.%2BM.%2BC.%26aulast%3DVillasenor%2BLlerena%26aufirst%3DM.%2BJ.%26aulast%3DMunoz%2BFernandez%26aufirst%3DL.%26atitle%3DMicellar%2520electrokinetic%2520chromatographic%2520method%2520for%2520the%2520determination%2520of%2520letrozole%252C%2520citalopram%2520and%2520their%2520metabolites%2520in%2520human%2520urine%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2008%26volume%3D1185%26spage%3D281%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For oxidation of nilvadipine see:</p></div><div class="NLM_citation" id="rightTab-cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Terashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiokawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, H.</span><span> </span><span class="NLM_article-title">Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">â</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=1415-1425&author=S.+Terashitaauthor=Y.+Tokumaauthor=T.+Fujiwaraauthor=Y.+Shiokawaauthor=K.+Okumuraauthor=H.+Noguchi&title=Metabolism+of+nilvadipine%2C+a+new+dihydropyridine+calcium+antagonist%2C+in+rats+and+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTokuma%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DShiokawa%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DH.%26atitle%3DMetabolism%2520of%2520nilvadipine%252C%2520a%2520new%2520dihydropyridine%2520calcium%2520antagonist%252C%2520in%2520rats%2520and%2520dogs%26jtitle%3DXenobiotica%26date%3D1987%26volume%3D17%26spage%3D1415%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wit, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Genderen, H.</span><span> </span><span class="NLM_article-title">Metabolism of the herbicide 2,6-dichlorobenzonitrile in rabbits and rats</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">â</span> <span class="NLM_lpage">706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1966&pages=698-706&author=J.+G.+Witauthor=H.+van+Genderen&title=Metabolism+of+the+herbicide+2%2C6-dichlorobenzonitrile+in+rabbits+and+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWit%26aufirst%3DJ.%2BG.%26aulast%3Dvan%2BGenderen%26aufirst%3DH.%26atitle%3DMetabolism%2520of%2520the%2520herbicide%25202%252C6-dichlorobenzonitrile%2520in%2520rabbits%2520and%2520rats%26jtitle%3DBiochem.%2520J.%26date%3D1966%26volume%3D101%26spage%3D698%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hutson, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoadley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donninger, C.</span><span> </span><span class="NLM_article-title">Mercapturic acid formation in the metabolism of 2-chloro-4-ethylamino-6-(1-methyl-1-cyanoethylamino)-<i>s</i>-triazine in the rat</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">â</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf60169a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1970&pages=507-512&author=D.+H.+Hutsonauthor=E.+C.+Hoadleyauthor=M.+H.+Griffithsauthor=C.+Donninger&title=Mercapturic+acid+formation+in+the+metabolism+of+2-chloro-4-ethylamino-6-%281-methyl-1-cyanoethylamino%29-s-triazine+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjf60169a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf60169a035%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DD.%2BH.%26aulast%3DHoadley%26aufirst%3DE.%2BC.%26aulast%3DGriffiths%26aufirst%3DM.%2BH.%26aulast%3DDonninger%26aufirst%3DC.%26atitle%3DMercapturic%2520acid%2520formation%2520in%2520the%2520metabolism%2520of%25202-chloro-4-ethylamino-6-%25281-methyl-1-cyanoethylamino%2529-s-triazine%2520in%2520the%2520rat%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D1970%26volume%3D18%26spage%3D507%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tanii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">Influence of ethanol on the in vivo and in vitro metabolism of nitriles in mice</span> <span class="citation_source-journal">Arch. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2FBF00340977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3964080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL28Xht1Ckurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1986&pages=171-176&author=H.+Taniiauthor=K.+Hashimoto&title=Influence+of+ethanol+on+the+in+vivo+and+in+vitro+metabolism+of+nitriles+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of ethanol on the in vivo and in vitro metabolism of nitriles in mice</span></div><div class="casAuthors">Tanii, Hideji; Hashimoto, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-6</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    </div><div class="casAbstract">The effect of EtOH  [64-17-5] on metab. of 20 nitriles was studied in vivo and in vitro in mice.  The hepatic microsomal metabolizing activity for nitriles was at a max. 13 h after EtOH dosing (4.0 g/kg).  Using microsomes from mice pretreated with EtOH under the above conditions, enhancement of the in vitro metab. of nitriles was 1.00-1.83 compared with the glucose-treated control.  When mice were orally given nitriles 13 h after dosing with either EtOH (4.0 g/kg) or glucose (7.0 g/kg), the hepatic metabolizing activity of nitriles for the EtOH-treated group was always higher than that for the glucose group, although no change in the content of hepatic microsomal cytochrome P 450  [9035-51-2] was obsd. between the 2 groups.  However, EtOH added to the incubation mixt. inhibited the in vitro metab. of most nitriles.  Evidently EtOH can enhance the acute toxicity of nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXhcc0k5uTZ7Vg90H21EOLACvtfcHk0liLGQtOvOu40w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1Ckurc%253D&md5=dbd8ed200e84144d02f3fd68f099b63a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2FBF00340977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00340977%26sid%3Dliteratum%253Aachs%26aulast%3DTanii%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DInfluence%2520of%2520ethanol%2520on%2520the%2520in%2520vivo%2520and%2520in%2520vitro%2520metabolism%2520of%2520nitriles%2520in%2520mice%26jtitle%3DArch.%2520Toxicol.%26date%3D1986%26volume%3D58%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Singh, P. D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, S. P.</span><span> </span><span class="NLM_article-title">Metabolism of mandelonitrile in the rat</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2207</span><span class="NLM_x">â</span> <span class="NLM_lpage">2209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=2207-2209&author=P.+D.+A.+Singhauthor=J.+R.+Jacksonauthor=S.+P.+James&title=Metabolism+of+mandelonitrile+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%2BD.%2BA.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DJames%26aufirst%3DS.%2BP.%26atitle%3DMetabolism%2520of%2520mandelonitrile%2520in%2520the%2520rat%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D2207%26epage%3D2209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, A. I.</span><span> </span><span class="NLM_article-title">Synthesis of 2-tetralones via a novel 1,2-carbonyl transposition of 1-tetralones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3243</span><span class="NLM_x">â</span> <span class="NLM_lpage">3246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=3243-3246&author=D.+C.+Prydeauthor=S.+S.+Henryauthor=A.+I.+Meyers&title=Synthesis+of+2-tetralones+via+a+novel+1%2C2-carbonyl+transposition+of+1-tetralones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DHenry%26aufirst%3DS.%2BS.%26aulast%3DMeyers%26aufirst%3DA.%2BI.%26atitle%3DSynthesis%2520of%25202-tetralones%2520via%2520a%2520novel%25201%252C2-carbonyl%2520transposition%2520of%25201-tetralones%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D3243%26epage%3D3246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aiai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudy-Flocâh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grel, P.</span><span> </span><span class="NLM_article-title">First Sharpless epoxidation of electrophilic 2-cyano allylic alcohols</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2249</span><span class="NLM_x">â</span> <span class="NLM_lpage">2252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=2249-2252&author=M.+Aiaiauthor=A.+Robertauthor=M.+Baudy-Floc%E2%80%99hauthor=P.+Le+Grel&title=First+Sharpless+epoxidation+of+electrophilic+2-cyano+allylic+alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAiai%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DA.%26aulast%3DBaudy-Floc%25E2%2580%2599h%26aufirst%3DM.%26aulast%3DLe%2BGrel%26aufirst%3DP.%26atitle%3DFirst%2520Sharpless%2520epoxidation%2520of%2520electrophilic%25202-cyano%2520allylic%2520alcohols%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1995%26volume%3D6%26spage%3D2249%26epage%3D2252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Miyashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikoshi, A.</span><span> </span><span class="NLM_article-title">Fluoride-promoted epoxidation of Î±,Î²-unsaturated compounds</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=285-288&author=M.+Miyashitaauthor=T.+Suzukiauthor=A.+Yoshikoshi&title=Fluoride-promoted+epoxidation+of+%CE%B1%2C%CE%B2-unsaturated+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyashita%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYoshikoshi%26aufirst%3DA.%26atitle%3DFluoride-promoted%2520epoxidation%2520of%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520compounds%26jtitle%3DChem.%2520Lett.%26date%3D1987%26spage%3D285%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einolf, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D.</span><span> </span><span class="NLM_article-title">Absorption, metabolism, and excretion of [<sup>14</sup>C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">â</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=536-544&author=H.+Heauthor=P.+Tranauthor=H.+Yinauthor=H.+Smithauthor=Y.+Batardauthor=L.+Wangauthor=H.+Einolfauthor=H.+Guauthor=J.+B.+Mangoldauthor=V.+Fischerauthor=D.+Howard&title=Absorption%2C+metabolism%2C+and+excretion+of+%5B14C%5Dvildagliptin%2C+a+novel+dipeptidyl+peptidase+4+inhibitor%2C+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DTran%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DH.%26aulast%3DBatard%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DEinolf%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DMangold%26aufirst%3DJ.%2BB.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHoward%26aufirst%3DD.%26atitle%3DAbsorption%252C%2520metabolism%252C%2520and%2520excretion%2520of%2520%255B14C%255Dvildagliptin%252C%2520a%2520novel%2520dipeptidyl%2520peptidase%25204%2520inhibitor%252C%2520in%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D536%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Urinary metabolites of pinacidil. II. Species difference in the metabolism of pinacidil</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">â</span> <span class="NLM_lpage">656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1993&pages=649-656&author=K.+Sakamotoauthor=Y.+Nakamura&title=Urinary+metabolites+of+pinacidil.+II.+Species+difference+in+the+metabolism+of+pinacidil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DUrinary%2520metabolites%2520of%2520pinacidil.%2520II.%2520Species%2520difference%2520in%2520the%2520metabolism%2520of%2520pinacidil%26jtitle%3DXenobiotica%26date%3D1993%26volume%3D23%26spage%3D649%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Urinary metabolites of pinacidil: I. Isolation and identification of the metabolites in rat urine</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">â</span> <span class="NLM_lpage">400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1993&pages=391-400&author=K.+Sakamotoauthor=Y.+Nakamura&title=Urinary+metabolites+of+pinacidil%3A+I.+Isolation+and+identification+of+the+metabolites+in+rat+urine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DUrinary%2520metabolites%2520of%2520pinacidil%253A%2520I.%2520Isolation%2520and%2520identification%2520of%2520the%2520metabolites%2520in%2520rat%2520urine%26jtitle%3DXenobiotica%26date%3D1993%26volume%3D23%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For an example where nitrile hydrolysis may be present or an artifact of the analysis technique see ref <a onclick="showRef(event, 'cit10h'); return false;" href="javascript:void(0);" class="ref cit10h">10h</a>. An extensive metabolic profiling of lersivirine identified less than two percent of metabolites arising from nitrile hydrolysis.<a onclick="showRef(event, 'cit6e'); return false;" href="javascript:void(0);" class="ref cit6e">(6e)</a></p></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Le Questel, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, C.</span><span> </span><span class="NLM_article-title">Hydrogen-bond acceptor properties of nitriles: a combined crystallographic and ab initio theoretical investigation</span> <span class="citation_source-journal">J. Phys. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2F1099-1395%28200006%2913%3A6%3C347%3A%3AAID-POC251%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Kmsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=347-358&author=J.-Y.+Le+Questelauthor=M.+Berthelotauthor=C.+Laurence&title=Hydrogen-bond+acceptor+properties+of+nitriles%3A+a+combined+crystallographic+and+ab+initio+theoretical+investigation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen-bond acceptor properties of nitriles: a combined crystallographic and ab initio theoretical investigation</span></div><div class="casAuthors">Le Questel, Jean-Yves; Berthelot, Michel; Laurence, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-358</span>CODEN:
                <span class="NLM_cas:coden">JPOCEE</span>;
        ISSN:<span class="NLM_cas:issn">0894-3230</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The H-bond ability of N in X-Câ¡NÂ·Â·Â·HO-R systems was studied using crystallog. data retrieved from the Cambridge Structural Database and via ab initio calcns.  The classification of H-bond geometries by the nature of the donor shows that the strength of the interaction increases in the order H2O â alcs. < phenols.  If the H-bond geometries are classified according to the nature of the acceptor inside each sample of donor, the strongest H bonds are always obsd. for "push-pull" nitriles, as obsd. in soln. on the pKHB scale for such mols.  Ab initio MO calcns. are then used to compute descriptors of H-bond basicity (enthalpy ÎHÂ°, H-bond length and min. electrostatic potential of the base) for H-bond formation between H2O and 18 nitriles embracing a wide range of structure and basicity.  Correlations between the H-bond basicity scale pKHB and these quantum-mech. descriptors allow the calcn. of pKHB values for exptl. inaccessible bases and the treatment of polyfunctional nitriles.  They also confirm the super-basicity of the nitrile group of cimetidine (I), a well known antiulcer drug.  This property might be relevant in the mol. recognition of I by the H2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bBQPgdH--7Vg90H21EOLACvtfcHk0lhzV8wq7iXKFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Kmsbs%253D&md5=bf5ce14ba874919ad07b71c58bc2645a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F1099-1395%28200006%2913%3A6%3C347%3A%3AAID-POC251%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-1395%2528200006%252913%253A6%253C347%253A%253AAID-POC251%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BQuestel%26aufirst%3DJ.-Y.%26aulast%3DBerthelot%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DC.%26atitle%3DHydrogen-bond%2520acceptor%2520properties%2520of%2520nitriles%253A%2520a%2520combined%2520crystallographic%2520and%2520ab%2520initio%2520theoretical%2520investigation%26jtitle%3DJ.%2520Phys.%2520Org.%2520Chem.%26date%3D2000%26volume%3D13%26spage%3D347%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> The mean bond length of 1.14 Ã was obtained by averaging 5059 nitriles located in the Cambridge Structural Database.</p></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sheppard, W. A.</span> In  <span class="citation_source-book">The Chemistry of the Cyano Group</span>; <span class="NLM_contrib-group">Rappoport, Z.</span>, Ed.; <span class="NLM_publisher-name">Interscience</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1970</span><span class="NLM_x">; </span>Chapter 5.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&author=W.+A.+Sheppardauthor=Z.+Rappoport&title=The+Chemistry+of+the+Cyano+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DW.%2BA.%26btitle%3DThe%2520Chemistry%2520of%2520the%2520Cyano%2520Group%26aulast%3DRappoport%26aufirst%3DZ.%26pub%3DInterscience%26date%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">Based on a comparison of <i>A</i> values for nitrile and methyl groups:</p></div><span class="NLM_contrib-group">Eliel, E. L.; Wilen, S. H.; Mander, L. N.</span> <span class="citation_source-book">Stereochemistry of Organic Compounds</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1994</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">696</span>â <span class="NLM_lpage">697</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=696-697&author=E.+L.+Eliel&author=S.+H.+Wilen&author=L.+N.+Mander&title=Stereochemistry+of+Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEliel%26aufirst%3DE.%2BL.%26btitle%3DStereochemistry%2520of%2520Organic%2520Compounds%26pub%3DWiley%26date%3D1994%26spage%3D696%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">See, for example, the cocrystal structures of cathepsin K with bound inhibitor: </p></div><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomuraa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohdaa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasakia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemuraa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadaa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometania, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasakia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacobb, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missbachb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattmannb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betscharta, C.</span><span> </span><span class="NLM_article-title">Novel scaffold for cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6096</span><span class="NLM_x">â</span> <span class="NLM_lpage">6100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2007.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17911019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6096-6100&author=N.+Tenoauthor=T.+Miyakeauthor=T.+Eharaauthor=O.+Irieauthor=J.+Sakakiauthor=O.+Ohmoriauthor=H.+Gunjiauthor=N.+Matsuuraauthor=K.+Masuyaauthor=Y.+Hitomiauthor=K.+Nonomuraaauthor=M.+Horiuchiaauthor=K.+Gohdaaauthor=A.+Iwasakiaauthor=I.+Umemuraaauthor=S.+Tadaaauthor=M.+Kometaniaauthor=G.+Iwasakiaauthor=S.+W.+Cowan-Jacobbauthor=M.+Missbachbauthor=R.+Lattmannbauthor=C.+Betscharta&title=Novel+scaffold+for+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel scaffold for cathepsin K inhibitors</span></div><div class="casAuthors">Teno, Naoki; Miyake, Takahiro; Ehara, Takeru; Irie, Osamu; Sakaki, Junichi; Ohmori, Osamu; Gunji, Hiroki; Matsuura, Naoko; Masuya, Keiichi; Hitomi, Yuko; Nonomura, Kazuhiko; Horiuchi, Miyuki; Gohda, Keigo; Iwasaki, Atsuko; Umemura, Ichiro; Tada, Sachiyo; Kometani, Motohiko; Iwasaki, Genji; Cowan-Jacob, Sandra W.; Missbach, Martin; Lattmann, Rene; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6096-6100</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pyrrolopyrimidine, a novel scaffold, allows to adjust interactions within the S3 subsite of cathepsin K.  The core intermediate 10 (I) facilitated the P3 optimization and identified highly potent and selective cathepsin K inhibitors 11-20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovAekeL5ajUrVg90H21EOLACvtfcHk0liQU-pIQsbzlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N&md5=9320305ef6bd02c637ffb0dd1afd367d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DEhara%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DSakaki%26aufirst%3DJ.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DGunji%26aufirst%3DH.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DHitomi%26aufirst%3DY.%26aulast%3DNonomuraa%26aufirst%3DK.%26aulast%3DHoriuchia%26aufirst%3DM.%26aulast%3DGohdaa%26aufirst%3DK.%26aulast%3DIwasakia%26aufirst%3DA.%26aulast%3DUmemuraa%26aufirst%3DI.%26aulast%3DTadaa%26aufirst%3DS.%26aulast%3DKometania%26aufirst%3DM.%26aulast%3DIwasakia%26aufirst%3DG.%26aulast%3DCowan-Jacobb%26aufirst%3DS.%2BW.%26aulast%3DMissbachb%26aufirst%3DM.%26aulast%3DLattmannb%26aufirst%3DR.%26aulast%3DBetscharta%26aufirst%3DC.%26atitle%3DNovel%2520scaffold%2520for%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6096%26epage%3D6100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">The hydrogen bond acceptor properties of nitriles are variously described as âmedium to weakâ<a onclick="showRef(event, 'cit21a'); return false;" href="javascript:void(0);" class="ref cit21a">(21a)</a> and excellent.<a onclick="showRef(event, 'cit21b'); return false;" href="javascript:void(0);" class="ref cit21b">(21b)</a></p></div><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pKBHX Database: toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4073</span><span class="NLM_x">â</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.-Y.+Le+Questelauthor=E.+Renault&title=The+pKBHX+Database%3A+toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0liQU-pIQsbzlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.-Y.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pKBHX%2520Database%253A%2520toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4073%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Allerhand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleyer, P.</span><span> </span><span class="NLM_article-title">von Rague nitriles and isonitriles as proton acceptors in hydrogen bonding: correlation of ÎÎ½OH with acceptor structure</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">â</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00890a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=866-870&author=A.+Allerhandauthor=P.+Schleyer&title=von+Rague+nitriles+and+isonitriles+as+proton+acceptors+in+hydrogen+bonding%3A+correlation+of+%CE%94%CE%BDOH+with+acceptor+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fja00890a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00890a006%26sid%3Dliteratum%253Aachs%26aulast%3DAllerhand%26aufirst%3DA.%26aulast%3DSchleyer%26aufirst%3DP.%26atitle%3Dvon%2520Rague%2520nitriles%2520and%2520isonitriles%2520as%2520proton%2520acceptors%2520in%2520hydrogen%2520bonding%253A%2520correlation%2520of%2520%25CE%2594%25CE%25BDOH%2520with%2520acceptor%2520structure%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26spage%3D866%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A,</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palusczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17Î±-hydroxylase/C17,20-lyase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">â</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000955s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=672-680&author=M.+Recanatiniauthor=A.+Bisiauthor=A.+Cavalliauthor=F.+Bellutiauthor=S.+Gobbiauthor=A%2C+Rampaauthor=P.+Valentiauthor=M.+Palzerauthor=A.+Palusczakauthor=R.+W.+Hartmann&title=A+new+class+of+nonsteroidal+aromatase+inhibitors%3A+design+and+synthesis+of+chromone+and+xanthone+derivatives+and+inhibition+of+the+P450+enzymes+aromatase+and+17%CE%B1-hydroxylase%2FC17%2C20-lyase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm000955s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000955s%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRampa%26aufirst%3DA%252C%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DPalzer%26aufirst%3DM.%26aulast%3DPalusczak%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DA%2520new%2520class%2520of%2520nonsteroidal%2520aromatase%2520inhibitors%253A%2520design%2520and%2520synthesis%2520of%2520chromone%2520and%2520xanthone%2520derivatives%2520and%2520inhibition%2520of%2520the%2520P450%2520enzymes%2520aromatase%2520and%252017%25CE%25B1-hydroxylase%252FC17%252C20-lyase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D672%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batzl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rihs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span> </span><span class="NLM_article-title">Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">â</span> <span class="NLM_lpage">1400</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00062a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1393-1400&author=P.+Furetauthor=C.+Batzlauthor=A.+Bhatnagarauthor=E.+Francotteauthor=G.+Rihsauthor=M.+Lang&title=Aromatase+inhibitors%3A+synthesis%2C+biological+activity%2C+and+binding+mode+of+azole-type+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm00062a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00062a012%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DBatzl%26aufirst%3DC.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DFrancotte%26aufirst%3DE.%26aulast%3DRihs%26aufirst%3DG.%26aulast%3DLang%26aufirst%3DM.%26atitle%3DAromatase%2520inhibitors%253A%2520synthesis%252C%2520biological%2520activity%252C%2520and%2520binding%2520mode%2520of%2520azole-type%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D1393%26epage%3D1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">Modeling indicates that the nitrile mimics the carbonyl by interacting with amino acids at the active site, possibly through hydrogen bonds.<a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kelloff, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubet, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawk, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigman, C. C.</span><span> </span><span class="NLM_article-title">Aromatase inhibitors as potential cancer chemopreventives</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=65-78&author=G.+J.+Kelloffauthor=R.+A.+Lubetauthor=R.+Liebermanauthor=K.+Eisenhauerauthor=V.+E.+Steeleauthor=J.+A.+Crowellauthor=E.+T.+Hawkauthor=C.+W.+Booneauthor=C.+C.+Sigman&title=Aromatase+inhibitors+as+potential+cancer+chemopreventives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelloff%26aufirst%3DG.%2BJ.%26aulast%3DLubet%26aufirst%3DR.%2BA.%26aulast%3DLieberman%26aufirst%3DR.%26aulast%3DEisenhauer%26aufirst%3DK.%26aulast%3DSteele%26aufirst%3DV.%2BE.%26aulast%3DCrowell%26aufirst%3DJ.%2BA.%26aulast%3DHawk%26aufirst%3DE.%2BT.%26aulast%3DBoone%26aufirst%3DC.%2BW.%26aulast%3DSigman%26aufirst%3DC.%2BC.%26atitle%3DAromatase%2520inhibitors%2520as%2520potential%2520cancer%2520chemopreventives%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D1998%26volume%3D7%26spage%3D65%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Browne, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnager, A.</span><span> </span><span class="NLM_article-title">Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">â</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=725-736&author=L.+J.+Browneauthor=C.+Gudeauthor=H.+Rodriguezauthor=R.+E.+Steeleauthor=A.+Bhatnager&title=Fadrozole+hydrochloride%3A+a+potent%2C+selective%2C+nonsteroidal+inhibitor+of+aromatase+for+the+treatment+of+estrogen-dependent+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a038%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DL.%2BJ.%26aulast%3DGude%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DH.%26aulast%3DSteele%26aufirst%3DR.%2BE.%26aulast%3DBhatnager%26aufirst%3DA.%26atitle%3DFadrozole%2520hydrochloride%253A%2520a%2520potent%252C%2520selective%252C%2520nonsteroidal%2520inhibitor%2520of%2520aromatase%2520for%2520the%2520treatment%2520of%2520estrogen-dependent%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D725%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bhatnagar, A. S.</span><span> </span><span class="NLM_article-title">The discovery and mechanism of action of letrozole</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2Fs10549-007-9696-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17912633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=7-17&author=A.+S.+Bhatnagar&title=The+discovery+and+mechanism+of+action+of+letrozole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and mechanism of action of letrozole</span></div><div class="casAuthors">Bhatnagar, Ajay S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Because estrogen contributes to the promotion and progression of breast cancer, a greater understanding of the role of estrogen in breast cancer has led to therapeutic strategies targeting estrogen synthesis, the estrogen receptor, and intracellular signaling pathways.  The enzyme aromatase catalyzes the final step in estrogen biosynthesis and was identified as an attractive target for selective inhibition.  Modern third-generation aromatase inhibitors (AIs) effectively block the prodn. of estrogen without exerting effects on other steroidogenic pathways.  The discovery of letrozole (Femara) achieved the goal of discovering a highly potent and totally selective AI.  Letrozole has greater potency than other AIs, including anastrozole, exemestane, formestane, and aminoglutethimide.  Moreover, letrozole produces near complete inhibition of aromatase in peripheral tissues and is assocd. with greater suppression of estrogen than is achieved with other AIs.  The potent anti-tumor effects of letrozole were demonstrated in several animal models.  Studies with MCF-7Ca xenografts successfully predicted that letrozole would be clin. superior to the previous gold std. tamoxifen and also indicated that it may be more effective than other AIs.  An extensive program of randomized clin. trials has demonstrated the clin. benefits of letrozole across the spectrum of hormone-responsive breast cancer in postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAJhzeEx05lrVg90H21EOLACvtfcHk0liMKac4SQ9ShA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlektrbL&md5=4215659d9116c2cb13d100d04b4acb66</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9696-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9696-3%26sid%3Dliteratum%253Aachs%26aulast%3DBhatnagar%26aufirst%3DA.%2BS.%26atitle%3DThe%2520discovery%2520and%2520mechanism%2520of%2520action%2520of%2520letrozole%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D105%26spage%3D7%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">â</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1210%2Fme.2006-0281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17095574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWisLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=401-414&author=Y.+Hongauthor=B.+Yuauthor=M.+Shermanauthor=Y.-C.+Yuanauthor=D.+Zhouauthor=S.+Chen&title=Molecular+basis+for+the+aromatization+reaction+and+exemestane-mediated+irreversible+inhibition+of+human+aromatase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase</span></div><div class="casAuthors">Hong, Yanyan; Yu, Bin; Sherman, Mark; Yuan, Yate-Ching; Zhou, Dujin; Chen, Shiuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">401-414</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Aromatase converts androgens to arom. estrogens.  Aromatase inhibitors have been used as first-line drugs in the treatment of hormone-dependent breast cancer.  Structural basis of the aromatization reaction and drug recognition by aromatase has remained elusive because of its unknown three-dimensional structure.  In this study, recombinant human aromatase was expressed and purified from Escherichia coli.  Using this purified and active prepn., the three-dimensional folding of aromatase was revealed by proteomic anal.  Combined with site-directed mutagenesis, several crit. residues involved in enzyme catalysis and suicide inhibition by exemestane were evaluated.  Based on our results, a new clamping mechanism of substrate/exemestane binding to the active site is proposed.  These structure-function studies of aromatase would provide useful information to design more effective aromatase inhibitors for the prevention and the treatment of hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri-iuXzRqjmLVg90H21EOLACvtfcHk0liMKac4SQ9ShA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWisLc%253D&md5=2071364cd5e744da728d25fdb8e3a118</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1210%2Fme.2006-0281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2006-0281%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DSherman%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DY.-C.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DMolecular%2520basis%2520for%2520the%2520aromatization%2520reaction%2520and%2520exemestane-mediated%2520irreversible%2520inhibition%2520of%2520human%2520aromatase%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D401%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ahokoshi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irjala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taalikka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manninen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halonen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kangas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huupponen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">â</span> <span class="NLM_lpage">704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1046%2Fj.0306-5251.2001.01488.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=11736883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVenug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2001&pages=702-704&author=O.+Ahokoshiauthor=K.+Irjalaauthor=M.+Taalikkaauthor=P.+Manninenauthor=K.+Halonenauthor=L.+Kangasauthor=E.+Salminenauthor=R.+Huupponenauthor=H.+Scheinin&title=Pharmacokinetics+of+finrozole+%28MPV-2213ad%29%2C+a+novel+selective+aromatase+inhibitor%2C+in+healthy+men"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men</span></div><div class="casAuthors">Ahokoshi, Outi; Irjala, Kerttu; Taalikka, Mikko; Manninen, Pekka; Halonen, Kaija; Kangas, Lauri; Salminen, Eeva; Huupponen, Risto; Scheinin, Harry</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">702-704</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The objective was to investigate the pharmacokinetics of finrozole (MPV-2213ad), a novel competitive aromatase enzyme inhibitor, in healthy male volunteers.  The study was an open, partly randomized cross-over study including 23 volunteers receiving single doses of 3, 9 mg or 30 mg of finrozole as tablets or soln. with 14 days between the administrations.  The highest dose was given as tablets only.  Serum concns. of finrozole were detd. using high performance liq. chromatog. combined with mass spectrometry.  The mean time to peak serum concn. ranged from 2.5 to 3.1, and 0.6-0.7 h after tablets and soln., resp.  The Cmax values increased as the dose increased.  The calcd. apparent mean elimination half-life (t1/2,z) was approx. 3 h after the soln., and approx. 8 h after the tablet.  The AUC(0,â) after finrozole tablets increased proportionally from 3 mg to 9 mg and from 3 to 30 mg.  The calcd. relative mean bioavailabilities (AUC(0,â) - ratio) for the 3 mg and 9 mg doses of finrozole as tablets were 89% and 78%, resp.  The absorption of finrozole from the tablet formulation was relatively rapid, and the apparent elimination half-life was longer after the tablet than after the soln., probably reflecting overlap of the absorption with the elimination phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWxsxsdh-wK7Vg90H21EOLACvtfcHk0lgBgaRRC5iIzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVenug%253D%253D&md5=86128f354fdb5cb611fead2d33cf7ad5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1046%2Fj.0306-5251.2001.01488.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0306-5251.2001.01488.x%26sid%3Dliteratum%253Aachs%26aulast%3DAhokoshi%26aufirst%3DO.%26aulast%3DIrjala%26aufirst%3DK.%26aulast%3DTaalikka%26aufirst%3DM.%26aulast%3DManninen%26aufirst%3DP.%26aulast%3DHalonen%26aufirst%3DK.%26aulast%3DKangas%26aufirst%3DL.%26aulast%3DSalminen%26aufirst%3DE.%26aulast%3DHuupponen%26aufirst%3DR.%26aulast%3DScheinin%26aufirst%3DH.%26atitle%3DPharmacokinetics%2520of%2520finrozole%2520%2528MPV-2213ad%2529%252C%2520a%2520novel%2520selective%2520aromatase%2520inhibitor%252C%2520in%2520healthy%2520men%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2001%26volume%3D52%26spage%3D702%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Roumen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeters, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmen, J. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beugels, I. P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custers, E. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Gooyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieterse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilbers, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, J. F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vekemans, J. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottenheijm, H. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermans, J. J. R.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1<i>H</i>-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1712</span><span class="NLM_x">â</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901356d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1712-1725&author=L.+Roumenauthor=J.+W.+Peetersauthor=J.+M.+A.+Emmenauthor=I.+P.+E.+Beugelsauthor=E.+M.+G.+Custersauthor=M.+de+Gooyerauthor=R.+Plateauthor=K.+Pieterseauthor=P.+A.+J.+Hilbersauthor=J.+F.+M.+Smitsauthor=J.+A.+J.+Vekemansauthor=D.+Leysenauthor=H.+C.+J.+Ottenheijmauthor=H.+M.+Janssenauthor=J.+J.+R.+Hermans&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+of+1-benzyl-1H-imidazoles+as+selective+inhibitors+of+aldosterone+synthase+%28CYP11B2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901356d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901356d%26sid%3Dliteratum%253Aachs%26aulast%3DRoumen%26aufirst%3DL.%26aulast%3DPeeters%26aufirst%3DJ.%2BW.%26aulast%3DEmmen%26aufirst%3DJ.%2BM.%2BA.%26aulast%3DBeugels%26aufirst%3DI.%2BP.%2BE.%26aulast%3DCusters%26aufirst%3DE.%2BM.%2BG.%26aulast%3Dde%2BGooyer%26aufirst%3DM.%26aulast%3DPlate%26aufirst%3DR.%26aulast%3DPieterse%26aufirst%3DK.%26aulast%3DHilbers%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DSmits%26aufirst%3DJ.%2BF.%2BM.%26aulast%3DVekemans%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DLeysen%26aufirst%3DD.%26aulast%3DOttenheijm%26aufirst%3DH.%2BC.%2BJ.%26aulast%3DJanssen%26aufirst%3DH.%2BM.%26aulast%3DHermans%26aufirst%3DJ.%2BJ.%2BR.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520of%25201-benzyl-1H-imidazoles%2520as%2520selective%2520inhibitors%2520of%2520aldosterone%2520synthase%2520%2528CYP11B2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1712%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Parkkinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanen, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivula, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouvinen, J.</span><span> </span><span class="NLM_article-title">Crystal structures of an enantioselective Fab-fragment in free and complex forms</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2006&pages=471-480&author=T.+Parkkinenauthor=T.+K.+Nevanenauthor=A.+Koivulaauthor=J.+Rouvinen&title=Crystal+structures+of+an+enantioselective+Fab-fragment+in+free+and+complex+forms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParkkinen%26aufirst%3DT.%26aulast%3DNevanen%26aufirst%3DT.%2BK.%26aulast%3DKoivula%26aufirst%3DA.%26aulast%3DRouvinen%26aufirst%3DJ.%26atitle%3DCrystal%2520structures%2520of%2520an%2520enantioselective%2520Fab-fragment%2520in%2520free%2520and%2520complex%2520forms%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D357%26spage%3D471%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Chemistry and structural biology of androgen receptor</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3352</span><span class="NLM_x">â</span> <span class="NLM_lpage">3370</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr020456u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Witr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=3352-3370&author=W.+Gaoauthor=C.+E.+Bohlauthor=J.+T.+Dalton&title=Chemistry+and+structural+biology+of+androgen+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31aR"><div class="casContent"><span class="casTitleNuber">31a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and structural biology of androgen receptor</span></div><div class="casAuthors">Gao, Wenqing; Bohl, Casey E.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3352-3370</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Androgen receptor (AR) is a sol. protein that functions as an intracellular transcriptional factor.  AR function is regulated by the binding of androgens, which initiates sequential conformational changes of the receptor that affect receptor-protein interactions and receptor-DNA interactions.  AR-regulated gene expression is responsible for male sexual differentiation and male pubertal changes.  AR ligands are widely used in a variety of clin. applications (i.e., agonists are employed for hypogonadism, while antagonists are used for prostate cancer therapy).  The current review focuses on well-characterized AR ligands that bind to the AR with high affinity and integrates discussion regarding the biol., metab., and structure-activity relationships for therapeutic and emerging classes of AR ligands.  The known AR ligands can be classified as steroidal or nonsteroidal based on their structure or as agonist or antagonist based on their ability to activate or inhibit transcription of AR target genes.  Synthetic AR ligands were first developed by modifying the steroidal structure of endogenous androgens.  The structure-activity relationship of these steroidal AR ligands is well documented and is only be briefly summarized in this review.  However, low oral bioavailability, poor pharmacokinetic properties, and side effects have limited the use of many steroidal AR ligands.  Until recently, it was considered impossible to sep. the androgenic and anabolic effects of AR ligands due to their reliance on a single AR.  However, newly discovered nonsteroidal AR ligands may provide a new strategy to achieve tissue selectivity, as is possible with estrogen receptor ligands.  Novel nonsteroidal pharmacophores are summarized in this review with discussion of the emerging structure-activity relationships and examples of their tissue selectivity included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGociW1GV0jzxrVg90H21EOLACvtfcHk0lgBgaRRC5iIzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Witr0%253D&md5=2f81782984773c7395f51171c2613667</span></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1021%2Fcr020456u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020456u%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DW.%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DChemistry%2520and%2520structural%2520biology%2520of%2520androgen%2520receptor%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D3352%26epage%3D3370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Singh, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrie, F.</span><span> </span><span class="NLM_article-title">Androgen receptor antagonists (antiandrogens): structureâactivity relationships</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">â</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F0929867003375371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=10637363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12rsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=211-247&author=S.+M.+Singhauthor=S.+Gauthierauthor=F.+Labrie&title=Androgen+receptor+antagonists+%28antiandrogens%29%3A+structure%E2%88%92activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31b</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen receptor antagonists (antiandrogens): structure-activity relationships</span></div><div class="casAuthors">Singh, Shankar M.; Gauthier, Sylvain; Labrie, Fernand</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-247</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 161 refs.  Prostate cancer, acne, seborrhea, hirsutism, and androgenic alopecia are well recognized to depend upon an excess or increased sensitivity to androgens or to be at least sensitive to androgens.  It thus seems logical to use antiandrogens as therapeutic agents to prevent androgens from binding to the androgen receptor.  The two predominant naturally occurring androgens are testosterone (T) and dihydrotestosterone (DHT).  DHT is the more potent androgen in vivo and in vitro.  All androgen-responsive genes are activated by androgen receptor (AR) bound to either T or DHT and it is believed that AR is more transcriptionally active when bound to DHT than T.  The two classes of antiandrogens, presently available, are the steroidal derivs., all of which possess mixed agonistic and antagonistic activities, and the pure non-steroidal antiandrogens of the class of flutamide and its derivs.  The intrinsic androgenic, estrogenic and glucocorticoid activities of steroidal derivs. have limited their use in the treatment of prostate cancer.  The non-steroidal flutamide and its derivs. display pure antiandrogenic activity, without exerting agonistic or any other hormonal activity.  Flutamide (89) and its derivs., Casodex (108) and Anandron (114), are highly effective in the treatment of prostate cancer.  The combination of flutamide and Anandron with castration has shown prolongation of life in prostate cancer.  Furthermore, combined androgen blockade in assocn. with radical prostatectomy or radiotherapy are very effective in the treatment of localized prostate cancer.  Such an approach certainly raises the hope of a further improvement in prostate cancer therapy.  However, all antiandrogens, developed so-far display moderate affinity for the androgen receptor, and thus moderate efficacy in vitro and in vivo.  There is thus a need for next-generation antiandrogens, which could display an equal or even higher affinity for AR compared to the natural androgens, and at the same time maintain its pure antiandrogenic activity, and thus providing improved androgen blockade using possibly antiandrogens alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrufSBc6mxWqLVg90H21EOLACvtfcHk0lhJH1yfDukuuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12rsbg%253D&md5=e38003b98538072c00d57e2da1d2b139</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.2174%2F0929867003375371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867003375371%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BM.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DLabrie%26aufirst%3DF.%26atitle%3DAndrogen%2520receptor%2520antagonists%2520%2528antiandrogens%2529%253A%2520structure%25E2%2588%2592activity%2520relationships%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D211%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wellington, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keam, S. J.</span><span> </span><span class="NLM_article-title">Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">â</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2165%2F00002512-200724020-00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17313204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=169-171&author=K.+Wellingtonauthor=S.+J.+Keam&title=Spotlight+on+bicalutamide+150mg+in+the+treatment+of+locally+advanced+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer</span></div><div class="casAuthors">Wellington, Keri; Keam, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-171</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Bicalutamide (Casodex) is a competitive androgen receptor antagonist that inactivates androgen-regulated prostate cell growth and function, leading to cell apoptosis and inhibition of prostate cancer growth.  It is administered orally as a once-daily dose.  In the EU and a no. of other countries, bicalutamide 150 mg/day is approved in men with locally advanced nonmetastatic prostate cancer as immediate therapy either as an adjuvant to active treatment or as monotherapy as an alternative to surgical or medical castration.  Combined anal. of the three trials that comprise the bicalutamide Early Prostate Cancer program showed that bicalutamide administered in conjunction with std. care in men with locally advanced prostate cancer offers disease-free survival benefits over std. care alone and is generally well tolerated.  Overall survival was improved to a greater extent in the subgroup of patients who received bicalutamide plus radiation therapy compared with radiation therapy alone.  Men with localized prostate cancer do not benefit from the addn. of bicalutamide to std. care.  Combined anal. of two other studies in men with locally advanced prostate cancer show that bicalutamide monotherapy offers better tolerability and higher health-related quality-of-life scores for sexual interest and phys. capacity compared with surgical or medical castration, while achieving disease-free and overall survival durations that were not significantly different.  Thus, when treatment options are being evaluated, bicalutamide as adjuvant therapy or monotherapy should be considered as an alternative to other available hormonal therapies in men with locally advanced prostate cancer, esp. in those who wish to maintain an active lifestyle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGr0AhMTRO6rVg90H21EOLACvtfcHk0lhJH1yfDukuuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsbw%253D&md5=ccd4458e34985d032edf2ba1c5baaba6</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.2165%2F00002512-200724020-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200724020-00008%26sid%3Dliteratum%253Aachs%26aulast%3DWellington%26aufirst%3DK.%26aulast%3DKeam%26aufirst%3DS.%2BJ.%26atitle%3DSpotlight%2520on%2520bicalutamide%2520150mg%2520in%2520the%2520treatment%2520of%2520locally%2520advanced%2520prostate%2520cancer%26jtitle%3DDrugs%2520Aging%26date%3D2007%26volume%3D24%26spage%3D169%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fradet, Y.</span><span> </span><span class="NLM_article-title">Bicalutamide (Casodex) in the treatment of prostate cancer</span> <span class="citation_source-journal">Exp. Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">â</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1586%2F14737140.4.1.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=14748655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVGmsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=37-48&author=Y.+Fradet&title=Bicalutamide+%28Casodex%29+in+the+treatment+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Bicalutamide (Casodex) in the treatment of prostate cancer</span></div><div class="casAuthors">Fradet, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-48</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Prostate cancer is an important health care issue in men worldwide.  With the advent of prostate-specific antigen screening and improved diagnostic techniques, prostate cancer is now being diagnosed in younger men and at earlier disease stages.  As a result, patients often live with their disease for many years after diagnosis.  This shift in the patient profile has focused attention to the impact of treatment on quality of life.  Medical/surgical castration has traditionally been the mainstay of hormonal therapy but is assocd. with side effects including loss of libido and impotence.  Nonsteroidal antiandrogens such as bicalutamide (Casodex) offer an effective alternative to castration with potential quality-of-life benefits.  This paper reviews the evidence concerning the use of bicalutamide at all stages of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5VWR9COicwrVg90H21EOLACvtfcHk0lhJH1yfDukuuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVGmsLw%253D&md5=d6ba5c8a85a70bf8d04fce3adc29c613</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1586%2F14737140.4.1.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.4.1.37%26sid%3Dliteratum%253Aachs%26aulast%3DFradet%26aufirst%3DY.%26atitle%3DBicalutamide%2520%2528Casodex%2529%2520in%2520the%2520treatment%2520of%2520prostate%2520cancer%26jtitle%3DExp.%2520Rev.%2520Anticancer%2520Ther.%26date%3D2004%26volume%3D4%26spage%3D37%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kirkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">â</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990027x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=581-590&author=L.+Kirkovskyauthor=A.+Mukherjeeauthor=D.+Yinauthor=J.+T.+Daltonauthor=D.+D.+Miller&title=Chiral+nonsteroidal+affinity+ligands+for+the+androgen+receptor.+1.+Bicalutamide+analogues+bearing+electrophilic+groups+in+the+B+aromatic+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm990027x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990027x%26sid%3Dliteratum%253Aachs%26aulast%3DKirkovsky%26aufirst%3DL.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DYin%26aufirst%3DD.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DChiral%2520nonsteroidal%2520affinity%2520ligands%2520for%2520the%2520androgen%2520receptor.%25201.%2520Bicalutamide%2520analogues%2520bearing%2520electrophilic%2520groups%2520in%2520the%2520B%2520aromatic%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D581%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">6201</span><span class="NLM_x">â</span> <span class="NLM_lpage">6206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1073%2Fpnas.0500381102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15833816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=6201-6206&author=C.+E.+Bohlauthor=W.+Gaoauthor=D.+D.+Millerauthor=C.+E.+Bellauthor=J.+T.+Dalton&title=Structural+basis+for+antagonism+and+resistance+of+bicalutamide+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span></div><div class="casAuthors">Bohl, Casey E.; Gao, Wenqing; Miller, Duane D.; Bell, Charles E.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6201-6206</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Carcinoma of the prostate is the most commonly diagnosed cancer in men.  The current pharmacol. treatment of choice for progressive androgen-dependent prostate cancer is the nonsteroidal antiandrogen, bicalutamide, either as monotherapy or with adjuvant castration or LH-releasing hormone superagonists to block the synthesis of endogenous testosterone.  To date, no nonsteroidal or antagonist-bound androgen receptor (AR) structure is available.  The authors solved the x-ray crystal structure of the mutant W741L AR ligand-binding domain bound to R-bicalutamide at 1.8-Ã resoln.  This mutation confers agonist activity to bicalutamide and is likely involved in bicalutamide withdrawal syndrome.  The three-dimensional structure demonstrates that the B ring of R-bicalutamide in the W741L mutant is accommodated at the location of the indole ring of Trp-741 in the WT AR bound to dihydrotestosterone.  Knowledge of the binding mechanism for R-bicalutamide will provide mol. rationale for the development of new antiandrogens and selective AR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQ1V6LCoc07Vg90H21EOLACvtfcHk0lhceJoEnURhlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D&md5=0ca230450eba66abd4136bfb95928ce0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0500381102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0500381102%26sid%3Dliteratum%253Aachs%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DBell%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DStructural%2520basis%2520for%2520antagonism%2520and%2520resistance%2520of%2520bicalutamide%2520in%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D6201%26epage%3D6206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Van Dort, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.-W.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">â</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1045-1047&author=M.+E.+Van+Dortauthor=Y.-W.+Jung&title=Synthesis+and+structure%E2%88%92activity+studies+of+side-chain+derivatized+arylhydantoins+for+investigation+as+androgen+receptor+radioligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDort%26aufirst%3DM.%2BE.%26aulast%3DJung%26aufirst%3DY.-W.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520studies%2520of%2520side-chain%2520derivatized%2520arylhydantoins%2520for%2520investigation%2520as%2520androgen%2520receptor%2520radioligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1045%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Li, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iula, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dettling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanmugasundaram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Camp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen-Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boys, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samas, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoge, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovdahl, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asbill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciotti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7010</span><span class="NLM_x">â</span> <span class="NLM_lpage">7014</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8009316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7010-7014&author=J.+J.+Liauthor=D.+M.+Iulaauthor=M.+N.+Nguyenauthor=L.-Y.+Huauthor=D.+Dettlingauthor=T.+R.+Johnsonauthor=D.+Y.+Duauthor=V.+Shanmugasundaramauthor=J.+A.+Van+Campauthor=Z.+Wangauthor=G.+H.+Williamauthor=Y.+Wen-Songauthor=M.+L.+Boysauthor=K.+J.+Wadeauthor=E.+M.+Drummondauthor=B.+M.+Samasauthor=B.+A.+Lefkerauthor=G.+S.+Hogeauthor=M.+J.+Lovdahlauthor=J.+Asbillauthor=M.+Carrollauthor=M.+A.+Meadeauthor=S.+M.+Ciottiauthor=T.+Krieger-Burke&title=Rational+design+and+synthesis+of+4-%28%281R%2C2R%29-2-hydroxycyclohexyl%29-2%28trifluoromethyl%29benzonitrile+%28PF-998425%29%2C+a+novel%2C+nonsteroidal+androgen+receptor+antagonist+devoid+of+phototoxicity+for+dermatological+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm8009316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8009316%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DIula%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DM.%2BN.%26aulast%3DHu%26aufirst%3DL.-Y.%26aulast%3DDettling%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DT.%2BR.%26aulast%3DDu%26aufirst%3DD.%2BY.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DVan%2BCamp%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWilliam%26aufirst%3DG.%2BH.%26aulast%3DWen-Song%26aufirst%3DY.%26aulast%3DBoys%26aufirst%3DM.%2BL.%26aulast%3DWade%26aufirst%3DK.%2BJ.%26aulast%3DDrummond%26aufirst%3DE.%2BM.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DHoge%26aufirst%3DG.%2BS.%26aulast%3DLovdahl%26aufirst%3DM.%2BJ.%26aulast%3DAsbill%26aufirst%3DJ.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DMeade%26aufirst%3DM.%2BA.%26aulast%3DCiotti%26aufirst%3DS.%2BM.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%25204-%2528%25281R%252C2R%2529-2-hydroxycyclohexyl%2529-2%2528trifluoromethyl%2529benzonitrile%2520%2528PF-998425%2529%252C%2520a%2520novel%252C%2520nonsteroidal%2520androgen%2520receptor%2520antagonist%2520devoid%2520of%2520phototoxicity%2520for%2520dermatological%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7010%26epage%3D7014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kern, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terefenko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrodin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yudt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span> </span><span class="NLM_article-title">5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6666</span><span class="NLM_x">â</span> <span class="NLM_lpage">6669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6666-6669&author=J.+C.+Kernauthor=E.+Terefenkoauthor=E.+Trybulskiauthor=T.+J.+Berrodinauthor=J.+Cohenauthor=R.+C.+Winnekerauthor=M.+R.+Yudtauthor=Z.+Zhangauthor=Y.+Zhuauthor=P.+Zhang&title=5-Aryl+indanones+and+derivatives+as+non-steroidal+progesterone+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKern%26aufirst%3DJ.%2BC.%26aulast%3DTerefenko%26aufirst%3DE.%26aulast%3DTrybulski%26aufirst%3DE.%26aulast%3DBerrodin%26aufirst%3DT.%2BJ.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DYudt%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26atitle%3D5-Aryl%2520indanones%2520and%2520derivatives%2520as%2520non-steroidal%2520progesterone%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6666%26epage%3D6669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, L.</span><span> </span><span class="NLM_article-title">Andrew Fensome receives Robertson Award</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span></span><div class="citationLinks">[<a href="/doi/10.1021/cen-v085n037.p040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Gqs7zP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=40&author=L.+Wang&title=Andrew+Fensome+receives+Robertson+Award"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Arnold takes Genencor Prize in Enzyme Engineering</span></div><div class="casAuthors">Wang, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Engineering News</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">40</span>CODEN:
                <span class="NLM_cas:coden">CENEAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-2347</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Frances H. Arnold, Dick & Barbara Dickinson Professor of Chem. Engineering & Biochem. at California Institute of Technol., is the recipient of the 2007 Award in Enzyme Engineering, sponsored by Genencor.  Arnold pioneered directed evolution, an approach to protein engineering that is used in thousands of labs. worldwide and enables many industrial and medical biotechnol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofKHTQzl6zxLVg90H21EOLACvtfcHk0lhceJoEnURhlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Gqs7zP&md5=43138e0323b613325f11fdf62fa22a99</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1021%2Fcen-v085n037.p040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v085n037.p040%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DAndrew%2520Fensome%2520receives%2520Robertson%2520Award%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2007%26volume%3D85%26spage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fensome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malakian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terefenko, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, J.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationship of novel 6-aryl-1,4-dihydrobenzo[<i>d</i>][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5092</span><span class="NLM_x">â</span> <span class="NLM_lpage">5095</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050358b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5092-5095&author=A.+Fensomeauthor=R.+Benderauthor=R.+Chopraauthor=J.+Cohenauthor=M.+A.+Collinsauthor=V.+Hudakauthor=K.+Malakianauthor=S.+Lockheadauthor=A.+Ollandauthor=K.+Svensonauthor=E.+A.+Terefenkoauthor=R.+J.+Unwallaauthor=J.+M.+Wilhelmauthor=S.+Wolfromauthor=Y.+Zhuauthor=R.+C.+Winnekerauthor=J.+Wrobel&title=Synthesis+and+structure%E2%88%92activity+relationship+of+novel+6-aryl-1%2C4-dihydrobenzo%5Bd%5D%5B1%2C3%5Doxazine-2-thiones+as+progesterone+receptor+modulators+leading+to+the+potent+and+selective+nonsteroidal+progesterone+receptor+agonist+tanaproget"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1021%2Fjm050358b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050358b%26sid%3Dliteratum%253Aachs%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DBender%26aufirst%3DR.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%2BA.%26aulast%3DHudak%26aufirst%3DV.%26aulast%3DMalakian%26aufirst%3DK.%26aulast%3DLockhead%26aufirst%3DS.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DTerefenko%26aufirst%3DE.%2BA.%26aulast%3DUnwalla%26aufirst%3DR.%2BJ.%26aulast%3DWilhelm%26aufirst%3DJ.%2BM.%26aulast%3DWolfrom%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DWrobel%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520novel%25206-aryl-1%252C4-dihydrobenzo%255Bd%255D%255B1%252C3%255Doxazine-2-thiones%2520as%2520progesterone%2520receptor%2520modulators%2520leading%2520to%2520the%2520potent%2520and%2520selective%2520nonsteroidal%2520progesterone%2520receptor%2520agonist%2520tanaproget%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5092%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zhou, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayne, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span> </span><span class="NLM_article-title">Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3349</span><span class="NLM_x">â</span> <span class="NLM_lpage">3360</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100052k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3349-3360&author=H.-B.+Zhouauthor=J.+H.+Leeauthor=C.+G.+Mayneauthor=K.+E.+Carlsonauthor=J.+A.+Katzenellenbogen&title=Imaging+progesterone+receptor+in+breast+tumors%3A+synthesis+and+receptor+binding+affinity+of+fluoroalkyl-substituted+analogues+of+tanaproget"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm100052k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100052k%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-B.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMayne%26aufirst%3DC.%2BG.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DImaging%2520progesterone%2520receptor%2520in%2520breast%2520tumors%253A%2520synthesis%2520and%2520receptor%2520binding%2520affinity%2520of%2520fluoroalkyl-substituted%2520analogues%2520of%2520tanaproget%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3349%26epage%3D3360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Shivakumar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancet, J. E.</span><span> </span><span class="NLM_article-title">The role of farnesyl transferase inhibitors in the treatment of patients with leukemia and myelodysplastic syndrome</span> <span class="citation_source-journal">Clin. Leuk.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.3816%2FCLK.2006.n.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFKqtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=80-83&author=L.+Shivakumarauthor=J.+E.+Lancet&title=The+role+of+farnesyl+transferase+inhibitors+in+the+treatment+of+patients+with+leukemia+and+myelodysplastic+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of farnesyl transferase inhibitors in the treatment of patients with leukemia and myelodysplastic syndrome</span></div><div class="casAuthors">Shivakumar, Latha; Lancet, Jeffrey E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Leukemia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">80-83</span>CODEN:
                <span class="NLM_cas:coden">CLLEAW</span>;
        ISSN:<span class="NLM_cas:issn">1931-6925</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group</span>)
        </div><div class="casAbstract">A review.  Farnesyl transferase inhibitors (FTIs) inhibit farnesylation of various proteins playing a key role in cell growth and proliferation, including Ras, Rho, lamins, and centromere proteins.  Several FTIs have demonstrated antitumor activity in preclin. models of several tumors, including hematol. malignancies.  Nonpeptidomimetic FTIs, tipifarnib, lonafarnib, and BMS-214662 have demonstrated promising clin. activity along with acceptable toxicity profiles in the setting of leukemias and myelodysplastic syndrome (MDS).  Tipifarnib and lonafarnib are in the most advanced stages of clin. development for the treatment of hematol. malignancies, including acute myeloid leukemia, chronic myeloid leukemia and MDS.  Treatment with tipifarnib has been effective in the treatment of patients with acute myeloid leukemia and MDS, in the first-line and postremission (maintenance therapy) settings.  Continuous administration of lonafarnib resulted in hematol. responses in patients with chronic myeloid leukemia and MDS with tolerable toxicities.  Based on the results from various preliminary studies, FTIs are being pursued as important therapeutic options for the management of a variety of hematopoietic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomT1Lg9kO-prVg90H21EOLACvtfcHk0liq6Jff3plzcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFKqtbs%253D&md5=dd2df1d2c566049ccbe045923c72d7c5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3816%2FCLK.2006.n.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLK.2006.n.011%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DL.%26aulast%3DLancet%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520role%2520of%2520farnesyl%2520transferase%2520inhibitors%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520leukemia%2520and%2520myelodysplastic%2520syndrome%26jtitle%3DClin.%2520Leuk.%26date%3D2006%26volume%3D1%26spage%3D80%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bailey, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulkerin, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span> </span><span class="NLM_article-title">Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3623</span><span class="NLM_x">â</span> <span class="NLM_lpage">3629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1158%2F1078-0432.CCR-07-0158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17510207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCquro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3623-3629&author=H.+H.+Baileyauthor=D.+B.+Albertiauthor=J.+P.+Thomasauthor=D.+L.+Mulkerinauthor=K.+A.+Bingerauthor=M.+M.+Gottardisauthor=R.+E.+Martellauthor=G.+Wilding&title=Phase+I+trial+of+weekly+paclitaxel+and+BMS-214662+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of Weekly Paclitaxel and BMS-214662 in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Bailey, Howard H.; Alberti, Dona B.; Thomas, James P.; Mulkerin, Daniel L.; Binger, Kimberly A.; Gottardis, Marco M.; Martell, Robert E.; Wilding, George</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3623-3629</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To assess the max. tolerated dose (MTD), dose-limiting toxicity (DLT), pharmacodynamics, and antitumor activity of continuous weekly-administered paclitaxel and BMS-214662, a novel farnesyl transferase inhibitor.  Exptl. DESIGN: Patients were treated every week as tolerated with i.v. paclitaxel (fixed dose, 80 mg/m2/wk) administered over 1 h followed by i.v.  BMS-214662 (escalating doses, 80-245 mg/m2/wk) over 1 h starting 30 min after completion of paclitaxel.  RESULTS: Twenty-six patients received 94 courses (one course, 21 days) of study treatment.  Two patients received five courses of BMS-214662 as a weekly 24-h infusion (209 mg/m2/wk).  The most common toxicities were grade 1 to 2 nausea/vomiting and/or diarrhea.  DLTs obsd. at or near the MTD (200 mg/m2/wk) were grade 4 febrile neutropenia with sepsis occurring on day 2 of course 1 (245 mg/m2/wk), reversible grade 3 to 4 serum transaminase increases on day 2, and grade 3 diarrhea (200 and 245 mg/m2/wk).  Objective partial responses were obsd. in patients with pretreated head and neck, ovarian, and hormone-refractory prostate carcinomas, and leiomyosarcoma.  The obsd. pharmacokinetics of paclitaxel and BMS-214662 imply no interaction between the two.  Significant inhibition (>80%) of farnesyl transferase activity in peripheral mononuclear cells was obsd. at the end of BMS-214662 infusion.  CONCLUSIONS: Pretreated patients with advanced malignancies can tolerate weekly paclitaxel and BMS-214662 at doses that achieve objective clin. benefit.  Due to multiple DLTs occurring at the expanded MTD, the recommended phase 2 dose and schedule is paclitaxel (80 mg/m2 over 1 h) and BMS-214662 (160 mg/m2 over 1 h) administered weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprmFlxN5xPIbVg90H21EOLACvtfcHk0liq6Jff3plzcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCquro%253D&md5=75209f76ca1a9779d481c2f26f503214</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0158%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DH.%2BH.%26aulast%3DAlberti%26aufirst%3DD.%2BB.%26aulast%3DThomas%26aufirst%3DJ.%2BP.%26aulast%3DMulkerin%26aufirst%3DD.%2BL.%26aulast%3DBinger%26aufirst%3DK.%2BA.%26aulast%3DGottardis%26aufirst%3DM.%2BM.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DWilding%26aufirst%3DG.%26atitle%3DPhase%2520I%2520trial%2520of%2520weekly%2520paclitaxel%2520and%2520BMS-214662%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3623%26epage%3D3629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Caponigro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, J.</span><span> </span><span class="NLM_article-title">Farnesyl transferase inhibitors in clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">â</span> <span class="NLM_lpage">954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=943-954&author=F.+Caponigroauthor=M.+Casaleauthor=J.+Bryce&title=Farnesyl+transferase+inhibitors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaponigro%26aufirst%3DF.%26aulast%3DCasale%26aufirst%3DM.%26aulast%3DBryce%26aufirst%3DJ.%26atitle%3DFarnesyl%2520transferase%2520inhibitors%2520in%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D943%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Jorgensen, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holyoake, T. L.</span><span> </span><span class="NLM_article-title">Characterization of cancer stem cells in chronic myeloid leukaemia</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">â</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1042%2FBST0351347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17956348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eqsr7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1347-1351&author=H.+G.+Jorgensenauthor=T.+L.+Holyoake&title=Characterization+of+cancer+stem+cells+in+chronic+myeloid+leukaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of cancer stem cells in chronic myeloid leukaemia</span></div><div class="casAuthors">Jorgensen, H. G.; Holyoake, T. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1347-1351</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  CML (chronic myeloid leukemia) is a myeloproliferative disease that originates in an HSC (hemopoietic stem cell) as a result of the t(9;22) translocation, giving rise to the Ph (Philadelphia chromosome) and bcr-abl oncoprotein.  The disease starts in CP (chronic phase), but as a result of genomic instability, it progresses over time to accelerated phase and then to BC (blast crisis), becoming increasingly resistant to therapy.  Bcr-abl is a constitutively active tyrosine kinase that was targeted by TKIs (tyrosine kinase inhibitors), including IM (imatinib mesylate), nilotinib and dasatinib.  The authors have developed various flow cytometry techniques suitable for isolation of candidate CML stem cells from CP patients at diagnosis that efflux Hoechst dye, express CD34, lack CD38 and are cytokine-non-responsive in culture over periods of up to 12 days in growth factors.  These stem cells were shown to regenerate bcr-abl-pos. hemopoiesis in immunocompromised mice upon transplantation.  The authors previously demonstrated that IM was antiproliferative for CML stem cells but did not induce apoptosis.  Clin. experience now confirms that IM may not target CML stem cells in vivo with few patients achieving complete mol. remission and relapse occurring rapidly upon drug withdrawal.  The authors' recent efforts have focused on understanding why CML stem cells are resistant to IM and on trying to find novel ways to induce apoptosis of this population.  The authors have shown that CML stem cells express very high levels of functional wild-type bcr-abl; no kinase domain mutations were detected in the stem cell population.  Dasatinib, a more potent multitargeted TKI than IM, inhibits bcr-abl activity more efficiently than IM but still does not induce apoptosis of the stem cell population.  Most recently, the authors have tested a no. of novel drug combinations and found that FTIs (farnesyl transferase inhibitors) have activity against CML.  BMS-214662 is the most effective of these and induces apoptosis of phenotypically and functionally defined CML stem cells in vitro, as a single agent and in combination with IM or dasatinib.  The effect against CML stem cells is selective with little effect on normal stem cells.  The drug is also effective against BC CML stem cells and equally effective against wild-type and mutant bcr-abl, including the most resistant mutant T315I.  In assocn. with apoptosis, there is activation of caspase 8 and caspase 3, inhibition of the MAPK pathway, IAP-1 (inhibitor of apoptosis protein-1), NF-ÎºB (nuclear factor ÎºB) and iNOS (inducible nitric oxide synthase).  Furthermore, BMS-214662 synergizes with MEK1/2 [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) kinase 1/2] inhibitors, suggesting a second mechanism other that RAS inhibition for induction of apoptosis.  The authors' intentions are now to explore the activity of BMS-214662 in other cancer stem cell disorders and to move this preclin. work to a clin. trial combining dasatinib with BMS-214662 in CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxx1OoamSXibVg90H21EOLACvtfcHk0lh0ut9n3zzPRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eqsr7O&md5=a799ec24869d0a1fff5dbc2a69780054</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1042%2FBST0351347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0351347%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DH.%2BG.%26aulast%3DHolyoake%26aufirst%3DT.%2BL.%26atitle%3DCharacterization%2520of%2520cancer%2520stem%2520cells%2520in%2520chronic%2520myeloid%2520leukaemia%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D1347%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Reid, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span> </span><span class="NLM_article-title">Crystal structures of the anticancer clinical candidates R115777 (tipifarnib) and BMS-214662 complexed with protein farnesyltransferase suggest a mechanism of FTI selectivity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6877</span><span class="NLM_x">â</span> <span class="NLM_lpage">6884</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049723b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=6877-6884&author=T.+S.+Reidauthor=L.+S.+Beese&title=Crystal+structures+of+the+anticancer+clinical+candidates+R115777+%28tipifarnib%29+and+BMS-214662+complexed+with+protein+farnesyltransferase+suggest+a+mechanism+of+FTI+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi049723b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049723b%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DT.%2BS.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26atitle%3DCrystal%2520structures%2520of%2520the%2520anticancer%2520clinical%2520candidates%2520R115777%2520%2528tipifarnib%2529%2520and%2520BMS-214662%2520complexed%2520with%2520protein%2520farnesyltransferase%2520suggest%2520a%2520mechanism%2520of%2520FTI%2520selectivity%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D6877%26epage%3D6884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penhallow, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-7-cyano-2,3,4,5-tetrahydro-1-(1<i>H</i>-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1<i>H</i>-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">â</span> <span class="NLM_lpage">3595</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000248z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3587-3595&author=J.+T.+Huntauthor=C.+Z.+Dingauthor=R.+Batorskyauthor=M.+Bednarzauthor=R.+Bhideauthor=Y.+Choauthor=S.+Chongauthor=S.+Chaoauthor=J.+Gullo-Brownauthor=P.+Guoauthor=S.+K.+Kimauthor=F.+Y.+F.+Leeauthor=K.+Leftherisauthor=A.+Millerauthor=T.+Mittauthor=M.+Patelauthor=B.+A.+Penhallowauthor=C.+Riccaauthor=W.+C.+Roseauthor=R.+C.+Schmidtauthor=W.+A.+Slusarchykauthor=G.+Viteauthor=V.+Manne&title=Discovery+of+%28R%29-7-cyano-2%2C3%2C4%2C5-tetrahydro-1-%281H-imidazol-4-ylmethyl%29-3-%28phenylmethyl%29-4-%282-thienylsulfonyl%29-1H-1%2C4-benzodiazepine+%28BMS-214662%29%2C+a+farnesyltransferase+inhibitor+with+potent+preclinical+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm000248z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000248z%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DBatorsky%26aufirst%3DR.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DBhide%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DChong%26aufirst%3DS.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DMitt%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPenhallow%26aufirst%3DB.%2BA.%26aulast%3DRicca%26aufirst%3DC.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DSchmidt%26aufirst%3DR.%2BC.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BA.%26aulast%3DVite%26aufirst%3DG.%26aulast%3DManne%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520%2528R%2529-7-cyano-2%252C3%252C4%252C5-tetrahydro-1-%25281H-imidazol-4-ylmethyl%2529-3-%2528phenylmethyl%2529-4-%25282-thienylsulfonyl%2529-1H-1%252C4-benzodiazepine%2520%2528BMS-214662%2529%252C%2520a%2520farnesyltransferase%2520inhibitor%2520with%2520potent%2520preclinical%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3587%26epage%3D3595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Martin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiel, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaney, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regine, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohiuddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosato, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschel, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, S. M.</span><span> </span><span class="NLM_article-title">A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5447</span><span class="NLM_x">â</span> <span class="NLM_lpage">5454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1158%2F1078-0432.CCR-04-0248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15328183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFSltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=5447-5454&author=N.+E.+Martinauthor=T.+B.+Brunnerauthor=K.+D.+Kielauthor=T.+F.+DeLaneyauthor=W.+F.+Regineauthor=M.+Mohiuddinauthor=E.+F.+Rosatoauthor=D.+G.+Hallerauthor=J.+P.+Stevensonauthor=D.+Smithauthor=B.+Pramanikauthor=J.+Tepperauthor=W.+K.+Tanakaauthor=B.+Morrisonauthor=P.+Deutschauthor=A.+K.+Guptaauthor=R.+J.+Muschelauthor=W.+G.+McKennaauthor=E.+J.+Bernhardauthor=S.+M.+Hahn&title=A+phase+I+trial+of+the+dual+farnesyltransferase+and+geranylgeranyltransferase+inhibitor+L-778%2C123+and+radiotherapy+for+locally+advanced+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer</span></div><div class="casAuthors">Martin, Neil E.; Brunner, Thomas B.; Kiel, Krystina D.; DeLaney, Thomas F.; Regine, William F.; Mohiuddin, Mohammed; Rosato, Ernest F.; Haller, Daniel G.; Stevenson, James P.; Smith, Debbie; Pramanik, Barnali; Tepper, Joel; Tanaka, Wesley K.; Morrison, Briggs; Deutsch, Paul; Gupta, Anjali K.; Muschel, Ruth J.; McKenna, W. Gillies; Bernhard, Eric J.; Hahn, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5447-5454</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Preclin. and clin. studies have demonstrated that inhibition of prenylation can radiosensitize cell lines with activation of Ras and produce clin. response in patients with cancer.  The aim of this study was to det. the maximally tolerated dose of the dual farnesyltransferase and geranylgeranyltransferase I inhibitor L-778,123 in combination with radiotherapy for patients with locally advanced pancreatic cancer.  L-778,123 was given by continuous i.v. infusion with concomitant radiotherapy to 59.4 Gy in std. fractions.  Two L-778,123 dose levels were tested: 280 mg/m2/day over weeks 1, 2, 4, and 5 for dose level 1; and 560 mg/m2/day over weeks 1, 2, 4, 5, and 7 for dose level 2.  There were no dose-limiting toxicities obsd. in the eight patients treated on dose level 1.  Two of the four patients on dose level 2 experienced dose-limiting toxicities consisting of grade 3 diarrhea in one case and grade 3 gastrointestinal hemorrhage assocd. with grade 3 thrombocytopenia and neutropenia in the other case.  Other common toxicities were mild neutropenia, dehydration, hyperglycemia, and nausea/vomiting.  One patient on dose level 1 showed a partial response of 6 mo in duration.  Both reversible inhibition of HDJ2 farnesylation and radiosensitization of a study patient-derived cell line were demonstrated in the presence of L-778,123.  K-RAS mutations were found in three of the four patients evaluated.  The combination of L-778,123 and radiotherapy at dose level 1 showed acceptable toxicity in patients with locally advanced pancreatic cancer.  Radiosensitization of a patient-derived pancreatic cancer cell line was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-CjOMRzk8JLVg90H21EOLACvtfcHk0lh0ut9n3zzPRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFSltLg%253D&md5=cb80a9340dbafafced681366cceaf51c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-0248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-0248%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DN.%2BE.%26aulast%3DBrunner%26aufirst%3DT.%2BB.%26aulast%3DKiel%26aufirst%3DK.%2BD.%26aulast%3DDeLaney%26aufirst%3DT.%2BF.%26aulast%3DRegine%26aufirst%3DW.%2BF.%26aulast%3DMohiuddin%26aufirst%3DM.%26aulast%3DRosato%26aufirst%3DE.%2BF.%26aulast%3DHaller%26aufirst%3DD.%2BG.%26aulast%3DStevenson%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DTepper%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DW.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DDeutsch%26aufirst%3DP.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DMuschel%26aufirst%3DR.%2BJ.%26aulast%3DMcKenna%26aufirst%3DW.%2BG.%26aulast%3DBernhard%26aufirst%3DE.%2BJ.%26aulast%3DHahn%26aufirst%3DS.%2BM.%26atitle%3DA%2520phase%2520I%2520trial%2520of%2520the%2520dual%2520farnesyltransferase%2520and%2520geranylgeranyltransferase%2520inhibitor%2520L-778%252C123%2520and%2520radiotherapy%2520for%2520locally%2520advanced%2520pancreatic%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D5447%26epage%3D5454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Reid, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span> </span><span class="NLM_article-title">Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-i by different binding modes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">9000</span><span class="NLM_x">â</span> <span class="NLM_lpage">9008</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049280b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=9000-9008&author=T.+S.+Reidauthor=S.+B.+Longauthor=L.+S.+Beese&title=Crystallographic+analysis+reveals+that+anticancer+clinical+candidate+L-778%2C123+inhibits+protein+farnesyltransferase+and+geranylgeranyltransferase-i+by+different+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi049280b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049280b%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DT.%2BS.%26aulast%3DLong%26aufirst%3DS.%2BB.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26atitle%3DCrystallographic%2520analysis%2520reveals%2520that%2520anticancer%2520clinical%2520candidate%2520L-778%252C123%2520inhibits%2520protein%2520farnesyltransferase%2520and%2520geranylgeranyltransferase-i%2520by%2520different%2520binding%2520modes%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D9000%26epage%3D9008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Burstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badwe, R.</span><span> </span><span class="NLM_article-title">Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">â</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1200%2FJCO.2009.25.8707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=20142587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1301-1307&author=H.+J.+Bursteinauthor=Y.+Sunauthor=L.+Y.+Dirixauthor=Z.+Jiangauthor=R.+Paridaensauthor=A.+R.+Tanauthor=A.+Awadaauthor=A.+Ranadeauthor=S.+Jiaoauthor=G.+Schwartzauthor=R+Abbasauthor=C.+Powellauthor=K.+Turnbullauthor=J.+Vermetteauthor=C.+Zacharchukauthor=R.+Badwe&title=Neratinib%2C+an+irreversible+ErbB+receptor+tyrosine+kinase+inhibitor%2C+in+patients+with+advanced+ErbB2-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span></div><div class="casAuthors">Burstein, Harold J.; Sun, Yan; Dirix, Luc Y.; Jiang, Zefei; Paridaens, Robert; Tan, Antoinette R.; Awada, Ahmad; Ranade, Anantbhushan; Jiao, Shunchang; Schwartz, Gary; Abbas, Richat; Powell, Christine; Turnbull, Kathleen; Vermette, Jennifer; Zacharchuk, Charles; Badwe, Rajendra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1301-1307</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Neratinib is an oral, irreversible pan-ErbB receptor tyrosine kinase inhibitor.  The efficacy and safety of neratinib were evaluated in two cohorts of patients with advanced ErbB2-pos. breast cancer-those with and those without prior trastuzumab treatment-in an open-label, multicenter, phase II trial.  Patients in the two cohorts (prior trastuzumab, n = 66; no prior trastuzumab, n = 70) received oral neratinib 240 mg once daily.  The primary end point was the 16-wk progression-free survival (PFS) rate for the evaluable population (prior trastuzumab, n = 63; no prior trastuzumab, n = 64), as assessed by independent review.  The 16-wk PFS rates were 59% for patients with prior trastuzumab treatment and 78% for patients with no prior trastuzumab treatment.  Median PFS was 22.3 and 39.6 wk, resp.  Objective response rates were 24% among patients with prior trastuzumab treatment and 56% in the trastuzumab-naive cohort.  The most common adverse events were diarrhea, nausea, vomiting, and fatigue.  Diarrhea was the most frequent grades 3 to 4 adverse event, occurring in 30% of patients with prior trastuzumab treatment and in 13% of patients with no prior trastuzumab treatment, which prompted dose redns. in 29% and 4% of patients, resp., but treatment discontinuation in only one patient.  No neratinib-related, grades 3 or 4 cardiotoxicity was reported.  Oral neratinib showed substantial clin. activity and was reasonably well tolerated among both heavily pretreated and trastuzumab-naive patients who had advanced, ErbB2-pos. breast cancer.  Diarrhea was the most common adverse effect but was manageable with antidiarrheal agents and dose modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbEv1WYAZUbVg90H21EOLACvtfcHk0lgf8dUsFBnHZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D&md5=11b07ce171753c7499b50d52786859e8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.8707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.8707%26sid%3Dliteratum%253Aachs%26aulast%3DBurstein%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DA.%2BR.%26aulast%3DAwada%26aufirst%3DA.%26aulast%3DRanade%26aufirst%3DA.%26aulast%3DJiao%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%26aulast%3DAbbas%26aufirst%3DR%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DTurnbull%26aufirst%3DK.%26aulast%3DVermette%26aufirst%3DJ.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DBadwe%26aufirst%3DR.%26atitle%3DNeratinib%252C%2520an%2520irreversible%2520ErbB%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520ErbB2-positive%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1301%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozer, H.</span><span> </span><span class="NLM_article-title">Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">â</span> <span class="NLM_lpage">1751</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1735-1751&author=P.+Boseauthor=H.+Ozer&title=Neratinib%3A+an+oral%2C+irreversible+dual+EGFR%2FHER2+inhibitor+for+breast+and+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DOzer%26aufirst%3DH.%26atitle%3DNeratinib%253A%2520an%2520oral%252C%2520irreversible%2520dual%2520EGFR%252FHER2%2520inhibitor%2520for%2520breast%2520and%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D1735%26epage%3D1751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Erlichman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, J. P.</span><span> </span><span class="NLM_article-title">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2252</span><span class="NLM_x">â</span> <span class="NLM_lpage">2260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1200%2FJCO.2005.01.8960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16710023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2252-2260&author=C.+Erlichmanauthor=M.+Hidalgoauthor=J.+P.+Boni&title=Phase+I+study+of+EKB-569%2C+an+irreversible+inhibitor+of+the+epidermal+growth+factor+receptor%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span></div><div class="casAuthors">Erlichman, Charles; Hidalgo, Manuel; Boni, Joseph P.; Martins, Patricia; Quinn, Susan E.; Zacharchuk, Charles; Amorusi, Peter; Adjei, Alex A.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2252-2260</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The max. tolerated dose (MTD) and the dose-limiting toxicities of EKB-569, a selective, irreversible inhibitor of the epidermal growth factor receptor (EGFR), when administered orally once daily on an intermittent-dose schedule (14 days of a 28-day cycle) or on a continuous-dose schedule (each day of a 28-day cycle), were detd. in patients with advanced solid tumors.  Planned dose escalation was 25, 50, 75, 125, 175, and 225 mg.  Pharmacokinetic sampling was performed on days 1 and 14 for the intermittent-dose cohort and on days 1 and 15 for the continuous-dose cohort.  Thirty patients received a median of two cycles (range, one to 10 cycles) in the intermittent-dose cohort; 29 patients received a median of three cycles (range, one to eight cycles) in the continuous-dose cohort.  Dose-limiting toxicity was grade 3 diarrhea, and the MTD was 75 mg EKB-569 per day for both cohorts.  Other common toxicities included rash, nausea, and asthenia.  Exposure to EKB-569 was dose proportional.  At the MTD, the mean Â± std. deviation terminal half-life was 21.7 Â± 4.2 h and peak concn. increased 1.2-fold from day 1 to day 14/15.  No major antitumor responses were obsd.  However, one patient with non-small-cell lung cancer and one with cutaneous squamous cell carcinoma had stable disease for 33 and 24 wk, resp.  The MTD of once-daily oral EKB-569 is 75 mg.  The tolerable toxicity profile and long half-life of this irreversible EGFR inhibitor warrant its further evaluation as a single agent and in combination with other drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWU_wd20ORbVg90H21EOLACvtfcHk0lgf8dUsFBnHZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D&md5=3a7766538e63808314fe4ea73b5f766d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.8960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.8960%26sid%3Dliteratum%253Aachs%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DJ.%2BP.%26atitle%3DPhase%2520I%2520study%2520of%2520EKB-569%252C%2520an%2520irreversible%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2252%26epage%3D2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godin-Heymann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brannigan, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isselbacher, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">7665</span><span class="NLM_x">â</span> <span class="NLM_lpage">7670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=7665-7670&author=E.+L.+Kwakauthor=R.+Sordellaauthor=D.+W.+Bellauthor=N.+Godin-Heymannauthor=R.+A.+Okimotoauthor=B.+W.+Branniganauthor=P.+L.+Harrisauthor=D.+R.+Driscollauthor=P.+Fidiasauthor=T.+J.+Lynchauthor=S.+K.+Rabindranauthor=J.+P.+McGinnisauthor=A.+Wissnerauthor=S.+V.+Sharmaauthor=K.+J.+Isselbacherauthor=J.+Settlemanauthor=D.+A.+Haber&title=Irreversible+inhibitors+of+the+EGF+receptor+may+circumvent+acquired+resistance+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DGodin-Heymann%26aufirst%3DN.%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBrannigan%26aufirst%3DB.%2BW.%26aulast%3DHarris%26aufirst%3DP.%2BL.%26aulast%3DDriscoll%26aufirst%3DD.%2BR.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26aulast%3DIsselbacher%26aufirst%3DK.%2BJ.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DIrreversible%2520inhibitors%2520of%2520the%2520EGF%2520receptor%2520may%2520circumvent%2520acquired%2520resistance%2520to%2520gefitinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D7665%26epage%3D7670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">â</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.-H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.-K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+mutation+in+EGFR+kinase+causes+drug+resistance+by+increasing+the+affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0lgKA2M2xqjH0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520mutation%2520in%2520EGFR%2520kinase%2520causes%2520drug%2520resistance%2520by%2520increasing%2520the%2520affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingalls, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nittoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganzo, F.</span><span> </span><span class="NLM_article-title">Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3635</span><span class="NLM_x">â</span> <span class="NLM_lpage">3648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=3635-3648&author=A.+Wissnerauthor=H.+L.+Fraserauthor=C.+L.+Ingallsauthor=R.+G.+Dushinauthor=M.+B.+Floydauthor=K.+Cheungauthor=T.+Nittoliauthor=M.+R.+Raviauthor=X.+Tanauthor=F.+Loganzo&title=Dual+irreversible+kinase+inhibitors%3A+quinazoline-based+inhibitors+incorporating+two+independent+reactive+centers+with+each+targeting+different+cysteine+residues+in+the+kinase+domains+of+EGFR+and+VEGFR-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFraser%26aufirst%3DH.%2BL.%26aulast%3DIngalls%26aufirst%3DC.%2BL.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DNittoli%26aufirst%3DT.%26aulast%3DRavi%26aufirst%3DM.%2BR.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLoganzo%26aufirst%3DF.%26atitle%3DDual%2520irreversible%2520kinase%2520inhibitors%253A%2520quinazoline-based%2520inhibitors%2520incorporating%2520two%2520independent%2520reactive%2520centers%2520with%2520each%2520targeting%2520different%2520cysteine%2520residues%2520in%2520the%2520kinase%2520domains%2520of%2520EGFR%2520and%2520VEGFR-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D3635%26epage%3D3648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">â</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53aR"><div class="casContent"><span class="casTitleNuber">53a</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Nonselective Kinase Inhibition: Striking the Right Balance</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1413-1437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Marketed kinase inhibitors (MKIs) can deliver superior efficacy compared to inhibitors with high specificity for a single kinase, and the recent introduction of several MKIs to the market opens the door to a new era of safer and effective anticancer therapy.  The key to combining high efficacy with acceptable safety is to inhibit multiple targets in a selectively nonselective fashion.  Strategies for intentionally designing MKIs are emerging, but the field is still in its infancy and we are as medicinal chemists currently on the steepest part of the learning curve.  MTDD can be time-consuming and expensive, and we need to become more proficient first at identifying disease-relevant target combinations and second at discovering MKIs that combine optimal physicochem. and biol. properties.  Bold and innovative medicinal chem. strategies are required to tackle "difficult combinations" where the disease rationale is compelling but where it is a struggle to combine all the desired attributes of an oral MKI drug into a single mol.  At present it is unclear to what extent MKIs with highly tuned selectivity profiles can be rationally designed, particularly for targets that are unrelated by sequence.  In addn. to the well-known selectivity challenge, the physicochem. property profiles of AT P-competitive MKIs can be inherently challenging and limited scope for patentability can also be a serious hindrance.  On the plus side, the amt. of kinase-specific structural information is growing very rapidly, and ultimately this may reveal distinct features and design rules that enable a medicinal chemist to rationally modify and refine the profile of MKIs.  In addn., increasing SAR knowledge is emerging from large scale panel screening with the binding profiles starting to reveal to medicinal chemists how chem. structure affects cross-reactivity across large parts of the kinome.  The merit of MKIs compared with single kinase inhibitors is a subject of controversy in drug discovery that is unlikely to be resolved in the near future.  At the start of a new MTDD project, a rigorous debate needs to take place as to whether it makes more sense to seek a combination of highly selective agents or a DML.  Many factors need to be taken into account in this decision such as the no., similarity, and promiscuity of the targets in the profile and the disease area.  Conformational plasticity and the occurrence of multiple binding modes complicate the in silico prediction of kinase polypharmacol. based solely upon protein structure.  The use of ligand-based similarity to assess the feasibility of a given combination can add real value.  Currently, serendipity plays a significant role in MKI discovery and many, if not most, MKIs have been discovered by chance during the search for selective inhibitors.  Medicinal chemists need to be alert to the possibilities when a surprising combination is found by chance.  To exploit such serendipity, you need a good appreciation of when you have a sufficiently high quality starting compd. and then you need to be able to make and test sufficient analogs to explore your new disease-based hypothesis.  MKIs are costly to develop and are consequently priced at a premium level, so they will need to show clear improvements in order to get reimbursement.  There have already been problems with reimbursement for some MKIs in some markets due to concerns from funding bodies over insufficient efficacy.  The true value of MKIs relative to other anticancer drugs still has to be established, and the results from recent clin. trials have been mixed.  Despite the broad activity profile of many MKIs, the patient response can be inconsistent and unpredictable.  The identification of predictive biomarkers of response or resistance is a crit. step to ascertain which specific combination of targets produces a significant clin. benefit with respect to specific tumor types.  More clin. feedback is needed to facilitate the design of the next generation of inhibitors with more precisely defined profiles.  Although it might seem immeasurably distant at the present time, the ultimate goal should be to derive the prerequisite knowledge and tools so that MTDD becomes a rational endeavor rather than a black box approach that relies upon serendipity.  This will help banish claims that MKIs are merely dirty, nonspecific drugs with insufficient specificity for treating a wider range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-L-NWmtdikbVg90H21EOLACvtfcHk0lgKA2M2xqjH0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF&md5=3c915b5debf9d005993c8ad31c68bc2e</span></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit53b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Keller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafhause, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummendorf, T. H.</span><span> </span><span class="NLM_article-title">Bosutinib</span> <span class="citation_source-journal">Recent Res. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2F978-3-642-01222-8_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=20072835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgsLnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=119-127&author=G.+Kellerauthor=P.+Schafhauseauthor=T.+H.+Brummendorf&title=Bosutinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53bR"><div class="casContent"><span class="casTitleNuber">53b</span><div class="casTitle"><span class="NLM_cas:atitle">Bosutinib</span></div><div class="casAuthors">Keller, Gunhild; Schafhausen, Philippe; Bruemmendorf, Tim H.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Results in Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">Small Molecules in Oncology</span>),
    <span class="NLM_cas:pages">119-127</span>CODEN:
                <span class="NLM_cas:coden">RRCRBU</span>;
        ISSN:<span class="NLM_cas:issn">0080-0015</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Bosutinib (SKI-606) is a 7-alkoxy-3-quinolinecarbonitrile, which functions as a dual inhibitor of Src and Abl kinases.  In biochem. and proliferation assays, the compd. was shown to be active against src family kinases and Bcr-Abl at IC50s of 100 and 90 nM, resp.  The bcr-abl fusion gene product, a consecutively activated tyrosine kinase, which is crucial for the development of chronic myeloid leukemia (CML), is highly sensitive to bosutinib.  Interestingly, distinctly lower concns. of the dual src/abl inhibitor are required to ablate Bcr-Abl phosphorylation when compared to first-generation tyrosine kinase inhibitor imatinib (IM).  Bosutinib is a potent inhibitor of CML cell proliferation in vitro and in vivo expts. and has demonstrated promising harboring results in CML patients resistance or intolerance to IM in ongoing phase I/II clin. trials.  Remarkably, bosutinib has been found to be capable of overcoming the majority of IM-resistant bcr-abl mutations.  A randomized open label phase III clin. study to compare the efficacy of bosutinib and IM in first-line therapy of Ph+ chronic phase (CP) CML has recently been initiated.  In a phase I/II clin. study with subjects suffering from advanced stages of solid tumors, long-term responses have also been reported.  In conclusion, Bosutinib is a promising novel small mol. inhibitor for targeted therapy of CML and solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGremOsWiws7jrVg90H21EOLACvtfcHk0lgLETrLzVeh5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgsLnE&md5=9b601b52d7c0aec8b9b2ebf375bb3b16</span></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-01222-8_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-01222-8_9%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DG.%26aulast%3DSchafhause%26aufirst%3DP.%26aulast%3DBrummendorf%26aufirst%3DT.%2BH.%26atitle%3DBosutinib%26jtitle%3DRecent%2520Res.%2520Cancer%26date%3D2010%26volume%3D184%26spage%3D119%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Gunby, R. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sottocornola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mologni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartari, C. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belloni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapozza, L.</span><span> </span><span class="NLM_article-title">Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5759</span><span class="NLM_x">â</span> <span class="NLM_lpage">5768</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060380k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5759-5768&author=R.+H+Gunbyauthor=S.+Ahmedauthor=R.+Sottocornolaauthor=M.+Gasserauthor=S.+Redaelliauthor=L.+Mologniauthor=C.+J+Tartariauthor=V.+Belloniauthor=C.+Gambacorti-Passeriniauthor=L.+Scapozza&title=Structural+insights+into+the+ATP+binding+pocket+of+the+anaplastic+lymphoma+kinase+by+site-directed+mutagenesis%2C+inhibitor+binding+analysis%2C+and+homology+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm060380k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060380k%26sid%3Dliteratum%253Aachs%26aulast%3DGunby%26aufirst%3DR.%2BH%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DSottocornola%26aufirst%3DR.%26aulast%3DGasser%26aufirst%3DM.%26aulast%3DRedaelli%26aufirst%3DS.%26aulast%3DMologni%26aufirst%3DL.%26aulast%3DTartari%26aufirst%3DC.%2BJ%26aulast%3DBelloni%26aufirst%3DV.%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26aulast%3DScapozza%26aufirst%3DL.%26atitle%3DStructural%2520insights%2520into%2520the%2520ATP%2520binding%2520pocket%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520by%2520site-directed%2520mutagenesis%252C%2520inhibitor%2520binding%2520analysis%252C%2520and%2520homology%2520modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5759%26epage%3D5768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek-Klumpers, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">â</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1107-1131&author=H.-R.+Tsouauthor=E.+G.+Overbeek-Klumpersauthor=W.+A.+Hallettauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=R.+S.+Michalakauthor=R.+Nilakantanauthor=C.+Discafaniauthor=J.+Golasauthor=S.+K.+Rabindranauthor=R.+Shenauthor=X.+Shiauthor=Y.+F.+Wangauthor=J.+Upeslacisauthor=A.+Wissner&title=Optimization+of+6%2C7-disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+orally+active%2C+irreversible+inhibitors+of+human+epidermal+growth+factor+receptor-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1021%2Fjm040159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040159c%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DOverbeek-Klumpers%26aufirst%3DE.%2BG.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMichalak%26aufirst%3DR.%2BS.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DUpeslacis%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DOptimization%2520of%25206%252C7-disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520orally%2520active%252C%2520irreversible%2520inhibitors%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520kinase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1107%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span> </span><span class="NLM_article-title">4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3244</span><span class="NLM_x">â</span> <span class="NLM_lpage">3256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000206a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3244-3256&author=A.+Wissnerauthor=D.+M.+Bergerauthor=D.+H.+Boschelliauthor=M.+B.+Floydauthor=L.+M.+Greenbergerauthor=B.+C.+Gruberauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=R.+Nilakantanauthor=M.+F.+Reichauthor=R.+Shenauthor=H.-R.+Tsouauthor=E.+Upeslacisauthor=Y.+F.+Wangauthor=B.+Wuauthor=F.+Yeauthor=N.+Zhang&title=4-Anilino-6%2C7-dialkoxyquinoline-3-carbonitrile+inhibitors+of+epidermal+growth+factor+receptor+kinase+and+their+bioisosteric+relationship+to+the+4-anilino-6%2C7-dialkoxyquinazoline+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1021%2Fjm000206a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000206a%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DUpeslacis%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26atitle%3D4-Anilino-6%252C7-dialkoxyquinoline-3-carbonitrile%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520and%2520their%2520bioisosteric%2520relationship%2520to%2520the%25204-anilino-6%252C7-dialkoxyquinazoline%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3244%26epage%3D3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Boschelli, D. H.</span><span> </span><span class="NLM_article-title">4-Anilino-3-quinolinecarbonitriles: an emerging class of kinase inhibitorsâan update</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">â</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlShtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=457-463&author=D.+H.+Boschelli&title=4-Anilino-3-quinolinecarbonitriles%3A+an+emerging+class+of+kinase+inhibitors%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">4-Anilino-3-quinolinecarbonitriles: an emerging class of kinase inhibitors - an update</span></div><div class="casAuthors">Boschelli, Diane H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Reviews--Online</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-463</span>CODEN:
                <span class="NLM_cas:coden">MCREC9</span>;
        ISSN:<span class="NLM_cas:issn">1567-2034</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2000, Wyeth disclosed that 4-(3-bromoanilino)-6,7-dimethoxy-3-quinolinecarbonitrile was a potent and selective EGFR kinase inhibitor.  Subsequent reports showed that variation of the substituents on the 4-anilino group of the 3-quminolinecarbonitrile core changed the kinase specificity from EGFR to either Src or MEK.  This article is an update of a 2002 review that summarized Wyeth's efforts in the area of 4-anilino-3-qumiolinecarbonitrile kinase inhibitors.  Since then, Wyeth has reported the SAR of EKB-569, an irreversible EGFR inhibitor currently in clin. trials.  Variation of the 4-anilino group of EKB-569 provided HKI-272, a dual inhibitor of EGFR and HER-2.  In addn., the 3-quinolinecarbonitnrile analogs of known quinazoline EGFR inhibitors were prepd.  SKI-606, initially reported to be a Src inhibitor, was found to also inhibit Abl kinase and therefore could be a potential alternative treatment to Gleevec.  SKI-606 was also efficacious in a rat model of stroke.  Addnl. Src kinase inhibitors, including some tricyclic analogs, were obtained by variation of the substituent at C-7.  Finally, 3-quinolinecarbonitrile MEK inhibitors with potent cell activity were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqpIUJ4gjFrVg90H21EOLACvtfcHk0lgM3C5le8ID6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlShtLc%253D&md5=416e305ae8cb1a7b306daa2423ba5e25</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26atitle%3D4-Anilino-3-quinolinecarbonitriles%253A%2520an%2520emerging%2520class%2520of%2520kinase%2520inhibitors%25E2%2580%2594an%2520update%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2004%26volume%3D1%26spage%3D457%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span> </span><span class="NLM_article-title">Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles: analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">â</span> <span class="NLM_lpage">2897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2893-2897&author=A.+Wissnerauthor=M.+B.+Floydauthor=S.+K.+Rabindranauthor=R.+Nilakantanauthor=L.+M.+Greenbergerauthor=R.+Shenauthor=Y.-F.+Wangauthor=H.-R.+Tsou&title=Syntheses+and+EGFR+and+HER-2+kinase+inhibitory+activities+of+4-anilinoquinoline-3-carbonitriles%3A+analogues+of+three+important+4-anilinoquinazolines+currently+undergoing+clinical+evaluation+as+therapeutic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DSyntheses%2520and%2520EGFR%2520and%2520HER-2%2520kinase%2520inhibitory%2520activities%2520of%25204-anilinoquinoline-3-carbonitriles%253A%2520analogues%2520of%2520three%2520important%25204-anilinoquinazolines%2520currently%2520undergoing%2520clinical%2520evaluation%2520as%2520therapeutic%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2893%26epage%3D2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Torrance, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discfani, C. M.</span><span> </span><span class="NLM_article-title">Combinatorial chemoprevention of intestinal neoplasia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">â</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2F79534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=10973323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1024-1028&author=C.+J.+Torranceauthor=P.+E.+Jacksonauthor=E.+Montgomeryauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=A.+Wissnerauthor=M.+Nunesauthor=P.+Frostauthor=C.+M.+Discfani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57bR"><div class="casContent"><span class="casTitleNuber">57b</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial chemoprevention of intestinal neoplasia</span></div><div class="casAuthors">Torrance, Christopher J.; Jackson, Peta E.; Montgomery, Elizabeth; Kinzler, Kenneth W.; Vogelstein, Bert; Wissner, Allan; Nunes, Maria; Frost, Philip; Discafani, Carolyn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1024-1028</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A combination of two drugs afforded remarkable protection from intestinal neoplasia in APCMin/+ mice, a murine model of human familial adenomatous polyposis (FAP).  One of the drugs was sulindac, a prototypical non-steroidal anti-inflammatory drug with established chemopreventive activity.  The second drug was EKB569, a newly developed, irreversible inhibitor of the epidermal growth factor receptor kinase.  Although 100% of the untreated APCMin/+ mice developed -20 polyps, nearly half the mice treated with these two agents developed no polyps at all.  These results suggest a powerful strategy for the chemoprevention of human colonic neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysAYwWewtCrVg90H21EOLACvtfcHk0lgM3C5le8ID6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D&md5=2b1da2bdcd72fec51856ff25643efd4c</span></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=10.1038%2F79534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79534%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BE.%26aulast%3DMontgomery%26aufirst%3DE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DM.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DDiscfani%26aufirst%3DC.%2BM.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D1024%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wawrzak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, D. B.</span><span> </span><span class="NLM_article-title">Structure-based design of potent inhibitors of scytalone dehydratase: displacement of a water molecule from the active site</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">17735</span><span class="NLM_x">â</span> <span class="NLM_lpage">17744</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981848r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK1cXns1ahur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=17735-17744&author=J.+M.+Chenauthor=S.+L.+Xuauthor=Z.+Wawrzakauthor=G.+S.+Basarabauthor=D.+B.+Jordan&title=Structure-based+design+of+potent+inhibitors+of+scytalone+dehydratase%3A+displacement+of+a+water+molecule+from+the+active+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent Inhibitors of Scytalone Dehydratase: Displacement of a Water Molecule from the Active Site</span></div><div class="casAuthors">Chen, James M.; Xu, Simon L.; Wawrzak, Zdzislaw; Basarab, Gregory S.; Jordan, Douglas B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17735-17744</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Scytalone dehydratase (SD) is a mol. target of inhibitor design efforts aimed at protecting rice plants from the fungal disease caused by Magnaporthe grisea.  As detd. from x-ray diffraction data of an SD-inhibitor complex [Lundqvist et al. (1994) Structure (London) 2, 937-944], there is an extended hydrogen-bonding network between protein side chains, the inhibitor, and two bound water mols.  From models of SD complexed to quinazoline and benzotriazine inhibitors, a new class of potent SD inhibitors involving the displacement of an active-site water mol. were designed.  We were able to increase inhibitory potency by synthesizing compds. with a nitrile functionality displayed into the space occupied by one of the crystallog. water mols.  Sixteen inhibitors are compared.  The net conversion of potent quinazoline and benztriazine inhibitors to cyanoquinolines and cyanocinnolines increased binding potency 2-20-fold.  Replacement of the nitrile with a hydrogen atom lowered binding affinity 100-30 000-fold.  X-ray crystallog. data at 1.65 Ã resoln. on a SD-inhibitor complex confirmed that the nitrile functionality displaced the water mol. as intended and that a favorable orientation was created with tyrosines 30 and 50 which had been part of the hydrogen-bonding network with the water mol.  Addnl. data on inhibitors presented herein reveals the importance of two hydrogen-bonding networks toward inhibitory potency: one between Asn131 and an appropriately positioned inhibitor heteroatom and one between a bound water mol. and a second inhibitor heteroatom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmVth3Jjz37Vg90H21EOLACvtfcHk0lgM3C5le8ID6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1ahur8%253D&md5=e75ce5e856763fbded15acc1db5421d1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbi981848r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981848r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DS.%2BL.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DJordan%26aufirst%3DD.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520inhibitors%2520of%2520scytalone%2520dehydratase%253A%2520displacement%2520of%2520a%2520water%2520molecule%2520from%2520the%2520active%2520site%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D17735%26epage%3D17744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Bayram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheorghiade, M.</span><span> </span><span class="NLM_article-title">Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">47G</span><span class="NLM_x">â</span> <span class="NLM_lpage">58G</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=47G-58G&author=M.+Bayramauthor=L.+De+Lucaauthor=M.+B.+Massieauthor=M.+Gheorghiade&title=Reassessment+of+dobutamine%2C+dopamine%2C+and+milrinone+in+the+management+of+acute+heart+failure+syndromes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBayram%26aufirst%3DM.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DMassie%26aufirst%3DM.%2BB.%26aulast%3DGheorghiade%26aufirst%3DM.%26atitle%3DReassessment%2520of%2520dobutamine%252C%2520dopamine%252C%2520and%2520milrinone%2520in%2520the%2520management%2520of%2520acute%2520heart%2520failure%2520syndromes%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2005%26volume%3D96%26spage%3D47G%26epage%3D58G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Hannon, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housmans, P. R.</span><span> </span><span class="NLM_article-title">Inotropic therapy</span> <span class="citation_source-journal">Adv. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVant7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1-15&author=J.+D.+Hannonauthor=P.+R.+Housmans&title=Inotropic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Inotropic therapy</span></div><div class="casAuthors">Hannon, James D.; Housmans, Philippe R.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cardiovascular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">69LKDN</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review on inotropic therapy, emphasizing on epinephrine, norepinephrine, dopamine, dobutamine, milrinone and levosimendan, as well as the evolving therapies, such as SERCA expression and myosin activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSeiUijEFUV7Vg90H21EOLACvtfcHk0lgqz0Z9ZJE-qg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVant7w%253D&md5=0b4bd0fd5c44070b2f50fb15a35b33c1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHannon%26aufirst%3DJ.%2BD.%26aulast%3DHousmans%26aufirst%3DP.%2BR.%26atitle%3DInotropic%2520therapy%26jtitle%3DAdv.%2520Cardiovasc.%2520Pharmacol.%26date%3D2008%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Mizushige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yukiiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span> </span><span class="NLM_article-title">Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">â</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=163-174&author=K.+Mizushigeauthor=T.+Uedaauthor=K.+Yukiiriauthor=H.+Suzuki&title=Olprinone%3A+a+phosphodiesterase+III+inhibitor+with+positive+inotropic+and+vasodilator+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizushige%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DYukiiri%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DH.%26atitle%3DOlprinone%253A%2520a%2520phosphodiesterase%2520III%2520inhibitor%2520with%2520positive%2520inotropic%2520and%2520vasodilator%2520effects%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2002%26volume%3D20%26spage%3D163%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wojtczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, V.</span><span> </span><span class="NLM_article-title">Structural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 Ã of the human serum transthyretinâmilrinone complex</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">6202</span><span class="NLM_x">â</span> <span class="NLM_lpage">6206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=6202-6206&author=A.+Wojtczakauthor=J.+R.+Luftauthor=V.+Cody&title=Structural+aspects+of+inotropic+bipyridine+binding.+Crystal+structure+determination+to+1.9+%C3%85+of+the+human+serum+transthyretin%E2%88%92milrinone+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DLuft%26aufirst%3DJ.%2BR.%26aulast%3DCody%26aufirst%3DV.%26atitle%3DStructural%2520aspects%2520of%2520inotropic%2520bipyridine%2520binding.%2520Crystal%2520structure%2520determination%2520to%25201.9%2520%25C3%2585%2520of%2520the%2520human%2520serum%2520transthyretin%25E2%2588%2592milrinone%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D6202%26epage%3D6206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cody, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojtczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciszak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennemann, G.</span><span> </span><span class="NLM_article-title">Differences in inhibitor and substrate binding in transthyretin crystal complexes</span> <span class="citation_source-journal">Prog. Thyroid Res., Proc. Int. Thyroid Conf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">â</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK3sXpsVCquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=793-796&author=V.+Codyauthor=A.+Wojtczakauthor=E.+Ciszakauthor=J.+Luftauthor=A.+Gordonauthor=J.+Grossauthor=G.+Hennemann&title=Differences+in+inhibitor+and+substrate+binding+in+transthyretin+crystal+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62bR"><div class="casContent"><span class="casTitleNuber">62b</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in inhibitor and substrate binding in transthyretin crystal complexes</span></div><div class="casAuthors">Cody, Vivian; Wojtczak, Andrzej; Ciszak, Ewa; Luft, Joseph</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">793-6</span>CODEN:
                <span class="NLM_cas:coden">58JYAY</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Balkema</span>)
        </div><div class="casAbstract">Crystal structure detns. of transthyretin-competitor cocrystd. complexes were investigated and preliminary results of 4 inhibitor complexes [3,3'-diiodothyronine, the bromoflavonoids 3-methyl-6,4'-dihydroxy-3',5'-dibromoflavone (EMD 21388) and 4,6,2',4'-tetrahydroxy-3',5'-dibromoaurone (EMD 47021), and the ionotropic cardioactive drug milrinone are presented.  Results indicated that EMD 21388 and EMD 47021, competitive inhibitors of T4 binding to transthyretin, occupy the hormone binding site in different ways from T4 as well as from models proposed from computer graphic studies.  In the case of milrinone and 3,3'-diiodothyronine, binding was similar to that of T4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAiP9_YQ1ObVg90H21EOLACvtfcHk0lgqz0Z9ZJE-qg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpsVCquw%253D%253D&md5=3be00963db946881ab306c04997d00ed</span></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCody%26aufirst%3DV.%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DCiszak%26aufirst%3DE.%26aulast%3DLuft%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DHennemann%26aufirst%3DG.%26atitle%3DDifferences%2520in%2520inhibitor%2520and%2520substrate%2520binding%2520in%2520transthyretin%2520crystal%2520complexes%26jtitle%3DProg.%2520Thyroid%2520Res.%252C%2520Proc.%2520Int.%2520Thyroid%2520Conf.%26date%3D1991%26spage%3D793%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Cody, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojtczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blas, S. D.</span><span> </span><span class="NLM_article-title">Structureâactivity relationships of milrinone analogs determined in vitro in a rabbit heart membrane Ca<sup>2+</sup>-ATPase model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1990</span><span class="NLM_x">â</span> <span class="NLM_lpage">1997</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00011a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1990-1997&author=V.+Codyauthor=A.+Wojtczakauthor=F.+B.+Davisauthor=P.+J.+Davisauthor=S.+D.+Blas&title=Structure%E2%88%92activity+relationships+of+milrinone+analogs+determined+in+vitro+in+a+rabbit+heart+membrane+Ca2%2B-ATPase+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm00011a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00011a018%26sid%3Dliteratum%253Aachs%26aulast%3DCody%26aufirst%3DV.%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DF.%2BB.%26aulast%3DDavis%26aufirst%3DP.%2BJ.%26aulast%3DBlas%26aufirst%3DS.%2BD.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520milrinone%2520analogs%2520determined%2520in%2520vitro%2520in%2520a%2520rabbit%2520heart%2520membrane%2520Ca2%252B-ATPase%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1990%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Thornber, C. W.</span><span> </span><span class="NLM_article-title">Isosterism and molecular modification in drug design</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">â</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1039%2Fcs9790800563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL3cXktlKmsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1979&pages=563-580&author=C.+W.+Thornber&title=Isosterism+and+molecular+modification+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Isosterism and molecular modification in drug design</span></div><div class="casAuthors">Thornber, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">563-80</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    </div><div class="casAbstract">A review  with 76 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Xf7UcnFrA7Vg90H21EOLACvtfcHk0ljvVbswT0s51A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktlKmsL0%253D&md5=25e8bd3c46affd25b72fbf87a44a3b27</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1039%2Fcs9790800563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcs9790800563%26sid%3Dliteratum%253Aachs%26aulast%3DThornber%26aufirst%3DC.%2BW.%26atitle%3DIsosterism%2520and%2520molecular%2520modification%2520in%2520drug%2520design%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D1979%26volume%3D8%26spage%3D563%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Matthews, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitten, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barney, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, T.</span><span> </span><span class="NLM_article-title">Synthesis and cardiotonic activity of novel biimidazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00163a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=317-327&author=D.+P.+Matthewsauthor=J.+R.+McCarthyauthor=J.+P.+Whittenauthor=P.+R.+Kastnerauthor=C.+L.+Barneyauthor=F.+N.+Marshallauthor=M.+A.+Ertelauthor=T.+Burkhardauthor=P.+J.+Sheaauthor=T.+Kariya&title=Synthesis+and+cardiotonic+activity+of+novel+biimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm00163a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00163a052%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BP.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DKastner%26aufirst%3DP.%2BR.%26aulast%3DBarney%26aufirst%3DC.%2BL.%26aulast%3DMarshall%26aufirst%3DF.%2BN.%26aulast%3DErtel%26aufirst%3DM.%2BA.%26aulast%3DBurkhard%26aufirst%3DT.%26aulast%3DShea%26aufirst%3DP.%2BJ.%26aulast%3DKariya%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520cardiotonic%2520activity%2520of%2520novel%2520biimidazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D317%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefaniak, M. H.</span><span> </span><span class="NLM_article-title">2(1<i>H</i>)-Quinolinones with cardiac stimulant activity. 3. Synthesis and biological properties of 6-imidazol-1-yl derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1552</span><span class="NLM_x">â</span> <span class="NLM_lpage">1558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00127a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1552-1558&author=A.+S.+Bellauthor=S.+F.+Campbellauthor=D.+S.+Morrisauthor=D.+A.+Robertsauthor=M.+H.+Stefaniak&title=2%281H%29-Quinolinones+with+cardiac+stimulant+activity.+3.+Synthesis+and+biological+properties+of+6-imidazol-1-yl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm00127a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00127a025%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DCampbell%26aufirst%3DS.%2BF.%26aulast%3DMorris%26aufirst%3DD.%2BS.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DStefaniak%26aufirst%3DM.%2BH.%26atitle%3D2%25281H%2529-Quinolinones%2520with%2520cardiac%2520stimulant%2520activity.%25203.%2520Synthesis%2520and%2520biological%2520properties%2520of%25206-imidazol-1-yl%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1552%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cecchetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabarrini, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, S.</span><span> </span><span class="NLM_article-title">From cromakalim to different structural classes of KATP channel openers</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">â</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802606777323683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16787279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2is78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1049-1068&author=V.+Cecchettiauthor=O.+Tabarriniauthor=S.+Sabatini&title=From+cromakalim+to+different+structural+classes+of+KATP+channel+openers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67aR"><div class="casContent"><span class="casTitleNuber">67a</span><div class="casTitle"><span class="NLM_cas:atitle">From cromakalim to different structural classes of KATP channel openers</span></div><div class="casAuthors">Cecchetti, Violetta; Tabarrini, Oriana; Sabatini, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1049-1068</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP-Sensitive K channel openers (KATPCOs) are a group of compds. with a broad spectrum of potential therapeutic applications, as they constitute efficient tools for dampening cell excitability.  Interest in the KATPCOs was triggered in the early 1980s by the discovery of the benzopyran-based structure cromakalim (CRK), which is a powerful smooth muscle relaxant.  CRK can be considered the archetype of KATPCOs and is by far the most mimicked structure.  In many structure-activity studies various substitutions were made at the different positions of the benzopyran ring permitting the optimal activity to be correlated with a specific set of structural characteristics and stereochem. features of the mol.  Thus, many potent benzopyran derivs. were identified.  The benzopyran nucleus itself was also modified in both the arom. ring and in the pyran moiety.  The intention of this review is to bring together all the different structural classes of KATPCOs arising from the replacement of CRK benzopyran-based structure with various ring systems; design, structure-activity relationship, and synthesis will be given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Quwwyf_G0bVg90H21EOLACvtfcHk0ljvVbswT0s51A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2is78%253D&md5=8ff46cc2949761da891d0a5f2fbb7e2a</span></div><a href="/servlet/linkout?suffix=cit67a&amp;dbid=16384&amp;doi=10.2174%2F156802606777323683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777323683%26sid%3Dliteratum%253Aachs%26aulast%3DCecchetti%26aufirst%3DV.%26aulast%3DTabarrini%26aufirst%3DO.%26aulast%3DSabatini%26aufirst%3DS.%26atitle%3DFrom%2520cromakalim%2520to%2520different%2520structural%2520classes%2520of%2520KATP%2520channel%2520openers%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2006%26volume%3D6%26spage%3D1049%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit67b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Salamon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannhold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, W.</span><span> </span><span class="NLM_article-title">6-Sulfonylchromenes as highly potent KATP-channel openers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">â</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010999g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1086-1089&author=E.+Salamonauthor=R.+Mannholdauthor=H.+Weberauthor=H.+Lemoineauthor=W.+Frank&title=6-Sulfonylchromenes+as+highly+potent+KATP-channel+openers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67b&amp;dbid=16384&amp;doi=10.1021%2Fjm010999g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010999g%26sid%3Dliteratum%253Aachs%26aulast%3DSalamon%26aufirst%3DE.%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DWeber%26aufirst%3DH.%26aulast%3DLemoine%26aufirst%3DH.%26aulast%3DFrank%26aufirst%3DW.%26atitle%3D6-Sulfonylchromenes%2520as%2520highly%2520potent%2520KATP-channel%2520openers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1086%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovnyak, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span> </span><span class="NLM_article-title">Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3711</span><span class="NLM_x">â</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990196h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3711-3717&author=C.+Z.+Dingauthor=G.+C.+Rovnyakauthor=R.+N.+Misraauthor=G.+J.+Groverauthor=A.+V.+Millerauthor=S.+Z.+Ahmedauthor=Y.+Kellyauthor=D.+E.+Normandinauthor=P.+G.+Slephauthor=K.+S.+Atwal&title=Cardioselective+antiischemic+ATP-sensitive+potassium+channel+%28KATP%29+openers.+6.+Effect+of+modifications+at+C6+of+benzopyranyl+cyanoguanidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1021%2Fjm990196h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990196h%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DRovnyak%26aufirst%3DG.%2BC.%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DMiller%26aufirst%3DA.%2BV.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DKelly%26aufirst%3DY.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DCardioselective%2520antiischemic%2520ATP-sensitive%2520potassium%2520channel%2520%2528KATP%2529%2520openers.%25206.%2520Effect%2520of%2520modifications%2520at%2520C6%2520of%2520benzopyranyl%2520cyanoguanidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3711%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit68b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzwonczyk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCullough, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span> </span><span class="NLM_article-title">Cardioselective anti-ischemic ATP-sensitive potassium channel openers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3971</span><span class="NLM_x">â</span> <span class="NLM_lpage">3974</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00076a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3971-3974&author=K.+S.+Atwalauthor=G.+J.+Groverauthor=S.+Z.+Ahmedauthor=F.+N.+Ferraraauthor=T.+W.+Harperauthor=K.+S.+Kimauthor=P.+G.+Slephauthor=S.+Dzwonczykauthor=A.+D.+Russellauthor=S.+Morelandauthor=J.+R.+McCulloughauthor=D.+E.+Normandin&title=Cardioselective+anti-ischemic+ATP-sensitive+potassium+channel+openers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=10.1021%2Fjm00076a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00076a027%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DFerrara%26aufirst%3DF.%2BN.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DDzwonczyk%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DA.%2BD.%26aulast%3DMoreland%26aufirst%3DS.%26aulast%3DMcCullough%26aufirst%3DJ.%2BR.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26atitle%3DCardioselective%2520anti-ischemic%2520ATP-sensitive%2520potassium%2520channel%2520openers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3971%26epage%3D3974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gaspar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snipes, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busija, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domoki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busija, D. W.</span><span> </span><span class="NLM_article-title">ROS-independent preconditioning in neurons via activation of mitoKATP channels by BMS-191095</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1090</span><span class="NLM_x">â</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fsj.jcbfm.9600611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18212794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1SgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1090-1103&author=T.+Gasparauthor=J.+A.+Snipesauthor=A.+R.+Busijaauthor=B.+Kisauthor=F.+Domokiauthor=F.+Bariauthor=D.+W.+Busija&title=ROS-independent+preconditioning+in+neurons+via+activation+of+mitoKATP+channels+by+BMS-191095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69aR"><div class="casContent"><span class="casTitleNuber">69a</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-independent preconditioning in neurons via activation of mitoKATP channels by BMS-191095</span></div><div class="casAuthors">Gaspar, Tamas; Snipes, James A.; Busija, Anna R.; Kis, Bela; Domoki, Ferenc; Bari, Ferenc; Busija, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1090-1103</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Previously, we have shown that the selective mitochondrial ATP-sensitive potassium (mitoKATP) channel opener BMS-191095 (BMS) induces neuronal preconditioning (PC); however, the exact mechanism of BMS-induced neuroprotection remains unclear.  In this study, we have identified key components of the cascade resulting in delayed neuronal PC with BMS using isolated rat brain mitochondria and primary cultures of rat cortical neurons.  BMS depolarized isolated mitochondria without an increase in reactive oxygen species (ROS) generation and induced rapid phosphorylation of Akt and glycogen synthase kinase-3Î².  Long-term (3 days) treatment of neurons with BMS resulted in sustained mitochondrial depolarization, decreased basal ROS generation, and elevated ATP levels.  This treatment also elicited almost complete protection against glutamate excitotoxicity, which could be abolished using the phosphoinositide 3-kinase (PI3K) inhibitor wortmannin, but not with the superoxide dismutase (SOD) mimetic M40401.  Long-term BMS treatment induced a PI3K-dependent increase in the expression and activity of catalase without affecting manganese SOD and copper/zinc-dependent SOD.  Finally, the catalase inhibitor 3-aminotriazole dose-dependently antagonized the neuroprotective effect of BMS-induced PC.  In summary, BMS depolarizes mitochondria without ROS generation, activates the PI3K-Akt pathway, improves ATP content, and increases catalase expression.  These mechanisms appear to play important roles in the neuroprotective effect of BMS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt0AMIgX8ybLVg90H21EOLACvtfcHk0liQeEJOQWR-jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1SgsL0%253D&md5=f4abef03fc1e89e81ec8a295691b940e</span></div><a href="/servlet/linkout?suffix=cit69a&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600611%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DT.%26aulast%3DSnipes%26aufirst%3DJ.%2BA.%26aulast%3DBusija%26aufirst%3DA.%2BR.%26aulast%3DKis%26aufirst%3DB.%26aulast%3DDomoki%26aufirst%3DF.%26aulast%3DBari%26aufirst%3DF.%26aulast%3DBusija%26aufirst%3DD.%2BW.%26atitle%3DROS-independent%2520preconditioning%2520in%2520neurons%2520via%2520activation%2520of%2520mitoKATP%2520channels%2520by%2520BMS-191095%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2008%26volume%3D28%26spage%3D1090%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit69b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rovnyak, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzwonczyk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santafianos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traeger, S. C.</span><span> </span><span class="NLM_article-title">Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(<i>N</i>-aryl)-substituted benzopyran derivatives with high selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9605905" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=24-34&author=G.+C.+Rovnyakauthor=S.+Z.+Ahmedauthor=C.+Z.+Dingauthor=S.+Dzwonczykauthor=F.+N.+Ferraraauthor=W.+G.+Humphreysauthor=G.+J.+Groverauthor=D.+Santafianosauthor=K.+S.+Atwalauthor=A.+J.+Bairdauthor=L.+G.+McLaughlinauthor=D.+E.+Normandinauthor=P.+G.+Slephauthor=S.+C.+Traeger&title=Cardioselective+antiischemic+ATP-sensitive+potassium+channel+%28KATP%29+openers.+5.+Identification+of+4-%28N-aryl%29-substituted+benzopyran+derivatives+with+high+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69b&amp;dbid=16384&amp;doi=10.1021%2Fjm9605905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9605905%26sid%3Dliteratum%253Aachs%26aulast%3DRovnyak%26aufirst%3DG.%2BC.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DDzwonczyk%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DF.%2BN.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DSantafianos%26aufirst%3DD.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DBaird%26aufirst%3DA.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DL.%2BG.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26atitle%3DCardioselective%2520antiischemic%2520ATP-sensitive%2520potassium%2520channel%2520%2528KATP%2529%2520openers.%25205.%2520Identification%2520of%25204-%2528N-aryl%2529-substituted%2520benzopyran%2520derivatives%2520with%2520high%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D24%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Horino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagechika, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]heptenyloxy)benzopyran derivatives and their analogs</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">â</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1998&pages=602-609&author=H.+Horinoauthor=T.+Mimuraauthor=K.+Kagechikaauthor=M.+Ohtaauthor=H.+Kuboauthor=M.+Kitagawa&title=Synthesis+and+antihypertensive+activity+of+4-%28diazabicyclo%5B4.1.0%5Dheptenyloxy%29benzopyran+derivatives+and+their+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorino%26aufirst%3DH.%26aulast%3DMimura%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DH.%26aulast%3DKitagawa%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%25204-%2528diazabicyclo%255B4.1.0%255Dheptenyloxy%2529benzopyran%2520derivatives%2520and%2520their%2520analogs%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1998%26volume%3D46%26spage%3D602%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit70b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bergmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gericke, R.</span><span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2<i>H</i>-1-benzopyrans and related compounds, new potassium channel activators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">â</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00164a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=492-504&author=R.+Bergmannauthor=R.+Gericke&title=Synthesis+and+antihypertensive+activity+of+4-%281%2C2-dihydro-2-oxo-1-pyridyl%29-2H-1-benzopyrans+and+related+compounds%2C+new+potassium+channel+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70b&amp;dbid=16384&amp;doi=10.1021%2Fjm00164a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00164a005%26sid%3Dliteratum%253Aachs%26aulast%3DBergmann%26aufirst%3DR.%26aulast%3DGericke%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%25204-%25281%252C2-dihydro-2-oxo-1-pyridyl%2529-2H-1-benzopyrans%2520and%2520related%2520compounds%252C%2520new%2520potassium%2520channel%2520activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D492%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traeger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickinson, K. E. J.</span><span> </span><span class="NLM_article-title">Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970762d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=271-275&author=K.+S.+Atwalauthor=G.+J.+Groverauthor=N.+J.+Lodgeauthor=D.+E.+Normandinauthor=S.+C.+Traegerauthor=P.+G.+Slephauthor=R.+B.+Cohenauthor=C.+C.+Brysonauthor=K.+E.+J.+Dickinson&title=Binding+of+ATP-sensitive+potassium+channel+%28KATP%29+openers+to+cardiac+membranes%3A+correlation+of+binding+affinities+with+cardioprotective+and+smooth+muscle+relaxing+potencies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm970762d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970762d%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DNormandin%26aufirst%3DD.%2BE.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DCohen%26aufirst%3DR.%2BB.%26aulast%3DBryson%26aufirst%3DC.%2BC.%26aulast%3DDickinson%26aufirst%3DK.%2BE.%2BJ.%26atitle%3DBinding%2520of%2520ATP-sensitive%2520potassium%2520channel%2520%2528KATP%2529%2520openers%2520to%2520cardiac%2520membranes%253A%2520correlation%2520of%2520binding%2520affinities%2520with%2520cardioprotective%2520and%2520smooth%2520muscle%2520relaxing%2520potencies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D271%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1742-7843.2006.pto_295.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16918708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1egsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=91-95&author=C.+Sanchez&title=The+pharmacology+of+citalopram+enantiomers%3A+the+antagonism+by+R-citalopram+on+the+effect+of+S-citalopram"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram</span></div><div class="casAuthors">Sanchez, Connie</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-95</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent results on the in vivo and in vitro pharmacol. of escitalopram are summarized.  The exact mol. mechanism by which R-citalopram inhibits the effect of S-citalopram on the serotonin transporter remains to be elucidated.  Preliminary evidence indicates an effect of R-citalopram on the assocn. of escitalopram with the high affinity primary site, and on its dissocn. from the serotonin transporter, via an allosteric mechanism.  Escitalopram can be considered as an allosteric serotonin reuptake inhibitor.  This serotonin dual action in binding to two sites on the serotonin transporter (both the primary site and the allosteric site) is hypothesized to be responsible for a longer binding to, and therefore greater inhibition of the serotonin transporter by escitalopram.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYDiKuN86bVg90H21EOLACvtfcHk0lgxvI7PXDS5BQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1egsrk%253D&md5=7ab6c4f4549d521e3fb01a42621fc5e2</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2006.pto_295.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2006.pto_295.x%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DThe%2520pharmacology%2520of%2520citalopram%2520enantiomers%253A%2520the%2520antagonism%2520by%2520R-citalopram%2520on%2520the%2520effect%2520of%2520S-citalopram%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2006%26volume%3D99%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Koldso, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severinsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiborg, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinning, S.</span><span> </span><span class="NLM_article-title">The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">â</span> <span class="NLM_lpage">1322</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja906923j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=1311-1322&author=H.+Koldsoauthor=K.+Severinsenauthor=T.+T.+Tranauthor=L.+Celikauthor=H.+H.+Jensenauthor=O.+Wiborgauthor=B.+Schiottauthor=S.+Sinning&title=The+two+enantiomers+of+citalopram+bind+to+the+human+serotonin+transporter+in+reversed+orientations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fja906923j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja906923j%26sid%3Dliteratum%253Aachs%26aulast%3DKoldso%26aufirst%3DH.%26aulast%3DSeverinsen%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%2BT.%26aulast%3DCelik%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DH.%2BH.%26aulast%3DWiborg%26aufirst%3DO.%26aulast%3DSchiott%26aufirst%3DB.%26aulast%3DSinning%26aufirst%3DS.%26atitle%3DThe%2520two%2520enantiomers%2520of%2520citalopram%2520bind%2520to%2520the%2520human%2520serotonin%2520transporter%2520in%2520reversed%2520orientations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D1311%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Puchler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plenker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitanai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, P. U.</span><span> </span><span class="NLM_article-title">The pharmacokinetic profile of RS-8359</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">S11</span><span class="NLM_x">â</span> <span class="NLM_lpage">S16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1997&pages=S11-S16&author=K.+Puchlerauthor=K.+Sasaharaauthor=A.+Plenkerauthor=T.+Nitanaiauthor=P.+U.+Witte&title=The+pharmacokinetic+profile+of+RS-8359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuchler%26aufirst%3DK.%26aulast%3DSasahara%26aufirst%3DK.%26aulast%3DPlenker%26aufirst%3DA.%26aulast%3DNitanai%26aufirst%3DT.%26aulast%3DWitte%26aufirst%3DP.%2BU.%26atitle%3DThe%2520pharmacokinetic%2520profile%2520of%2520RS-8359%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1997%26volume%3D12%26spage%3DS11%26epage%3DS16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Takasaki, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitanai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span> </span><span class="NLM_article-title">Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug-metabolizing enzymes</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">â</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=135-141&author=W.+Takasakiauthor=M.+Yamamuraauthor=A.+Nozakiauthor=T.+Nitanaiauthor=K.+Sasaharaauthor=K.+Itohauthor=Y.+Tanaka&title=Stereoselective+pharmacokinetics+of+RS-8359%2C+a+selective+and+reversible+MAO-A+inhibitor%2C+by+species-dependent+drug-metabolizing+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakasaki%26aufirst%3DW.%26aulast%3DYamamura%26aufirst%3DM.%26aulast%3DNozaki%26aufirst%3DA.%26aulast%3DNitanai%26aufirst%3DT.%26aulast%3DSasahara%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DStereoselective%2520pharmacokinetics%2520of%2520RS-8359%252C%2520a%2520selective%2520and%2520reversible%2520MAO-A%2520inhibitor%252C%2520by%2520species-dependent%2520drug-metabolizing%2520enzymes%26jtitle%3DChirality%26date%3D2005%26volume%3D17%26spage%3D135%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span> </span><span class="NLM_article-title">Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">â</span> <span class="NLM_lpage">706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=698-706&author=K.+Itohauthor=K.+Hoshinoauthor=A.+Endoauthor=T.+Asakawaauthor=K.+Yamakamiauthor=C.+Nojiauthor=T.+Kosakaauthor=Y.+Tanaka&title=Chiral+inversion+of+RS-8359%3A+a+selective+and+reversible+MAO-A+inhibitor+via+oxido-reduction+of+keto-alcohol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DA.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DYamakami%26aufirst%3DK.%26aulast%3DNoji%26aufirst%3DC.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DChiral%2520inversion%2520of%2520RS-8359%253A%2520a%2520selective%2520and%2520reversible%2520MAO-A%2520inhibitor%2520via%2520oxido-reduction%2520of%2520keto-alcohol%26jtitle%3DChirality%26date%3D2006%26volume%3D18%26spage%3D698%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Khan, A.</span><span> </span><span class="NLM_article-title">Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">â</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1753-1764&author=A.+Khan&title=Vilazodone%2C+a+novel+dual-acting+serotonergic+antidepressant+for+managing+major+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%26atitle%3DVilazodone%252C%2520a%2520novel%2520dual-acting%2520serotonergic%2520antidepressant%2520for%2520managing%2520major%2520depression%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D1753%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Heinrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boettcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gericke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfried, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Amsterdam, C.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationship in a class of indolebutylpiperazines as dual 5-HT1A receptor agonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4684</span><span class="NLM_x">â</span> <span class="NLM_lpage">4692</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040793q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4684-4692&author=T.+Heinrichauthor=H.+Boettcherauthor=R.+Gerickeauthor=G.+D.+Bartoszykauthor=S.+Anzaliauthor=C.+A.+Seyfriedauthor=H.+E.+Greinerauthor=C.+van+Amsterdam&title=Synthesis+and+structure%E2%88%92activity+relationship+in+a+class+of+indolebutylpiperazines+as+dual+5-HT1A+receptor+agonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm040793q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040793q%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DBoettcher%26aufirst%3DH.%26aulast%3DGericke%26aufirst%3DR.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26aulast%3DAnzali%26aufirst%3DS.%26aulast%3DSeyfried%26aufirst%3DC.%2BA.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3Dvan%2BAmsterdam%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520in%2520a%2520class%2520of%2520indolebutylpiperazines%2520as%2520dual%25205-HT1A%2520receptor%2520agonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4684%26epage%3D4692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, M. S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loudon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlek, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span> </span><span class="NLM_article-title">Design of [<i>R</i>-(<i>Z</i>)]-(+)-Î±-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the <i>N</i>-methoxyimidoyl nitrile group as a novel ester bioisostere</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4265</span><span class="NLM_x">â</span> <span class="NLM_lpage">4280</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9702903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4265-4280&author=S.+M.+Bromidgeauthor=F.+Brownauthor=F.+Cassidyauthor=M.+S.+G.+Clarkauthor=S.+Dabbsauthor=M.+S.+Hadleyauthor=J.+Hawkinsauthor=J.+M.+Loudonauthor=C.+B.+Naylorauthor=B.+S.+Orlekauthor=G.+J.+Riley&title=Design+of+%5BR-%28Z%29%5D-%28%2B%29-%CE%B1-%28methoxyimino%29-1-azabicyclo%5B2.2.2%5Doctane-3-acetonitrile+%28SB+202026%29%2C+a+functionally+selective+azabicyclic+muscarinic+M1+agonist+incorporating+the+N-methoxyimidoyl+nitrile+group+as+a+novel+ester+bioisostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm9702903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9702903%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBrown%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DF.%26aulast%3DClark%26aufirst%3DM.%2BS.%2BG.%26aulast%3DDabbs%26aufirst%3DS.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DLoudon%26aufirst%3DJ.%2BM.%26aulast%3DNaylor%26aufirst%3DC.%2BB.%26aulast%3DOrlek%26aufirst%3DB.%2BS.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26atitle%3DDesign%2520of%2520%255BR-%2528Z%2529%255D-%2528%252B%2529-%25CE%25B1-%2528methoxyimino%2529-1-azabicyclo%255B2.2.2%255Doctane-3-acetonitrile%2520%2528SB%2520202026%2529%252C%2520a%2520functionally%2520selective%2520azabicyclic%2520muscarinic%2520M1%2520agonist%2520incorporating%2520the%2520N-methoxyimidoyl%2520nitrile%2520group%2520as%2520a%2520novel%2520ester%2520bioisostere%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4265%26epage%3D4280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Vialla, A.</span><span> </span><span class="NLM_article-title">Propericiazine (Neuleptil), chemistry, and pharmacology</span> <span class="citation_source-journal">Encephale</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFGktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1969&pages=3-7&author=A.+Vialla&title=Propericiazine+%28Neuleptil%29%2C+chemistry%2C+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Propericiazine (Neuleptil), chemistry, and pharmacology</span></div><div class="casAuthors">Vialla, A.</div><div class="citationInfo"><span class="NLM_cas:title">Encephale</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3-7</span>CODEN:
                <span class="NLM_cas:coden">ENCEAN</span>;
        ISSN:<span class="NLM_cas:issn">0013-7006</span>.
    </div><div class="casAbstract">A summary of available information on 8909 R.P. (propericiazine) regarding chem. structure, phys. props., metabolism, pharmacol., toxicol., and human tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NlBODZpMS7Vg90H21EOLACvtfcHk0lhEbcPmNkyw_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFGktQ%253D%253D&md5=f03739bb835201fffc4a94c813dc37d0</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVialla%26aufirst%3DA.%26atitle%3DPropericiazine%2520%2528Neuleptil%2529%252C%2520chemistry%252C%2520and%2520pharmacology%26jtitle%3DEncephale%26date%3D1969%26volume%3D58%26spage%3D3%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Favre, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubin, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frija-Orvoen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejoyeux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Acosta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermadi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span> </span><span class="NLM_article-title">Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome</span> <span class="citation_source-journal">Hum. Psychopharmacol. Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">â</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fhup.718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16118830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2qsL3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=511-519&author=J.-D.+Favreauthor=H.+Allainauthor=H.-J.+Aubinauthor=E.+Frija-Orvoenauthor=C.+Gilletauthor=M.+Lejoyeuxauthor=A.+Payenauthor=M.+Weberauthor=S.+Garcia-Acostaauthor=I.+Kermadiauthor=M.+Dib&title=Double-blind+study+of+cyamemazine+and+diazepam+in+the+alcohol+withdrawal+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81aR"><div class="casContent"><span class="casTitleNuber">81a</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome</span></div><div class="casAuthors">Favre, Jean-Daniel; Allain, Herve; Aubin, Henri-Jean; Frija-Orvoen, Elizabeth; Gillet, Claudine; Lejoyeux, Michel; Payen, Alain; Weber, Michel; Garcia-Acosta, Stephanie; Kermadi, Imane; Dib, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">511-519</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objective Cyamemazine is an original phenothiazine deriv. which showed similar efficacy and tolerability to lorazepam during ethanol withdrawal in mice.  This study investigated cyamemazine for its efficacy and tolerability in alc.-dependent patients electing an alc. withdrawal procedure, in comparison with diazepam.  Method A multicenter, randomized, double-blind study in 89 alc.-dependent patients (CIWA-Ar score between 10 and 30), electing an alc. withdrawal procedure, was used to find EDs of cyamemazine and to compare it with diazepam for efficacy and tolerability.  On day 1 (D1), cyamemazine or diazepam (50 mg and 10 mg capsule, resp.) were administered at hourly intervals to reduce CIWA-Ar = 5, up to a max. of eight administrations.  Starting from D2, the compds. were given twice a day in progressively decreasing doses during a max. period of 13 days (Dend).  Results At h8 (8 h after the first treatment of D1), therapeutic success (CIWA-Ar score â¤ 5) was achieved in 32 out of 43 ITT patients treated with cyamemazine (74.4%), a value very similar to that of diazepam (32/44; 72.7%).  Most such patients (29/32) were controlled with 2-6 capsules of cyamemazine (100-300 mg).  In the PP population, cyamemazine (n = 28) was significantly non-inferior to diazepam (n = 33), with a threshold of 10% for non-inferiority bound and 2.5% for one-sided type I error rate.  Such therapeutic similarity was confirmed by the anal. of other efficacy criteria.  Safety anal. did not show substantial differences between the two treatments.  Conclusions Cyamemazine showed similar efficacy and tolerability to diazepam for the treatment of alc. withdrawal symptoms at therapeutic doses in the range 100-300 mg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo22g6qHFCNrVg90H21EOLACvtfcHk0lhEbcPmNkyw_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2qsL3P&md5=5d6a1e28f677c3da42ac8a1b66a3a83d</span></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1002%2Fhup.718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhup.718%26sid%3Dliteratum%253Aachs%26aulast%3DFavre%26aufirst%3DJ.-D.%26aulast%3DAllain%26aufirst%3DH.%26aulast%3DAubin%26aufirst%3DH.-J.%26aulast%3DFrija-Orvoen%26aufirst%3DE.%26aulast%3DGillet%26aufirst%3DC.%26aulast%3DLejoyeux%26aufirst%3DM.%26aulast%3DPayen%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DGarcia-Acosta%26aufirst%3DS.%26aulast%3DKermadi%26aufirst%3DI.%26aulast%3DDib%26aufirst%3DM.%26atitle%3DDouble-blind%2520study%2520of%2520cyamemazine%2520and%2520diazepam%2520in%2520the%2520alcohol%2520withdrawal%2520syndrome%26jtitle%3DHum.%2520Psychopharmacol.%2520Clin.%2520Exp.%26date%3D2005%26volume%3D20%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lemoine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermadi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Acosta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garay, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dib, M.</span><span> </span><span class="NLM_article-title">Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.pnpbp.2005.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16243418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGls7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=131-137&author=P.+Lemoineauthor=I.+Kermadiauthor=S.+Garcia-Acostaauthor=R.+P.+Garayauthor=M.+Dib&title=Double-blind%2C+comparative+study+of+cyamemazine+vs.+bromazepam+in+the+benzodiazepine+withdrawal+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome</span></div><div class="casAuthors">Lemoine, Patrick; Kermadi, Imane; Garcia-Acosta, Stephanie; Garay, Ricardo P.; Dib, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-137</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyamemazine is an anxiolytic antipsychotic, which reduces ethanol withdrawal symptoms.  Here, we investigated if cyamemazine can be also effective as substitute drug to facilitate benzodiazepine withdrawal.  A total of 168 patients treated with benzodiazepines for at least 3 mo and with a < 18 score in the Hamilton Anxiety Rating Scale (HARS) were included in the study.  Previous benzodiazepine treatment was withdrawn, and patients were randomized to a 4-wk treatment with cyamemazine (25-50 mg q.d.) or bromazepam (3-6 mg q.d.), followed by 2 wk of placebo.  The primary efficacy variable was the maximal anxiety rebound as measured with the HARS during the 42 days of treatment.  No statistically significant differences between treatment groups were found for the extent or incidence of rebound anxiety.  Considering all dropout patients as withdrawal failures, after 6 mo of follow-up, 56/84 patients in the cyamemazine group (66.7%) and 55/84 patients in the bromazepam group (65.5%) were successfully withdrawn. 28 patients in the cyamemazine group and 18 in the bromazepam group had an adverse event, including anxiety, insomnia, dry mouth and somnolence.  No extra-pyramidal symptoms were reported.  In conclusion, cyamemazine was comparable to bromazepam in ensuring successful benzodiazepine withdrawal and in controlling the acute benzodiazepine withdrawal syndrome.  Cyamemazine may be useful to facilitate benzodiazepine withdrawal in those patients where bromazepam substitution is not appropriate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdpkcTEVaqUbVg90H21EOLACvtfcHk0lgaxK_9x6pmTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGls7rL&md5=b40bd0cd8cbe1ada7ebb16d4012b825f</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2005.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2005.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DLemoine%26aufirst%3DP.%26aulast%3DKermadi%26aufirst%3DI.%26aulast%3DGarcia-Acosta%26aufirst%3DS.%26aulast%3DGaray%26aufirst%3DR.%2BP.%26aulast%3DDib%26aufirst%3DM.%26atitle%3DDouble-blind%252C%2520comparative%2520study%2520of%2520cyamemazine%2520vs.%2520bromazepam%2520in%2520the%2520benzodiazepine%2520withdrawal%2520syndrome%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2006%26volume%3D30%26spage%3D131%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Patat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paty, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindmarch, I.</span><span> </span><span class="NLM_article-title">Pharmacodynamic profile of zaleplon, a new non-benzodiazepine hypnotic agent</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">â</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fhup.310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12404558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms1Srsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=369-392&author=A.+Patatauthor=I.+Patyauthor=I.+Hindmarch&title=Pharmacodynamic+profile+of+zaleplon%2C+a+new+non-benzodiazepine+hypnotic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic profile of zaleplon, a new non-benzodiazepine hypnotic agent</span></div><div class="casAuthors">Patat, Alain; Paty, Isabelle; Hindmarch, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">369-392</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The challenge in developing hypnotic agents for the treatment of insomnia is to balance the sedative effect needed at bedtime with the residual sedation on awakening.  Zaleplon is a novel pyrazolopyrimidine hypnotic agent that acts as a selective agonist to the brain omega receptor situated on the alpha subunit of the GABA A receptor complex.  Zaleplon was proven to be an effective hypnotic drug as it consistently and significantly reduced latency to persistent sleep in insomniac patients for doses of 10 mg and above in polysomnog. studies.  The pharmacodynamic profile of zaleplon on psychomotor performance, actual driving and cognitive function, including memory, was assessed in several randomized, double-blind, placebo-controlled studies in healthy young subjects as well as insomniac patients by using various pos. controls (zolpidem, zopiclone, triazolam and flurazepam).  The recommended hypnotic dose of zaleplon in young adults (10 mg) produced minimal or no impairment of psychomotor and memory performance even when administered during the night as little as 1 h before waking.  No impairment of actual driving was obsd. when zaleplon 10 mg was administered either at bedtime or in the middle of the night as little as 4 h before waking.  Zaleplon 20 mg, twice the recommended dose, generally produced significant impairment of performance and cognitive functions when these functions were measured at the time of peak plasma concn., i.e. 1 h after dose administration, and no impairment of driving abilities was obsd. 4 h after a middle-of-the-night administration.  In contrast, consistent detrimental residual effects on various aspects of psychomotor and cognitive functions were obsd. with the therapeutic doses of the various commonly prescribed hypnotic agents used as comparators, e.g. zolpidem 10 mg up to 5 h after dose administration, zopiclone 7.5 mg up to 10 h after, flurazepam 30 mg up to 14 h after and triazolam 0.25 mg up to 6 h after.  Also, zolpidem 10 mg and zopiclone 7.5 mg were also shown to significantly impair driving ability the next morning when this was measured 4 h and up to 10 h after dose administration, resp.  The present review shows that zaleplon 10 mg has little or no residual effect when administered in the middle of the night, as late as 1 h before waking, and is devoid of impairment of driving abilities as assessed by actual driving 4 h after dose administration.  The lack of clin. significant or minimally statistically significant residual effects of zaleplon even at its peak concn. may be explained by its unique pharmacokinetic (rapid elimination half-life) and pharmacodynamic (low affinity, and specific binding profile to various subunits of the GABAA receptor) profiles.  These properties allow zaleplon to be used for treatment of symptoms only when they occur, either at bedtime or later in the night, without incurring significant risk of developing next-day impairment of psychomotor and cognitive functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEZhhQtQTkd7Vg90H21EOLACvtfcHk0lgaxK_9x6pmTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms1Srsrg%253D&md5=32568e09ff25802d0d14b22e39e5ba95</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fhup.310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhup.310%26sid%3Dliteratum%253Aachs%26aulast%3DPatat%26aufirst%3DA.%26aulast%3DPaty%26aufirst%3DI.%26aulast%3DHindmarch%26aufirst%3DI.%26atitle%3DPharmacodynamic%2520profile%2520of%2520zaleplon%252C%2520a%2520new%2520non-benzodiazepine%2520hypnotic%2520agent%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2001%26volume%3D16%26spage%3D369%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Sanger, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrault, G.</span><span> </span><span class="NLM_article-title">Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0014-2999%2896%2900510-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=8905326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK28XmtV2jt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=1996&pages=35-42&author=D.+J.+Sangerauthor=E.+Morelauthor=G.+Perrault&title=Comparison+of+the+pharmacological+profiles+of+the+hypnotic+drugs%2C+zaleplon+and+zolpidem"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem</span></div><div class="casAuthors">Sanger, David J.; Morel, Eliane; Perrault, Ghislaine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The BZ1 (Ï1)-selective compd., zolpidem, is a clin. effective hypnotic drug with a pharmacol. profile which differs from those of benzodiazepine anxiolytics and hypnotics.  Zaleplon (CL 284,846) has recently been described as a hypnotic agent which also has BZ1 (Ï1) receptor selectivity.  The pharmacol. effects of zolpidem and zaleplon were therefore compared in mice and rats.  Both drugs blocked tonic convulsions induced in mice by pentylenetetrazole and electroconvulsive shock and clonic convulsions induced by isoniazid.  Zaleplon was more potent than zolpidem but the maximal effect of zolpidem for increasing the latency to isoniazid-induced convulsions was greater than that of zaleplon.  Little tolerance developed to the anticonvulsant effect of zaleplon against isoniazid-induced seizures following twice daily administration of 10 or 30 mg/kg for 10 days.  Both compds. reduced locomotor activity and produced motor deficits in the rotarod and loaded grid tests in mice.  However, while zaleplon produced all three effects at similar doses, zolpidem showed the greatest potency for reducing locomotion.  Zaleplon and zolpidem also decreased locomotion and produced a rotarod deficit in rats.  Again, the difference between the doses giving rise to these two effects was greater for zolpidem than for zaleplon.  In a drug discrimination procedure using rats trained to discriminate a dose (5 mg/kg) of chlordiazepoxide, zaleplon produced partial substitution for chlordiazepoxide at doses which greatly reduced response rates.  These results show that zaleplon and zolpidem have similar pharmacol. profiles, presumably related to their BZ1 (Ï 1) receptor selectivity.  However, the difference between doses producing motor deficits (rotarod, loaded grid) and those giving rise to other effects (anticonvulsant, decreased locomotion) was greater for zolpidem than for zaleplon.  This difference may be related to a greater in vivo intrinsic activity of zolpidem as indicated by the different efficacies of the two drugs to antagonize isoniazid-induced convulsions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrStY2JEXGKIbVg90H21EOLACvtfcHk0lgaxK_9x6pmTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtV2jt7s%253D&md5=ab5173b02670dc20786d1341f290c739</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900510-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900510-9%26sid%3Dliteratum%253Aachs%26aulast%3DSanger%26aufirst%3DD.%2BJ.%26aulast%3DMorel%26aufirst%3DE.%26aulast%3DPerrault%26aufirst%3DG.%26atitle%3DComparison%2520of%2520the%2520pharmacological%2520profiles%2520of%2520the%2520hypnotic%2520drugs%252C%2520zaleplon%2520and%2520zolpidem%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D313%26spage%3D35%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Munoz-Islas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Mena, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano-Cuenca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lopez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centurion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehrotra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MaassenVanDenBrink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalon, C. M.</span><span> </span><span class="NLM_article-title">Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">â</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fsj.bjp.0706839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16880765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos12msro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=82-91&author=E.+Munoz-Islasauthor=S.+Guptaauthor=L.+R.+Jimenez-Menaauthor=J.+Lozano-Cuencaauthor=A.+Sanchez-Lopezauthor=D.+Centurionauthor=S.+Mehrotraauthor=A.+MaassenVanDenBrinkauthor=C.+M.+Villalon&title=Donitriptan%2C+but+not+sumatriptan%2C+inhibits+capsaicin-induced+canine+external+carotid+vasodilatation+via+5-HT1B+rather+than+5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors</span></div><div class="casAuthors">Munoz-Islas, E.; Gupta, S.; Jimenez-Mena, L. R.; Lozano-Cuenca, J.; Sanchez-Lopez, A.; Centurion, D.; Mehrotra, S.; MaassenVanDenBrink, A.; Villalon, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-91</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It has been suggested that during a migraine attack capsaicin-sensitive trigeminal sensory nerves release calcitonin gene-related peptide (CGRP), resulting in cranial vasodilatation and central nociception; hence, trigeminal inhibition may prevent this vasodilatation and abort migraine headache.  This study investigated the effects of the agonists sumatriptan (5-HT1B/1D water-sol.), donitriptan (5-HT1B/1D lipid-sol.), PNU-142633 (5-HT1D water-sol.) and PNU-109291 (5-HT1D lipid-sol.) on vasodilator responses to capsaicin, Î±-CGRP and acetylcholine in dog external carotid artery.  Exptl. approach: 59 vagosympathectomized dogs were anesthetized with sodium pentobarbitone.  Blood pressure and heart rate were recorded with a pressure transducer, connected to a cannula inserted into a femoral artery.  A precalibrated flow probe was placed around the common carotid artery, with ligation of the internal carotid and occipital branches, and connected to an ultrasonic flowmeter.  The thyroid artery was cannulated for infusion of agonists.  Intracarotid infusions of capsaicin, Î±-CGRP and acetylcholine dose-dependently increased blood flow through the carotid artery.  These responses remained unaffected after i.v. infusions of sumatriptan, PNU-142633, PNU-109291 or physiol. saline; in contrast, donitriptan significantly attenuated the vasodilator responses to capsaicin, but not those to Î±-CGRP or acetylcholine.  Only sumatriptan and donitriptan dose-dependently decreased the carotid blood flow.  Interestingly, i.v. administration of the antagonist, SB224289 (5-HT1B), but not of BRL15572 (5-HT1D), abolished the inhibition by donitriptan.  Our results suggest that the inhibition produced by donitriptan of capsaicin-induced external carotid vasodilatation is mainly mediated by 5-HT1B, rather than 5-HT1D, receptors, probably by a central mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0WlWWrUIx4rVg90H21EOLACvtfcHk0lhmHqe8GfLsOA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos12msro%253D&md5=31bb6cdac12dc4caff3ba7ba147ebdb8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706839%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Islas%26aufirst%3DE.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DJimenez-Mena%26aufirst%3DL.%2BR.%26aulast%3DLozano-Cuenca%26aufirst%3DJ.%26aulast%3DSanchez-Lopez%26aufirst%3DA.%26aulast%3DCenturion%26aufirst%3DD.%26aulast%3DMehrotra%26aufirst%3DS.%26aulast%3DMaassenVanDenBrink%26aufirst%3DA.%26aulast%3DVillalon%26aufirst%3DC.%2BM.%26atitle%3DDonitriptan%252C%2520but%2520not%2520sumatriptan%252C%2520inhibits%2520capsaicin-induced%2520canine%2520external%2520carotid%2520vasodilatation%2520via%25205-HT1B%2520rather%2520than%25205-HT1D%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D82%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verscheure, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, G. W.</span><span> </span><span class="NLM_article-title">Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: further insights into its mechanism of action relevant to headache relief</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">â</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1124%2Fjpet.102.047225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12606602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt12lsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=749-754&author=R.+Letienneauthor=Y.+Verscheureauthor=M.+Perezauthor=B.+Le+Grandauthor=F.+C.+Colpaertauthor=G.+W.+John&title=Donitriptan+selectively+decreases+jugular+venous+oxygen+saturation+in+the+anesthetized+pig%3A+further+insights+into+its+mechanism+of+action+relevant+to+headache+relief"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: Further insights into its mechanism of action relevant to headache relief</span></div><div class="casAuthors">Letienne, Robert; Verscheure, Yvan; Perez, Michel; Le Grand, Bruno; Colpaert, Francis C.; John, Gareth W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">749-754</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of donitriptan on systemic arterial-jugular venous oxygen satn. difference were evaluated in pentobarbitone-anesthetized pigs.  Oxygen and carbon dioxide partial pressures in systemic arterial and jugular venous blood as well as Hb oxygen satn. were detd. by conventional blood gas anal.  Vehicle (40% polyethyleneglycol in saline, n = 9) or donitriptan (0.01, 0.04, 0.16, 0.63, 2.5, 10, and 40 Î¼g/kg, n = 7) were cumulatively infused over 15 min/dose.  The involvement of 5-hydroxytryptamine1B (5-HT1B) receptors was assessed in the presence of the 5-HT1B/1D receptor antagonist, GR 127935.  Donitriptan decreased markedly and dose dependently jugular venous oxygen satn. [ED50 0.5 (0.3-1.1) Î¼g/kg], in parallel with increases in carotid vascular resistance [ED50 0.9 (0.7-1.1) Î¼g/kg].  Since arterial oxygen satn. and partial pressure remained unchanged, donitriptan significantly increased arteriovenous oxygen satn. difference from 0.63 Î¼g/kg (maximal variation: 57Â±18%, P < 0.05 compared with vehicle).  Unexpectedly, donitriptan from 2.5 Î¼g/kg induced marked and significant increases in carbon dioxide partial pressure (pVCO2) in venous blood (maximal increase 18.8Â±5.7%; P < 0.05 compared with vehicle).  Pretreatment with GR 127935 (0.63 mg/kg, n = 5) abolished the fall in venous oxygen satn. and the increase in carotid vascular resistance and reduced the increases in pVCO2 induced by donitriptan.  The results demonstrate that donitriptan, via 5-HT1B receptor activation, decreases the oxygen satn. of venous blood draining the head, concomitantly with cranial vasoconstriction.  Since donitriptan also increased pVCO2, an effect upon cerebral oxygen consumption and metab. is suggested in addn. to cranial vasoconstriction, which may be relevant to its headache-relieving effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLrcnmGaVoV7Vg90H21EOLACvtfcHk0lhmHqe8GfLsOA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt12lsro%253D&md5=709486177f70bd841fa3dc4b9ab2c5f2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.047225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.047225%26sid%3Dliteratum%253Aachs%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DVerscheure%26aufirst%3DY.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26aulast%3DJohn%26aufirst%3DG.%2BW.%26atitle%3DDonitriptan%2520selectively%2520decreases%2520jugular%2520venous%2520oxygen%2520saturation%2520in%2520the%2520anesthetized%2520pig%253A%2520further%2520insights%2520into%2520its%2520mechanism%2520of%2520action%2520relevant%2520to%2520headache%2520relief%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D749%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Mehellou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Twenty-six years of anti-HIV drug discovery: Where do we stand and where do we go?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">â</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900492g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=521-538&author=Y.+Mehellouauthor=E.+De+Clercq&title=Twenty-six+years+of+anti-HIV+drug+discovery%3A+Where+do+we+stand+and+where+do+we+go%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm900492g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900492g%26sid%3Dliteratum%253Aachs%26aulast%3DMehellou%26aufirst%3DY.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DTwenty-six%2520years%2520of%2520anti-HIV%2520drug%2520discovery%253A%2520Where%2520do%2520we%2520stand%2520and%2520where%2520do%2520we%2520go%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D521%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Hughes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, R. D.</span><span> </span><span class="NLM_article-title">New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2445</span><span class="NLM_x">â</span> <span class="NLM_lpage">2466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1517%2F14656560903176446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19678794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCgsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2445-2466&author=C.+A.+Hughesauthor=L.+Robinsonauthor=A.+Tsengauthor=R.+D.+MacArthur&title=New+antiretroviral+drugs%3A+a+review+of+the+efficacy%2C+safety%2C+pharmacokinetics%2C+and+resistance+profile+of+tipranavir%2C+darunavir%2C+etravirine%2C+rilpivirine%2C+maraviroc%2C+and+raltegravir"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir</span></div><div class="casAuthors">Hughes, Christine A.; Robinson, Linda; Tseng, Alice; MacArthur, Rodger D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2445-2466</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The introduction and approval of new antiretroviral agents in the US and Canada bring new opportunities and new challenges.  Arguably, for the first time ever, clinicians have the drugs necessary to achieve the goal of suppressing HIV RNA to levels less than 50 copies/mL in even the most treatment-experienced patients and in those with extensive drug-limiting resistance mutations.  However, the use of these new agents is complicated by many drug-drug interactions and - to some extent - pre-existing mutations.  To derive max. durability from the use of these newer drugs, a thorough understanding of their indications and limitations is crit.  To thoroughly review the six most recently approved or soon-to-be-approved antiretroviral drugs in the US and Canada: tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.  Discussion of the indications for, and pharmacokinetics, resistance profile, activity, toxicity, and clin. trials results of, the six new agents.  These six new agents have resulted in marked progress towards the goal of being able to provide HIV-infected individuals with the drugs necessary to achieve decades of durable suppression of HIV without substantial toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TA0zt9ijibVg90H21EOLACvtfcHk0lhmHqe8GfLsOA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCgsrbI&md5=f8193ed818b0304dbb718b8668fe9170</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1517%2F14656560903176446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903176446%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DC.%2BA.%26aulast%3DRobinson%26aufirst%3DL.%26aulast%3DTseng%26aufirst%3DA.%26aulast%3DMacArthur%26aufirst%3DR.%2BD.%26atitle%3DNew%2520antiretroviral%2520drugs%253A%2520a%2520review%2520of%2520the%2520efficacy%252C%2520safety%252C%2520pharmacokinetics%252C%2520and%2520resistance%2520profile%2520of%2520tipranavir%252C%2520darunavir%252C%2520etravirine%252C%2520rilpivirine%252C%2520maraviroc%252C%2520and%2520raltegravir%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D2445%26epage%3D2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nuttall, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thake, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferkany, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchnick, M. A.</span><span> </span><span class="NLM_article-title">Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [<sup>14</sup>C]dapivirine for 7 days</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">â</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=909-914&author=J.+P.+Nuttallauthor=D.+C.+Thakeauthor=M.+G.+Lewisauthor=J.+W.+Ferkanyauthor=J.+W.+Romanoauthor=M.+A.+Mitchnick&title=Concentrations+of+dapivirine+in+the+rhesus+macaque+and+rabbit+following+once+daily+intravaginal+administration+of+a+gel+formulation+of+%5B14C%5Ddapivirine+for+7+days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNuttall%26aufirst%3DJ.%2BP.%26aulast%3DThake%26aufirst%3DD.%2BC.%26aulast%3DLewis%26aufirst%3DM.%2BG.%26aulast%3DFerkany%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BW.%26aulast%3DMitchnick%26aufirst%3DM.%2BA.%26atitle%3DConcentrations%2520of%2520dapivirine%2520in%2520the%2520rhesus%2520macaque%2520and%2520rabbit%2520following%2520once%2520daily%2520intravaginal%2520administration%2520of%2520a%2520gel%2520formulation%2520of%2520%255B14C%255Ddapivirine%2520for%25207%2520days%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit88b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Herrewege, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michiels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Roey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kestens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P.</span><span> </span><span class="NLM_article-title">In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">â</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=337-339&author=Y.+Van+Herrewegeauthor=J.+Michielsauthor=J.+Van+Roeyauthor=K.+Fransenauthor=L.+Kestensauthor=J.+Balzariniauthor=P.+Lewiauthor=G.+Vanhamauthor=P.+Janssen&title=In+vitro+evaluation+of+nonnucleoside+reverse+transcriptase+inhibitors+UC-781+and+TMC120-R147681+as+human+immunodeficiency+virus+microbicides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHerrewege%26aufirst%3DY.%26aulast%3DMichiels%26aufirst%3DJ.%26aulast%3DVan%2BRoey%26aufirst%3DJ.%26aulast%3DFransen%26aufirst%3DK.%26aulast%3DKestens%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DLewi%26aufirst%3DP.%26aulast%3DVanham%26aufirst%3DG.%26aulast%3DJanssen%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitors%2520UC-781%2520and%2520TMC120-R147681%2520as%2520human%2520immunodeficiency%2520virus%2520microbicides%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D337%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Emerging anti-HIV drugs</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">â</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1517%2F14728214.10.2.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15934866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=241-274&author=E.+De+Clercq&title=Emerging+anti-HIV+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging anti-HIV drugs</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-274</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There are now exactly 20 anti-HIV drugs licenced (approved) for clin. use, and > 30 anti-HIV compds. under (pre)clin. development.  The licenced anti-HIV drugs fall into five categories: nucleoside reverse transcriptase inhibitors (NRTIs: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir and emtricitabine); nucleotide reverse transcriptase inhibitors (NtRTIs: tenofovir disproxil fumarate); non-nucleoside reverse transcriptase inhibitors (NNRTIs: nevirapine, delavirdine and efavirenz); protease inhibitors (PIs: saquinavir, indinavir, ritonavir, nelfinavir, amprenavir, lopinavir, atazanavir and fosamprenavir); and fusion inhibitors (FIs: enfuvirtide).  The compds. that are currently under clin. (Phase I, II or III) or preclin. investigation are either targeted at the same specific viral proteins as the licenced compds. (i.e., reverse transcriptase [NRTIs: PSI-5004, (-)-dOTC, DPC-817, elvucitabine, alovudine, MIV-210, amdoxovir, DOT; NNRTIs: thiocarboxanilide, UC-781, capravirine, dapivirine, etravirine, rilpivirine], protease [PIs: tipranavir, TMC-114]) or other specific viral proteins (i.e., gp120: cyanovirin N; attachment inhibitors: Als, such as BMS-488043; integrase: L-870,812, PDPV-165; capsid proteins: PA-457, Î±-HCG); or cellular proteins (CD4 down-modulators: CADAs; CXCR4 antagonists: AMD-070, CS-3955; CCR5 antagonists: TAK-220, SCH-D, AK-602, UK-427857).  Combination therapy is likely to remain the gold std. for the treatment of AIDS so as to maximize potency, minimize toxicity and diminish the risk for resistance development.  Ideally, pill burden should be reduced to once-daily dosing so as to optimize the patient's compliance and reduce the treatment costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxT0HJuG64arVg90H21EOLACvtfcHk0lhdKr8cfUccYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVygs7c%253D&md5=8b3186fe7585205c72c9bb25c6493382</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.2.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.2.241%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DEmerging%2520anti-HIV%2520drugs%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D241%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors</span> <span class="citation_source-journal">Prog. Biophys. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.pbiomolbio.2004.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15572156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVahu7bJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=209-231&author=K.+Dasauthor=P.+J.+Lewiauthor=S.+H.+Hughesauthor=E.+Arnold&title=Crystallography+and+the+design+of+anti-AIDS+drugs%3A+conformational+flexibility+and+positional+adaptability+are+important+in+the+design+of+non-nucleoside+HIV-1+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors</span></div><div class="casAuthors">Das, Kalyan; Lewi, Paul J.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-231</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug resistance is a key cause of failure for treatment of HIV infection.  The efficacy of non-nucleoside reverse transcriptase inhibiting (NNRTI) drugs is impaired by rapid emergence of drug-resistance mutations.  A multidisciplinary effort led to the discovery of the potent NNRTIs dapivirine and etravirine, both of which are diarylpyrimidine (DAPY) derivs.  Systematic structural and mol. modeling studies of HIV-1 reverse transcriptase (RT)/NNRTI complexes revealed different modes of inhibitor binding, and some of the DAPY inhibitors can bind to RT in different conformations.  The torsional flexibility ("wiggling") of the inhibitors can generate numerous conformational variants and the compactness of the inhibitors permits significant repositioning and reorientation (translation and rotation) within the pocket ("jiggling").  Such adaptations appear to be crit. for the ability of the diarylpyrimidine NNRTIs to retain their potency against a wide range of drug-resistant HIV-1 RTs.  Exploitation of inhibitor conformational flexibility (such as torsional flexibility about strategically located chem. bonds) can be a powerful element of drug design, esp. for the design of drugs that will be effective against rapidly mutating targets (which is a collection of related targets).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHOTy1wHSn77Vg90H21EOLACvtfcHk0lhdKr8cfUccYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVahu7bJ&md5=8a99e29ecdfd6e630e8c2ec6363b3618</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2004.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2004.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DK.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DCrystallography%2520and%2520the%2520design%2520of%2520anti-AIDS%2520drugs%253A%2520conformational%2520flexibility%2520and%2520positional%2520adaptability%2520are%2520important%2520in%2520the%2520design%2520of%2520non-nucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D88%26spage%3D209%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jonge, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koymans, L. M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daeyaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludovici, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Corte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavash, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de BÃ©thune, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2550</span><span class="NLM_x">â</span> <span class="NLM_lpage">2560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030558s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisl2it70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2550-2560&author=K.+Dasauthor=A.+D.+Clarkauthor=P.+J.+Lewiauthor=J.+Heeresauthor=M.+R.+De+Jongeauthor=L.+M.+H.+Koymansauthor=H.+M.+Vinkersauthor=F.+Daeyaertauthor=D.+W.+Ludoviciauthor=M.+J.+Kuklaauthor=B.+De+Corteauthor=R.+W.+Kavashauthor=C.+Y.+Hoauthor=H.+Yeauthor=M.+A.+Lichtensteinauthor=K.+Andriesauthor=R.+Pauwelsauthor=M.+P.+de+B%C3%A9thuneauthor=P.+L.+Boyerauthor=P.+Clarkauthor=S.+H.+Hughesauthor=P.+A.+J.+Janssenauthor=E.+Arnold&title=Roles+of+conformational+and+positional+adaptability+in+structure-based+design+of+TMC125-R165335+%28etravirine%29+and+related+non-nucleoside+reverse+transcriptase+inhibitors+that+are+highly+potent+and+effective+against+wild-type+and+drug-resistant+HIV-1+variants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (Etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants</span></div><div class="casAuthors">Das, Kalyan; Clark, Arthur D., Jr.; Lewi, Paul J.; Heeres, Jan; De Jonge, Marc R.; Koymans, Lucien M. H.; Vinkers, H. Maarten; Daeyaert, Frederik; Ludovici, Donald W.; Kukla, Michael J.; De Corte, Bart; Kavash, Robert W.; Ho, Chih Y.; Ye, Hong; Lichtenstein, Mark. A.; Andries, Koen; Pauwels, Rudi; De Bethune, Marie-Pierre; Boyer, Paul L.; Clark, Patrick; Hughes, Stephen H.; Janssen, Paul A. J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2550-2560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial drop in viral load similar to that obsd. with a five-drug combination in naive patients and retains potency in patients infected with NNRTI-resistant HIV-1 variants.  TMC125-R165335 and related anti-AIDS drug candidates can bind the enzyme RT in multiple conformations and thereby escape the effects of drug-resistance mutations.  Structural studies showed that this inhibitor and other diarylpyrimidine (DAPY) analogs can adapt to changes in the NNRTI-binding pocket in several ways: (1) DAPY analogs can bind in at least two conformationally distinct modes; (2) within a given binding mode, torsional flexibility ("wiggling") of DAPY analogs permits access to numerous conformational variants; and (3) the compact design of the DAPY analogs permits significant repositioning and reorientation (translation and rotation) within the pocket ("jiggling").  Such adaptations appear to be crit. for potency against wild-type and a wide range of drug-resistant mutant HIV-1 RTs.  Exploitation of favorable components of inhibitor conformational flexibility (such as torsional flexibility about strategically located chem. bonds) can be a powerful drug design concept, esp. for designing drugs that will be effective against rapidly mutating targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNFqXwggOSMLVg90H21EOLACvtfcHk0lhOaj_Zxde49w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisl2it70%253D&md5=56c2fce83bead1990e138ee7486a373d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm030558s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030558s%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DDe%2BJonge%26aufirst%3DM.%2BR.%26aulast%3DKoymans%26aufirst%3DL.%2BM.%2BH.%26aulast%3DVinkers%26aufirst%3DH.%2BM.%26aulast%3DDaeyaert%26aufirst%3DF.%26aulast%3DLudovici%26aufirst%3DD.%2BW.%26aulast%3DKukla%26aufirst%3DM.%2BJ.%26aulast%3DDe%2BCorte%26aufirst%3DB.%26aulast%3DKavash%26aufirst%3DR.%2BW.%26aulast%3DHo%26aufirst%3DC.%2BY.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DLichtenstein%26aufirst%3DM.%2BA.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3Dde%2BB%25C3%25A9thune%26aufirst%3DM.%2BP.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DRoles%2520of%2520conformational%2520and%2520positional%2520adaptability%2520in%2520structure-based%2520design%2520of%2520TMC125-R165335%2520%2528etravirine%2529%2520and%2520related%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520that%2520are%2520highly%2520potent%2520and%2520effective%2520against%2520wild-type%2520and%2520drug-resistant%2520HIV-1%2520variants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2550%26epage%3D2560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Faetkenheuer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plettenburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. M.</span><span> </span><span class="NLM_article-title">Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">â</span> <span class="NLM_lpage">2122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=2115-2122&author=G.+Faetkenheuerauthor=S.+Staszewskiauthor=A.+Plettenburgauthor=F.+Hackmanauthor=G.+Laytonauthor=L.+McFadyenauthor=J.+Davisauthor=T.+M.+Jenkins&title=Activity%2C+pharmacokinetics+and+safety+of+lersivirine+%28UK-453%2C061%29%2C+a+next-generation+nonnucleoside+reverse+transcriptase+inhibitor%2C+during+7-day+monotherapy+in+HIV-1-infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaetkenheuer%26aufirst%3DG.%26aulast%3DStaszewski%26aufirst%3DS.%26aulast%3DPlettenburg%26aufirst%3DA.%26aulast%3DHackman%26aufirst%3DF.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DMcFadyen%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DJenkins%26aufirst%3DT.%2BM.%26atitle%3DActivity%252C%2520pharmacokinetics%2520and%2520safety%2520of%2520lersivirine%2520%2528UK-453%252C061%2529%252C%2520a%2520next-generation%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitor%252C%2520during%25207-day%2520monotherapy%2520in%2520HIV-1-infected%2520patients%26jtitle%3DAIDS%26date%3D2009%26volume%3D23%26spage%3D2115%26epage%3D2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit92b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abdel-Malak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mousa, S. A.</span><span> </span><span class="NLM_article-title">The rise of second-generation non-nucleoside reverse transcriptase inhibitors: etravirine, rilpivirine, UK-453061 and RDEA-806</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">â</span> <span class="NLM_lpage">699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1358%2Fdof.2008.033.08.1206423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKmsrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=691-699&author=M.+Abdel-Malakauthor=C.+Gallatiauthor=S.+A.+Mousa&title=The+rise+of+second-generation+non-nucleoside+reverse+transcriptase+inhibitors%3A+etravirine%2C+rilpivirine%2C+UK-453061+and+RDEA-806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92bR"><div class="casContent"><span class="casTitleNuber">92b</span><div class="casTitle"><span class="NLM_cas:atitle">The rise of second-generation non-nucleoside reverse transcriptase inhibitors: etravirine, rilpivirine, UK-453061 and RDEA-806</span></div><div class="casAuthors">Abdel-Malak, Mark; Gallati, Christine; Mousa, Shaker A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">691-699</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a crucial component of current highly active antiretroviral therapy (HAART) treatments for HIV-1 infection.  One of the major limitations of the two most widely used NNRTIs, efavirenz and nevirapine, is their low genetic barrier to resistance, in addn. to their undesirable side effects.  The goal of current investigational NNRTI development is to create a safe, well-tolerated drug with a high genetic barrier to resistance that is active against known NNRTI-assocd. resistance mutations.  This review discusses three investigational NNRTIs, rilpivirine (TMC-278), UK-453061 and RDEA-806, which are at different stages of development, as well as etravirine (TMC-125), a second-generation NNRTI that was recently granted accelerated approval by the FDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoAT-pAXVU_rVg90H21EOLACvtfcHk0lhOaj_Zxde49w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKmsrfE&md5=dd1eceaf192811f1e0127f4a1419c0b5</span></div><a href="/servlet/linkout?suffix=cit92b&amp;dbid=16384&amp;doi=10.1358%2Fdof.2008.033.08.1206423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2008.033.08.1206423%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Malak%26aufirst%3DM.%26aulast%3DGallati%26aufirst%3DC.%26aulast%3DMousa%26aufirst%3DS.%2BA.%26atitle%3DThe%2520rise%2520of%2520second-generation%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%253A%2520etravirine%252C%2520rilpivirine%252C%2520UK-453061%2520and%2520RDEA-806%26jtitle%3DDrugs%2520Future%26date%3D2008%26volume%3D33%26spage%3D691%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 3: optimisation of physicochemical properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5603</span><span class="NLM_x">â</span> <span class="NLM_lpage">5606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2009.08.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19717303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5603-5606&author=C.+E.+Mowbrayauthor=R.+Corbauauthor=M.+Hawesauthor=L.+H.+Jonesauthor=J.+E.+Millsauthor=M.+Perrosauthor=M.+D.+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+3%3A+optimisation+of+physicochemical+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93aR"><div class="casContent"><span class="casTitleNuber">93a</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole NNRTIs 3: Optimisation of physicochemical properties</span></div><div class="casAuthors">Mowbray, Charles E.; Corbau, Romuald; Hawes, Michael; Jones, Lyn H.; Mills, James E.; Perros, Manos; Selby, Matthew D.; Stupple, Paul A.; Webster, Rob; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5603-5606</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our efforts to reduce overall lipophilicity and increase ligand-lipophilicity efficiency (LLE) by modification of the 3- and 5-substituents of pyrazole I, a novel non-nucleoside HIV reverse transcriptase inhibitor (NNRTI) prototype were unsuccessful.  In contrast replacement of the substituted benzyl group with corresponding phenylthio or phenoxy groups resulted in marked improvements in potency, ligand efficiency (LE) and LLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoctiZUAaZLMrVg90H21EOLACvtfcHk0lhOaj_Zxde49w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E&md5=f25509e8183b985daae551f052c3e3e7</span></div><a href="/servlet/linkout?suffix=cit93a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.043%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25203%253A%2520optimisation%2520of%2520physicochemical%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5603%26epage%3D5606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit93b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mowbray, C. E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinton, F. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5857</span><span class="NLM_x">â</span> <span class="NLM_lpage">5860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5857-5860&author=C.+E+Mowbrayauthor=C.+Burtauthor=R.+Corbauauthor=S.+Gaytonauthor=M.+Hawesauthor=M.+Perrosauthor=I.+Tranauthor=D.+A+Priceauthor=F.+J+Quintonauthor=M.+D+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+4%3A+selection+of+UK-453%2C061+%28lersivirine%29+as+a+development+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DGayton%26aufirst%3DS.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DPrice%26aufirst%3DD.%2BA%26aulast%3DQuinton%26aufirst%3DF.%2BJ%26aulast%3DSelby%26aufirst%3DM.%2BD%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25204%253A%2520selection%2520of%2520UK-453%252C061%2520%2528lersivirine%2529%2520as%2520a%2520development%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5857%26epage%3D5860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Hoegberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahlberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noreen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kangasmetsae, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahlberg, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LÃ¶vgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridborg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BÃ¤ckbro, K.</span><span> </span><span class="NLM_article-title">Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structureâactivity relationship studies of PETT analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">â</span> <span class="NLM_lpage">4160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4150-4160&author=M.+Hoegbergauthor=C.+Sahlbergauthor=P.+Engelhardtauthor=R.+Noreenauthor=J.+Kangasmetsaeauthor=N.+G.+Johanssonauthor=B.+Oebergauthor=L.+Vrangauthor=H.+Zhangauthor=B.-L.+Sahlbergauthor=T.+Ungeauthor=S.+L%C3%B6vgrenauthor=K.+Fridborgauthor=K.+B%C3%A4ckbro&title=Urea-PETT+compounds+as+a+new+class+of+HIV-1+reverse+transcriptase+inhibitors.+3.+Synthesis+and+further+structure%E2%88%92activity+relationship+studies+of+PETT+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoegberg%26aufirst%3DM.%26aulast%3DSahlberg%26aufirst%3DC.%26aulast%3DEngelhardt%26aufirst%3DP.%26aulast%3DNoreen%26aufirst%3DR.%26aulast%3DKangasmetsae%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DOeberg%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSahlberg%26aufirst%3DB.-L.%26aulast%3DUnge%26aufirst%3DT.%26aulast%3DL%25C3%25B6vgren%26aufirst%3DS.%26aulast%3DFridborg%26aufirst%3DK.%26aulast%3DB%25C3%25A4ckbro%26aufirst%3DK.%26atitle%3DUrea-PETT%2520compounds%2520as%2520a%2520new%2520class%2520of%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors.%25203.%2520Synthesis%2520and%2520further%2520structure%25E2%2588%2592activity%2520relationship%2520studies%2520of%2520PETT%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4150%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crostarosa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aravantinou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akpogheneta, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasny, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piatak, M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chudolij, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zydowsky, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbiani, M.</span><span> </span><span class="NLM_article-title">A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">e8060</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1-14&issue=e8060&author=F.+Crostarosaauthor=M.+Aravantinouauthor=O.+J.+Akpoghenetaauthor=E.+Jasnyauthor=A.+Shawauthor=J.+Kenneyauthor=M.+Piatakauthor=J.+D.+Lifsonauthor=A.+Teitelbaumauthor=L.+Huauthor=A.+Chudolijauthor=T.+M.+Zydowskyauthor=J.+Blanchardauthor=A.+Gettieauthor=M.+Robbiani&title=A+macaque+model+to+study+vaginal+HSV-2%2Fimmunodeficiency+virus+co-infection+and+the+impact+of+HSV-2+on+microbicide+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrostarosa%26aufirst%3DF.%26aulast%3DAravantinou%26aufirst%3DM.%26aulast%3DAkpogheneta%26aufirst%3DO.%2BJ.%26aulast%3DJasny%26aufirst%3DE.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DKenney%26aufirst%3DJ.%26aulast%3DPiatak%26aufirst%3DM.%26aulast%3DLifson%26aufirst%3DJ.%2BD.%26aulast%3DTeitelbaum%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DChudolij%26aufirst%3DA.%26aulast%3DZydowsky%26aufirst%3DT.%2BM.%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DGettie%26aufirst%3DA.%26aulast%3DRobbiani%26aufirst%3DM.%26atitle%3DA%2520macaque%2520model%2520to%2520study%2520vaginal%2520HSV-2%252Fimmunodeficiency%2520virus%2520co-infection%2520and%2520the%2520impact%2520of%2520HSV-2%2520on%2520microbicide%2520efficacy%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3De8060%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit95b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fernandez-Romero, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turville, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titchen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudol, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbiani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckheit, R. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. M.</span><span> </span><span class="NLM_article-title">Carrageenan/MIV-150 (PC-815), a combination microbicide</span> <span class="citation_source-journal">Sex. Transm. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtVGh" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=9-14&author=J.+A.+Fernandez-Romeroauthor=M.+Thornauthor=S.+G.+Turvilleauthor=K.+Titchenauthor=K.+Sudolauthor=J.+Liauthor=T.+Millerauthor=M.+Robbianiauthor=R.+A.+Maguireauthor=R.+W.+Buckheitauthor=T.+L.+Hartmanauthor=D.+M.+Phillips&title=Carrageenan%2FMIV-150+%28PC-815%29%2C+a+combination+microbicide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95bR"><div class="casContent"><span class="casTitleNuber">95b</span><div class="casTitle"><span class="NLM_cas:atitle">Carrageenan/MIV-150 (PC-815), a Combination Microbicide</span></div><div class="casAuthors">Fernandez-Romero, Jose A.; Thorn, Mitchell; Turville, Stuart G.; Titchen, Kanani; Sudol, Kristin; Li, Jifan; Miller, Todd; Robbiani, Melissa; Maguire, Robin A.; Buckheit, Robert W., Jr.; Hartman, Tracy L.; Phillips, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Sexually Transmitted Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">STRDDM</span>;
        ISSN:<span class="NLM_cas:issn">0148-5717</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: The objective of this article is to study the effect of PC-815, a novel combination microbicide contg. carrageenan and the nonnucleoside reverse transcriptase inhibitor (NNRTI) MIV-150, in blocking HIV-1 and HIV-2 infections in vitro as compared with Carraguard alone.  GOAL: The goal of this study was to develop a combination microbicide that is more efficacious than Carraguard against HIV-1 and HIV-2.  Study design: The microtiter syncytial assay was used to evaluate: (1) the antiviral and virucidal activity of MIV-150 against HIV-1MN; (2) the additive effect of MIV-150 when combined with carrageenan; and (3) a possible interference of seminal fluid in the antiviral activity of these compds.  Results: MIV-150 effectively inactivated free virus.  Combination of MIV-150 and Carraguard demonstrated an additive antiviral effect.  Seminal fluid had no effect on the antiviral activity of MIV-150 or Carraguard.  The av. concn. that blocks 50% of infection (EC50) for PC-815 was approx. 10 times stronger than Carraguard for the different clin. isolates used in the study.  Conclusion: Theor., PC-815 is likely to be a more efficacious microbicide than Carraguard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPg-FD1H2srVg90H21EOLACvtfcHk0lhKVpKzt3_IEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtVGh&md5=3b1e11d70010dd34e7db05ee9ca75ae3</span></div><a href="/servlet/linkout?suffix=cit95b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Romero%26aufirst%3DJ.%2BA.%26aulast%3DThorn%26aufirst%3DM.%26aulast%3DTurville%26aufirst%3DS.%2BG.%26aulast%3DTitchen%26aufirst%3DK.%26aulast%3DSudol%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DRobbiani%26aufirst%3DM.%26aulast%3DMaguire%26aufirst%3DR.%2BA.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DHartman%26aufirst%3DT.%2BL.%26aulast%3DPhillips%26aufirst%3DD.%2BM.%26atitle%3DCarrageenan%252FMIV-150%2520%2528PC-815%2529%252C%2520a%2520combination%2520microbicide%26jtitle%3DSex.%2520Transm.%2520Dis.%26date%3D2006%26volume%3D34%26spage%3D9%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Zhou, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissling, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayers, D.</span><span> </span><span class="NLM_article-title">Microdose pharmacokinetics of IDX899 and IDX989, candidate HIV-1 non-nucleoside reverse transcriptase inhibitors, following oral and intravenous administration in healthy male subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1408</span><span class="NLM_x">â</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1177%2F0091270009343698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19776293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1408-1416&author=X.-J.+Zhouauthor=R.+C.+Garnerauthor=S.+Nicholsonauthor=C.+J.+Kisslingauthor=D.+Mayers&title=Microdose+pharmacokinetics+of+IDX899+and+IDX989%2C+candidate+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors%2C+following+oral+and+intravenous+administration+in+healthy+male+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Microdose pharmacokinetics of IDX899 and IDX989, candidate HIV-1 non-nucleoside reverse transcriptase inhibitors, following oral and intravenous administration in healthy male subjects</span></div><div class="casAuthors">Zhou, Xiao-Jian; Garner, R. Colin; Nicholson, Sheila; Kissling, C. James; Mayers, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1408-1416</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">IDX899 and IDX989 are new non-nucleoside reverse-transcriptase inhibitors (NNRTIs) that exhibit potent inhibition of HIV-1 replication, including NNRTI-resistant mutants.  This microdose study investigates the pharmacokinetics and detd. oral bioavailability.  For each compd., 4 healthy male subjects are randomized to receive via a crossover design a single 100-Î¼g oral and i.v. dose together with 100 nCi of [14C]-labeled drug.  Plasma and urine samples are obtained over a period of 168 h postdose and analyzed for total, unchanged drug and major metabolites using an accelerator mass spectrometry method.  Based on total radioactivity, oral absorption is near complete.  For the parent drug, mean abs. bioavailability is 61% and 65% for IDX899 and IDX989, resp.  Both compds. are extensively metabolized esp. after oral dosing.  Obsd. terminal phase half-lives after oral and i.v. doses range from 4 to 10 h and are comparable for the 2 compds.  Urine excretion of radioactivity for both compds. is less than 10%.  These data show for the first time that IDX899 and IDX989 possess favorable pharmacokinetic properties in humans, including high mean abs. bioavailability and long half-life.  IDX899 has been selected based on these initial pharmacokinetic assessments and other criteria as the candidate for further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARInsgz8HPbVg90H21EOLACvtfcHk0ljAuy4pGMyorw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLvO&md5=2bb99ad00f2630d15e6066f349dbf94b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1177%2F0091270009343698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009343698%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.-J.%26aulast%3DGarner%26aufirst%3DR.%2BC.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DKissling%26aufirst%3DC.%2BJ.%26aulast%3DMayers%26aufirst%3DD.%26atitle%3DMicrodose%2520pharmacokinetics%2520of%2520IDX899%2520and%2520IDX989%252C%2520candidate%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%252C%2520following%2520oral%2520and%2520intravenous%2520administration%2520in%2520healthy%2520male%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D1408%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Pascual, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasothan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Febuxostat</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=191-192&author=E.+Pascualauthor=F.+Siveraauthor=U.+Yasothanauthor=P.+Kirkpatrick&title=Febuxostat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPascual%26aufirst%3DE.%26aulast%3DSivera%26aufirst%3DF.%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DFebuxostat%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D191%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eger, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T.</span><span> </span><span class="NLM_article-title">An extremely potent inhibitor of xanthine oxidoreductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1848</span><span class="NLM_x">â</span> <span class="NLM_lpage">1855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=1848-1855&author=K.+Okamotoauthor=B.+T.+Egerauthor=T.+Nishinoauthor=S.+Kondoauthor=E.+F.+Paiauthor=T.+Nishino&title=An+extremely+potent+inhibitor+of+xanthine+oxidoreductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DEger%26aufirst%3DB.%2BT.%26aulast%3DNishino%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DAn%2520extremely%2520potent%2520inhibitor%2520of%2520xanthine%2520oxidoreductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D1848%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Sato, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashizawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, O.</span><span> </span><span class="NLM_article-title">Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051âa xanthine oxidoreductase inhibitor for the treatment of hyperuricemia</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6225</span><span class="NLM_x">â</span> <span class="NLM_lpage">6229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6225-6229&author=T+Satoauthor=N.+Ashizawaauthor=K.+Matsumotoauthor=T.+Iwanagaauthor=H.+Nakamuraauthor=T.+Inoueauthor=O.+Nagata&title=Discovery+of+3-%283-cyano-4-pyridyl%29-5-%284-pyridyl%29-1%2C2%2C4-triazole%2C+FYX-051%E2%80%94a+xanthine+oxidoreductase+inhibitor+for+the+treatment+of+hyperuricemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT%26aulast%3DAshizawa%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DO.%26atitle%3DDiscovery%2520of%25203-%25283-cyano-4-pyridyl%2529-5-%25284-pyridyl%2529-1%252C2%252C4-triazole%252C%2520FYX-051%25E2%2580%2594a%2520xanthine%2520oxidoreductase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hyperuricemia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6225%26epage%3D6229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hille, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eger, B. T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T.</span><span> </span><span class="NLM_article-title">The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">7931</span><span class="NLM_x">â</span> <span class="NLM_lpage">7936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=7931-7936&author=K.+Okamotoauthor=K.+Matsumotoauthor=R.+Hilleauthor=B.+T+Egerauthor=E.+F.+Paiauthor=T.+Nishino&title=The+crystal+structure+of+xanthine+oxidoreductase+during+catalysis%3A+implications+for+reaction+mechanism+and+enzyme+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DHille%26aufirst%3DR.%26aulast%3DEger%26aufirst%3DB.%2BT%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DThe%2520crystal%2520structure%2520of%2520xanthine%2520oxidoreductase%2520during%2520catalysis%253A%2520implications%2520for%2520reaction%2520mechanism%2520and%2520enzyme%2520inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D7931%26epage%3D7936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Pratley, R. E.</span><span> </span><span class="NLM_article-title">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">â</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1517%2F14656560802694713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19191685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=503-512&author=R.+E.+Pratley&title=Alogliptin%3A+a+new%2C+highly+selective+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Pratley, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-512</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Alogliptin is a potent, highly selective dipeptidyl peptidase-4 inhibitor now undergoing clin. testing to support a new drug application for the treatment of type 2 diabetes.  Objective: To provide an overview of the mechanism by which alogliptin reduces hyperglycemia and to summarize the pharmacol., efficacy and safety of the drug.  Methods: A Medline search was conducted and abstrs. and presentations from recent American Diabetes Assocn. and European Assocn. for the Study of Diabetes (EASD) meetings were reviewed.  The results of phase II and phase III human studies were evaluated for clin. efficacy, safety and tolerability in patients with type 2 diabetes.  Results/conclusions: Alogliptin is effective as a treatment for type 2 diabetes, either as monotherapy or in combination with metformin, thiazolidinediones, sulfonylureas and insulin.  It is well tolerated and has an excellent safety profile.  Addnl. studies are needed to evaluate the long-term safety and efficacy of alogliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVASaAmsEezrVg90H21EOLACvtfcHk0ljAuy4pGMyorw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVaiurY%253D&md5=26b93655020e344a7a063a25aaed728d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1517%2F14656560802694713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560802694713%26sid%3Dliteratum%253Aachs%26aulast%3DPratley%26aufirst%3DR.%2BE.%26atitle%3DAlogliptin%253A%2520a%2520new%252C%2520highly%2520selective%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D503%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Andukuri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drincic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendell, M.</span><span> </span><span class="NLM_article-title">Alogliptin: a new addition to the class of DPP-4 inhibitors</span> <span class="citation_source-journal">Diabetes, Metab. Syndr. Obes.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">â</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWmtrrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=117-126&author=R.+Andukuriauthor=A.+Drincicauthor=M.+Rendell&title=Alogliptin%3A+a+new+addition+to+the+class+of+DPP-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102aR"><div class="casContent"><span class="casTitleNuber">102a</span><div class="casTitle"><span class="NLM_cas:atitle">Alogliptin: a new addition to the class of DPP-4 inhibitors</span></div><div class="casAuthors">Andukuri, Radha; Drincic, Andjela; Rendell, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Metabolic Syndrome and Obesity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-126</span>CODEN:
                <span class="NLM_cas:coden">DMSOAD</span>;
        ISSN:<span class="NLM_cas:issn">1178-7007</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Alogliptin is an oral antihyperglycemic agent that is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4).  Inhibition of DPP-4 elevates levels of the incretin hormones glucagon-like peptide (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) by preventing their degrdn.  To review the evolution of alogliptin and its pharmacokinetics, pharmacodynamics, clin. efficacy and adverse effects.  In addn., we compared alogliptin to other DPP-4 inhibitors.  A comprehensive literature search was performed using the term 'alogliptin'.  Original research articles and review articles as well as scientific abstrs. were included.  Alogliptin raises postprandial levels of GLP-1.  It has excellent bioavailability exhibiting a median Tmax ranging from 1 to 2 h and a mean half-life of 12.4 to 21.4 h across all doses.  When given as monotherapy, mean Hb A1c (HbA1c) redns. achieved were 0.5% to 0.6%.  Combination therapy yielded similar redns. (-0.5% with metformin, -0.6% with glyburide, -0.8% with pioglitazone and -0.6% with insulin).  Administration of alogliptin does not promote wt. loss but has not resulted in wt. gain.  The agent is relatively well tolerated with few adverse effects, the major finding being a marginally higher rate of skin events, primarily pruritus.  Alogliptin causes significant redns. in HbA1c when used alone or in combination with other oral agents in patients with type 2 diabetes similar to other DPP-4 inhibitors in current clin. use.  The side effect profile also does not differ from that of other DPP-4 inhibitors.  However, long-term studies are necessary before the place of alogliptin in the management of type 2 diabetes can be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL2BZsv0XCALVg90H21EOLACvtfcHk0lhum7vcN0sEqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWmtrrI&md5=1c7eb061b36ea68ae65c64f206673608</span></div><a href="/servlet/linkout?suffix=cit102a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndukuri%26aufirst%3DR.%26aulast%3DDrincic%26aufirst%3DA.%26aulast%3DRendell%26aufirst%3DM.%26atitle%3DAlogliptin%253A%2520a%2520new%2520addition%2520to%2520the%2520class%2520of%2520DPP-4%2520inhibitors%26jtitle%3DDiabetes%252C%2520Metab.%2520Syndr.%2520Obes.%26date%3D2009%26volume%3D2%26spage%3D117%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit102b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">589</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">â</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.ejphar.2008.04.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18538760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVCmt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=589&publication_year=2008&pages=306-314&author=B.+Leeauthor=L.+Shiauthor=D.+B.+Kasselauthor=T.+Asakawaauthor=K.+Takeuchiauthor=R.+J.+Christopher&title=Pharmacokinetic%2C+pharmacodynamic%2C+and+efficacy+profiles+of+alogliptin%2C+a+novel+inhibitor+of+dipeptidyl+peptidase-4%2C+in+rats%2C+dogs%2C+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102bR"><div class="casContent"><span class="casTitleNuber">102b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys</span></div><div class="casAuthors">Lee, Bumsup; Shi, Lihong; Kassel, Daniel B.; Asakawa, Tomoko; Takeuchi, Koji; Christopher, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">589</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">306-314</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of the present research was to characterize the pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel quinazolinone-based dipeptidyl peptidase-4 (DPP-4) inhibitor.  Alogliptin potently inhibited human DPP-4 in vitro (mean IC50, â¼ 6.9 nM) and exhibited > 10,000-fold selectivity for DPP-4 over the closely related serine proteases DPP-2, DPP-8, DPP-9, fibroblast activation protein/seprase, prolyl endopeptidase, and tryptase (IC50 > 100,000 nM).  Abs. oral bioavailability of alogliptin in rats, dogs, and monkeys was 45%, 86%, and 72% to 88%, resp.  After a single oral dose of alogliptin, plasma DPP-4 inhibition was obsd. within 15 min and max. inhibition was > 90% in rats, dogs, and monkeys; inhibition was sustained for 12 h in rats (43%) and dogs (65%) and 24 h in monkeys (> 80%).  From Emax modeling, 50% inhibition of DPP-4 activity was obsd. at a mean alogliptin plasma concn. (EC50) of 3.4 to 5.6 ng/mL (10.0 to 16.5 nM) in rats, dogs, and monkeys.  In Zucker fa/fa rats, a single dose of alogliptin (0.3, 1, 3, and 10 mg/kg) inhibited plasma DPP-4 (91% to 100% at 2 h and 20% to 66% at 24 h), increased plasma GLP-1 (2- to 3-fold increase in AUC0-20 min) and increased early-phase insulin secretion (1.5- to 2.6-fold increase in AUC0-20 min) and reduced blood glucose excursion (31%-67% decrease in AUC0-90 min) after oral glucose challenge.  Alogliptin (30 and 100 mg/kg) had no effect on fasting plasma glucose in normoglycemic rats.  In summary, these data suggest that alogliptin is a potent and highly selective DPP-4 inhibitor with demonstrated efficacy in Zucker fa/fa rats and potential for once-daily dosing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEb5VESLzp5rVg90H21EOLACvtfcHk0lhum7vcN0sEqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVCmt7o%253D&md5=51aee5f0d4021832896d021a25b64f54</span></div><a href="/servlet/linkout?suffix=cit102b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.04.047%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26atitle%3DPharmacokinetic%252C%2520pharmacodynamic%252C%2520and%2520efficacy%2520profiles%2520of%2520alogliptin%252C%2520a%2520novel%2520inhibitor%2520of%2520dipeptidyl%2520peptidase-4%252C%2520in%2520rats%252C%2520dogs%252C%2520and%2520monkeys%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D589%26spage%3D306%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II.</span><span> </span><span class="NLM_article-title">Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">â</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070104l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2297-2300&author=J.+Fengauthor=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+A.+Staffordauthor=S.+W.+Kaldorauthor=D.+B.+Kasselauthor=M.+Navreauthor=L.+Shiauthor=R.+J.+Skeneauthor=T.+Asakawaauthor=K.+Takeuchiauthor=R.+Xuauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Discovery+of+alogliptin%3A+a+potent%2C+selective%2C+bioavailable%2C+and+efficacious+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm070104l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070104l%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520alogliptin%253A%2520a%2520potent%252C%2520selective%252C%2520bioavailable%252C%2520and%2520efficacious%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2297%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Johnson, H. G.</span><span> </span><span class="NLM_article-title">New anti-allergy drugsâthe lodoxamides</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">â</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1980&pages=343-345&author=H.+G.+Johnson&title=New+anti-allergy+drugs%E2%80%94the+lodoxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DH.%2BG.%26atitle%3DNew%2520anti-allergy%2520drugs%25E2%2580%2594the%2520lodoxamides%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1980%26volume%3D1%26spage%3D343%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">TYB-2285 (Toyobo)</span> <span class="citation_source-journal">Curr. Opin. Anti-Inflammatory Immunomodulatory Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">â</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=113-116&author=P.+Norman&title=TYB-2285+%28Toyobo%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DTYB-2285%2520%2528Toyobo%2529%26jtitle%3DCurr.%2520Opin.%2520Anti-Inflammatory%2520Immunomodulatory%2520Invest.%2520Drugs%26date%3D2000%26volume%3D2%26spage%3D113%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit105b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsushima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, T.</span><span> </span><span class="NLM_article-title">Novel antiallergic and antiinflammatory agents. Part II: synthesis and pharmacology of TYB-2285 and its related compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">â</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=1077-1087&author=M.+Banauthor=H.+Taguchiauthor=T.+Katsushimaauthor=M.+Takahashiauthor=K.+Shinodaauthor=A.+Watanabeauthor=T.+Tominaga&title=Novel+antiallergic+and+antiinflammatory+agents.+Part+II%3A+synthesis+and+pharmacology+of+TYB-2285+and+its+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DH.%26aulast%3DKatsushima%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DShinoda%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DTominaga%26aufirst%3DT.%26atitle%3DNovel%2520antiallergic%2520and%2520antiinflammatory%2520agents.%2520Part%2520II%253A%2520synthesis%2520and%2520pharmacology%2520of%2520TYB-2285%2520and%2520its%2520related%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D1077%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Ortolani, S.</span><span> </span><span class="NLM_article-title">Strontium ranelate: a new first-line treatment for patients with postmenopausal osteoporosis</span> <span class="citation_source-journal">Postmenopausal Osteoporosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ahtb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=247-253&author=S.+Ortolani&title=Strontium+ranelate%3A+a+new+first-line+treatment+for+patients+with+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Strontium ranelate: a new first-line treatment for patients with postmenopausal osteoporosis</span></div><div class="casAuthors">Ortolani, S.</div><div class="citationInfo"><span class="NLM_cas:title">Postmenopausal Osteoporosis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">69IQIV</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Strontium ranelate is composed of an org. moiety (ranelic acid) and two atoms of stable (non-radioactive) strontium.  It is capable of stimulating bone formation while inhibiting bone resorption.  The scientific rationale for the use of this agent in osteoporosis, and the results of the first major clin. studies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1jWupUCtYt7Vg90H21EOLACvtfcHk0lic1lqFW_gONA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ahtb7M&md5=28eb3360641b7e93cdfa4276ae925ddc</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrtolani%26aufirst%3DS.%26atitle%3DStrontium%2520ranelate%253A%2520a%2520new%2520first-line%2520treatment%2520for%2520patients%2520with%2520postmenopausal%2520osteoporosis%26jtitle%3DPostmenopausal%2520Osteoporosis%26date%3D2006%26spage%3D247%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maimoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badoud, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois-Ferriere, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammann, P.</span><span> </span><span class="NLM_article-title">Strontium ranelate improves implant osseointegration</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1436</span><span class="NLM_x">â</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=1436-1441&author=L.+Maimounauthor=T.+C.+Brennanauthor=I.+Badoudauthor=V.+Dubois-Ferriereauthor=R.+Rizzoliauthor=P.+Ammann&title=Strontium+ranelate+improves+implant+osseointegration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaimoun%26aufirst%3DL.%26aulast%3DBrennan%26aufirst%3DT.%2BC.%26aulast%3DBadoud%26aufirst%3DI.%26aulast%3DDubois-Ferriere%26aufirst%3DV.%26aulast%3DRizzoli%26aufirst%3DR.%26aulast%3DAmmann%26aufirst%3DP.%26atitle%3DStrontium%2520ranelate%2520improves%2520implant%2520osseointegration%26jtitle%3DBone%26date%3D2010%26volume%3D46%26spage%3D1436%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit107b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">There has been some question as to whether this dual action mechanism operates: </p></div><span class="NLM_contrib-group">Blake, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compston, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogelman, I.</span><span> </span><span class="NLM_article-title">Could strontium ranelate have a synertistic role in the treatment of osteoporosis?</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1354</span><span class="NLM_x">â</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1359%2Fjbmr.090601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19558313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaitrvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=1354-1357&author=G.+M.+Blakeauthor=J.+E.+Compstonauthor=I.+Fogelman&title=Could+strontium+ranelate+have+a+synertistic+role+in+the+treatment+of+osteoporosis%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107bR"><div class="casContent"><span class="casTitleNuber">107b</span><div class="casTitle"><span class="NLM_cas:atitle">Could strontium ranelate have a synertistic role in the treatment of osteoporosis?</span></div><div class="casAuthors">Blake, Glen M.; Compston, Juliet E.; Fogelman, Ignac</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1354-1357</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">A review.  The research of Recker et al. (2009) entitled 'Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochem. markers of bone turnover in postmenopausal women with osteoporosis' is reviewed with commentary and refs.  These authors present results from a randomized active comparator study in osteoporotic postmenopausal women that provide compelling evidence that treatment with strontium ranelate (SrR) has only a modest effect on bone remodeling as assessed by biochem. markers of bone turnover and bone histomorphometry.  They report that changes in biochem. markers during 6-mo treatment with SrR failed to confirm any bone-forming activity.  They conclude that the modest effect of SrR on bone remodeling and cell activity may indicate that its effects on fracture redn. are mediated by a different mechanism than that obsd. with anabolic or the more potent antiresorptive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2DZqwfRKnoLVg90H21EOLACvtfcHk0lic1lqFW_gONA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaitrvE&md5=3721c0ea3647f0feb685fe91636a3cc0</span></div><a href="/servlet/linkout?suffix=cit107b&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.090601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.090601%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DG.%2BM.%26aulast%3DCompston%26aufirst%3DJ.%2BE.%26aulast%3DFogelman%26aufirst%3DI.%26atitle%3DCould%2520strontium%2520ranelate%2520have%2520a%2520synertistic%2520role%2520in%2520the%2520treatment%2520of%2520osteoporosis%253F%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D1354%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pasqualotto, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldani, L. Z.</span><span> </span><span class="NLM_article-title">Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">â</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=165-174&author=A.+C.+Pasqualottoauthor=K.+O.+Thieleauthor=L.+Z.+Goldani&title=Novel+triazole+antifungal+drugs%3A+focus+on+isavuconazole%2C+ravuconazole+and+albaconazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasqualotto%26aufirst%3DA.%2BC.%26aulast%3DThiele%26aufirst%3DK.%2BO.%26aulast%3DGoldani%26aufirst%3DL.%2BZ.%26atitle%3DNovel%2520triazole%2520antifungal%2520drugs%253A%2520focus%2520on%2520isavuconazole%252C%2520ravuconazole%2520and%2520albaconazole%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit108b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Petrikkos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skiada, A.</span><span> </span><span class="NLM_article-title">Recent advances in antifungal chemotherapy</span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">â</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.ijantimicag.2007.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17524625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFartrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=108-117&author=G.+Petrikkosauthor=A.+Skiada&title=Recent+advances+in+antifungal+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108bR"><div class="casContent"><span class="casTitleNuber">108b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in antifungal chemotherapy</span></div><div class="casAuthors">Petrikkos, George; Skiada, Anna</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  For over 50 years, amphotericin B deoxycholate (AmBD) has been the 'gold std.' in antifungal chemotherapy, despite its frequent toxicities.  However, improved treatment options for invasive fungal infections (IFIs) have been developed during the last 15 years.  Newer antifungal agents, including less toxic lipid prepns. of AmBD, triazoles and the echinocandins, have been added to our armamentarium against IFIs.  Some of these newer drugs can now replace AmBD as primary therapy (e.g. caspofungin for candidiasis, voriconazole for aspergillosis), while others offer new therapeutic options for difficult-to-treat IFIs (e.g. posaconazole for zygomycosis, fusariosis and chromoblastomycosis).  It is interesting that extended use of newer antifungals such as fluconazole, despite decreasing the mortality attributed to candidiasis, resulted in selection of species resistant to several antifungals (Candida krusei, Candida glabrata); while several publications suggest that prolonged use of voriconazole may expose severely immunocompromised patients to the risk of zygomycosis (breakthrough).  On the other hand, the differences in the mode of action of newer antifungals such as echinocandins raise the question whether combination antifungal therapy is more effective than monotherapy.  Finally, the availability of an oral formulation with excellent biosafety of several newer antifungals (e.g. posaconazole) makes them candidates for prophylactic or prolonged maintenance therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMHOCuOah7RbVg90H21EOLACvtfcHk0lic1lqFW_gONA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFartrc%253D&md5=e07e916c897a5867e356f11201914bd8</span></div><a href="/servlet/linkout?suffix=cit108b&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2007.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2007.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DPetrikkos%26aufirst%3DG.%26aulast%3DSkiada%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520antifungal%2520chemotherapy%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2007%26volume%3D30%26spage%3D108%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit108c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yamazumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. N.</span><span> </span><span class="NLM_article-title">In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of <i>Cryptococcus neoformans</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2883</span><span class="NLM_x">â</span> <span class="NLM_lpage">2886</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2883-2886&author=T.+Yamazumiauthor=M.+A.+Pfallerauthor=S.+A.+Messerauthor=A.+Houstonauthor=R.+J.+Hollisauthor=R.+N.+Jones&title=In+vitro+activities+of+ravuconazole+%28BMS-207147%29+against+541+clinical+isolates+of+Cryptococcus+neoformans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamazumi%26aufirst%3DT.%26aulast%3DPfaller%26aufirst%3DM.%2BA.%26aulast%3DMesser%26aufirst%3DS.%2BA.%26aulast%3DHouston%26aufirst%3DA.%26aulast%3DHollis%26aufirst%3DR.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DIn%2520vitro%2520activities%2520of%2520ravuconazole%2520%2528BMS-207147%2529%2520against%2520541%2520clinical%2520isolates%2520of%2520Cryptococcus%2520neoformans%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2883%26epage%3D2886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Three-dimensional model of lanosterol 14Î±-demethylase from <i>Cryptococcus neoformans</i>: active-site characterization and insights into azole binding</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3487</span><span class="NLM_x">â</span> <span class="NLM_lpage">3495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3487-3495&author=C.+Shengauthor=Z.+Miaoauthor=H.+Jiauthor=J.+Yaoauthor=W.+Wangauthor=X.+Cheauthor=G.+Dongauthor=J.+Luauthor=W.+Guoauthor=W.+Zhang&title=Three-dimensional+model+of+lanosterol+14%CE%B1-demethylase+from+Cryptococcus+neoformans%3A+active-site+characterization+and+insights+into+azole+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DThree-dimensional%2520model%2520of%2520lanosterol%252014%25CE%25B1-demethylase%2520from%2520Cryptococcus%2520neoformans%253A%2520active-site%2520characterization%2520and%2520insights%2520into%2520azole%2520binding%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3487%26epage%3D3495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schmitt-Hoffmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spickermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeckel, K.</span><span> </span><span class="NLM_article-title">Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4885</span><span class="NLM_x">â</span> <span class="NLM_lpage">4890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4885-4890&author=A.+Schmitt-Hoffmannauthor=B.+Roosauthor=J.+Spickermannauthor=M.+Heepauthor=E.+Peterfaiauthor=D.+J.+Edwardsauthor=K.+Stoeckel&title=Effect+of+mild+and+moderate+liver+disease+on+the+pharmacokinetics+of+isavuconazole+after+intravenous+and+oral+administration+of+a+single+dose+of+the+prodrug+BAL8557"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt-Hoffmann%26aufirst%3DA.%26aulast%3DRoos%26aufirst%3DB.%26aulast%3DSpickermann%26aufirst%3DJ.%26aulast%3DHeep%26aufirst%3DM.%26aulast%3DPeterfai%26aufirst%3DE.%26aulast%3DEdwards%26aufirst%3DD.%2BJ.%26aulast%3DStoeckel%26aufirst%3DK.%26atitle%3DEffect%2520of%2520mild%2520and%2520moderate%2520liver%2520disease%2520on%2520the%2520pharmacokinetics%2520of%2520isavuconazole%2520after%2520intravenous%2520and%2520oral%2520administration%2520of%2520a%2520single%2520dose%2520of%2520the%2520prodrug%2520BAL8557%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4885%26epage%3D4890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit110b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verweij, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederhold, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lass-Florl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghannoum, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinea, J.</span><span> </span><span class="NLM_article-title">In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries</span> <span class="citation_source-journal">J. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">â</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19567347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFylt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=272-281&author=P.+E.+Verweijauthor=G.+M.+Gonzalezauthor=N.+P.+Wiederholdauthor=C.+Lass-Florlauthor=P.+Warnauthor=M.+Heepauthor=M.+A.+Ghannoumauthor=J.+Guinea&title=In+vitro+antifungal+activity+of+isavuconazole+against+345+mucorales+isolates+collected+at+study+centers+in+eight+countries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110bR"><div class="casContent"><span class="casTitleNuber">110b</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries</span></div><div class="casAuthors">Verweij, P. E.; Gonzalez, G. M.; Wiederhold, N. P.; Lass-Florl, C.; Warn, P.; Heep, M.; Ghannoum, M. A.; Guinea, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">Although mucormycoses (formerly zygomycoses) are relatively uncommon, they are assocd. with high mortality and treatment options are limited.  Isavuconazole is a novel, water sol., broad-spectrum azole in clin. development for the treatment of invasive aspergillosis and candidiasis.  The objective of this report was to collate data on the in vitro activity of isavuconazole against a collection of 345 diverse Mucorales isolates, collected and tested at eight study centers in Europe, Mexico and North America.  Each study center undertook min. inhibitory concn. (MIC) susceptibility testing of their isolates, according to EUCAST or CLSI guidelines.  Across all study centers, isavuconazole exhibited MIC50 values of 1-4 mg/L and MIC90 values of 4-16 mg/L against the five genera.  There were also marked differences in MIC distributions, which could be ascribed to differences in inoculum and/or endpoint.  EUCAST guidelines appeared to generate modal MICs 2-fold higher than CLSI.  These results confirm that isavuconazole possesses at least partial antifungal activity against Mucorales.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoShda_vi7UOLVg90H21EOLACvtfcHk0ljnbdf5QCHWrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFylt78%253D&md5=989fc1da0071586ef267a83a9817f6eb</span></div><a href="/servlet/linkout?suffix=cit110b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerweij%26aufirst%3DP.%2BE.%26aulast%3DGonzalez%26aufirst%3DG.%2BM.%26aulast%3DWiederhold%26aufirst%3DN.%2BP.%26aulast%3DLass-Florl%26aufirst%3DC.%26aulast%3DWarn%26aufirst%3DP.%26aulast%3DHeep%26aufirst%3DM.%26aulast%3DGhannoum%26aufirst%3DM.%2BA.%26aulast%3DGuinea%26aufirst%3DJ.%26atitle%3DIn%2520vitro%2520antifungal%2520activity%2520of%2520isavuconazole%2520against%2520345%2520mucorales%2520isolates%2520collected%2520at%2520study%2520centers%2520in%2520eight%2520countries%26jtitle%3DJ.%2520Chemother.%26date%3D2009%26volume%3D21%26spage%3D272%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, K.</span><span> </span><span class="NLM_article-title">Lipoprotein lipase activator NO-1886</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=133-142&author=W.+Yinauthor=K.+Tsutsumi&title=Lipoprotein+lipase+activator+NO-1886"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DTsutsumi%26aufirst%3DK.%26atitle%3DLipoprotein%2520lipase%2520activator%2520NO-1886%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2003%26volume%3D21%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Blake, P.</span><span> </span><span class="NLM_article-title">An overview of clinical trial experience with epanolol</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=81-85&author=P.+Blake&title=An+overview+of+clinical+trial+experience+with+epanolol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DP.%26atitle%3DAn%2520overview%2520of%2520clinical%2520trial%2520experience%2520with%2520epanolol%26jtitle%3DDrugs%26date%3D1989%26volume%3D38%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit112b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Harry, J. D.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of epanolol. Pharmacodynamic aspects</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=18-27&author=J.+D.+Harry&title=Clinical+pharmacology+of+epanolol.+Pharmacodynamic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarry%26aufirst%3DJ.%2BD.%26atitle%3DClinical%2520pharmacology%2520of%2520epanolol.%2520Pharmacodynamic%2520aspects%26jtitle%3DDrugs%26date%3D1989%26volume%3D38%26spage%3D18%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tanii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">Structureâtoxicity relationship of aliphatic nitriles</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">â</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0378-4274%2884%2990077-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=6474517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2cXmt1Ciurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1984&pages=267-272&author=H.+Taniiauthor=K.+Hashimoto&title=Structure%E2%88%92toxicity+relationship+of+aliphatic+nitriles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113aR"><div class="casContent"><span class="casTitleNuber">113a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-toxicity relationship of aliphatic nitriles</span></div><div class="casAuthors">Tanii, Hideji; Hashimoto, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-72</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    </div><div class="casAbstract">Acute toxicity, in vitro metab., and structure-toxicity relations of aliph. mononitriles were examd. in mice pretreated with CCl4  [56-23-5].  The LD50 in mice pretreated with CCl4 (LD50-CCl4) was increased in most nitriles compared to that in untreated animals (LD50-control) with different degrees among compds.  Microsomal metab. of nitriles to cyanide was completely inhibited when microsomes were prepd. from livers of mice pretreated with CCl4.  Log (1/LD50-CCl4) was a linear function of partition coeff., log P, i.e., log (1/LD50-CCl4) = -0.371 log P-0.152, and the equation was significant, provided aceto-  [75-05-8] and 3-hydroxypropionitrile  [109-78-4] were omitted from the anal.  These 2 compds. seem to be different from the others in exerting their biol. effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRW3q6SVdzE7Vg90H21EOLACvtfcHk0lhcYPn6Y9BKHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmt1Ciurs%253D&md5=035dc260fe0055b320eb388f7f67a72d</span></div><a href="/servlet/linkout?suffix=cit113a&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2884%2990077-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252884%252990077-8%26sid%3Dliteratum%253Aachs%26aulast%3DTanii%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592toxicity%2520relationship%2520of%2520aliphatic%2520nitriles%26jtitle%3DToxicol.%2520Lett.%26date%3D1984%26volume%3D22%26spage%3D267%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit113b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ahmed, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieff, N. M.</span><span> </span><span class="NLM_article-title">Aliphatic nitriles: metabolism and toxicity</span> <span class="citation_source-journal">Prog. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL3sXltFOhtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1983&pages=229-294&author=A.+E.+Ahmedauthor=N.+M.+Trieff&title=Aliphatic+nitriles%3A+metabolism+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113bR"><div class="casContent"><span class="casTitleNuber">113b</span><div class="casTitle"><span class="NLM_cas:atitle">Aliphatic nitriles: metabolism and toxicity</span></div><div class="casAuthors">Ahmed, A. E.; Trieff, N. M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Drug Metabolism</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">229-94</span>CODEN:
                <span class="NLM_cas:coden">PDMEDP</span>;
        ISSN:<span class="NLM_cas:issn">0364-8974</span>.
    </div><div class="casAbstract">A review with many refs. on the metab., toxicity, and environmental impact of aliph. nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnlhtDsizb7Vg90H21EOLACvtfcHk0lhcYPn6Y9BKHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltFOhtLc%253D&md5=7bfd3e56a5b91f79cff2fdde2ff3c4a7</span></div><a href="/servlet/linkout?suffix=cit113b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%2BE.%26aulast%3DTrieff%26aufirst%3DN.%2BM.%26atitle%3DAliphatic%2520nitriles%253A%2520metabolism%2520and%2520toxicity%26jtitle%3DProg.%2520Drug%2520Metab.%26date%3D1983%26volume%3D7%26spage%3D229%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit113c"><span><div class="note"><p class="first last">For recent AMES analyses of several alkylnitriles see the following: </p></div><span class="NLM_contrib-group">Wu, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hseu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. C.</span><span> </span><span class="NLM_article-title">Comparative investigations of genotoxic activity of five nitriles in the comet assay and the Ames test</span> <span class="citation_source-journal">J. Hazard. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">â</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113c&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.jhazmat.2009.03.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19414215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlyjsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2009&pages=492-497&author=J.-C.+Wuauthor=Y.+C.+Hseuauthor=C.-H.+Chenauthor=S.-H.+Wangauthor=S.+C.+Chen&title=Comparative+investigations+of+genotoxic+activity+of+five+nitriles+in+the+comet+assay+and+the+Ames+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113cR"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative investigations of genotoxic activity of five nitriles in the comet assay and the Ames test</span></div><div class="casAuthors">Wu, Jong-C.; Hseu, You C.; Chen, Chin-H.; Wang, Shu- H.; Chen, Ssu. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hazardous Materials</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">492-497</span>CODEN:
                <span class="NLM_cas:coden">JHMAD9</span>;
        ISSN:<span class="NLM_cas:issn">0304-3894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two short-term assays, the modified Ames test and the comet assay, were carried out to evaluate the genotoxicity of 5 nitriles (acetonitrile, propionitrile, methacrylonitrile, butyronitrile, and benzonitrile).  With the comet assay, all the nitriles studied were found to induce the genotoxicity in human lymphocytes and Hep G2 cells.  Except for butyronitrile, the genotoxic potency in lymphocytes was more pronounced than that in Hep G2 cells, and the rank order of genotoxicity induced by these 5 nitriles in lymphocytes was different from that in Hep G2 cells, indicating that the pathways leading to genotoxicity in both types of cells were different.  In the modified Ames test, no tested nitriles showed mutagenic activity on Salmonella typhimurium strain TA 98 and TA 100 with and without metabolic activation.  Comparing the results obtained from both tests, the comet assay seems to be more sensitive than the modified Ames test.  Thus, the comet assay can be used to detect the genotoxicity of all nitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9dHOwwV-HrVg90H21EOLACvtfcHk0lhcYPn6Y9BKHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlyjsrY%253D&md5=176179197fe05f8293c609b2bb30c723</span></div><a href="/servlet/linkout?suffix=cit113c&amp;dbid=16384&amp;doi=10.1016%2Fj.jhazmat.2009.03.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhazmat.2009.03.121%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-C.%26aulast%3DHseu%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DWang%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DS.%2BC.%26atitle%3DComparative%2520investigations%2520of%2520genotoxic%2520activity%2520of%2520five%2520nitriles%2520in%2520the%2520comet%2520assay%2520and%2520the%2520Ames%2520test%26jtitle%3DJ.%2520Hazard.%2520Mater.%26date%3D2009%26volume%3D169%26spage%3D492%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, D. A.</span><span> </span><span class="NLM_article-title">Anastrozole use in early stage breast cancer of post-menopausal women</span> <span class="citation_source-journal">Clin. Med. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19794821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKjs73O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=141-156&author=M.+Milaniauthor=G.+Jhaauthor=D.+A.+Potter&title=Anastrozole+use+in+early+stage+breast+cancer+of+post-menopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114aR"><div class="casContent"><span class="casTitleNuber">114a</span><div class="casTitle"><span class="NLM_cas:atitle">Anastrozole use in early stage breast cancer of post-menopausal women</span></div><div class="casAuthors">Milani, Monica; Jha, Gautam; Potter, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Medicine: Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-156</span>CODEN:
                <span class="NLM_cas:coden">CMTLCY</span>;
        ISSN:<span class="NLM_cas:issn">1179-1713</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica</span>)
        </div><div class="casAbstract">A review.  The majority of breast cancers express the estrogen receptor and depend on estradiol (E2) for their growth.  Hormonal therapy aims at depriving estrogen signaling either by using selective estrogen receptor modulators (SERM)-that interfere with the binding of E2 to its receptor (ER)-or aromatase inhibitors (AI)-that block the aromatase-dependent synthesis of E2.  While SERMs are recommended for both pre- and post-menopausal patients, AIs are indicated only for post-menopausal patients.  For the past 20 years, the SERM tamoxifen has been considered the "gold std." for the treatment of hormone receptor pos. breast cancers.  However, tamoxifen's role is now challenged by third generation AIs, such as anastrozole, which exhibit greater efficacy in the adjuvant setting in several recently reported trials.  This review will focus on anastrozole's mechanism of action, dosing, pharmacol., pharmacokinetics, and clin. applications.  It will briefly discuss the clin. trials that detd. anastrozole's efficacy in the treatment of advanced breast cancer (ABC) and in the neo-adjuvant setting.  Finally, it will present the clin. trials that established anastrozole as a frontline agent in the treatment of post-menopausal women with hormone receptor pos. early breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohKKI6OgFNxLVg90H21EOLACvtfcHk0lhnZ-CPTxqh0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKjs73O&md5=e8b154730698d2aa438aa6dddddd540c</span></div><a href="/servlet/linkout?suffix=cit114a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilani%26aufirst%3DM.%26aulast%3DJha%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DD.%2BA.%26atitle%3DAnastrozole%2520use%2520in%2520early%2520stage%2520breast%2520cancer%2520of%2520post-menopausal%2520women%26jtitle%3DClin.%2520Med.%2520Ther.%26date%3D2009%26volume%3D1%26spage%3D141%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit114b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gangadhara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelli, G.</span><span> </span><span class="NLM_article-title">Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women</span> <span class="citation_source-journal">Ther. Clin. Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19753124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yltL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=291-300&author=S.+Gangadharaauthor=G.+Bertelli&title=Long-term+efficacy+and+safety+of+anastrozole+for+adjuvant+treatment+of+early+breast+cancer+in+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114bR"><div class="casContent"><span class="casTitleNuber">114b</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women</span></div><div class="casAuthors">Gangadhara, Sharath; Bertelli, Gianfilippo</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-300</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1178-203X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  For more than 20 years, tamoxifen has been the gold std. for the adjuvant treatment of postmenopausal women with hormone-responsive early breast cancer.  However, recent randomized trials have shown efficacy and tolerability benefits with the third-generation aromatase inhibitor anastrozole, resulting in an increased use of this agent in the adjuvant setting.  Data on anastrozole's long-term efficacy and tolerability are therefore of interest in clin. practice and will be reviewed here, esp. in the light of the 100-mo anal. of the ATAC (Anastrozole, Tamoxifen Alone or in Combination) trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwHF4VpLSG0bVg90H21EOLACvtfcHk0lhnZ-CPTxqh0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yltL8%253D&md5=97242d458accd9c554107e80c252b946</span></div><a href="/servlet/linkout?suffix=cit114b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangadhara%26aufirst%3DS.%26aulast%3DBertelli%26aufirst%3DG.%26atitle%3DLong-term%2520efficacy%2520and%2520safety%2520of%2520anastrozole%2520for%2520adjuvant%2520treatment%2520of%2520early%2520breast%2520cancer%2520in%2520postmenopausal%2520women%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2009%26volume%3D5%26spage%3D291%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modeling</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">603</span><span class="NLM_x">â</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=603-618&issue=3&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Non-steroidal+aromatase+inhibitors+based+on+a+biphenyl+scaffold%3A+synthesis%2C+in+vitro+SAR%2C+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DNon-steroidal%2520aromatase%2520inhibitors%2520based%2520on%2520a%2520biphenyl%2520scaffold%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520and%2520molecular%2520modeling%26jtitle%3DChemMedChem%26date%3D2008%26issue%3D3%26spage%3D603%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit115b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2940</span><span class="NLM_x">â</span> <span class="NLM_lpage">2952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2940-2952&issue=5&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Dual+aromatase-sulfatase+inhibitors+based+on+the+anastrozole+template%3A+synthesis%2C+in+vitro+SAR%2C+molecular+modelling+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDual%2520aromatase-sulfatase%2520inhibitors%2520based%2520on%2520the%2520anastrozole%2520template%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520molecular%2520modelling%2520and%2520in%2520vivo%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26issue%3D5%26spage%3D2940%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cooper-DeHoff, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handberg, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legler, U. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepine, C. J.</span><span> </span><span class="NLM_article-title">INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study</span> <span class="citation_source-journal">Expert Rev. Cardiovasc. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">â</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1586%2Ferc.09.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19900016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2ksrjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1329-1340&author=R.+M.+Cooper-DeHoffauthor=E.+M.+Handbergauthor=G.+Manciaauthor=Q.+Zhouauthor=A.+Championauthor=U.+F.+Leglerauthor=C.+J.+Pepine&title=INVEST+revisited%3A+review+of+findings+from+the+International+Verapamil+SR-Trandolapril+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116aR"><div class="casContent"><span class="casTitleNuber">116a</span><div class="casTitle"><span class="NLM_cas:atitle">INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study</span></div><div class="casAuthors">Cooper-DeHoff, Rhonda M.; Handberg, Eileen M.; Mancia, Giuseppe; Zhou, Qian; Champion, Annette; Legler, Udo F.; Pepine, Carl J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Cardiovascular Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1340</span>CODEN:
                <span class="NLM_cas:coden">ERCTAS</span>;
        ISSN:<span class="NLM_cas:issn">1477-9072</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The International Verapamil SR-Trandolapril Study (INVEST), a randomized trial of 22,576 predominantly elderly patients with an av. 2.7-yr follow-up, compared a calcium antagonist-led strategy (verapamil SR plus trandolapril) with a Î²-blocker-led strategy (atenolol plus hydrochlorothiazide) for hypertension treatment and prevention of cardiovascular outcomes in coronary artery disease patients.  Patients received individualized dose and drug titrn. following a flexible, multi-drug, guideline-based treatment algorithm, with the objective of achieving optimal blood pressure (BP) control individualized for comorbidities (e.g., diabetes).  The primary outcome (PO) was first occurrence of death (all-cause), nonfatal myocardial infarction or nonfatal stroke.  The strategies resulted in significant and very similar BP redn., with approx. 70% of patients in both strategies achieving BP control (<140/90 mmHg).  Increasing no. of office visits with BP in control was assocd. with reduced risk of the PO.  Overall, there was no difference in the PO comparing the strategies; however, new-onset diabetes occurred more frequently in those assigned the atenolol strategy.  This report summarizes findings from INVEST and puts them in perspective with our current state of knowledge derived from other large hypertension treatment trials.  INVEST findings support that BP redn. is important for prevention of adverse cardiovascular morbidity and mortality, and selection of antihypertensive agents should be based on patient comorbidities and other risk factors (e.g., risk for diabetes) and not necessarily that any one drug be given to all.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7JaZ_1oRZ57Vg90H21EOLACvtfcHk0lhnZ-CPTxqh0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2ksrjM&md5=86cc8f0acf12ec0e77e1df0e7ab5edef</span></div><a href="/servlet/linkout?suffix=cit116a&amp;dbid=16384&amp;doi=10.1586%2Ferc.09.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Ferc.09.102%26sid%3Dliteratum%253Aachs%26aulast%3DCooper-DeHoff%26aufirst%3DR.%2BM.%26aulast%3DHandberg%26aufirst%3DE.%2BM.%26aulast%3DMancia%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DChampion%26aufirst%3DA.%26aulast%3DLegler%26aufirst%3DU.%2BF.%26aulast%3DPepine%26aufirst%3DC.%2BJ.%26atitle%3DINVEST%2520revisited%253A%2520review%2520of%2520findings%2520from%2520the%2520International%2520Verapamil%2520SR-Trandolapril%2520Study%26jtitle%3DExpert%2520Rev.%2520Cardiovasc.%2520Ther.%26date%3D2009%26volume%3D7%26spage%3D1329%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit116b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sica, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisant, L. M.</span><span> </span><span class="NLM_article-title">Pharmacologic and therapeutic considerations in hypertension therapy with calcium channel blockers: focus on verapamil</span> <span class="citation_source-journal">J. Clin. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1524-6175.2007.06504.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVKjtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1-22&author=D.+A.+Sicaauthor=L.+M.+Prisant&title=Pharmacologic+and+therapeutic+considerations+in+hypertension+therapy+with+calcium+channel+blockers%3A+focus+on+verapamil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116bR"><div class="casContent"><span class="casTitleNuber">116b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic and therapeutic considerations in hypertension therapy with calcium channel blockers: focus on verapamil</span></div><div class="casAuthors">Sica, Domenic A.; Prisant, L. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hypertension (Shelton, CT, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2, Suppl. 2</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">JCHYFN</span>;
        ISSN:<span class="NLM_cas:issn">1524-6175</span>.
    
            (<span class="NLM_cas:orgname">Le Jacq Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past 2 decades, calcium channel blockers have emerged as important and useful agents for treating hypertension.  The safety of this drug class has been vigorously debated for some time, and it has only been in the past few years that such debate has been quieted by favorable outcomes data with these compds.  Calcium channel blockers are a heterogeneous group of compds. as alike as they are dissimilar.  Calcium channel blockers can be sepd. into dihydropyridine and nondihydropyridine subclasses, with representatives of the latter being verapamil and diltiazem.  A lengthy treatment experience exists for verapamil, a compd. that has progressed from an immediate-release to a sustained-release and, more recently, a delayed/sustained-release formulation designated for administration at bedtime.  This latter formulation synchronizes drug delivery with the early morning rise in blood pressure, which is a particularly attractive feature when viewed in the context of the distinctive pharmacokinetic and pharmacodynamic features of verapamil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgY1o3sbX-fLVg90H21EOLACvtfcHk0lhsogdlURU_Uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVKjtLs%253D&md5=26d0e822546b776080ea986a6ab7980b</span></div><a href="/servlet/linkout?suffix=cit116b&amp;dbid=16384&amp;doi=10.1111%2Fj.1524-6175.2007.06504.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1524-6175.2007.06504.x%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DD.%2BA.%26aulast%3DPrisant%26aufirst%3DL.%2BM.%26atitle%3DPharmacologic%2520and%2520therapeutic%2520considerations%2520in%2520hypertension%2520therapy%2520with%2520calcium%2520channel%2520blockers%253A%2520focus%2520on%2520verapamil%26jtitle%3DJ.%2520Clin.%2520Hypertens.%26date%3D2007%26volume%3D9%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Brogden, R. N</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P.</span><span> </span><span class="NLM_article-title">Gallopamil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart disease</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">â</span> <span class="NLM_lpage">115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1994&pages=93-115&author=R.+N+Brogdenauthor=P.+Benfield&title=Gallopamil.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+potential+in+ischaemic+heart+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrogden%26aufirst%3DR.%2BN%26aulast%3DBenfield%26aufirst%3DP.%26atitle%3DGallopamil.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520potential%2520in%2520ischaemic%2520heart%2520disease%26jtitle%3DDrugs%26date%3D1994%26volume%3D47%26spage%3D93%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Mannhold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtje, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koke, V.</span><span> </span><span class="NLM_article-title">Importance of nitrile substitution for the calcium antagonistic action of verapamil</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">â</span> <span class="NLM_lpage">998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fardp.19863191107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2sXht1eguw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1986&pages=990-998&author=R.+Mannholdauthor=H.+D.+Holtjeauthor=V.+Koke&title=Importance+of+nitrile+substitution+for+the+calcium+antagonistic+action+of+verapamil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of nitrile substitution for the calcium antagonistic action of verapamil</span></div><div class="casAuthors">Mannhold, Raimund; Hoeltje, Hans Dieter; Koke, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">990-8</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    </div><div class="casAbstract">The effects of (Â±)-verapamil (I)  [56949-77-0], its congeners, obtained by exchange of the nitrile substituent, and D 846 (II)  [103768-76-9], a structural isomer, on the contractile activity were investigated in isotonically contracting cat papillary muscle.  Results indicate that the nitrile substituent is essential for the neg. inotropic action of verapamil.  Investigations with an ortho disubstituted structural isomer of verapamil showed an unchanged mode of action, while potency is decreased.  These findings can be explained on the basis of differences in the steric and electronic properties of the mols. under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXA0EE76sNXrVg90H21EOLACvtfcHk0lhsogdlURU_Uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXht1eguw%253D%253D&md5=85324463efafbd3a8db9d8b6251fcbf8</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fardp.19863191107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19863191107%26sid%3Dliteratum%253Aachs%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DHoltje%26aufirst%3DH.%2BD.%26aulast%3DKoke%26aufirst%3DV.%26atitle%3DImportance%2520of%2520nitrile%2520substitution%2520for%2520the%2520calcium%2520antagonistic%2520action%2520of%2520verapamil%26jtitle%3DArch.%2520Pharm.%26date%3D1986%26volume%3D319%26spage%3D990%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Cheng, R. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonov, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhorov, B. S.</span><span> </span><span class="NLM_article-title">Structural model for phenylalkylamine binding to L-type calcium channels</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">28332</span><span class="NLM_x">â</span> <span class="NLM_lpage">28342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=28332-28342&author=R.+C.+K.+Chengauthor=D.+B.+Tikhonovauthor=B.+S.+Zhorov&title=Structural+model+for+phenylalkylamine+binding+to+L-type+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DR.%2BC.%2BK.%26aulast%3DTikhonov%26aufirst%3DD.%2BB.%26aulast%3DZhorov%26aufirst%3DB.%2BS.%26atitle%3DStructural%2520model%2520for%2520phenylalkylamine%2520binding%2520to%2520L-type%2520calcium%2520channels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D28332%26epage%3D28342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citarella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span> </span><span class="NLM_article-title">Novel multidrug resistance reversal agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">â</span> <span class="NLM_lpage">2161</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9804477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2145-2161&author=D.+Bergerauthor=R.+Citarellaauthor=M.+Dutiaauthor=L.+Greenbergerauthor=W.+Hallettauthor=R.+Paulauthor=D.+Powell&title=Novel+multidrug+resistance+reversal+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120a&amp;dbid=16384&amp;doi=10.1021%2Fjm9804477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9804477%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DD.%26aulast%3DCitarella%26aufirst%3DR.%26aulast%3DDutia%26aufirst%3DM.%26aulast%3DGreenberger%26aufirst%3DL.%26aulast%3DHallett%26aufirst%3DW.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DD.%26atitle%3DNovel%2520multidrug%2520resistance%2520reversal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2145%26epage%3D2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit120b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Teodori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quidu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier-Suillerot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapecchi, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">â</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980440p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1687-1697&author=E.+Teodoriauthor=S.+Deiauthor=P.+Quiduauthor=R.+Budriesiauthor=A.+Chiariniauthor=A.+Garnier-Suillerotauthor=F.+Gualtieriauthor=D.+Manettiauthor=M.+N.+Romanelliauthor=S.+Scapecchi&title=Design%2C+synthesis%2C+and+in+vitro+activity+of+catamphiphilic+reverters+of+multidrug+resistance%3A+discovery+of+a+selective%2C+highly+efficacious+chemosensitizer+with+potency+in+the+nanomolar+range"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120b&amp;dbid=16384&amp;doi=10.1021%2Fjm980440p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980440p%26sid%3Dliteratum%253Aachs%26aulast%3DTeodori%26aufirst%3DE.%26aulast%3DDei%26aufirst%3DS.%26aulast%3DQuidu%26aufirst%3DP.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DChiarini%26aufirst%3DA.%26aulast%3DGarnier-Suillerot%26aufirst%3DA.%26aulast%3DGualtieri%26aufirst%3DF.%26aulast%3DManetti%26aufirst%3DD.%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DScapecchi%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520activity%2520of%2520catamphiphilic%2520reverters%2520of%2520multidrug%2520resistance%253A%2520discovery%2520of%2520a%2520selective%252C%2520highly%2520efficacious%2520chemosensitizer%2520with%2520potency%2520in%2520the%2520nanomolar%2520range%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1687%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Rennard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knobil, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabe, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locantore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonica, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnhart, F.</span><span> </span><span class="NLM_article-title">The efficacy and safety of cilomilast in COPD</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3-57&author=S.+Rennardauthor=K.+Knobilauthor=K.+F.+Rabeauthor=A.+Morrisauthor=N.+Schachterauthor=N.+Locantoreauthor=W.+G.+Canonicaauthor=Y.+Zhuauthor=F.+Barnhart&title=The+efficacy+and+safety+of+cilomilast+in+COPD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRennard%26aufirst%3DS.%26aulast%3DKnobil%26aufirst%3DK.%26aulast%3DRabe%26aufirst%3DK.%2BF.%26aulast%3DMorris%26aufirst%3DA.%26aulast%3DSchachter%26aufirst%3DN.%26aulast%3DLocantore%26aufirst%3DN.%26aulast%3DCanonica%26aufirst%3DW.%2BG.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DBarnhart%26aufirst%3DF.%26atitle%3DThe%2520efficacy%2520and%2520safety%2520of%2520cilomilast%2520in%2520COPD%26jtitle%3DDrugs%26date%3D2008%26volume%3D68%26spage%3D3%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Christensen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWolf, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnette, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslinski, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochnowicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grous, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillegas, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâLeary Bartus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torphy, T. J.</span><span> </span><span class="NLM_article-title">1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">â</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970090r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=821-835&author=S.+B.+Christensenauthor=A.+Guiderauthor=C.+J.+Forsterauthor=J.+G.+Gleasonauthor=P.+E.+Benderauthor=J.+M.+Karpinskiauthor=W.+E.+DeWolfauthor=M.+S.+Barnetteauthor=D.+C.+Underwoodauthor=D.+E.+Griswoldauthor=L.+B.+Cieslinskiauthor=M.+Burmanauthor=S.+Bochnowiczauthor=R.+R.+Osbornauthor=C.+D.+Manningauthor=M.+Grousauthor=L.+M.+Hillegasauthor=J.+O%E2%80%99Leary+Bartusauthor=M.+D.+Ryanauthor=D.+S.+Egglestonauthor=R.+C.+Haltiwangerauthor=T.+J.+Torphy&title=1%2C4-Cyclohexanecarboxylates%3A+potent+and+selective+inhibitors+of+phosophodiesterase+4+for+the+treatment+of+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm970090r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970090r%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DGuider%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DC.%2BJ.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBender%26aufirst%3DP.%2BE.%26aulast%3DKarpinski%26aufirst%3DJ.%2BM.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DBarnette%26aufirst%3DM.%2BS.%26aulast%3DUnderwood%26aufirst%3DD.%2BC.%26aulast%3DGriswold%26aufirst%3DD.%2BE.%26aulast%3DCieslinski%26aufirst%3DL.%2BB.%26aulast%3DBurman%26aufirst%3DM.%26aulast%3DBochnowicz%26aufirst%3DS.%26aulast%3DOsborn%26aufirst%3DR.%2BR.%26aulast%3DManning%26aufirst%3DC.%2BD.%26aulast%3DGrous%26aufirst%3DM.%26aulast%3DHillegas%26aufirst%3DL.%2BM.%26aulast%3DO%25E2%2580%2599Leary%2BBartus%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DM.%2BD.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DTorphy%26aufirst%3DT.%2BJ.%26atitle%3D1%252C4-Cyclohexanecarboxylates%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosophodiesterase%25204%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D821%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Ochiai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Orally active PDE4 inhibitors with therapeutic potential</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1323</span><span class="NLM_x">â</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1323-1327&author=H.+Ochiaiauthor=T.+Ohtaniauthor=A.+Ishidaauthor=K.+Kishikawaauthor=T.+Obataauthor=H.+Nakaiauthor=M.+Toda&title=Orally+active+PDE4+inhibitors+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOchiai%26aufirst%3DH.%26aulast%3DOhtani%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DA.%26aulast%3DKishikawa%26aufirst%3DK.%26aulast%3DObata%26aufirst%3DT.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DOrally%2520active%2520PDE4%2520inhibitors%2520with%2520therapeutic%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1323%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Kodimuthali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabaris, S. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, M.</span><span> </span><span class="NLM_article-title">Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">â</span> <span class="NLM_lpage">5489</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800582j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5471-5489&author=A.+Kodimuthaliauthor=S.+S.+L.+Jabarisauthor=M.+Pal&title=Recent+advances+on+phosphodiesterase+4+inhibitors+for+the+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm800582j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800582j%26sid%3Dliteratum%253Aachs%26aulast%3DKodimuthali%26aufirst%3DA.%26aulast%3DJabaris%26aufirst%3DS.%2BS.%2BL.%26aulast%3DPal%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520on%2520phosphodiesterase%25204%2520inhibitors%2520for%2520the%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5471%26epage%3D5489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizizad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span> </span><span class="NLM_article-title">Structural basis for the activity of drugs that inhibit phosphodiesterases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2233</span><span class="NLM_x">â</span> <span class="NLM_lpage">2247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.str.2004.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15576036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2233-2247&author=G.+L.+Cardauthor=B.+P.+Englandauthor=Y.+Suzukiauthor=D.+Fongauthor=B.+Powellauthor=B.+Leeauthor=C.+Luuauthor=M.+Tabrizizadauthor=S.+Gilletteauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.-H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+J.+Zhang&title=Structural+basis+for+the+activity+of+drugs+that+inhibit+phosphodiesterases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases</span></div><div class="casAuthors">Card, Graeme L.; England, Bruce P.; Suzuki, Yoshihisa; Fong, Daniel; Powell, Ben; Lee, Byunghun; Luu, Catherine; Tabrizizad, Maryam; Gillette, Sam; Ibrahim, Prabha N.; Artis, Dean R.; Bollag, Gideon; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2233-2247</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases.  The authors describe the high-resoln. crystal structures of the catalytic domains of PDE4B, PDE4D, and PDE5A with ten different inhibitors, including the drug candidates cilomilast and roflumilast, for respiratory diseases.  These cocrystal structures reveal a common scheme of inhibitor binding to the PDEs: (i) a hydrophobic clamp formed by highly conserved hydrophobic residues that sandwich the inhibitor in the active site; (ii) hydrogen bonding to an invariant glutamine that controls the orientation of inhibitor binding.  A scaffold can be readily identified for any given inhibitor based on the formation of these two types of conserved interactions.  These structural insights will enable the design of isoform-selective inhibitors with improved binding affinity and should facilitate the discovery of more potent and selective PDE inhibitors for the treatment of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8l4KWCohSy7Vg90H21EOLACvtfcHk0liQeePE6vq_eQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K&md5=0fa91e4b9047e3df3946c526592be396</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520activity%2520of%2520drugs%2520that%2520inhibit%2520phosphodiesterases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D2233%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Noble, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTavish, D.</span><span> </span><span class="NLM_article-title">Levocabastine: an update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">â</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1032-1049&author=S.+Nobleauthor=D.+McTavish&title=Levocabastine%3A+an+update+of+its+pharmacology%2C+clinical+efficacy+and+tolerability+in+the+topical+treatment+of+allergic+rhinitis+and+conjunctivitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DS.%26aulast%3DMcTavish%26aufirst%3DD.%26atitle%3DLevocabastine%253A%2520an%2520update%2520of%2520its%2520pharmacology%252C%2520clinical%2520efficacy%2520and%2520tolerability%2520in%2520the%2520topical%2520treatment%2520of%2520allergic%2520rhinitis%2520and%2520conjunctivitis%26jtitle%3DDrugs%26date%3D1995%26volume%3D50%26spage%3D1032%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottiger, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M.</span><span> </span><span class="NLM_article-title">New insights in postoperative pain therapy</span> <span class="citation_source-journal">Anasthesiol Intensivmed Notfallmed Schmerzther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">â</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1055%2Fs-2004-814314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15042506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A280%3ADC%252BD2c7kslyktg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=157-164&author=A.+Brackauthor=B.+W.+Bottigerauthor=M.+Schafer&title=New+insights+in+postoperative+pain+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127aR"><div class="casContent"><span class="casTitleNuber">127a</span><div class="casTitle"><span class="NLM_cas:atitle">New insights in postoperative pain therapy</span></div><div class="casAuthors">Brack A; Bottiger B W; Schafer M</div><div class="citationInfo"><span class="NLM_cas:title">Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-64</span>
        ISSN:<span class="NLM_cas:issn">0939-2661</span>.
    </div><div class="casAbstract">In this review, novel clinical studies on postoperative pain therapy are summarized.  Based on these studies, several conclusions can be drawn: i) following tonsillectomy, postoperative therapy with NSAIDs leads to a significant increase in the number of reoperations; thus NSAIDs should be used with caution; ii) COX-2 inhibitors in combination with intravenous opioids improve recovery and functional outcome after knee replacement surgery; iii) the combination therapy of different non-opioid analgesics has no proven clinical efficacy and should not be used routinely; iv) patients' age is not a determinant in postoperative opioid titration after surgery; in contrast, it does predict opioid consumption during the first postoperative day; v) morphine and piritramide have identical analgesic efficacy and induce nausea and vomiting with the incidence; opioid selection can, thus, be based on economic considerations and vi) if tramadol is ineffective in postoperative pain therapy, this might be caused by an allelic variant of one of the cytochrome P450 enzymes (CYP2D6); these patients should be treated with a different opioid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlxfC9Cq1Eu3qj_yg7twvpfW6udTcc2eaBnV2nbb-Shbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7kslyktg%253D%253D&md5=ecb88b77d074e41b99f50301e202e135</span></div><a href="/servlet/linkout?suffix=cit127a&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-814314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-814314%26sid%3Dliteratum%253Aachs%26aulast%3DBrack%26aufirst%3DA.%26aulast%3DBottiger%26aufirst%3DB.%2BW.%26aulast%3DSchafer%26aufirst%3DM.%26atitle%3DNew%2520insights%2520in%2520postoperative%2520pain%2520therapy%26jtitle%3DAnasthesiol%2520Intensivmed%2520Notfallmed%2520Schmerzther%26date%3D2004%26volume%3D39%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit127b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bouillon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kietzmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meineke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeft, A.</span><span> </span><span class="NLM_article-title">Population pharmacokinetics of piritramide in surgical patients</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1999&pages=7-15&author=T.+Bouillonauthor=D.+Kietzmannauthor=R.+Portauthor=I.+Meinekeauthor=A.+Hoeft&title=Population+pharmacokinetics+of+piritramide+in+surgical+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouillon%26aufirst%3DT.%26aulast%3DKietzmann%26aufirst%3DD.%26aulast%3DPort%26aufirst%3DR.%26aulast%3DMeineke%26aufirst%3DI.%26aulast%3DHoeft%26aufirst%3DA.%26atitle%3DPopulation%2520pharmacokinetics%2520of%2520piritramide%2520in%2520surgical%2520patients%26jtitle%3DAnesthesiology%26date%3D1999%26volume%3D90%26spage%3D7%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit127c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Freye, E.</span><span> </span><span class="NLM_article-title">Postoperative pain treatment</span> <span class="citation_source-journal">Anaesthesiol. Reanim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">â</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127c&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=1686169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127c&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A280%3ADyaK387ltlaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1991&pages=379-392&author=E.+Freye&title=Postoperative+pain+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127cR"><div class="casContent"><span class="casTitleNuber">127c</span><div class="casTitle"><span class="NLM_cas:atitle">Postoperative pain treatment</span></div><div class="casAuthors">Freye E</div><div class="citationInfo"><span class="NLM_cas:title">Anaesthesiologie und Reanimation</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">379-92</span>
        ISSN:<span class="NLM_cas:issn">0323-4983</span>.
    </div><div class="casAbstract">The postoperative care of patients usually is characterized by the fact that the individual need of pain killers is not sufficiently recognized.  An opioid given only when asked for, results in an underdosage as the patient does not receive the analgesic in time, so that he suffers pain.  As there is insufficient knowledge with regard to the pharmacology of opioids which can be used for postoperative pain therapy, physicians and nurses usually tend to give a lower dose in order to avoid any possible side-effects.  Considerations which lead to opioid underdosage include: the development of addiction and possible side-effects such as respiratory depression, heavy sedation, possible constipation and urinary retention.  The aim in postoperative pain therapy is a time-contingent dosing after careful intravenous titration of the compound in the lower dose range during continuous supervision.  Thus, the individual need in the recovery room can be estimated.  Only such a procedure helps to keep the patient pain-free over a long period of time, reduces the workload of nurses during the night, results in the reduction of complications and finally may even reduce the hospital stay.  Piritramide is a compound which has a number of potential advantages with regard to efficacy and side-effects in postoperative pain therapy.  It has the highest analgesic potency among those compounds suitable for postoperative pain therapy; when compared with pethidine, pentazocine or nalbuphine it shows remarkable cardiovascular stability.  In comparison to morphine, pethidine and pentazocine, piritramide has a lower incidence of nausea and vomiting.  With a mean duration of action of up to six hours, piritramide has an advantage over pentazocine (3 hours), pethidine (2-3 hours) and morphine (5-6 hours).  Compared to other mixed narcotic analgesics, piritramide does not induce dysphoric side-effects when given in the higher dose range and does not lead to addiction.  It is derived from the same group of agents such as fentanyl or alfentanil which are used in neuroleptanaesthesia so that there is an increase in analgesia one to the interaction with the same receptor site.  Piritramide has a fast onset of action, 2-5 minutes after intravenous injection and a peak action after 10 minutes.  In comparison to pethidine it has no cardiovascular effects, in particular no myocardial depression or increased myocardial oxygen demand (MVO2).  Last but not least, the cost-effectiveness is a financial factor of increasing importance to the institution that runs the hospital.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_OKFQZ1VQ0Nts4TFFB11gfW6udTcc2eaBnV2nbb-Shbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387ltlaiug%253D%253D&md5=5b9e4f021ec85202864ed757dc1286fd</span></div><a href="/servlet/linkout?suffix=cit127c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFreye%26aufirst%3DE.%26atitle%3DPostoperative%2520pain%2520treatment%26jtitle%3DAnaesthesiol.%2520Reanim.%26date%3D1991%26volume%3D16%26spage%3D379%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Jackson, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. E. H.</span><span> </span><span class="NLM_article-title">The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma</span> <span class="citation_source-journal">J. Pharmacol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">â</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2F0160-5402%2887%2990069-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=3682841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaL2sXmt1ygtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1987&pages=189-197&author=L.+S.+Jacksonauthor=J.+E.+H.+Stafford&title=The+evaluation+and+application+of+a+radioimmunoassay+for+the+measurement+of+diphenoxylic+acid%2C+the+major+metabolite+of+diphenoxylate+hydrochloride+%28Lomotil%29%2C+in+human+plasma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma</span></div><div class="casAuthors">Jackson, L. S.; Stafford, J. E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Methods</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-97</span>CODEN:
                <span class="NLM_cas:coden">JPMED9</span>;
        ISSN:<span class="NLM_cas:issn">0160-5402</span>.
    </div><div class="casAbstract">Antibodies to diphenoxylic acid (I) the pharmacol. active metabolite of Lomotil, were used to develop a precise and specific radioimmunoassay for the measurement of I in human plasma.  Plasma I levels in human volunteers rose to a mean max. level of 87.8 ng mL-1 3.3 h after dosing with 10 mg Lomotil.  By 24 h, plasma levels had decreased to 14.26 ng mL-1.  The appearance and elimination of plasma I could be described by a biexponential  function.  The appearance half-life was 0.82 h, and the elimination half-life was 7.24 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAq-T4TUzAL7Vg90H21EOLACvtfcHk0liCyci0GjTE9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmt1ygtr8%253D&md5=3c14d05f03974a512b6343a12ff74cb2</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2F0160-5402%2887%2990069-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0160-5402%252887%252990069-6%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DL.%2BS.%26aulast%3DStafford%26aufirst%3DJ.%2BE.%2BH.%26atitle%3DThe%2520evaluation%2520and%2520application%2520of%2520a%2520radioimmunoassay%2520for%2520the%2520measurement%2520of%2520diphenoxylic%2520acid%252C%2520the%2520major%2520metabolite%2520of%2520diphenoxylate%2520hydrochloride%2520%2528Lomotil%2529%252C%2520in%2520human%2520plasma%26jtitle%3DJ.%2520Pharmacol.%2520Methods%26date%3D1987%26volume%3D18%26spage%3D189%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Fleming, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span> </span><span class="NLM_article-title">Unsaturated nitriles: conjugate additions of carbon nucleophiles to a recalcitrant class of acceptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2035</span><span class="NLM_x">â</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr020045d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFKhurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=2035-2078&author=F.+F.+Flemingauthor=Q.+Wang&title=Unsaturated+nitriles%3A+conjugate+additions+of+carbon+nucleophiles+to+a+recalcitrant+class+of+acceptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Unsaturated Nitriles: Conjugate Additions of Carbon Nucleophiles to a Recalcitrant Class of Acceptors</span></div><div class="casAuthors">Fleming, Fraser F.; Wang, Qunzhao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2035-2077</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The review surveys conjugate addns. of various carbon nucleophiles to Î±,Î²-unsatd. nitriles not bearing an addnl. electron-withdrawing group.  The reactions of alkenenitriles are grouped according to the nature of a nucleophile and include addns. of Grignard and copper reagents, radical addns. of various organometallics, addn. of stabilized carbanions, addns. of enamines, etc.  Conjugate addns. to alkynenitriles are also reviewed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX3P5jUE6kwbVg90H21EOLACvtfcHk0lhG6l7P2W2aKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFKhurc%253D&md5=006c51a35bc2fcbf90b4cabe0709e1a6</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fcr020045d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020045d%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DUnsaturated%2520nitriles%253A%2520conjugate%2520additions%2520of%2520carbon%2520nucleophiles%2520to%2520a%2520recalcitrant%2520class%2520of%2520acceptors%26jtitle%3DChem.%2520Rev.%26date%3D2003%26volume%3D103%26spage%3D2035%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Seeberger, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, R. A.</span><span> </span><span class="NLM_article-title">Levodopa/carbidopa/entacapone in Parkinsonâs disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">â</span> <span class="NLM_lpage">940</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1586%2Fern.09.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19589043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=929-940&author=L.+C.+Seebergerauthor=R.+A.+Hauser&title=Levodopa%2Fcarbidopa%2Fentacapone+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Levodopa/carbidopa/entacapone in Parkinson's disease</span></div><div class="casAuthors">Seeberger, Lauren C.; Hauser, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">929-940</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is assocd. with the development of motor complications.  Mounting evidence indicates the short half-life of levodopa and resultant pulsatile stimulation of striatal dopamine receptors leads to wearing off, motor fluctuations and dyskinesias.  Longer acting dopaminergic agents, such as dopamine agonists, are less likely to cause motor fluctuations and dyskinesias but are not as efficacious for control of motor symptoms.  Therefore, there is interest in exploring ways to deliver levodopa in a more continuous fashion, in an effort to maintain benefit through the day and reduce the development of motor fluctuations and dyskinesias.  A dopa decarboxylase inhibitor (DDCI), such as carbidopa or benserazide, is administered with levodopa to attenuate its peripheral conversion to dopamine, reduce nausea and increase central bioavailability.  When levodopa is administered with a DDCI, its main route of peripheral metab. is via catechol-O-Me transferase (COMT).  A COMT inhibitor can be added to the combination of levodopa and a DDCI to further extend the levodopa peripheral half-life and increase central bioavailability.  Stalevo is a combination tablet comprised of levodopa, carbidopa, and the COMT inhibitor entacapone.  It is available in fixed-dose combinations of levodopa/carbidopa/entacapone, 50/12.5/200, 75/18.75/200, 100/25/200, 125/31.25/200, 150/37.5/200 and 200/50/200 mg.  Stalevo is currently approved for use in Parkinson's disease patients with end-of-dose wearing off.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGVC48bEG7YrVg90H21EOLACvtfcHk0lhG6l7P2W2aKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtLs%253D&md5=e4fd4790ddf82f86134bde9dc17231ca</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1586%2Fern.09.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.64%26sid%3Dliteratum%253Aachs%26aulast%3DSeeberger%26aufirst%3DL.%2BC.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26atitle%3DLevodopa%252Fcarbidopa%252Fentacapone%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D929%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lees, A. J.</span><span> </span><span class="NLM_article-title">Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinsonâs disease</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1755-5949.2007.00035.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18482101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvValsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=83-93&author=A.+J.+Lees&title=Evidence-based+efficacy+comparison+of+tolcapone+and+entacapone+as+adjunctive+therapy+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131aR"><div class="casContent"><span class="casTitleNuber">131a</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinson's disease</span></div><div class="casAuthors">Lees, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The relative efficacy has not been adequately established for the two catechol-O-methyltransferase (COMT) inhibitors that are currently available for adjunctive therapy in Parkinson's disease; tolcapone and entacapone.  A recent Cochrane meta-anal. of 14 studies in 2566 patients, conducted to assess the efficacy and safety of tolcapone and entacapone, found both to be statistically superior to placebo in increasing ON time and decreasing OFF time.  The meta-anal. also showed that the weighted mean difference from baseline to endpoint in tolcapone-treated patients was twice that in entacapone-treated patients for both placebo-cor. ON time and OFF time.  Withdrawal rates were generally lower for tolcapone.  Two addnl. studies have examd. the switch between tolcapone and entacapone.  In 40 Parkinson's disease patients with fluctuations who were switched from tolcapone to entacapone, improvements in ON time and redns. in OFF time were approx. twice the magnitude for tolcapone than for entacapone.  In a second study examg. the switch from entacapone to tolcapone, the results for several exploratory variables also suggested that tolcapone has greater efficacy than entacapone.  These findings indicate that tolcapone should be considered in all patients with entacapone-refractory motor fluctuations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXBklO3rk1LrVg90H21EOLACvtfcHk0lhG6l7P2W2aKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvValsr4%253D&md5=05ad47a9c34a362e745e9b04bbe763de</span></div><a href="/servlet/linkout?suffix=cit131a&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2007.00035.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2007.00035.x%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%2BJ.%26atitle%3DEvidence-based%2520efficacy%2520comparison%2520of%2520tolcapone%2520and%2520entacapone%2520as%2520adjunctive%2520therapy%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2008%26volume%3D14%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit131b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Clinical pharmacology and therapeutic use of COMT inhibition in Parkinsonâs disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">IV/37</span><span class="NLM_x">â</span> <span class="NLM_lpage">IV/48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=IV%2F37-IV%2F48&author=A.+Gordinauthor=D.+J.+Brooks&title=Clinical+pharmacology+and+therapeutic+use+of+COMT+inhibition+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520pharmacology%2520and%2520therapeutic%2520use%2520of%2520COMT%2520inhibition%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3DIV%252F37%26epage%3DIV%252F48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tervoa, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">NyrÃ¶nenb, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¶nkkÃ¶a, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posoa, A.</span><span> </span><span class="NLM_article-title">A structureâactivity relationship study of catechol-<i>O</i>-methyltransferase inhibitors combining molecular docking and 3D QSAR methods</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=797-810&author=A.+J.+Tervoaauthor=T.+H.+Nyr%C3%B6nenbauthor=T.+R%C3%B6nkk%C3%B6aauthor=A.+Posoa&title=A+structure%E2%88%92activity+relationship+study+of+catechol-O-methyltransferase+inhibitors+combining+molecular+docking+and+3D+QSAR+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTervoa%26aufirst%3DA.%2BJ.%26aulast%3DNyr%25C3%25B6nenb%26aufirst%3DT.%2BH.%26aulast%3DR%25C3%25B6nkk%25C3%25B6a%26aufirst%3DT.%26aulast%3DPosoa%26aufirst%3DA.%26atitle%3DA%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520of%2520catechol-O-methyltransferase%2520inhibitors%2520combining%2520molecular%2520docking%2520and%25203D%2520QSAR%2520methods%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2003%26volume%3D17%26spage%3D797%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For cocrystalization of COMT with a related inhibitor see the following:</p></div><div class="NLM_citation" id="rightTab-cit132b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span> </span><span class="NLM_article-title">Crystallization and preliminary crystallographic characterization of catechol-<i>O</i>-methyltransferase in complex with its cosubstrate and an inhibitor</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">D57</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">â</span> <span class="NLM_lpage">908</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D57&publication_year=2001&pages=906-908&author=M.+L.+Rodriguesauthor=M.+Archerauthor=M.+J.+Bonifacioauthor=P.+Soares-da-Silvaauthor=M.+A.+Carrondo&title=Crystallization+and+preliminary+crystallographic+characterization+of+catechol-O-methyltransferase+in+complex+with+its+cosubstrate+and+an+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26atitle%3DCrystallization%2520and%2520preliminary%2520crystallographic%2520characterization%2520of%2520catechol-O-methyltransferase%2520in%2520complex%2520with%2520its%2520cosubstrate%2520and%2520an%2520inhibitor%26jtitle%3DActa%2520Crystallogr.%26date%3D2001%26volume%3DD57%26spage%3D906%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit132c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matias, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Kinetics and crystal structure of catechol-<i>O</i>-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">â</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=795-805&author=M.+J.+Bonifacioauthor=M.+Archerauthor=M.+L.+Rodriguesauthor=P.+M.+Matiasauthor=D.+A.+Learmonthauthor=M.+A.+Carrondoauthor=P.+Soares-da-Silva&title=Kinetics+and+crystal+structure+of+catechol-O-methyltransferase+complex+with+co-substrate+and+a+novel+inhibitor+with+potential+therapeutic+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DMatias%26aufirst%3DP.%2BM.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DKinetics%2520and%2520crystal%2520structure%2520of%2520catechol-O-methyltransferase%2520complex%2520with%2520co-substrate%2520and%2520a%2520novel%2520inhibitor%2520with%2520potential%2520therapeutic%2520application%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D795%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Reine, N. J.</span><span> </span><span class="NLM_article-title">Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane</span> <span class="citation_source-journal">Clin. Tech. Small Anim. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1053%2Fj.ctsap.2007.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17542193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A280%3ADC%252BD2szjtFaktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=18-25&author=N.+J.+Reine&title=Medical+management+of+pituitary-dependent+hyperadrenocorticism%3A+mitotane+versus+trilostane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane</span></div><div class="casAuthors">Reine Nyssa J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical techniques in small animal practice</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-25</span>
        ISSN:<span class="NLM_cas:issn">1096-2867</span>.
    </div><div class="casAbstract">Pituitary-dependent hyperadrenocorticism is a common endocrine disorder in dogs in the United States.  Once a diagnosis is established, a decision must be made whether or not to pursue treatment, and if so, which medication to use.  Historically, mitotane (Lysodren, o,p'-DDD, Bristol-Myers Squibb, New York) has been the most commonly used treatment for medical management.  Its use is complicated and comes with many potential side effects, making many practitioners wary of its use.  Recently, trilostane has been proven to be an effective treatment of pituitary-dependent hyperadrenocorticism and is approved for use in other countries.  Treatment with trilostane is somewhat simpler and the incidence of side effects seems to be less when compared with mitotane therapy.  Either treatment can be a safe and effective method of treatment for pituitary-dependent hyperadrenocorticism when the practitioner and client are well educated regarding their use and an appropriate monitoring protocol is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh_BgfmzyKLmLFM_lbR1VmfW6udTcc2eZGKohXqEv1Wbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szjtFaktw%253D%253D&md5=f608420380f602f42400351d8d76d3ad</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1053%2Fj.ctsap.2007.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ctsap.2007.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DReine%26aufirst%3DN.%2BJ.%26atitle%3DMedical%2520management%2520of%2520pituitary-dependent%2520hyperadrenocorticism%253A%2520mitotane%2520versus%2520trilostane%26jtitle%3DClin.%2520Tech.%2520Small%2520Anim.%2520Pract.%26date%3D2007%26volume%3D22%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Puddefoot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malouitre, S. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, G. P.</span><span> </span><span class="NLM_article-title">Non-competitive steroid inhibition of oestrogen receptor functions</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2Fijc.10547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12209583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2002&pages=17-22&author=J.+R.+Puddefootauthor=S.+Barkerauthor=H.+R.+Gloverauthor=S.+D.+M.+Malouitreauthor=G.+P.+Vinson&title=Non-competitive+steroid+inhibition+of+oestrogen+receptor+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Non-competitive steroid inhibition of oestrogen receptor functions</span></div><div class="casAuthors">Puddefoot, John R.; Barker, Stewart; Glover, Hilary R.; Malouitre, Sylvanie D. M.; Vinson, Gavin P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-22</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Currently available antiestrogens, such as tamoxifen, are competitive inhibitors that bind to the ligand binding sites of estrogen receptors, ERÎ± and ERÎ².  The search for alternative anti-hormone therapies is prompted by the need for drugs that are effective when tumors become tamoxifen resistant.  The existence of different receptor isoforms also raise the possibility of improving selectivity.  Earlier use of the 3Î²-hydroxysteroid dehydrogenase inhibitor, trilostane (4Î±,5-epoxy-17Î²-hydroxy-3-oxo-5Î±-androstane-2Î±-carbonitrile), suggested that it had beneficial actions in breast cancer that were only partially attributable to inhibition of steroidogenesis.  The present studies on the interactions of trilostane with estrogen receptors show that it (i) inhibits estrogen-stimulated proliferation in MCF-7 breast cancer cells, (ii) enhances the affinity of estradiol binding to ER in rat uteri and specifically increases estradiol binding to an ERÎ²-like isoform, (iii) inhibits ERÎ± and ERÎ² binding to the classical vitellogenin gene estrogen response element (ERE) and (iv) inhibits estrogen-stimulated gene transcription in ERE-linked reporter systems in MCF-7 cells.  The results demonstrate a novel, presumably allosteric, mode of antiestrogen action.  The beneficial actions of trilostane in breast cancer may be attributed to the combination of this antiestrogen effect with its well documented suppression of steroidogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXRx5v_vaMbVg90H21EOLACvtfcHk0lhJSJVeUOl8lA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVejtr8%253D&md5=a61f89821270b45f2b00be9bcae6c9d9</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1002%2Fijc.10547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10547%26sid%3Dliteratum%253Aachs%26aulast%3DPuddefoot%26aufirst%3DJ.%2BR.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DGlover%26aufirst%3DH.%2BR.%26aulast%3DMalouitre%26aufirst%3DS.%2BD.%2BM.%26aulast%3DVinson%26aufirst%3DG.%2BP.%26atitle%3DNon-competitive%2520steroid%2520inhibition%2520of%2520oestrogen%2520receptor%2520functions%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2002%26volume%3D101%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Huq, F.</span><span> </span><span class="NLM_article-title">Molecular modelling analysis of the metabolism of trilostane</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">â</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=353-358&author=F.+Huq&title=Molecular+modelling+analysis+of+the+metabolism+of+trilostane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuq%26aufirst%3DF.%26atitle%3DMolecular%2520modelling%2520analysis%2520of%2520the%2520metabolism%2520of%2520trilostane%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2007%26volume%3D2%26spage%3D353%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Thomas, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshkelani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrell, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucholtz, K. M.</span><span> </span><span class="NLM_article-title">Structure/function of the inhibition of human 3Î²-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.jsbmb.2008.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVCitbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=66-73&author=J.+L.+Thomasauthor=V.+L.+Mackauthor=J.+A.+Glowauthor=D.+Moshkelaniauthor=J.+R.+Terrellauthor=K.+M.+Bucholtz&title=Structure%2Ffunction+of+the+inhibition+of+human+3%CE%B2-hydroxysteroid+dehydrogenase+type+1+and+type+2+by+trilostane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Structure/function of the inhibition of human 3Î²-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane</span></div><div class="casAuthors">Thomas, James L.; Mack, Vance L.; Glow, Jason A.; Moshkelani, Delaram; Terrell, J. Ross; Bucholtz, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">66-73</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The human type 1 (placenta, breast tumors) and type 2 (gonads, adrenals) isoforms of 3Î²-hydroxysteroid dehydrogenase/isomerase (3Î²-HSD) are key enzymes in biosynthesis of all active steroid hormones.  Human 3Î²-HSD1 is a crit. enzyme in the conversion of DHEA to estradiol in breast tumors and may be a major target enzyme for the treatment of breast cancer.  3Î²-HSD2 participates in the prodn. of cortisol and aldosterone in the human adrenal gland.  The goals of this project are to evaluate the role of the 2Î±-cyano group on trilostane (2Î±-cyano-4Î±,5Î±-epoxy-17Î²-ol-androstane-3-one) and det. which amino acids may be crit. for 3Î²-HSD1 specificity.  Trilostane without the 2Î±-cyano group, 4Î±,5Î±-epoxy-testosterone, was synthesized.  Using our structural model of 3Î²-HSD1, trilostane or 4Î±,5Î±-epoxy-testosterone was docked in the active site using Autodock 3.0, and the potentially crit. residues (Met187 and Ser124) were identified.  The M187T and S124T mutants of 3Î²-HSD1 were created, expressed and purified.  Dixon analyses of the inhibition of wild-type 3Î²-HSD1, 3Î²-HSD2, M187T and S124T by trilostane and 4Î±,5Î±-epoxy-testosterone suggest that the 2Î±-cyano group of trilostane is anchored by Ser124 in both isoenzymes.  Kinetic analyses of cofactor and substrate utilization as well as the inhibition kinetics of M187T and the wild-type enzymes suggest that the 16-fold higher-affinity inhibition of 3Î²-HSD1 by trilostane may be related to the presence of Met187 in 3Î²-HSD1 and Thr187 in 3Î²-HSD2.  This structure/function information may lead to the prodn. of more highly specific inhibitors of 3Î²-HSD1 to block the hormone-dependent growth of breast tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSbMzVATeG4LVg90H21EOLACvtfcHk0lhw7pkUM591ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVCitbw%253D&md5=bf741e014162365900e0bc0887987a5a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2008.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2008.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BL.%26aulast%3DMack%26aufirst%3DV.%2BL.%26aulast%3DGlow%26aufirst%3DJ.%2BA.%26aulast%3DMoshkelani%26aufirst%3DD.%26aulast%3DTerrell%26aufirst%3DJ.%2BR.%26aulast%3DBucholtz%26aufirst%3DK.%2BM.%26atitle%3DStructure%252Ffunction%2520of%2520the%2520inhibition%2520of%2520human%25203%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520and%2520type%25202%2520by%2520trilostane%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D2008%26volume%3D111%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Niwano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, A.</span><span> </span><span class="NLM_article-title">Lanoconazole and its related optically active compound NND-502: novel antifungal imidazoles with a ketene dithioacetal structure</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Infect. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">â</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F1568012033483097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVektLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=147-160&author=Y.+Niwanoauthor=T.+Ohmiauthor=A.+Seoauthor=H.+Kodamaauthor=H.+Kogaauthor=A.+Sakai&title=Lanoconazole+and+its+related+optically+active+compound+NND-502%3A+novel+antifungal+imidazoles+with+a+ketene+dithioacetal+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Lanoconazole and its related optically active compound NND-502: Novel antifungal imidazoles with a ketene dithioacetal structure</span></div><div class="casAuthors">Niwano, Yoshimi; Ohmi, Tetsuto; Seo, Akira; Kodama, Hiroki; Koga, Hiroyasu; Sakai, Atsusi</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Infective Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-160</span>CODEN:
                <span class="NLM_cas:coden">CMCAFL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0126</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Imidazole antifungal agents have been successfully developed in medicine mainly for the treatment of superficial skin fungal infections.  Through the screening for novel imidazole compds., it was found that remarkable augmentation of in vitro antifungal activity is brought by the introduction of imidazole moiety to a unique structure ketene dithioacetal, and among these imidazole compds. (Â±)-(E)-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolyl-acetonitrile (generic name: lanoconazole, CAS 101530-10-3) is now available as a topical drug used for the treatment of superficial skin fungal infections in Japan.  Lanoconazole exerted 30-700 times more potent activity as measured by MICs (min. inhibitory concns.) against dermatophytes than did other antifungal imidazole compds., bifonazole and clotrimazole.  In therapeutic expts. using guinea pig models of infections, lanoconazole also exhibited excellent curative effect on two tinea models (tinea pedis and tinea corporis) and a cutaneous candidiasis model as compared to other ref. agent, bifonazole, clotrimazole and/or tolnaftate, a thiocarbamate class of compd., in term of eradicating fungi from the infected loci.  Since lanoconazole is a racemic compd. and only the R-enantiomer was found to be active, extensive screening for optically active-related compd. was further conducted.  As a result, an optically active compd. NND-502 was found to have more potent antifungal activity than lanoconazole and terbinafine, an allylamine class of antifungal agent.  In an in vivo study with a guinea pig model of tinea pedis, short-term treatment regimen of topical NND-502 achieved a complete mycol. cure, while that of topical lanoconazole and terbinafine did not.  Furthermore, the potentiality of the compd. for the oral and i.v. treatment of aspergillosis, one of the major deep-seated fungal infections, has been found out as well as for the topical treatment of dermatophytosis.  The oral regimen of NND-502 in a murine model of systemic aspergillosis was apparently superior to that of itraconazole, a triazole compd., in terms of prolonging survival.  I.v. NND-502 also proved highly effective in a rat model of pulmonary aspergillosis compared with i.v. amphotericin B in terms of not only prolonging survival but also eradication of fungi from the lung.  These encouraging results suggest that the related compds. of lanoconazole could bring considerable progress in the antifungal chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozibWyXs9KOrVg90H21EOLACvtfcHk0lhw7pkUM591ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVektLY%253D&md5=ed81a414fc3f7a9904f3f252c1a7be60</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.2174%2F1568012033483097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568012033483097%26sid%3Dliteratum%253Aachs%26aulast%3DNiwano%26aufirst%3DY.%26aulast%3DOhmi%26aufirst%3DT.%26aulast%3DSeo%26aufirst%3DA.%26aulast%3DKodama%26aufirst%3DH.%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DA.%26atitle%3DLanoconazole%2520and%2520its%2520related%2520optically%2520active%2520compound%2520NND-502%253A%2520novel%2520antifungal%2520imidazoles%2520with%2520a%2520ketene%2520dithioacetal%2520structure%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Infect.%2520Agents%26date%3D2003%26volume%3D2%26spage%3D147%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, R.</span><span> </span><span class="NLM_article-title">In vitro antifungal activities of luliconazole, a new topical imidazole</span> <span class="citation_source-journal">Med. Mycol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">â</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1080%2F13693780802541518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19115136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ansr7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=640-647&author=H.+Kogaauthor=Y.+Nanjohauthor=K.+Makimuraauthor=R.+Tsuboi&title=In+vitro+antifungal+activities+of+luliconazole%2C+a+new+topical+imidazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antifungal activities of luliconazole, a new topical imidazole</span></div><div class="casAuthors">Koga, Hiroyasu; Nanjoh, Yasuko; Makimura, Koichi; Tsuboi, Ryoji</div><div class="citationInfo"><span class="NLM_cas:title">Medical Mycology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">640-647</span>CODEN:
                <span class="NLM_cas:coden">MEMYFR</span>;
        ISSN:<span class="NLM_cas:issn">1369-3786</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Luliconazole is a topical antifungal drug newly developed in Japan.  The present study compares the in vitro antifungal activity of luliconazole against clin. important dermatomycotic fungi with that of other representative antifungal drugs.  The ref. drugs chosen were five classes of nine topical agents, i.e., allylamine (terbinafine), thiocarbamate (liranaftate), benzylamine (butenafine), morpholine (amorolfine), and azole (ketoconazole, clotrimazole, neticonazole, miconazole and bifonazole).  The min. inhibitory concns. (MIC) of luliconazole and the ref. drugs against Trichophyton spp. (T. rubrum, T. mentagrophytes and T. tonsurans) and Candida albicans were measured by the standardized broth microdilution method.  Luliconazole demonstrated greater potency against Trichophyton spp. (MIC range: â¤0.00012-0.002 Î¼g/mL) than the ref. drugs, with T. rubrum being the most susceptible to it.  Luliconazole was also highly active against Candida albicans (MIC range: 0.031-0.13 Î¼g/mL), proving to be more potent than terbinafine, liranaftate, butenafine, amorolfine, and bifonazole, but less than ketoconazole, clotrimazole, neticonazole, and miconazole.  Further, the MIC of luliconazole against Malassezia restricta, an important pathogenic agent involved in seborrhoeic dermatitis, was very low (MIC range: 0.004-0.016 Î¼g/mL) suggesting action comparable to or stronger than that of ketoconazole.  These results indicate a possible clin. role for luliconazole with its broad-spectrum antimycotic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHAEAWw-uEs7Vg90H21EOLACvtfcHk0lhw7pkUM591ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ansr7O&md5=29eb4f67c521a1c7b1790e91438b274b</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1080%2F13693780802541518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13693780802541518%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DNanjoh%26aufirst%3DY.%26aulast%3DMakimura%26aufirst%3DK.%26aulast%3DTsuboi%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520antifungal%2520activities%2520of%2520luliconazole%252C%2520a%2520new%2520topical%2520imidazole%26jtitle%3DMed.%2520Mycol.%26date%3D2009%26volume%3D47%26spage%3D640%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Niwano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span> </span><span class="NLM_article-title">Inhibition of sterol 14Î±-demethylation of <i>Candida albicans</i> with NND-502, a novel optically active imidazole antimycotic agent</span> <span class="citation_source-journal">Med. Mycol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1046%2Fj.1365-280X.1999.00243.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=10520160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFaks7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1999&pages=351-355&author=Y.+Niwanoauthor=H.+Kogaauthor=H.+Kodamaauthor=K.+Kanaiauthor=T.+Miyazakiauthor=H.+Yamaguchi&title=Inhibition+of+sterol+14%CE%B1-demethylation+of+Candida+albicans+with+NND-502%2C+a+novel+optically+active+imidazole+antimycotic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of sterol 14Î±-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent</span></div><div class="casAuthors">Niwano, Y.; Koga, H.; Kodama, H.; Kanai, K.; Miyazaki, T.; Yamaguchi, H.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Mycology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">351-355</span>CODEN:
                <span class="NLM_cas:coden">MEMYFR</span>;
        ISSN:<span class="NLM_cas:issn">1369-3786</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To investigate the mode of action of the newly synthesized optically active imidazole compd., NND-502 [(-)-(E)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazoly lacetonitrile], its effect on ergosterol biosynthesis in cell-free exts. of Candida albicans was examd. and compared with that of the (S)-enantiomer of NND-502 in addn. to lanoconazole and bifonazole, both of which are clin. used for the treatment of dermatomycoses.  NND-502 was found to interfere with ergosterol biosynthesis by inhibition of sterol 14Î±-demethylase, while no interference due to the (S)-enantiomer of NND-502 was found, indicating that the stereochem. orientation of the 2,4-dichlorophenyl group plays an important role in the interaction with the enzyme.  In terms of drug concn. exerting 50% inhibition of ergosterol biosynthesis, NND-502 was 2.5 and 28 times more effective than that of lanoconazole and bifonazole, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2GWTYGpgwGbVg90H21EOLACvtfcHk0lh_q9LFIRoA0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFaks7o%253D&md5=65ed217203262ba026fc93c6ba3e0d3d</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-280X.1999.00243.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-280X.1999.00243.x%26sid%3Dliteratum%253Aachs%26aulast%3DNiwano%26aufirst%3DY.%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DH.%26aulast%3DKanai%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520sterol%252014%25CE%25B1-demethylation%2520of%2520Candida%2520albicans%2520with%2520NND-502%252C%2520a%2520novel%2520optically%2520active%2520imidazole%2520antimycotic%2520agent%26jtitle%3DMed.%2520Mycol.%26date%3D1999%26volume%3D37%26spage%3D351%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Huq, F.</span><span> </span><span class="NLM_article-title">A molecular modelling analysis of luliconazole, lanconazole, and bifonazole</span> <span class="citation_source-journal">J. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">â</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.3923%2Fjpt.2007.567.573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2rsb7P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=567-573&author=F.+Huq&title=A+molecular+modelling+analysis+of+luliconazole%2C+lanconazole%2C+and+bifonazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular modelling analysis of luliconazole, lanconazole, and bifonazole</span></div><div class="casAuthors">Huq, Fazlul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-573</span>CODEN:
                <span class="NLM_cas:coden">JPTOB4</span>;
        ISSN:<span class="NLM_cas:issn">1816-496X</span>.
    
            (<span class="NLM_cas:orgname">Academic Journals</span>)
        </div><div class="casAbstract">In this study, mol. modeling analyses based on mol. mechanics, semi-empirical (PM3) and DFT (at B3LYP/6-31G* level) calcns. have been carried out to obtain insight into their toxicity.  The results of the analyses show that LLZ, LCZ and BFZ have LUMO-HOMO energy differences ranging from 4.5 to 4.9 eV, indicating that the compds. would be moderately inert with BFZ being the most inert one.  The mol. surfaces of all the compds. are found to possess significant amts. of pos. charged electron-deficient regions so that they may be subject to nucleophilic attacks by glutathione and nucleobases in DNA, thus causing cellular toxicity due to glutathione depletion and DNA damage due to oxidn. of nucleobases.  However, because of kinetic inertness of the mols., the rates of such adverse reactions are expected to be low.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplTGutIeREA7Vg90H21EOLACvtfcHk0lh_q9LFIRoA0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2rsb7P&md5=87a4d87e1c2feea31b236d3a42446dd8</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.3923%2Fjpt.2007.567.573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3923%252Fjpt.2007.567.573%26sid%3Dliteratum%253Aachs%26aulast%3DHuq%26aufirst%3DF.%26atitle%3DA%2520molecular%2520modelling%2520analysis%2520of%2520luliconazole%252C%2520lanconazole%252C%2520and%2520bifonazole%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D2%26spage%3D567%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ogasawara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span> </span><span class="NLM_article-title">Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">â</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1097%2F00006231-200301000-00017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=12501022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpsl2nt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=71-76&author=K.+Ogasawaraauthor=A.+Nodaauthor=S.+Yasudaauthor=M.+Kobayashiauthor=H.+Yukawaauthor=A.+Ogawa&title=Effect+of+calcium+antagonist+on+cerebral+blood+flow+and+oxygen+metabolism+in+patients+with+hypertension+and+chronic+major+cerebral+artery+occlusion%3A+a+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141aR"><div class="casContent"><span class="casTitleNuber">141a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study</span></div><div class="casAuthors">Ogasawara, K.; Noda, A.; Yasuda, S.; Kobayashi, M.; Yukawa, H.; Ogawa, A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-76</span>CODEN:
                <span class="NLM_cas:coden">NMCODC</span>;
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the effect of a calcium antagonist, nilvadipine, on cerebral blood flow and oxygen metab., we prospectively examd. five ischemic stroke patients, with both hypertension and chronic major cerebral artery occlusion, using positron emission tomog.  The blood pressure showed a significant decrease after 3 mo of nilvadipine treatment, the cerebral blood flow in the affected regions showed a significant increase and the oxygen extn. fraction showed a significant decrease.  We conclude that nilvadipine is a safe and effective antihypertensive agent for patients with both hypertension and chronic major cerebral artery occlusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonAgEH1woZb7Vg90H21EOLACvtfcHk0lh_q9LFIRoA0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpsl2nt7Y%253D&md5=c4ad86ad121f90d7afff6882749249ef</span></div><a href="/servlet/linkout?suffix=cit141a&amp;dbid=16384&amp;doi=10.1097%2F00006231-200301000-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00006231-200301000-00017%26sid%3Dliteratum%253Aachs%26aulast%3DOgasawara%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DYukawa%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DA.%26atitle%3DEffect%2520of%2520calcium%2520antagonist%2520on%2520cerebral%2520blood%2520flow%2520and%2520oxygen%2520metabolism%2520in%2520patients%2520with%2520hypertension%2520and%2520chronic%2520major%2520cerebral%2520artery%2520occlusion%253A%2520a%2520positron%2520emission%2520tomography%2520study%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2003%26volume%3D24%26spage%3D71%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit141b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rosenthal, J.</span><span> </span><span class="NLM_article-title">Nilvadipine: profile of a new calcium antagonist. An overview</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">S92</span><span class="NLM_x">â</span> <span class="NLM_lpage">S107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=S92-S107&author=J.+Rosenthal&title=Nilvadipine%3A+profile+of+a+new+calcium+antagonist.+An+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DJ.%26atitle%3DNilvadipine%253A%2520profile%2520of%2520a%2520new%2520calcium%2520antagonist.%2520An%2520overview%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1994%26volume%3D24%26spage%3DS92%26epage%3DS107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimitsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatip-Al-Khatib, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, M.</span><span> </span><span class="NLM_article-title">Nilvadipine prevents the impairment of spatial memory induced by cerebral ischemia combined with Î²-amyloid in rats</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">â</span> <span class="NLM_lpage">701</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1248%2Fbpb.30.698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17409505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1aktLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=698-701&author=K.+Iwasakiauthor=N.+Egashiraauthor=Y.+Takagakiauthor=Y.+Yoshimitsuauthor=I.+Hatip-Al-Khatibauthor=K.+Mishimaauthor=M.+Fujiwara&title=Nilvadipine+prevents+the+impairment+of+spatial+memory+induced+by+cerebral+ischemia+combined+with+%CE%B2-amyloid+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142aR"><div class="casContent"><span class="casTitleNuber">142a</span><div class="casTitle"><span class="NLM_cas:atitle">Nilvadipine prevents the impairment of spatial memory induced by cerebral ischemia combined with Î²-amyloid in rats</span></div><div class="casAuthors">Iwasaki, Katsunori; Egashira, Nobuaki; Takagaki, Yuki; Yoshimitsu, Yoshitaka; Hatip-Al-Khatib, Izzettin; Mishima, Kenichi; Fujiwara, Michihiro</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">698-701</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">In the present study, we examd. the effects of nilvadipine and amlodipine, both dihydropyridine-deriv. calcium antagonists, on the impairment of spatial memory induced by a combination of ischemia and Î²-amyloid (AÎ²).  Nilvadipine (3.2 mg/kg, i.p.) significantly prevented the impairment of spatial memory and neuronal apoptosis in this model.  By contrast, amlodipine had no effect on this impairment of spatial memory.  These findings suggest that nilvadipine may prevent impairment of spatial memory by inhibiting neuronal apoptosis; this drug might therefore be useful for the prevention of the progression to dementia in Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTi-aa9p9SabVg90H21EOLACvtfcHk0lh_q9LFIRoA0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1aktLk%253D&md5=cd01d76ba9717a2644a7065a186af10c</span></div><a href="/servlet/linkout?suffix=cit142a&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.698%26sid%3Dliteratum%253Aachs%26aulast%3DIwasaki%26aufirst%3DK.%26aulast%3DEgashira%26aufirst%3DN.%26aulast%3DTakagaki%26aufirst%3DY.%26aulast%3DYoshimitsu%26aufirst%3DY.%26aulast%3DHatip-Al-Khatib%26aufirst%3DI.%26aulast%3DMishima%26aufirst%3DK.%26aulast%3DFujiwara%26aufirst%3DM.%26atitle%3DNilvadipine%2520prevents%2520the%2520impairment%2520of%2520spatial%2520memory%2520induced%2520by%2520cerebral%2520ischemia%2520combined%2520with%2520%25CE%25B2-amyloid%2520in%2520rats%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D698%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit142b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Paris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescentini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span> </span><span class="NLM_article-title">Nilvadipine antagonizes both AÎ² vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">999</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">â</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.brainres.2003.11.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=14746921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntVymsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=999&publication_year=2004&pages=53-61&author=D.+Parisauthor=A.+Quadrosauthor=J.+Humphreyauthor=N.+Patelauthor=R.+Crescentiniauthor=F.+Crawfordauthor=M.+Mullan&title=Nilvadipine+antagonizes+both+A%CE%B2+vasoactivity+in+isolated+arteries%2C+and+the+reduced+cerebral+blood+flow+in+APPsw+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142bR"><div class="casContent"><span class="casTitleNuber">142b</span><div class="casTitle"><span class="NLM_cas:atitle">Nilvadipine antagonizes both AÎ² vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice</span></div><div class="casAuthors">Paris, Daniel; Quadros, Amita; Humphrey, James; Patel, Nikunj; Crescentini, Robert; Crawford, Fiona; Mullan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">999</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The development of Alzheimer's disease (AD) is generally thought to correlate with cerebral accumulation of AÎ².  It has previously been shown that AÎ² peptides enhance vasoconstriction in isolated arteries and oppose certain vasorelaxants.  Moreover, exogenous application of AÎ² peptides causes cerebral vasoconstriction in rodents and in transgenic mouse models of AD that overexpress AÎ² there is reduced cerebral blood flow.  In the present study, we investigated the effect of nilvadipine, a dihydropyridine-type calcium channel blocker, on AÎ² induced vasoconstriction in isolated arteries and in vivo on cerebral blood flow (CBF) of an AD transgenic mouse model overexpressing AÎ² (Tg APPsw line 2576).  Nilvadipine completely inhibited the vasoactivity elicited by AÎ² in rat aortae and in human middle cerebral arteries.  The effect of a short treatment duration (2 wk) with nilvadipine on regional CBF was investigated in 13-mo-old Tg APPsw mice and control littermates using a laser Doppler imager.  Addnl., CBF was also measured in 20-mo-old Tg APPsw mice and control littermates that were chronically treated with nilvadipine for 7 mo.  Untreated Tg APPsw mice showed a redn. of regional CBF compared to their untreated control littermates.  Nilvadipine restored cortical perfusion levels in Tg APPsw to values similar to those obsd. in control littermates without notably affecting the CBF of control mice.  All together, these data suggest that nilvadipine might be useful for the treatment of oligemia assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPAsFU2LFYELVg90H21EOLACvtfcHk0ljTnoXULdGwEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntVymsw%253D%253D&md5=840da6848325db1a2d622193c46480c9</span></div><a href="/servlet/linkout?suffix=cit142b&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2003.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2003.11.061%26sid%3Dliteratum%253Aachs%26aulast%3DParis%26aufirst%3DD.%26aulast%3DQuadros%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DCrescentini%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DMullan%26aufirst%3DM.%26atitle%3DNilvadipine%2520antagonizes%2520both%2520A%25CE%25B2%2520vasoactivity%2520in%2520isolated%2520arteries%252C%2520and%2520the%2520reduced%2520cerebral%2520blood%2520flow%2520in%2520APPsw%2520transgenic%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2004%26volume%3D999%26spage%3D53%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Zhang, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymon, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narla, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirling, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payvandi, F.</span><span> </span><span class="NLM_article-title">The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-Î± production with antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">â</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=951-959&author=L.-H.+Zhangauthor=L.+Wuauthor=H.+K.+Raymonauthor=R.+S.+Chenauthor=L.+Corralauthor=M.+A.+Shirleyauthor=R.+K.+Narlaauthor=J.+Gamezauthor=G.+W.+Mullerauthor=D.+I.+Stirlingauthor=J.+B.+Bartlettauthor=P.+H.+Schaferauthor=F.+Payvandi&title=The+synthetic+compound+CC-5079+is+a+potent+inhibitor+of+tubulin+polymerization+and+tumor+necrosis+factor-%CE%B1+production+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-H.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DRaymon%26aufirst%3DH.%2BK.%26aulast%3DChen%26aufirst%3DR.%2BS.%26aulast%3DCorral%26aufirst%3DL.%26aulast%3DShirley%26aufirst%3DM.%2BA.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DGamez%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DG.%2BW.%26aulast%3DStirling%26aufirst%3DD.%2BI.%26aulast%3DBartlett%26aufirst%3DJ.%2BB.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DPayvandi%26aufirst%3DF.%26atitle%3DThe%2520synthetic%2520compound%2520CC-5079%2520is%2520a%2520potent%2520inhibitor%2520of%2520tubulin%2520polymerization%2520and%2520tumor%2520necrosis%2520factor-%25CE%25B1%2520production%2520with%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D951%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogler, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanwick, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of 3,3-diarylacrylonitriles as tubulin polymerization inhibitors</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">4241</span><span class="NLM_x">â</span> <span class="NLM_lpage">4244</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo800428b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=4241-4244&author=Z.+Fangauthor=Y.+Songauthor=T.+Sarkarauthor=E.+Hamelauthor=W.+E.+Foglerauthor=G.+E.+Agostonauthor=P.+E.+Fanwickauthor=M.+Cushman&title=Stereoselective+synthesis+of+3%2C3-diarylacrylonitriles+as+tubulin+polymerization+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjo800428b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo800428b%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DSarkar%26aufirst%3DT.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFogler%26aufirst%3DW.%2BE.%26aulast%3DAgoston%26aufirst%3DG.%2BE.%26aulast%3DFanwick%26aufirst%3DP.%2BE.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DStereoselective%2520synthesis%2520of%25203%252C3-diarylacrylonitriles%2520as%2520tubulin%2520polymerization%2520inhibitors%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D4241%26epage%3D4244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nieminen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollesello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, Z.</span><span> </span><span class="NLM_article-title">Effects of levosimendan on the energy balance: preclinical and clinical evidence</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">â</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=302-310&author=M.+S.+Nieminenauthor=P.+Polleselloauthor=G.+Vajdaauthor=Z.+Papp&title=Effects+of+levosimendan+on+the+energy+balance%3A+preclinical+and+clinical+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNieminen%26aufirst%3DM.%2BS.%26aulast%3DPollesello%26aufirst%3DP.%26aulast%3DVajda%26aufirst%3DG.%26aulast%3DPapp%26aufirst%3DZ.%26atitle%3DEffects%2520of%2520levosimendan%2520on%2520the%2520energy%2520balance%253A%2520preclinical%2520and%2520clinical%2520evidence%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2009%26volume%3D53%26spage%3D302%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit145b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whig, J.</span><span> </span><span class="NLM_article-title">Levosimendan</span> <span class="citation_source-journal">J. Anaesthesiol., Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">â</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2qur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=79-82&author=S.+Guptaauthor=S.+Gargauthor=J.+Whig&title=Levosimendan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145bR"><div class="casContent"><span class="casTitleNuber">145b</span><div class="casTitle"><span class="NLM_cas:atitle">Levosimendan</span></div><div class="casAuthors">Gupta, Sushil; Garg, Shuchita; Whig, Jagdeep</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Anaesthesiology, Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-82</span>CODEN:
                <span class="NLM_cas:coden">JAPHFW</span>;
        ISSN:<span class="NLM_cas:issn">0970-9185</span>.
    
            (<span class="NLM_cas:orgname">Research Society of Anaesthesiology Clinical Pharmacology</span>)
        </div><div class="casAbstract">A review.  Levosimendan is one of the calcium sensitizers of the heart, used mainly in the management of the decompensated congestive heart failure.  It is a unique drug that improves hemodynamics without much risk of dysrrhythmias as seen with most of the inotropic agents.  The mechanism of action, pharmacol. effects and indications, and adverse effects of levosimendan are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFe-kQ5UtOf7Vg90H21EOLACvtfcHk0ljF9lq79PCrcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2qur4%253D&md5=a64c4886abaf58f646b03e775c4ad583</span></div><a href="/servlet/linkout?suffix=cit145b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DWhig%26aufirst%3DJ.%26atitle%3DLevosimendan%26jtitle%3DJ.%2520Anaesthesiol.%252C%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D25%26spage%3D79%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Sasho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, K.</span><span> </span><span class="NLM_article-title">Synthesis of 2-imidazolidinylidene propanedinitrile derivatives as stimulators of gastrointestinal motility. 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">â</span> <span class="NLM_lpage">579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00057a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=572-579&author=S.+Sashoauthor=H.+Obaseauthor=S.+Ichikawaauthor=T.+Kitazawaauthor=H.+Nonakaauthor=R.+Yoshizakiauthor=A.+Ishiiauthor=K.+Shuto&title=Synthesis+of+2-imidazolidinylidene+propanedinitrile+derivatives+as+stimulators+of+gastrointestinal+motility.+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm00057a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00057a007%26sid%3Dliteratum%253Aachs%26aulast%3DSasho%26aufirst%3DS.%26aulast%3DObase%26aufirst%3DH.%26aulast%3DIchikawa%26aufirst%3DS.%26aulast%3DKitazawa%26aufirst%3DT.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DYoshizaki%26aufirst%3DR.%26aulast%3DIshii%26aufirst%3DA.%26aulast%3DShuto%26aufirst%3DK.%26atitle%3DSynthesis%2520of%25202-imidazolidinylidene%2520propanedinitrile%2520derivatives%2520as%2520stimulators%2520of%2520gastrointestinal%2520motility.%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D572%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">King, B. F.</span><span> </span><span class="NLM_article-title">Novel P2X7 receptor antagonists ease the pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">â</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fsj.bjp.0707266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17471176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFemtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=565-567&author=B.+F.+King&title=Novel+P2X7+receptor+antagonists+ease+the+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147aR"><div class="casContent"><span class="casTitleNuber">147a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel P2X7 receptor antagonists ease the pain</span></div><div class="casAuthors">King, B. F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-567</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In recent months, a series of chem. diverse antagonists has been identified for the ATP-gated P2X7 receptor.  In particular, two classes of highly-selective competitive P2X7 antagonists have been developed by Michael Jarvis and his colleagues at Abbott Labs.  These di-substituted tetrazole and cyanoguanidine derivs. are outstanding for a no. of reasons (not least their stability, selectivity, potency and, of course, reversibility); most exciting is their near equal potency at human and rodent P2X7 isoforms.  Armed with drugs such as A740003 and newer A438079, Jarvis and colleagues have explored the role of P2X7 receptors in the onset and persistence of chronic pain in animal models.  Their findings, and applicability to the human condition, are reviewed in this current issue of British Journal of Pharmacol.  This accompanying Commentary describes the progress made by Jarvis and others in developing novel P2X7 antagonists for pain relief.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7XZ7FPV45OLVg90H21EOLACvtfcHk0ljF9lq79PCrcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFemtr4%253D&md5=545fae7c8efcbfd9afe870bdaaf7e353</span></div><a href="/servlet/linkout?suffix=cit147a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707266%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DB.%2BF.%26atitle%3DNovel%2520P2X7%2520receptor%2520antagonists%2520ease%2520the%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D565%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit147b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, B.-C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jass, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humora, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madding, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venit, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, W. J.</span><span> </span><span class="NLM_article-title">Regio- and stereoselective ring opening of epoxide with cyanoguanidine dianions, a facile synthesis of the KATP opener BMS-180448</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">â</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=1337-1340&author=B.-C+Chenauthor=S.+L.+Quinlanauthor=J.+G.+Reidauthor=P.+A.+Jassauthor=T.+P.+Robinsonauthor=W.+A.+Earlyauthor=E.+J.+Delaneyauthor=M.+J.+Humoraauthor=G.+D.+Maddingauthor=J.+J.+Venitauthor=W.+J.+Winter&title=Regio-+and+stereoselective+ring+opening+of+epoxide+with+cyanoguanidine+dianions%2C+a+facile+synthesis+of+the+KATP+opener+BMS-180448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.-C%26aulast%3DQuinlan%26aufirst%3DS.%2BL.%26aulast%3DReid%26aufirst%3DJ.%2BG.%26aulast%3DJass%26aufirst%3DP.%2BA.%26aulast%3DRobinson%26aufirst%3DT.%2BP.%26aulast%3DEarly%26aufirst%3DW.%2BA.%26aulast%3DDelaney%26aufirst%3DE.%2BJ.%26aulast%3DHumora%26aufirst%3DM.%2BJ.%26aulast%3DMadding%26aufirst%3DG.%2BD.%26aulast%3DVenit%26aufirst%3DJ.%2BJ.%26aulast%3DWinter%26aufirst%3DW.%2BJ.%26atitle%3DRegio-%2520and%2520stereoselective%2520ring%2520opening%2520of%2520epoxide%2520with%2520cyanoguanidine%2520dianions%252C%2520a%2520facile%2520synthesis%2520of%2520the%2520KATP%2520opener%2520BMS-180448%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D1337%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit147c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Toombs, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shebuski, R. J.</span><span> </span><span class="NLM_article-title">U-89232 [BMS-189365], a novel antiischemic agent derived from cromakalim</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=303-316&author=C.+F.+Toombsauthor=R.+J.+Shebuski&title=U-89232+%5BBMS-189365%5D%2C+a+novel+antiischemic+agent+derived+from+cromakalim"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToombs%26aufirst%3DC.%2BF.%26aulast%3DShebuski%26aufirst%3DR.%2BJ.%26atitle%3DU-89232%2520%255BBMS-189365%255D%252C%2520a%2520novel%2520antiischemic%2520agent%2520derived%2520from%2520cromakalim%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D1994%26volume%3D12%26spage%3D303%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Donetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cereda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellora, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallazzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Soldato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giachetti, A.</span><span> </span><span class="NLM_article-title">(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">â</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00369a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=380-386&author=A.+Donettiauthor=E.+Ceredaauthor=E.+Belloraauthor=A.+Gallazziauthor=C.+Bazzanoauthor=P.+Vanoniauthor=P.+Del+Soldatoauthor=R.+Michelettiauthor=F.+Paganiauthor=A.+Giachetti&title=%28Imidazolylphenyl%29formamidines.+A+structurally+novel+class+of+potent+histamine+H2+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm00369a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00369a025%26sid%3Dliteratum%253Aachs%26aulast%3DDonetti%26aufirst%3DA.%26aulast%3DCereda%26aufirst%3DE.%26aulast%3DBellora%26aufirst%3DE.%26aulast%3DGallazzi%26aufirst%3DA.%26aulast%3DBazzano%26aufirst%3DC.%26aulast%3DVanoni%26aufirst%3DP.%26aulast%3DDel%2BSoldato%26aufirst%3DP.%26aulast%3DMicheletti%26aufirst%3DR.%26aulast%3DPagani%26aufirst%3DF.%26aulast%3DGiachetti%26aufirst%3DA.%26atitle%3D%2528Imidazolylphenyl%2529formamidines.%2520A%2520structurally%2520novel%2520class%2520of%2520potent%2520histamine%2520H2%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D380%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Haaksma, E. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademaker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriks, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span> </span><span class="NLM_article-title">Studies on the active molecular species of the H2-receptor antagonists cimetidine and mifentidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">â</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00384a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=208-211&author=E.+E.+J.+Haaksmaauthor=B.+Rademakerauthor=K.+Kramerauthor=J.+C.+Eriksauthor=A.+Bastauthor=H.+Timmerman&title=Studies+on+the+active+molecular+species+of+the+H2-receptor+antagonists+cimetidine+and+mifentidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm00384a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00384a036%26sid%3Dliteratum%253Aachs%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3DRademaker%26aufirst%3DB.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DEriks%26aufirst%3DJ.%2BC.%26aulast%3DBast%26aufirst%3DA.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DStudies%2520on%2520the%2520active%2520molecular%2520species%2520of%2520the%2520H2-receptor%2520antagonists%2520cimetidine%2520and%2520mifentidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D208%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><div class="note"><p class="first last">For leading references see the following: </p></div><span class="NLM_contrib-group">Makowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raczynska, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmurzynski, L.</span><span> </span><span class="NLM_article-title">Ab initio study of possible and preferred basic site(s) in polyfunctional <i>N</i>1,<i>N</i>1-dimethyl-<i>N</i>2-cyanoformamidine</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">â</span> <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp002458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=869-874&author=M.+Makowskiauthor=E.+D.+Raczynskaauthor=L.+Chmurzynski&title=Ab+initio+study+of+possible+and+preferred+basic+site%28s%29+in+polyfunctional+N1%2CN1-dimethyl-N2-cyanoformamidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjp002458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp002458t%26sid%3Dliteratum%253Aachs%26aulast%3DMakowski%26aufirst%3DM.%26aulast%3DRaczynska%26aufirst%3DE.%2BD.%26aulast%3DChmurzynski%26aufirst%3DL.%26atitle%3DAb%2520initio%2520study%2520of%2520possible%2520and%2520preferred%2520basic%2520site%2528s%2529%2520in%2520polyfunctional%2520N1%252CN1-dimethyl-N2-cyanoformamidine%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2001%26volume%3D105%26spage%3D869%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Yanagisawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span> </span><span class="NLM_article-title">Histamine H2 receptor antagonists. 1. Synthesis of <i>N</i>-cyano and <i>N</i>-carbamoyl amidine derivatives and their biological activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">â</span> <span class="NLM_lpage">857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00373a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=849-857&author=I.+Yanagisawaauthor=Y.+Hirataauthor=Y.+Ishii&title=Histamine+H2+receptor+antagonists.+1.+Synthesis+of+N-cyano+and+N-carbamoyl+amidine+derivatives+and+their+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fjm00373a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00373a007%26sid%3Dliteratum%253Aachs%26aulast%3DYanagisawa%26aufirst%3DI.%26aulast%3DHirata%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DY.%26atitle%3DHistamine%2520H2%2520receptor%2520antagonists.%25201.%2520Synthesis%2520of%2520N-cyano%2520and%2520N-carbamoyl%2520amidine%2520derivatives%2520and%2520their%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D849%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Eda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukaya, C.</span><span> </span><span class="NLM_article-title">Novel potassium-channel openers: preparation and pharmacological evaluation of racemic and optically active <i>N</i>-(6-amino-3-pyridyl)-<i>N</i>â²-bicycloalkyl-<i>N</i>â²â²-cyanoguanidine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">â</span> <span class="NLM_lpage">1990</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00039a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1983-1990&author=M.+Edaauthor=T.+Takemotoauthor=S.+Onoauthor=T.+Okadaauthor=K.+Kosakaauthor=M.+Gohdaauthor=S.+Matznoauthor=N.+Nakamuraauthor=C.+Fukaya&title=Novel+potassium-channel+openers%3A+preparation+and+pharmacological+evaluation+of+racemic+and+optically+active+N-%286-amino-3-pyridyl%29-N%E2%80%B2-bicycloalkyl-N%E2%80%B2%E2%80%B2-cyanoguanidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm00039a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00039a011%26sid%3Dliteratum%253Aachs%26aulast%3DEda%26aufirst%3DM.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKosaka%26aufirst%3DK.%26aulast%3DGohda%26aufirst%3DM.%26aulast%3DMatzno%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DFukaya%26aufirst%3DC.%26atitle%3DNovel%2520potassium-channel%2520openers%253A%2520preparation%2520and%2520pharmacological%2520evaluation%2520of%2520racemic%2520and%2520optically%2520active%2520N-%25286-amino-3-pyridyl%2529-N%25E2%2580%25B2-bicycloalkyl-N%25E2%2580%25B2%25E2%2580%25B2-cyanoguanidine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1983%26epage%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebisu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukaya, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hihara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiraku, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanouchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span> </span><span class="NLM_article-title">Novel potassium channel openers: synthesis and pharmacological evaluation of new <i>N</i>-(substituted-3-pyridyl)-<i>N</i>â²-alkylthioureas and related compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00027a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=18-35&author=T.+Takemotoauthor=M.+Edaauthor=T.+Okadaauthor=H.+Sakashitaauthor=S.+Matznoauthor=M.+Gohdaauthor=H.+Ebisuauthor=N.+Nakamuraauthor=C.+Fukayaauthor=C.+Hiharaauthor=M.+Eirakuauthor=K.+Yamanouchiauthor=K.+Yokoyama&title=Novel+potassium+channel+openers%3A+synthesis+and+pharmacological+evaluation+of+new+N-%28substituted-3-pyridyl%29-N%E2%80%B2-alkylthioureas+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm00027a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00027a003%26sid%3Dliteratum%253Aachs%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DEda%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DMatzno%26aufirst%3DS.%26aulast%3DGohda%26aufirst%3DM.%26aulast%3DEbisu%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DFukaya%26aufirst%3DC.%26aulast%3DHihara%26aufirst%3DC.%26aulast%3DEiraku%26aufirst%3DM.%26aulast%3DYamanouchi%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26atitle%3DNovel%2520potassium%2520channel%2520openers%253A%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%2520new%2520N-%2528substituted-3-pyridyl%2529-N%25E2%2580%25B2-alkylthioureas%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D18%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwabara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, S.</span><span> </span><span class="NLM_article-title">Structureâactivity studies of <i>N</i>-cyano-3-pyridinecarboxamidines and their amide and thioamide congeners</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">â</span> <span class="NLM_lpage">2488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2485-2488&author=T.+Nakajimaauthor=T.+Kashiwabaraauthor=T.+Izawaauthor=S.+Nakajima&title=Structure%E2%88%92activity+studies+of+N-cyano-3-pyridinecarboxamidines+and+their+amide+and+thioamide+congeners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DKashiwabara%26aufirst%3DT.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DS.%26atitle%3DStructure%25E2%2588%2592activity%2520studies%2520of%2520N-cyano-3-pyridinecarboxamidines%2520and%2520their%2520amide%2520and%2520thioamide%2520congeners%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2485%26epage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Ganellin, C. R.</span><span> </span><span class="NLM_article-title">Discovery of the antiulcer drug Tagamet</span> <span class="citation_source-journal">Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">â</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1002%2F0471780103.ch10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFelt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=295-311&author=C.+R.+Ganellin&title=Discovery+of+the+antiulcer+drug+Tagamet"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the antiulcer drug Tagamet</span></div><div class="casAuthors">Ganellin, C. Robin</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery and Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295-311</span>CODEN:
                <span class="NLM_cas:coden">69IHOA</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review on the anti-ulcer drug Tagamet (cimetidine) and the level of knowledge prevailing at the time (1964-1972) the research leading to its discovery was carried out.  The pharmacol. characterization of histamine receptors is discussed, together with the old treatment options for peptic ulcer disease and the search for new anti-ulcer drugs.  The search for an H2-receptor histamine antagonist, development of a clin. candidate drug for peptic ulcer, and discovery of cimetidine as a breakthrough in the treatment of peptic ulcer disease are addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdymfTAfY0HLVg90H21EOLACvtfcHk0lhOLdvEXXJoJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFelt70%253D&md5=8c25608a8774ea8080248c15c3c12c59</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1002%2F0471780103.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471780103.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26atitle%3DDiscovery%2520of%2520the%2520antiulcer%2520drug%2520Tagamet%26jtitle%3DDrug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D1%26spage%3D295%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Scheinfeld, N.</span><span> </span><span class="NLM_article-title">Cimetidine: a review of the recent developments and reports in cutaneous medicine</span> <span class="citation_source-journal">Dermatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=4&issue=2&author=N.+Scheinfeld&title=Cimetidine%3A+a+review+of+the+recent+developments+and+reports+in+cutaneous+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScheinfeld%26aufirst%3DN.%26atitle%3DCimetidine%253A%2520a%2520review%2520of%2520the%2520recent%2520developments%2520and%2520reports%2520in%2520cutaneous%2520medicine%26jtitle%3DDermatology%26date%3D2003%26volume%3D9%26issue%3D2%26spage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeaton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">â</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16596218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Cjtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=1021-1030&author=F.+Lefrancauthor=P.+Yeatonauthor=J.+Brotchiauthor=R.+Kiss&title=Cimetidine%2C+an+unexpected+anti-tumor+agent%2C+and+its+potential+for+the+treatment+of+glioblastoma+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)</span></div><div class="casAuthors">Lefranc, Florence; Yeaton, Paul; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1030</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A review.  Cimetidine (CIM), the prototypical histamine H2 receptor antagonist (H2RA), was brought to market based on its ability to accelerate healing of gastrointestinal ulcers through the inhibition of gastric acid secretion.  Cimetidine, the most studied H2RA, has been demonstrated to possess anti-tumor activity against colon, gastric and kidney cancers, and melanomas.  This activity involves a no. of different mechanisms of action: (a) CIM antagonizes tumor cell-mediated interleukin-1-induced activation of selectins in liver sinusoids, inhibiting tumor cell binding on liver sinusoids, thereby reducing the development of liver metastasis; (b) histamine acts as a growth factor in various tumor cell types via the activation of H2 receptors; CIM therefore may antagonize this effect; (c) CIM acts as an immunomodulator by enhancing the host's immune response to tumor cells.  With respect to malignant gliomas, CIM added to temozolomide was superior in vivo when compared to temozolomide alone in extending survival of nude mice with human glioblastoma cells orthotopically xenografted into their brain.  We review the various mechanisms of action potentially assocd. with the therapeutic effects of CIM in the case of exptl. glioblastomas, observations we hope will encourage clin. investigation of CIM in the management of highly malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpinT-J1wkTTrVg90H21EOLACvtfcHk0ljZgc_aT6V-MA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Cjtbs%253D&md5=210e996682a29d2306afae83b5201aba</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DYeaton%26aufirst%3DP.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DCimetidine%252C%2520an%2520unexpected%2520anti-tumor%2520agent%252C%2520and%2520its%2520potential%2520for%2520the%2520treatment%2520of%2520glioblastoma%2520%2528review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D28%26spage%3D1021%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Friedel, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogden, R. N.</span><span> </span><span class="NLM_article-title">Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">â</span> <span class="NLM_lpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=929-967&author=H.+A.+Friedelauthor=R.+N.+Brogden&title=Pinacidil.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+potential+in+the+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedel%26aufirst%3DH.%2BA.%26aulast%3DBrogden%26aufirst%3DR.%2BN.%26atitle%3DPinacidil.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520potential%2520in%2520the%2520treatment%2520of%2520hypertension%26jtitle%3DDrugs%26date%3D1990%26volume%3D39%26spage%3D929%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guth, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1111%2Fj.1365-2125.2004.02083.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=15206991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlGrsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=40-51&author=B.+D.+Guthauthor=H.+Narjesauthor=H.-D.+Schubertauthor=P.+Tanswellauthor=A.+Riedelauthor=G.+Nehmiz&title=Pharmacokinetics+and+pharmacodynamics+of+terbogrel%2C+a+combined+thromboxane+A2+receptor+and+synthase+inhibitor%2C+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159aR"><div class="casContent"><span class="casTitleNuber">159a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects</span></div><div class="casAuthors">Guth, Brian D.; Narjes, Hans; Schubert, Hans-Dieter; Tanswell, Paul; Riedel, Axel; Nehmiz, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-51</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims: To characterize the pharmacokinetics of terbogrel, a new combined thromboxane A2 (TxA2) receptor and synthase inhibitor, in healthy human subjects after single or multiple oral administration.  Methods: Forty-eight healthy male subjects received a single oral dose (10, 25, 50, 100, 150 or 200 mg) of terbogrel or placebo and 32 different subjects received one of the following treatments twice daily for 7 days: 50, 100 or 150 mg terbogrel, placebo, or once-a-day 330 mg acetylsalicylic acid.  Results: Terbogrel was well tolerated without obvious adverse effects following either a single oral dose or administration over 7 days.  Plasma drug concns. were dose-linear and there was no accumulation over 7 days.  There was a dose-dependent blockade of TxA2 receptors and of inhibition of thromboxane synthase activity with values for IC50 of 12 ng ml-1 and 6.7 ng ml-1, resp.  At the highest dose tested (150 mg) there was almost complete inhibition of thromboxane synthase and thromboxane receptor occupancy.  Even at trough concns., receptor occupancy remained above 80% and thromboxane synthase was still completely inhibited.  These two activities were assocd. with a dose-dependent inhibition of platelet aggregation (>80% at the 150 mg dose of terbogrel) and enhanced prostacyclin prodn.  Conclusions: Terbogrel is a potent agent having two distinct, complimentary pharmacodynamic actions, namely inhibition of thromboxane synthase and antagonism of the TxA2 receptor.  The antithrombotic effect of terbogrel was dose-dependent and was assocd. with enhanced prostacyclin prodn.  Terbogrel is an attractive candidate for long-term therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpowTWvRF75rVg90H21EOLACvtfcHk0liXQnWIDpXTnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlGrsbY%253D&md5=8e922fa97c25f132e8e007679efec79b</span></div><a href="/servlet/linkout?suffix=cit159a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2004.02083.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2004.02083.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuth%26aufirst%3DB.%2BD.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DSchubert%26aufirst%3DH.-D.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DRiedel%26aufirst%3DA.%26aulast%3DNehmiz%26aufirst%3DG.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520terbogrel%252C%2520a%2520combined%2520thromboxane%2520A2%2520receptor%2520and%2520synthase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D58%26spage%3D40%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit159b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Soyka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guth, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenberger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, T. H.</span><span> </span><span class="NLM_article-title">Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">â</span> <span class="NLM_lpage">1249</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9707941" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1235-1249&author=R.+Soykaauthor=B.+D.+Guthauthor=H.+M.+Weisenbergerauthor=P.+Lugerauthor=T.+H.+Mueller&title=Guanidine+derivatives+as+combined+thromboxane+A2+receptor+antagonists+and+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159b&amp;dbid=16384&amp;doi=10.1021%2Fjm9707941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707941%26sid%3Dliteratum%253Aachs%26aulast%3DSoyka%26aufirst%3DR.%26aulast%3DGuth%26aufirst%3DB.%2BD.%26aulast%3DWeisenberger%26aufirst%3DH.%2BM.%26aulast%3DLuger%26aufirst%3DP.%26aulast%3DMueller%26aufirst%3DT.%2BH.%26atitle%3DGuanidine%2520derivatives%2520as%2520combined%2520thromboxane%2520A2%2520receptor%2520antagonists%2520and%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1235%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjoerkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeaettelae, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span> </span><span class="NLM_article-title">Anticancer agent CHS-828 inhibits cellular synthesis of NAD</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">â</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2008&pages=799-804&author=U.+H.+Olesenauthor=M.+K.+Christensenauthor=F.+Bjoerklingauthor=M.+Jaeaettelaeauthor=P.+B.+Jensenauthor=M.+Sehestedauthor=S.+J.+Nielsen&title=Anticancer+agent+CHS-828+inhibits+cellular+synthesis+of+NAD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DChristensen%26aufirst%3DM.%2BK.%26aulast%3DBjoerkling%26aufirst%3DF.%26aulast%3DJaeaettelae%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26atitle%3DAnticancer%2520agent%2520CHS-828%2520inhibits%2520cellular%2520synthesis%2520of%2520NAD%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D367%26spage%3D799%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit160b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johanson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvidsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaerd, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlman, H.</span><span> </span><span class="NLM_article-title">Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude mice</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2005&pages=171-176&author=V.+Johansonauthor=Y.+Arvidssonauthor=L.+Koelbyauthor=P.+Bernhardtauthor=C.+Swaerdauthor=O.+Nilssonauthor=H.+Ahlman&title=Antitumoural+effects+of+the+pyridyl+cyanoguanidine+CHS+828+on+three+different+types+of+neuroendocrine+tumours+xenografted+to+nude+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohanson%26aufirst%3DV.%26aulast%3DArvidsson%26aufirst%3DY.%26aulast%3DKoelby%26aufirst%3DL.%26aulast%3DBernhardt%26aufirst%3DP.%26aulast%3DSwaerd%26aufirst%3DC.%26aulast%3DNilsson%26aufirst%3DO.%26aulast%3DAhlman%26aufirst%3DH.%26atitle%3DAntitumoural%2520effects%2520of%2520the%2520pyridyl%2520cyanoguanidine%2520CHS%2520828%2520on%2520three%2520different%2520types%2520of%2520neuroendocrine%2520tumours%2520xenografted%2520to%2520nude%2520mice%26jtitle%3DNeuroendocrinology%26date%3D2005%26volume%3D82%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauparlant, P.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">â</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.-O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Bergerauthor=M.+Mitchellauthor=G.+C.+Shoreauthor=P.+Beauparlant&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0lhCG19FHQJ3Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.-O.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DShore%26aufirst%3DG.%2BC.%26aulast%3DBeauparlant%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choi, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, C. K.</span><span> </span><span class="NLM_article-title">KR-31378, a potassium-channel opener, induces the protection of retinal ganglion cells in rat retinal ischemic models</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">â</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1254%2Fjphs.FP0072067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19372634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSgurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=511-517&author=A+Choiauthor=J.-S.+Choiauthor=Y.-J.+Yoonauthor=K.-A.+Kimauthor=C.+K.+Joo&title=KR-31378%2C+a+potassium-channel+opener%2C+induces+the+protection+of+retinal+ganglion+cells+in+rat+retinal+ischemic+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162aR"><div class="casContent"><span class="casTitleNuber">162a</span><div class="casTitle"><span class="NLM_cas:atitle">KR-31378, a potassium-channel opener, induces the protection of retinal ganglion cells in rat retinal ischemic models</span></div><div class="casAuthors">Choi, Anho; Choi, Jun-Sub; Yoon, Yone-Jung; Kim, Kyung-A.; Joo, Choun-Ki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">KR-31378 is a newly developed KATP-channel opener.  To investigate the ability of KR-31378 to protect retinal ganglion cells (RGC), expts. were conducted using two retinal ischemia models.  Retinal ischemia was induced by transient high intraocular pressure (IOP) for acute ischemia and by three episcleral vein occlusion for chronic retinal ischemia.  KR-31378 was injected i.p. and administered orally in the acute and chronic ischemia models, resp.  Under the condition of chronic ischemia, RGC d. in the KR-31378-treated group was statistically higher than that in the non-treated group, and IOP was reduced.  In the acute retinal ischemia model, 90% of RGC were degenerated after one week in non-treated retina, but, RGC in KR-31378-treated retina were protected from ischemic damage in a dose-dependent manner and showed inhibited glial fibrillary acidic protein (GFAP) expression.  Furthermore, the KR-31378 protective effect was inhibited by glibenclamide treatment in acute ischemia.  These findings indicate that systemic KR-31378 treatment may protect against ischemic injury-induced ganglion cell loss in glaucoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnmAoVbiyex7Vg90H21EOLACvtfcHk0lhCG19FHQJ3Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSgurg%253D&md5=c97cebbce36aa58dc26bb7bb66bd2e95</span></div><a href="/servlet/linkout?suffix=cit162a&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0072067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0072067%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DA%26aulast%3DChoi%26aufirst%3DJ.-S.%26aulast%3DYoon%26aufirst%3DY.-J.%26aulast%3DKim%26aufirst%3DK.-A.%26aulast%3DJoo%26aufirst%3DC.%2BK.%26atitle%3DKR-31378%252C%2520a%2520potassium-channel%2520opener%252C%2520induces%2520the%2520protection%2520of%2520retinal%2520ganglion%2520cells%2520in%2520rat%2520retinal%2520ischemic%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D109%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit162b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jeong, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji-Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun-Ok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eun, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suk, L. H.</span><span> </span><span class="NLM_article-title">Effects of a new neuroprotective agent KR-31378 on liver cytochrome P450s in male Sprague Dawley rats</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">â</span> <span class="NLM_lpage">804</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1007%2FBF02980023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=14609126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVGiurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=800-804&author=T.+C.+Jeongauthor=J.+Ji-Youngauthor=J.+H.+Youngauthor=L.+D.+Haauthor=K.+Sun-Okauthor=L.+Hongauthor=Y.+S.+Eunauthor=L.+H.+Suk&title=Effects+of+a+new+neuroprotective+agent+KR-31378+on+liver+cytochrome+P450s+in+male+Sprague+Dawley+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162bR"><div class="casContent"><span class="casTitleNuber">162b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a new neuroprotective agent KR-31378 on liver cytochrome P450s in male Sprague Dawley rats</span></div><div class="casAuthors">Jeong, Tae Cheon; Kim, Ji-young; Ji, Hye Young; Lee, Dong Ha; Kim, Sun-ok; Lim, Hong; Yoo, Sung Eun; Lee, Hye Suk</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">800-804</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">The effects of KR-31378, a neuroprotective agent for ischemia-reperfusion damage, on liver microsomal cytochrome P450s (CYPs) were investigated in male Sprague Dawley rats.  When rats were treated orally with KR-31378 for 7 consecutive days, CYP3A-selective erythromycin N-demethylase (ERDM) activity was significantly induced in a dose-dependent manner.  In Western immunoblotting, CYP3A proteins were clearly induced by treatment with KR-31378.  Within 24 h after treatment with 80 mg/kg of KR-31378, ERDM activity was induced in liver microsomes in accompanied by induction of the level of CYP3A proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb-fX8UN1dVrVg90H21EOLACvtfcHk0lhCG19FHQJ3Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVGiurk%253D&md5=5fd08c4d3f6ae163cfdaf85055132489</span></div><a href="/servlet/linkout?suffix=cit162b&amp;dbid=16384&amp;doi=10.1007%2FBF02980023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02980023%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DT.%2BC.%26aulast%3DJi-Young%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DJ.%2BH.%26aulast%3DHa%26aufirst%3DL.%2BD.%26aulast%3DSun-Ok%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DEun%26aufirst%3DY.%2BS.%26aulast%3DSuk%26aufirst%3DL.%2BH.%26atitle%3DEffects%2520of%2520a%2520new%2520neuroprotective%2520agent%2520KR-31378%2520on%2520liver%2520cytochrome%2520P450s%2520in%2520male%2520Sprague%2520Dawley%2520rats%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2003%26volume%3D26%26spage%3D800%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Khun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, P.</span><span> </span><span class="NLM_article-title">Molecular recognition of ligands in dipeptidyl peptidase IV</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">â</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163a&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802607780091064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163a&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17352681" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=609-619&author=B.+Khunauthor=M.+Hennigauthor=P.+Mattei&title=Molecular+recognition+of+ligands+in+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163a&amp;dbid=16384&amp;doi=10.2174%2F156802607780091064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091064%26sid%3Dliteratum%253Aachs%26aulast%3DKhun%26aufirst%3DB.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DMattei%26aufirst%3DP.%26atitle%3DMolecular%2520recognition%2520of%2520ligands%2520in%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D609%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit163b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">11 years of cyanopyrrolidines as DPP-IV inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">â</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163b&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802607780091000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17352679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=579-595&author=J.-U.+Peters&title=11+years+of+cyanopyrrolidines+as+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163bR"><div class="casContent"><span class="casTitleNuber">163b</span><div class="casTitle"><span class="NLM_cas:atitle">11 years of cyanopyrrolidines as DPP-IV inhibitors</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyanopyrrolidines (cyanopyrrolidides, pyrrolidine-2-nitriles, prolinenitriles) as inhibitors of the serine protease dipeptidyl peptidase IV (DPP-IV, DP IV, CD26, EC 3.4.14.5) were first reported in 1995.  The interest in this compd. class grew immensely when DPP-IV was discovered as a target for the treatment of type 2 diabetes.  The research on cyanopyrrolidines cumulated in the discoveries of vildagliptin (LAF237, NVP-LAF237) and saxagliptin (BMS-477118).  These compds. entered Phase III clin. trials in 2004 and 2005, resp., and an application for market approval has been filed for vildagliptin in 2006.  Today cyanopyrrolidines are, as judged by the nos. of patent applications, the most prominent of several series of DPP-IV inhibitors, and have the potential to become valuable medicines for type 2 diabetes in the near future.  This review summarizes some historical aspects of the discovery of cyanopyrrolidine DPP-IV inhibitors, and then focuses mainly on structure-activity-relationships, the evolution of different subseries, the possibilities to improve on the chem. instability that is assocd. with this compd. class, and on the discoveries of vildagliptin and saxagliptin.  Within this context, the properties of individual compds. and results from biol. studies are discussed.  The rationale of DPP-IV inhibition, clin. data, and the relevance of selectivity over related proteases are extensively reviewed in other contributions to this issue of Curr.  Top. Med. Chem., and are therefore only very briefly touched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMheLlajHi0LVg90H21EOLACvtfcHk0lgwb0lMT0HxGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D&md5=1aed687f83d3d35a2a581956ce4b82e0</span></div><a href="/servlet/linkout?suffix=cit163b&amp;dbid=16384&amp;doi=10.2174%2F156802607780091000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091000%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3D11%2520years%2520of%2520cyanopyrrolidines%2520as%2520DPP-IV%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit163c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninan, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kervinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neeper, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayoumy, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebert, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, K. J.</span><span> </span><span class="NLM_article-title">Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">â</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=123-128&author=L.+Qiaoauthor=C.+A.+Baumannauthor=C.+S.+Cryslerauthor=N.+S.+Ninanauthor=M.+C.+Abadauthor=J.+C.+Spurlinoauthor=R.+L.+DesJarlaisauthor=J.+Kervinenauthor=M.+P.+Neeperauthor=S.+S.+Bayoumyauthor=R.+Williamsauthor=I.+C.+Deckmanauthor=M.+Dasguptaauthor=R.+L.+Reedauthor=N.+D.+Huebertauthor=B.+E.+Tomczukauthor=K.+J.+Moriarty&title=Discovery%2C+SAR%2C+and+X-ray+structure+of+novel+biaryl-based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DC.%2BA.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DNinan%26aufirst%3DN.%2BS.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DKervinen%26aufirst%3DJ.%26aulast%3DNeeper%26aufirst%3DM.%2BP.%26aulast%3DBayoumy%26aufirst%3DS.%2BS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DReed%26aufirst%3DR.%2BL.%26aulast%3DHuebert%26aufirst%3DN.%2BD.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMoriarty%26aufirst%3DK.%2BJ.%26atitle%3DDiscovery%252C%2520SAR%252C%2520and%2520X-ray%2520structure%2520of%2520novel%2520biaryl-based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D123%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit163d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hughes, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villhauer, E. B.</span><span> </span><span class="NLM_article-title">NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">11597</span><span class="NLM_x">â</span> <span class="NLM_lpage">11603</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi990852f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=11597-11603&author=T.+E.+Hughesauthor=M.+D.+Moneauthor=M.+E.+Russellauthor=S.+C.+Weldonauthor=E.+B.+Villhauer&title=NVP-DPP728+%281-%5B%5B%5B2-%5B%285-cyanopyridin-2-yl%29amino%5Dethyl%5Damino%5Dacetyl%5D-2-cyano-%28S%29-pyrrolidine%29%2C+a+slow-binding+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163d&amp;dbid=16384&amp;doi=10.1021%2Fbi990852f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990852f%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DT.%2BE.%26aulast%3DMone%26aufirst%3DM.%2BD.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DWeldon%26aufirst%3DS.%2BC.%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26atitle%3DNVP-DPP728%2520%25281-%255B%255B%255B2-%255B%25285-cyanopyridin-2-yl%2529amino%255Dethyl%255Damino%255Dacetyl%255D-2-cyano-%2528S%2529-pyrrolidine%2529%252C%2520a%2520slow-binding%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D11597%26epage%3D11603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Saxagliptin</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">â</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2103-2114&author=S.+Dhillonauthor=J.+Weber&title=Saxagliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DSaxagliptin%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D2103%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit164b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Deacon, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span> </span><span class="NLM_article-title">Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Adv. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">â</span> <span class="NLM_lpage">499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=488-499&author=C.+F.+Deaconauthor=J.+J.+Holst&title=Saxagliptin%3A+a+new+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26atitle%3DSaxagliptin%253A%2520a%2520new%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DAdv.%2520Ther.%26date%3D2009%26volume%3D26%26spage%3D488%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johnson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braceras, R.</span><span> </span><span class="NLM_article-title">An update of recent trials with vildagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165a&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyhtbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=235-243&author=J.+T.+Johnsonauthor=K.+L.+Goldenauthor=R.+Braceras&title=An+update+of+recent+trials+with+vildagliptin%2C+a+dipeptidyl+peptidase-4+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165aR"><div class="casContent"><span class="casTitleNuber">165a</span><div class="casTitle"><span class="NLM_cas:atitle">An update of recent trials with vildagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Johnson, John T.; Golden, Kish L.; Braceras, Rogelio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy Technology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-243</span>CODEN:
                <span class="NLM_cas:coden">JPTEEB</span>;
        ISSN:<span class="NLM_cas:issn">8755-1225</span>.
    
            (<span class="NLM_cas:orgname">Harvey Whitney Books Co.</span>)
        </div><div class="casAbstract">Objective: To review the clin. efficacy and tolerability of vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, for the treatment of type 2 diabetes, based on recent Phase 3 trials.  Data Sources: Primary literature and review articles were obtained via a MEDLINE search (2005-Nov. 2007) using the search terms diabetes, vildagliptin, and LAF-237.  Addnl. data from abstrs. presented at clin. meetings were included when appropriate.  Study Selection: Nine double-blind, randomized, multicenter, parallel-group trials and vildagliptin studies were identified and reviewed.  Data Synthesis: Vildagliptin, a selective DPP-4 inhibitor, has been shown to produce clin. significant redns. in Hb A1c (A1C) levels when used as monotherapy (0.6-1%) or in combination with other glucose-lowering agents (mean decrease 0.7%).  Phase 3 trials indicated a 24- to 52-wk sustained effect on redn. of blood glucose in patients with type 2 diabetes.  The primary endpoint for all trials was change from baseline A1C.  In the intent-to-treat population, baseline A1C was compared with end-of-study A1C.  More than 2,500 patients with type 2 diabetes enrolled in monotherapy trials; an addnl. 2,119 participated in combination therapy trials.  Males outnumbered females, and all groups included obese patients.  The most common adverse effects reported were nasopharyngitis, headache, and dizziness.  Vildagliptin was wt.-neutral and produced a rate of hypoglycemia similar to that of placebo.  Conclusions: Vildagliptin appears to be a promising agent for the management of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_h6CxIJ0UbVg90H21EOLACvtfcHk0lhbaM9cWLSMnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyhtbbI&md5=e0812ff082b196d848ad54fab339f25f</span></div><a href="/servlet/linkout?suffix=cit165a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BT.%26aulast%3DGolden%26aufirst%3DK.%2BL.%26aulast%3DBraceras%26aufirst%3DR.%26atitle%3DAn%2520update%2520of%2520recent%2520trials%2520with%2520vildagliptin%252C%2520a%2520dipeptidyl%2520peptidase-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Pharm.%2520Technol.%26date%3D2009%26volume%3D25%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit165b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mathieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrande, E.</span><span> </span><span class="NLM_article-title">Vildagliptin: a new oral treatment for type 2 diabetes mellitus</span> <span class="citation_source-journal">Vasc. Health Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">â</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165b&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=19337548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlWgt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1349-1360&author=C.+Mathieuauthor=E.+Degrande&title=Vildagliptin%3A+a+new+oral+treatment+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165bR"><div class="casContent"><span class="casTitleNuber">165b</span><div class="casTitle"><span class="NLM_cas:atitle">Vildagliptin: a new oral treatment for type 2 diabetes mellitus</span></div><div class="casAuthors">Mathieu, Chantal; Degrande, Evy</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1349-1360</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1178-2048</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Vildagliptin is a new oral antidiabetic agent that enhances pancreatic islet cell responsiveness to glucose.  An extensive clin. program involving approx. 22,000 patients and 7000 patient-years of exposure to vildagliptin has shown that the agent is well tolerated and efficacious in improving glycemic control in patients with type 2 diabetes mellitus (T2DM).  Monotherapy trials have shown that significant HbA1c lowering is accompanied by body wt.-neutral and lipid-neutral effects, low risk of edema, and low risk of hypoglycemia.  These characteristics make vildagliptin a favorable partner for combination therapy.  Studies of vildagliptin as an add-on to metformin have shown significant improvements in glycemic control (comparable to that of thiazolidinedione add-on), with the combination being well tolerated and assocd. with low risks for hypoglycemia and adverse effects on wt. or lipid levels.  Good tolerability and clin. relevant improvements in glycemic control have also been obsd. with vildagliptin as an add-on treatment to sulfonylurea, thiazolidinedione, or insulin treatment or in initial combination treatment with pioglitazone.  Improved Î²-cell function and glycemic control have been shown with vildagliptin in subjects with impaired glucose tolerance and in T2DM patients with mild hyperglycemia, with some evidence in the latter suggesting the potential for modifying disease course.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQeNzdA5tYLVg90H21EOLACvtfcHk0lhbaM9cWLSMnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlWgt70%253D&md5=6f1e386644333e07493a3058d213ca68</span></div><a href="/servlet/linkout?suffix=cit165b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DC.%26aulast%3DDegrande%26aufirst%3DE.%26atitle%3DVildagliptin%253A%2520a%2520new%2520oral%2520treatment%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DVasc.%2520Health%2520Risk%2520Manage.%26date%3D2008%26volume%3D4%26spage%3D1349%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Willand, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesquiere, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhibitor NVP-DPP728</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5741</span><span class="NLM_x">â</span> <span class="NLM_lpage">5746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5741-5746&author=N.+Willandauthor=J.+Joossensauthor=J.-C.+Gesquiereauthor=A.+L.+Tartarauthor=D.+M.+Evansauthor=M.+B.+Roe&title=Solid+and+solution+phase+syntheses+of+the+2-cyanopyrrolidide+DPP-IV+inhibitor+NVP-DPP728"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilland%26aufirst%3DN.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DGesquiere%26aufirst%3DJ.-C.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DSolid%2520and%2520solution%2520phase%2520syntheses%2520of%2520the%25202-cyanopyrrolidide%2520DPP-IV%2520inhibitor%2520NVP-DPP728%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5741%26epage%3D5746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span> </span><span class="NLM_article-title">Molecular recognition of proteinâligand complexes: applications to drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">â</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr960370z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=1359-1472&author=R.+E.+Babineauthor=S.+L.+Bender&title=Molecular+recognition+of+protein%E2%88%92ligand+complexes%3A+applications+to+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fcr960370z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr960370z%26sid%3Dliteratum%253Aachs%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DBender%26aufirst%3DS.%2BL.%26atitle%3DMolecular%2520recognition%2520of%2520protein%25E2%2588%2592ligand%2520complexes%253A%2520applications%2520to%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D1359%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Loeser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimmig, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetschow, M.</span><span> </span><span class="NLM_article-title">Interaction of papain-like cysteine proteases with dipeptide-derived nitriles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7688</span><span class="NLM_x">â</span> <span class="NLM_lpage">7707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7688-7707&author=R.+Loeserauthor=K.+Schillingauthor=E.+Dimmigauthor=M.+Guetschow&title=Interaction+of+papain-like+cysteine+proteases+with+dipeptide-derived+nitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoeser%26aufirst%3DR.%26aulast%3DSchilling%26aufirst%3DK.%26aulast%3DDimmig%26aufirst%3DE.%26aulast%3DGuetschow%26aufirst%3DM.%26atitle%3DInteraction%2520of%2520papain-like%2520cysteine%2520proteases%2520with%2520dipeptide-derived%2520nitriles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7688%26epage%3D7707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Metzler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanchunas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span> </span><span class="NLM_article-title">Involvement of DPP-IV catalytic residues in enzymeâsaxagliptin complex formation</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">â</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1110%2Fps.073253208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18227430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=240-250&author=W.+J.+Metzlerauthor=J.+Yanchunasauthor=C.+Weigeltauthor=K.+Kishauthor=H.+E.+Kleiauthor=D.+Xieauthor=Y.+Zhangauthor=M.+Corbettauthor=J.+K.+Tamuraauthor=B.+Heauthor=L.+G.+Hamannauthor=M.+S.+Kirbyauthor=J.+Marcinkeviciene&title=Involvement+of+DPP-IV+catalytic+residues+in+enzyme%E2%88%92saxagliptin+complex+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation</span></div><div class="casAuthors">Metzler, William J.; Yanchunas, Joseph; Weigelt, Carolyn; Kish, Kevin; Klei, Herbert E.; Xie, Dianlin; Zhang, Yaqun; Corbett, Martin; Tamura, James K.; He, Bin; Hamann, Lawrence G.; Kirby, Mark S.; Marcinkeviciene, Jovita</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-250</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The inhibition of DPP-IV by saxagliptin has been proposed to occur through formation of a covalent but reversible complex.  To evaluate further the mechanism of inhibition, we detd. the x-ray crystal structure of the DPP-IV:saxagliptin complex.  This structure reveals covalent attachment between S630 and the inhibitor nitrile carbon (C-O distance <1.3 Ã).  To investigate whether this serine addn. is assisted by the catalytic His-Asp dyad, we generated two mutants of DPP-IV, S630A and H740Q, and assayed them for ability to bind inhibitor.  DPP-IVH740Q bound saxagliptin with an â¼1000-fold redn. in affinity relative to DPP-IVWT, while DPP-IVS630A showed no evidence for binding inhibitor.  An analog of saxagliptin lacking the nitrile group showed unchanged binding properties to the both mutant proteins, highlighting the essential role S630 and H740 play in covalent bond formation between S630 and saxagliptin.  Further supporting mechanism-based inhibition by saxagliptin, NMR spectra of enzyme-saxagliptin complexes revealed the presence of three downfield resonances with low fractionation factors characteristic of short and strong hydrogen bonds (SSHB).  Comparison of the NMR spectra of various wild-type and mutant DPP-IV:ligand complexes enabled assignment of a resonance at â¼14 ppm to H740.  Two addnl. DPP-IV mutants, Y547F and Y547Q, generated to probe potential stabilization of the enzyme-inhibitor complex by this residue, did not show any differences in inhibitor binding either by ITC or NMR.  Together with the previously published enzymic data, the structural and binding data presented here strongly support a histidine-assisted covalent bond formation between S630 hydroxyl oxygen and the nitrile group of saxagliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JzGRDJ1J7rVg90H21EOLACvtfcHk0lipJAQmAS5tcw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D&md5=d76619e8d6843e595a5bc971191a4828</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1110%2Fps.073253208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.073253208%26sid%3Dliteratum%253Aachs%26aulast%3DMetzler%26aufirst%3DW.%2BJ.%26aulast%3DYanchunas%26aufirst%3DJ.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCorbett%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DJ.%2BK.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26atitle%3DInvolvement%2520of%2520DPP-IV%2520catalytic%2520residues%2520in%2520enzyme%25E2%2588%2592saxagliptin%2520complex%2520formation%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D240%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschenes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percivala, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeaua, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ThÃ©riena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective non-basic cathepsin K inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1985</span><span class="NLM_x">â</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2005.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=16413777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1985-1989&author=C.+S.+Liauthor=D.+Deschenesauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=J.+Y.+Gauthierauthor=D.+B.+Kimmelauthor=S.+Legerauthor=F.+Masseauthor=M.+E.+McGrathauthor=D.+J.+McKayauthor=M.+D.+Percivalaauthor=D.+Riendeauaauthor=S.+B.+Rodanauthor=M.+Th%C3%A9rienaauthor=V.+L.+Truongauthor=G.+Wesolowskiauthor=R.+Zamboniauthor=W.+C.+Black&title=Identification+of+a+potent+and+selective+non-basic+cathepsin+K+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent and selective non-basic cathepsin K inhibitor</span></div><div class="casAuthors">Li, Chun Sing; Deschenes, Denis; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Gauthier, Jacques Yves; Kimmel, Donald. B.; Leger, Serge; Masse, Frederic; McGrath, Mary E.; McKay, Daniel J.; Percival, M. David; Riendeau, Denis; Rodan, Sevgi B.; Therien, Michel; Truong, Vouy-Linh; Wesolowski, Gregg; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1985-1989</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous study with trifluoroethylamine as a P2-P3 amide isostere of cathepsin K inhibitor, further optimization led to identification of L-873724 (I) as a potent and selective non-basic cathepsin K inhibitor.  This compd. showed excellent pharmacokinetics and efficacy in an ovariectomized (OVX) rhesus monkey model.  The vols. of distribution close to unity were consistent with this compd. not being lysosomotropic, which is a characteristic of basic cathepsin K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVLlTt9kYhrVg90H21EOLACvtfcHk0lipJAQmAS5tcw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D&md5=e63e471204893774e5a617993ed9be18</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DDeschenes%26aufirst%3DD.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPercivala%26aufirst%3DM.%2BD.%26aulast%3DRiendeaua%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DTh%25C3%25A9riena%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520non-basic%2520cathepsin%2520K%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1985%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, Le T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lia, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MassÃ©a, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmerc, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ThÃ©rien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">â</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=Le+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liaauthor=F.+Mass%C3%A9aauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmercauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Th%C3%A9rienauthor=V.+L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lgq2gkk0aUzkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DLe%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLia%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9a%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmerc%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Opar, A.</span><span> </span><span class="NLM_article-title">Late-stage osteoporosis drugs illustrate challenges in the field</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">â</span> <span class="NLM_lpage">759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=757-759&author=A.+Opar&title=Late-stage+osteoporosis+drugs+illustrate+challenges+in+the+field"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOpar%26aufirst%3DA.%26atitle%3DLate-stage%2520osteoporosis%2520drugs%2520illustrate%2520challenges%2520in%2520the%2520field%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D757%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Frizler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirnberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisay, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetschow, M.</span><span> </span><span class="NLM_article-title">Development of nitrile-based peptidic inhibitors of cysteine cathepsins</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">â</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.2174%2F156802610790725452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=20166952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=294-322&author=M.+Frizlerauthor=M.+Stirnbergauthor=M.+T.+Sisayauthor=M.+Guetschow&title=Development+of+nitrile-based+peptidic+inhibitors+of+cysteine+cathepsins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Development of nitrile-based peptidic inhibitors of cysteine cathepsins</span></div><div class="casAuthors">Frizler, Maxim; Stirnberg, Marit; Sisay, Mihiret Tekeste; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-322</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now becoming clear that several papain-like cysteine cathepsins are involved in the pathophysiol. of diseases such as osteoporosis, autoimmune disorders, and cancer.  Therefore, the development of potent and selective cathepsin inhibitors is an attractive subject for medicinal chemists.  New advances have been made for nitrile-based inhibitors, leading to the identification of the cathepsin K inhibitor odanacatib and other candidates with potential for therapeutic use.  This review summarizes the development of peptidic and peptidomimetic compds. with an electrophilic nitrile 'warhead' as inhibitors of the cysteine cathepsins B, S, L, C, and K.  Peptide nitriles have been shown to reversibly react with the active site cysteine under formation of a covalent thioimidate adduct.  The structural optimization with respect to the positions P3, P2, P1, P1', and P2' resulted in the identification of potent and selective inhibitors of the corresponding cathepsins.  The underlying structure-activity relationships are discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV5N3L7sVS7Vg90H21EOLACvtfcHk0lgq2gkk0aUzkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1entL8%253D&md5=8b0004f6aca64540b7f206ecc8527ff4</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.2174%2F156802610790725452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725452%26sid%3Dliteratum%253Aachs%26aulast%3DFrizler%26aufirst%3DM.%26aulast%3DStirnberg%26aufirst%3DM.%26aulast%3DSisay%26aufirst%3DM.%2BT.%26aulast%3DGuetschow%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520nitrile-based%2520peptidic%2520inhibitors%2520of%2520cysteine%2520cathepsins%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2010%26volume%3D10%26spage%3D294%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Ward, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekkali, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giradot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrapchak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeTuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spero, D. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">â</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020209i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5471-5482&author=Y.+D.+Wardauthor=D.+S.+Thomsonauthor=L.+L.+Fryeauthor=C.+L.+Cywinauthor=T.+Morwickauthor=M.+J.+Emmanuelauthor=R.+Zindellauthor=D.+McNeilauthor=Y.+Bekkaliauthor=M.+Giradotauthor=M.+Hrapchakauthor=M.+DeTuriauthor=K.+Craneauthor=D.+Whiteauthor=S.+Pavauthor=Y.+Wangauthor=M.-H.+Haoauthor=C.+A.+Grygonauthor=M.+E.+Labadiaauthor=D.+M.+Freemanauthor=W.+Davidsonauthor=J.+L.+Hopkinsauthor=M.+L.+Brownauthor=D.+M.+Spero&title=Design+and+synthesis+of+dipeptide+nitriles+as+reversible+and+potent+cathepsin+S+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fjm020209i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020209i%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DY.%2BD.%26aulast%3DThomson%26aufirst%3DD.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DEmmanuel%26aufirst%3DM.%2BJ.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DMcNeil%26aufirst%3DD.%26aulast%3DBekkali%26aufirst%3DY.%26aulast%3DGiradot%26aufirst%3DM.%26aulast%3DHrapchak%26aufirst%3DM.%26aulast%3DDeTuri%26aufirst%3DM.%26aulast%3DCrane%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DM.-H.%26aulast%3DGrygon%26aufirst%3DC.%2BA.%26aulast%3DLabadia%26aufirst%3DM.%2BE.%26aulast%3DFreeman%26aufirst%3DD.%2BM.%26aulast%3DDavidson%26aufirst%3DW.%26aulast%3DHopkins%26aufirst%3DJ.%2BL.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DSpero%26aufirst%3DD.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dipeptide%2520nitriles%2520as%2520reversible%2520and%2520potent%2520cathepsin%2520S%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5471%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duraiswami, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graybill, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygielko, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. K.</span><span> </span><span class="NLM_article-title">2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2â²,3â²:4,5]thieno[2,3-<i>b</i>]pyridine derivatives as selective progesterone receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4916</span><span class="NLM_x">â</span> <span class="NLM_lpage">4919</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4916-4919&author=Y.+Wangauthor=C.+Duraiswamiauthor=K.+P.+Madaussauthor=T.+B.+Tranauthor=S.+P.+Williamsauthor=S.-J.+Dengauthor=T.+L.+Graybillauthor=M.+Hammondauthor=D.+G.+Jonesauthor=E.+T.+Grygielkoauthor=J.+D.+Brayauthor=S.+K.+Thompson&title=2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6%2C7%2C8%2C9-tetrahydropyrido%5B2%E2%80%B2%2C3%E2%80%B2%3A4%2C5%5Dthieno%5B2%2C3-b%5Dpyridine+derivatives+as+selective+progesterone+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDuraiswami%26aufirst%3DC.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DTran%26aufirst%3DT.%2BB.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DDeng%26aufirst%3DS.-J.%26aulast%3DGraybill%26aufirst%3DT.%2BL.%26aulast%3DHammond%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DD.%2BG.%26aulast%3DGrygielko%26aufirst%3DE.%2BT.%26aulast%3DBray%26aufirst%3DJ.%2BD.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26atitle%3D2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6%252C7%252C8%252C9-tetrahydropyrido%255B2%25E2%2580%25B2%252C3%25E2%2580%25B2%253A4%252C5%255Dthieno%255B2%252C3-b%255Dpyridine%2520derivatives%2520as%2520selective%2520progesterone%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4916%26epage%3D4919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Chen, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C. N.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis and anticancer activities of new podophyllotoxin derivatives: 4-Î²-cyano-4-deoxy-4â²-demethylepipodophyllotoxin and 4-Î²-carboxyl-4-deoxy-4â²-demethylepipodophyllotoxin</span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">â</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltV2ls7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=505-508&author=Z.+X.+Chenauthor=W.+Y.+Maauthor=C.+N.+Zhang&title=Stereoselective+synthesis+and+anticancer+activities+of+new+podophyllotoxin+derivatives%3A+4-%CE%B2-cyano-4-deoxy-4%E2%80%B2-demethylepipodophyllotoxin+and+4-%CE%B2-carboxyl-4-deoxy-4%E2%80%B2-demethylepipodophyllotoxin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis and anticancer activities of new podophyllotoxin derivatives: 4-Î²-cyano-4-deoxy-4'-demethylepipodophyllotoxin and 4-Î²-carboxyl-4-deoxy-4'-demethylepipodophyllotoxin</span></div><div class="casAuthors">Chen, Zai Xin; Ma, Wei Yong; Zhang, Chun Nian</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">505-508</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Chinese Chemical Society</span>)
        </div><div class="casAbstract">4Î²-Cyano-4-deoxy-4'-demethylepipodophyllotoxin I (R = CN) was synthesized from 4'-demethylepipodophyllotoxin I (R = OH) and Me3SiCN in the presence of BF3Â·Et2O.  4Î²-Carboxyl-4-deoxy-4'-demethylepipodophyllotoxin I (R = CO2H) was obtained by hydrolyzing I (R = CN) in acetic acid and HCl.  Both of the new podophyllotoxin derivs. showed very high anticancer activities against L1210, and KB cell lines in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr92sO68ziBB7Vg90H21EOLACvtfcHk0lj2XS1eHaTa_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltV2ls7s%253D&md5=095cffd33d1b11cd07913a07e3f78c27</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%2BX.%26aulast%3DMa%26aufirst%3DW.%2BY.%26aulast%3DZhang%26aufirst%3DC.%2BN.%26atitle%3DStereoselective%2520synthesis%2520and%2520anticancer%2520activities%2520of%2520new%2520podophyllotoxin%2520derivatives%253A%25204-%25CE%25B2-cyano-4-deoxy-4%25E2%2580%25B2-demethylepipodophyllotoxin%2520and%25204-%25CE%25B2-carboxyl-4-deoxy-4%25E2%2580%25B2-demethylepipodophyllotoxin%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D11%26spage%3D505%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Nogrady, T.; Weaver, D. F.</span> <span class="citation_source-book">Medicinal Chemistry: A Molecular and Biochemical Approach</span>; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">22</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=22&author=T.+Nogrady&author=D.+F.+Weaver&title=Medicinal+Chemistry%3A+A+Molecular+and+Biochemical+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNogrady%26aufirst%3DT.%26btitle%3DMedicinal%2520Chemistry%253A%2520A%2520Molecular%2520and%2520Biochemical%2520Approach%26pub%3DOxford%2520University%2520Press%26date%3D2005%26spage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="note"><p class="first last">ADME is an common acronym describing the pharamacokinetics and pharmacology of an active pharmaceutical ingredient within an organism: absorption, distribution, metabolism, and excretion.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lj2XS1eHaTa_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">KeserÃ¼, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">â</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C3%BCauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit180b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D. J.</span><span> </span><span class="NLM_article-title">Is there a difference between leads and drugs? A historical perspective</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">â</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci010366a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180b&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1308-1315&author=T.+I.+Opreaauthor=A.+M.+Davisauthor=S.+J.+Teagueauthor=P.+D.+J.+Leeson&title=Is+there+a+difference+between+leads+and+drugs%3F+A+historical+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180bR"><div class="casContent"><span class="casTitleNuber">180b</span><div class="casTitle"><span class="NLM_cas:atitle">Is There a Difference between Leads and Drugs? A Historical Perspective</span></div><div class="casAuthors">Oprea, Tudor I.; Davis, Andrew M.; Teague, Simon J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To be considered for further development, lead structures should display the following properties: (1) simple chem. features, amenable for chem. optimization; (2) membership to an established SAR series; (3) favorable patent situation; and (4) good absorption, distribution, metab., and excretion (ADME) properties.  There are two distinct categories of leads: those that lack any therapeutic use (i.e., "pure" leads), and those that are marketed drugs themselves but have been altered to yield novel drugs.  We have previously analyzed the design of leadlike combinatorial libraries starting from 18 lead and drug pairs of structures (S. J. Teague et al. Angew. Chem., Int. Ed. Engl. 1999, 38, 3743-3748).  Here, we report results based on an extended dataset of 96 lead-drug pairs, of which 62 are lead structures that are not marketed as drugs, and 75 are drugs that are not presumably used as leads.  We examd. the following properties: MW (mol. wt.), CMR (the calcd. mol. refractivity), RNG (the no. of rings), RTB (the no. of rotatable bonds), the no. of hydrogen bond donors (HDO) and acceptors (HAC), the calcd. logarithm of the n-octanol/water partition (CLogP), the calcd. logarithm of the distribution coeff. at pH 7.4 (LogD74), the Daylight-fingerprint druglike score (DFPS), and the property and pharmacophore features score (PPFS).  The following differences were obsd. between the medians of drugs and leads: ÎMW = 69; ÎCMR = 1.8; ÎRNG = ÎHAC =1; ÎRTB = 2; ÎCLogP = 0.43; ÎLogD74 = 0.97; ÎHDO = 0; ÎDFPS = 0.15; ÎPPFS = 0.12.  Lead structures exhibit, on the av., less mol. complexity (less MW, less no. of rings and rotatable bonds), are less hydrophobic (lower CLogP and LogD74), and less druglike (lower druglike scores).  These findings indicate that the process of optimizing a lead into a drug results in more complex structures.  This information should be used in the design of novel combinatorial libraries that are aimed at lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4E0R8n7tLrVg90H21EOLACvtfcHk0liNsM1KBzixKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D&md5=422b9cf937168d9c2f3d1c8429648ea0</span></div><a href="/servlet/linkout?suffix=cit180b&amp;dbid=16384&amp;doi=10.1021%2Fci010366a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010366a%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DIs%2520there%2520a%2520difference%2520between%2520leads%2520and%2520drugs%253F%2520A%2520historical%2520perspective%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D1308%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="note"><p class="first last">The term logâ<i>P</i> is the ratio of an un-ionized drug distributed between octanol and water phases at equilibrium. High logâ<i>P</i> ratios correlate with increased lipophilicity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="note"><p class="first last">The term logâ<i>D</i> is the 1-octanolâwater coefficient at different pH values.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm100762r&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm100762r&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm100762r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0liNsM1KBzixKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100762r&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-22%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm100762r%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100762r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b1145fd8a3d36","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
